<SEC-DOCUMENT>0001396814-22-000068.txt : 20221103
<SEC-HEADER>0001396814-22-000068.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103143211
ACCESSION NUMBER:		0001396814-22-000068
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pacira BioSciences, Inc.
		CENTRAL INDEX KEY:			0001396814
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510619477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35060
		FILM NUMBER:		221357475

	BUSINESS ADDRESS:	
		STREET 1:		5401 WEST KENNEDY BOULEVARD
		STREET 2:		SUITE 890
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		813-553-6680

	MAIL ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacira Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20101029

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIRA INC
		DATE OF NAME CHANGE:	20080318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Acquisition Corp
		DATE OF NAME CHANGE:	20070418
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pcrx-20220930.htm
<DESCRIPTION>10-Q - PCRX - 9.30.2022
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8,d:bcbdf7459db64b749005ba498f2d18fe--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:pcrx="http://www.pacira.com/20220930" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pcrx-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN18zLTEtMS0xLTk4Njc0_2cd43b58-1367-4370-8bba-1594960846b1">0001396814</ix:nonNumeric><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN180LTEtMS0xLTk4Njc0_ceee02a5-5b68-4734-9c9e-7d9567cac98a">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN182LTEtMS0xLTk4Njc0_b549eaef-c25b-488f-9d19-3bb3752df78a">2022</ix:nonNumeric><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN183LTEtMS0xLTk4Njc0_5d82faad-9981-461d-b65f-052b6b848bd3">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN184LTEtMS0xLTk4Njc0_4e8818bb-78e5-4d1d-a061-98d5a4791afe">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy0wLTEtMS05ODY3NA_6319c949-5d0c-4651-ba59-8ba255c6fe96">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember</ix:nonNumeric><ix:nonNumeric contextRef="i144ecb23bdc84f3ca01452f1878c55ef_D20220101-20220930" name="pcrx:AccountsReceivablePaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzMg_bfd25119-5362-4514-9063-c69b91c15797">P0D</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i95bfbbda29cb41b08ec5f11badc01723_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjcz_65afcda3-91f0-4961-9bc1-f720a8bb37a3">0.0373413</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930" decimals="INF" name="pcrx:DebtInstrumentMarketPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjY2_a601101f-a4ca-4583-91ea-8c2435ea3e6b">0.993</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5680d8d8935c48d2a766d861284f7f24_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjU2_8c426b83-c692-40ff-a051-71d0acb10bbc">.0139324</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pcrx-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cb9b12dd08b4498ad442b10cdd5b751_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ic44364ce38c044838833d136327e1683_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iaf5db5136edb4258bb25992f7a708439_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b07e519ec647d98d89e6ff41f57c17_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296396fbc9e84eba9ec04154af9e9c1e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5fa65067bcc41bebdf6822950026442_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad8f81f091924fc3a4edff3d54a6825d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i651ac2daa5d14c668a7fe9f65787fa0b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7048adc212324bc0b035c0020bd464ce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd81ae54732c47849b986c561fdfa792_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbfb9a42fd243c890be52ee0d74fd8f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66278c6f4cce4fd2ad08c5c059665f38_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869d18b1d1484493b15aac75f097bce8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01926f9c07cb4651b749c885c0a99ef8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54aab0893c1f40f491d1e7a3b7a97718_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc550af62b504ae58f1e161f47a65942_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1472000d14eb451bb7a3794aff155744_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c26ed78e9b4b63aed76cbf74cf8f4a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba08fe64fae4c57bf8911a0904d2df9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i017393d821a848799eb138394bd7839e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9287e79f6d44d568cf917866e4551b3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd43125dbda74778b63a9be02be0a13c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9791b8fe7b3a4f12800eef3e3a5c6bf6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf819b6879b403cafbbce9b6339e7b0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1421c3f2c2d74fd99b18bfdda0e895a0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae46cd944c6d419186595743d38a8f81_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa66a357a47d49b68b18893d24be3af3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6d00233f14343878bcb73daec21f9e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7be9d002e9444fd18292f0d89d043d25_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e11e72269fb497ba643fca620eefeaf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic26efb05ce904daca36d5ba11271c6a9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a219071ecbb42ac9eb93d05379e1467_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1cb7d17f0c248e29e06df39baf41859_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3e655fae2f146fc934fcf31ce6ec541_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c1bd8c69f7453fb0c4b1269e35f69b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05e3b6239474b029b08b6f0046dce35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea53f33c63e42cfb873ac4aa0686769_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ca30657d70a4d3ab6e32635d54c30ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8275aa05c35d448d97c72eaa9bb0a095_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680c262defe742b6a537fb5624221e69_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia35d775120e64ebf8502bf3e34c34978_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33df00d3d4b243f9ad70111a564bd482_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd0cb764acb47c09483deef5d55ead6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib213f4e105874831a0ebdb89ae27881e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ac36a407c64570801dc9eeb4a4c82d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idad438652c2a484a8de75c3c8971bdef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3de17f0c49946a488093a9951839714_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40f13326d7884e5090d68f3d0a570ff2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b3530d8956b418fb81361eeb95b183f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i041c1e3222e444948ec64a03cb444a3e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if31c04f6a8b042bf8a5b262a586ee559_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f778c46a68241c395e54cb6cccc6e03_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada9dd15075e4cd895a69a423bad73c7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>pcrx:product</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>pcrx:segment</xbrli:measure></xbrli:unit><xbrli:context id="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id798a30004274993babf49e9b98be123_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2a7621b4bba342699674426138465e98_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491f1c40eec747d48c2a3cbf996a653f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idea3269a015844a88e20bfa8a2c5db42_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d204d59893479994e548d189f110c0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8428c526394e7b892c82c1100eae05_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785ba673e38b4971a09e28476d230f20_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40d9bb0c3093491f8fd4cc029445495a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c2f2c9bc8c54a0298a54156ff906c36_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81faa5db9ab84d9abcedc8d10f6aadd6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ee1fd141184820a1033d1e2b620500_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dcf246ea00f4772961db833e7e6c9c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc07e896b4645dfa4efb71cc229b19c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e7ecfa4c964440a2946a9bd17bcb30_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if36a483a5fae482eabe15aad4726bdf2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba56a5bf30fa44d791bf3d27fae3998c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab43b03e7f045cfa6ba5b01ccc9f663_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7066383d00444bb7d24779d5fcd386_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i144ecb23bdc84f3ca01452f1878c55ef_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b7f09cd3fa46f7bef2e7b988c8c155_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaced5e5f9bc940a892330f204dd2244f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie744a5ac2c014227987bdfeeacecae8c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b27bac4a4f40deae2b2f890f8e66b2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb8393abab9472ba432b3023d43f876_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bec708640aa4fe89373e8a8b5097698_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie304082b6d1244319404c24adf4df95d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b382af13b04dad89a0b67e8cbed57b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff9b5c1afd24751ac47466df9cf7363_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0d71636ef1a41278d664b9a58e7b14a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7b8f126963466480f241a2ea73cd74_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22145e0671d24d3192e811839a75fcc6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58db0d23a27d413abf5cf179a882a86e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ca564b922e4b24926c90284b7d52f5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774694031232442bade01c3100051d55_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b6428ad6264377b5daa3a69ab1fb5e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa17d6ce32084dc195161c9e6c47a57c_D20211119-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pcrx:RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac35326c08e44e7cb67d82dcebbcba61_I20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i083491131603445e901ef44a6b4db810_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3422a161284fd4968428139893ccc3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efbe146066f4b189710fe01037a4e39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01ba6850e6cf4817a5abb640bffde50e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabadf7b6a1224bb3916ef669ce65a34d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if230c3c362c544bea9bc5d678fd8606c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93a4a3f2486495096df65f35513637d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6aef198937e45468ba17175b8a02cbd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69260eaa59884a4b80bee5f89c48b5ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84837eb6c88478cb22b5e730913d7da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1083fc7b3c5544e99ac79b620bd148fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5850959cee0b45c5999d3d9d0ee56a23_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452f6f29fd7a4cefaf5db7fc6d5b7fcc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaea5ef1bea14e64a8f9e557b76fefec_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5ea19425754b48a8d743a2a9a4c06f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb3d023787140b4a618c948c7de865a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i933d53b6705f4e2d828a014e7a4ef1cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if677311d787345c3a160575158dda8a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>pcrx:lease</xbrli:measure></xbrli:unit><xbrli:context id="if7c59933724e48839a86397a939f4299_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f168810ed0344c59194941cdbda381d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b1660ea8f84974983336799383b47d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5538bd98f04aad8cfd55a06c19a09f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63a4085601e44fbebf50e56e2d711b28_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6afb0c5544774a4eb8b7b594661ac03b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80de923b605d461ca51c7f2b04879428_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3b5083d5dd4003b0ab03be5387f445_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f78b1e6ad44ec488026a91fa089205_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2518c182890b404d9c0847b899ec72e3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1806dce28b54192bab8601ab3c1447b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if14d12e11ebf4258a8f69637d5c05212_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f1500ac81e40438b8cf99c85734a41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9fe0493cf0469887c610902f910cc7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if98c89d2075848e490be94b7892ae381_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7972eed61fdd41bfa7003be5de760617_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0661863911fa4ee69bffbcb43e697fc9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2c21af05a4477e9c7bb7850db493fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67521500add4fed80583b1a16d61ffc_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d7be76ce2e48f592161d85a4fefa90_I20211230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ab9cb4fb474f0294e6a5ee5da125cb_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9083b4c816cc413aa9ab5d4153e040e9_D20251231-20251231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-31</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c3a50af1fd40f4bf123c711ae0554e_I20261207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-12-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>pcrx:payment</xbrli:measure></xbrli:unit><xbrli:context id="i23248a32f20143cdb17ce6c0f3073d59_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50e0fe6fa704b639d0ebd924808a630_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0685a2f4f2664048921f005c41b7445f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ff7019c657c48dc88b1a004ea06e6c4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1f16b7c4a44c2f9845617ce7eb7a49_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba3b8babde24b29a32cda10f955ab31_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pcrx:FederalReserveBankOfNYRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87421aa4628142b0b44a3829fc1f2eca_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e8761921961454aac57dbb378009c76_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e99e58b6bd44e40ab5470c217d31556_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4512c74066e24feca38c2f9325150125_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsPriorToFebruary32023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i296d96d871454ea38915dae663029fed_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d9551dea4644c58fe6c52777f083d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia37f7fd3e4cb4abda635243010c825e3_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1cf140155284958b08b2b1f0924c732_D20211206-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c781235586e428f8b7c97e2da13c07b_I20211206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9637107d21ec4490b98079479563d736_I20220107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0758a7b3ffcf4223ab706cc6d93df47d_D20170301-20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95bfbbda29cb41b08ec5f11badc01723_D20170502-20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-02</xbrli:startDate><xbrli:endDate>2017-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5680d8d8935c48d2a766d861284f7f24_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4eb1feab7a4455a8715a95b460650a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad677feff1b3471c9fc3894136f1cb76_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if395814f8be54df8ae589815c8b5ea5f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68b2cb6f7435421fb55a6eb4e5b93ba0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9990062454b491199857f28489640fe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if461dd01e8a747b98348bf5b481bc5ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5390f0263e84d2991820ff5956b0b46_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d52c9f53b64c98807e28bf9ce30a2b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i842c641ed23b47fbae6ff4979db04f5f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237dd059fd944899a066705c4dd92003_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if76389ec090e4b37a494b0f226302069_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04816a7095884e6e9859291f3a1985f6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7032c8982294d0285e1776d6d06b048_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6c853b9ab94c81b8a41af53226deb3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b0c51b1b8584e129f7c49e3e49e3733_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf9551aa20b403f82af345d31ef1338_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7601e3ac14b4439db842e414e541e541_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff74a397bde40f0a00c0186334cb04b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd4e8e0384e49248615b7e238b8f37b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if45c48f822014fffa77939a3f9445eee_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee79fc7c43e4c82a749f7a396f9b49a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if235f229d1e54baa9183a582add02676_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45972db0acf74f51a6a8fe893af05d41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c1875ee869245698fc37dffd27e30da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a2c111588354614880539cfc8ac9953_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pcrx:TELABioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib134093c2a3f489ab847df33ed43d3d9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib75b83d0d5d841d190c5b865d08cd08d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0126ce4313418d8ce64bdcbb8482ca_I20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f13ce1ab564a898d9dac5545791a08_D20211119-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f7942c168654d229d7c5f4bb6f53cff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8692b80a10c4971a257a0b3f42d44bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie699db1e7648442b83c51b5a1a49d064_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b34aaa056564bd9be196339b6471fcc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3e45d0874045948ab68adfba7d11f7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29b825b5067840dc9cd04185cca37592_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba4b68f7ebb74b26a54592d12d2be099_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac8229fdddc4b69a07f14f03a89a3a3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie856966ca92d41f78bca76f98d68d66a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e57fefd18bb42ddbe9674fd60b5a57f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a2e05d68194f6d893829de561923ae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id902659ce35844918702ed4963f48b60_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab55c6e18cd7486e97de5fe845e97e9b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6855240812b48478df36a10542449d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56063439710147d8a4fccb6b50441d1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4218e46259cf49069b7aa7ce6e397e10_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5cc90199d454f10b36d87b70479ee68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b51ea16b9440a08b69736ae59a5c23_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146ccf9c46794ec58b3fd078eac868ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54ee273867e240459470219b08af7a1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i256e4a972f804ea4afc1c0c32264da1c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f12bda689b34c1cb5adb0a61348d595_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5602cffde8af4cd59ea67824357bd7cf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ced79204c94980b9c38c4970517274_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25002d007da945f7b1fd37b64ad6fbb5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i457f0d7ed7f3471fbea7fe35bd757052_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib20bc844b2ac4123acffb7c0cf235838_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d61d593f234e0aab86db49aa1ab359_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>pcrx:customer</xbrli:measure></xbrli:unit><xbrli:context id="i44e9ad15636e471c976e2609f64d7dc1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf48d4523ea34480aebe47808748c1a3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fbc9b9c3e414c91b056f6e47ff38cff_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b779e5e08f8409f8661541db1c36b0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea427b466be34ebbba3f1a1d2684ca8b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic94fe1291d1b4789b165b90d7885e3f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae887f18bb20483e8ff30cc6ed2e8c0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7211501c213a4e7599a5684dd5be37a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82c2ca1fca444babc5bb300a97a1bc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fad952d06634849a67e5b1217dd68bf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3320bc9569d4047a853e2db8903a804_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c19447cd504d5ab3f69d4b883be660_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f98a360a3864c079bacf7afbc9066c7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc597a5032a411686eef62dd04fb5fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0138beec6b884dd68edbbf43f505701b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a40479823647ddb96d0a3dbc1e6577_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i129b1978433c487181ff9a7d935fca2a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77aee1ee825a4993985deaa770a072c4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f003f3e1a84055b8f4cfecb523624c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacde86a59c774f04b954ca896a5a70e2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e0f3d97cd74e64991c04f3f85804e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i000ca49114364850ace4c02275016d71_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i393b09d63da340a388d84a9a521340e9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705ca31dbd8c46188969e5de6c1b9bec_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i025386fe742f4458ba40cf3c14ab73ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia380efcf48764d14911365055786a8c1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97de2860387c4ebb9d4c67d302888d0c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23baf9eae53648b5862c179217f38259_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c025fee8f64b4a80f4a122c03be02f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9e30e4f3ae45789d654ae03283e68f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0115f45cca34fe59169ae1673caf52a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if92e2ee8bc084934add5e4997216b20b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d19f95d9c4e41ff8e7135be13df1713_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d338010b91c405c9adcfebc639f8496_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="offeringperiod"><xbrli:measure>pcrx:offeringPeriod</xbrli:measure></xbrli:unit><xbrli:context id="i9d47dbf4731e40a8817c9b98685f2fad_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd2ba2d5b0b4cbd856acd935fe9e469_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i485078b5973a4f38a864235574eace6d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80aa21cf123146cfa48d76c6340c8f02_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d47a9c9bbe34e8a884b57b4a1b7c7d7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i751881f6186c4a20b2999971312c68ea_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia902e06002164005b91ff53bfc5574a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ec2fd985f1484584f9e9321ebe8636_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66cdb3b9475d440585c31ef8170080cd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica8d4ccba77d49c585c7d57451c690c9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033a677bcf7842e8962e783e4ecdff17_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic925042152574d9896e5d11b213d65ef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0529b24441114da8aea1d86d3e46324d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i220fe9ca1ed949bdacf99f33c990cd98_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c341f2698fe409ab358a241336259db_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f355a2653684c24b57b2f7c5f946633_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c1d51f4133f426395546e41d42a7bf2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b9602474ee4df3a8cdbf721f6b53ec_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999eddb8433c487184e9e575bd4a8c32_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569b3dcd44504f2ebc2b67589ca1ef77_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92a9bde52b5e4954a236c46394ef2fe1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8d9d4db1ba04e1288564adf8e895b8c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia097c92a4047403d82b24978021270af_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01b4d60757d4870804d497766e7943c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7925b0863c1647ce89e8613307298317_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ddd46a4b60a416c94127599c856aa48_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f95987401124116b24759ace715aa41_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fc8460b9894b6cb2fb0b2e035270ae_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095b5a48440040b98f786b561073678f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d0d73926a8453fbff3d3a2959a9f19_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47e4065f3bf84a769793c677aa707755_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6952928bc30b45c094b9931501de819e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6b8329aab94b669b97bbc6cc18e60c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2090540004814f58aec0fe11cbfc0491_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be6662b540d42b5b071db1e7701ffd5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb5ac33a93d943dfa41d95c7fbb2fa8c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie470b1ec9ebc496c8a8a2b82cee22927_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2c777abcf4b469ebafc9aa977f3f943_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4df205ee98b9479fa0df23571a4898df_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ec8193fb584c849fb512a1ebd30246_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ee845af90843f89f53ceeb7e4f835b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1904086f824643bbbbb99866420b64c8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icada30aef3ab4b739d33763eef827871_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8157b496ab44079fe9f2e4512f3b32_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fd88738e5c447e82122a8f75186048_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac64608b237d43f0a6a93d7bdccf7a88_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e41fa8486f34ea58ad7ceac10e1140e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166df1f4bcd2446d844456bfb7f76005_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fac746bbf294b19acb69210d7229116_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17b1073570b241519f375ef761e56fc8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia28ed82e949f407abfcf436c06550157_I20200320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1a035c480c4e9cb20e78a99005a535_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibcbdf7459db64b749005ba498f2d18fe_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV80Mzk4MDQ2NTEzMTk2_4ebfae74-1701-4742-81ef-f0ac018dfa79">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6ZDI4NzM2NzM0ZjNhNDllNjgzZTM5MmYzYTNkZjUxZWUvdGFibGVyYW5nZTpkMjg3MzY3MzRmM2E0OWU2ODNlMzkyZjNhM2RmNTFlZV8xLTAtMS0xLTk4Njc0_188dca1a-7d3a-4ffd-af13-8b72f0f38b4d">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8xMjg_7f4ec577-00f1-4cb0-ac09-523060bb8a57">September&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6ZDMwZmI4MjE2NTUzNDI3NGI0N2EzOGEwZTFlOGY2ZjkvdGFibGVyYW5nZTpkMzBmYjgyMTY1NTM0Mjc0YjQ3YTM4YTBlMWU4ZjZmOV8wLTAtMS0xLTk4Njc0_c4636ab9-edaa-4d73-984f-a43a2b0c3328">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160; to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgy_49155740-2729-4892-bcae-05b3281639e4">001-35060</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="pcrx-20220930_g1.jpg" alt="pcrx-20220930_g1.jpg" style="height:96px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"/></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgz_5dc58a88-74d9-4440-837b-535d5c26bd43">PACIRA BIOSCIENCES,&#160;INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.435%"><tr><td style="width:1.0%"></td><td style="width:48.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MDM0YjhlNjMzMWFlNDM1ZGIxYTFiYzE0OTRjNmJmODcvdGFibGVyYW5nZTowMzRiOGU2MzMxYWU0MzVkYjFhMWJjMTQ5NGM2YmY4N18wLTAtMS0xLTk4Njc0_ecf82df8-44b1-4dbe-b33b-f5ed02a0f5e7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MDM0YjhlNjMzMWFlNDM1ZGIxYTFiYzE0OTRjNmJmODcvdGFibGVyYW5nZTowMzRiOGU2MzMxYWU0MzVkYjFhMWJjMTQ5NGM2YmY4N18wLTItMS0xLTk4Njc0_ca3b82b2-5e03-43b1-825a-6c2193e8722b">51-0619477</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>&#160;Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg1_b2778b44-08a2-456c-a255-1fc0f41d2594">5401 West Kennedy Boulevard, Suite 890</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg2_e45bd0a9-d343-44aa-8d7c-e6dcc4fc0033">Tampa</ix:nonNumeric>, <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc2_24cf679d-efc2-409c-9362-c7399a875829">Florida</ix:nonNumeric>, <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDcz_0ec6f867-7708-49c6-acfd-6cb4b41ee383">33609</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address and Zip Code of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgw_5f05c899-31ab-45c6-b5dc-e500b9146aed">813</ix:nonNumeric>) <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc0_35dbfeae-68d5-4b59-9e69-7513519adb3a">553-6680</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.758%"><tr><td style="width:1.0%"></td><td style="width:37.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTAtMS0xLTk4Njc0_eda39013-36a5-47c7-a78b-329bf15f366d">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTItMS0xLTk4Njc0_b268756e-dde8-462e-8f8c-96fbec0c7f88">PCRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTQtMS0xLTk4Njc0_bb97cb5c-bb8f-4f93-831d-b0eeeacf22e3">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg0_295c65ca-4bc0-4727-88a8-08ec91a1f369">Yes</ix:nonNumeric>   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files.)&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc3_e6efa9c2-87cd-4c26-959b-1c8bbdf3d97e">Yes</ix:nonNumeric>&#160;   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8wLTEtMS0xLTk4Njc0_0c07a61c-10d7-4169-8381-367a05c444a4">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8xLTUtMS0xLTk4Njc0_258339f7-c7e3-4bc3-8629-18298746971f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8yLTUtMS0xLTk4Njc0_5a337e07-3424-4cf8-8b8c-7608649e761d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgx_cb3c7b46-1bec-4139-9832-3b061ac7c459">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Yes   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;1, 2022, <ix:nonFraction unitRef="shares" contextRef="i4cb9b12dd08b4498ad442b10cdd5b751_I20221101" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8xOTg1_17f783fe-adb6-4d1d-b8df-d4e45aeea7e0">45,882,088</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value per share, were outstanding.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED SEPTEMBER 30, 2022</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="9" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_10">PART&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_13">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_19">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_22">Condensed Consolidated Statements of Comprehensive</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_22"> (L</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_22">oss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_22"> Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_22">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_25">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_25">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_28">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_31">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_94">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_94">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_118">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_118">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_121">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_121">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_121">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_124">PART&#160;II. OTHER INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_127">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_127">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_127">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_130">Item&#160;1A.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_130">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_130">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_133">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_133">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_136">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_136">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_136">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_139">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_139">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_139">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_142">Item&#160;5.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_142">Other Information</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_142">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_145">Item&#160;6.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_145">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_145">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_148">Signatures</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_148">53</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 3</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_10"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I &#8212; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS (Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMy0xLTEtMS05ODY3NA_c71cedfe-ee49-4473-8cf7-99310d67f3bd">109,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMy0zLTEtMS05ODY3NA_e9af60ab-c81b-47a3-ac7c-929248bd0560">585,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Short-term available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNC0xLTEtMS05ODY3NA_efc8307b-1727-45bf-999b-8774565281d4">219,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNC0zLTEtMS05ODY3NA_fc83da9b-9aac-41d0-9cf9-16f879eb7600">70,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNS0xLTEtMS05ODY3NA_82fd73e6-3da8-4202-9913-ac79e835a0ff">93,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNS0zLTEtMS05ODY3NA_29b06308-0af2-4a12-910d-7a17d395c605">96,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNi0xLTEtMS05ODY3NA_4854d5cd-6fea-41e5-88da-e3116f559808">96,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNi0zLTEtMS05ODY3NA_e7aef72e-e35d-4df2-8219-3c2743d55487">98,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNy0xLTEtMS05ODY3NA_6df64da6-e1ca-48b0-acf4-de66d5c4bd31">14,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNy0zLTEtMS05ODY3NA_9c3a9a36-b743-4a80-a6ba-048c6ddaea9f">14,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOC0xLTEtMS05ODY3NA_12925e03-70f4-45df-94bb-e8cddb219509">533,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOC0zLTEtMS05ODY3NA_cdfc279d-7673-480a-a988-5a2a03492a9d">866,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOS0xLTEtMS05ODY3NA_fae7fcd5-be96-408f-a927-3bb630cb9134">17,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOS0zLTEtMS05ODY3NA_be543947-38db-4630-951a-e6afdcabc270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTAtMS0xLTEtOTg2NzQ_7ecc2c6d-e70d-49c9-b7da-ab676495d12b">193,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTAtMy0xLTEtOTg2NzQ_22ac3beb-7984-42b2-b5cf-94b36aed30df">188,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTEtMS0xLTEtOTg2NzQ_ec90c284-d32c-4aa6-aef5-d75951004745">69,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTEtMy0xLTEtOTg2NzQ_be93040c-2268-45db-99f7-c0eba2cdf224">76,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTItMS0xLTEtOTg2NzQ_870c5155-5a55-4de6-8afa-cfb8881e7688">157,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTItMy0xLTEtOTg2NzQ_884cb324-a4f0-45ca-b102-d3b5ac2d6d1e">145,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTMtMS0xLTEtOTg2NzQ_880ef663-df53-4ebd-b6f1-1d1e12d09c78">581,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTMtMy0xLTEtOTg2NzQ_2d2344c6-6ff6-4ff9-ad47-c1775a7b38e3">623,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTQtMS0xLTEtOTg2NzQ_b794e3bb-4989-4bee-9e3c-e39bd9cffa93">155,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTQtMy0xLTEtOTg2NzQ_be860b2e-45f8-4f42-a5b9-b57c5ac04be9">153,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:EquityMethodInvestmentsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTUtMS0xLTEtOTg2NzQ_940570d4-6479-4418-ae33-1c9dce48e902">26,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="pcrx:EquityMethodInvestmentsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTUtMy0xLTEtOTg2NzQ_ce4c9509-1532-4a83-94a4-4406396d7ae9">21,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTYtMS0xLTEtOTg2NzQ_bbac4d92-3325-4e2d-8339-b04d921d9c68">1,734,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTYtMy0xLTEtOTg2NzQ_e4706f6f-3e28-40f9-b1c6-5e733a8f678b">2,075,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjAtMS0xLTEtOTg2NzQ_def3d7d0-ab93-4445-b2f7-1b8b9e35956d">12,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjAtMy0xLTEtOTg2NzQ_efe75cb4-34a5-4f08-92ec-f5187f1d8ad9">10,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjEtMS0xLTEtOTg2NzQ_e0a4d985-4d5f-4210-bdaa-7bfc4ce779a0">76,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjEtMy0xLTEtOTg2NzQ_55dbee0b-e95d-440d-9920-9e1f276019a8">127,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjItMS0xLTEtOTg2NzQ_9eb61531-7f1a-44a6-87f2-6de8a3753f00">8,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjItMy0xLTEtOTg2NzQ_737d9685-0206-4480-96f0-3659442e3288">7,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMS0xLTEtOTg2NzQ_9bf36189-df6b-4795-83ec-4de92de99b5c"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMS0xLTEtOTg2NzQ_f2e16591-8ebf-4375-a95f-5d522fb18127">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMy0xLTEtOTg2NzQ_c065178b-da9c-4c40-852e-96f393620292"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMy0xLTEtOTg2NzQ_eb2de966-d2d0-4f14-8667-4bed5f3b1a40">350,466</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjUtMS0xLTEtOTg2NzQ_390a8d46-f3a0-4f80-8fac-234db1d5d0ce">33,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjUtMy0xLTEtOTg2NzQ_e3cdf087-4db1-41e2-a16c-4eebf67ef638">24,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjYtMS0xLTEtOTg2NzQ_30ab4a30-35c2-41c9-9ccf-54f025941f89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjYtMy0xLTEtOTg2NzQ_eea548f3-52d9-479b-9584-ec39cfade03a">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjctMS0xLTEtOTg2NzQ_d44f7d9d-d427-4c10-905c-9696da9872db">131,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjctMy0xLTEtOTg2NzQ_b2363186-6e40-4c75-82fc-ce1a1dc44770">521,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjgtMS0xLTEtOTg2NzQ_60e6f9d3-7a75-4713-8cd8-daea7b08b30c">404,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjgtMy0xLTEtOTg2NzQ_2ea60384-3a1c-4d91-83f0-3b326e59628f">339,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjktMS0xLTEtOTg2NzQ_f06ed714-6717-4fb7-8dcb-5f1320565bbb">309,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjktMy0xLTEtOTg2NzQ_f4545005-d9eb-4d49-a207-52df0e9bbe02">335,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzAtMS0xLTEtOTg2NzQ_c6b7a3fa-a740-4592-995a-1ca642eafdc4">65,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzAtMy0xLTEtOTg2NzQ_582c3ff2-1c70-491b-9d90-a2632e4a3700">71,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:ContingentConsiderationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzItMS0xLTEtOTg2NzQ_f0196aa5-566f-486b-8457-ac2a2f0ab134">34,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="pcrx:ContingentConsiderationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzItMy0xLTEtOTg2NzQ_ce410278-bf8c-4500-a529-9cce341d6e1a">57,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzMtMS0xLTEtOTg2NzQ_bd600ecc-ae91-4dee-863a-db109ea9aab3">19,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzMtMy0xLTEtOTg2NzQ_2ba92397-de2e-48a9-a65d-7edfd6c7ecc3">19,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzQtMS0xLTEtOTg2NzQ_e81b6c6d-00a9-4f20-a976-ae464615b3ae">964,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzQtMy0xLTEtOTg2NzQ_229ee98c-089b-4796-9ec3-928aaac7cdd0">1,344,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzUtMS0xLTEtOTg2NzQ_43e7c82c-b79c-4afd-b107-a6d26cf5d166"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzUtMy0xLTEtOTg2NzQ_c8e8cda3-aca6-483f-b3f6-f4a40f09c521"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zMQ_546f60f0-6ab4-49bd-b7a2-a91909853604"><ix:nonFraction unitRef="usdPerShare" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zMQ_ab292bdc-00ed-4c69-ae94-d7fded2ec334">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zNQ_4d959fae-8d3d-4ab4-84b6-e3b899168b71"><ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zNQ_f632aca4-548f-4343-8cdb-d4188ca9bab3">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_751bfd37-6dd5-4828-8f43-cbf266863332"><ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_ba2bbc4f-97d3-4bfa-ba42-640f2130a2c0"><ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_d126ea19-01bf-4cba-9f69-24f45687612f"><ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_df5639b3-3a98-430c-8de0-9cd3d9e4e0c9">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMS0xLTEtOTg2NzQ_8bfcf65d-e312-474f-8b59-4becc23bd677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMy0xLTEtOTg2NzQ_a4b2a644-28ab-4bbc-98b7-6ecd3060bf8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8yOA_063ad3c6-1e4e-41ab-b1ce-70436c9d48bf"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8yOA_6f47748e-68a6-481c-85f7-0d0abdaf5f3f">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8zMg_4b894b52-4538-4e4a-b10b-1b9cf4d04c8f"><ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8zMg_f6f50fb9-c31a-4651-9674-530619c62721">250,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF81NA_95af870f-9d1e-417c-b3de-a17b157bd8bb"><ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF81NA_fae7ee35-79f3-4484-b01e-e654f9cfa3db">45,864,319</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF82MQ_d7268599-1113-4308-b7be-32794f6ce84d"><ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF82MQ_f8d05e93-29ce-46af-bb34-5c4e04e681eb">44,734,308</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMS0xLTEtOTg2NzQ_97396be6-75f4-43d1-9fd6-5badf95e05b7">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMy0xLTEtOTg2NzQ_14140ab2-2085-4741-b579-0ba37c9ced36">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzktMS0xLTEtOTg2NzQ_0a1849b9-eed5-453d-852a-ba85294f8caf">909,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzktMy0xLTEtOTg2NzQ_a195295c-13a6-478a-aa18-775701296990">942,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDAtMS0xLTEtOTg2NzQ_e0c1ffb0-d25a-4be9-975d-962342c04836">138,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDAtMy0xLTEtOTg2NzQ_708a1c2d-9e36-439b-8b7a-5ba0fe21f227">211,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDEtMS0xLTEtOTg2NzQ_1137743f-952f-4199-a220-291647090bcf">670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDEtMy0xLTEtOTg2NzQ_c854787b-99ee-4c40-bbbf-6c016c61f3ed">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDItMS0xLTEtOTg2NzQ_6fef2e32-976f-4ebc-b062-a11300cad361">770,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDItMy0xLTEtOTg2NzQ_c893d614-0ac6-4780-b9ba-a337975517d0">730,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDMtMS0xLTEtOTg2NzQ_2640360a-a40b-4b2c-a41c-850bcdf2ab43">1,734,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDMtMy0xLTEtOTg2NzQ_74df8cab-e143-4196-8354-712af205fac0">2,075,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 4</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy0xLTEtMS05ODY3NA_027d2047-5a31-4a8d-a77d-7deaa9e152e2">166,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy0zLTEtMS05ODY3NA_4239ab9d-ebb7-4788-b3d5-1904058d1d1d">126,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy01LTEtMS05ODY3NA_6b5ea118-0be1-4325-bfb1-372190f60e21">492,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy03LTEtMS05ODY3NA_9baafae7-baf0-4dc8-8cd1-4de9f174379c">380,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b07e519ec647d98d89e6ff41f57c17_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC0xLTEtMS05ODY3NA_20142d0b-f232-4fcc-b70b-9d5bdaa018c3">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296396fbc9e84eba9ec04154af9e9c1e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC0zLTEtMS05ODY3NA_48b78d55-3fc2-4cc9-b9f9-939be1ab37ed">931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5fa65067bcc41bebdf6822950026442_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC01LTEtMS05ODY3NA_1d8e1f74-5c86-4094-8a2e-b316aa0045b5">2,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8f81f091924fc3a4edff3d54a6825d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC03LTEtMS05ODY3NA_05ab593f-be82-4e13-9a21-bb63a0ee5c2c">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651ac2daa5d14c668a7fe9f65787fa0b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS0xLTEtMS05ODY3NA_53816db3-e64e-4eb9-bcc7-b1409fcf862b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7048adc212324bc0b035c0020bd464ce_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS0zLTEtMS05ODY3NA_a16d69ab-1674-4092-9bc7-78f01ef71aff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd81ae54732c47849b986c561fdfa792_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS01LTEtMS05ODY3NA_b1558919-b5cb-4f8e-abcf-936e8f45f206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbfb9a42fd243c890be52ee0d74fd8f_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS03LTEtMS05ODY3NA_7872caf1-f629-44c9-8487-59bd478024a4">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi0xLTEtMS05ODY3NA_219e94e5-723b-480e-82e1-1f8116cfb062">167,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi0zLTEtMS05ODY3NA_8ddee0aa-f6d2-4262-9891-887b1d9481e0">127,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi01LTEtMS05ODY3NA_7967caed-ae15-4a66-979e-a2d099fa3f80">494,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi03LTEtMS05ODY3NA_11f0fd00-f260-4400-8486-be0d20a43170">382,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC0xLTEtMS05ODY3NA_4205f4c3-b7f5-4872-971e-4ece3161d2e6">50,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC0zLTEtMS05ODY3NA_b18c5928-be08-4643-b0f8-ffaf7078c74f">34,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC01LTEtMS05ODY3NA_5dd31a18-3b95-4c1c-b468-1dee1b8999ac">137,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC03LTEtMS05ODY3NA_15d261cd-86b8-4f65-9f05-a1905ed2cf00">101,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS0xLTEtMS05ODY3NA_26fe22a6-e021-4ad8-8f14-f31a688ef160">19,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS0zLTEtMS05ODY3NA_981128a2-d9e2-4b0d-b6ec-de0c8c9deb1b">11,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS01LTEtMS05ODY3NA_ac47759d-fcd2-4b0a-a671-d69c2a751fa7">67,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS03LTEtMS05ODY3NA_b7c4e987-0cb1-4870-b9f5-8fe45acae4d5">40,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtMS0xLTEtOTg2NzQ_8154ec35-fe70-4b79-b9bc-ecef3084bbcf">61,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtMy0xLTEtOTg2NzQ_ab948910-0a0e-404c-a100-57dc4de76491">47,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtNS0xLTEtOTg2NzQ_a77a8589-faad-48b8-a93d-655fb6112c9f">190,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtNy0xLTEtOTg2NzQ_428876e5-017f-404f-aedd-c2a3921e961e">147,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtMS0xLTEtOTg2NzQ_fc0b7f35-c39b-48b0-8f23-18e909d94319">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtMy0xLTEtOTg2NzQ_8713f210-eeb8-4fed-ab52-1c2df4e714e7">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtNS0xLTEtOTg2NzQ_bcafee84-195b-480e-9a03-3d4092154289">42,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtNy0xLTEtOTg2NzQ_48e994b2-e4b8-4a08-82c6-ffef6915f7da">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related charges (gains) and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItMS0xLTEtOTg2NzQ_dab47847-f352-4f85-9f9f-626b67df7162">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItMy0xLTEtOTg2NzQ_e7f0f127-b522-4e0d-bdb5-908ddf4cb00e">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItNS0xLTEtOTg2NzQ_66c79df4-d0bc-4a4d-947d-738b4b63d6c8">13,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItNy0xLTEtOTg2NzQ_013e5fdf-847e-471f-b256-a01f7f3124ee">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtMS0xLTEtOTg2NzQ_46936b31-e495-4cfc-9cfa-73be9d56bea8">146,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtMy0xLTEtOTg2NzQ_faabd8bd-f5a7-4663-b638-7ee8b906a0e1">96,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtNS0xLTEtOTg2NzQ_9918f075-9883-484c-b779-2f8e4085d706">424,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtNy0xLTEtOTg2NzQ_8860e540-636d-4e28-ad7f-d40c036d5c01">296,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtMS0xLTEtOTg2NzQ_58aaf121-17aa-448f-8b22-e8a04b6252a4">21,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtMy0xLTEtOTg2NzQ_29e1eca0-7baf-4a8e-9832-8fb1fa3e85d8">31,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtNS0xLTEtOTg2NzQ_0fe1924d-8569-41c1-a134-2eaeec5c4138">69,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtNy0xLTEtOTg2NzQ_5e774dc4-fb4a-4793-8823-6c5bf62bfb0a">85,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtMS0xLTEtOTg2NzQ_5cfdac29-5eea-4a72-80fd-eb515fa9dde6">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtMy0xLTEtOTg2NzQ_acf01d4c-bcf5-43ad-9155-cdb28750f7cf">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtNS0xLTEtOTg2NzQ_fd305f2f-0b11-429e-b244-61c656ba933b">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtNy0xLTEtOTg2NzQ_8dfd1e0c-af38-448e-b545-5d548bcea1df">816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctMS0xLTEtOTg2NzQ_3fa3fb7c-aede-4c8f-9154-b1fc9e898dc2">9,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctMy0xLTEtOTg2NzQ_65a44e65-e229-485a-a9e1-89101e7ba152">7,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctNS0xLTEtOTg2NzQ_464622ab-74dd-449c-8f8f-32685e4496a0">28,935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctNy0xLTEtOTg2NzQ_1612558c-a700-4f9c-bf78-02ccef48ab89">21,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktMS0xLTEtOTg2NzQ_beba2856-878b-4e6d-9a4a-dc28e4c316cf">10,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktMy0xLTEtOTg2NzQ_f0a96f6b-dd24-4a40-9d2c-853ded3794e8">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktNS0xLTEtOTg2NzQ_367f50cc-5f7a-4a99-9ec1-1d387080a23d">11,369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktNy0xLTEtOTg2NzQ_a402d1d1-d300-496a-a9e8-19fe2dbe0a3e">2,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtMS0xLTEtOTg2NzQ_0cdabb0f-ecee-4cfd-8a8f-0f5d1c98c866">19,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtMy0xLTEtOTg2NzQ_c882893b-c3d1-47c0-8b7b-1b2711538272">7,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtNS0xLTEtOTg2NzQ_03e76bb4-4b48-41de-88b1-a01fc2155877">38,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtNy0xLTEtOTg2NzQ_a57d55f8-177b-4053-bf5c-111662f4068c">23,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtMS0xLTEtOTg2NzQ_39d9839e-9d87-4d6e-a5cf-a101e9d202d0">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtMy0xLTEtOTg2NzQ_638474c3-04d3-449a-bfe4-89a16028b021">24,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtNS0xLTEtOTg2NzQ_e3b71839-9a9d-4e80-ad49-5f912851df60">31,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtNy0xLTEtOTg2NzQ_6b634c4a-ebcc-4a04-8aa3-f00ac5a876e5">62,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItMS0xLTEtOTg2NzQ_f896e5f7-df3b-4760-acd9-dfe022ba7559">2,762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItMy0xLTEtOTg2NzQ_36f6c8db-c4ea-40bc-8f34-b56f0993c9dc">6,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItNS0xLTEtOTg2NzQ_ec3180a1-0491-4d8b-b8df-40d0807d1363">5,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItNy0xLTEtOTg2NzQ_c787b57e-9a00-4433-9513-8ba62019efab">15,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtMS0xLTEtOTg2NzQ_f48cc3a8-79e0-4de7-ada5-67044dfae48f">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtMy0xLTEtOTg2NzQ_f4406619-ff2c-4bb6-be4f-f8668b9be63b">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtNS0xLTEtOTg2NzQ_ab980016-e6e4-42a6-a4a0-e131d31fcc28">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtNy0xLTEtOTg2NzQ_1bc06a1d-2d7e-41cb-8e2c-1a838b431bcb">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net (loss) income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtMS0xLTEtOTg2NzQ_43ea56d1-d044-47cc-81a6-bb2a748b01f2">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtMy0xLTEtOTg2NzQ_5a5db082-4a01-41ee-a33b-c4ecc55423ca">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtNS0xLTEtOTg2NzQ_3bf2e61f-7940-4899-8b83-a8611f77a766">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtNy0xLTEtOTg2NzQ_546617d8-30ef-4bd6-bd0f-d67543772567">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net (loss) income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctMS0xLTEtOTg2NzQ_f42ade57-c300-4577-92b8-b2606be0cade">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctMy0xLTEtOTg2NzQ_dc271691-78fb-4ae1-82c7-8c1d172041c7">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctNS0xLTEtOTg2NzQ_99ce4a82-6f88-4fc3-82df-5b8ba1c82e0d">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctNy0xLTEtOTg2NzQ_8c70a7b4-676a-4389-b46e-21189242e088">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktMS0xLTEtOTg2NzQ_c6d91402-8b7e-4f9e-ab91-f7fb81f16c0e">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktMy0xLTEtOTg2NzQ_27cabe97-a6dc-4ff2-8110-7299b555803b">44,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktNS0xLTEtOTg2NzQ_f2686cd9-e94e-4017-a2d1-46dc73377464">45,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktNy0xLTEtOTg2NzQ_17a6e6b6-ed03-4e85-baad-927da9ec59d9">44,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtMS0xLTEtOTg2NzQ_6c96ab6f-b17a-47ae-93a4-77c54d54f656">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtMy0xLTEtOTg2NzQ_3e3e0715-4a81-4437-adb8-03fdb85d5a55">45,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtNS0xLTEtOTg2NzQ_b1825366-705e-4e1a-bfcd-cbc539b18706">52,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtNy0xLTEtOTg2NzQ_93417ea0-cf60-43a3-8efd-ffd6759713ba">45,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 5</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi0xLTEtMS05ODY3NA_f48cc3a8-79e0-4de7-ada5-67044dfae48f">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi0zLTEtMS05ODY3NA_7082ea28-d75f-4608-92a5-5cb89eee3304">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi01LTEtMS05ODY3NA_ab980016-e6e4-42a6-a4a0-e131d31fcc28">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi03LTEtMS05ODY3NA_39c82f9d-678e-4e10-baaa-1dd1f1ba2b00">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC0xLTEtMS05ODY3NA_7db55b77-fcc5-4074-af4d-f8a5e0bc124c">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC0zLTEtMS05ODY3NA_00ac5cc0-0c55-4648-bbff-2caeb27ceb24">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC01LTEtMS05ODY3NA_ef4a3ebc-444e-4e40-8b3f-1f4a34a21e8c">1,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC03LTEtMS05ODY3NA_801a4e53-19b1-47b4-a64e-065d65c1241e">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS0xLTEtMS05ODY3NA_277bd40f-6bdf-4c00-a1cb-72fa63e56913">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS0zLTEtMS05ODY3NA_1d33329a-6e23-4d01-9996-0dabc545d35e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS01LTEtMS05ODY3NA_0fdc30c7-af27-4917-b57b-ff08af1da920">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS03LTEtMS05ODY3NA_8f915f9f-9465-454a-99b3-acabd4723b30">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi0xLTEtMS05ODY3NA_61f65872-b638-40c3-aa1e-d059be0687ca">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi0zLTEtMS05ODY3NA_b613faf9-32d9-4d1f-985d-579c64ccee0e">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi01LTEtMS05ODY3NA_6c968823-67e1-44ed-a277-762f57683cf6">837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi03LTEtMS05ODY3NA_447c7771-4612-477b-96a0-bc1913e273e9">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (loss) income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy0xLTEtMS05ODY3NA_f047dffa-f0ea-4b0f-a29b-6c835363e9e2">758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy0zLTEtMS05ODY3NA_61de0535-71c4-4504-a4b5-e5c84d84a475">17,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy01LTEtMS05ODY3NA_88bda21a-74cb-4959-9d4e-9eccb7d64fa8">25,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy03LTEtMS05ODY3NA_a6c8ae83-e3e4-4d85-8193-6cb34377f25a">46,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 6</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66278c6f4cce4fd2ad08c5c059665f38_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0xLTEtMS05ODY3NA_45561305-d797-4639-98f4-2f3c463b2eab">45,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66278c6f4cce4fd2ad08c5c059665f38_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0zLTEtMS05ODY3NA_7f775008-7d04-48cb-a00d-01c344badea0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869d18b1d1484493b15aac75f097bce8_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi01LTEtMS05ODY3NA_b3d74513-11d1-43e9-b107-df666dfa7e3d">895,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01926f9c07cb4651b749c885c0a99ef8_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi03LTEtMS05ODY3NA_44eea11b-2c9f-493a-8eca-5c13db702a35">137,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54aab0893c1f40f491d1e7a3b7a97718_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi05LTEtMS05ODY3NA_73e089b2-93a7-44c6-bcad-060312968aec">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc550af62b504ae58f1e161f47a65942_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0xMS0xLTEtOTg2NzQ_142a8c7e-dbaf-45f8-a6f6-71131c0bf24c">756,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0xLTEtMS05ODY3NA_edb14acf-c7fd-4ca6-9d75-462188887a33">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0zLTEtMS05ODY3NA_680ed419-a354-4c95-a560-08bfc557d554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1472000d14eb451bb7a3794aff155744_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC01LTEtMS05ODY3NA_8b6e10ac-e77d-4319-841d-eba2761cbb94">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0xMS0xLTEtOTg2NzQ_5b5a09ca-188a-47fb-aee6-cb2279e5d596">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNS0xLTEtMS05ODY3NA_582d0ba7-3db2-4fba-bccb-646e091d9a47">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNS0xMS0xLTEtOTg2NzQ_0b1fac5b-24bd-4e85-82a0-1a1687c08a3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1472000d14eb451bb7a3794aff155744_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNy01LTEtMS05ODY3NA_5d485064-6e52-48eb-ac30-69a25880d519">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNy0xMS0xLTEtOTg2NzQ_bd6ee5dd-41f6-4234-bd7d-8f599268d0bf">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2c26ed78e9b4b63aed76cbf74cf8f4a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTEtOS0xLTEtOTg2NzQ_8b885208-d732-4695-8013-ea857f226b8e">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTEtMTEtMS0xLTk4Njc0_aa57b29a-ccc6-429f-a584-844937aa5873">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifba08fe64fae4c57bf8911a0904d2df9_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTItNy0xLTEtOTg2NzQ_7342213b-07c1-409f-b520-01527edc239b">693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTItMTEtMS0xLTk4Njc0_b77313ab-fa37-4bee-a9d4-abc9593f8982">693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i017393d821a848799eb138394bd7839e_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMS0xLTEtOTg2NzQ_df9d97ff-d9c9-486b-b6bf-59a1b7f9d869">45,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017393d821a848799eb138394bd7839e_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMy0xLTEtOTg2NzQ_1d1a0b87-21a2-4af8-b384-eca0b623e115">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtNS0xLTEtOTg2NzQ_da973955-bca2-459b-9706-937fb0561483">909,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9287e79f6d44d568cf917866e4551b3_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtNy0xLTEtOTg2NzQ_d952bd0c-5516-4d5c-85d2-bd6225c1204c">138,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtOS0xLTEtOTg2NzQ_45ebfce5-3349-45c9-8f0d-055f2e462159">670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMTEtMS0xLTk4Njc0_96530451-1eff-449e-a609-053e0a7a9ab5">770,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd43125dbda74778b63a9be02be0a13c_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0xLTEtMS05ODY3NA_275cad75-bea0-48c8-932a-bbd118cdb1dd">44,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd43125dbda74778b63a9be02be0a13c_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0zLTEtMS05ODY3NA_b77584a0-70de-416b-bf13-c8b7279f1534">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9791b8fe7b3a4f12800eef3e3a5c6bf6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi01LTEtMS05ODY3NA_5ee1e3e0-422c-4ce0-9ea1-d04b1b7945fd">911,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdf819b6879b403cafbbce9b6339e7b0_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi03LTEtMS05ODY3NA_fd319940-b6f4-422f-97dd-0cdfca1e7269">224,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1421c3f2c2d74fd99b18bfdda0e895a0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi05LTEtMS05ODY3NA_f0bf62ec-f207-43aa-8b92-54e2da6b3f2d">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae46cd944c6d419186595743d38a8f81_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0xMS0xLTEtOTg2NzQ_697a9175-af7a-48a4-9159-6a21c7432068">687,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0xLTEtMS05ODY3NA_4e0bcc61-07e6-4d04-9748-039124c17ace">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0zLTEtMS05ODY3NA_46e2be08-a740-432d-9378-becbb566273e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS01LTEtMS05ODY3NA_a9b6593d-7605-4da3-8827-4cd10354f023">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0xMS0xLTEtOTg2NzQ_7c61a7e3-afae-437b-a80e-cc48233046c8">3,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNi0xLTEtMS05ODY3NA_4e5536b2-4371-4032-8ccc-b36655719a3c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNi0xMS0xLTEtOTg2NzQ_b796f9b7-2881-4c08-9346-acddca9c041c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfOC01LTEtMS05ODY3NA_e3200aa0-aad0-4785-9df4-b1fc1472e0a1">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfOC0xMS0xLTEtOTg2NzQ_2933b380-7327-42f8-bd8a-bdfa31c3925f">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa66a357a47d49b68b18893d24be3af3_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTItOS0xLTEtOTg2NzQ_667606ed-af36-482e-8424-6e25e21750ae">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTItMTEtMS0xLTk4Njc0_107ad3f0-a8ed-440f-8a18-4e2b1935a53d">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d00233f14343878bcb73daec21f9e8_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTMtNy0xLTEtOTg2NzQ_437c2db9-2b95-40a4-9bd9-a33a89c9a818">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTMtMTEtMS0xLTk4Njc0_0b0e7a2e-e02e-4dca-b72b-f51636d20fa7">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMS0xLTEtOTg2NzQ_d454f2bf-85f0-4cdd-84b4-42ccc1ff0334">44,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMy0xLTEtOTg2NzQ_fbedf440-3910-4024-9818-353a1ac24cad">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e11e72269fb497ba643fca620eefeaf_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtNS0xLTEtOTg2NzQ_3a4e3b14-703e-4610-a311-80042d48ed90">925,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic26efb05ce904daca36d5ba11271c6a9_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtNy0xLTEtOTg2NzQ_96c43ee7-4b28-4601-8538-5e11b5ccaaf1">206,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtOS0xLTEtOTg2NzQ_78e4ca46-ae47-4763-b1b7-f5f7e748786a">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMTEtMS0xLTk4Njc0_f1d95c97-d275-4ddc-a3d5-46f2df37fd87">718,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3e655fae2f146fc934fcf31ce6ec541_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0xLTEtMS05ODY3NA_fe211e78-29ba-4ab2-b805-3f8998050450">44,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e655fae2f146fc934fcf31ce6ec541_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0zLTEtMS05ODY3NA_f8ab6cf7-fad5-4f24-8f45-fe0e49240218">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c1bd8c69f7453fb0c4b1269e35f69b_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi01LTEtMS05ODY3NA_bdaef836-a4d6-43c8-8355-321ea113a91a">942,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05e3b6239474b029b08b6f0046dce35_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi03LTEtMS05ODY3NA_ea81fd5c-1f3a-4f4f-a797-33d4aeadbf68">211,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi05LTEtMS05ODY3NA_9055d633-7b7f-42e8-a113-a3ef6d39be91">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0xMS0xLTEtOTg2NzQ_178105d2-74bf-414e-b001-3a9178d996bd">730,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy0wLTEtMS05ODY3NA_6319c949-5d0c-4651-ba59-8ba255c6fe96">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ea53f33c63e42cfb873ac4aa0686769_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy01LTEtMS05ODY3NA_84445427-a4fe-43f2-a660-201596f5ea05">96,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca30657d70a4d3ab6e32635d54c30ce_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy03LTEtMS05ODY3NA_3e6a33df-0131-43fb-8dd5-2587d704332d">47,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8275aa05c35d448d97c72eaa9bb0a095_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy0xMS0xLTEtOTg2NzQ_eee498f5-91e5-46c8-ac86-1cef868364c3">49,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0xLTEtMS05ODY3NA_463a8ae4-f25c-4535-afe1-3ac29ba7a447">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0zLTEtMS05ODY3NA_ddd774b3-a287-491c-a7fa-e5a4acc17335">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS01LTEtMS05ODY3NA_9f83ff0b-0510-4638-9243-4bce0a72a845">23,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0xMS0xLTEtOTg2NzQ_f3f78f68-e200-4fce-96d7-ab6ee0516b8b">23,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNi0xLTEtMS05ODY3NA_9bd42d6e-c624-4b30-9230-f52aa7c64ab9">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNi0xMS0xLTEtOTg2NzQ_6d1fd590-0671-42d7-83f5-5bf276a2387a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy0xLTEtMS05ODY3NA_96d9fc1f-f45e-434b-b3f8-a4d66a38f575">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy01LTEtMS05ODY3NA_8033d59d-0c48-4a47-b3d7-6f1b007b5fe6">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy0xMS0xLTEtOTg2NzQ_85a2c102-2ebf-475a-8db1-5ff9d2518179">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOC01LTEtMS05ODY3NA_ce55c182-019d-47fe-8aef-52ec9e634297">35,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOC0xMS0xLTEtOTg2NzQ_06c4db17-8616-4628-b476-9ad28804d73c">35,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS0xLTEtMS05ODY3NA_4c5dd3f8-5940-450a-bb10-78e70ab83948">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS01LTEtMS05ODY3NA_6baa2190-8861-4776-81c9-a281b514db45">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS0xMS0xLTEtOTg2NzQ_a0850176-597d-4865-b8e8-41ec3fafc1e7">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTItOS0xLTEtOTg2NzQ_055481b6-d5b2-46af-93c0-aeb5ca17dd4b">837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTItMTEtMS0xLTk4Njc0_fb45f5bd-fb22-42f8-a2fc-7ed63febe50d">837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia35d775120e64ebf8502bf3e34c34978_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTMtNy0xLTEtOTg2NzQ_4b6a0732-c661-47de-8ada-d8bc5f2de645">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTMtMTEtMS0xLTk4Njc0_38fa309b-b344-467d-a249-8a5ebadf0d6e">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i017393d821a848799eb138394bd7839e_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMS0xLTEtOTg2NzQ_d0ed6c03-de4d-4924-ae36-cd65047e5855">45,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017393d821a848799eb138394bd7839e_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMy0xLTEtOTg2NzQ_9440f5ab-f0c5-4fac-a306-4b2bad464048">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtNS0xLTEtOTg2NzQ_f389adbc-0be3-40c1-924d-38825eaf5f26">909,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9287e79f6d44d568cf917866e4551b3_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtNy0xLTEtOTg2NzQ_ce9d709d-954f-4784-8eef-bbed72623fe5">138,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtOS0xLTEtOTg2NzQ_7e86cfa2-42c4-4a0e-b978-d024d6ce1a09">670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMTEtMS0xLTk4Njc0_082446ee-d6fa-411f-bf8c-75c72d2cfe92">770,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33df00d3d4b243f9ad70111a564bd482_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0xLTEtMS05ODY3NA_6a708071-3034-4859-bf23-faa9d8ccad63">43,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33df00d3d4b243f9ad70111a564bd482_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0zLTEtMS05ODY3NA_3e4c0564-0472-4bb6-afcd-2983f76a8d54">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd0cb764acb47c09483deef5d55ead6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi01LTEtMS05ODY3NA_08f22ddc-c24d-42c9-8fc9-2f88c9eb24a5">873,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib213f4e105874831a0ebdb89ae27881e_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi03LTEtMS05ODY3NA_c80662f2-bd89-4e64-a521-aa6740a8fb99">253,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ac36a407c64570801dc9eeb4a4c82d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi05LTEtMS05ODY3NA_436566be-18f3-4776-b7e9-38cbd9e5e209">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0xMS0xLTEtOTg2NzQ_7578b526-cd9c-43b9-a1d1-e2d586ba4ad1">619,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0xLTEtMS05ODY3NA_18b8f1df-ae1a-46ba-9c62-5f184ab15955">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0zLTEtMS05ODY3NA_3e95bfbd-f339-4a8e-9e73-59abaf25053e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS01LTEtMS05ODY3NA_3ff60c96-0dff-4052-87c0-2653e538f2ee">19,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0xMS0xLTEtOTg2NzQ_dfae0da0-5d9e-475e-a44b-7e80ebc27311">19,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNi0xLTEtMS05ODY3NA_b8c42b0f-ed73-46e7-b3dc-71bae0f4cbb5">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNi0xMS0xLTEtOTg2NzQ_39de2c73-e5a1-4e38-950e-5ed37402a0ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy0xLTEtMS05ODY3NA_d2d18960-528a-4791-9e2f-66c0efb31384">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy01LTEtMS05ODY3NA_0ea78e07-4725-4d1d-8834-a1a8c68bb7f0">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy0xMS0xLTEtOTg2NzQ_6f540176-83cf-4775-a8ff-305fe4c2d4ad">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfOC01LTEtMS05ODY3NA_3d4af7bd-0714-4f00-89e8-1ac491e1371c">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfOC0xMS0xLTEtOTg2NzQ_164d6d2f-6f3f-4a41-848a-e88f4399ed86">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTItOS0xLTEtOTg2NzQ_3ec603d1-4bbd-48e5-b520-661c7cafe8a8">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTItMTEtMS0xLTk4Njc0_7666d12c-67a1-4f10-babe-e7cf44301f54">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f13326d7884e5090d68f3d0a570ff2_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTMtNy0xLTEtOTg2NzQ_0ea97f98-8e34-4f4b-910c-bc82ec657e78">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTMtMTEtMS0xLTk4Njc0_27fb74d0-a5ef-45bd-a28d-304f0d288fbc">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMS0xLTEtOTg2NzQ_f8092483-2958-47fb-b948-3460b6ace718">44,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMy0xLTEtOTg2NzQ_22456cce-98d2-4db3-8b71-12b93b3a1b3c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e11e72269fb497ba643fca620eefeaf_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtNS0xLTEtOTg2NzQ_f7cc36a7-d817-4794-add1-2f2c4d8f2e38">925,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic26efb05ce904daca36d5ba11271c6a9_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtNy0xLTEtOTg2NzQ_253f7a17-3a50-42c0-ae84-3b800ba2ad5c">206,765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtOS0xLTEtOTg2NzQ_4fd6ebfb-f0db-4b3c-a873-c6505bb16b18">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMTEtMS0xLTk4Njc0_9f251368-8854-4529-80d7-4aac1abbc781">718,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 8</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMy0xLTEtMS05ODY3NA_598976c1-da3c-4529-84d4-da995271b516">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMy0zLTEtMS05ODY3NA_7512137c-72a0-4628-811d-ec00122cad8a">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNS0xLTEtMS05ODY3NA_9c0619a6-530b-46c3-a2e9-5dc52569012b">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNS0zLTEtMS05ODY3NA_1a51c2c4-7204-4bbc-933e-e1f8036d532d">12,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of fixed assets and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNi0xLTEtMS05ODY3NA_6fe7b167-2f77-4ede-ac5f-284adbd3f28d">61,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNi0zLTEtMS05ODY3NA_f5604445-9f7f-4bdc-9f7d-9f3b107f701f">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNy0xLTEtMS05ODY3NA_98ae40db-ef19-41d8-a226-02d7388ec794">2,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNy0zLTEtMS05ODY3NA_a26d384c-d459-492a-94c9-d79abecdfaf6">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfOC0xLTEtMS05ODY3NA_28f6986e-75af-457f-bed3-b4b424aec851">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfOC0zLTEtMS05ODY3NA_4856ca8a-fe12-48d0-839e-7421a41a5a09">17,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on disposal of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTAtMS0xLTEtOTg2NzQ_c6d951fe-65b9-4d06-825a-31493f0fb387">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTAtMy0xLTEtOTg2NzQ_f0480c2d-70f5-49a8-a8d6-73acc647ed9d">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTEtMS0xLTEtOTg2NzQ_27d2f5a7-b2f1-40c9-b5d5-ee0440da8dfd">35,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTEtMy0xLTEtOTg2NzQ_2631c74f-db29-4612-88b8-201b06c4582d">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Changes in contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTItMS0xLTEtOTg2NzQ_3bc3155f-7765-4633-a5af-a8bfd38b6752">23,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTItMy0xLTEtOTg2NzQ_e7115382-4faa-4b6e-b269-305ac13aedc7">2,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Impairment of investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMS0xLTEtMTA0ODM5_0de0fd8f-45e4-4364-8d34-1928623bc536">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMy0xLTEtMTA0ODM5_6692d603-0070-481b-8b27-e1084a0bbf5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMS0xLTEtOTg2NzQ_3f03b561-a3cd-481a-8605-54312941d1af">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMy0xLTEtOTg2NzQ_c67759ed-dee8-4615-846d-98c542a21af9">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTUtMS0xLTEtOTg2NzQ_4263eea1-a2c0-42b8-855e-5632437fdcb3">2,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTUtMy0xLTEtOTg2NzQ_b6d479a2-3852-42c7-b663-eecc1df47d73">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTYtMS0xLTEtOTg2NzQ_ad564d06-55e2-4723-aa9f-ed631f94ab63">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTYtMy0xLTEtOTg2NzQ_4641ccdf-816e-4b73-af8e-db217dd0f3bc">2,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTctMS0xLTEtOTg2NzQ_a7067d85-1ec1-43cd-b6b1-73f9635525ee">568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTctMy0xLTEtOTg2NzQ_99972266-978a-4ca9-985c-fd800da7b01c">907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTgtMS0xLTEtOTg2NzQ_b3e300ce-3595-4ed2-906c-b3bf1718bcb7">4,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTgtMy0xLTEtOTg2NzQ_1d20b32a-ee3a-4b59-b022-ad26c2f7724d">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses and income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTktMS0xLTEtOTg2NzQ_c4c47a7c-bea1-471f-8ff1-441d226fcf1b">23,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTktMy0xLTEtOTg2NzQ_a0ac9647-df89-43e9-8105-cd80dde3473e">17,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjAtMS0xLTEtOTg2NzQ_6dd45daa-f81a-446b-b956-0da2ae65f6b2">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjAtMy0xLTEtOTg2NzQ_79085b06-3fdd-41fe-88a3-b9d8bc37eb25">1,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjEtMS0xLTEtOTg2NzQ_a1ca4f12-2ee5-476e-beab-df2d42bee3bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjEtMy0xLTEtOTg2NzQ_cb162ed1-8c0d-4256-99dc-be871915961f">5,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjItMS0xLTEtOTg2NzQ_e6811549-a38b-4a2f-8a77-f75d79069444">103,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjItMy0xLTEtOTg2NzQ_01352289-1065-4508-8738-5fa294982138">102,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjUtMS0xLTEtOTg2NzQ_670e5c79-e88f-4cf9-bdcb-b7929b87f584">24,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjUtMy0xLTEtOTg2NzQ_149f7b1f-0719-406c-9bc6-01b135889d45">36,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjYtMS0xLTEtOTg2NzQ_edfa3c0d-4936-4596-be03-853108b0d2d2">319,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjYtMy0xLTEtOTg2NzQ_75fea244-75f2-40c9-9a55-5966bcfc4b30">513,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sales of available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjctMS0xLTEtOTg2NzQ_541ac4f5-39fd-432a-bf66-4fcb1164282d">152,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjctMy0xLTEtOTg2NzQ_7ac3bc16-1ec7-417e-bf6b-328a802d9666">470,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:PaymentOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjgtMS0xLTEtOTg2NzQ_dfb9b2f8-7252-43a0-856d-4ca824e99ed8">32,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:PaymentOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjgtMy0xLTEtOTg2NzQ_19ce2cb5-f7b6-443d-9988-4432e07d510e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of equity and debt investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjktMS0xLTEtOTg2NzQ_827bee79-d549-4ad9-8329-5cb4073bfb2c">13,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjktMy0xLTEtOTg2NzQ_711d3e3a-7515-4c0e-a619-cbb5cda5c7b7">17,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sale of equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzAtMS0xLTEtOTg2NzQ_644f46ca-d7cb-4c29-b5d3-24c91490cc3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzAtMy0xLTEtOTg2NzQ_a1918b01-2b73-4558-bd19-1b92def82e61">9,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzItMS0xLTEtOTg2NzQ_15b60e0b-bda9-4b53-ab13-6d3726bcfbe9">236,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzItMy0xLTEtOTg2NzQ_2e7bca36-8dca-49db-947a-9dd48fb57b18">87,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzQtMS0xLTEtOTg2NzQ_cf3b01ed-4b09-4021-a656-3bc8cb9933a5">23,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzQtMy0xLTEtOTg2NzQ_c7325d77-d8a9-4faf-b459-7b804e9f20a7">19,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzUtMS0xLTEtOTg2NzQ_ebce0725-a7d8-4b65-be6f-d25a396f1c46">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzUtMy0xLTEtOTg2NzQ_dce60bf0-43d9-4b53-9641-b7a214a2c28c">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of 2022 convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3530d8956b418fb81361eeb95b183f_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzgtMS0xLTEtOTg2NzQ_f7f220ec-37ba-431f-ac1e-e416cd7fccc6">156,960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041c1e3222e444948ec64a03cb444a3e_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzgtMy0xLTEtOTg2NzQ_f2b8f70d-a496-4193-99a3-b6e9b3094e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of 2024 convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if31c04f6a8b042bf8a5b262a586ee559_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzktMS0xLTEtOTg2NzQ_40f4b23e-e01c-40e8-9db3-b4f0f61829ce">192,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f778c46a68241c395e54cb6cccc6e03_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzktMy0xLTEtOTg2NzQ_f0be64cf-c594-482c-a3a9-1f2af6dfa9bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of Term loan B facility maturing December 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDAtMS0xLTEtOTg2NzQ_ed0adfcc-b069-47cf-9a21-d77450f14bc0">18,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDAtMy0xLTEtOTg2NzQ_b8b9aa30-f8f0-4940-b6b3-484693b98c4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration to MyoScience, Inc. securityholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDQtMS0xLTEtOTg2NzQ_2152d6fb-decc-4d43-8ab0-04c11443ec87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDQtMy0xLTEtOTg2NzQ_edcaafe5-84a8-4e99-8fa0-42c8c2bb38a1">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDUtMS0xLTEtOTg2NzQ_435237b7-2871-4fa8-85be-705c754b9da3">343,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDUtMy0xLTEtOTg2NzQ_4e7aae26-36b9-4b51-91ee-a35c475508b5">19,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDYtMS0xLTEtOTg2NzQ_3cca62ad-e9ee-42e7-9fda-eef5ba193c62">476,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDYtMy0xLTEtOTg2NzQ_99f4363b-3951-416a-9d3d-1f138767d6b0">34,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDctMS0xLTEtOTg2NzQ_30d257eb-94ed-43c8-85a4-c2edff5deb79">585,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDctMy0xLTEtOTg2NzQ_f5b7efbf-1b8b-4e5e-aff3-0ffc909b9ee1">99,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDgtMS0xLTEtOTg2NzQ_186fada9-ac95-4006-b39d-187baa3ceae4">109,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDgtMy0xLTEtOTg2NzQ_8505d55f-9e13-431b-9922-56ceeb3097f9">134,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTUtMS0xLTEtOTg2NzQ_a4e8bcb3-5f39-47af-89ac-01169b78ce49">23,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTUtMy0xLTEtOTg2NzQ_9c784ce8-f730-4782-908c-6564dbf2fd4d">5,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTYtMS0xLTEtOTg2NzQ_5323232f-6814-449f-bd60-10cea72b6673">4,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTYtMy0xLTEtOTg2NzQ_40dc73b9-a3df-4ee5-bbc4-d90c4a896916">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Issuance of common stock from conversion of 2022 convertible senior notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTgtMS0xLTEtOTg2NzQ_ea0079b5-5393-4a42-9152-c136cf7d67df">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTgtMy0xLTEtOTg2NzQ_935ac6cc-30d6-40ac-b4c9-36a3bfa685fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNjItMS0xLTEtOTg2NzQ_8af82c68-8224-4b43-8256-f17dc1903547">5,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNjItMy0xLTEtOTg2NzQ_88bc4cd4-0ddb-43ad-83c2-9e164a2fc3e7">4,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 9</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfNDIxMw_925f9c80-c50e-4df2-a02d-47c5f5259e89" continuedAt="i4881eeed0f264f10b74e2714a54637f4" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4881eeed0f264f10b74e2714a54637f4"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The Company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#8217;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#8220;MyoScience Acquisition&#8221;). The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to targeted nerves.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from <ix:nonFraction unitRef="product" contextRef="iada9dd15075e4cd895a69a423bad73c7_D20220101-20220930" decimals="INF" name="pcrx:ConcentrationRiskNumberOfProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfMTg3Mw_d290964a-15a2-411e-bed6-4b45b27d6cea">three</ix:nonFraction> products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as <ix:nonFraction unitRef="segment" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfMjY2OQ_fa3fb813-92ba-499c-b8c5-3f8092f2af17">one</ix:nonFraction> reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, the Company&#8217;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#8217;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#8217;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc5Ng_8d46b75e-c550-4ad4-925b-0d1faeeb0a96" continuedAt="i94aea64428ec4fb182693444e8ea4323" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i94aea64428ec4fb182693444e8ea4323" continuedAt="i9ee5c277d4d94000abcca4cb836068da"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc4MA_08be6e69-b2f5-4edf-8864-808f14bdaeb3" continuedAt="i2fa47c5f384c487a83630d65ba247301" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i9ee5c277d4d94000abcca4cb836068da" continuedAt="i4d9c89ec9d9f421ea4b0450f9d05d6b7"><ix:continuation id="i2fa47c5f384c487a83630d65ba247301"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div></ix:continuation><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDgwNA_134ef0eb-999b-4bb5-99f9-1c4587c9837e" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc3Mw_8e681b6c-2f70-4b26-87a7-672fc91104a5" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930" decimals="INF" name="pcrx:ConcentrationRiskNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfMjk0MQ_f034ad8b-3a0b-43ed-9d96-448f3c39c321">three</ix:nonFraction> largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id798a30004274993babf49e9b98be123_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi0xLTEtMS05ODY3NA_fab1e1c6-f9a8-4c1a-a77f-39fb455286d2">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a7621b4bba342699674426138465e98_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi0zLTEtMS05ODY3NA_662f42fa-f294-4600-a227-dcd6203dd9e7">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i491f1c40eec747d48c2a3cbf996a653f_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi01LTEtMS05ODY3NA_1b9b481b-6667-4449-8c90-801ec3f76d0f">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idea3269a015844a88e20bfa8a2c5db42_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi03LTEtMS05ODY3NA_5703d61d-7bbb-4b68-896b-50f8e380686e">31</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4d204d59893479994e548d189f110c0_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy0xLTEtMS05ODY3NA_b1cbdba9-7d8a-4bed-9537-af8869189efc">22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e8428c526394e7b892c82c1100eae05_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy0zLTEtMS05ODY3NA_929de998-8181-43b4-850f-0b952ea4212b">28</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i785ba673e38b4971a09e28476d230f20_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy01LTEtMS05ODY3NA_3e2c64c9-0ff1-42fc-8b1b-8ad931208ff7">23</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40d9bb0c3093491f8fd4cc029445495a_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy03LTEtMS05ODY3NA_2e016874-1383-441f-84d2-973138c354ce">28</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c2f2c9bc8c54a0298a54156ff906c36_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC0xLTEtMS05ODY3NA_5cae7521-1ba9-49f5-a743-fd9a67dfeb68">22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81faa5db9ab84d9abcedc8d10f6aadd6_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC0zLTEtMS05ODY3NA_b15bfc42-c869-437c-a308-5c943576694e">26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35ee1fd141184820a1033d1e2b620500_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC01LTEtMS05ODY3NA_7a8bae87-5353-43b9-ba63-19c33790ad7b">22</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0dcf246ea00f4772961db833e7e6c9c5_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC03LTEtMS05ODY3NA_78840e1d-e276-4059-b122-7fb52ab40df0">26</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4cc07e896b4645dfa4efb71cc229b19c_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS0xLTEtMS05ODY3NA_f5e3ded8-ca21-4324-bc94-794bf5047afd">75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75e7ecfa4c964440a2946a9bd17bcb30_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS0zLTEtMS05ODY3NA_4eccc19a-5c71-489b-bae1-a91747b9f879">85</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if36a483a5fae482eabe15aad4726bdf2_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS01LTEtMS05ODY3NA_a7d017ec-902a-44f9-a07d-40f76927c8ab">76</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba56a5bf30fa44d791bf3d27fae3998c_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS03LTEtMS05ODY3NA_8e58fab8-3e96-486d-9bc4-ef7f3b142524">85</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of revenues from the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930" decimals="INF" name="pcrx:ConcentrationRiskNumberOfCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfMzAzOQ_f034ad8b-3a0b-43ed-9d96-448f3c39c321">three</ix:nonFraction> largest wholesalers have shifted in the current year with the addition of ZILRETTA sales, which began in November 2021 following the completion of the Flexion Acquisition (as defined below).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc4OQ_b053d4d6-1bf3-4040-8faf-73aec978c5fe" continuedAt="i9e543f8bf37d4854837b2791e037afd9" escape="true">Recently Adopted Accounting Pronouncements</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><ix:continuation id="i4d9c89ec9d9f421ea4b0450f9d05d6b7" continuedAt="ia8fa14b119684e78848f14c1cd5db5a2"><ix:continuation id="i9e543f8bf37d4854837b2791e037afd9" continuedAt="i2bbcf0fc891348cea26c20d9e6478b68"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia8fa14b119684e78848f14c1cd5db5a2"><ix:continuation id="i2bbcf0fc891348cea26c20d9e6478b68">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $<ix:nonFraction unitRef="usd" contextRef="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDY0Nw_dd529ce0-c8ec-4bc5-88bc-d60e4179bd15">64.9</ix:nonFraction>&#160;million, reduced accumulated deficit by $<ix:nonFraction unitRef="usd" contextRef="i4ab43b03e7f045cfa6ba5b01ccc9f663_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDY4Mg_b3d3fd48-1694-40cd-8d06-46800c1204b9">47.2</ix:nonFraction>&#160;million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i3a7066383d00444bb7d24779d5fcd386_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDcyNA_c77fe3f4-b21d-46c7-b142-e275ca5a8f57">96.5</ix:nonFraction>&#160;million and decreased deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc2OQ_49d4a6dc-bd5a-43e3-a431-da73ec83ba87">15.7</ix:nonFraction>&#160;million.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 11</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfNDYxNA_3a357851-b691-488f-ab02-69bf2fa20268" continuedAt="if54e6cf034ec4ce083fd1cad2390d7ca" escape="true">REVENUE</ix:nonNumeric></span></div><ix:continuation id="if54e6cf034ec4ce083fd1cad2390d7ca" continuedAt="i8457a553c4054f009fce66242b872228"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#8217;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenues are recorded at the time the products are transferred to the customer.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy and doctors. Payment terms generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzMg_bfd25119-5362-4514-9063-c69b91c15797">zero</span> to <ix:nonNumeric contextRef="ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930" name="pcrx:AccountsReceivablePaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzOA_4f2d4767-21ec-424d-b105-9c6dfbbb5d0f">97</ix:nonNumeric> days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i8457a553c4054f009fce66242b872228"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfNDYxMQ_62063e5b-1d23-4afc-8366-febe2c434252" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b7f09cd3fa46f7bef2e7b988c8c155_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy0yLTEtMS05ODY3NA_56666266-c01a-4386-a90c-2775a662edf0">132,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaced5e5f9bc940a892330f204dd2244f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy00LTEtMS05ODY3NA_ac496ac5-9d92-4316-8fa7-5570d14a8a2c">121,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie744a5ac2c014227987bdfeeacecae8c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy02LTEtMS05ODY3NA_30e3ae90-cd1f-4cd6-9ea8-a27d7b6f1b8e">398,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b27bac4a4f40deae2b2f890f8e66b2_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy04LTEtMS05ODY3NA_b486a77f-e084-4a80-a436-d989d449f10e">366,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb8393abab9472ba432b3023d43f876_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC0yLTEtMS05ODY3NA_d9fbe22e-9647-4834-a21d-447f5f7eee90">26,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bec708640aa4fe89373e8a8b5097698_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC00LTEtMS05ODY3NA_0fdeaf72-9ad3-492f-b619-3e95a95ed51b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie304082b6d1244319404c24adf4df95d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC02LTEtMS05ODY3NA_9d85851b-cba3-4932-b841-06aa46fa0192">77,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b382af13b04dad89a0b67e8cbed57b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC04LTEtMS05ODY3NA_ebb5933c-5647-4c13-9eb9-c97bda3af095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ff9b5c1afd24751ac47466df9cf7363_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS0yLTEtMS05ODY3NA_da6676c4-2e06-4ec2-80f9-bd9d5da4f22f">4,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d71636ef1a41278d664b9a58e7b14a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS00LTEtMS05ODY3NA_902604cf-4c4c-4e9e-96d1-f04add597f43">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7b8f126963466480f241a2ea73cd74_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS02LTEtMS05ODY3NA_4b4f4d1c-f08c-4d61-be66-921eeec5dcb5">10,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22145e0671d24d3192e811839a75fcc6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS04LTEtMS05ODY3NA_4bc012fe-f314-4c0c-95d7-59bceddd8675">11,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58db0d23a27d413abf5cf179a882a86e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi0yLTEtMS05ODY3NA_a4e15b5f-9cbb-4875-b34a-d009ef3734c9">2,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ca564b922e4b24926c90284b7d52f5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi00LTEtMS05ODY3NA_5753e09a-ecf7-44d7-b216-e0e24d9cfe21">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774694031232442bade01c3100051d55_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi02LTEtMS05ODY3NA_72a93a79-3791-4fb8-81b2-b0cb0ad7bc3f">5,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b6428ad6264377b5daa3a69ab1fb5e_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi04LTEtMS05ODY3NA_14fb4eae-9082-4c18-afb5-db7124d77aaa">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy0yLTEtMS05ODY3NA_2404d1f7-4f08-4204-a060-cb1ce20c9b65">166,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy00LTEtMS05ODY3NA_9b68710c-adb2-402b-8c67-9ddfcfb6b04b">126,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy02LTEtMS05ODY3NA_26f75266-c27c-4a88-bb81-d7d398189f4e">492,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy04LTEtMS05ODY3NA_8de7ad88-488d-4c58-82de-915f8c78847f">380,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1Nw_4f351ae3-8f26-437a-96eb-aac6d9ae775b" continuedAt="i37fa4eec6d2c494e99e6b4c6665bf5a1" escape="true">FLEXION ACQUISITION</ix:nonNumeric></span></div><ix:continuation id="i37fa4eec6d2c494e99e6b4c6665bf5a1" continuedAt="i01feb43e9e3248bf91c9e3c8fbd15e75"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, the Company acquired Flexion (the &#8220;Flexion Acquisition&#8221;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total consideration for the Flexion Acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNTcy_c426f284-ca53-4043-9636-978cd7cdf4fe">578.8</ix:nonFraction>&#160;million consisting of: (i) $<ix:nonFraction unitRef="usd" contextRef="ifa17d6ce32084dc195161c9e6c47a57c_D20211119-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNTk0_4c5c3991-d6af-4e2e-b9d6-5c7cf4146cd2">448.5</ix:nonFraction>&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $<ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNzE4_c3d6b97b-166d-48cd-8840-91a13438dfbf">85.1</ix:nonFraction>&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $<ix:nonFraction unitRef="usd" contextRef="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfODAy_56b9dda8-6bd5-4a0b-9afd-d12334b0df90">45.2</ix:nonFraction>&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $<ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMTEzNw_393bd784-cfe8-4d13-9a09-d77d6b4a82e9">380.2</ix:nonFraction>&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the nine months ended September&#160;30, 2022. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i01feb43e9e3248bf91c9e3c8fbd15e75" continuedAt="ia257870e96384895a2c6e84143e31ba9"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1OA_776feb83-72f0-4bf4-b018-ee2b86e46319" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is finalizing its valuation of certain tax accounts, and anticipates finalizing the purchase price allocation as the information necessary to complete the analyses is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.348%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMi0yLTEtMS05ODY3NA_4b2ebf4a-7b0b-439e-b774-c55422a333f0">113,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMi02LTEtMS05ODY3NA_5f604f97-6452-4966-8f2d-6b962971fec3">113,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMy0yLTEtMS05ODY3NA_e8134ba6-2587-4c30-aabc-42a48d339384">11,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMy02LTEtMS05ODY3NA_e25728e4-5bd8-4c2b-b193-fb778184c8db">11,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNC0yLTEtMS05ODY3NA_763e8391-5c2f-482b-8638-f8833e9f04d2">32,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNC02LTEtMS05ODY3NA_1347a2cb-6e7b-499b-8a43-b1c5f4b7f92b">32,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNS0yLTEtMS05ODY3NA_041fe1c6-14d1-4729-8512-a852dcd01362">29,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNS02LTEtMS05ODY3NA_bda3eea2-0d24-482a-a799-b13bee746465">29,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNi0yLTEtMS05ODY3NA_748654e3-3d04-45c8-98a2-7f1ba6eb5d4b">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNi02LTEtMS05ODY3NA_5b720355-55dc-4aab-a84e-b1534acefedd">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNy0yLTEtMS05ODY3NA_82c8f098-1bb7-49ed-8b65-6bc9acbe8bd9">23,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNy02LTEtMS05ODY3NA_c7494025-b7cb-4d22-9224-f860dc34c30f">23,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC0yLTEtMS05ODY3NA_f70c6ee6-2c8b-4080-b49a-7f40438dd50f">58,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" sign="-" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC00LTEtMS0xMDQ0NzE_fff1bc3e-906e-44ab-a181-71a5b7e630ab">10,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC02LTEtMS05ODY3NA_9472249b-2096-47b1-a482-2074ec1d4765">47,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOS0yLTEtMS05ODY3NA_a09d2359-7179-45ac-9c49-b8b7835d7f0f">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOS02LTEtMS05ODY3NA_b5dfaec3-57d5-4cda-b4c3-1b287a2b39af">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTAtMi0xLTEtOTg2NzQ_099ca187-a852-40d2-9fc4-50ffb8b927a2">480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTAtNi0xLTEtOTg2NzQ_b4a12310-d4c9-481b-89e3-1721c8398517">480,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTEtMi0xLTEtOTg2NzQ_7a497b91-94b4-44f3-849c-2822fd0ad306">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTEtNi0xLTEtOTg2NzQ_5b6a21fd-e0ad-4aa2-be8a-3e068705e265">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItMi0xLTEtOTg2NzQ_75ff0aee-7b3d-4fd7-bcaa-48b53992f56b">820,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" sign="-" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItNC0xLTEtOTg2NzQ_84dbb4ee-adfe-4d11-8a33-164ee0a309f6">10,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItNi0xLTEtOTg2NzQ_dd57779c-fb33-4baf-a8ee-a854d8f0e306">810,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTQtMi0xLTEtOTg2NzQ_b4dca3ba-2a5e-42d0-ad64-ee01a2a71db2">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTQtNi0xLTEtOTg2NzQ_8c2a65ab-c482-446f-9f71-7f7cc029b595">9,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtMi0xLTEtOTg2NzQ_29b5288b-b388-4faf-aa59-dc93def177b0">22,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtNC0xLTEtOTg2NzQ_60627291-8de0-4de4-9893-fe1e202bb910">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtNi0xLTEtOTg2NzQ_f53033e8-c2a1-49a1-a8d0-9aa1262623c5">23,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTYtMi0xLTEtOTg2NzQ_14ebe6e1-fb7c-4eec-b1a6-0a3269cff581">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTYtNi0xLTEtOTg2NzQ_03f878c2-5102-44c5-a9fc-57013d931fc6">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTctMi0xLTEtOTg2NzQ_4252e45d-e29d-4f05-99f5-5aa8e63a4b63">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTctNi0xLTEtOTg2NzQ_e850d648-b6db-4eaf-b232-ed3a033a85ab">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTgtMi0xLTEtOTg2NzQ_cbee7eb2-af6b-47e4-b69a-7722f67512ff">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTgtNi0xLTEtOTg2NzQ_e91596e0-3b36-4473-85fa-e1f2a51b4660">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTktMi0xLTEtOTg2NzQ_08062670-9aa5-4bae-863a-bc91859f97f4">201,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTktNi0xLTEtOTg2NzQ_72321e25-6688-40cc-8c18-bce8d85f5adc">201,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtMi0xLTEtOTg2NzQ_b6cfde94-7495-46a3-b56b-2d728a2fa2c4">251,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtNC0xLTEtOTg2NzQ_f3e5bd1d-b2df-4233-83c8-1e7a8aca3b67">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtNi0xLTEtOTg2NzQ_3eb48224-6eda-477c-8772-616784b0f18e">252,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtMi0xLTEtOTg2NzQ_6e980571-6e65-472d-b66c-4c4bcd5b7fc7">569,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" sign="-" name="pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtNC0xLTEtOTg2NzQ_83e54ae3-acf4-4dbb-a466-87cffa09af4f">12,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtNi0xLTEtOTg2NzQ_80df320b-cca1-4bac-85c3-9acb38cbd351">557,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItMi0xLTEtOTg2NzQ_e30e9b2e-da1d-4b04-8766-23668b9defc9">9,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItNC0xLTEtOTg2NzQ_64e9e70c-0360-4aad-9df2-64622256cf1b">12,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItNi0xLTEtOTg2NzQ_1b879501-4de6-4011-8b1b-0dede4fa19a8">21,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtMi0xLTEtOTg2NzQ_90469655-7d83-41ae-aba7-4df0e1ec33a5">578,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtNC0xLTEtOTg2NzQ_63d703f2-b04d-48cb-bd25-6751689631e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtNi0xLTEtOTg2NzQ_31f0e8ad-cc04-4467-9e23-66784c4472df">578,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents the finalization of a tax study and pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Summary of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the unaudited pro forma summary of operations for the three and nine-month periods ended September&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1OQ_58d772b8-78ff-4f7a-9115-9f91a3d7473f" continuedAt="ic7439a33051c4fbf95b08deb59f4b133" escape="true">This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):</ix:nonNumeric></span><ix:continuation id="ic7439a33051c4fbf95b08deb59f4b133"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMS0xLTEtMS05ODY3NA_c891465c-537a-4f01-acb9-9aabd0158233">149,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMS0zLTEtMS05ODY3NA_2c86f5cb-d7f2-42be-b3e3-580773dda0cd">456,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMi0xLTEtMS05ODY3NA_28e3e25f-b2e0-4b74-b688-1301becf4190">10,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMi0zLTEtMS05ODY3NA_8f26c792-dac2-475c-a04e-780acc1f3a22">31,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0xLTEtMS05ODY3NA_07b56102-d80f-43b3-b9c3-70c48a342cd8"><ix:nonFraction unitRef="usdPerShare" contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0xLTEtMS05ODY3NA_3f5f92be-cd73-4c13-97de-e1e6a4dca1b9">0.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0zLTEtMS05ODY3NA_445fefa2-f24d-497d-9840-70870bd877c9"><ix:nonFraction unitRef="usdPerShare" contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0zLTEtMS05ODY3NA_a618443c-1137-461d-8fd3-44bc91cbb546">0.71</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="ia257870e96384895a2c6e84143e31ba9"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Recognition of the income tax benefit resulting from decreasing Flexion&#8217;s existing valuation allowance on deferred tax assets for the three and nine months ended September&#160;30, 2021;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Removal of Flexion&#8217;s interest expense and associated deferred financing cost amortization related to the $<ix:nonFraction unitRef="usd" contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119" decimals="-5" name="pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzI4MA_eab001a3-68b1-4cb8-af79-75a7e48ce01e">85.1</ix:nonFraction>&#160;million of debt not assumed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Adjustments to the Company&#8217;s interest income for the cash used to acquire Flexion; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional cost of goods sold related to a step-up value in inventory;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional amortization expense from the acquired developed technology intangible assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional depreciation of Flexion&#8217;s fixed assets; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional lease expense on Flexion&#8217;s right-of-use, or ROU, assets.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all of the above adjustments were adjusted for the applicable tax impact.</span></div></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_49"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RleHRyZWdpb246MWE4OTg5MmVhM2FhNGE1YThiNmQyZTk4OTMwNDkxZjBfOTg_f1d281d2-b680-4432-ace8-6a463280df8f" continuedAt="ie7e18b8214024c93b806c00cbdca8f5d" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ie7e18b8214024c93b806c00cbdca8f5d"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RleHRyZWdpb246MWE4OTg5MmVhM2FhNGE1YThiNmQyZTk4OTMwNDkxZjBfMTAx_b2124a30-ae30-4bcc-84f9-c266040838e9" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMi0xLTEtMS05ODY3NA_a5029136-2481-4750-b2ff-6aebea61d3d9">35,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMi0zLTEtMS05ODY3NA_18272335-d3a7-499b-817c-e42e04692269">36,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMy0xLTEtMS05ODY3NA_c6fb76ef-9fd4-41eb-90bf-73270b5ce14c">35,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMy0zLTEtMS05ODY3NA_7c47a1df-571e-4cf8-8211-3e922b442e50">35,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNC0xLTEtMS05ODY3NA_6d570647-4242-4ece-8d5d-33c6b6668aea">26,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNC0zLTEtMS05ODY3NA_bb4aef54-2eb8-48c4-9e8b-764a2eb0bc07">27,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNS0xLTEtMS05ODY3NA_780982b7-0f75-400b-829e-320117082f47">96,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNS0zLTEtMS05ODY3NA_44981186-bbff-49f3-861b-ff66c743a505">98,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTAyNg_26549dc8-2e6b-4763-9462-be8515a0db48" continuedAt="i0c304e469e4042ceafc6c0dd0c33d97b" escape="true">FIXED ASSETS</ix:nonNumeric></span></div><ix:continuation id="i0c304e469e4042ceafc6c0dd0c33d97b"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTAzMw_27fd48a6-09ac-40e6-855b-0d2a621dd14a" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3422a161284fd4968428139893ccc3_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMi0xLTEtMS05ODY3NA_adbbed56-e125-4fc1-958a-23207c3e0051">118,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efbe146066f4b189710fe01037a4e39_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMi0zLTEtMS05ODY3NA_a999f4a4-ea71-44f5-acac-0f422769839b">117,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ba6850e6cf4817a5abb640bffde50e_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMy0xLTEtMS05ODY3NA_bc9152f4-dccd-442a-bb0c-1c8582c430a0">61,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabadf7b6a1224bb3916ef669ce65a34d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMy0zLTEtMS05ODY3NA_52001e18-1af9-48c2-8ba9-f0498f4949a3">59,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if230c3c362c544bea9bc5d678fd8606c_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNC0xLTEtMS05ODY3NA_51149f1c-e3f4-456f-999f-48a635a48c50">14,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a4a3f2486495096df65f35513637d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNC0zLTEtMS05ODY3NA_185c17e3-85fa-4d54-907d-c3976b25240d">13,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6aef198937e45468ba17175b8a02cbd_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNS0xLTEtMS05ODY3NA_e2d1b968-a2d4-429b-b42d-3bdf54d5df17">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69260eaa59884a4b80bee5f89c48b5ee_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNS0zLTEtMS05ODY3NA_1490446b-6bc9-47de-bdbd-5ea2cab327a1">2,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84837eb6c88478cb22b5e730913d7da_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNi0xLTEtMS05ODY3NA_c06ef8dd-e98a-4e22-9834-7fe32a1d58aa">98,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1083fc7b3c5544e99ac79b620bd148fa_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNi0zLTEtMS05ODY3NA_d53d187d-d962-439b-a599-b2cb16d71751">80,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNy0xLTEtMS05ODY3NA_26b25c63-5638-485d-8c0f-2adf151f6a94">295,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNy0zLTEtMS05ODY3NA_4fe711ef-59b2-4d1e-8682-30c1f9db9f02">273,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOC0xLTEtMS05ODY3NA_7a493fb3-995d-4fd5-94e9-95d31138115f">101,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOC0zLTEtMS05ODY3NA_893bf161-273c-4d65-a6bd-eea9698ca4ff">85,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOS0xLTEtMS05ODY3NA_6e8e31ce-149c-45b1-b343-2270dad8cc84">193,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOS0zLTEtMS05ODY3NA_a6fcd261-5f17-4c10-98b5-630d79ffb655">188,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTgx_b96cecd9-f0f0-4362-a46e-f8d72c0561d4">5.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTg4_a9364c1f-4ee8-46dd-a02e-5a1a062a6ea0">3.8</ix:nonFraction> million, respectively. For the three months ended September&#160;30, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i5850959cee0b45c5999d3d9d0ee56a23_D20220701-20220930" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMjU0_7c80cd79-af11-4cce-bb0c-d20ea0f3dd7c">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i452f6f29fd7a4cefaf5db7fc6d5b7fcc_D20210701-20210930" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMjYx_13fd66cf-0e8c-4c62-97e7-41ad56f97550">0.9</ix:nonFraction> million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and 2021, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMzk0_5591fda7-35a9-4b44-8947-5db70d451ec0">18.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDAx_6044ebc0-6e37-4dca-b466-d4714f67334e">9.6</ix:nonFraction> million, respectively. For the nine months ended September&#160;30, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="icaea5ef1bea14e64a8f9e557b76fefec_D20220101-20220930" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDUx_96b87ff8-6f35-401d-b03f-07ed2933bf09">2.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifd5ea19425754b48a8d743a2a9a4c06f_D20210101-20210930" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDU4_0df09384-8c19-4e1f-8758-12c36024ea2a">3.0</ix:nonFraction>&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $<ix:nonFraction unitRef="usd" contextRef="i2fb3d023787140b4a618c948c7de865a_I20220930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNjg0_3a1652a8-a9c4-413a-918c-cb9b7c223877">57.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i933d53b6705f4e2d828a014e7a4ef1cb_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNjkx_872c6b22-6661-4e8a-87a5-b9771f8e1a96">65.4</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNzc1_5900e075-7f0b-4368-85c3-c9dd8a6dece4">3.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNzgy_e133b885-57a7-441d-8fb0-f6aac71dea4e">2.4</ix:nonFraction>&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 15</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxMg_2ecf274d-4aff-452f-944f-3032805a0e43" continuedAt="ie4aaf95b276a4802b8b54e05074f6de6" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="ie4aaf95b276a4802b8b54e05074f6de6" continuedAt="i08e7c87e97db4219a8076350b44b29c1"><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL and iovera&#176; manufacturing facility in San Diego, California. These leases have remaining terms up to <ix:nonNumeric contextRef="if677311d787345c3a160575158dda8a6_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxMA_a7b9cb97-0e3c-49db-85e1-3fa189396ddb">7.9</ix:nonNumeric> years, some of which provide renewal options at the then-current market value. The Company also has <ix:nonFraction unitRef="lease" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="pcrx:NumberOfLeases" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAwNg_0b702aec-5ef5-4bc5-a3c0-c626e25b6119">two</ix:nonFraction> embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis. During the three months ended September 30, 2022, the Company entered into a partial sublease for the former Flexion research and development laboratory in Woburn, Massachusetts which resulted in a $<ix:nonFraction unitRef="usd" contextRef="if7c59933724e48839a86397a939f4299_I20220731" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMzEwOA_c597f283-2c66-44c7-865d-0690fbc95480">0.4</ix:nonFraction>&#160;million ROU asset reclassified to a fixed asset.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxNw_31da7188-284d-437d-91fe-5041aeffd6ca" continuedAt="i8abe6ee9ae034ab9b856f88775295788" escape="true">Total operating lease expense, net is as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i8abe6ee9ae034ab9b856f88775295788" continuedAt="iea8d927f0ead4738a5132f012fcfaaef"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy0yLTEtMS05ODY3NA_951d2207-b015-4089-b217-6c4455b860f7">3,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy00LTEtMS05ODY3NA_792f8a63-b150-47ba-b20f-920d63ff6690">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy02LTEtMS05ODY3NA_06036bca-2830-4413-b33c-7d9782c2699c">10,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy04LTEtMS05ODY3NA_2b740ff0-82c0-4eb5-a158-f98ec4150885">8,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC0yLTEtMS05ODY3NA_ad2f7d07-1708-40bf-8e25-f2887dfc2d92">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC00LTEtMS05ODY3NA_fae66da2-d791-4576-94ef-a380256bfcef">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC02LTEtMS05ODY3NA_12f5ecaf-f8cb-4d5e-a3c0-a986a54af993">1,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC04LTEtMS05ODY3NA_29bdfa49-b4a5-40d7-acf0-87d9d30c7b38">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS0yLTEtMS0xMDE0ODY_89f525e5-e92c-4815-9e5e-01d21170cf5a">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS00LTEtMS0xMDE0ODY_1691e1e1-2522-41ce-a3d2-2b8c7dab452c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS02LTEtMS0xMDE0ODY_9a54fbe1-6d0e-43e3-9da9-4f6864e6a5b0">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS04LTEtMS0xMDE0ODY_4a1dc761-61b2-4171-a116-a2b8895f6dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Lease expense, net of sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS0yLTEtMS05ODY3NA_0bc58605-d4e2-40b8-87a3-577bc34ebcca">3,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS00LTEtMS05ODY3NA_f1f3e55e-c32c-47b6-b9c0-dd81f46d6304">3,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS02LTEtMS05ODY3NA_2f92c005-c16b-4d16-8dba-973e7b04bcb4">11,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS04LTEtMS05ODY3NA_f0ad5bf0-7d47-4530-834e-7ee2c5d205d5">10,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfMy0yLTEtMS05ODY3NA_d7f23489-7a94-4f64-8b21-838cf9ba1161">9,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfMy00LTEtMS05ODY3NA_6d20102f-787d-4d45-81f8-3ef8e9ee4cca">9,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfNC0yLTEtMS05ODY3NA_33349104-229e-4fad-be21-7228519bcd4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfNC00LTEtMS05ODY3NA_67c54181-7b2b-488c-9781-b9aa60682f9e">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. <ix:continuation id="iea8d927f0ead4738a5132f012fcfaaef" continuedAt="i5abee407ba894693ab3b81dbd2a125de">The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</ix:continuation></span><ix:continuation id="i5abee407ba894693ab3b81dbd2a125de"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic44364ce38c044838833d136327e1683_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMi0yLTEtMS05ODY3NA_5bc5595a-9ce4-4de1-a914-37037a39efed">7.11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMi00LTEtMS05ODY3NA_79355077-a586-4ad9-98b6-bd0506530343">8.46</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMy0yLTEtMS05ODY3NA_48ee7a42-97e5-4774-a562-dc9a1f4444a2">6.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMy00LTEtMS05ODY3NA_4ad66491-2509-4a96-84d7-9c21b9585a46">6.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxNQ_ca6f4f3a-ca51-428a-991f-3f97047e0faa" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMS0yLTEtMS05ODY3NA_09edfd84-abba-4d37-aa21-cf3ea70fffeb">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMi0yLTEtMS05ODY3NA_94f7e753-d968-456b-9b53-1fff487e26b7">13,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMy0yLTEtMS05ODY3NA_24392524-8f3a-4094-b0c4-870443796138">13,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNC0yLTEtMS05ODY3NA_de87ee91-5191-4a41-b68f-69e5b3bed670">12,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNS0yLTEtMS05ODY3NA_b3a2287c-ccc7-44d9-b944-f5b2c156624e">12,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNi0yLTEtMS05ODY3NA_9985daa4-97e5-41b6-857e-69bc692e3944">39,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNy0yLTEtMS05ODY3NA_7bc2eff6-591c-4d9c-b759-61be76a71ea3">94,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfOC0yLTEtMS05ODY3NA_a8677b26-295b-4799-9bef-239baa0d49a1">20,543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfOS0yLTEtMS05ODY3NA_b8bd0f9b-246a-40f5-aa98-cb3b1a82def4">73,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i08e7c87e97db4219a8076350b44b29c1"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAwOA_e4ba772a-48bf-4532-8323-10365b64328f" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company has entered into <ix:nonFraction unitRef="segment" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMTU4NA_a925d230-f7f9-405a-ac5e-5bcd6aaa48e3">one</ix:nonFraction> lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMS0yLTEtMS05ODY3NA_62d6802e-c54a-4cee-b425-cbed12d344a1">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMi0yLTEtMS05ODY3NA_664772ef-9691-4a5f-8af9-d7b1040557b7">492</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMy0yLTEtMS05ODY3NA_9664ed4b-d6b4-4076-b2bc-3c8c9f7e711f">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNC0yLTEtMS05ODY3NA_ba1a4132-0619-4959-b31f-40c51981d4e7">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNS0yLTEtMS05ODY3NA_3fae7996-f418-4d8f-b068-9202d5ca5bf2">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNi0yLTEtMS05ODY3NA_1630fb23-3191-405c-89fc-adc69c47514e">443</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNy0yLTEtMS05ODY3NA_39d602ab-ecae-476c-ba33-5b0b30ce1be3">2,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_58"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjc0Mg_324de568-187e-4b01-b75c-d3f5a12f64d1" continuedAt="i5a7b945374b04984a5a6747682d567f1" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i5a7b945374b04984a5a6747682d567f1" continuedAt="ib9910a68153b4e44bea4daba70d8ac43"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), MyoScience, Inc., or MyoScience, (the &#8220;MyoScience Acquisition&#8221;) in April 2019 and the Flexion Acquisition in November 2021. The balances at September&#160;30, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfNDcy_993a0c4e-0bb5-4d6c-a57c-4247d2586396">157.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfNDc5_7c13ee47-8e9b-42a0-9660-e0341fc6e91e">145.2</ix:nonFraction>&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i7f168810ed0344c59194941cdbda381d_I20220331" decimals="-5" name="pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfOTgw_8c2d18a6-8bde-4540-be9f-4071aae32596">32.0</ix:nonFraction>&#160;million when annual net sales collected reached $<ix:nonFraction unitRef="usd" contextRef="i7f168810ed0344c59194941cdbda381d_I20220331" decimals="-5" name="pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTAyMw_1efd1a89-5be3-44f2-8fd7-efa2a2ed914a">500.0</ix:nonFraction>&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjczNw_86543ee2-4c99-4eb4-abdd-8710ec691953" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS0yLTEtMS05ODY3NA_5bd2e98c-3925-4f75-aaa9-c2f5805b442c">590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS00LTEtMS05ODY3NA_a5d42153-8aa9-43a5-8382-3fe73aeb0853">70,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS02LTEtMS05ODY3NA_0ba96514-ae36-43c5-88cf-9d37d10edf50">519,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29b1660ea8f84974983336799383b47d_D20220101-20220930" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS04LTEtMS05ODY3NA_9ea47be4-12ab-4b2b-9c56-2f20707dc121">10 years, 5 months</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi0yLTEtMS05ODY3NA_3a5cf9ec-9386-4bae-b414-f855a228e11a">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi00LTEtMS05ODY3NA_27add85a-ca4b-43f5-bae5-9343f20fddbc">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi02LTEtMS05ODY3NA_775cd507-b1f0-4979-8722-e3edc9ddfef0">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63a4085601e44fbebf50e56e2d711b28_D20220101-20220930" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi04LTEtMS05ODY3NA_b468c229-a721-48c6-a578-d9a74e947daa">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy0yLTEtMS05ODY3NA_3689234b-d007-4ef7-b6d8-7826467b3850">590,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy00LTEtMS05ODY3NA_330024b3-ea13-4f62-9f6c-7c26b928e747">70,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy02LTEtMS05ODY3NA_8de301e7-3745-42fb-b568-351cef6184b4">520,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6afb0c5544774a4eb8b7b594661ac03b_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNC0yLTEtMS05ODY3NA_18d747b9-a09f-48fb-8723-7f3b8b958342">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6afb0c5544774a4eb8b7b594661ac03b_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNC02LTEtMS05ODY3NA_00e8160d-2c77-4b7c-862f-3e0899155d44">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS0yLTEtMS05ODY3NA_61a57b4d-8554-4711-bde8-11d1ceaaf3df">651,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS00LTEtMS05ODY3NA_62b8633e-e9c1-40cd-8780-ed54b15f218d">70,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS02LTEtMS05ODY3NA_4027e51f-b6de-4b48-ad5e-5e4f1815157b">581,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80de923b605d461ca51c7f2b04879428_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC0yLTEtMS05ODY3NA_42631f1e-e02f-4811-8158-d438a5c36a75">590,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80de923b605d461ca51c7f2b04879428_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC00LTEtMS05ODY3NA_849fdbd2-0542-4e12-bab9-753419260c9d">27,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80de923b605d461ca51c7f2b04879428_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC02LTEtMS05ODY3NA_10ecb8f6-6112-4c5f-ba2e-3cc8c3fbdb23">562,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1b3b5083d5dd4003b0ab03be5387f445_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC04LTEtMS05ODY3NA_afa10849-c731-4173-975e-88ee0766a88b">10 years, 5 months</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS0yLTEtMS05ODY3NA_f6fe965a-5966-42db-9aea-5a923a476e89">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS00LTEtMS05ODY3NA_2384ea58-7ce1-4cd1-b4c1-683286f8dcc4">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS02LTEtMS05ODY3NA_15b4ac84-e512-4d59-b6e4-2c9aafd0dffa">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2518c182890b404d9c0847b899ec72e3_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS04LTEtMS05ODY3NA_3954018d-14cf-413e-8d27-b73ef8fd84dc">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtMi0xLTEtOTg2NzQ_60617c2d-85ef-4540-9ee8-22331e167afa">590,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtNC0xLTEtOTg2NzQ_ed150737-3350-4662-ac32-984e2192c05a">27,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtNi0xLTEtOTg2NzQ_a6f10238-b162-49cc-8ad8-8ecc8620136d">562,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTEtMi0xLTEtOTg2NzQ_ce0b9fec-a3cf-445c-b24c-d7dc1b03c316">61,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTEtNi0xLTEtOTg2NzQ_4127a9f4-a129-4fe7-8995-03f756d4dda7">61,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItMi0xLTEtOTg2NzQ_05bb0522-e664-4386-a7b8-e1846d06b94f">651,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItNC0xLTEtOTg2NzQ_9f83046a-9182-453e-8232-e216e46b5ce1">27,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItNi0xLTEtOTg2NzQ_d0061cd8-fe95-4d0b-a252-9651918c3cd9">623,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTQ5MA_785b5b8f-1d5c-4b3a-ae1b-d8986ec8695e">14.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTQ5Nw_56b8787d-3575-405e-83f8-6dca14053ac4">43.0</ix:nonFraction>&#160;million, respectively. Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTU5Nw_579c85b0-05bb-4b38-8367-f5450276a608">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTYwNA_52d5dbb3-3001-42f4-a97a-7378454c82f4">5.9</ix:nonFraction>&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="ib9910a68153b4e44bea4daba70d8ac43"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTk3OQ_a3ba780d-9c55-46f6-a3b5-ea787b571927">14.3</ix:nonFraction>&#160;million for the remaining three months of 2022, $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjAxNw_b69b4d10-7d61-4a01-aaa5-889cae60fe53">57.3</ix:nonFraction>&#160;million from 2023 to 2030, $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjAzOQ_133cd6c7-08fc-4f87-ae52-571bb759cadc">37.4</ix:nonFraction>&#160;million in 2031, $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjA1MQ_5661c951-4f21-4575-8294-272f63cba1e3">7.9</ix:nonFraction>&#160;million in 2032 and $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjA2Ng_9b9edc63-6e5c-4204-9a73-cca205587641">2.2</ix:nonFraction>&#160;million in 2033.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. During the three months ended June 30, 2022, a triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.</span></div></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;9&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTM_9bcbf378-12a1-4b73-a42a-2d13365cf2f6" continuedAt="i3aa7d327529a47d08d9427a2ab90d399" escape="true">DEBT </ix:nonNumeric></span></div><ix:continuation id="i3aa7d327529a47d08d9427a2ab90d399" continuedAt="i99594931292541839fb12f8fcb3d4d72"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTk_4f2bbf78-d5fc-4b5e-a4dc-cb4fe7a574e4" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMi0xLTEtMS05ODY3NA_f4d55a67-6836-409b-948d-85394f19d81e">343,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMi0zLTEtMS05ODY3NA_85e61040-cfca-4f07-88f3-918758c4bfdb">359,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjhiMThmYjc3MTA4NTRiYzk5ZDFkOWEwM2MxNDY2MDdhXzQ_3d6ae893-6641-44fa-a647-212382a7c6e2">0.750</ix:nonFraction>% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0xLTEtMS05ODY3NA_dca54da7-a4d6-4890-8f64-ccadcf5ee898">395,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0zLTEtMS05ODY3NA_d55033ab-244d-4fed-b88a-04bc406a1ba2">330,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83f1500ac81e40438b8cf99c85734a41_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOmFmOWYzZmZmNDkzZDRhMDg4ZGNkM2E1MjM3MDFjZDdhXzQ_a8ed2b34-4a0d-481e-ab51-91bf61ce2d21">3.375</ix:nonFraction>% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9fe0493cf0469887c610902f910cc7_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0xLTEtMS05ODY3NA_96c6c115-ea21-468c-87e4-16e7b62429f1">8,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if98c89d2075848e490be94b7892ae381_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0zLTEtMS05ODY3NA_ef5ee70a-030d-4328-9618-b5bb09676c7c">201,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7972eed61fdd41bfa7003be5de760617_I20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjJmODExNzFhODhkNTRjMzc4Y2MwOTVhYWMwMzY5ZWYxXzQ_a02f333e-a2c6-439d-b41f-15074634341a">2.375</ix:nonFraction>% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0xLTEtMS05ODY3NA_10dde62a-7ce0-4f13-8a5d-a646b7acf1f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0zLTEtMS05ODY3NA_5c3a08c5-2b38-4ea2-82ec-b7e55137625a">157,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0661863911fa4ee69bffbcb43e697fc9_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNi0xLTEtMS05ODY3NA_2c3a670a-057f-4b96-b50b-a0e7ab82d09c">747,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2c21af05a4477e9c7bb7850db493fd_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNi0zLTEtMS05ODY3NA_66ccc359-28af-43e7-b264-d41440611d8b">1,049,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a term loan credit agreement (the &#8220;Credit Agreement&#8221;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#8220;Term Loan&#8221;) was issued at a <ix:nonFraction unitRef="number" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="2" name="pcrx:DebtInstrumentDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDU5_2a6cc4a6-5eea-4401-9bc6-98c25d05ce5d">3</ix:nonFraction>% discount and allows for a single-advance term loan B facility in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTUx_d4a17cdb-5f16-4e4a-b274-9ad79392f513">375.0</ix:nonFraction>&#160;million, which is secured by substantially all of the Company&#8217;s and each subsidiary guarantor&#8217;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $<ix:nonFraction unitRef="usd" contextRef="ia67521500add4fed80583b1a16d61ffc_D20211201-20211231" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTYz_d889d885-d911-4ae5-8a94-7f1365de3690">363.8</ix:nonFraction>&#160;million after deducting an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="ib5d7be76ce2e48f592161d85a4fefa90_I20211230" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTAxMg_8e7277d6-6f7f-43e3-a491-98f200d7ef1e">11.2</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NDQ_daaf9fbc-5b71-4e18-b2d7-1698febf65bf" continuedAt="ifbe7273557e2425f94a7c6e35cc844dc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMi0xLTEtMS05ODY3NA_61aef715-13d8-4429-8e01-72d15af0d30d">356,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMi0zLTEtMS05ODY3NA_b639ff8d-6c0d-4007-9b48-9cbb7ee637eb">375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMy0xLTEtMS05ODY3NA_87c6e8cd-b990-4522-a06a-a0e4c0f86806">3,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMy0zLTEtMS05ODY3NA_4101073d-ad73-47f2-a6cf-c0e2d1026701">4,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNC0xLTEtMS05ODY3NA_717487aa-9fbf-48c0-9082-a9da358a231b">8,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNC0zLTEtMS05ODY3NA_7ee4e531-55db-4ceb-9a37-7f67bc114f73">11,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNS0xLTEtMS05ODY3NA_e7d5bf03-3708-492e-83ea-2b8f03bbaa57">343,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNS0zLTEtMS05ODY3NA_0fc828be-eecb-4192-b1df-2c39d34d73c6">359,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $<ix:nonFraction unitRef="usd" contextRef="i25ab9cb4fb474f0294e6a5ee5da125cb_D20220630-20220630" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTE5Nw_8ff63b5d-bc5e-4a43-b853-840e6a1f3bf4">9.4</ix:nonFraction>&#160;million commencing June 30, 2022, increasing to $<ix:nonFraction unitRef="usd" contextRef="i9083b4c816cc413aa9ab5d4153e040e9_D20251231-20251231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI0MA_0c06cb46-9e1d-4a51-8289-de79b17096ad">14.1</ix:nonFraction>&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $<ix:nonFraction unitRef="usd" contextRef="id5c3a50af1fd40f4bf123c711ae0554e_I20261207" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMyMw_f46043f0-5293-4442-bcd2-f78f0f1dbbe8">188.0</ix:nonFraction>&#160;million due at maturity. During 2022, the Company is required to make <ix:nonFraction unitRef="payment" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="INF" name="pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NjA_270e8c7f-5106-4f29-aebe-c2518d93becf">three</ix:nonFraction> quarterly payments totaling $<ix:nonFraction unitRef="usd" contextRef="i23248a32f20143cdb17ce6c0f3073d59_D20220101-20221231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQyMg_3e6df71b-25a6-4c4e-ba5f-d44873cf50ad">28.1</ix:nonFraction>&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#8217;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are <ix:nonFraction unitRef="number" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTk4Mg_b4b9e685-cff4-46e2-ad42-ca15bd4239ac">2</ix:nonFraction>% in the first loan year plus an interest make-whole payment, <ix:nonFraction unitRef="number" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjA0NQ_057cea9e-92c0-46b4-839c-b715290913ea">2</ix:nonFraction>% in the second loan year, <ix:nonFraction unitRef="number" contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930" decimals="2" name="pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjA3Mw_09580f33-3d57-4246-86c0-659d2a705d7c">1</ix:nonFraction>% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the nine months ended September&#160;30, 2022, the Company made scheduled principal payments of $<ix:nonFraction unitRef="usd" contextRef="ib50e0fe6fa704b639d0ebd924808a630_D20220101-20220930" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjM2NQ_986c2f30-5e20-4a89-899d-82096e0eaa6b">18.8</ix:nonFraction>&#160;million in the aggregate.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than <ix:nonFraction unitRef="number" contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930" decimals="INF" name="pcrx:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjU0Ng_c37d4b45-2b2f-4fcd-88a5-955274aacc9d">1.75</ix:nonFraction> to 1.00 and (ii) liquidity, at any time, of at least $<ix:nonFraction unitRef="usd" contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930" decimals="-5" name="pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjYwMA_9e4ddde0-f403-4372-a9dd-871af6d492e3">150.0</ix:nonFraction>&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i99594931292541839fb12f8fcb3d4d72" continuedAt="i7225076c511c483d83a952e2669fc5e4"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events of default and other provisions. As of September&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a <ix:nonFraction unitRef="number" contextRef="i1ff7019c657c48dc88b1a004ea06e6c4_D20220101-20220930" decimals="INF" name="pcrx:DebtInstrumentVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzEyNg_e082a61c-9061-4ce2-94f3-48fd1fd59bb6">75</ix:nonFraction> basis points floor) plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930" decimals="INF" name="pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzE3OA_4654ac98-b95c-4b1e-8a0d-2216866e50c3">700</ix:nonFraction> basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a <ix:nonFraction unitRef="number" contextRef="i7a1f16b7c4a44c2f9845617ce7eb7a49_D20220101-20220930" decimals="INF" name="pcrx:DebtInstrumentVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzMxMg_84f83c0b-d14e-40a4-a470-bdd43149c702">175</ix:nonFraction> basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus <ix:nonFraction unitRef="number" contextRef="ifba3b8babde24b29a32cda10f955ab31_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzUwMQ_5769a119-3b5f-436f-94bf-a4788df425c9">50</ix:nonFraction> basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus <ix:nonFraction unitRef="number" contextRef="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930" decimals="INF" name="pcrx:DebtInstrumentBasisSpreadOneOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzU5Ng_3c4b117d-18bc-4e57-b802-887afee878d1">100</ix:nonFraction> basis points, subject to certain exceptions, plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i87421aa4628142b0b44a3829fc1f2eca_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzY3Mw_e400cd67-7ace-43ea-91b1-2e4b828815ca">600</ix:nonFraction> basis points. As of September&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of <ix:nonFraction unitRef="number" contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzc5Mg_5a5a95df-7204-4ada-bea0-f72fcac35000">9.21</ix:nonFraction>%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i7e8761921961454aac57dbb378009c76_I20200731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzg5MA_fcc7a22d-4cd4-42f0-af5d-f3a0627f1e8b">402.5</ix:nonFraction>&#160;million in aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i7e8761921961454aac57dbb378009c76_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzkzMA_2e6157c1-f3dd-4a7e-8797-81d8da8b7c04">0.750</ix:nonFraction>% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i7e8761921961454aac57dbb378009c76_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDExNQ_5c8c7217-372a-4a0b-9261-b881a8b324fc">0.750</ix:nonFraction>% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:continuation id="ifbe7273557e2425f94a7c6e35cc844dc" continuedAt="i9572cb46e84043e98a5265dfa00fb774"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOmM2NjI5ODg4OTgzZTRjODlhMmUwZTA4Mjc1YjBlMzA2XzQ_867f9643-0b08-416d-b35d-187a86c6b623">0.750</ix:nonFraction>% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0xLTEtMS05ODY3NA_f119127c-ddfa-4dfa-804d-4fff94d5e74f">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0zLTEtMS05ODY3NA_37b4f31b-8273-47f1-9cd1-263eb5e652df">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMy0xLTEtMS05ODY3NA_e3dbfda8-d177-4e65-a4e1-9d49f5789079">6,990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMy0zLTEtMS05ODY3NA_4f4664bf-8ec9-4cda-b540-010345022d8f">7,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNC0xLTEtMS05ODY3NA_9ea6e470-8926-4729-b886-23d773ce8d5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNC0zLTEtMS05ODY3NA_f18f3ea6-4ac2-4a67-bd88-b0a1f54b04c2">64,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNS0xLTEtMS05ODY3NA_6a18f560-2297-4a3c-a70b-2ef3fbe2cb94">395,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNS0zLTEtMS05ODY3NA_1c779abb-f3db-451f-aa01-da5557aa0d89">330,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i6e99e58b6bd44e40ab5470c217d31556_D20200701-20200731" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDM5NA_d7868f01-c8bf-4ad5-9b95-51d8a3fbbeb3">390.0</ix:nonFraction>&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $<ix:nonFraction unitRef="usd" contextRef="i4512c74066e24feca38c2f9325150125_I20200731" decimals="-5" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDU2Mg_9f7d13ac-177b-40ad-89c4-e561ff2dce9d">185.0</ix:nonFraction>&#160;million in aggregate principal amount of its then-outstanding <ix:nonFraction unitRef="number" contextRef="i4512c74066e24feca38c2f9325150125_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDYxOQ_497ca9a8-c2ab-4182-81c8-9a55c6ee632e">2.375</ix:nonFraction>% convertible senior notes due 2022 in privately-negotiated transactions for a total of $<ix:nonFraction unitRef="usd" contextRef="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDcwOA_68f1c5ae-7430-442a-8687-6c24010793fc">211.1</ix:nonFraction>&#160;million of cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#8217;s common stock was greater than <ix:nonFraction unitRef="number" contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDk5MA_0fc22ef9-7582-4fac-af0d-7b8c699d02bf">130</ix:nonFraction>% of the conversion price then applicable for at least <ix:nonFraction unitRef="d" contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTA0Ng_7a50acef-8b46-4a17-9165-c1b2d08104ad">20</ix:nonFraction> out of the last <ix:nonFraction unitRef="d" contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTA2NQ_75942f6c-eba7-4267-b5af-bb880e72aff3">30</ix:nonFraction> consecutive trading days of the quarter. During the quarter ended&#160;September&#160;30, 2022, this condition for conversion was not met.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="pcrx:SettlementPeriodConvertibleDebtConversionRequest" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTU1NQ_639bfc3f-7c44-4f00-951d-4bcd7f966ab1">40</ix:nonNumeric> consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i296d96d871454ea38915dae663029fed_I20200731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjAyNA_2e8150ad-cecb-4b22-84d0-718ef6380c92">71.78</ix:nonFraction> per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i296d96d871454ea38915dae663029fed_I20200731" decimals="3" name="pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjI4MA_4daaa3e7-6d12-428a-b1a4-b7bd0c66b929">32.5</ix:nonFraction>% to the closing sale price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i296d96d871454ea38915dae663029fed_I20200731" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjMxMg_724373f2-d10c-4c3d-82ef-3e7e8bfb436a">54.17</ix:nonFraction> per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $993</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $<ix:nonFraction unitRef="usd" contextRef="i96d9551dea4644c58fe6c52777f083d4_D20220101-20220930" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjk0OA_9e169c85-e48f-4295-9015-e7eb2933e64e">402.5</ix:nonFraction>&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i7225076c511c483d83a952e2669fc5e4" continuedAt="i48ab233e928a48c28f81b22a03bb4531"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzUyMA_7e1cd91d-be18-4aa1-ad72-a91200dd5265">130</ix:nonFraction>% of the conversion price then in effect for (i) each of at least <ix:nonFraction unitRef="segment" contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzU4Nw_e739f416-1880-4136-8fd8-17c841dcf4f6">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="d" contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzY0Mw_76fffc71-016b-45a3-a0c4-146e926314e7">30</ix:nonFraction> consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) <ix:nonFraction unitRef="number" contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930" decimals="INF" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzkyMw_b3dbe66f-935f-41aa-b11b-9a06288512e3">100</ix:nonFraction>% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s condensed consolidated balance sheet at September&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $<ix:nonFraction unitRef="usd" contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTIwNw_5a4a8aac-8605-4d56-a155-767f462ec3fd">201.3</ix:nonFraction>&#160;million principal amount of <ix:nonFraction unitRef="number" contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTIzMA_e3e50d9b-8d77-422a-8d72-1417f7d632ed">3.375</ix:nonFraction>% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;), pursuant to the indenture, dated as of May 2, 2017 (the &#8220;Original Flexion Indenture&#8221;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#8220;Flexion Trustee&#8221;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#8220;First Supplemental Flexion Indenture&#8221; and, together with the Original Flexion Indenture, the &#8220;Flexion Indenture&#8221;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of <ix:nonFraction unitRef="number" contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTgxNQ_0d850760-c040-42a5-b1e0-05a118a05348">3.375</ix:nonFraction>% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#8217;s common stock, or a combination thereof, at Flexion&#8217;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ia37f7fd3e4cb4abda635243010c825e3_I20170502" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTAzOTk_26a9a71d-9c22-440f-9576-8927ccf88ee2">26.78</ix:nonFraction> per share of Flexion&#8217;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#8220;Notice&#8221;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to <ix:nonFraction unitRef="number" contextRef="ia1cf140155284958b08b2b1f0924c732_D20211206-20220106" decimals="2" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTEyNjg_e11378bc-e120-470d-8f63-080ac0293101">100</ix:nonFraction>% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#8217;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c781235586e428f8b7c97e2da13c07b_I20211206" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTIwNTc_3b32df81-b54c-408b-96d0-d09207eb66d3">317.40</ix:nonFraction> in cash and (ii) <ix:nonFraction unitRef="shares" contextRef="i7c781235586e428f8b7c97e2da13c07b_I20211206" decimals="INF" name="pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTIwNzc_403ce07e-805d-4f11-aaba-2958287f148c">37.3413</ix:nonFraction> CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#8217;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $<ix:nonFraction unitRef="usd" contextRef="i9637107d21ec4490b98079479563d736_I20220107" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI2MDk_1b512ec4-d4cf-419d-9e66-af1e648b9697">192.6</ix:nonFraction>&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At September&#160;30, 2022, the remaining principal outstanding is $<ix:nonFraction unitRef="usd" contextRef="i2a9fe0493cf0469887c610902f910cc7_I20220930" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI4MzE_1fe01cfc-db42-4851-bcdc-9dcb12908c27">8.6</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i48ab233e928a48c28f81b22a03bb4531"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i0758a7b3ffcf4223ab706cc6d93df47d_D20170301-20170331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI5Mjk_c6cdce10-0bbc-403c-b37b-760a477ea5f2">345.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI5NjU_0f579970-94e9-43dd-9dab-2f05f48feb0d">2.375</ix:nonFraction>% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMwNjk_5ca5567d-c36c-4bf1-b4bd-5e0badbdc44c">2.375</ix:nonFraction>% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $<ix:nonFraction unitRef="usd" contextRef="i4512c74066e24feca38c2f9325150125_I20200731" decimals="-5" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMyNjM_ef5b5892-dc81-4713-9cd0-8bb6724b2c4d">185.0</ix:nonFraction>&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMzNjg_eaa1c0f4-93d7-450e-857a-0926f9c7bc76">211.1</ix:nonFraction>&#160;million in cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><ix:continuation id="i9572cb46e84043e98a5265dfa00fb774"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjU4MGM5MTEyMGE3MDRlNGU4NjA4YzVhNGU5MWNhY2M0XzQ_48dfc21c-765a-4755-8a33-f39c4e38dc4d">2.375</ix:nonFraction>% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0xLTEtMS05ODY3NA_3a56883a-1491-42c5-ab80-87fccfea52ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0zLTEtMS05ODY3NA_613ad293-4bf3-480d-8667-bec843fae50c">160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMy0xLTEtMS05ODY3NA_ddc09c96-bea5-48df-9b39-7059e56ad55c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMy0zLTEtMS05ODY3NA_4e51cc8a-3b96-4f79-8bc5-ea09758cb307">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNC0xLTEtMS05ODY3NA_96bbbeff-66e6-493f-a3e0-4d585408df68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNC0zLTEtMS05ODY3NA_52fe98c2-7ff7-4f6d-bc45-a6759aab7bf3">1,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNS0xLTEtMS05ODY3NA_2f0a0a66-9e18-4ed1-b4c8-ed044dd69547">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNS0zLTEtMS05ODY3NA_78a7f441-18d4-48db-993c-390cbf3d0baf">157,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM1OTc_edc06d3f-8399-49e1-8074-2489eb63ee5a">160.0</ix:nonFraction>&#160;million and a conversion premium of $<ix:nonFraction unitRef="usd" contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2Mjg_325b3fc1-0f00-4617-b099-58dc1d985496">4.8</ix:nonFraction>&#160;million through a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2NTc_23cbc4dc-c2ee-4ffc-98ab-2dc178286b13">156.9</ix:nonFraction>&#160;million and the issuance of <ix:nonFraction unitRef="shares" contextRef="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2ODA_4078d907-1d61-46f8-bf8c-060e6d440378">101,521</ix:nonFraction> shares of the Company&#8217;s common stock, which increased additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM3Njc_db832f0e-4e4d-4b38-9ee4-2a0db6c2099a">3.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="pcrx:ScheduleOfInterestExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTE_57aba889-b404-4f94-9f30-c7f709c411e9" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi0xLTEtMS05ODY3NA_87dbcdac-d8be-438e-bc63-7959233bf614">9,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi0zLTEtMS05ODY3NA_cdef4db2-1d94-46b2-a867-c923e731a5e1">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi01LTEtMS05ODY3NA_27cf3704-456c-478c-812b-6fef2d22dcf9">26,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi03LTEtMS05ODY3NA_7544d7b9-3220-438c-9c9d-8404224c53f9">5,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy0xLTEtMS05ODY3NA_e5b378c4-839e-4023-b68f-96fcb0c5208e">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy0zLTEtMS05ODY3NA_dfe5caed-a1cc-4dcb-9868-49141465f8fa">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy01LTEtMS05ODY3NA_8658bc71-7a36-43fd-991a-047de89f9af5">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy03LTEtMS05ODY3NA_35734f52-be88-4324-87b2-702a2fe2a6f1">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC0xLTEtMS05ODY3NA_cc658a76-188c-4bb1-84ce-848f9a063109">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC0zLTEtMS05ODY3NA_a1c39ebf-9554-42b8-be65-914817b1d10a">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC01LTEtMS05ODY3NA_aae4c268-2377-42c6-8b40-c27f42d62d4c">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC03LTEtMS05ODY3NA_fdc8e976-9f4d-43dd-be5f-fd391abb529e">17,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS0xLTEtMS05ODY3NA_2c204b5a-0415-4420-bbbe-19fc20ce8eba">1,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS0zLTEtMS05ODY3NA_17e70936-c82a-4c32-b514-87f5f1714904">881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS01LTEtMS05ODY3NA_f669d51a-484a-4c4e-95bb-ec946d7f3a61">2,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS03LTEtMS05ODY3NA_439bd56e-c44f-4ae2-95ad-fab49f91022c">3,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi0xLTEtMS05ODY3NA_5ce88246-df83-4a88-a0bc-dfa2d03b2df5">9,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi0zLTEtMS05ODY3NA_da94f298-4eb6-4660-a333-844295d1b3bc">7,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi01LTEtMS05ODY3NA_8b50af27-e9ad-432f-bad9-712f5f7373b0">28,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi03LTEtMS05ODY3NA_9741c4df-5d87-4fa0-b804-f34246fdd443">21,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC0xLTEtMS05ODY3NA_9cbd2f3e-54ad-4d7c-a71c-28b3140ed0c8">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC0zLTEtMS05ODY3NA_5f3bdd41-b318-45ef-986d-7169f753de11">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC01LTEtMS05ODY3NA_0f7d72ec-0e32-4818-b676-a0f9ce1a28b5">5.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC03LTEtMS05ODY3NA_25fa9700-be49-40cc-8351-f4c4b0e920ac">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div id="ibcbdf7459db64b749005ba498f2d18fe_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg0Nw_c3cfa7c2-6de7-4db5-a98a-4a7fc227b566" continuedAt="ie95b320f6ac84259a453b853bace6bac" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="ie95b320f6ac84259a453b853bace6bac" continuedAt="i44540a0891e849fda653a2142bb1aa46"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i44540a0891e849fda653a2142bb1aa46" continuedAt="id28936c8d1604dd187def233b408fd2f"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions, whereas an equity investment was fully impaired during the three months ended September 30, 2022. </span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg1MQ_c9217aae-a3f7-4d9e-973d-9b02aa9f2a2d" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC0yLTEtMS05ODY3NA_08f3df14-fd2b-497c-9139-352ae45bb94b">15,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC00LTEtMS05ODY3NA_40b67c6a-9820-4259-b986-35a52c0ef9ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC02LTEtMS05ODY3NA_e194b0bb-ef5a-4499-a3a0-f76312180c7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC04LTEtMS05ODY3NA_ac1be9e0-a84a-4a20-ae51-e9305acbaf9b">15,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS0yLTEtMS05ODY3NA_709f01cb-c26c-45b2-bbfb-64acb8a5a0c0">5,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS00LTEtMS05ODY3NA_95b3727b-54fd-4b39-805a-ebc6aee9aa63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS02LTEtMS05ODY3NA_8c569659-5f14-4de8-9a1e-94aef5e4afd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS04LTEtMS05ODY3NA_205543e8-64e4-4176-9b6f-496bd72ea494">5,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy0yLTEtMS05ODY3NA_0a7d180e-bc05-4b97-966c-b7c8fc2f2882">34,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy00LTEtMS05ODY3NA_96c0f6ea-9232-4cac-9a97-4639443b90d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy02LTEtMS05ODY3NA_04d01265-3464-4f01-9c5b-e367b4e8ff36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy04LTEtMS05ODY3NA_0e88fce0-c92a-40f2-a071-725a6c37a945">34,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68b2cb6f7435421fb55a6eb4e5b93ba0_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtMi0xLTEtOTg2NzQ_feb15e17-8081-48cc-a3f1-d0fe28f5286b">343,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9990062454b491199857f28489640fe_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtNC0xLTEtOTg2NzQ_46125c7b-3141-4e51-af6c-20bcb403667e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if461dd01e8a747b98348bf5b481bc5ca_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtNi0xLTEtOTg2NzQ_30a28cc3-a741-4560-9317-142e84304c57">343,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5390f0263e84d2991820ff5956b0b46_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtOC0xLTEtOTg2NzQ_adf78bdd-19e1-4c9a-8e81-4e11a171f3b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpkNjMzNTA4YjhiNjg0NTNkOWVhMDdiMmJmNDQ3MTkyMl83_1d1c39db-1b31-41ac-9e7b-0df7fcf28b49">0.750</ix:nonFraction>% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d52c9f53b64c98807e28bf9ce30a2b_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtMi0xLTEtOTg2NzQ_6cded9e5-5846-4083-bd7f-5a4fc6ce6b9d">395,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842c641ed23b47fbae6ff4979db04f5f_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtNC0xLTEtOTg2NzQ_9801d90f-1dfe-490b-ae2e-9ef4227ed481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237dd059fd944899a066705c4dd92003_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtNi0xLTEtOTg2NzQ_1487ec93-91f8-42ea-8043-925dea00dfce">399,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if76389ec090e4b37a494b0f226302069_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtOC0xLTEtOTg2NzQ_29b70f9b-75e7-4625-bd05-abc5b2598f91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i04816a7095884e6e9859291f3a1985f6_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpiMjg1ZDAzN2Q0ODA0MzhhYjY3NjgwMzk4ODdiZmI2ZF83_70951b1f-f6d8-4678-bec0-a543da366bca">3.375</ix:nonFraction>% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7032c8982294d0285e1776d6d06b048_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItMi0xLTEtOTg2NzQ_2ae6e206-e2b3-45f5-a0de-d6ab026e4289">8,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd6c853b9ab94c81b8a41af53226deb3_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItNC0xLTEtOTg2NzQ_cea8e03e-5aac-4d40-8235-8a80d4b8daab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0c51b1b8584e129f7c49e3e49e3733_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItNi0xLTEtOTg2NzQ_dce5d80d-1d17-4271-be2e-1f520be21e12">8,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf9551aa20b403f82af345d31ef1338_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItOC0xLTEtOTg2NzQ_56c837eb-e2fb-43a7-8264-c1433e2d8dcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $<ix:nonFraction unitRef="usdPerShare" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTk4NA_f1b98404-48f1-4096-bfe9-278773ce6a59">53.19</ix:nonFraction> per share at September&#160;30, 2022 compared to a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjAzNw_5dca8cb7-1e8e-422e-83da-ebe4dde90851">71.78</ix:nonFraction> per share. Therefore, at September&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is <ix:nonFraction unitRef="shares" contextRef="i7601e3ac14b4439db842e414e541e541_D20220101-20220930" decimals="-5" name="pcrx:DebtInstrumentConvertibleConversionPremiumShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5NA_c55da7f8-0c22-4914-8f43-6cd8bb07919d">5.6</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Convertible Note Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg2Nw_d28fb059-251a-45aa-8359-38b3d10db797" continuedAt="i6e32ec8b49814693bf79e65dc480be83" escape="true">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):</ix:nonNumeric></span></div><div style="margin-top:4pt"><ix:continuation id="i6e32ec8b49814693bf79e65dc480be83"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff74a397bde40f0a00c0186334cb04b_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0yLTEtMS0xMDY4NzM_0b1773ed-7545-4faa-bf64-292e61bc7319">12,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd4e8e0384e49248615b7e238b8f37b_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS00LTEtMS0xMDY4NzM_ea57a0a3-efb9-4cb1-91d6-f705584f47b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS02LTEtMS0xMDY4NzM_6bbf947c-2c9f-4333-a1e2-b15fc24aa485">12,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0yLTEtMS0xMDY4NzM_ee8f00fc-fc02-4589-a14e-a79ce31c4ec2">12,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi00LTEtMS0xMDY4NzM_d63b98dc-9d27-48a4-a576-e5ec6b962083">4,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi02LTEtMS0xMDY4NzM_25bbbc23-74e3-4970-9dd9-b2fcc3e48f77">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0yLTEtMS0xMDY4Nzc_5e351037-c8c4-401f-8949-b86fe48cf1de">11,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy00LTEtMS0xMDY4Nzc_01f316d1-9f50-4f53-84b4-9eaac1b49c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy02LTEtMS0xMDY4Nzc_5078bd6c-8ea7-4f8b-8ec9-6fc4e9db43d4">11,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231" decimals="-3" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0yLTEtMS0xMDY4NzU_c91c2298-4a10-4025-a08d-c9d65212f70a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC00LTEtMS0xMDY4NzU_e035b4fc-434c-4e06-9132-e0a95824a9d4">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC02LTEtMS0xMDY4NzU_e6cc9372-a02b-40af-beb7-34dc84744732">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee79fc7c43e4c82a749f7a396f9b49a_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0xLTEtMS05ODY3NA_59515b43-48b0-46d1-8146-7d808d7bcc5b">14,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if235f229d1e54baa9183a582add02676_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0zLTEtMS05ODY3NA_f1935459-c272-4767-a781-60a691f9324c">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS01LTEtMS05ODY3NA_022d6134-4cc5-4b6e-8251-bc2c3d0c4b91">18,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0xLTEtMS05ODY3NA_d8536d83-0eb2-47ca-b174-4722093ee1bd">11,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0zLTEtMS05ODY3NA_10ef47e7-ec9d-4551-9af8-51af0046f218">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi01LTEtMS05ODY3NA_b49f4743-90cf-472f-83e7-65ec9015d2e3">13,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0yLTEtMS0xMDMzMzk_76557da4-53c3-4dd0-9e88-7fa400d171e9">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930" decimals="-3" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy00LTEtMS0xMDMzMzk_e2121338-6335-4835-9d00-b899e99f0a23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy02LTEtMS0xMDMzMzk_67e042a3-9e23-4186-8aca-c859234d4336">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930" decimals="-3" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0xLTEtMS05ODY3NA_9fe495ce-622a-426d-a310-b87f049e30fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0zLTEtMS05ODY3NA_90391213-ecff-44d0-85b2-24f4a5143ff5">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy01LTEtMS05ODY3NA_df386d98-7161-4735-a8b5-f7538317316c">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45972db0acf74f51a6a8fe893af05d41_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0xLTEtMS05ODY3NA_f15bc591-6c1a-4735-bf1c-5dcf7a691472">15,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1875ee869245698fc37dffd27e30da_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0zLTEtMS05ODY3NA_ed31cc61-3464-40f9-ae0c-8f83bdb1871f">5,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC01LTEtMS05ODY3NA_45f1cf46-47b4-4612-9e33-ed22327d6f80">21,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, an impairment of an equity investment of $<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTA5OTUxMTY0MTYxNQ_7dbd6263-7824-44ad-af16-b3d8dc165abf"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTA5OTUxMTY0MTYxNQ_e51c3db9-4362-4e7a-9fed-78eb0e88b5e2">10.0</ix:nonFraction></ix:nonFraction>&#160;million was recorded within other, net</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statements of operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, the Company sold an equity investment for net cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i7a2c111588354614880539cfc8ac9953_D20220101-20220930" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5OTAyMzI2OTI1Mw_7bd7628a-4067-4255-8d40-a3387f4bd56f">9.1</ix:nonFraction>&#160;million and recognized a realized loss of $<ix:nonFraction unitRef="usd" contextRef="i7a2c111588354614880539cfc8ac9953_D20220101-20220930" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5OTAyMzI2OTIzOQ_8ed9e0bc-0917-4b74-9341-712815f5bee2">2.6</ix:nonFraction>&#160;million, which was recorded in other, net in the condensed consolidated statements of operations. The fair value of the divested equity investment was based on a Level 1 input.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="id28936c8d1604dd187def233b408fd2f" continuedAt="i2e64ac60de684d23a7e0045c6ee92f7a"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Contingent Consideration</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib134093c2a3f489ab847df33ed43d3d9_I20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjk5Mw_2050a007-80f2-45f1-baff-66fc5794ab59">34.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib75b83d0d5d841d190c5b865d08cd08d_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMzAwMA_381bc02c-6a21-440b-9d8f-98ddf8adf1b6">57.6</ix:nonFraction>&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $<ix:nonFraction unitRef="usd" contextRef="ief0126ce4313418d8ce64bdcbb8482ca_I20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDE1NA_0a5ce8d8-b618-48d1-891e-222b06b8ff58">425.5</ix:nonFraction>&#160;million if certain regulatory and commercial milestones are met. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within <ix:nonNumeric contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119" name="pcrx:ContingentConsiderationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDM1OQ_ce587eb8-a265-49c5-8c00-f7fa836969c0">60</ix:nonNumeric> days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDU0NQ_12fff21a-bd1a-47ea-8c2e-d94a2b7a9d75">45.2</ix:nonFraction>&#160;million, which represented the Company&#8217;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $<ix:nonFraction unitRef="usd" contextRef="ia6f13ce1ab564a898d9dac5545791a08_D20211119-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDc3NA_2f4a5174-e4eb-4a99-b5ba-1a88aa98321a">1.2</ix:nonFraction>&#160;million liability. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded gains of $<ix:nonFraction unitRef="usd" contextRef="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDg0Ng_d4293afe-f3f7-4847-8fd6-658b2f05b358">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDg1Mw_05687c1c-1617-452a-8a4d-3e82e81fb03d">13.8</ix:nonFraction>&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At September&#160;30, 2022, the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i8f7942c168654d229d7c5f4bb6f53cff_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTE0Mg_41830fa6-93e0-45a5-b874-2dfa36981871">14.4</ix:nonFraction>% and the probability of success for the remaining regulatory milestone was <ix:nonFraction unitRef="number" contextRef="if8692b80a10c4971a257a0b3f42d44bb_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTIyMw_360ecd6f-bd62-44b3-8dc1-6eedf2c811fe">20.0</ix:nonFraction>%. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $<ix:nonFraction unitRef="usd" contextRef="ie699db1e7648442b83c51b5a1a49d064_I20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTM0OA_48a9548d-cc79-43bd-9c13-80d7a3142192">32.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1b34aaa056564bd9be196339b6471fcc_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTM1NQ_638dac1e-f6e9-442a-a0b9-9bcea4db27ec">46.4</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430" decimals="-5" name="pcrx:ContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTU2OQ_ee71eef4-c236-4ab8-bcb4-0f357a1976c8">100.0</ix:nonFraction> million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within <ix:nonNumeric contextRef="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430" name="pcrx:ContingentConsiderationPaymentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTc4Nw_73fc7db8-6bae-4a7c-af84-2068173be0d1">60</ix:nonNumeric> days of the end of the fiscal quarter of achievement. As of September&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $<ix:nonFraction unitRef="usd" contextRef="i6c3e45d0874045948ab68adfba7d11f7_I20220930" decimals="-5" name="pcrx:ContingentConsiderationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTkyMA_3d7b309e-7f75-479a-89f9-151a12ea8b43">43.0</ix:nonFraction>&#160;million. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized contingent consideration gains of $<ix:nonFraction unitRef="usd" contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTk4MQ_1cb442ec-7aa4-430f-9794-7c6e05040dc0">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTk4OA_66ae55e7-a445-49b4-a84b-4b1a08c06412">9.6</ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized contingent consideration gains of $<ix:nonFraction unitRef="usd" contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjIxMg_b12aeecb-b184-4236-a979-adca3ce170ae">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjI1Mw_16b97e36-5cee-4791-81de-aa5259f735b8">2.1</ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At September&#160;30, 2022, the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="iba4b68f7ebb74b26a54592d12d2be099_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjM1OQ_86cb5260-bfb0-4915-a945-0529a27b34ce">12.8</ix:nonFraction>% and the probability of success for the regulatory milestone that has not yet been met was reduced to <ix:nonFraction unitRef="number" contextRef="i8ac8229fdddc4b69a07f14f03a89a3a3_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjQ2Mw_0d240e60-9ffe-4636-a7d8-f7f6a25fd7d1">zero</ix:nonFraction>. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $<ix:nonFraction unitRef="usd" contextRef="i6c3e45d0874045948ab68adfba7d11f7_I20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjU5Nw_dd820756-f251-4a54-9875-a22bc82c432e">1.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie856966ca92d41f78bca76f98d68d66a_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjYwNA_11a8270a-2676-4a45-a3a4-0e0dd93efe5f">11.2</ix:nonFraction>&#160;million, respectively.</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg2OA_23e8183d-5baf-4e72-b48d-f71f4b17eb27" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e57fefd18bb42ddbe9674fd60b5a57f_I20220930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOmI5MmVmY2VjYzA3MjQwNWRhMDRhMGNkMWUwYTU4Y2E3XzQ_34b26783-5e28-4daf-86e8-3b6c67901f2f">13.98</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i06a2e05d68194f6d893829de561923ae_I20220930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOmI5MmVmY2VjYzA3MjQwNWRhMDRhMGNkMWUwYTU4Y2E3XzEw_b6511be9-1f19-413d-9378-3e908531fc9d">14.77</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id902659ce35844918702ed4963f48b60_I20220930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjE0ZmQ2NDdlOWUwODQzMWFiZDZmNzUzNTJmNDAyZjM2XzQ_4250cc1e-8de8-4523-a132-0dee497cb9f8">12.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iab55c6e18cd7486e97de5fe845e97e9b_I20220930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjE0ZmQ2NDdlOWUwODQzMWFiZDZmNzUzNTJmNDAyZjM2XzEw_1c5d3601-126a-4dc0-9d62-856cca3ecfa6">13.28</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6855240812b48478df36a10542449d4_I20220930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOjdkNmVmYmMyMDNmNzRiMTM5NGYwZTBkNDcyZTE5ZjkzXzQ_135bf32c-de16-4501-a15c-180a77297a08">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i56063439710147d8a4fccb6b50441d1a_I20220930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOjdkNmVmYmMyMDNmNzRiMTM5NGYwZTBkNDcyZTE5ZjkzXzEw_dee7ab6b-9191-4a96-92d8-d0de7043e3b4">20</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4218e46259cf49069b7aa7ce6e397e10_I20220930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjcyZmVjMmQxYzk5MjRiY2JhZTA0MTNjZDcxOGZjZmM2XzQ_262d1571-4c83-44e6-ae33-e0882ba1c967">0</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg3MA_e28a83f4-a64d-4b05-9fa6-5848f691af45" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5cc90199d454f10b36d87b70479ee68_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfMS0yLTEtMS05ODY3NA_4bfc0f16-f7d3-400e-bc24-c0d1a5ddf124">57,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34b51ea16b9440a08b69736ae59a5c23_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfMy0yLTEtMS05ODY3NA_fc0d0db2-cf13-4615-8aa1-4847f80d83ea">23,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146ccf9c46794ec58b3fd078eac868ca_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfNi0yLTEtMS05ODY3NA_d711fee8-4dac-41aa-a12c-b28159677c7e">34,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i2e64ac60de684d23a7e0045c6ee92f7a" continuedAt="if9c744d98376448c91c6da877e622e27"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate, federal agency and government bonds with maturities greater than three months, but less than one year. Noncurrent investments consist of federal agency bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term investments are reported in other comprehensive income (loss). At September&#160;30, 2022 and December&#160;31, 2021, all of the Company&#8217;s short-term and noncurrent investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.&#160;</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg3Mg_c83ec8ee-dd2b-4e8c-9866-01cf31632a93" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term and noncurrent available-for-sale investments at September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee273867e240459470219b08af7a1a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi0yLTEtMS05ODY3NA_2536e05b-c0d6-459f-b2fe-6eccdf7c24d0">22,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee273867e240459470219b08af7a1a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi00LTEtMS05ODY3NA_581aa6ea-5b25-4a29-ba7f-8f8497420a48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54ee273867e240459470219b08af7a1a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi02LTEtMS05ODY3NA_9feed586-b87a-460d-8630-1663870cbb66">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ee273867e240459470219b08af7a1a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi04LTEtMS05ODY3NA_d7714a65-e525-453b-b66d-02bae1ed9b96">22,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy0yLTEtMS05ODY3NA_c6c1d942-c2ad-4151-9ae7-8c554901554e">169,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy00LTEtMS05ODY3NA_e97c726f-271c-4c5e-af00-867cbe477fd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy02LTEtMS05ODY3NA_d8007898-e681-456e-8143-c62cc171567f">903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy04LTEtMS05ODY3NA_e65f92e8-c371-4945-9e60-3dc0306fa4ab">168,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC0yLTEtMS05ODY3NA_1c5093f6-d021-4956-ad2d-8ba010ab8725">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC00LTEtMS05ODY3NA_825cbc67-89b9-4de1-ae02-1db9ef776cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC02LTEtMS05ODY3NA_bd61f160-f4e7-46e9-bf95-85177e25f6c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC04LTEtMS05ODY3NA_324f6cb2-fdaf-466a-b3c2-77c48092324c">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS0yLTEtMS0xMDI0OTk_c609eaae-4111-4217-a9f5-b6a9d2768246">24,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS00LTEtMS0xMDI0OTk_df0b11f6-0825-481f-9200-37b94db550cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS02LTEtMS0xMDI0OTk_74c900ce-87f0-44d6-abbf-21f17feff287">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS04LTEtMS0xMDI0OTk_9b3de95b-9e67-4b51-99a7-235d7846acfa">24,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS0yLTEtMS05ODY3NA_8aeb062c-71ef-4d0b-b741-f84dee938ac0">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS00LTEtMS05ODY3NA_6e2fd76e-5cfc-4e25-9f16-b402e0fe6174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS02LTEtMS05ODY3NA_cd92ad49-d776-4946-9565-534e717915a5">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS04LTEtMS05ODY3NA_ad5347f2-8099-4e4b-aa02-a532405f7d94">1,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ced79204c94980b9c38c4970517274_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi0yLTEtMS05ODY3NA_03d93a7f-ca96-4d96-a867-b5d67fcb310d">220,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ced79204c94980b9c38c4970517274_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi00LTEtMS05ODY3NA_1c5e0fd1-532f-4e1e-8399-56a05b6098a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4ced79204c94980b9c38c4970517274_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi02LTEtMS05ODY3NA_fa61bd72-8c2b-4bb4-8ef9-00fa38f6eff5">1,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ced79204c94980b9c38c4970517274_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi04LTEtMS05ODY3NA_a192566d-75e0-4a8a-a67a-8efa460cb5fe">219,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtMi0xLTEtMTAyNTU4_bd5d5906-dd16-4e86-95ac-717a26736bbf">17,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtNC0xLTEtMTAyNTU4_f66e1704-4da1-484a-afd4-06dd68fb9b87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtNi0xLTEtMTAyNTU4_75e30efc-caf5-4477-834e-a520fb704a34">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtOC0xLTEtMTAyNTU4_012c1a23-a3f4-4d13-a0b5-19d337e6910b">17,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItMi0xLTEtOTg2NzQ_85e898c4-1857-4735-a4a7-286548e98fa1">238,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItNC0xLTEtOTg2NzQ_b74e0442-b0a9-43cd-be42-2118ac1077a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItNi0xLTEtOTg2NzQ_057a29ea-3939-464c-bf57-a6ac8fa1a83f">1,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItOC0xLTEtOTg2NzQ_96f0b099-4428-46e7-99bd-d8dc5133c44b">236,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi0yLTEtMS05ODY3NA_434614f7-e826-4c08-afe3-3f01eaaccd18">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi00LTEtMS05ODY3NA_946bb407-c516-45ce-83ef-2228c5bbead0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi02LTEtMS05ODY3NA_538285e2-bf06-4fd1-9f68-a0f5681ae00e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi04LTEtMS05ODY3NA_9238a0e9-2183-4423-b559-21b0a0c8782e">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy0yLTEtMS05ODY3NA_0a792f2b-bc38-49a7-bd0c-8fc1f1ab1880">57,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy00LTEtMS05ODY3NA_d642c9e3-6a42-42e0-9660-8e19a3029484">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy02LTEtMS05ODY3NA_fb99cb52-981a-4e7f-a356-b995675d00d0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy04LTEtMS05ODY3NA_282adb9b-550e-4b7e-83d0-eed4d120edf6">57,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC0yLTEtMS05ODY3NA_e3fbd6b4-96e7-4ce5-9d06-4db5731d27ec">9,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC00LTEtMS05ODY3NA_b1db1714-363c-4a0b-823b-60a125af9009">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC02LTEtMS05ODY3NA_43b3ccf0-a110-477f-b476-1cd0358d38a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC04LTEtMS05ODY3NA_76c1eefd-4bd7-4cf8-b026-24315ffe0581">10,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi0yLTEtMS05ODY3NA_c4e49f66-9a9d-41d1-b3ac-05ad34527d98">70,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi00LTEtMS05ODY3NA_827cbb33-b86a-403f-b1d7-eb3c6930a91e">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi02LTEtMS05ODY3NA_604ddefe-cd36-4228-ba32-84bf6acf3316">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi04LTEtMS05ODY3NA_f61643d3-d95b-49a2-889d-8b0f07785a84">70,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $<ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="-5" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODQ5OA_e3e5b3bb-072c-42e2-8896-74d947c78138">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="-5" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODUwNQ_aad8704a-51f4-4dd3-bc0c-22e40fac2a4b">0.1</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of September&#160;30, 2022, <ix:nonFraction unitRef="customer" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="pcrx:NumberOfMajorCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODkwNA_849215b0-a20d-44b0-9314-7e10a5df5b72">three</ix:nonFraction> wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="i44e9ad15636e471c976e2609f64d7dc1_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk4OA_d97ec081-244c-46b6-90ab-231b74ad0374">33</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ibf48d4523ea34480aebe47808748c1a3_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk5Mg_dd963209-21ee-4111-9d1c-d5813e312738">18</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9fbc9b9c3e414c91b056f6e47ff38cff_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk5OQ_fee73592-3050-448a-88c5-90f870577298">18</ix:nonFraction>%. At December&#160;31, 2021, <ix:nonFraction unitRef="segment" contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231" decimals="INF" name="pcrx:NumberOfMajorCustomers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTAxMA_c8d8adf5-c19b-47f9-956a-102c2e66bdf1">four</ix:nonFraction> wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="i1b779e5e08f8409f8661541db1c36b0e_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTA5NA_91607487-9ecb-46a2-aa70-773718e417e8">30</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="iea427b466be34ebbba3f1a1d2684ca8b_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTA5OA_1bae2840-9495-4e9d-8dff-9d5b942b4e72">20</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ic94fe1291d1b4789b165b90d7885e3f7_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTEwMg_e2339398-ae15-409f-9b5f-122c6a0e24fa">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iae887f18bb20483e8ff30cc6ed2e8c0e_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTEwOQ_30d722fb-2bcd-4b70-b8fd-8a62d6b4ae7e">11</ix:nonFraction>%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if9c744d98376448c91c6da877e622e27">Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2022 and December&#160;31, 2021, the Company did <ix:nonFraction unitRef="usd" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTc2Mg_2500a1ab-0507-4288-b69f-7463779bd886"><ix:nonFraction unitRef="usd" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTc2Mg_70c7b89e-42a1-40ad-a0bf-6995fa48c738">no</ix:nonFraction></ix:nonFraction>t deem any allowances for credit losses on its accounts receivable necessary.</ix:continuation></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_70"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMjYw_663dd376-4ce3-4510-9322-012b30b489a8" continuedAt="i73bcbc2dd1f04678b4b1c34a065dfd01" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i73bcbc2dd1f04678b4b1c34a065dfd01" continuedAt="i913e30240c834cabb6538996920e4945"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income </span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMjUx_b4b4f12a-6343-43d9-a513-6d246f98530d" continuedAt="i8de17b6c0545401bb6c03b2269da9dde" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7211501c213a4e7599a5684dd5be37a7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS0yLTEtMS05ODY3NA_9edcbb54-8f06-4342-add3-114b266c5764">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82c2ca1fca444babc5bb300a97a1bc6_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS00LTEtMS05ODY3NA_8fb1b801-84e6-436a-9dfb-9b5d257be498">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS02LTEtMS05ODY3NA_f178a2b2-7023-4d5c-837f-f0d3cddb23ce">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fad952d06634849a67e5b1217dd68bf_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMi0yLTEtMS05ODY3NA_cb1a45a3-d3f7-4872-a510-048ee2917de6">1,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMi02LTEtMS05ODY3NA_44062d97-dbd8-4ee2-a212-79e18e1a639d">1,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3320bc9569d4047a853e2db8903a804_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMy00LTEtMS05ODY3NA_ef900075-e1e4-45c1-9158-8ce2f1a9c4a9">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMy02LTEtMS05ODY3NA_7258c2d3-dcb9-443a-9310-404fe08f88b4">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97c19447cd504d5ab3f69d4b883be660_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS0yLTEtMS05ODY3NA_30888000-3f4c-41d5-ac8a-2d6f8d11a5ee">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f98a360a3864c079bacf7afbc9066c7_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS00LTEtMS05ODY3NA_59ac8e8a-bc5d-44e9-a90b-69dc6e45d5c6">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS02LTEtMS05ODY3NA_210c12ac-7967-4803-a09b-04f1487dfbd4">670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc597a5032a411686eef62dd04fb5fb_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS0yLTEtMS05ODY3NA_e2354012-db7a-4bc1-872d-f898db9455b4">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0138beec6b884dd68edbbf43f505701b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS00LTEtMS05ODY3NA_fd780a4d-d8f3-4eb6-babf-31c1c3288cf3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ac36a407c64570801dc9eeb4a4c82d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS02LTEtMS05ODY3NA_1a60de53-245d-4184-80a7-1ceb64ca55eb">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5a40479823647ddb96d0a3dbc1e6577_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMi0yLTEtMS05ODY3NA_454f5756-196c-4a30-9936-a65d93ec21e1">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMi02LTEtMS05ODY3NA_2146b305-4e9d-4b14-9712-828c966e0b41">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i129b1978433c487181ff9a7d935fca2a_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMy00LTEtMS05ODY3NA_206ecf26-f299-4714-b2e3-4d8ba17eb8e4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMy02LTEtMS05ODY3NA_1f75251f-0258-4f3d-947c-61cd5f4a3552">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77aee1ee825a4993985deaa770a072c4_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC0yLTEtMS05ODY3NA_35cd8ca8-fbcb-479f-bba7-4f06bc47f689">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f003f3e1a84055b8f4cfecb523624c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC00LTEtMS05ODY3NA_1b72bfb6-b15e-40e7-94df-0a2b6ffd2abc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC02LTEtMS05ODY3NA_ddf97450-3d98-4de6-a2bf-7630145332b3">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="i913e30240c834cabb6538996920e4945"><ix:continuation id="i8de17b6c0545401bb6c03b2269da9dde">(1) Net of a $<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMTA5OTUxMTYyODk1Ng_17b82061-d5bc-4e63-8f02-84d616865284">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMTA5OTUxMTYyODk3MA_5389ac49-041f-4e3e-a80a-965de723f371">0.1</ix:nonFraction>&#160;million tax benefit for the nine months ended September&#160;30, 2022 and 2021, respectively.</ix:continuation></ix:continuation> </span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_73"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;12&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI4OQ_f9a5c1ce-acaa-4152-b56e-8d3c4d09499e" continuedAt="i77f250eca1ee4b5b8da1da9a1344afa9" escape="true">STOCK PLANS</ix:nonNumeric></span></div><ix:continuation id="i77f250eca1ee4b5b8da1da9a1344afa9" continuedAt="ia1234a9ca0bc49e3b89bf6a285946e1e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI5Mw_cbda036f-bc0c-4f9d-a60e-082541a4a61e" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacde86a59c774f04b954ca896a5a70e2_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi0yLTEtMS05ODY3NA_e8ffa5d0-7077-469e-b56a-1909c5010a73">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e0f3d97cd74e64991c04f3f85804e8_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi00LTEtMS05ODY3NA_2694632f-34b4-4fb1-b89d-d8f9e315826f">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000ca49114364850ace4c02275016d71_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi02LTEtMS05ODY3NA_5b6d7d78-4000-427b-87fb-4e968eebdc71">4,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393b09d63da340a388d84a9a521340e9_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi04LTEtMS05ODY3NA_50059a5c-8a9a-4be0-98b6-72a96afa631a">4,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705ca31dbd8c46188969e5de6c1b9bec_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy0yLTEtMS05ODY3NA_817c005f-c8f9-449e-812d-ea9fb71bf07c">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025386fe742f4458ba40cf3c14ab73ca_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy00LTEtMS05ODY3NA_264e6f0b-51f8-4ae2-8f72-4fa4f9dc4e2b">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia380efcf48764d14911365055786a8c1_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy02LTEtMS05ODY3NA_7c0c791c-4b61-449e-b7fc-4a459ed98408">4,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97de2860387c4ebb9d4c67d302888d0c_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy04LTEtMS05ODY3NA_16b0b961-c979-4823-8960-0ad5f4ab1af5">3,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23baf9eae53648b5862c179217f38259_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC0yLTEtMS05ODY3NA_c0ca3f57-4f63-45d2-bbbf-6fcb85b5aa44">9,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c025fee8f64b4a80f4a122c03be02f_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC00LTEtMS05ODY3NA_6e89040c-7a69-4ef5-b010-82dcb478ddda">8,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9e30e4f3ae45789d654ae03283e68f_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC02LTEtMS05ODY3NA_e1b8708c-7446-4a0f-a9d4-bcc86d5be07d">26,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0115f45cca34fe59169ae1673caf52a_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC04LTEtMS05ODY3NA_0854f6db-615e-4c78-b0b8-7c1ac5b65f4a">23,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS0yLTEtMS05ODY3NA_6021cca4-4689-4d2d-b8c1-e5adcf77760c">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS00LTEtMS05ODY3NA_b6b2c336-8480-4fb8-9d08-3fe1b5d9b4da">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS02LTEtMS05ODY3NA_2d828605-477c-4b2c-9276-40ae07ff353c">35,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS04LTEtMS05ODY3NA_e09fb60c-c743-4bbe-b6d6-a37f243d7d97">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC0yLTEtMS05ODY3NA_98ce7a31-eb76-472c-95fb-05c17bc44341">6,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC00LTEtMS05ODY3NA_ca19ac33-bf63-4bad-8777-94f6de62e2b9">6,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC02LTEtMS05ODY3NA_1ed1936d-59ca-40b0-85d7-d8bbc404264b">20,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:Compensationexpensefromstockoptionsemployees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC04LTEtMS05ODY3NA_182b431f-7436-443c-8e5f-68e9395a4c5d">19,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS0yLTEtMS05ODY3NA_ed6899ca-5689-4a86-b9a8-108fbe5a189c">5,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS00LTEtMS05ODY3NA_1db0c542-98f5-4393-8649-4c4188601a7e">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS02LTEtMS05ODY3NA_900da4ea-23eb-42e7-b8d6-6c0328ffed93">14,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS04LTEtMS05ODY3NA_8754003d-06af-4aa2-9635-47bb62aebe6e">11,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtMi0xLTEtOTg2NzQ_31d76e60-9651-4bd9-88e6-4809913f01ff">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtNC0xLTEtOTg2NzQ_0ce04107-d725-4fff-b92e-034bf722f1f6">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtNi0xLTEtOTg2NzQ_a7d08432-60c2-4dad-be9d-579453a3c090">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtOC0xLTEtOTg2NzQ_4146dc9b-cf57-4c0f-84eb-dceabb35c824">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtMi0xLTEtOTg2NzQ_30a25427-084f-49f0-9b3a-4f9145cb8ba2">12,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtNC0xLTEtOTg2NzQ_e969c70f-c17a-4876-9d41-1cb82bbce7a1">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtNi0xLTEtOTg2NzQ_1727aea1-17e5-47ec-a4c7-3d7503f31548">35,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtOC0xLTEtOTg2NzQ_53a4697f-893f-4893-add7-7db46671058e">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="ia1234a9ca0bc49e3b89bf6a285946e1e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTMwMA_f5789c39-85c9-41dc-823e-696c45580b07" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMS0yLTEtMS05ODY3NA_2602f0c3-2383-40a9-8d37-a28be193f7b9">6,050,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMS00LTEtMS05ODY3NA_117b1d8c-bfc0-427d-b0da-1ec8bd1f4eb5">49.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMi0yLTEtMS05ODY3NA_9fd6fb09-031e-41b3-a60b-56c603c70936">1,034,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMi00LTEtMS05ODY3NA_d86776ce-75eb-467a-9126-4ce7f831c776">60.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMy0yLTEtMS05ODY3NA_24e63625-bae7-43dc-b842-df261528ad98">667,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMy00LTEtMS05ODY3NA_6649c8cf-5d8e-4394-99a6-4f93ee6f42c4">35.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNC0yLTEtMS05ODY3NA_0860cde3-81dd-47f3-9c70-646515946fb3">88,766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNC00LTEtMS05ODY3NA_f50acb23-720e-48f7-a561-b9cb1c875bb7">54.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNS0yLTEtMS05ODY3NA_1840a118-6b39-423f-893b-d1f82374481d">24,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNS00LTEtMS05ODY3NA_17f8671f-dde1-46dc-947b-fb9a5a72df4e">78.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNi0yLTEtMS05ODY3NA_507659eb-f892-45b7-8e8b-b6195b92e14b">6,303,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic44364ce38c044838833d136327e1683_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNi00LTEtMS05ODY3NA_97c5c529-fee8-468d-95ff-d805b1a08ce8">52.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if92e2ee8bc084934add5e4997216b20b_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMS0yLTEtMS05ODY3NA_d661c0c5-c4c2-408d-ac2b-50b55679b152">955,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if92e2ee8bc084934add5e4997216b20b_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMS00LTEtMS05ODY3NA_d7bcc0ab-d152-4a11-ba3f-937a709e86c2">52.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMi0yLTEtMS05ODY3NA_8d2168fa-07e2-4142-84c7-88dc5ef15322">598,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMi00LTEtMS05ODY3NA_ad87ae40-759b-49cf-81e0-9d5eb7210df2">60.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMy0yLTEtMS05ODY3NA_2abed545-45eb-4f04-93a0-b3e7475fde56">323,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMy00LTEtMS05ODY3NA_e5e2fa12-cf1a-4d77-b3da-3eef36ef4a53">50.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNC0yLTEtMS05ODY3NA_584d2728-aa82-44ae-8b4f-6a3058490a1e">68,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNC00LTEtMS05ODY3NA_0de38d49-8bf1-4770-b7d4-053a2ff7b3d2">55.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d19f95d9c4e41ff8e7135be13df1713_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNS0yLTEtMS05ODY3NA_768333a8-d61d-4da5-a137-e90f1dc97920">1,162,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1d19f95d9c4e41ff8e7135be13df1713_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNS00LTEtMS05ODY3NA_81719d5c-6113-4867-a6fe-6b347af7d3cb">57.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2022 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfNDE1_0ae30215-4420-4b76-bbbe-a7efd721994a">25.66</ix:nonFraction> per share. <ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI5NQ_d59b3076-b0cd-46fb-8e86-3af44d85cd04" continuedAt="ia4ee3bd75d974a66a64cee16f19348e2" escape="true">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><ix:continuation id="ia4ee3bd75d974a66a64cee16f19348e2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMS0yLTEtMS05ODY3NA_089d71ff-40bd-4318-a952-494457fef1be">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMi0yLTEtMS05ODY3NA_c2cad05f-2ba6-4814-b15d-b5902972d6b8">2.84</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMy0yLTEtMS05ODY3NA_b6a2b57a-8773-4b1c-b45f-13d5bb9e9453">45.14</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfNC0yLTEtMS05ODY3NA_5563e5bc-5885-42fa-9276-c3f86898e3be">4.92</ix:nonNumeric> years</span></td></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional <ix:nonFraction unitRef="shares" contextRef="i8d338010b91c405c9adcfebc639f8496_D20220601-20220630" decimals="INF" name="pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfODUw_d936f06f-cdcf-42c3-a119-298f8c3c96d9">500,000</ix:nonFraction> shares.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP features <ix:nonFraction unitRef="offeringperiod" contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930" decimals="INF" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfODc5_b2c869e9-238c-4da9-8638-5ff48be3243f">two</ix:nonFraction> <ix:nonNumeric contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTMxMg_aa8105f1-e68b-4c21-a5d0-0027a4c3e568">six-month</ix:nonNumeric> offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at <ix:nonFraction unitRef="number" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTA3MA_d4444e1b-389e-4f83-aa85-81dabcd716d8">85</ix:nonFraction>% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTIzNg_0db1077c-3a23-4db6-8b96-cf6f9f5a93b8">36,729</ix:nonFraction> shares were purchased and issued through the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 26</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;13&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE4MA_c83b397a-7a7e-4a44-bc50-e515692f800c" continuedAt="i62c1b59d924f414887fe3be961487110" escape="true">NET INCOME (LOSS) PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i62c1b59d924f414887fe3be961487110" continuedAt="i4cde334df7084a7fba45cbcc747e0d30"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive. As the Company reported a net loss for the three months ended September 30, 2022, no potentially dilutive securities have been included in the computation of diluted net loss per share for that period.</span></div><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE4NA_746bb5a7-ca0e-4e5a-b4a9-9739f390b7ca" escape="true"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net (loss) income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy0xLTEtMS05ODY3NA_f48cc3a8-79e0-4de7-ada5-67044dfae48f">693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy0zLTEtMS05ODY3NA_58e41d88-49e3-4553-a922-6e7edc184d51">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy01LTEtMS05ODY3NA_ab980016-e6e4-42a6-a4a0-e131d31fcc28">26,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy03LTEtMS05ODY3NA_b27bb123-5ef1-4d14-94df-0ec585974a2c">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC0xLTEtMS05ODY3NA_7f6a41dd-888d-4b87-b012-e04be4de452f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC0zLTEtMS05ODY3NA_c5d19f7e-80ac-4d11-8118-059c7e15ec74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC01LTEtMS05ODY3NA_c3eee492-eb81-4c3f-9b31-d007a0467e29">3,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC03LTEtMS05ODY3NA_c18c47fb-20e9-4101-aed1-d26bd9b22049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net (loss) income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi0xLTEtMS05ODY3NA_78475df2-f864-4809-ab58-a0f2c5beaef0">693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi0zLTEtMS05ODY3NA_7cfe59e1-8dcd-4b33-b9b1-93b8bec7c602">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi01LTEtMS05ODY3NA_f8f9105b-da1d-4772-8a9d-44f3933fc485">29,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToParentDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi03LTEtMS05ODY3NA_5775ff02-b4e7-4642-a614-a7380066e56c">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtMS0xLTEtOTg2NzQ_4407822d-33c6-400a-b1bc-0fa19ff776e9">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtMy0xLTEtOTg2NzQ_debdcd64-f87d-46e9-b518-a58f7b098000">44,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtNS0xLTEtOTg2NzQ_79fd11b2-2233-4e2b-a250-1d17610ba7d3">45,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtNy0xLTEtOTg2NzQ_55b6875f-3769-4d18-a06e-9f8410d6fe53">44,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d47dbf4731e40a8817c9b98685f2fad_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtMS0xLTEtOTg2NzQ_f6503e27-2741-4f30-bfa4-00eeac74b17a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iacd2ba2d5b0b4cbd856acd935fe9e469_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtMy0xLTEtOTg2NzQ_7b1050f6-801e-4681-a9d6-681196149b51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i485078b5973a4f38a864235574eace6d_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtNS0xLTEtOTg2NzQ_e59ca6a8-9459-4304-82e8-853a409ce4a8">5,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80aa21cf123146cfa48d76c6340c8f02_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtNy0xLTEtOTg2NzQ_be692cde-2011-46e8-8f60-cf87de9abd2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d47a9c9bbe34e8a884b57b4a1b7c7d7_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtMS0xLTEtOTg2NzQ_7e2560a3-f25f-4fcd-a79a-f4f05a389bcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i751881f6186c4a20b2999971312c68ea_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtMy0xLTEtOTg2NzQ_cf6b861f-b886-4403-b805-c916b64fa163">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtNS0xLTEtOTg2NzQ_39bd860d-33fb-4632-8d86-7bb04dacc0cf">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia902e06002164005b91ff53bfc5574a6_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtNy0xLTEtOTg2NzQ_5ed96083-e3e8-4e75-8dd7-22c96f95e1a4">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25ec2fd985f1484584f9e9321ebe8636_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctMS0xLTEtOTg2NzQ_e59e8317-bca1-452b-bf9f-6863235f1dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66cdb3b9475d440585c31ef8170080cd_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctMy0xLTEtOTg2NzQ_dd02afe8-ec61-4aa0-904f-79f7a504ff83">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctNS0xLTEtOTg2NzQ_ea6f0861-e9df-4021-982b-99fbae4e5b8c">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica8d4ccba77d49c585c7d57451c690c9_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctNy0xLTEtOTg2NzQ_3a34400e-efa4-4794-8930-a3c5d2bfa68d">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtMS0xLTEtOTg2NzQ_316e2c6c-8f1f-4abc-826a-19a4839a6033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtMy0xLTEtOTg2NzQ_0bbd62e0-2b01-4a7e-94e3-7ed744217cd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtNS0xLTEtOTg2NzQ_cb06d0d3-4a6b-428e-8c32-de137b9385ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtNy0xLTEtOTg2NzQ_62ee3eaa-9ce9-4b3d-becc-0e29bf216332">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i033a677bcf7842e8962e783e4ecdff17_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktMS0xLTEtOTg2NzQ_b3559c5f-59ea-4139-a2be-6edb9266ff3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic925042152574d9896e5d11b213d65ef_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktMy0xLTEtOTg2NzQ_bf732e85-2b03-474c-855d-cf5ed786a7be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktNS0xLTEtOTg2NzQ_448c8115-569c-4c47-b2c1-666270be371e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0529b24441114da8aea1d86d3e46324d_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktNy0xLTEtOTg2NzQ_b13193d6-1005-427c-bbb7-8100a64025c0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtMS0xLTEtOTg2NzQ_17397c47-ab7c-4fa9-b3d6-89bdedd4dbe4">45,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtMy0xLTEtOTg2NzQ_503d1b5f-24bd-4493-8fdb-75bf3dd98423">45,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtNS0xLTEtOTg2NzQ_a67da67e-2eb0-4eb8-bbbc-d3fc5707b5b7">52,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtNy0xLTEtOTg2NzQ_7a567812-a2c2-4df5-8dd8-4c130b74ce5e">45,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net (loss) income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtMS0xLTEtOTg2NzQ_d49999db-89d8-492e-b3d9-f2a9026b1a4f">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtMy0xLTEtOTg2NzQ_dbaa5452-1c05-4ac5-a0ef-a579224e063f">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtNS0xLTEtOTg2NzQ_efa7b3ac-15fa-47dd-ba84-61f1b68a1c36">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtNy0xLTEtOTg2NzQ_93829c9d-a33b-4645-bb00-25e29169e51f">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net (loss) income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtMS0xLTEtOTg2NzQ_219c9acd-aea1-40d8-ab80-9996efa18d41">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtMy0xLTEtOTg2NzQ_5132e1d3-4682-4076-b75f-3ddd23138ea9">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtNS0xLTEtOTg2NzQ_80c81a89-ab19-4e84-80c2-5984a7b81ee8">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtNy0xLTEtOTg2NzQ_e25312bd-9e80-45b8-84f0-402d20b91550">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-indent:22.5pt"><ix:continuation id="i4cde334df7084a7fba45cbcc747e0d30"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE3NA_c4fedaf1-65b6-4d2f-aab7-a525556ca4d9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i220fe9ca1ed949bdacf99f33c990cd98_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi0xLTEtMS05ODY3NA_1ade277b-9159-4a94-a0a6-83939e234194">6,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c341f2698fe409ab358a241336259db_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi0zLTEtMS05ODY3NA_ef76dbca-dfc3-4998-99b0-ee23ff27897d">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f355a2653684c24b57b2f7c5f946633_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi01LTEtMS05ODY3NA_dc3fe9b3-56d0-41e4-9d40-11fa4b5bd026">2,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c1d51f4133f426395546e41d42a7bf2_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi03LTEtMS05ODY3NA_f23e2024-92df-4a3c-90e2-2b8e75e53ecd">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20b9602474ee4df3a8cdbf721f6b53ec_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy0xLTEtMS05ODY3NA_425c6c0f-d9c7-45c6-a392-9d8ceda57bd6">5,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i999eddb8433c487184e9e575bd4a8c32_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy0zLTEtMS05ODY3NA_adf22000-df46-4614-975d-a88373bfbdbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i569b3dcd44504f2ebc2b67589ca1ef77_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy01LTEtMS05ODY3NA_25cd9a55-69e8-49a3-b3b1-735f36e92db7">797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92a9bde52b5e4954a236c46394ef2fe1_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy03LTEtMS05ODY3NA_9ca1b545-df30-4baa-869e-8a666099130f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8d9d4db1ba04e1288564adf8e895b8c_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC0xLTEtMS05ODY3NA_14bcb732-a8b3-4fd0-96c5-133e33545aba">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia097c92a4047403d82b24978021270af_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC0zLTEtMS05ODY3NA_6e4b5234-cd9c-4aa0-ad3b-f347a461c521">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib01b4d60757d4870804d497766e7943c_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC01LTEtMS05ODY3NA_85519894-414d-4f97-85cf-55709f69512d">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7925b0863c1647ce89e8613307298317_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC03LTEtMS05ODY3NA_8bc3c88b-81cc-4ed5-b835-7f8a3d97f528">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ddd46a4b60a416c94127599c856aa48_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS0xLTEtMS05ODY3NA_ae92843a-327e-4f54-9031-88bcb7a03a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f95987401124116b24759ace715aa41_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS0zLTEtMS05ODY3NA_34bee8c1-ff7d-441f-8318-43a9db5798cf">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09fc8460b9894b6cb2fb0b2e035270ae_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS01LTEtMS05ODY3NA_7e89dd14-25fd-46f7-9ad3-f3c311f552d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i095b5a48440040b98f786b561073678f_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS03LTEtMS05ODY3NA_98628323-0228-4b32-a2cb-ff3190933c04">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi0xLTEtMS05ODY3NA_e1cb18b9-20a2-4598-b53a-cfb2fd825195">13,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi0zLTEtMS05ODY3NA_ce93f604-94f8-483f-b1d4-84f69ba675bb">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi01LTEtMS05ODY3NA_ad79f8aa-27be-4437-9e97-85f574ecfd3b">3,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi03LTEtMS05ODY3NA_e6dd6089-c754-4f08-88c2-a28a106cee23">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_79"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RleHRyZWdpb246MWZiZmJmZjhjZDIyNGY3ZjgxYWYyZDY5NTJhNGE0MjlfODk4_d2f4c00d-864d-4e92-9fe9-d92ef1f7b650" continuedAt="i692e2929c0f141eb9b48dce385799739" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i692e2929c0f141eb9b48dce385799739" continuedAt="i598a855246d64d219b60c105c164d427"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RleHRyZWdpb246MWZiZmJmZjhjZDIyNGY3ZjgxYWYyZDY5NTJhNGE0MjlfOTAy_ab739fc0-5b38-4293-aecc-0ccc8a365e51" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense are as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy0xLTEtMS05ODY3NA_b414c296-59cd-46f7-af44-d95d6e6d2ea0">9,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy0zLTEtMS05ODY3NA_b4e9f9dd-7945-412f-bb5b-d342061878b5">25,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy01LTEtMS05ODY3NA_6d914667-b9a9-49da-8994-4a19264b3839">39,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy03LTEtMS05ODY3NA_cc9d2d3d-a335-4563-bc95-9008eba9e209">66,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC0xLTEtMS05ODY3NA_b216657a-de9a-4779-9840-30a439f9dd58">7,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC0zLTEtMS05ODY3NA_62f805eb-52c0-4579-bc27-9bde70054749">936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC01LTEtMS05ODY3NA_757ea225-92fb-4fd7-80b5-9a17a562db33">8,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC03LTEtMS05ODY3NA_a3fad465-5b04-4b52-a6fb-f8183ffc546f">4,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS0xLTEtMS05ODY3NA_e41c11d9-47e9-42e7-a2eb-bdb254fb823c">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS0zLTEtMS05ODY3NA_5f15d572-6fb1-4765-aadf-00b5f188b25f">24,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS01LTEtMS05ODY3NA_adf83c9d-fc8d-4703-9949-32ef20f4b85e">31,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS03LTEtMS05ODY3NA_b4b081f5-382b-4a30-a74f-9f058262cb6c">62,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy0xLTEtMS05ODY3NA_bf34d959-61f6-4370-ba42-b61049a4151b">2,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy0zLTEtMS05ODY3NA_21614968-eeb1-4625-9db9-2f0a6c0d4974">6,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy01LTEtMS05ODY3NA_6474c640-f42d-4c02-b19d-10c42584959a">5,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy03LTEtMS05ODY3NA_508f62fc-4e6a-43d1-b815-3883bcb26b24">15,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC0xLTEtMS05ODY3NA_89f13f35-f983-4f5e-b432-e1f154aa715e">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC0zLTEtMS05ODY3NA_6199770a-7d12-4507-a4b2-7f9b43d54e7e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC01LTEtMS05ODY3NA_cbeb762d-11b4-4740-afd0-50dc670b33ac">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC03LTEtMS05ODY3NA_638bdaee-8fd9-45c6-a754-7878bf615dd2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating re</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sults adjusted for certain discrete tax items. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates for the three months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation and valuation allowances recorded against non-U.S. results and deductible capital losses. The three months ended September&#160;30, 2022 also includes benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i598a855246d64d219b60c105c164d427" continuedAt="ie7203672348a43bc9937c46c4d049844">The Company&#8217;s effective tax rates for the nine months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive co</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7203672348a43bc9937c46c4d049844">mpensation costs and valuation allowances recorded against non-U.S. results and deductible capital losses, offset by benefits related to stock based compensation. The nine months ended September&#160;30, 2022 also include benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 28</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;15&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjQ1Mw_2ceb7844-3df7-44df-97d6-e46ac39601de" continuedAt="if6de7706a83f43b6868fa2d7287222a9" escape="true">ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER</ix:nonNumeric></span></div><ix:continuation id="if6de7706a83f43b6868fa2d7287222a9"><ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjQ1NA_495735b4-25f0-4b33-8666-e2452253a429" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related charges (gains) and other for the three and nine months ended September&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi0xLTEtMS05ODY3NA_c03c4d8a-34a6-4ab2-bdab-72e6fba9419e">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi0zLTEtMS05ODY3NA_8f5bfdcd-e913-4f3b-afe3-0623c23a208f">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi01LTEtMS05ODY3NA_8066dd08-df7e-474f-b252-1dd43c7132f4">4,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi03LTEtMS05ODY3NA_ee51238c-8ed9-4055-923d-2457ec125632">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d0d73926a8453fbff3d3a2959a9f19_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy0xLTEtMS05ODY3NA_6250704a-2db9-4b2c-a470-c4ae2a96934e">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e4065f3bf84a769793c677aa707755_D20210701-20210930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy0zLTEtMS05ODY3NA_09f4b465-255d-4fbf-93af-8508fe0109a6">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6952928bc30b45c094b9931501de819e_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy01LTEtMS05ODY3NA_840d1358-a451-4f3b-9b24-b60f82c10856">4,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6b8329aab94b669b97bbc6cc18e60c_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy03LTEtMS05ODY3NA_fe253f41-a693-4ae7-b661-776b2be5e539">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2090540004814f58aec0fe11cbfc0491_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC0xLTEtMS05ODY3NA_971eb3e5-a214-49cf-8e19-fc05166aecac">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be6662b540d42b5b071db1e7701ffd5_D20210701-20210930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC0zLTEtMS05ODY3NA_50d8a3ba-bdd3-41f2-891d-1465c4f6b52e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5ac33a93d943dfa41d95c7fbb2fa8c_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC01LTEtMS05ODY3NA_15403090-cfe9-457f-a61e-c987379ddf35">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie470b1ec9ebc496c8a8a2b82cee22927_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC03LTEtMS05ODY3NA_fbd71147-7676-42d8-b1ae-7fa7c10d5124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS0xLTEtMS05ODY3NA_0a04327d-5081-4a0b-abba-b2f40b509b10">1,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS0zLTEtMS05ODY3NA_0109cdc2-b78c-4ba4-bc21-93326312869b">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS01LTEtMS05ODY3NA_6baaf6cb-d4ad-4a0a-82e3-215fa64ca5a8">10,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS03LTEtMS05ODY3NA_6171a192-8ff4-4fea-a523-09879d997ae8">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2c777abcf4b469ebafc9aa977f3f943_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi0xLTEtMS05ODY3NA_e9fd30aa-f30e-4813-9e7c-81191714b430">520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi0zLTEtMS05ODY3NA_493dd91e-7cc0-4827-8df1-b83efab6d068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4df205ee98b9479fa0df23571a4898df_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi01LTEtMS05ODY3NA_66399573-1a41-4740-afd8-7848f0a30caa">13,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi03LTEtMS05ODY3NA_2b3f0d0e-ad73-4974-8bcd-ba490aaa0336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy0xLTEtMS05ODY3NA_17003a7c-bc8f-49cd-971b-304fbbb21e15">523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy0zLTEtMS05ODY3NA_dad17bad-dce1-407d-8d51-5bb7f5898f63">1,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy01LTEtMS05ODY3NA_62cb3ded-d041-45d4-81f5-f95badb45368">9,557</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy03LTEtMS05ODY3NA_84eb16c8-921a-4e68-991b-1075b1d970fd">2,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ec8193fb584c849fb512a1ebd30246_D20220701-20220930" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC0xLTEtMS05ODY3NA_6c48c803-f495-4c25-96c9-d81c91d8d706">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ee845af90843f89f53ceeb7e4f835b_D20210701-20210930" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC0zLTEtMS05ODY3NA_3f583b90-1f11-479c-97e6-3be125e590f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1904086f824643bbbbb99866420b64c8_D20220101-20220930" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC01LTEtMS05ODY3NA_4ad9c8be-e252-4313-92f0-b0c11ad27cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icada30aef3ab4b739d33763eef827871_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnContractTermination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC03LTEtMS05ODY3NA_e79f43aa-659c-41eb-b23a-4e1afbde06a2">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges (gains) and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930" decimals="-3" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS0xLTEtMS05ODY3NA_0485a940-7bad-48f8-8234-176fe73fcb89">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930" decimals="-3" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS0zLTEtMS05ODY3NA_a5bad508-d2fc-460c-8e08-b5ec63b33c1c">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS01LTEtMS05ODY3NA_1977bd66-078d-44ce-8f0c-5d7efae9ca84">13,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930" decimals="-3" name="pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS03LTEtMS05ODY3NA_10e6cefd-3c07-47fe-b863-2b952c20219e">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="ied8157b496ab44079fe9f2e4512f3b32_D20220701-20220930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjkz_237f49da-0175-4beb-ab3d-da14b14ad297">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i80fd88738e5c447e82122a8f75186048_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMzAw_0a996a61-87f7-4bf8-a7ee-9503887a38d5">10.2</ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, respectively</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. The Company recognized acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="iac64608b237d43f0a6a93d7bdccf7a88_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTA5OTUxMTYzMDYxNA_811208b5-0267-472d-bedf-1efba4e59b61"><ix:nonFraction unitRef="usd" contextRef="i7e41fa8486f34ea58ad7ceac10e1140e_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTA5OTUxMTYzMDYxNA_8c856c36-6d74-42e6-b533-5d4b8a4103f1">1.0</ix:nonFraction></ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to legal fees. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfNjcz_1f2234c7-86c3-4c78-bdfc-78c22fb8eea5">45.2</ix:nonFraction>&#160;million, which represents the Company&#8217;s potential achievement of meeting regulatory and sales-based milestones. During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfODI5_573d30b5-976f-4b32-a59a-8672e1221aa2">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfODM2_5acc3703-93e5-4c97-940e-ac68e32505b2">13.8</ix:nonFraction>&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTMwMQ_5f1aa970-0a9c-48ac-bd16-295ea897e28d">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTMwOA_a28a2d85-497d-4c97-b9b5-26e87f761a65">9.6</ix:nonFraction>&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTQwOQ_f612f751-4325-4ba0-8193-a65a85f78eb3">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTQ1MA_4110949e-df46-4674-bbce-05c031092df7">2.1</ix:nonFraction>&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjE5OTAyMzI1OTIwMA_2317926e-026b-4d53-91e1-cfe2e580b53b"><ix:nonFraction unitRef="usd" contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjE5OTAyMzI1OTIwMA_baa594d8-947d-404f-891c-8867d11aa056">0.4</ix:nonFraction></ix:nonFraction>&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to one-time termination benefits fees.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product, which resulted in dissolution costs of $<ix:nonFraction unitRef="usd" contextRef="i166df1f4bcd2446d844456bfb7f76005_D20210101-20210930" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjMzMQ_086abb12-629f-400b-98d3-80da7c466d65">3.0</ix:nonFraction>&#160;million for the nine months ended September 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 29</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;16&#8212;<ix:nonNumeric contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfODk2Mw_79f3d744-d1a3-49da-b770-7436303e0314" continuedAt="i695e4f85763a48d6917192531bfd27f2" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i695e4f85763a48d6917192531bfd27f2" continuedAt="i498810056fc144b5b2a15c6dc3b6d613"><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $<ix:nonFraction unitRef="usd" contextRef="i4fac746bbf294b19acb69210d7229116_D20201001-20201031" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfMTczNw_a5c68a0c-4a58-4328-825b-148b105331da">30.0</ix:nonFraction>&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eVenus Pharmaceutical Laboratories Litigations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#8217;495 patent).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#8217;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#8217;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#8217;s ANDA submission.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#8217;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#8217;336 patent). eVenus further alleges in the Notice Letter that both the &#8217;495 patent and the &#8217;366 patent are invalid and/or not infringed.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#8217;495 and &#8217;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#8217;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These litigations are in their early stages, and the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Development Foundation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#8217;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#8217;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><ix:continuation id="i498810056fc144b5b2a15c6dc3b6d613"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#8217;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hong Kong Pharma Tainuo Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i17b1073570b241519f375ef761e56fc8_D20200101-20201231" decimals="-5" name="pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfNzgyOQ_9f13e421-42e4-4463-bff5-055823a585be">10.0</ix:nonFraction>&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of December 31, 2021. The Company was also eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="ia28ed82e949f407abfcf436c06550157_I20200320" decimals="-5" name="pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfNzk5MQ_bc88040d-5ff0-4d46-9b3d-dcd9ac95d518">32.5</ix:nonFraction>&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company submitted a letter to HK Tainuo associated with this license agreement seeking a mutual decision to end the licensing agreement. As of September&#160;30, 2022, $<ix:nonFraction unitRef="usd" contextRef="iea1a035c480c4e9cb20e78a99005a535_I20220930" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfMTA5OTUxMTYzNzIxNg_21191411-77af-4253-ad99-34e33c4903e7">10.0</ix:nonFraction>&#160;million was recognized as part of acquisition accounting within other liabilities in the condensed consolidated balance sheet related to this matter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 31</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and in accordance with the rules and regulations of the United States Securities and Exchange Commission, or SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q and certain other communications made by us contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to: the Flexion Acquisition (as defined below) and the costs and benefits thereof, our growth and future operating results and trends, our strategy, plans, objectives, expectations (financial or otherwise) and intentions, future financial results and growth potential, anticipated product portfolio, development programs, strategic alliances, patent terms and intellectual property. For this purpose, any statement that is not a statement of historical fact should be considered a forward-looking statement. We often use the words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;can&#8221; and similar expressions to help identify forward-looking statements. We cannot assure you that our estimates, assumptions and expectations will prove to have been correct. Actual results may differ materially from these indicated by such forward-looking statements as a result of various important factors, including risks relating to, among others: risks associated with acquisitions, such as the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the transaction will not occur; the possibility that if we do not achieve the perceived benefits of the Flexion Acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our shares could decline; the impact of the COVID-19 pandemic on elective surgeries, our manufacturing and supply chain, global and United States, or U.S., economic conditions, and our business, including our revenues, financial condition and results of operations; the success of our sales and manufacturing efforts in support of the commercialization of EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (bupivacaine liposome injectable suspension), ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) and iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and the rate and degree of market acceptance of EXPAREL, ZILRETTA and iovera&#176;; the size and growth of the potential markets for EXPAREL, ZILRETTA and iovera&#176; and our ability to serve those markets; our plans to expand the use of EXPAREL, ZILRETTA and iovera&#176; to additional indications and opportunities, and the timing and success of any related clinical trials for EXPAREL, ZILRETTA and iovera&#176;; the commercial success of EXPAREL, ZILRETTA and iovera&#176;; the related timing and success of United States Food and Drug Administration, or FDA, supplemental New Drug Applications, or sNDAs, and premarket notification 510(k)s; the related timing and success of European Medicines Agency, or EMA, Marketing Authorization Applications, or MAA; our plans to evaluate, develop and pursue additional product candidates utilizing our proprietary multivesicular liposome, or pMVL, drug delivery technology; the approval of the commercialization of our products in other jurisdictions; clinical trials in support of an existing or potential pMVL-based product; our commercialization and marketing capabilities, our ability to successfully construct an additional EXPAREL manufacturing suite in San Diego, California; our ability to successfully complete a ZILRETTA capacity expansion project in Swindon, England; the outcome of any litigation; the ability to successfully integrate Flexion or any future acquisitions into our existing business; the recoverability of our deferred tax assets; and assumptions associated with contingent consideration payments. Important factors could cause our actual results to differ materially from those indicated or implied by forward-looking statements, and as such we anticipate that subsequent events and developments will cause our views to change. Except as required by applicable law, we undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing our views as of any date subsequent to the date of the filing of this Quarterly Report on Form&#160;10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include items mentioned herein and the matters discussed and referenced in Part&#160;I-Item&#160;1A. &#8220;Risk Factors&#8221; included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and in other reports as filed with the SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references to &#8220;Pacira,&#8221; &#8220;we,&#8221; the &#8220;Company,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this Quarterly Report on Form&#160;10-Q refer to Pacira BioSciences,&#160;Inc. and its subsidiaries.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 32</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is the industry leader in our commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. We are also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. Our long-acting, local analgesic EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (bupivacaine liposome injectable suspension) was commercially launched in April 2012. EXPAREL utilizes our unique pMVL drug delivery technology that encapsulates drugs without altering their molecular structure and releases them over a desired period of time. In the U.S., EXPAREL is the only opioid-free, long-acting local and regional analgesic approved for infiltration, field blocks and interscalene brachial plexus nerve block to produce local or regional postsurgical analgesia. EXPAREL is also approved for infiltration in pediatric patients aged six years and older in the U.S. In the European Union, or E.U., and the United Kingdom, or U.K., EXPAREL is approved as a brachial plexus block or femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults. Since its initial approval in 2011, more than 11 million patients have been treated with EXPAREL. We drop-ship EXPAREL directly to end-users based on orders placed to wholesalers or directly to us, and there is no product held by wholesalers. With the acquisition of Flexion Therapeutics, Inc. (&#8220;Flexion&#8221;) in November 2021 (the &#8220;Flexion Acquisition&#8221;), we acquired ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension), the first and only extended-release, intra-articular therapy that can provide major relief for osteoarthritis, or OA, knee pain for three months and has the potential to become an alternative to hyaluronic acid, or HA, and platelet rich plasma, or PRP, injections or other early intervention treatments. With the acquisition of MyoScience, Inc. (the &#8220;MyoScience Acquisition&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in April 2019, we acquired iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to targeted nerves, which we sell directly to end users. EXPAREL, ZILRETTA and the iovera&#176; system are highly complementary products as long-acting, non-opioid therapies that alleviate pain.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pursue the expanded use of EXPAREL, ZILRETTA and iovera&#176; in additional procedures; progress our earlier-stage product candidate pipeline; advance regulatory activities for EXPAREL, ZILRETTA, iovera&#176; and other product candidates; invest in sales and marketing resources for EXPAREL, ZILRETTA and iovera&#176;; expand and enhance our manufacturing capacity for EXPAREL, ZILRETTA and iovera&#176;; invest in products, businesses and technologies; and support legal matters.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Flexion Acquisition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we completed the Flexion Acquisition pursuant to an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), under which Flexion became our wholly owned subsidiary and added ZILRETTA, a non-opioid corticosteroid that employs a proprietary microsphere technology to provide extended pain relief, to our commercial offering. The addition of ZILRETTA to our innovative non-opioid product portfolio directly aligns with our mission to provide an opioid alternative to as many patients as possible and address medical needs along the neural pain pathway.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration of $578.8&#160;million included an initial payment of $428.3 million which represented $8.50 in cash per share of Flexion common stock, $20.2 million paid to settle restricted stock units and in-the-money stock options, an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by us and $45.2&#160;million in contingent consideration representing the fair value of contingent value rights, or CVRs, that were issued in conjunction with the Flexion Acquisition. The Merger Agreement provided for one non-tradeable CVR per share of Flexion common stock as well as one CVR per share for certain Flexion equity awards. Each CVR entitles Flexion shareholders to contingent milestone payments of up to an aggregate of $8.00 in cash per share of Flexion common stock if certain milestones are met on or prior to December 31, 2030. Up to an additional $380.2 million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, our revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact our business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on our customers and suppliers and longer lead-times or the inability to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that we are unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to actively monitor the situation and implement measures recommended by federal, state or local authorities, or that we determine are in the best interests of our patients, employees, partners, suppliers, shareholders and stakeholders. For a description of risks facing us that relate to the COVID-19 pandemic or any other future pandemic, epidemic or outbreak of contagious disease, see our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Highlights</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The U.S. Patent and Trademark Office, or USPTO, issued Patent No. 11,452,691 in October 2022, which is a chemical composition patent and was submitted in the FDA Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). With this patent, there are eight EXPAREL patents listed in the Orange Book, each with an expiration date of January 22, 2041. We also received a Notice of Allowance from the USPTO for a U.S. Patent Application that is a product by process patent for EXPAREL. After issuance, we will submit this patent for listing in the Orange Book.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In September 2022, we announced positive topline results from two Phase 3 registration studies of EXPAREL as a single-dose nerve block for postsurgical regional analgesia in lower extremity surgeries. The first study, which evaluated EXPAREL as a femoral nerve block in the adductor canal in patients undergoing total knee arthroplasty, or TKA, achieved the primary endpoint demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl (p&lt;0.01). EXPAREL also achieved a statistically significant reduction in postsurgical opioid consumption through 96 hours (p&lt;0.01) compared with bupivacaine HCl, a key secondary endpoint. The second study, which evaluated EXPAREL as a sciatic nerve block in the popliteal fossa in patients undergoing bunionectomy, achieved the primary endpoint by demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl (p&lt;0.00001). EXPAREL also achieved statistically significant reductions in postsurgical opioid consumption (p&lt;0.00001) and percentage of opioid-free subjects (p&lt;0.001) through 96 hours compared with bupivacaine HCl, which were key secondary endpoints. EXPAREL was well tolerated with a safety profile consistent with bupivacaine HCl. With these positive results, we plan to submit an sNDA to the FDA early next year seeking expansion of the EXPAREL label to include femoral nerve block in the adductor canal.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;In September 2022, we announced that the EMA&#8217;s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for an expanded indication of EXPAREL to include use in children aged 6 years and older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds. We expect a decision from the European Commission, or EC, on the expanded indication in November 2022. The positive opinion was based on the results of the Phase 3 PLAY study of EXPAREL infiltration in pediatric patients undergoing spinal or cardiac surgeries. Overall findings were consistent with the pharmacokinetic and safety profiles for adult patients with no safety concerns identified at a dose of 4 mg/kg. The EC decision will be applicable to all 27 E.U. member states plus Iceland, Norway and Liechtenstein. The data is still under review in the U.K. EXPAREL was initially approved by the EC and in the U.K. in November 2020 as a brachial plexus block or femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPAREL</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., EXPAREL is currently indicated in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. In the E.U., EXPAREL is indicated as a brachial plexus block and femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EXPAREL Label and Global Expansion</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Lower extremity nerve block. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have completed two Phase 3 registration studies of EXPAREL as a nerve block in lower extremity surgeries. In September 2022, we announced positive topline results from two Phase 3 registration studies of EXPAREL as a single-dose nerve block for postsurgical regional analgesia in lower extremity surgeries. The first study, which evaluated EXPAREL as a femoral nerve block in the adductor canal in patients undergoing TKA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">achieved the primary endpoint demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl (p&lt;0.01). EXPAREL also achieved a statistically significant reduction in postsurgical opioid consumption through 96 hours (p&lt;0.01) compared with bupivacaine HCl, a key secondary endpoint. The second study, which evaluated EXPAREL as a sciatic nerve block in the popliteal fossa in patients undergoing bunionectomy, achieved the primary endpoint by demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl (p&lt;0.00001). EXPAREL also achieved statistically significant reductions in postsurgical opioid consumption (p&lt;0.00001) and percentage of opioid-free subjects (p&lt;0.001) through 96 hours compared with bupivacaine HCl, which were key secondary endpoints. EXPAREL was well tolerated with a safety profile consistent with bupivacaine HCl. With these positive results, we plan to submit an sNDA to the FDA early next year seeking expansion of the EXPAREL label to include femoral nerve block in the adductor canal.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pediatrics. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are working with the FDA to finalize our studies to support expansion of the EXPAREL single-dose infiltration label to include patients under six years of age. We have met with the FDA to discuss appropriate studies of EXPAREL in pediatric patients aged 0 to less than 6 years of age. We expect that these studies, if successful, will be the basis for an sNDA seeking expansion of the EXPAREL label to include this patient population for single-dose infiltration. We are also discussing our regulatory strategy for EXPAREL administered as a nerve block in the pediatric setting. We are working with both the FDA and the EMA with the goal of harmonizing our pediatric clinical studies between the two regions.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Stellate ganglion block. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Planning is underway for a multicenter registration study of EXPAREL as a stellate ganglion block for treating refractory cardiac ventricular dysrhythmias and for use to prevent postoperative atrial fibrillation after open heart surgery. We are working with a steering committee of Key Opinion Leaders in regional anesthesia and stellate ganglion blocks to help finalize study design. After we meet with the FDA to align on our regulatory strategy for expanding the EXPAREL label to include stellate ganglion block, we expect to proceed with a registration trial. We believe a stellate ganglion block utilizing EXPAREL will last for several days and address a significant unmet need in patients with ventricular and atrial dysrhythmias.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Global expansion. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prioritized the European and Latin American markets for global expansion. In Europe, we were granted marketing authorization by the EC in November 2020 for EXPAREL as a brachial plexus block or femoral nerve block for treatment of post-operating pain in adults and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults, and in September 2022, we received a positive opinion recommending an expanded indication to include children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds. We launched EXPAREL in the U.K. and targeted E.U. countries in the fourth quarter of 2021. In Latin America, we have a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL. Eurofarma has the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia and Mexico. In addition, Eurofarma will be responsible for regulatory filings for EXPAREL in these countries. We will receive royalties and are also eligible to receive regulatory- and commercial-based milestone payments that are triggered by the achievement of certain events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ZILRETTA</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZILRETTA was approved by the FDA in October 2017 and launched in the U.S. shortly thereafter. We market ZILRETTA through our ZILRETTA and iovera&#176; sales force of approximately 50 Treatment Solutions Managers who are providing clinicians with two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complementary and standalone non-opioid solutions for managing OA pain. ZILRETTA is the first and only extended-release, intra-articular therapy for OA knee pain. ZILRETTA employs a proprietary microsphere technology combining triamcinolone acetonide, or TA, a commonly administered, immediate-release corticosteroid, with a poly lactic-co-glycolic acid, or PLGA, matrix to provide extended pain relief. PLGA is a proven extended-release delivery vehicle that is metabolized to carbon dioxide and water as it releases drug in the intra-articular space and is used in other approved drug products and surgical devices. The ZILRETTA microspheres slowly and continuously release triamcinolone acetonide into the knee to provide significant pain relief for 12 weeks, with some people experiencing pain relief through 16 weeks.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe ZILRETTA&#8217;s extended-release profile may also provide effective treatment for OA pain of the shoulder, and we intend to initiate a Phase 3 trial investigating ZILRETTA in shoulder OA in 2023 after aligning with the FDA on study design. In addition, we are planning a study comparing ZILRETTA to immediate release triamcinolone acetonide in patients with Type 2 diabetes and are evaluating a repeat dosing study.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ZILRETTA Clinical Benefits</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZILRETTA combines a commonly administered steroid, TA, with PLGA, delivering a 32 milligram dose of TA to provide extended therapeutic concentrations in the joint and persistent analgesic effect.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the strength of its pivotal and other clinical trials, we believe that ZILRETTA represents an important treatment option for the millions of patients in the U.S. in need of safe and effective extended relief from OA knee pain. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pivotal Phase 3 trial, on which the approval of ZILRETTA was based, showed that ZILRETTA significantly reduced OA knee pain for 12 weeks, with some people experiencing pain relief through Week 16. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the magnitude and duration of pain relief provided by ZILRETTA in clinical trials were clinically meaningful with the magnitude of pain relief among the largest seen to date in OA clinical trials. The overall frequency of treatment-related adverse events in these trials was similar to those observed with placebo, and no drug-related serious adverse events were reported. We believe that ZILRETTA holds the potential to become the corticosteroid of choice given its safety and efficacy profile, and the fact that it is the first and only extended-release corticosteroid on the market. In September 2021, the American Association of Orthopaedic Surgeons, or AAOS, updated its evidence-based clinical practice guidelines, finding ZILRETTA can improve patient outcomes over traditional immediate-release corticosteroids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">iovera&#176;</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The iovera&#176; system is an FDA-approved, non-opioid handheld cryoanalgesia device used to produce precise, controlled doses of cold temperature to targeted nerves. It has been FDA 510(k) cleared in the U.S., has a CE mark in the E.U. and is cleared for marketing in Canada for the blocking of pain. We believe the iovera&#176; system is highly complementary to EXPAREL and ZILRETTA as a non-opioid therapy that alleviates pain using a non-pharmacological nerve block to disrupt pain signals being transmitted to the brain from the site of injury or surgery. It is also indicated for the relief of pain and symptoms associated with arthritis of the knee for up to 90 days.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iovera&#176; Clinical Benefits</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a growing body of clinical data demonstrating success with iovera&#176; treatment for OA of the knee. Surgical intervention is typically a last resort for patients suffering from OA of the knee. In one study, the majority of the patients suffering from OA of the knee experienced pain relief up to 150 days after being treated with iovera&#176;.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary findings demonstrated reductions in opioids, including:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The daily morphine equivalent consumption in the per protocol group analysis was significantly lower at 72 hours (p&lt;0.05), 6 weeks (p&lt;0.05) and 12 weeks (p&lt;0.05).</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients who were administered iovera&#176; were far less likely to take opioids six weeks after surgery. The number of patients taking opioids six weeks after TKA in the control group was three times the number of patients taking opioids in the cryoanalgesia group (14% vs. 44%, p&lt;0.01).</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients in the iovera&#176; group demonstrated a statistically significant reduction in pain scores from their baseline pain scores at 72 hours (p&lt;0.05) and at 12 weeks (p&lt;0.05).</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these data validate iovera&#176; as a clinically meaningful non-opioid alternative for patients undergoing TKA, and that iovera&#176; offers the opportunity to provide patients with non-opioid pain control well in advance of any necessary surgical intervention through a number of key product attributes:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is safe and effective with immediate pain relief that can last for months as the nerve regenerates over time;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is repeatable;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The iovera&#176; technology does not risk damage to the surrounding tissue;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is a convenient handheld device with a single-use procedure-specific Smart Tip; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; can be delivered precisely using ultrasound guidance or an anatomical landmark.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the AAOS updated its evidence-based clinical practice guidelines, reporting that denervation therapy&#8212;including cryoneurolysis&#8212;may reduce knee pain and improve function in patients with symptomatic OA of the knee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also encouraged by usage of iovera&#176; in other areas. Key opinion leaders in orthopedics, spine and anesthesia are interested in replacing heat-based radiofrequency ablation with iovera&#176; cold therapy. There is interest across a wide range of treatment opportunities such as low back pain, spine, spasticity and rib fracture. We intend to use investigator-initiated studies and grants to develop data across these areas.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iovera&#176; Global Expansion</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#176; in Canada. We began selling iovera&#176; in Canada in the fourth quarter of 2021. Additionally, we began selling iovera&#176; in the E.U. through a contracted sales force in the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Osteoarthritis Market</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OA is the most common form of arthritis. It is also called degenerative joint disease and occurs most frequently in the hands, hips and knees. With OA, the cartilage within a joint begins to break down and the underlying bone begins to change. These changes usually develop slowly and get worse over time. OA can cause pain, stiffness and swelling. In some cases it also causes reduced function and disability; some people are no longer able to do daily tasks or work. According to the CDC, OA affects over 32.5 million adults in the U.S.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lifetime risk of developing symptomatic knee OA is 45 percent. The prevalence of symptomatic knee OA increases with each decade of life, with the annual incidence of knee OA being highest between age 55 and 64 years old. There are 14 million individuals in the U.S. who have symptomatic knee OA, and nearly two million are under the age of 45. Surgical intervention is typically a last resort for patients suffering from OA of the knee.</span></div><div><span><br/></span></div><div style="text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the addition of ZILRETTA to our product offering, we can now offer clinicians the flexibility to individualize OA knee pain treatment with either ZILRETTA or a drug-free nerve block with iovera&#176; based on patient factors and preference, physician training, site of care and reimbursement considerations.</span></div><div style="text-indent:22.3pt"><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_103"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Development Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PCRX-201 (Formerly FX-201)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">PCRX-201 was added to our portfolio as part of the Flexion Acquisition. PCRX-201 is a gene therapy product candidate designed to provide &#8220;on demand&#8221; production of an anti-inflammatory protein, interleukin-1 receptor antagonist (IL-1Ra) whenever inflammation is detected in the joint. Based upon very compelling initial Phase 1 efficacy and safety data for PCRX-201, we are working with investigators and plan to request an FDA meeting to discuss the regulatory pathway forward for OA of the knee&#8212;a very important and exciting addition to our durable non-opioid pain management pipeline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PCRX-301 (Formerly FX-301)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PCRX-301 is a locally administered Na</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:1.41pt;vertical-align:baseline">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.7 inhibitor, known as funapide, formulated for extended release in a thermosensitive hydrogel. The initial development of PCRX-301 was intended to support administration as a peripheral analgesic lower extremity nerve block for management of post-operative pain. In September 2022, based on the results of a completed phase 1 study, we decided to discontinue further development of PCRX-301 due to a lack of clinical efficacy when compared to placebo and issues with the hydrogel formulation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">pMVL-Based Clinical Programs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the proven safety, flexibility and customizability of our pMVL drug delivery technology platform for acute, sub-acute and chronic pain applications, we have several pMVL-based products in clinical development. Following data readouts from preclinical and feasibility studies for these candidates, we have prioritized three programs for clinical development: (i) PCRX-401, a dexamethasone-pMVL for low back pain; (ii) PCRX-501, a high potency bupivacaine-pMVL for longer-lasting pain relief (20.0 mg/mL) and (iii) a bupivacaine-pMVL for intrathecal analgesia (13.3 mg/mL). We are planning to initiate the second half of our Phase 1 study of low-concentration bupivacaine-pMVL for intrathecal analgesia in late 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External Innovation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In parallel to our internal clinical programs, our business development team continues to pursue innovative acquisition targets that are complementary to EXPAREL, ZILRETTA and iovera&#176; and that we believe are of great interest to the surgical and anesthesia audiences we are already calling on today. We are using a combination of strategic investments, in-licensing and acquisition transactions to build out a pipeline of innovation to improve patients&#8217; journeys along the neural pain pathway. Select strategic investments we have made to support promising early stage platforms are summarized below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Development Stage</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description of Platform Technology</span></td><td colspan="3" style="background-color:#eaeaea;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Potential Therapeutic Areas</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carthronix, Inc.</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phase 1-Ready</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">CX-011, an intra-articular injection designed to slow joint degeneration by mediating IL-6 cytokines</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Knee OA</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genascence Corporation</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phase 2-Ready</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AAV vector-based gene therapy targeting Interleukin 1 Receptor Antagonist (IL-1Ra)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Knee OA</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GeneQuine Biotherapeutics GmbH</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Helper-dependent adenoviral vectors (HDAd) that enter joint cells to confer multi-year gene expression</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OA and other musculoskeletal disorders</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spine BioPharma, LLC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Phase 3</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">SB01 7-amino acid chain peptide that binds to and induces down regulation of transforming growth factor, beta 1 (TGF&#946;1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Degenerative disc disease</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Portfolio and Internal Pipeline</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current product portfolio and internal product candidate pipeline, along with anticipated milestones over the next 12 to 18 months, are summarized in the table below:</span></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><img src="pcrx-20220930_g2.jpg" alt="pcrx-20220930_g2.jpg" style="height:640px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- NOCITA</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> is a registered trademark of Aratana Therapeutics, Inc., a wholly owned subsidiary of Elanco Animal Health, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pacira Training Facilities</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we opened the Pacira Innovation and Training center of Tampa (the &#8220;PITT&#8221;). We designed this facility to help advance clinician understanding of the latest local, regional and field block approaches for managing pain. The PITT provides an unparalleled training environment for healthcare providers working to reduce or eliminate patient exposure to opioids. The PITT supports a full range of educational events to advance clinician understanding of the latest local, regional, and field block approaches for managing pain and reducing or eliminating exposure to opioids. Our corporate headquarters are also located at the PITT.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PITT consists of approximately 13,000 square-feet of fully adaptable space and is equipped with state-of-the-art technology and audio/visual capabilities and features several distinct training spaces including a simulation lab equipped with seven ultrasound scanning stations; a lecture hall featuring a 4&#189;-foot tall by 24-foot wide liquid crystal display video wall to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">support live, virtual and even global presentations; and a green-screen broadcast studio designed to livestream content with single or multiple hosts.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our EXPAREL programs, we are hosting ongoing workshops to train new users on best practice techniques for iovera&#176; administration at the PITT. Led by healthcare professionals, these labs include didactic lectures and hands-on trainings including live model nerve scanning and identification using ultrasound and peripheral nerve stimulation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At no fee to the organization, the PITT also serves as a venue for national anesthesia provider organizations to host their own workshops and training sessions to educate healthcare providers.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have launched development plans for a second training facility in Houston, Texas. This 19,000 square-foot state-of-the-art facility will feature an adaptive lecture hall, broadcast studio and lab space for cadaver and other interactive workshops. These training centers are core to developing both our physician champions and community-based clinicians who want to stay on the forefront of opioid-sparing pain management. We expect to complete this facility before the end of 2022 which would immediately double our capacity and ability to host programs for EXPAREL, ZILRETTA and iovera&#176;.</span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_106"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three and Nine Months Ended September&#160;30, 2022 and 2021 </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales consist of (i) EXPAREL in the U.S., the E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, our bupivacaine liposome injectable suspension for veterinary use.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our revenues during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXPAREL</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZILRETTA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iovera&#176;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bupivacaine liposome injectable suspension</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net product sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,466&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) ZILRETTA net product sales began November 19, 2021, the date of the Flexion Acquisition.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXPAREL revenue increased 9% in the three and nine months ended September&#160;30, 2022 versus 2021 primarily due to increases of 7.2% in gross vial volume in both periods and increases of 3.7% and 3.8% in gross selling price per unit, respectively, partially offset by the sales mix of EXPAREL vial sizes. Although the demand for EXPAREL has continued to increase primarily as a result of Ambulatory Surgical Centers and anesthesiologists broadening the use of long-acting EXPAREL regional approaches as a foundation of multimodal opioid-minimization strategies that enable shifting inpatient procedures to 23-hour sites of care, the elective surgery market has faced post-pandemic-related challenges due to regional surges in COVID-19 variant cases, staffing shortages and fatigue from care teams addressing significant procedure backlogs. EXPAREL utilization remains above the overall sharp decline in elective surgical procedures relative to pre-pandemic baseline levels due to increased utilization in outpatient settings and emergent procedures.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition, we acquired ZILRETTA in November 2021, which is an extended-release corticosteroid treatment for OA knee pain. We recognized net product sales of $26.5 million and $77.5 million for the three and nine months ended September&#160;30, 2022, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales of iovera&#176; increased 7% in the three months ended September&#160;30, 2022 versus 2021 due to the rollout of generation 2 iovera&#176; products and an increased sales force. Net product sales of iovera&#176; decreased 5% in the nine months ended September&#160;30, 2022 versus 2021 primarily due to a delay in the transition from generation 1 to generation 2 iovera&#176; products and short-term variations in reimbursement policies in certain territories.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bupivacaine liposome injectable suspension net product sales increased over 100% in the three and nine months ended September&#160;30, 2022 versus 2021. Its related royalties decreased nominally in the three months ended September&#160;30, 2022 and increased 27% in the nine months ended September&#160;30, 2022 versus 2021 primarily due to the timing of orders placed by Aratana Therapeutics, Inc. for veterinary use. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any renewed government suspension of or reluctance of patients to have elective procedures would impact our future sales of EXPAREL, ZILRETTA and iovera&#176; during the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of activity with respect to our sales related allowances and accruals related to EXPAREL and ZILRETTA for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.701%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Service<br/>Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Government Rebates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,092)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Service<br/>Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Government<br/>Rebates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,633)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total reductions of gross product sales from sales-related allowances and accruals were $52.8 million and $23.3 million, or 9.7% and 5.8% of gross product sales, for the nine months ended September 30, 2022 and 2021, respectively. The overall increase in sales-related allowances and accruals as a percentage of gross product sales was primarily related to the addition of the ZILRETTA-related allowances and accruals.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Goods Sold</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold primarily relates to the costs to produce, package and deliver our products to customers. These expenses include labor, raw materials, manufacturing overhead and occupancy costs, depreciation of facilities, royalty payments, quality control and engineering.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cost of goods sold and gross margin during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50,678</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$101,248</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin decreased three percentage points in the three months ended September 30, 2022 versus 2021 primarily due to higher inventory reserves and the ZILRETTA step-up of fixed assets and inventory to fair value in accordance with purchase accounting, partially offset by an increase in gross margin associated with ZILRETTA. Gross margin decreased two percentage points in the nine months ended September 30, 2022 versus 2021, mainly due to higher inventory reserves and the ZILRETTA step-up of fixed assets and inventory to fair value in accordance with purchase accounting, partially offset by unplanned downtime in the prior period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses primarily consist of costs related to clinical trials and related outside services, product development and other research and development costs, including trials that we are conducting to generate new data for EXPAREL, ZILRETTA and iovera&#176; and stock-based compensation expense. Clinical and preclinical development expenses include costs for clinical personnel, clinical trials performed by third-parties, toxicology studies, materials and supplies, database management and other third-party fees. Product development and manufacturing capacity expansion expenses include development costs for our products, which include personnel, equipment, materials and contractor costs for process development and product candidates, development costs related to significant scale-ups of our manufacturing capacity and facility costs for our research space. Regulatory and other expenses include regulatory activities related to unapproved products and indications, medical information expenses and related personnel. Stock-based compensation expense relates to the costs of stock option grants, awards of restricted stock units, or RSUs, and our employee stock purchase plan, or ESPP.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a breakout of our research and development expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and preclinical development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,558</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and manufacturing capacity expansion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,318</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,047</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,655</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,257</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,761</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,292</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expense increased 68% in the three and nine months ended September&#160;30, 2022 versus 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical development expense increased over 100% in each of the three and nine month periods ended September&#160;30, 2022 versus 2021 due to ongoing expenses and completion of two EXPAREL lower extremity nerve block trials in bunionectomy and TKA, ongoing trials for the product candidates acquired as part of the Flexion Acquisition and toxicology studies for product development candidates. The prior year periods were affected by the COVID-19 pandemic, whereas the current year includes an expanded product candidate pipeline internally and as a result of the Flexion Acquisition.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product development and manufacturing capacity expansion expense increased 53% and 23% in the three and nine months ended September&#160;30, 2022 versus 2021, respectively, mainly attributable to the significant scale-up of our EXPAREL manufacturing capacity at our Science Center Campus in San Diego, California.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory and other expense increased 19% in the three months ended September&#160;30, 2022 versus 2021 related to our iovera&#176; clinical data registry. Regulatory and other expense increased 8% for the nine months ended September 30, 2022 as compared to the same period in 2021 in support of the E.U. EXPAREL pediatric submission and U.S. sNDA submission.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased 54% and 33% in the three and nine months ended September&#160;30, 2022 versus 2021, respectively, primarily due to greater equity awards outstanding for research and development personnel.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of compensation and benefits for our sales force and personnel that support our sales, marketing, medical and scientific affairs operations, payments to our marketing partners for the promotion and sale of our products, expenses related to communicating the health outcome benefits of our products, investments in provider-level market access and patient reimbursement support and educational programs for our customers. General and administrative expenses consist of compensation and benefits for legal, finance, regulatory activities related to approved products and indications, compliance, information technology, human resources, business development, executive management and other supporting personnel. It also includes professional fees for legal, audit, tax and consulting services. Stock-based compensation expense relates to the costs of stock option grants, RSU awards and our ESPP.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our selling, general and administrative expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,660</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,321</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,195</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,225</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total selling, general and administrative expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,856&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,546</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,191</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total selling, general and administrative expense increased 28% and&#160;29% in the three and nine months ended September&#160;30, 2022 versus 2021, respectively</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses increased 28% and 33% in the three and nine months ended September&#160;30, 2022 versus 2021, respectively. The increases were driven by sales force expansion supporting both ZILRETTA and iovera&#176;, following the completion of the Flexion Acquisition in November 2021 and fully staffing a contracted sales force in Europe. Increases also included expenses for patient reimbursement support for ZILRETTA. We are continuing our marketing investment in EXPAREL and iovera&#176;, which includes educational initiatives and programs related to the impact of opioids and postsurgical pain management and our national advocacy campaign designed to educate patients about non-opioid treatment options. Additionally, we continue our investment in clinician training in the use of EXPAREL and iovera&#176; at our PITT training facility in Tampa, Florida. The addition of ZILRETTA to our commercial portfolio provides clinicians with two unique OA treatment options to individualize patient care.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased 36% and 31% in the three and nine months ended September&#160;30, 2022 versus 2021, respectively. The increases in the three and nine months ended were driven by administrative support costs as a result of the Flexion Acquisition in November 2021, including transition expenses during integration, legal costs to support intellectual property protection and additional support for our expansion into European markets.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased 15% and 12% in the three and nine months ended September&#160;30, 2022 and 2021 primarily due to an increase in the number of equity awards outstanding for selling, general and administrative personnel.</span></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the amortization of acquired intangible assets during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of acquired intangible assets increased substantially in the three and nine months ended September&#160;30, 2022 versus 2021 due to the Flexion Acquisition. We acquired a developed technology intangible asset for ZILRETTA for OA knee pain, which is being amortized over a useful life of approximately ten years. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Charges (Gains) and Other</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the costs related to the Flexion Acquisition, MyoScience Acquisition, termination costs and other activities during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related charges (gains), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,232)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges (gains) and other</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,232)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total acquisition-related charges (gains) and other increased over 100% in the three months ended September&#160;30, 2022 versus 2021. Total acquisition-related charges (gains) and other decreased substantially in the nine months ended September&#160;30, 2022 versus 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, we recognized acquisition-related charges, net of $0.5 million. These charges are primarily related to severance and other employee related costs, legal and other professional fees, third-party services and other one-time charges associated with the Flexion Acquisition, which were partially offset by credits from changes in the fair value of contingent consideration related to the Flexion Acquisition and MyoScience Acquisition. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we recognized acquisition-related gains, net of $13.2 million. These gains were primarily driven by reductions in acquisition contingent consideration liabilities due to adjustments to near-term forecasts for the applicable period during which the Flexion contingent consideration may be achieved under the Merger Agreement and due to the reduced probability of meeting the MyoScience contingent consideration milestones by December 31, 2023, the expiration date for achieving those milestones</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These gains were partially offset by severance and other employee related costs, legal and other professional fees, third-party services and other one-time charges associated with the Flexion Acquisition</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Charges and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three and nine months ended September&#160;30, 2021, we recognized acquisition-related charges and other charges of $0.2 million and $2.3 million, respectively. Included in these three and nine month periods, as part of the MyoScience Acquisition, we recognized acquisition-related gains of $1.2 million and $2.1 million, respectively, related to changes in the fair value of contingent consideration. These gains were offset by acquisition-related charges of $1.4 million in both the three and nine month periods related to severance and acquisition-related fees. Also included in the nine months ended September&#160;30, 2021 is a $3.0 million charge related to the termination of an agreement with Nuance Biotech Co. Ltd to advance the development and commercialization of EXPAREL in China due to the lack of a viable regulatory pathway that adequately safeguards our intellectual property against the risk of a generic product. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Charges and Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements included herein, for more information.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (Expense) Income</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding other expense, net during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,220)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,202)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% +</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,547)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,111)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net increased by more than 100% and 67% in&#160;the three and nine months ended September&#160;30, 2022 versus 2021, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 34% and 36% increase in interest expense during the three and nine months ended September&#160;30, 2022, respectively, was due to the $375.0 million term loan B credit agreement (the &#8220;Term Loan&#8221;) entered into in December 2021. This increase was partially offset by the absence of debt discount amortization associated with our convertible notes in the current year due to adopting Accounting Standards Update, or ASU, 2020-06 in 2022, and the maturing of our 2.375% convertible senior notes due 2022, or 2022 Notes, on April 1, 2022. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements herein. The increase in interest expense was slightly offset by increases in interest income in the three and nine months ended September 30, 2022 versus 2021 due to higher interest rates and overall investment balance.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net expense during the three and nine months ended September 30, 2022 included a $10.0 million impairment related to an equity investment. Other, net for the nine months ended September 30, 2021 included a realized loss on the sale of an equity investment in the amount of $2.6&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our income tax expense during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Effective tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were 133% and 27% for the three months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. The effective tax rates were 17% and 25% for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. Income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation and valuation allowances recorded against non-U.S. results and capital losses. The three months ended September&#160;30, 2022 also includes benefits for a first quarter SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc), milestone payment and a fair value adjustment for Flexion contingent consideration. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the nine months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation and valuation allowances recorded against non-U.S. results and capital losses offset by benefits related to stock-based compensation. The nine months ended September&#160;30, 2022 also includes benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration.</span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_109"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2006, we have devoted most of our cash resources to manufacturing, research and development and selling, general and administrative activities related to the development and commercialization of EXPAREL. In addition, we acquired ZILRETTA as part of the Flexion Acquisition in November 2021 and iovera&#176; as part of the MyoScience Acquisition in April 2019. We are primarily dependent on the commercial success of EXPAREL and ZILRETTA. We have financed our operations primarily with the proceeds from the sale of convertible senior notes and other debt, common stock, product sales and collaborative licensing and milestone revenue. As of September&#160;30, 2022, we had an accumulated deficit of $138.6 million, cash and cash equivalents and available-for-sale investments of $346.1 million and working capital of $401.9 million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our cash and available-for-sale investments on hand will be adequate to cover our short-term liquidity needs, and that we would be able to access other sources of financing should the need arise.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law in response to the COVID-19 pandemic. The CARES Act, among other things, allows for certain measures to increase liquidity for businesses such as the deferral of employer payroll taxes, a tax credit for retaining employees and other provisions. We benefited from the provision to defer the payment of certain employer payroll taxes in the amount of $2.8 million for the year ended December 31, 2020 and remitted $1.4 million in December 2021. The remaining $1.4 million is due by December 31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Cash Flows Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(476,154)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, net cash provided by operating activities was $103.2 million, compared to $102.5 million during the nine months ended September&#160;30, 2021. The increase&#160;of $0.7 million was attributable to increased net product sales from both ZILRETTA, acquired as part of the Flexion Acquisition in November 2021, and EXPAREL, offset by increases in all operating expense lines to support the existing and newly acquired products and product candidates, a slightly lower gross margin and increased interest payments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, net cash used in investing activities was $236.4 million, which reflected $166.8 million of available-for-sale investment purchases (net of maturities), a $32.0 million contingent consideration milestone payment that had been achieved in the fourth quarter of 2021 associated with our 2007 acquisition of Pacira Pharmaceuticals, Inc. from Skyepharma, purchases of fixed assets of $24.6 million for fill lines for our products and equipment for an EXPAREL capacity expansion project at our Science Center Campus in San Diego, California and purchases of equity and debt investments of $13.0 million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, net cash used in investing activities was $87.7 million, which reflected $42.9 million of short-term and noncurrent available-for-sale investment purchases (net of maturities) and purchases of fixed assets of $36.7 million. Major fixed asset purchases included equipment for an EXPAREL capacity expansion project at our Science Center Campus in San Diego, California, and continuing expenditures for our expanding EXPAREL manufacturing capacity in Swindon, England in partnership with Thermo Fisher Scientific Services, Inc., or Thermo Fisher. In addition, we made $13.0&#160;million in equity investments, and also purchased a total of $4.2&#160;million in convertible notes. Further, we sold an equity investment for net cash proceeds of $9.1&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, net cash used in financing activities was $343.0 million, which primarily consisted of a $192.6 million principal repayment of the 3.375% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;) as part of a repurchase offer to the holders of the Flexion 2024 Notes that was triggered by the Flexion Acquisition, $157.0 million to settle the 2022 Notes that matured on April 1, 2022 and $18.8 million of scheduled repayments of Term Loan principal, partially offset by $23.5 million of proceeds from the exercise of stock options and $1.8 million from the issuance of common stock through our ESPP.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, net cash provided by financing activities was $19.3 million, which consisted of proceeds from the exercise of stock options of $19.0 million and $1.6 million from the issuance of common stock through our ESPP, partially offset by the $1.3&#160;million financing component of a $7.0&#160;million contingent consideration payment made to MyoScience securityholders.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2026 Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we entered into the $375.0 million Term Loan which is secured by substantially all of our and any subsidiary guarantor&#8217;s assets and is scheduled to mature on December 7, 2026, subject to certain exceptions set forth in the term loan credit agreement (the &#8220;Credit Agreement&#8221;). We may elect to borrow either alternate base rate borrowings or term benchmark borrowings. Each term loan borrowing which is an alternate base rate borrowing bears interest at a variable rate per annum equal to the Alternate Base Rate (as defined in the Credit Agreement) subject to a 1.75% floor, plus 6.00%. Each term loan borrowing which is a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement requires us to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0 million. The Credit Agreement also contains customary affirmative and negative covenants, financial covenants, representations and warranties, events of default and other provisions. As of September&#160;30, 2022, we were in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we made scheduled principal payments of $18.8&#160;million. At September&#160;30, 2022, we had $356.3 million in outstanding borrowings under the Term Loan. As a result of our entry into the Term Loan, our interest expense has increased in 2022. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Convertible Senior Notes</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we completed a private placement of $402.5 million in aggregate principal amount of our 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per annum, payable semiannually in arrears on February&#160;1 and August 1 of each year. The 2025 Notes mature on August 1, 2025. At September&#160;30, 2022, the outstanding principal on the 2025 Notes was $402.5 million. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Convertible Senior Notes</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, as part of the Flexion Acquisition, we assumed $201.3 million in aggregate principal amount of the Flexion 2024 Notes. The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. In January 2022, we repurchased $192.6 million aggregate principal amount of the Flexion 2024 Notes. At September&#160;30, 2022, the outstanding principal on the Flexion 2024 Notes was $8.6&#160;million. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Capital Requirements</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents, available-for-sale investments and cash received from product sales will be sufficient to enable us to fund our operating expenses, capital expenditure requirements and payment of the interest and principal on our Term Loan and our convertible notes, and any conversions of our Notes through the next 12 months. Our future use of operating cash and capital requirements will depend on many forward-looking factors, including, but not limited to, the following:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of successfully integrating Flexion into our existing business and expanding the commercialization of ZILRETTA;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of the potential Flexion milestone payments in connection with the Flexion Acquisition, which could be up to an aggregate of $425.5&#160;million if certain regulatory and commercial milestones are met. (See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the impact of the COVID-19 pandemic and global economic conditions, including the amounts and delays of suspended elective surgical procedures, clinical trials, longer lead-times for, the inability to secure a sufficient supply of materials or the inflationary impact on the cost of materials;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of and extent to which the holders of our convertible senior notes elect to convert their notes and the timing of principal and interest payments on our Term Loan;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and impact of increases to the variable interest rate on our Term Loan borrowings in accordance with the terms of the Credit Agreement;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and our ability to successfully continue to expand the commercialization of EXPAREL, ZILRETTA and iovera&#176;, including outside of the U.S.;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of expanding and maintaining our manufacturing facilities, including the current EXPAREL capacity expansion project at our Science Center Campus in San Diego, California and a ZILRETTA capital project at the Thermo Fisher site in Swindon, England;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of potential remaining milestone payments to MyoScience security holders, which could be up to an aggregate of $43.0&#160;million if certain regulatory and commercial milestones are met (See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of additional strategic investments, including additional investments under existing agreements;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs related to legal and regulatory issues;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of inflation on our product costs, operating expenses and business strategy;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of performing additional clinical trials for our products, including the additional pediatric trials required by the FDA and EMA as a condition of approval of EXPAREL;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs for the development and commercialization of other product candidates;</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of future payments under our employee benefit plans, including but not limited to our cash long-term incentive plan and non-qualified deferred compensation plan; and</span></div><div style="margin-bottom:8pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in products, businesses and technologies.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may require additional debt or equity financing to meet our future operating and capital requirements. We have no committed external sources of funds, and additional equity or debt financing may not be available on acceptable terms, if at all. In particular, capital market disruptions or negative economic conditions, especially in light of the COVID-19 pandemic, may hinder our access to capital.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_112"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for a discussion of recently issued accounting pronouncements and their impact or future potential impact on our financial results, if determinable. For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our most recent </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for a new lease described in Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, there have been no material changes in our contractual obligations relating to our indebtedness, lease obligations and purchase obligations from those reported in our Annual Report on Form 10-K for the year ended December&#160;31, 2021. For more information on our contractual obligations and commercial commitments, see Part II, Item 7 in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 48</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our cash equivalents and investment activities is to preserve principal while at the same time maximizing the income that we receive from our investments without significantly increasing risk. We invest in corporate bonds, commercial paper, asset-backed securities and U.S. Treasury and other government agency notes, which are reported at fair value. These securities are subject to interest rate risk and credit risk. This means that a change in prevailing interest rates may cause the fair value of the investment to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the interest rate later rises, we expect that the fair value of our investment will decline. A hypothetical 100 basis point increase in interest rates would have reduced the fair value of our available-for-sale securities at September&#160;30, 2022 by approximately $1.2&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our Notes are impacted by both the fair value of our common stock and interest rate fluctuations. As of&#160;September&#160;30, 2022, the estimated fair value of the 2025 Notes was $993 per $1,000 principal amount. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion of our Notes, which bear interest at a fixed rate. At September&#160;30, 2022, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6&#160;million of principal remains outstanding on the Flexion 2024 Notes. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan provided for a single-advance term loan in the principal amount of $375.0&#160;million and is scheduled to mature on December 7, 2026. Each term loan borrowing which is an alternate base rate borrowing bears interest at a variable rate per annum equal to the Alternate Base Rate (as defined in the Credit Agreement) subject to a 1.75% floor, plus 6.00%. Each term loan borrowing which is a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR rate (as defined in the Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%. At September&#160;30, 2022, we had $356.3 million in outstanding borrowings under the Term Loan. A hypothetical 100 basis point increase in interest rates would have increased interest expense during the three and nine months ended September&#160;30, 2022 by approximately $0.9&#160;million and $2.8&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition and as discussed in more detail in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements included herein, any future conversion rights for the Flexion 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the Flexion 2024 Notes. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with certain vendors and partners that operate in foreign jurisdictions. The more significant transactions are primarily denominated in the U.S. Dollar, subject to an annual adjustment based on changes in currency exchange rates.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our accounts receivable are primarily concentrated with four large wholesalers of pharmaceutical products. In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 49</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. As defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, disclosure controls and procedures are controls and other procedures which are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired Flexion (now Pacira Therapeutics, Inc., or Pacira Therapeutics). As such, the scope of our assessment of the effectiveness of our disclosure controls and procedures did not include the internal control over financial reporting of Pacira Therapeutics. These exclusions are consistent with the SEC Staff&#8217;s guidance that an assessment of a recently acquired business may be omitted from the scope of our assessment of the effectiveness of disclosure controls and procedures that are also part of internal control over financial reporting in the 12 months following the acquisition. Assets acquired in the Flexion Acquisition (excluding goodwill, intangible assets, and their related deferred taxes which are included within the scope of the assessment) accounted for a nominal fraction of our total assets and ZILRETTA represented 16% of our total revenue as of and for each of the three and nine months ended September&#160;30, 2022.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on that evaluation, our Chief Executive Officer and Chairman and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September&#160;30, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Flexion Acquisition, we have completed an evaluation of the Pacira Therapeutics internal control processes and procedures and have incorporated those processes and procedures into our internal control framework.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including the Chief Executive Officer and Chairman and our Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 50</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II &#8212; OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information related to Item 1. Legal Proceedings, refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed in Part I, Item 1A. &#8220;Risk Factors&#8221; in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm">Annual Report on Form 10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which could materially affect our business, financial condition, cash flows or future results. There have been no material changes in our risk factors included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021. The risks described in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ibcbdf7459db64b749005ba498f2d18fe_145"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed below are filed or furnished as part of this report.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302022xex311.htm">31.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302022xex312.htm">31.2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302022xex321.htm">32.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman and Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc. for the quarter ended September&#160;30, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income; (iv) the Condensed Consolidated Statements of Stockholders&#8217; Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Condensed Notes to Consolidated Financial Statements.*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 52</span></div></div></div><div id="ibcbdf7459db64b749005ba498f2d18fe_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibcbdf7459db64b749005ba498f2d18fe_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACIRA BIOSCIENCES,&#160;INC.<br/>(REGISTRANT)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID STACK</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHARLES A. REINHART, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2022 Form 10-Q  |  Page 53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>pcrx-9302022xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i86b134c054264ed8bd80ffda8525e383_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Stack, certify that&#58;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>pcrx-9302022xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2376e88b6a324bc9bbcb01daabd1c979_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Charles A. Reinhart, III, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>4
<FILENAME>pcrx-9302022xex321.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icbe972db727a47c29f50c2b09d943661_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C.&#160;&#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this Quarterly Report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. for the quarter ended September&#160;30, 2022, fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira BioSciences,&#160;Inc. at the dates and for the periods indicated.</font></div><div style="text-indent:27pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pcrx-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pcrx="http://www.pacira.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pacira.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.pacira.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>0000008 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.pacira.com/role/REVENUE">
        <link:definition>0000010 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITION" roleURI="http://www.pacira.com/role/FLEXIONACQUISITION">
        <link:definition>0000011 - Disclosure - FLEXION ACQUISITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.pacira.com/role/INVENTORIES">
        <link:definition>0000012 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETS" roleURI="http://www.pacira.com/role/FIXEDASSETS">
        <link:definition>0000013 - Disclosure - FIXED ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.pacira.com/role/LEASES">
        <link:definition>0000014 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0000015 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.pacira.com/role/DEBT">
        <link:definition>0000016 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS">
        <link:definition>0000017 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000018 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANS" roleURI="http://www.pacira.com/role/STOCKPLANS">
        <link:definition>0000019 - Disclosure - STOCK PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARE" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE">
        <link:definition>0000020 - Disclosure - NET INCOME (LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.pacira.com/role/INCOMETAXES">
        <link:definition>0000021 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDCHARGESGAINSANDOTHER" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER">
        <link:definition>0000022 - Disclosure - ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.pacira.com/role/REVENUETables">
        <link:definition>0000026 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONTables" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONTables">
        <link:definition>0000027 - Disclosure - FLEXION ACQUISITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.pacira.com/role/INVENTORIESTables">
        <link:definition>0000028 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSTables" roleURI="http://www.pacira.com/role/FIXEDASSETSTables">
        <link:definition>0000029 - Disclosure - FIXED ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.pacira.com/role/LEASESTables">
        <link:definition>0000030 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.pacira.com/role/DEBTTables">
        <link:definition>0000032 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>0000033 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000034 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSTables" roleURI="http://www.pacira.com/role/STOCKPLANSTables">
        <link:definition>0000035 - Disclosure - STOCK PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARETables" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables">
        <link:definition>0000036 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.pacira.com/role/INCOMETAXESTables">
        <link:definition>0000037 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables">
        <link:definition>0000038 - Disclosure - ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>0000039 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
        <link:definition>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
        <link:definition>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeDetails" roleURI="http://www.pacira.com/role/REVENUENarrativeDetails">
        <link:definition>0000042 - Disclosure - REVENUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEScheduleofDisaggregatedRevenueDetails" roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails">
        <link:definition>0000043 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONNarrativeDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails">
        <link:definition>0000044 - Disclosure - FLEXION ACQUISITION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails">
        <link:definition>0000045 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FLEXIONACQUISITIONScheduleofProFormaInformationDetails" roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails">
        <link:definition>0000046 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.pacira.com/role/INVENTORIESDetails">
        <link:definition>0000047 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSSummaryofMajorCategoriesDetails" roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails">
        <link:definition>0000048 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSNarrativeDetails" roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails">
        <link:definition>0000049 - Disclosure - FIXED ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.pacira.com/role/LEASESNarrativeDetails">
        <link:definition>0000050 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails">
        <link:definition>0000051 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails">
        <link:definition>0000052 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1">
        <link:definition>0000052 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails">
        <link:definition>0000053 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000054 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
        <link:definition>0000055 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCarryingValueofDebtDetails" roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails">
        <link:definition>0000056 - Disclosure - DEBT - Carrying Value of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.pacira.com/role/DEBTNarrativeDetails">
        <link:definition>0000057 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails">
        <link:definition>0000058 - Disclosure - DEBT - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofInterestExpenseDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails">
        <link:definition>0000059 - Disclosure - DEBT - Schedule of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>0000060 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails">
        <link:definition>0000061 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>0000062 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
        <link:definition>0000063 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
        <link:definition>0000064 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
        <link:definition>0000065 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDetails" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails">
        <link:definition>0000066 - Disclosure - STOCKHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
        <link:definition>0000067 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationActivityDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
        <link:definition>0000068 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSNarrativeDetails" roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails">
        <link:definition>0000069 - Disclosure - STOCK PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofValuationAssumptionsDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails">
        <link:definition>0000070 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
        <link:definition>0000071 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
        <link:definition>0000072 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails">
        <link:definition>0000073 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails">
        <link:definition>0000074 - Disclosure - ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails" roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails">
        <link:definition>0000075 - Disclosure - ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>0000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pcrx_DebtRedemptionTermsPriorToFebruary32023Member" abstract="true" name="DebtRedemptionTermsPriorToFebruary32023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" abstract="false" name="DebtInstrumentBasisSpreadTwoOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_MyoscienceAcquisitionMember" abstract="true" name="MyoscienceAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" abstract="false" name="AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" abstract="true" name="UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ConcentrationRiskNumberOfProducts" abstract="false" name="ConcentrationRiskNumberOfProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_NumberOfLeases" abstract="false" name="NumberOfLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximumValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LongTermInvestmentsMember" abstract="true" name="LongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FlexionAndMyoScienceAcquisitionMember" abstract="true" name="FlexionAndMyoScienceAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsAxis" abstract="true" name="DebtConversionAndRedemptionTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_MajorCustomerFourMember" abstract="true" name="MajorCustomerFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" abstract="false" name="DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_HongKongPharmaTainuoLtdMember" abstract="true" name="HongKongPharmaTainuoLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_BupivacaineLiposomeInjectableSuspensionMember" abstract="true" name="BupivacaineLiposomeInjectableSuspensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FlexionTherapeuticsIncMember" abstract="true" name="FlexionTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" abstract="true" name="StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" abstract="false" name="AcquisitionRelatedChargesProductDiscontinuationAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MeasurementInputExpectedMilestonePaymentMember" abstract="true" name="MeasurementInputExpectedMilestonePaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_SkyePharmaHoldingIncMember" abstract="true" name="SkyePharmaHoldingIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" abstract="false" name="AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentDiscountRate" abstract="false" name="DebtInstrumentDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_FlexionAcquisitionMember" abstract="true" name="FlexionAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" abstract="false" name="ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ScheduleOfInterestExpenseTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_TermLoanBFacilityDue2026Member" abstract="true" name="TermLoanBFacilityDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ConvertibleNotesReceivableMember" abstract="true" name="ConvertibleNotesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentConvertibleConversionPremiumShares" abstract="false" name="DebtInstrumentConvertibleConversionPremiumShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_NumberOfMajorCustomers" abstract="false" name="NumberOfMajorCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedFeesMember" abstract="true" name="AcquisitionRelatedFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" abstract="false" name="AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" abstract="true" name="DebtRedemptionTermsOnOrAfterAugust12023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FederalReserveBankOfNYRateMember" abstract="true" name="FederalReserveBankOfNYRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" abstract="true" name="RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerOneMember" abstract="true" name="MajorCustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2022Member" abstract="true" name="ConvertibleSeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" abstract="false" name="DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" abstract="false" name="AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MajorCustomerThreeMember" abstract="true" name="MajorCustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_SettlementPeriodConvertibleDebtConversionRequest" abstract="false" name="SettlementPeriodConvertibleDebtConversionRequest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentVariableRate" abstract="false" name="DebtInstrumentVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ThirdLargestCustomerMember" abstract="true" name="ThirdLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_EquityMethodInvestmentsAndOtherAssets" abstract="false" name="EquityMethodInvestmentsAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ThreeLargestCustomersMember" abstract="true" name="ThreeLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_CollaborativeLicensingAndMilestoneRevenueMember" abstract="true" name="CollaborativeLicensingAndMilestoneRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear1" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDueMay2024Member" abstract="true" name="ConvertibleSeniorNotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" abstract="false" name="CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_Compensationexpensefromstockoptionsemployees" abstract="false" name="Compensationexpensefromstockoptionsemployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ContingentConsideration" abstract="false" name="ContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" abstract="false" name="EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" abstract="false" name="ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2025Member" abstract="true" name="ConvertibleSeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerTwoMember" abstract="true" name="MajorCustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_IoveraMember" abstract="true" name="IoveraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_NuanceBiotechCo.Ltd.Member" abstract="true" name="NuanceBiotechCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LegalFeesMember" abstract="true" name="LegalFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationNoncurrent" abstract="false" name="ContingentConsiderationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" abstract="false" name="COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" abstract="false" name="DebtInstrumentConversionObligationPremiumOnCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" abstract="false" name="DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" abstract="false" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" abstract="true" name="MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2024Member" abstract="true" name="ConvertibleSeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear2" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_TELABioMember" abstract="true" name="TELABioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FortisMember" abstract="true" name="FortisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsDomain" abstract="true" name="DebtConversionAndRedemptionTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationCurrent" abstract="false" name="ContingentConsiderationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AccountsReceivablePaymentTerms" abstract="false" name="AccountsReceivablePaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" abstract="false" name="BusinessCombinationAcquisitionAndIntegrationRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" abstract="false" name="DebtInstrumentBasisSpreadOneOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" abstract="false" name="CompensationExpenseFromEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentMarketPrice" abstract="false" name="DebtInstrumentMarketPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ConcentrationRiskNumberOfCustomers" abstract="false" name="ConcentrationRiskNumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_ContingentConsiderationPaymentTerm" abstract="false" name="ContingentConsiderationPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_SecondLargestCustomerMember" abstract="true" name="SecondLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" abstract="true" name="EXPARELbupivacaineliposomeinjectablesuspensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" abstract="false" name="ProceedsFromDevelopmentAndCommercializationOfZILRETTA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ZILRETTAMember" abstract="true" name="ZILRETTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" abstract="false" name="DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" abstract="true" name="MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>pcrx-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_51556bef-a61f-4538-bbca-e0b54ed85af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:to="loc_us-gaap_PreferredStockValue_51556bef-a61f-4538-bbca-e0b54ed85af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9f44804b-aca0-4bbf-a9db-96e6f7c7fdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:to="loc_us-gaap_CommonStockValue_9f44804b-aca0-4bbf-a9db-96e6f7c7fdbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7d2c3fea-bb1f-4518-86cd-42db3c289403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7d2c3fea-bb1f-4518-86cd-42db3c289403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4792e668-8907-476c-b661-4c22dc542339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4792e668-8907-476c-b661-4c22dc542339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe6b1a2d-4843-4420-9c96-78dda32abcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6f54b039-9587-450a-8cd2-a76f24b1dea4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe6b1a2d-4843-4420-9c96-78dda32abcd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91438214-039d-4880-86f6-ff30fa7540f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91438214-039d-4880-86f6-ff30fa7540f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_0ae05b03-b5d1-493e-a1d9-cde988600e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:to="loc_us-gaap_ShortTermInvestments_0ae05b03-b5d1-493e-a1d9-cde988600e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8eecf438-7bb9-40b2-97ac-0ccb76c5c924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8eecf438-7bb9-40b2-97ac-0ccb76c5c924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b1f90471-be27-477b-9d32-e0246d4e6d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:to="loc_us-gaap_InventoryNet_b1f90471-be27-477b-9d32-e0246d4e6d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4027424-9354-41fa-8bf9-ccf58a7e6414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_23958b77-481a-4cd1-a464-58e86f1485d3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4027424-9354-41fa-8bf9-ccf58a7e6414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0fcadc43-8d68-44bf-a760-246d61e0dc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_AccountsPayableCurrent_0fcadc43-8d68-44bf-a760-246d61e0dc7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3ae2cfc4-1acb-4012-8a95-3ff1ef911090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3ae2cfc4-1acb-4012-8a95-3ff1ef911090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ebaa50fa-85dd-403f-8d86-2d2367a8b966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ebaa50fa-85dd-403f-8d86-2d2367a8b966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_8880883c-ee16-48d4-bf11-6350bf5f5def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_8880883c-ee16-48d4-bf11-6350bf5f5def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_501837e3-91d5-4bc6-9ca6-8c92f87a8562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_SecuredDebtCurrent_501837e3-91d5-4bc6-9ca6-8c92f87a8562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_c7bcdb73-e051-4a72-92a8-639efd8ce899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb5753ea-53b2-4c74-a117-88700b3f82a3" xlink:to="loc_us-gaap_TaxesPayableCurrent_c7bcdb73-e051-4a72-92a8-639efd8ce899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cbc4e16b-2f71-4c0d-be36-d1f12b8692cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_us-gaap_LiabilitiesCurrent_cbc4e16b-2f71-4c0d-be36-d1f12b8692cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_0b0c8c16-0b27-420a-8565-afcef70f640d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_0b0c8c16-0b27-420a-8565-afcef70f640d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_afb2f0fb-341c-4bb3-ae69-154c73c0f03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_us-gaap_SecuredLongTermDebt_afb2f0fb-341c-4bb3-ae69-154c73c0f03f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d2a4561-7863-434b-86c8-293a461215e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d2a4561-7863-434b-86c8-293a461215e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_4a2f31ca-dfbf-427c-a8eb-35e05ba89cfb" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_4a2f31ca-dfbf-427c-a8eb-35e05ba89cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_042855c9-93c2-45c2-976f-8401b5984b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d56e201c-c34c-459e-8ce2-46c80a9bfadb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_042855c9-93c2-45c2-976f-8401b5984b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7b4536d3-58d5-4527-81d1-89fbc559381e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_AssetsCurrent_7b4536d3-58d5-4527-81d1-89fbc559381e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_268aa1b0-eff0-49a1-b2a2-ffcb72b11124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_268aa1b0-eff0-49a1-b2a2-ffcb72b11124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_37f4d427-d8c8-48b5-ac8e-be4bb049608b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_37f4d427-d8c8-48b5-ac8e-be4bb049608b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fcac666e-946c-4f03-9fde-337f066c2f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_Goodwill_fcac666e-946c-4f03-9fde-337f066c2f58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_99b8e1bb-3f75-4531-a61b-642ea2562b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_99b8e1bb-3f75-4531-a61b-642ea2562b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_efdcc3e5-ffda-4d14-b7bd-d03a97fb6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_efdcc3e5-ffda-4d14-b7bd-d03a97fb6f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_7f56676a-0adc-4255-9114-dd0038ad4d77" xlink:href="pcrx-20220930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_7f56676a-0adc-4255-9114-dd0038ad4d77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_bb04a43b-ba75-49a0-9ff5-18310e1b7174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_46cb71cd-51e9-4146-afb7-d61cc1831f07" xlink:to="loc_us-gaap_LongTermInvestments_bb04a43b-ba75-49a0-9ff5-18310e1b7174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ba8ab88-d346-4bee-a36f-ebfc56e0df2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_78016ec9-c382-4339-90e5-8b03c496479a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ba8ab88-d346-4bee-a36f-ebfc56e0df2f" xlink:to="loc_us-gaap_Liabilities_78016ec9-c382-4339-90e5-8b03c496479a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_525c8aeb-637d-4658-abc2-ab5e1511a82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ba8ab88-d346-4bee-a36f-ebfc56e0df2f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_525c8aeb-637d-4658-abc2-ab5e1511a82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4415af7c-1a29-4186-86c2-d77571fa534d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ba8ab88-d346-4bee-a36f-ebfc56e0df2f" xlink:to="loc_us-gaap_StockholdersEquity_4415af7c-1a29-4186-86c2-d77571fa534d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0993c84f-4e50-417f-b012-aa0b4ff2ed4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3251e29-a819-4563-b946-ecd3a5d9d87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0993c84f-4e50-417f-b012-aa0b4ff2ed4e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3251e29-a819-4563-b946-ecd3a5d9d87a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_141272fd-ebf2-44c6-b1da-2a28bbacf4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0993c84f-4e50-417f-b012-aa0b4ff2ed4e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_141272fd-ebf2-44c6-b1da-2a28bbacf4e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_943eaffc-7522-4959-9a7b-dfe493c6c228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0c326b0-43fc-4d86-81c0-43a9b809eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_943eaffc-7522-4959-9a7b-dfe493c6c228" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0c326b0-43fc-4d86-81c0-43a9b809eaba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0fd60140-6b9c-427d-9eaf-9521a2822363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_943eaffc-7522-4959-9a7b-dfe493c6c228" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0fd60140-6b9c-427d-9eaf-9521a2822363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_bba4f99e-4ade-4b8b-9703-a5fbe7c4e739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:to="loc_us-gaap_CostOfRevenue_bba4f99e-4ade-4b8b-9703-a5fbe7c4e739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5f2dbdb4-6245-4c92-8013-c63be9ef7d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5f2dbdb4-6245-4c92-8013-c63be9ef7d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e668f845-13a8-4bd6-bb2f-91d2a76509f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e668f845-13a8-4bd6-bb2f-91d2a76509f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fdb9f387-e4ea-4d19-96b9-e79419d1ab2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fdb9f387-e4ea-4d19-96b9-e79419d1ab2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_bad01305-c7a2-4250-8947-cffa70e9bfaf" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ed1e10e8-9a8d-43d7-865e-9187a6e932ca" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_bad01305-c7a2-4250-8947-cffa70e9bfaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bac2bbbf-8505-45e0-bbb1-6f12c1a1b35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_59f63e88-0852-4e70-b0ef-4baf636e700b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bac2bbbf-8505-45e0-bbb1-6f12c1a1b35a" xlink:to="loc_us-gaap_CostsAndExpenses_59f63e88-0852-4e70-b0ef-4baf636e700b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_980f96d2-545b-47f9-9a6d-eef1a18d6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bac2bbbf-8505-45e0-bbb1-6f12c1a1b35a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_980f96d2-545b-47f9-9a6d-eef1a18d6b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1e088f46-fadb-45eb-95f0-633bef0566f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2f81c759-de53-47d0-9a7c-7662156ac817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1e088f46-fadb-45eb-95f0-633bef0566f9" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2f81c759-de53-47d0-9a7c-7662156ac817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_435d57cb-b059-4462-853f-1574bf8cf728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1e088f46-fadb-45eb-95f0-633bef0566f9" xlink:to="loc_us-gaap_InterestExpense_435d57cb-b059-4462-853f-1574bf8cf728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_88ab7272-e773-4b63-880f-684c8487007f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1e088f46-fadb-45eb-95f0-633bef0566f9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_88ab7272-e773-4b63-880f-684c8487007f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f081d6df-b074-454a-a5ae-6a76f2a497d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7d816741-c050-474f-8fdb-6ccdccca2548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f081d6df-b074-454a-a5ae-6a76f2a497d4" xlink:to="loc_us-gaap_NetIncomeLoss_7d816741-c050-474f-8fdb-6ccdccca2548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8e6bd9d9-eca7-462e-b5bd-54fc76963c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f081d6df-b074-454a-a5ae-6a76f2a497d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8e6bd9d9-eca7-462e-b5bd-54fc76963c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2ad10dd0-0a70-47c0-9ab5-8e61c5399891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c40e69ad-2388-4585-beb3-6fbb9cfeeaed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2ad10dd0-0a70-47c0-9ab5-8e61c5399891" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c40e69ad-2388-4585-beb3-6fbb9cfeeaed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_da880769-2507-4373-a120-a1ff74939c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2ad10dd0-0a70-47c0-9ab5-8e61c5399891" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_da880769-2507-4373-a120-a1ff74939c32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59c794d2-1e58-4b5b-9703-bb35ae01d612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f5e48fc8-608f-4576-90f7-b547819e6d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59c794d2-1e58-4b5b-9703-bb35ae01d612" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f5e48fc8-608f-4576-90f7-b547819e6d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b5ca8efd-b419-42fe-a799-1afb8b882a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59c794d2-1e58-4b5b-9703-bb35ae01d612" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b5ca8efd-b419-42fe-a799-1afb8b882a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c9a6c5-dc47-4d4a-b45c-91c3e5f99c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_59c794d2-1e58-4b5b-9703-bb35ae01d612" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c9a6c5-dc47-4d4a-b45c-91c3e5f99c7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fcdda933-141e-478c-bd69-d8c7fb54bace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_NetIncomeLoss_fcdda933-141e-478c-bd69-d8c7fb54bace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fb01d8ef-9771-4fbd-8d05-ad7e3600f639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fb01d8ef-9771-4fbd-8d05-ad7e3600f639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fbb5fb61-960b-4c91-957a-8c2ebeb5589c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fbb5fb61-960b-4c91-957a-8c2ebeb5589c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_8729c606-bb32-4d6f-9f59-fc6f2f4e497c" xlink:href="pcrx-20220930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_8729c606-bb32-4d6f-9f59-fc6f2f4e497c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f9f5edd1-3d1f-4ba3-a43c-409d54f9ffed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f9f5edd1-3d1f-4ba3-a43c-409d54f9ffed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c4abb87c-3a03-4eed-a374-1410796796a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c4abb87c-3a03-4eed-a374-1410796796a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_817fc261-2b99-4063-b683-56888c850be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_ShareBasedCompensation_817fc261-2b99-4063-b683-56888c850be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e961a7c-9404-4625-9fa8-76c05a81c4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e961a7c-9404-4625-9fa8-76c05a81c4ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2646d9f2-874c-4946-ba8b-3c7bd88633ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_AssetImpairmentCharges_2646d9f2-874c-4946-ba8b-3c7bd88633ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0d54a377-ef5e-442d-9b81-164770a2d1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0d54a377-ef5e-442d-9b81-164770a2d1fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_50f7fb1d-6ab4-43ff-b019-c1795de0f767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_50f7fb1d-6ab4-43ff-b019-c1795de0f767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0082b482-bf48-4a58-81c1-83449e4e243b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0082b482-bf48-4a58-81c1-83449e4e243b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a786529c-04e6-47b0-808f-949bfe660aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a786529c-04e6-47b0-808f-949bfe660aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fb427726-4542-4e96-8ef2-09e0ad827c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fb427726-4542-4e96-8ef2-09e0ad827c29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f1fd6421-29f7-4b4e-900c-02115d3e450b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f1fd6421-29f7-4b4e-900c-02115d3e450b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_0954112c-d7b9-4f1c-885a-fa69c420e15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_GainLossOnInvestments_0954112c-d7b9-4f1c-885a-fa69c420e15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_1eb7bc99-6fd1-4702-96cf-b381982b9765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_87586bb3-b8e1-456c-bfdc-578f3df63a5e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_1eb7bc99-6fd1-4702-96cf-b381982b9765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88503407-852a-4823-8f60-7fe9edb0e2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88503407-852a-4823-8f60-7fe9edb0e2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_6cd098b4-6b78-4482-b6a7-42cb0b2dd2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_6cd098b4-6b78-4482-b6a7-42cb0b2dd2bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f4c3b5b8-77c5-4af6-b165-373bd75c6b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_f4c3b5b8-77c5-4af6-b165-373bd75c6b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_d0c9dffc-5b67-4379-b7b9-13c07ac9f3d7" xlink:href="pcrx-20220930.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_pcrx_PaymentOfContingentConsideration_d0c9dffc-5b67-4379-b7b9-13c07ac9f3d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_71f4f6cf-aafe-4c46-b2f4-96a18f808cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_71f4f6cf-aafe-4c46-b2f4-96a18f808cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_d53d0f2a-84d6-48c3-8fff-dc8d072d0a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_377b5f77-e03f-4697-a5cb-447bde705a81" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_d53d0f2a-84d6-48c3-8fff-dc8d072d0a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ba3d78a0-9647-4117-9365-df57f6a86a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ba3d78a0-9647-4117-9365-df57f6a86a57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4e327aa1-4db3-4bd7-bfc8-cb8879cc072b" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4e327aa1-4db3-4bd7-bfc8-cb8879cc072b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_f98fd8ed-368b-4427-b2c7-7f035cccdf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_f98fd8ed-368b-4427-b2c7-7f035cccdf5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_63877967-00ea-4b24-941a-4e5b4e4c58e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_63877967-00ea-4b24-941a-4e5b4e4c58e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d52bc640-1ece-45ac-b602-b26b699f6438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf9ce488-b9c8-435f-84bf-2d7a803f434e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d52bc640-1ece-45ac-b602-b26b699f6438" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_35bb3bfc-b7fd-4f0d-9a0e-4f221da5a520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9de73114-2bce-40cf-af47-cb6c547e6d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_35bb3bfc-b7fd-4f0d-9a0e-4f221da5a520" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9de73114-2bce-40cf-af47-cb6c547e6d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_493d0573-afe7-4aad-9507-d0ba4a75f8be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_35bb3bfc-b7fd-4f0d-9a0e-4f221da5a520" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_493d0573-afe7-4aad-9507-d0ba4a75f8be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_1a47b323-c200-4371-b3e4-39a44772c5c7" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_99a434bd-4ede-40c2-a3b6-89d1e197041d" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_1a47b323-c200-4371-b3e4-39a44772c5c7" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_99a434bd-4ede-40c2-a3b6-89d1e197041d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_75307893-63b3-49f1-b990-cb805836837c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_1a47b323-c200-4371-b3e4-39a44772c5c7" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_75307893-63b3-49f1-b990-cb805836837c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75d4830f-be73-4266-8ee1-0cc41846ef4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_34e986d2-2f20-43b9-b096-f19a6337f6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75d4830f-be73-4266-8ee1-0cc41846ef4b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_34e986d2-2f20-43b9-b096-f19a6337f6e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f7d45076-7cf2-443c-b257-7e6fa4982810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_75d4830f-be73-4266-8ee1-0cc41846ef4b" xlink:to="loc_us-gaap_Goodwill_f7d45076-7cf2-443c-b257-7e6fa4982810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_11359796-05ba-4223-9d2e-bd145ad98dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_8e984828-392b-4811-8c38-6c51829f6c3c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_11359796-05ba-4223-9d2e-bd145ad98dd1" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_8e984828-392b-4811-8c38-6c51829f6c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3a90e643-5304-4f5e-a9c8-5d2e882db0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_11359796-05ba-4223-9d2e-bd145ad98dd1" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3a90e643-5304-4f5e-a9c8-5d2e882db0fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_845d25da-27ab-4b64-ac47-0b3536a5e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_845d25da-27ab-4b64-ac47-0b3536a5e05c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_9bf2ca00-e750-4b3a-825d-39a15e366766" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_9bf2ca00-e750-4b3a-825d-39a15e366766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8ec8fe98-890a-43bf-8687-8d4e39c5e4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8ec8fe98-890a-43bf-8687-8d4e39c5e4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_3d1c28c3-262a-47d9-b549-37792308946e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_3d1c28c3-262a-47d9-b549-37792308946e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d4c82dc2-9efe-4c83-92cb-e5bcfcf61dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d4c82dc2-9efe-4c83-92cb-e5bcfcf61dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_f906181a-f73a-4d38-b012-41761a9faa11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6c1f23e-3783-4568-bf38-d3024fd368b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_f906181a-f73a-4d38-b012-41761a9faa11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_07d9b832-6a7f-4a89-b7e9-a3cc2bf558d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_07d9b832-6a7f-4a89-b7e9-a3cc2bf558d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_340fa42c-5b84-4851-a969-df69b75c97a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_340fa42c-5b84-4851-a969-df69b75c97a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a2545874-65dc-41a0-aa51-1d7abeaf6255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a2545874-65dc-41a0-aa51-1d7abeaf6255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_78172108-318c-43a8-b501-d9ea215322f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_78172108-318c-43a8-b501-d9ea215322f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_95f76611-c633-4854-99d6-deef6008dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_95f76611-c633-4854-99d6-deef6008dbda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c25aff0e-9c78-402d-af28-28f3e295d289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c25aff0e-9c78-402d-af28-28f3e295d289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_766cda51-e1ee-41f9-861f-013515705a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_766cda51-e1ee-41f9-861f-013515705a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b376fc84-5761-4abf-b6fa-cd98ad79535f" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_b376fc84-5761-4abf-b6fa-cd98ad79535f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fecf02ab-694c-47e2-bf02-2b0c8660bcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fecf02ab-694c-47e2-bf02-2b0c8660bcc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_3460bfd3-91f5-4862-8cdf-03a37eecfce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_130c9c0e-7a2f-4eff-9fda-da2d05188ad5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_3460bfd3-91f5-4862-8cdf-03a37eecfce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_7dc7ec2b-36f1-46b9-975a-61ab406dfebf" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_37cc17d1-ccaa-4308-90dc-528a79914876" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_7dc7ec2b-36f1-46b9-975a-61ab406dfebf" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_37cc17d1-ccaa-4308-90dc-528a79914876" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_98cff673-a79d-47e6-a790-9efd9a73a0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_91394143-43f3-4e36-9f74-f8c049fbc4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_98cff673-a79d-47e6-a790-9efd9a73a0c1" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_91394143-43f3-4e36-9f74-f8c049fbc4d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_17445e7b-c8ea-46da-8a5b-2679bbaa61b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_98cff673-a79d-47e6-a790-9efd9a73a0c1" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_17445e7b-c8ea-46da-8a5b-2679bbaa61b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_826d73f4-3631-4b3b-bb94-26ff2b10752c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_98cff673-a79d-47e6-a790-9efd9a73a0c1" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_826d73f4-3631-4b3b-bb94-26ff2b10752c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7f04b3e4-6e85-4483-8159-db15cf31930e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ee6300af-3957-4983-8d4b-7202c7e247ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7f04b3e4-6e85-4483-8159-db15cf31930e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ee6300af-3957-4983-8d4b-7202c7e247ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_188b3b40-5c88-4ee2-b961-7db929e46b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7f04b3e4-6e85-4483-8159-db15cf31930e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_188b3b40-5c88-4ee2-b961-7db929e46b08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a43d6532-ca1a-4e57-a471-ee1def818f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_ba018cb0-a359-47a1-af0a-c21de6ce0555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a43d6532-ca1a-4e57-a471-ee1def818f3c" xlink:to="loc_us-gaap_OperatingLeaseCost_ba018cb0-a359-47a1-af0a-c21de6ce0555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a43fe40c-c6a5-4be6-abe6-6464fdc62e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a43d6532-ca1a-4e57-a471-ee1def818f3c" xlink:to="loc_us-gaap_VariableLeaseCost_a43fe40c-c6a5-4be6-abe6-6464fdc62e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_f3f6ed52-5880-4899-b03c-6e5245e7af35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a43d6532-ca1a-4e57-a471-ee1def818f3c" xlink:to="loc_us-gaap_SubleaseIncome_f3f6ed52-5880-4899-b03c-6e5245e7af35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60e416fe-a02a-4384-a05c-f5493db1693a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8097434c-0f99-472f-97f2-e0e8c64f4b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60e416fe-a02a-4384-a05c-f5493db1693a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8097434c-0f99-472f-97f2-e0e8c64f4b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b67b3937-8e52-48c6-bca6-55ec1a3883d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60e416fe-a02a-4384-a05c-f5493db1693a" xlink:to="loc_us-gaap_OperatingLeaseLiability_b67b3937-8e52-48c6-bca6-55ec1a3883d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_08b40ea8-ba1f-4a99-ab92-c5c870ca0ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_08b40ea8-ba1f-4a99-ab92-c5c870ca0ee5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3cfa8c5f-21f3-44a2-b595-0c5db36bfdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3cfa8c5f-21f3-44a2-b595-0c5db36bfdd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c5d4fcfe-5811-48d8-b5d0-e80331610d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c5d4fcfe-5811-48d8-b5d0-e80331610d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39171fac-d018-4204-9a3e-cce0a7aec5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39171fac-d018-4204-9a3e-cce0a7aec5ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a612181d-942a-4ee3-b3ac-b3be4e51e602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a612181d-942a-4ee3-b3ac-b3be4e51e602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_ee2dd020-24b9-4ae1-81a8-98feca47d5e8" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d152bb93-0a57-4820-919f-ff8ebf293a89" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_ee2dd020-24b9-4ae1-81a8-98feca47d5e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_6941f18d-2d35-409e-9e85-5599b9c4868e" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_6941f18d-2d35-409e-9e85-5599b9c4868e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_c8029ef6-3799-4224-baad-8a67a0df4638" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_c8029ef6-3799-4224-baad-8a67a0df4638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_9a754703-ab04-4c45-87b7-da8b2b41f690" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_9a754703-ab04-4c45-87b7-da8b2b41f690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_f0131fc1-c620-4f0e-b768-fa743e77cf5c" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_f0131fc1-c620-4f0e-b768-fa743e77cf5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_c1179e1c-124b-4aa7-8df2-58e2546bb1b9" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_c1179e1c-124b-4aa7-8df2-58e2546bb1b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_0f358915-2b68-4bcd-beb0-69d7501bbe5f" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_30d47c51-c988-4356-8b8b-f6f8ab6eeda0" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_0f358915-2b68-4bcd-beb0-69d7501bbe5f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3adc4c39-1ac0-43cf-8560-3128033fb106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3b2b1e77-949d-4602-808c-daa41626648d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_3adc4c39-1ac0-43cf-8560-3128033fb106" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3b2b1e77-949d-4602-808c-daa41626648d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e77f5c52-81b8-46fe-86f2-818c5962d269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_3adc4c39-1ac0-43cf-8560-3128033fb106" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e77f5c52-81b8-46fe-86f2-818c5962d269" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c8c6f74b-86ed-41c6-80df-97daa5d0032a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_3adc4c39-1ac0-43cf-8560-3128033fb106" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c8c6f74b-86ed-41c6-80df-97daa5d0032a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5c498c2-fa4b-4e68-9b1e-8a4dec84e9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35cb31c7-f67f-4329-82c2-a28b674e026b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5c498c2-fa4b-4e68-9b1e-8a4dec84e9a9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35cb31c7-f67f-4329-82c2-a28b674e026b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ebdd992-d543-4e40-a96c-35ba860e9e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5c498c2-fa4b-4e68-9b1e-8a4dec84e9a9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ebdd992-d543-4e40-a96c-35ba860e9e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a9ca44f5-2704-4a6f-bd26-09194a2fd6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5c498c2-fa4b-4e68-9b1e-8a4dec84e9a9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a9ca44f5-2704-4a6f-bd26-09194a2fd6f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cfa26240-450f-4c81-a0b0-e65d5f02fa88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_1ca738e8-1a95-4e2b-9b7d-28bc461bc106" xlink:href="pcrx-20220930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_cfa26240-450f-4c81-a0b0-e65d5f02fa88" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_1ca738e8-1a95-4e2b-9b7d-28bc461bc106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_15426ac4-0cf6-40aa-9005-88b4a9ae3ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_cfa26240-450f-4c81-a0b0-e65d5f02fa88" xlink:to="loc_us-gaap_RestrictedStockExpense_15426ac4-0cf6-40aa-9005-88b4a9ae3ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b52162b5-340a-4e6f-bfac-1b5ef655d8d2" xlink:href="pcrx-20220930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_cfa26240-450f-4c81-a0b0-e65d5f02fa88" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b52162b5-340a-4e6f-bfac-1b5ef655d8d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93b115bf-5d03-4de5-a0d2-0d79178ca45c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_889ffd49-a5af-4bb1-a1e2-10bba34fe305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93b115bf-5d03-4de5-a0d2-0d79178ca45c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_889ffd49-a5af-4bb1-a1e2-10bba34fe305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_26901c0d-e2ba-4c11-9722-fc74b52bd4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93b115bf-5d03-4de5-a0d2-0d79178ca45c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_26901c0d-e2ba-4c11-9722-fc74b52bd4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_376ea393-6ed6-46f5-afdf-ac3ad7e17c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93b115bf-5d03-4de5-a0d2-0d79178ca45c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_376ea393-6ed6-46f5-afdf-ac3ad7e17c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_ac3449ee-90f8-4849-adec-03c0473a78af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_65aa9b57-d489-4f03-abe7-9873e12af14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_ac3449ee-90f8-4849-adec-03c0473a78af" xlink:to="loc_us-gaap_NetIncomeLoss_65aa9b57-d489-4f03-abe7-9873e12af14c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_2fe7ab46-036b-44be-907a-724e6d8e7a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_ac3449ee-90f8-4849-adec-03c0473a78af" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_2fe7ab46-036b-44be-907a-724e6d8e7a99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4813aa46-6a34-4879-8551-ba627e1587fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_78c97568-7fad-4258-9bde-74b59717960f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4813aa46-6a34-4879-8551-ba627e1587fa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_78c97568-7fad-4258-9bde-74b59717960f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_49c93b53-ac93-4484-a8d4-c020562665f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4813aa46-6a34-4879-8551-ba627e1587fa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_49c93b53-ac93-4484-a8d4-c020562665f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_9bf11864-cfe1-4cfc-8a77-cde7ab7b319a" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_fce34438-fcd8-4454-bb2c-ac465427023b" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_9bf11864-cfe1-4cfc-8a77-cde7ab7b319a" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_fce34438-fcd8-4454-bb2c-ac465427023b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7126d2b8-3109-47ed-a97e-06731ff8e359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_9bf11864-cfe1-4cfc-8a77-cde7ab7b319a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7126d2b8-3109-47ed-a97e-06731ff8e359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_b136b389-b47d-454b-aed9-12cd286e53a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_9bf11864-cfe1-4cfc-8a77-cde7ab7b319a" xlink:to="loc_us-gaap_GainLossOnContractTermination_b136b389-b47d-454b-aed9-12cd286e53a6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>pcrx-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ic546e65786fa4d6a9b3797651f8fd61e_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20b75d39-fe90-40e0-a88f-7b054959be1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20b75d39-fe90-40e0-a88f-7b054959be1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_6b2dd32c-fa2e-488c-baa9-c6ef7286da90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_CostOfRevenue_6b2dd32c-fa2e-488c-baa9-c6ef7286da90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5938644d-f8cb-44ba-879f-05690561f80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5938644d-f8cb-44ba-879f-05690561f80e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_86594ac2-81af-49e7-b4d6-c8d033e610b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_86594ac2-81af-49e7-b4d6-c8d033e610b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_72edaed1-87aa-45da-9a2d-d65c12c72c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_72edaed1-87aa-45da-9a2d-d65c12c72c99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_24deaf06-bee0-4317-829a-56526dbd6f1d" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_24deaf06-bee0-4317-829a-56526dbd6f1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3e0b2fd4-d80a-4cdd-9a4d-423c6da083af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_CostsAndExpenses_3e0b2fd4-d80a-4cdd-9a4d-423c6da083af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5afaab75-a73c-411e-bccc-e9c57a8ae4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_OperatingIncomeLoss_5afaab75-a73c-411e-bccc-e9c57a8ae4d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d9f4f437-86c3-4fce-b249-cd1d2d055a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d9f4f437-86c3-4fce-b249-cd1d2d055a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_385beb3f-d2ed-466c-84c0-c9df64a61d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_InterestExpense_385beb3f-d2ed-466c-84c0-c9df64a61d15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bc8236e3-482f-4f8a-ac8e-afd20f30fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bc8236e3-482f-4f8a-ac8e-afd20f30fcf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b5d15642-068e-4ae8-98b6-7807f94204c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b5d15642-068e-4ae8-98b6-7807f94204c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a03e8354-ad6b-433d-b5bf-d527ecd145dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a03e8354-ad6b-433d-b5bf-d527ecd145dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f48159d8-0966-49b8-8a91-0616ec43094d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f48159d8-0966-49b8-8a91-0616ec43094d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5beac764-5d74-46b9-b8cd-8f3a0ac8fe56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_NetIncomeLoss_5beac764-5d74-46b9-b8cd-8f3a0ac8fe56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a8acd37b-005f-4063-96b7-c51c7793e64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:to="loc_us-gaap_EarningsPerShareBasic_a8acd37b-005f-4063-96b7-c51c7793e64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_772a3f7c-0e2a-4546-aba8-b4758620b282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_772a3f7c-0e2a-4546-aba8-b4758620b282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44d7009a-6551-451b-a790-2ea5b60b5db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44d7009a-6551-451b-a790-2ea5b60b5db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89a95aab-2a43-4614-b17d-341705d85662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89a95aab-2a43-4614-b17d-341705d85662" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:to="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eacdb13c-ded4-43b7-b24d-9cfa6111c03c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:to="loc_srt_ProductsAndServicesDomain_eacdb13c-ded4-43b7-b24d-9cfa6111c03c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:to="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5fdf9232-9eb4-41c2-be77-6c4c31e4a8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_us-gaap_ProductMember_5fdf9232-9eb4-41c2-be77-6c4c31e4a8fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_15ee0040-0964-4ced-8091-bd6702b4d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_us-gaap_RoyaltyMember_15ee0040-0964-4ced-8091-bd6702b4d4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_27fdb789-6c37-4889-bbd3-772279e8a379" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_27fdb789-6c37-4889-bbd3-772279e8a379" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i6f31da28b8b74a4894338a2a6c9d9060_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_92d9f16c-8063-4a0f-8e5f-2f5cd3c0c504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_SharesOutstanding_92d9f16c-8063-4a0f-8e5f-2f5cd3c0c504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a2c53495-6d0c-4637-bb2a-5eea5173db07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockholdersEquity_a2c53495-6d0c-4637-bb2a-5eea5173db07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fef9fb8-5ec2-433f-a186-5bbbe4207e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fef9fb8-5ec2-433f-a186-5bbbe4207e94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_38118e15-512a-4c5d-9145-aee964c0da47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_38118e15-512a-4c5d-9145-aee964c0da47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e840c5ea-47c5-46bb-808a-3c670536432a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e840c5ea-47c5-46bb-808a-3c670536432a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3229d75a-79ba-49cf-95ee-9f07524b97fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3229d75a-79ba-49cf-95ee-9f07524b97fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_34e98481-cdeb-4787-b08d-6cada68fe1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_34e98481-cdeb-4787-b08d-6cada68fe1b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_606604cf-8f64-4af7-9824-3d8dde7968fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_606604cf-8f64-4af7-9824-3d8dde7968fa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_555377c5-4999-4ad3-8f32-c593df390d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_555377c5-4999-4ad3-8f32-c593df390d49" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c2d39816-f3b8-47f8-ad07-a51e71377de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c2d39816-f3b8-47f8-ad07-a51e71377de7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f13b3eb-67cd-4f7c-8def-b925a918cc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f13b3eb-67cd-4f7c-8def-b925a918cc9c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a70d2cb2-8b01-40c7-b843-2f62ef3620b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a70d2cb2-8b01-40c7-b843-2f62ef3620b5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a93b3460-bea5-475c-aaf3-addbabab287d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_NetIncomeLoss_a93b3460-bea5-475c-aaf3-addbabab287d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ef93ca46-94d1-4bf9-97e7-b792aa824d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a2aeeb57-209f-4d9c-ad83-f2625a9e25cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_40ffe941-87d4-4120-ad24-d394436a6830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_40ffe941-87d4-4120-ad24-d394436a6830" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:to="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e11e2be0-f983-4544-a3ee-4e850afd4949_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:to="loc_us-gaap_EquityComponentDomain_e11e2be0-f983-4544-a3ee-4e850afd4949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:to="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66960e49-1756-4935-b455-b2402adfa51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_CommonStockMember_66960e49-1756-4935-b455-b2402adfa51e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9de760b3-c6cc-4898-af47-d9579e0f7577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9de760b3-c6cc-4898-af47-d9579e0f7577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4bcaa71e-6e15-4fc8-828b-0d31e4d8ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_RetainedEarningsMember_4bcaa71e-6e15-4fc8-828b-0d31e4d8ee25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_23d328a3-719f-46b0-8955-5cef7b88926a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_23d328a3-719f-46b0-8955-5cef7b88926a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_aa719aa8-5977-4985-bd16-78e01e401b1d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_aa719aa8-5977-4985-bd16-78e01e401b1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a1482bf6-243f-4495-b43c-87f6fd15ddd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a1482bf6-243f-4495-b43c-87f6fd15ddd9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i63912dd0202f4ef588c91e2fa57ab96b_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4654591-abd7-420b-8c16-8b5fdf2adec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_NetIncomeLoss_e4654591-abd7-420b-8c16-8b5fdf2adec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89d76513-6211-4dea-aa0f-cd124d809197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89d76513-6211-4dea-aa0f-cd124d809197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d0b29577-c11b-45c7-9251-319427dfec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d0b29577-c11b-45c7-9251-319427dfec5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_cd3766bb-abe0-4163-a2be-364290f20567" xlink:href="pcrx-20220930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_cd3766bb-abe0-4163-a2be-364290f20567" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_cd7d4fc9-52ba-4e46-9f6b-f2fa16b7531f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_cd7d4fc9-52ba-4e46-9f6b-f2fa16b7531f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_badadc86-d8b2-4b0a-92b6-9f05ee8ca09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_badadc86-d8b2-4b0a-92b6-9f05ee8ca09d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9fe4801d-b556-4a6a-aa89-39b48bf5101c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_ShareBasedCompensation_9fe4801d-b556-4a6a-aa89-39b48bf5101c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a73193a-424b-483f-82aa-ab01755a04e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a73193a-424b-483f-82aa-ab01755a04e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_006462db-4b49-43e6-81f4-38e1cc7b2634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_AssetImpairmentCharges_006462db-4b49-43e6-81f4-38e1cc7b2634" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f1e8d00b-c32d-4665-9432-9743583769cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f1e8d00b-c32d-4665-9432-9743583769cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f39a440-1249-439e-bc39-393eb4068b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f39a440-1249-439e-bc39-393eb4068b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a7961da2-87ce-40e9-bba6-5e743ecdb807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a7961da2-87ce-40e9-bba6-5e743ecdb807" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9d579089-2284-4419-893a-ef92e4b76f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9d579089-2284-4419-893a-ef92e4b76f56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a2cd2114-e37a-4b8c-ba19-3ec87172a3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a2cd2114-e37a-4b8c-ba19-3ec87172a3dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d7e1660-1756-48ec-8b76-ed54dfbd196c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d7e1660-1756-48ec-8b76-ed54dfbd196c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6fb7fea1-d2ea-4566-bf4b-c562945c6e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_GainLossOnInvestments_6fb7fea1-d2ea-4566-bf4b-c562945c6e5d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_ef757c43-3856-4e7c-8ca8-8b1c7d60db77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_ef757c43-3856-4e7c-8ca8-8b1c7d60db77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b60f269d-963f-461a-b6da-1a1984a9f62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b60f269d-963f-461a-b6da-1a1984a9f62b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_baada919-3efd-4cae-8539-a765c8f39bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_baada919-3efd-4cae-8539-a765c8f39bb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_de175858-764a-4f72-876d-f5259c8730ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_de175858-764a-4f72-876d-f5259c8730ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_78eeb371-8a4d-4eef-b657-2de8e4fcafb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_78eeb371-8a4d-4eef-b657-2de8e4fcafb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_363d3c3e-4ff3-493a-8652-7f01bf818b01" xlink:href="pcrx-20220930.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_pcrx_PaymentOfContingentConsideration_363d3c3e-4ff3-493a-8652-7f01bf818b01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_a35b09cc-0468-491c-83d8-a22186ea52a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_a35b09cc-0468-491c-83d8-a22186ea52a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_de1db03d-80db-46af-9a97-fcf81b8a657a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_de1db03d-80db-46af-9a97-fcf81b8a657a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_255f14ff-6503-4c7f-a4cf-0a777e76ceaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_255f14ff-6503-4c7f-a4cf-0a777e76ceaa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_27cb8953-5434-4279-90f5-9a996604a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_27cb8953-5434-4279-90f5-9a996604a3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4093e830-f6de-4922-bdba-7733fe2c9aca" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4093e830-f6de-4922-bdba-7733fe2c9aca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_e499402a-1568-4b7f-a26d-94862c0acdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_e499402a-1568-4b7f-a26d-94862c0acdc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_92cf7e05-5d94-485a-8ad5-268805b68203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_92cf7e05-5d94-485a-8ad5-268805b68203" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0cbf8d89-e507-46f4-abb7-16bd5e41a6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0cbf8d89-e507-46f4-abb7-16bd5e41a6a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4d16520-0ad8-4f06-a215-1bb68eccc2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4d16520-0ad8-4f06-a215-1bb68eccc2c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f72c9385-943f-4c91-bd93-1a7a06360796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f72c9385-943f-4c91-bd93-1a7a06360796" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9d30368-3493-4453-9aae-5785a133bcea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9d30368-3493-4453-9aae-5785a133bcea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a6b7721-3497-4fbc-9633-5c53c894432c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cd4d22e8-a5a1-4303-a076-4fb9eb894f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:to="loc_us-gaap_InterestPaidNet_cd4d22e8-a5a1-4303-a076-4fb9eb894f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6bd22674-2aeb-4891-93fe-8aef5e5b8bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6bd22674-2aeb-4891-93fe-8aef5e5b8bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_c31fc94d-dbf4-440a-b653-c2abb1959952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_c31fc94d-dbf4-440a-b653-c2abb1959952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_348cbfff-75b5-41b4-b243-0dfbe3ae624b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_348cbfff-75b5-41b4-b243-0dfbe3ae624b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_713d6ac8-279e-4fe8-bc05-1dae341d07d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_713d6ac8-279e-4fe8-bc05-1dae341d07d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_0532ea2f-80c5-4824-a6b3-8138c842a899" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_0532ea2f-80c5-4824-a6b3-8138c842a899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_95cf7239-6867-426b-88a7-5e888f1613b8" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_95cf7239-6867-426b-88a7-5e888f1613b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended" id="i5e0f14a2f6984d898d63042f43d2f25c_DESCRIPTIONOFBUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_ca51b347-9ed4-435a-9964-772fb138c1b6" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_ca51b347-9ed4-435a-9964-772fb138c1b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bdd12bb0-bc37-4da2-b48e-ee40e9d11375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:to="loc_us-gaap_NumberOfReportableSegments_bdd12bb0-bc37-4da2-b48e-ee40e9d11375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:to="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e5598c9-fe8f-4865-94f7-b22ec88b49a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e5598c9-fe8f-4865-94f7-b22ec88b49a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_f4c5dd73-ebd4-45db-bb2e-d46d50bf84b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:to="loc_us-gaap_SalesRevenueNetMember_f4c5dd73-ebd4-45db-bb2e-d46d50bf84b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a02b9fd5-abdc-4a77-8867-68be27780992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a02b9fd5-abdc-4a77-8867-68be27780992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_23a11b14-5fcb-465f-9385-2f0d04533d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_23a11b14-5fcb-465f-9385-2f0d04533d70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended" id="i40d5b805a77341a0820b3d24737ffe6a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers_38a4d688-9a2e-46f5-8eee-41624da97715" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:to="loc_pcrx_ConcentrationRiskNumberOfCustomers_38a4d688-9a2e-46f5-8eee-41624da97715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_36d943ad-6e63-4e4c-bf68-9285b87d74a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_36d943ad-6e63-4e4c-bf68-9285b87d74a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:to="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e032be29-c3d4-4632-954c-49c13a043070_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e032be29-c3d4-4632-954c-49c13a043070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_6119e160-5bd9-4bd8-aff8-554ca338c85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_6119e160-5bd9-4bd8-aff8-554ca338c85c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af3c424c-f488-4ce3-b1c2-654fb795308a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af3c424c-f488-4ce3-b1c2-654fb795308a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d000ca65-26b0-4b57-91b3-7f520ef7cfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:to="loc_us-gaap_SalesRevenueNetMember_d000ca65-26b0-4b57-91b3-7f520ef7cfa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:to="loc_srt_NameOfMajorCustomerDomain_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:to="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_56c8ee61-066a-441a-bb09-3dd1dcb51c92" xlink:href="pcrx-20220930.xsd#pcrx_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_LargestCustomerMember_56c8ee61-066a-441a-bb09-3dd1dcb51c92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_4e2bdfb7-97ef-4b9f-8575-6a2ab7430550" xlink:href="pcrx-20220930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_SecondLargestCustomerMember_4e2bdfb7-97ef-4b9f-8575-6a2ab7430550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_e91360f6-7291-4bbe-84de-33ba56ce39c7" xlink:href="pcrx-20220930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_ThirdLargestCustomerMember_e91360f6-7291-4bbe-84de-33ba56ce39c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_2e31fa55-0d58-4248-bb63-3fc406018c32" xlink:href="pcrx-20220930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_ThreeLargestCustomersMember_2e31fa55-0d58-4248-bb63-3fc406018c32" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended" id="i579c4ea06a1546f6bd9bba97b6cfefc9_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c1368621-de2a-4492-964b-52e17b14346e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_LongTermDebt_c1368621-de2a-4492-964b-52e17b14346e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a0cf249c-69fa-476e-b03d-f55e43a8f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_StockholdersEquity_a0cf249c-69fa-476e-b03d-f55e43a8f3a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_638e5407-3415-45a4-a2bc-bb0e756e76b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_638e5407-3415-45a4-a2bc-bb0e756e76b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_29c2c404-52e7-4230-aa05-ea49c8767927" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_29c2c404-52e7-4230-aa05-ea49c8767927" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9bec4144-53c7-4ded-b778-c8f011813325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:to="loc_us-gaap_EquityComponentDomain_9bec4144-53c7-4ded-b778-c8f011813325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:to="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0f47fd28-2a81-4812-80a3-c523e09e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:to="loc_us-gaap_RetainedEarningsMember_0f47fd28-2a81-4812-80a3-c523e09e2184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5ea36f07-7f74-498d-ac83-632891348221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5ea36f07-7f74-498d-ac83-632891348221" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="extended" id="ib6d978ff1eef4b6b8f761c7cf524c183_REVENUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_643487a6-4141-455b-b6a0-a73e867292a6" xlink:href="pcrx-20220930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_643487a6-4141-455b-b6a0-a73e867292a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:to="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c634d4e0-a8d4-4f89-8615-97259c2dc313_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:to="loc_srt_RangeMember_c634d4e0-a8d4-4f89-8615-97259c2dc313_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:to="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25aa7fb9-ac72-459f-8032-44b294b4de92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:to="loc_srt_MinimumMember_25aa7fb9-ac72-459f-8032-44b294b4de92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5be45341-96c0-442e-b615-b812ff707e8e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:to="loc_srt_MaximumMember_5be45341-96c0-442e-b615-b812ff707e8e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUEScheduleofDisaggregatedRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="extended" id="i06f92fc510f54d3896c1c9765ff89336_REVENUEScheduleofDisaggregatedRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7155b007-d17a-4141-b991-00f521839c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7155b007-d17a-4141-b991-00f521839c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:to="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b582c3e-0104-488e-8c27-0b36e0d6cee7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:to="loc_srt_ProductsAndServicesDomain_4b582c3e-0104-488e-8c27-0b36e0d6cee7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:to="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_9f34918f-7af3-4cca-8bce-b42498ee3184" xlink:href="pcrx-20220930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_9f34918f-7af3-4cca-8bce-b42498ee3184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember_afc11824-73ca-4d53-a179-04305322a875" xlink:href="pcrx-20220930.xsd#pcrx_ZILRETTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_ZILRETTAMember_afc11824-73ca-4d53-a179-04305322a875" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_9f6dca69-bee6-4649-94fb-bb2ed61f03c1" xlink:href="pcrx-20220930.xsd#pcrx_IoveraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_IoveraMember_9f6dca69-bee6-4649-94fb-bb2ed61f03c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a146b6e1-90c4-4a15-99c5-ee6821f276d8" xlink:href="pcrx-20220930.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a146b6e1-90c4-4a15-99c5-ee6821f276d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_32920de7-a66f-4795-93e8-8a07a1329f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_us-gaap_ProductMember_32920de7-a66f-4795-93e8-8a07a1329f48" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="extended" id="i83bd8f2b3b274af68b1f7b85291f6d7d_FLEXIONACQUISITIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0cb59b4d-c1f1-430f-8394-f94f324a3cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0cb59b4d-c1f1-430f-8394-f94f324a3cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd164e77-6875-4bd0-828c-e8b2d1e4e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd164e77-6875-4bd0-828c-e8b2d1e4e0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_9da09fc9-1be5-4816-a71a-84556413a8e8" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_9da09fc9-1be5-4816-a71a-84556413a8e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_82a26660-1073-4173-952d-a214cf0dd5c1" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_82a26660-1073-4173-952d-a214cf0dd5c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_746bd66c-bb19-4a9c-ae97-dc71b794ad7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_746bd66c-bb19-4a9c-ae97-dc71b794ad7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11588a33-2c72-4756-8db6-e9a0ac3b1173_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11588a33-2c72-4756-8db6-e9a0ac3b1173_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_f131c6f4-0ef0-486a-becc-12de505ba01a" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_f131c6f4-0ef0-486a-becc-12de505ba01a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4d845c78-5057-41f9-ac46-3a1e764bc30e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:to="loc_us-gaap_ClassOfStockDomain_4d845c78-5057-41f9-ac46-3a1e764bc30e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:to="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_a103336f-771c-4797-bd81-30c1d8901236" xlink:href="pcrx-20220930.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:to="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_a103336f-771c-4797-bd81-30c1d8901236" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended" id="i5dfbc8e3394f4a71899a84af962e410c_FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a69ca027-c422-4795-ae72-5112e1799716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a69ca027-c422-4795-ae72-5112e1799716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_31fd06f9-8f5d-4ef7-8f47-73d019243ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_31fd06f9-8f5d-4ef7-8f47-73d019243ec4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_39d3c6ef-0ad0-4ee6-96b8-a44d217ba164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_39d3c6ef-0ad0-4ee6-96b8-a44d217ba164" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_89d475a8-a81f-4539-b390-578166745fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_89d475a8-a81f-4539-b390-578166745fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_14e0290b-4acd-45ff-97c6-845f3be0e91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_14e0290b-4acd-45ff-97c6-845f3be0e91a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_343fff01-e76c-4e6e-8944-cd0b53f57c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_343fff01-e76c-4e6e-8944-cd0b53f57c02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d03e9602-6718-4377-b501-1473d44d881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d03e9602-6718-4377-b501-1473d44d881a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_bdf96c99-37e3-45f2-9e75-c11e5bdc04f7" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_bdf96c99-37e3-45f2-9e75-c11e5bdc04f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_890b7c08-fdf9-4304-89e0-479dbfd535dd" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_890b7c08-fdf9-4304-89e0-479dbfd535dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0dbd24be-6f33-4929-8810-d1505be68424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0dbd24be-6f33-4929-8810-d1505be68424" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cc38bbe6-91fe-4b42-a419-21e2dda7ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cc38bbe6-91fe-4b42-a419-21e2dda7ec27" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7bb2b47c-8d5a-4631-ab05-f75626fca2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7bb2b47c-8d5a-4631-ab05-f75626fca2c4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_e0f2b891-a775-483d-8462-db98935fc8c7" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_e0f2b891-a775-483d-8462-db98935fc8c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_69e9f0e7-8aef-4ee0-b8e6-313f66b9b6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_69e9f0e7-8aef-4ee0-b8e6-313f66b9b6cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_112a21ae-759c-4827-8922-ebcb20533d6c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_112a21ae-759c-4827-8922-ebcb20533d6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_5a0f5334-66e1-4f39-b921-1bff151eb02c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_5a0f5334-66e1-4f39-b921-1bff151eb02c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3dd929e8-34ef-4941-b2f2-96bcdde2a5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3dd929e8-34ef-4941-b2f2-96bcdde2a5a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_7559d2db-6c4c-42f9-9edf-8e1d1ace93c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_7559d2db-6c4c-42f9-9edf-8e1d1ace93c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_4ffb84f6-d806-41c6-bc86-bfecf9c5d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_4ffb84f6-d806-41c6-bc86-bfecf9c5d880" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6e7507c6-894b-4d36-9f57-f1353e582f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6e7507c6-894b-4d36-9f57-f1353e582f69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_843e23e6-7562-4f6a-adaa-6c20034320e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_843e23e6-7562-4f6a-adaa-6c20034320e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_109bb9c4-a749-4465-86c1-9385548497e3" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_109bb9c4-a749-4465-86c1-9385548497e3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b10df527-124f-4262-a867-544aef5cf6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b10df527-124f-4262-a867-544aef5cf6ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_db4ad5e9-c8a9-44c7-a8e8-d19c93a00995" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_db4ad5e9-c8a9-44c7-a8e8-d19c93a00995" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fb5c88d1-a952-4b7a-8325-d5beca16e069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_Goodwill_fb5c88d1-a952-4b7a-8325-d5beca16e069" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1f8c6d31-eb66-474b-9bfe-8b0d912055ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1f8c6d31-eb66-474b-9bfe-8b0d912055ba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d50436cf-ecf3-453f-a23e-b76d8739fe80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d50436cf-ecf3-453f-a23e-b76d8739fe80" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_a29b9a83-9e6a-4c05-9c3b-fd656e1ba59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_a29b9a83-9e6a-4c05-9c3b-fd656e1ba59c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_287157a4-6c42-4a87-b49e-25b6758fdc6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_287157a4-6c42-4a87-b49e-25b6758fdc6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_94213e65-f6d7-4455-ac98-416ac53ed1d0" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_94213e65-f6d7-4455-ac98-416ac53ed1d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONScheduleofProFormaInformationDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="extended" id="i9c96567a2b3449c698be1f9439ef2f9a_FLEXIONACQUISITIONScheduleofProFormaInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a3253de3-0c75-4bc9-8d3a-c9b6c1c3cd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a3253de3-0c75-4bc9-8d3a-c9b6c1c3cd73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75a462f9-0fd0-4d36-81f4-4fa0d456c8de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75a462f9-0fd0-4d36-81f4-4fa0d456c8de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b641b9f-f0d6-44cf-9fe4-a847a3b981a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b641b9f-f0d6-44cf-9fe4-a847a3b981a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_ecdd5cb1-423c-4d35-a3c4-6e1d33f51414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_ecdd5cb1-423c-4d35-a3c4-6e1d33f51414" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ffd45766-1bfa-4bb8-8ec5-73fd437918ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ffd45766-1bfa-4bb8-8ec5-73fd437918ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_f18bcfde-ccea-4113-b18a-0aa606441824" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_f18bcfde-ccea-4113-b18a-0aa606441824" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended" id="i51d022ff98b442b397edd93ba994b40a_FIXEDASSETSSummaryofMajorCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9d90aebc-dac6-4741-a84f-a3194a8e0559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9d90aebc-dac6-4741-a84f-a3194a8e0559" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ce669e-270c-4849-9425-01f58f0a78bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ce669e-270c-4849-9425-01f58f0a78bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bcb6a049-249e-44f4-932a-1b63664b21b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bcb6a049-249e-44f4-932a-1b63664b21b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3140f5a2-744b-48cc-8bdd-06f9b36357e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3140f5a2-744b-48cc-8bdd-06f9b36357e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a25cbdef-9136-420c-b3b2-3711bba1809a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a25cbdef-9136-420c-b3b2-3711bba1809a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_28f9b212-fe87-4d81-b9f3-af839450ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_28f9b212-fe87-4d81-b9f3-af839450ed7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_a43c6479-c76a-4cde-a2d0-eb635c3724c2" xlink:href="pcrx-20220930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_a43c6479-c76a-4cde-a2d0-eb635c3724c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0f7b35a6-7662-4758-95f3-c70849df5444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0f7b35a6-7662-4758-95f3-c70849df5444" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cf416231-076f-4fa5-a945-000e76c4805d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_ConstructionInProgressMember_cf416231-076f-4fa5-a945-000e76c4805d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="extended" id="i462e3200035748fea06e890331575f38_FIXEDASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f769ec07-1c87-46ed-b5fc-803f4a0e817e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_Depreciation_f769ec07-1c87-46ed-b5fc-803f4a0e817e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_c228dc53-569d-4c98-bf90-b79cf13101a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_InterestCostsCapitalized_c228dc53-569d-4c98-bf90-b79cf13101a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_93154c9a-93fd-40db-829f-e548a3d234cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_93154c9a-93fd-40db-829f-e548a3d234cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_2c675a74-ddbc-4d93-abaf-a1c34f6baed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_AssetRetirementObligation_2c675a74-ddbc-4d93-abaf-a1c34f6baed2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_312bf808-1e28-4432-b226-e31ca6bda3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:to="loc_us-gaap_ConstructionInProgressMember_312bf808-1e28-4432-b226-e31ca6bda3cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_978cf778-e456-413f-a070-e6fa5c0dd12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_978cf778-e456-413f-a070-e6fa5c0dd12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:to="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e3f3496e-efb3-4cd9-801c-e9397ff6be72_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:to="loc_srt_SegmentGeographicalDomain_e3f3496e-efb3-4cd9-801c-e9397ff6be72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:to="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_07f13088-d48e-48d1-aa2a-a9c98719bc78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:to="loc_srt_EuropeMember_07f13088-d48e-48d1-aa2a-a9c98719bc78" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i1ca059a9350d41fba562ff9ad108706c_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_22ad1a6b-c13f-4634-bf66-e317e97a8b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_22ad1a6b-c13f-4634-bf66-e317e97a8b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases_f63b2902-4386-440d-9112-4943fc431f9b" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_pcrx_NumberOfLeases_f63b2902-4386-440d-9112-4943fc431f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fbd688d7-cc1a-4918-8e78-bc29f6cc9ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fbd688d7-cc1a-4918-8e78-bc29f6cc9ec3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_f18e7e32-8bf9-4492-a549-83f8993a65d3" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_f18e7e32-8bf9-4492-a549-83f8993a65d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:to="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:to="loc_srt_RangeMember_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:to="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f701a7df-c304-4027-a9f5-0eed0d576480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:to="loc_srt_MaximumMember_f701a7df-c304-4027-a9f5-0eed0d576480" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i95ecf416647b41e7a2b635164fa2fe38_GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5503ad20-3247-4520-8b5a-5efa328b79b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_Goodwill_5503ad20-3247-4520-8b5a-5efa328b79b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_77ea99ba-0a05-4708-a978-733575a11ea0" xlink:href="pcrx-20220930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_77ea99ba-0a05-4708-a978-733575a11ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_77b0c698-2ffc-4b21-9a8a-ea5992cd9c40" xlink:href="pcrx-20220930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_77b0c698-2ffc-4b21-9a8a-ea5992cd9c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a1f2fa06-3968-4bfc-8124-56fed2f8be7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a1f2fa06-3968-4bfc-8124-56fed2f8be7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3f6cf294-02d6-4b27-a715-874a54b9aa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3f6cf294-02d6-4b27-a715-874a54b9aa7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d313b451-407d-49c4-86aa-5bab621035c3" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d313b451-407d-49c4-86aa-5bab621035c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_642143cf-6b6c-4add-84ba-06d1a3575c9b" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_642143cf-6b6c-4add-84ba-06d1a3575c9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_0be08b87-46dd-49aa-9b62-ccdc7bc01781" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_0be08b87-46dd-49aa-9b62-ccdc7bc01781" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_db3102b3-008c-478e-9875-2e1a0636f549" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_db3102b3-008c-478e-9875-2e1a0636f549" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:href="pcrx-20220930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_634a37c6-f0ef-4a3c-8224-422fb61228e0_default" xlink:href="pcrx-20220930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_634a37c6-f0ef-4a3c-8224-422fb61228e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:href="pcrx-20220930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_7c9d94b8-017b-4867-a143-a56a51b68feb" xlink:href="pcrx-20220930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_7c9d94b8-017b-4867-a143-a56a51b68feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7545a29c-e502-43a3-b3b1-9097168d7124_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7545a29c-e502-43a3-b3b1-9097168d7124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_7988475e-396c-4fd3-82c9-9414494eda25" xlink:href="pcrx-20220930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_7988475e-396c-4fd3-82c9-9414494eda25" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended" id="i013a24a025c940fd874fe74656a8a119_GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eed05fff-dc91-4bd6-b87e-c878431b6df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eed05fff-dc91-4bd6-b87e-c878431b6df3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9b380db7-25c2-4b40-8a72-c74b51964cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9b380db7-25c2-4b40-8a72-c74b51964cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861aa2-a232-489a-b87f-39509bf48307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861aa2-a232-489a-b87f-39509bf48307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c5b2f6cf-2ad9-4922-b774-db9aaf8f2115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c5b2f6cf-2ad9-4922-b774-db9aaf8f2115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80cd189b-9031-48af-94c7-4ca705317e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0095a02-f4f0-4256-b412-6c73fb090009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0095a02-f4f0-4256-b412-6c73fb090009" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29024124-50e9-4cf1-98a8-796b5be4da3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29024124-50e9-4cf1-98a8-796b5be4da3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66b2353c-ef41-4513-bde1-eaa6f0ada95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66b2353c-ef41-4513-bde1-eaa6f0ada95b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f83baee-5350-4461-b62d-235b4ada9e1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f83baee-5350-4461-b62d-235b4ada9e1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_340c97e9-7b94-47bb-bc58-08990a3e1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_340c97e9-7b94-47bb-bc58-08990a3e1e25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_717db851-3add-4584-9877-1388a44f4b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_717db851-3add-4584-9877-1388a44f4b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_598eb1dc-08a7-446c-af5e-bbb4da1941dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_598eb1dc-08a7-446c-af5e-bbb4da1941dd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTCarryingValueofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="extended" id="i57f072e5764a46729c65f676ad36f3a6_DEBTCarryingValueofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ed36707a-5c3e-4086-a879-25e999619a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:to="loc_us-gaap_LongTermDebt_ed36707a-5c3e-4086-a879-25e999619a50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b83a1f8-f838-4e7d-b192-17de8734c18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b83a1f8-f838-4e7d-b192-17de8734c18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:to="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:to="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83dd7a6e-619e-44ed-b307-e690f0b32c13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83dd7a6e-619e-44ed-b307-e690f0b32c13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_1ecf0d83-5ece-4fe9-9ced-13ab2721b2fa" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_1ecf0d83-5ece-4fe9-9ced-13ab2721b2fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8055bbf4-6173-4a58-bb34-62e9e622529b" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8055bbf4-6173-4a58-bb34-62e9e622529b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_aaf12adb-9ccd-4703-9032-3be530985420" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_aaf12adb-9ccd-4703-9032-3be530985420" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_e8b8865a-e8c4-4c56-b164-75b4f8143679" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_e8b8865a-e8c4-4c56-b164-75b4f8143679" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_88f1aa57-e50f-4bdb-9688-456fa83bc077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:to="loc_us-gaap_SecuredDebtMember_88f1aa57-e50f-4bdb-9688-456fa83bc077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_52ddce6f-4dfc-4365-96fb-64f581131795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:to="loc_us-gaap_UnsecuredDebtMember_52ddce6f-4dfc-4365-96fb-64f581131795" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended" id="if162d24ba8c048df81610c21a005d557_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate_01f364d2-82f6-4c2d-80d5-90749891ef41" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentDiscountRate_01f364d2-82f6-4c2d-80d5-90749891ef41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9a0f54db-59ec-4155-b967-e8a94b9fe6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9a0f54db-59ec-4155-b967-e8a94b9fe6a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_402b228c-5920-407b-b579-1dfa87df918e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_402b228c-5920-407b-b579-1dfa87df918e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_abfcd1a5-534c-4d70-be3c-9bca74ffcba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_abfcd1a5-534c-4d70-be3c-9bca74ffcba6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2dcc6202-5285-4078-9a31-4bd172f743f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2dcc6202-5285-4078-9a31-4bd172f743f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_9629e6c4-e351-4587-9494-0436bf299e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_9629e6c4-e351-4587-9494-0436bf299e0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_4f387deb-0489-4598-aef8-93183d3e39c4" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_4f387deb-0489-4598-aef8-93183d3e39c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_bc01488c-7c45-494b-8e02-bf2773dceba2" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_bc01488c-7c45-494b-8e02-bf2773dceba2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_e974c985-5c25-4236-a17b-50794d3b7035" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_e974c985-5c25-4236-a17b-50794d3b7035" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_d9f40953-5699-46db-82df-9014bdc8e2da" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_d9f40953-5699-46db-82df-9014bdc8e2da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_6e3d13af-c13b-4c72-a8af-0722d9592ebb" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_6e3d13af-c13b-4c72-a8af-0722d9592ebb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_ea699bf7-a337-4c38-aa8b-421a54a70ac6" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_ea699bf7-a337-4c38-aa8b-421a54a70ac6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate_c4ffe987-5899-460a-83b1-a7a1ccb72167" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentVariableRate_c4ffe987-5899-460a-83b1-a7a1ccb72167" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5bdb396b-d3b6-4e10-97f1-ad7c686b2d5f" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5bdb396b-d3b6-4e10-97f1-ad7c686b2d5f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_990a5f9e-667d-4c69-b323-616ebcfcc621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_990a5f9e-667d-4c69-b323-616ebcfcc621" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_517a9700-ab6a-46ae-9956-d2e5824e80b3" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_517a9700-ab6a-46ae-9956-d2e5824e80b3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c341df3b-3b63-431b-a463-52037f9f446e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c341df3b-3b63-431b-a463-52037f9f446e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c8dd947-83e2-4078-abeb-cb408e92e1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c8dd947-83e2-4078-abeb-cb408e92e1ce" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3725e643-a18f-4f7e-bc20-4cb2bd5f2ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3725e643-a18f-4f7e-bc20-4cb2bd5f2ef4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_610c450f-1e6f-4302-8a29-f771a6988c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_610c450f-1e6f-4302-8a29-f771a6988c9b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c28e2856-d276-4eb2-86d6-cea120012760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_RepaymentsOfDebt_c28e2856-d276-4eb2-86d6-cea120012760" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1af22507-80c4-4769-86df-45b4c71112df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1af22507-80c4-4769-86df-45b4c71112df" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4bfb0e6e-ef57-49be-84fd-32ba98e10e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4bfb0e6e-ef57-49be-84fd-32ba98e10e94" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3bc4014c-20c3-4408-bb24-7f9373827b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3bc4014c-20c3-4408-bb24-7f9373827b38" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_c599416e-a0bb-403b-8dfc-e38b69d321ad" xlink:href="pcrx-20220930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_c599416e-a0bb-403b-8dfc-e38b69d321ad" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b47005e9-af0b-499e-92fa-0a9d60b9221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b47005e9-af0b-499e-92fa-0a9d60b9221f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ef227095-0fe3-47e5-a3b9-6322644b5d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ef227095-0fe3-47e5-a3b9-6322644b5d80" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_ef8cc080-1775-41d3-a290-1f8609df3bd6" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_ef8cc080-1775-41d3-a290-1f8609df3bd6" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_d4c5e2bb-e187-4021-9e93-a1ab209fb2e0" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_d4c5e2bb-e187-4021-9e93-a1ab209fb2e0" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_cf0b557f-15dc-4fdf-96ad-5ff0221231c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_SharePrice_cf0b557f-15dc-4fdf-96ad-5ff0221231c2" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_dd41b501-bfb1-48c6-9423-a6d5481279d0" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_dd41b501-bfb1-48c6-9423-a6d5481279d0" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_0c25f3d5-ea6d-4596-9ddf-970c7effbc53" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_0c25f3d5-ea6d-4596-9ddf-970c7effbc53" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_6d88a081-b9bd-47f6-b789-43bd5105d98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_6d88a081-b9bd-47f6-b789-43bd5105d98a" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4e2ec0b2-eb57-4ed9-bf1a-e5a1bb2ba980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_LongTermDebt_4e2ec0b2-eb57-4ed9-bf1a-e5a1bb2ba980" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_83e97267-c73d-46bb-bd0c-83d1598f5099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_83e97267-c73d-46bb-bd0c-83d1598f5099" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_2069fa28-c929-4486-bf69-6ae78c60634a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_2069fa28-c929-4486-bf69-6ae78c60634a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_341fda8c-319e-4296-8560-932b4ef6c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_341fda8c-319e-4296-8560-932b4ef6c63d" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c5def754-9321-4c8f-9d1e-00534a610bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c5def754-9321-4c8f-9d1e-00534a610bdf" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd4f0c1c-8162-47d3-b05b-3ff759b736e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd4f0c1c-8162-47d3-b05b-3ff759b736e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_243e2306-d852-4b90-94ce-daeea1b6e952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:to="loc_us-gaap_SecuredDebtMember_243e2306-d852-4b90-94ce-daeea1b6e952" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_27a8cc9e-2d48-4f05-a702-91d1c6c0fa04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:to="loc_us-gaap_UnsecuredDebtMember_27a8cc9e-2d48-4f05-a702-91d1c6c0fa04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8253e303-112c-4b7c-b2ab-881748ac5dc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8253e303-112c-4b7c-b2ab-881748ac5dc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_299f9227-cb3a-495a-8eea-84fad34698b1" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_299f9227-cb3a-495a-8eea-84fad34698b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_9a7fe566-ab33-46f3-8c76-3f940870a454" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_9a7fe566-ab33-46f3-8c76-3f940870a454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3bd5f16e-ed99-41c8-a291-cd8f052e6ba5" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3bd5f16e-ed99-41c8-a291-cd8f052e6ba5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_30c55544-1860-4526-8d43-b50b6247b635" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_30c55544-1860-4526-8d43-b50b6247b635" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_4f423ea7-9a84-4802-85c6-c51072e0b8e2" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_4f423ea7-9a84-4802-85c6-c51072e0b8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_16f9f2b0-2d00-4192-aead-bf8742dee97c_default" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_16f9f2b0-2d00-4192-aead-bf8742dee97c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_69b4fb19-b746-402f-8f30-69eeb6f04e1f" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:to="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_69b4fb19-b746-402f-8f30-69eeb6f04e1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_b36d38f4-dca7-4a1f-af1c-093f8006a457" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_b36d38f4-dca7-4a1f-af1c-093f8006a457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3c331813-e2b8-4385-834f-f14811ec465f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3c331813-e2b8-4385-834f-f14811ec465f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_7630a19e-4a54-407f-a0e3-3a2b34f0d513" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:to="loc_srt_ScenarioForecastMember_7630a19e-4a54-407f-a0e3-3a2b34f0d513" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb12dceb-3ef3-4ef8-b0de-10aa034453b6_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:to="loc_dei_EntityDomain_fb12dceb-3ef3-4ef8-b0de-10aa034453b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:to="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_9e9615c6-490c-4285-8d1c-b3c26be11079" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_9e9615c6-490c-4285-8d1c-b3c26be11079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:to="loc_srt_RangeMember_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:to="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_523c16a0-a1a5-4407-bd46-31aca42dc779" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:to="loc_srt_MinimumMember_523c16a0-a1a5-4407-bd46-31aca42dc779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e967d2d5-f0c2-4235-a99f-f410a7446439_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:to="loc_us-gaap_VariableRateDomain_e967d2d5-f0c2-4235-a99f-f410a7446439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:to="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6cc5343c-1572-4484-a03e-4ae120c023a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6cc5343c-1572-4484-a03e-4ae120c023a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_44627667-36f4-48d8-8423-c2ca10954d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_us-gaap_BaseRateMember_44627667-36f4-48d8-8423-c2ca10954d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember_f336e865-ccd9-4a49-bf6b-d4233c27319a" xlink:href="pcrx-20220930.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_pcrx_FederalReserveBankOfNYRateMember_f336e865-ccd9-4a49-bf6b-d4233c27319a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0fe4c912-16b6-43a0-aa7b-186e9968592f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:to="loc_us-gaap_EquityComponentDomain_0fe4c912-16b6-43a0-aa7b-186e9968592f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:to="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_57b341a6-a126-48a5-9d1c-3bb11c019b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:to="loc_us-gaap_CommonStockMember_57b341a6-a126-48a5-9d1c-3bb11c019b2b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended" id="id237544bb477400da498cac2eafdb907_DEBTScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c19ca16-67be-44e8-a4e3-0218503bf272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c19ca16-67be-44e8-a4e3-0218503bf272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e2399298-5b04-43d3-a4cf-e5d2b965abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e2399298-5b04-43d3-a4cf-e5d2b965abbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f9dd7767-4d33-454b-9e7f-d1874bb598e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f9dd7767-4d33-454b-9e7f-d1874bb598e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5bd03111-6944-4d3d-a394-790cc5605ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5bd03111-6944-4d3d-a394-790cc5605ff0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_004f5688-6d51-4b1e-aaf7-018841385b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_LongTermDebt_004f5688-6d51-4b1e-aaf7-018841385b3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_94c4f551-692f-4dbd-8fa9-09f9594f1222_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_94c4f551-692f-4dbd-8fa9-09f9594f1222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e88afe72-53f7-431f-84e0-23606a64f25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:to="loc_us-gaap_SecuredDebtMember_e88afe72-53f7-431f-84e0-23606a64f25d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_fa6f6878-e4a4-43b9-b433-59bed3966b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:to="loc_us-gaap_UnsecuredDebtMember_fa6f6878-e4a4-43b9-b433-59bed3966b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_8bf2a745-6f7c-4ab2-ab6b-4081b23ebdf4" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_8bf2a745-6f7c-4ab2-ab6b-4081b23ebdf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8ec5217e-5475-4f01-a4df-fe9b01afb568" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8ec5217e-5475-4f01-a4df-fe9b01afb568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_cc96f6ff-e9e1-44aa-9614-d1c6d886d491" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_cc96f6ff-e9e1-44aa-9614-d1c6d886d491" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i0fcb521ad9a3440ebae304f7bced5e8d_FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_433377fe-48d5-4d28-b024-7caa5aeac310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_433377fe-48d5-4d28-b024-7caa5aeac310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_97ece78e-f366-4749-9859-6a0435748089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_97ece78e-f366-4749-9859-6a0435748089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_df5b98f1-bb53-472c-b6b2-1ab87fdf4325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_df5b98f1-bb53-472c-b6b2-1ab87fdf4325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a60c0056-a040-4b73-8d7b-624f2ee5303c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a60c0056-a040-4b73-8d7b-624f2ee5303c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_29de3d4a-1fcc-428d-b620-6ad1f3044a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentFairValue_29de3d4a-1fcc-428d-b620-6ad1f3044a5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8a54532e-524b-40c3-9026-f1fa4e647853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_SharePrice_8a54532e-524b-40c3-9026-f1fa4e647853" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_51e7043a-3cf6-4f19-83fe-5e9f44e76366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_51e7043a-3cf6-4f19-83fe-5e9f44e76366" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_2f4011b0-c488-4be5-b809-af64e1675a1f" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_2f4011b0-c488-4be5-b809-af64e1675a1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4773d62d-eb3e-4fb2-a9f1-34cd397961a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4773d62d-eb3e-4fb2-a9f1-34cd397961a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_84805b4d-3437-4ada-b007-df89d0ec4e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_84805b4d-3437-4ada-b007-df89d0ec4e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_700104b2-dbb0-471d-b4a9-74aac3297349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_700104b2-dbb0-471d-b4a9-74aac3297349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9bc1a444-d532-48a8-8169-18be61f86187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9bc1a444-d532-48a8-8169-18be61f86187" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8effdeec-ce5e-4f0f-bc4b-613066b04c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8effdeec-ce5e-4f0f-bc4b-613066b04c35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_75397cd2-9a03-4e49-9e60-184e8e483976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_75397cd2-9a03-4e49-9e60-184e8e483976" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_030cd867-9f9e-408b-96c2-414c8b70cab8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_030cd867-9f9e-408b-96c2-414c8b70cab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_9dad1ed5-930a-4579-b154-d96510547077" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_9dad1ed5-930a-4579-b154-d96510547077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_a7cfb44d-db3f-4fe6-8fcb-e7c3d49a3e93" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_a7cfb44d-db3f-4fe6-8fcb-e7c3d49a3e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_1fc727d1-4263-414d-b996-c8a226a91bd2" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_1fc727d1-4263-414d-b996-c8a226a91bd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbe54963-deb0-4188-baaa-710f9a299062_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbe54963-deb0-4188-baaa-710f9a299062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0792ed48-d4bd-4c2e-990f-b4dd77ac0f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:to="loc_us-gaap_SecuredDebtMember_0792ed48-d4bd-4c2e-990f-b4dd77ac0f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_0327b1d9-defa-4995-a292-6398b2282d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:to="loc_us-gaap_UnsecuredDebtMember_0327b1d9-defa-4995-a292-6398b2282d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0d8ae462-f1a7-436d-969e-6d95b07cd165_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:to="loc_srt_RangeMember_0d8ae462-f1a7-436d-969e-6d95b07cd165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:to="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8ac0e156-c00b-40b6-8d83-3aa72e254735" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:to="loc_srt_MaximumMember_8ac0e156-c00b-40b6-8d83-3aa72e254735" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="extended" id="id8a51f6f260e46499af159e43aca4a04_FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_740ee3e3-f17b-457c-a484-e9216f2ef900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_740ee3e3-f17b-457c-a484-e9216f2ef900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_e33f9e4d-6d2e-4f78-9935-983310956159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_e33f9e4d-6d2e-4f78-9935-983310956159" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_848f5a58-c766-4e73-a62f-e4a791403534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_848f5a58-c766-4e73-a62f-e4a791403534" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_ce38ef61-16ae-4751-b8fd-e5fe6443136c" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_ce38ef61-16ae-4751-b8fd-e5fe6443136c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_6b8004a4-3893-4ee2-aad9-f3db56e4af79" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_6b8004a4-3893-4ee2-aad9-f3db56e4af79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_859c86b6-62cc-465c-b83d-aeb3ea8a2dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da6beaef-6c17-4caf-8390-3af06e9340e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da6beaef-6c17-4caf-8390-3af06e9340e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ba69c8df-f416-4bca-85ac-4325b3c6579c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:to="loc_us-gaap_EquitySecuritiesMember_ba69c8df-f416-4bca-85ac-4325b3c6579c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember_f3e3298f-5a2e-48e1-8c2d-a08eb70403b5" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:to="loc_pcrx_ConvertibleNotesReceivableMember_f3e3298f-5a2e-48e1-8c2d-a08eb70403b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i1bef39fd0da14cee9e305b23af6f64c6_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_aaeba590-d132-4591-9c7d-e931c91ad4ad" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_aaeba590-d132-4591-9c7d-e931c91ad4ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_2b849009-3742-4141-b5fa-4cc4ed04245e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_2b849009-3742-4141-b5fa-4cc4ed04245e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_20eeea29-2dd5-4b3e-b319-35960735d637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_20eeea29-2dd5-4b3e-b319-35960735d637" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_844d6800-cce8-4e8f-b6f0-2ecc3f94d754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_844d6800-cce8-4e8f-b6f0-2ecc3f94d754" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_542a3101-b673-44d0-bda5-7c742dfa60c6" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_542a3101-b673-44d0-bda5-7c742dfa60c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_715210dd-067d-46d4-a8df-3d4b6abdf2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_715210dd-067d-46d4-a8df-3d4b6abdf2cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_094aa23a-e92e-4373-848d-72e14956f321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_094aa23a-e92e-4373-848d-72e14956f321" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_b6e791e0-9945-4e89-bca0-7288f557e801" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsideration_b6e791e0-9945-4e89-bca0-7288f557e801" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_2f2009ba-1b90-4448-a470-c75654506db1" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsiderationCurrent_2f2009ba-1b90-4448-a470-c75654506db1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_4dc07b75-9c4c-48ce-9e32-37b5b7ba88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_InterestReceivable_4dc07b75-9c4c-48ce-9e32-37b5b7ba88f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers_f08cbcc7-a277-4a3e-a804-37ab1d500d50" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_NumberOfMajorCustomers_f08cbcc7-a277-4a3e-a804-37ab1d500d50" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0e75bd31-496d-43c5-8c5a-316b4fbe32bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0e75bd31-496d-43c5-8c5a-316b4fbe32bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_87ff19fd-acf2-417c-ad07-f7bbdb4614b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_87ff19fd-acf2-417c-ad07-f7bbdb4614b9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b60cefa7-0bd5-40de-9623-62fa1a1a755e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b60cefa7-0bd5-40de-9623-62fa1a1a755e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:to="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_3b6bf089-8b40-4a92-9ec1-580b59cc4ce4" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:to="loc_pcrx_FlexionAcquisitionMember_3b6bf089-8b40-4a92-9ec1-580b59cc4ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_af082403-bfa6-43aa-882a-ef1dd6c04d06" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_af082403-bfa6-43aa-882a-ef1dd6c04d06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_4a7b785d-43c8-44c8-8b3f-33c26685b489" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_4a7b785d-43c8-44c8-8b3f-33c26685b489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8b43c0ee-d29b-40f8-b3a2-314e59d73409_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8b43c0ee-d29b-40f8-b3a2-314e59d73409_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_1c43cfd5-6282-40c6-a753-73d44bcaa8d4" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:to="loc_pcrx_ContingentConsiderationMember_1c43cfd5-6282-40c6-a753-73d44bcaa8d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_f70d809c-0569-4c2a-8060-f0d968d23e01" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:to="loc_pcrx_ContingentConsiderationMember_f70d809c-0569-4c2a-8060-f0d968d23e01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_049a1a55-3855-4ee3-8c37-acc0969d37fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_049a1a55-3855-4ee3-8c37-acc0969d37fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1b39672d-2534-483d-b921-b4387c2a84b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1b39672d-2534-483d-b921-b4387c2a84b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_77976b2c-c83b-4814-9241-10021b7b03aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_77976b2c-c83b-4814-9241-10021b7b03aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_89cab4ae-a33d-434a-88a2-1bafd70b0c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_89cab4ae-a33d-434a-88a2-1bafd70b0c38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_cdc663d9-97d7-4717-be85-d98a824a5075" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_cdc663d9-97d7-4717-be85-d98a824a5075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_069deea0-02b5-4454-b460-602a2050df2e" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_069deea0-02b5-4454-b460-602a2050df2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6c2bc36b-6753-4615-9b49-a7b42bc94d89_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:to="loc_srt_RangeMember_6c2bc36b-6753-4615-9b49-a7b42bc94d89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:to="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d2777ccc-bb33-45bb-840f-6c7d29340a99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:to="loc_srt_WeightedAverageMember_d2777ccc-bb33-45bb-840f-6c7d29340a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6648349-fe76-4652-9fa0-23f11c1465e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b6648349-fe76-4652-9fa0-23f11c1465e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_0fc2333f-1a04-4767-b000-73f25186fbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:to="loc_us-gaap_AccountsReceivableMember_0fc2333f-1a04-4767-b000-73f25186fbc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b7f849fe-149c-4364-8e4c-cd6d43602afc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b7f849fe-149c-4364-8e4c-cd6d43602afc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_514a6b53-1038-4068-a703-1fd7f5942c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_514a6b53-1038-4068-a703-1fd7f5942c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_726785e9-fdef-4ef8-85db-3340f513ef24_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:to="loc_srt_NameOfMajorCustomerDomain_726785e9-fdef-4ef8-85db-3340f513ef24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:to="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_d5ec6bf0-f965-4976-8929-cda0c9980c8a" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerOneMember_d5ec6bf0-f965-4976-8929-cda0c9980c8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_3e7f5e1f-eb9a-4474-bfef-fe7d505612d3" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerTwoMember_3e7f5e1f-eb9a-4474-bfef-fe7d505612d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_830cc24e-5965-47bc-8fa5-1144a8213c5a" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerThreeMember_830cc24e-5965-47bc-8fa5-1144a8213c5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember_cd4134e0-d8cb-4c7b-81e6-a70dde9b1966" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerFourMember_cd4134e0-d8cb-4c7b-81e6-a70dde9b1966" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9dc4c4e0-1690-4d03-ae6d-1150b6d660da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9dc4c4e0-1690-4d03-ae6d-1150b6d660da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember_b1ba6f98-ab33-4b1f-b778-b130d19b7be9" xlink:href="pcrx-20220930.xsd#pcrx_TELABioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:to="loc_pcrx_TELABioMember_b1ba6f98-ab33-4b1f-b778-b130d19b7be9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended" id="i4690fe3f887e425aa70f2c0f0e1d38d0_FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a5ee4375-e6b4-4a12-8b88-bc49458cfaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a5ee4375-e6b4-4a12-8b88-bc49458cfaff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d3d962cb-0087-4e69-be56-72c8eb24d335_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d3d962cb-0087-4e69-be56-72c8eb24d335_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_325162a4-4dbc-4772-9951-ae13c101f654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_325162a4-4dbc-4772-9951-ae13c101f654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a904ced9-814a-49a9-b967-9a40af10027a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:to="loc_srt_RangeMember_a904ced9-814a-49a9-b967-9a40af10027a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:to="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1f2c951-f260-49d7-ac4d-c2e21649c2f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:to="loc_srt_MinimumMember_b1f2c951-f260-49d7-ac4d-c2e21649c2f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e68d77b-79a1-4d41-bbe8-8a18bce68ed4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:to="loc_srt_MaximumMember_9e68d77b-79a1-4d41-bbe8-8a18bce68ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9726cc8-f14f-4ef1-ab04-45b6f72112ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9726cc8-f14f-4ef1-ab04-45b6f72112ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_1743e412-2cf8-4cc1-a8e1-92ad1bcda609" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:to="loc_pcrx_FlexionAcquisitionMember_1743e412-2cf8-4cc1-a8e1-92ad1bcda609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_71da25b5-53a1-44f7-b532-2d94e6038e87" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_71da25b5-53a1-44f7-b532-2d94e6038e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50dd7218-abdc-4f92-a06e-a7e08f33d37d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50dd7218-abdc-4f92-a06e-a7e08f33d37d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_cd9a2734-e678-49eb-802c-ddbcfcb6ef24" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:to="loc_pcrx_ContingentConsiderationMember_cd9a2734-e678-49eb-802c-ddbcfcb6ef24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6dc604c9-11c3-49c3-beec-c8e95a15d8d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6dc604c9-11c3-49c3-beec-c8e95a15d8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_92e01283-6750-439a-a679-d4158a217b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_92e01283-6750-439a-a679-d4158a217b56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_e5051ec6-c963-4eec-bee6-73f702372142" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_e5051ec6-c963-4eec-bee6-73f702372142" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended" id="i86a775ec64ac4ab6adec463e00d65c67_FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ca223685-86a9-4879-b1e4-3b0b953acb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ca223685-86a9-4879-b1e4-3b0b953acb48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_dea3088d-fcc8-43c7-ba48-970d166edce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_dea3088d-fcc8-43c7-ba48-970d166edce2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ec519dc4-2d85-448c-a389-306ecadc0bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_68b3e163-0cf2-450c-b454-a07259218341" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_pcrx_ContingentConsideration_68b3e163-0cf2-450c-b454-a07259218341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_1fa0f64d-0725-4b5a-9a4c-0550da9b7f67" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_1fa0f64d-0725-4b5a-9a4c-0550da9b7f67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_8000602b-4a64-4579-877c-8d4338b14085" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:to="loc_pcrx_ContingentConsiderationMember_8000602b-4a64-4579-877c-8d4338b14085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9f702c6-359f-4522-b9dd-22b3abcd0b11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9f702c6-359f-4522-b9dd-22b3abcd0b11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_0d12ec05-f01f-4fd4-aebb-be2fb0a95b5b" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_0d12ec05-f01f-4fd4-aebb-be2fb0a95b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_84c25df2-6304-4c2e-ab01-fc27896ab007" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:to="loc_pcrx_FlexionAcquisitionMember_84c25df2-6304-4c2e-ab01-fc27896ab007" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended" id="iddf9606b26954bc4a2d8acda41b60512_FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8784f4cb-ea20-4140-84fd-4d9c0aae6cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8784f4cb-ea20-4140-84fd-4d9c0aae6cf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e89580b2-092e-4db6-aed7-8955336cde43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e89580b2-092e-4db6-aed7-8955336cde43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1ecb9425-49bb-4413-a304-c279b8075f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1ecb9425-49bb-4413-a304-c279b8075f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4dd4a921-2bd4-4a71-94d9-e8532bc37e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4dd4a921-2bd4-4a71-94d9-e8532bc37e09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a074fbb2-84ac-4fa7-ae18-950a4cfcb785_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a074fbb2-84ac-4fa7-ae18-950a4cfcb785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_90fb6c87-08b3-4909-a4eb-9d8c3f33c8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_90fb6c87-08b3-4909-a4eb-9d8c3f33c8b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_64398be9-128e-4c12-af12-e197016ab03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_CommercialPaperMember_64398be9-128e-4c12-af12-e197016ab03d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_30182b49-380d-4321-97ea-422ac81d6e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_30182b49-380d-4321-97ea-422ac81d6e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_04f466eb-9ae3-4186-b54d-63e39fae96e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_04f466eb-9ae3-4186-b54d-63e39fae96e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_9cd19ba0-820a-4395-a571-d52b0c36685f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_9cd19ba0-820a-4395-a571-d52b0c36685f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentSecondaryCategorizationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:to="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_82d0572d-9336-4137-9dd6-6b04094e1477_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsBySecondaryCategorizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:to="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_82d0572d-9336-4137-9dd6-6b04094e1477_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsBySecondaryCategorizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:to="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_630287ff-8968-40a3-90d7-a66e5cfa7665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_630287ff-8968-40a3-90d7-a66e5cfa7665" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember_ffb1817c-3160-468c-8263-ef446358bf78" xlink:href="pcrx-20220930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:to="loc_pcrx_LongTermInvestmentsMember_ffb1817c-3160-468c-8263-ef446358bf78" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended" id="ic48bff657bde47ed88fe3f5926682083_STOCKHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0eda7d5c-aab3-4f7b-9ffe-4b56f59bef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_StockholdersEquity_0eda7d5c-aab3-4f7b-9ffe-4b56f59bef30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bab2ee40-5073-42c3-aa8c-765bbd85c774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bab2ee40-5073-42c3-aa8c-765bbd85c774" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c3c3ac8-e41c-454f-b75e-6a12dd44aa76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c3c3ac8-e41c-454f-b75e-6a12dd44aa76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_09055654-99d1-43ce-bc35-e661a211adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b8bebb12-7396-44b8-90cb-19c2130d3f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b8bebb12-7396-44b8-90cb-19c2130d3f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_05887bba-a8e7-4b51-98df-fdfc71673caa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:to="loc_us-gaap_EquityComponentDomain_05887bba-a8e7-4b51-98df-fdfc71673caa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:to="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_27027696-0179-4bc6-9770-17154e32bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_27027696-0179-4bc6-9770-17154e32bd63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b42a58a-53d3-4a1c-996f-548f08a5f309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b42a58a-53d3-4a1c-996f-548f08a5f309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_39cc9ec7-9398-4f8f-a4b9-65b69ce75c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_39cc9ec7-9398-4f8f-a4b9-65b69ce75c67" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended" id="i9367e3d25fc44388962359ef4e8ae780_STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2700b915-c524-4d7d-93a6-bb1c419c4ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2700b915-c524-4d7d-93a6-bb1c419c4ca3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_8540f693-a005-4f7a-99cb-f5723fde2d93" xlink:href="pcrx-20220930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_8540f693-a005-4f7a-99cb-f5723fde2d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_538dba40-6925-44b4-922e-76ccc80a7517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_us-gaap_RestrictedStockExpense_538dba40-6925-44b4-922e-76ccc80a7517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_0117c204-37c4-42b5-b945-593bf12ce619" xlink:href="pcrx-20220930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_0117c204-37c4-42b5-b945-593bf12ce619" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9a1b54a7-6429-43db-a08c-bfaa273d7450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_us-gaap_ShareBasedCompensation_9a1b54a7-6429-43db-a08c-bfaa273d7450" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56cf565a-f2ed-4b8c-8faa-c4738f3065c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56cf565a-f2ed-4b8c-8faa-c4738f3065c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_33bc6f4a-6275-4d20-a823-81a17495e37e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_CostOfSalesMember_33bc6f4a-6275-4d20-a823-81a17495e37e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0a31cae4-802c-4833-b0e0-50641454f306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0a31cae4-802c-4833-b0e0-50641454f306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_adc5ac9b-9e92-4424-ba6b-abe095a4728d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_adc5ac9b-9e92-4424-ba6b-abe095a4728d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended" id="icc44142c716d4fe098fc3f253b33d01b_STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f538b90c-249d-450c-a3d0-ff51cc831700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f538b90c-249d-450c-a3d0-ff51cc831700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e9b7a689-b054-41e8-9be6-5ec04757879a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e9b7a689-b054-41e8-9be6-5ec04757879a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0de3fd85-e412-4dfa-97e3-ceb21d28de69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0de3fd85-e412-4dfa-97e3-ceb21d28de69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cde08a3-18a4-443b-815e-530bd4003b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cde08a3-18a4-443b-815e-530bd4003b9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86857074-c478-4536-92da-d2587454d473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86857074-c478-4536-92da-d2587454d473" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2e3e2184-92cb-4f97-b842-42159f57e287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_850931a9-9965-4c68-b4ac-efa20b9ddfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_850931a9-9965-4c68-b4ac-efa20b9ddfd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19a47c15-794e-4b8c-9e27-3d01517f0066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19a47c15-794e-4b8c-9e27-3d01517f0066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f834de3c-96de-4e58-89d5-5c4d1c190bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f834de3c-96de-4e58-89d5-5c4d1c190bcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_13064b2b-0b12-4ae6-9e7a-6fadbed5de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_13064b2b-0b12-4ae6-9e7a-6fadbed5de17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ae79ee47-c919-4796-99d0-f59fce46d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ae79ee47-c919-4796-99d0-f59fce46d3c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e4e39d1e-22d1-4cc5-bb28-ab3301f3f65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c604ae09-f497-4546-8d0f-96428f4866bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c604ae09-f497-4546-8d0f-96428f4866bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2cfbafb-b711-4a18-a926-53307ade3594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2cfbafb-b711-4a18-a926-53307ade3594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bb3bd9b0-0b3c-4d45-b8ee-a9bff49d5cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bb3bd9b0-0b3c-4d45-b8ee-a9bff49d5cf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_53dbb2c4-1616-450d-b1c2-0a5483aa6737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_53dbb2c4-1616-450d-b1c2-0a5483aa6737" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_851fd7f7-7f0c-4218-97cf-262fb0ea9e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfa15801-0ec0-4b33-a448-53f83238aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfa15801-0ec0-4b33-a448-53f83238aef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb04141e-0891-4b99-bb4c-d5761cceeca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb04141e-0891-4b99-bb4c-d5761cceeca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0f61c540-a090-4f62-aedb-0cb2f4acf68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0f61c540-a090-4f62-aedb-0cb2f4acf68f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_22441cde-956b-4ac2-88c2-c25b7d5f0afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_22441cde-956b-4ac2-88c2-c25b7d5f0afe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70c5bcff-6e57-4996-93b0-06eeaa0abf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:to="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a637ad4c-040f-4548-b819-d7a7da6c7c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a637ad4c-040f-4548-b819-d7a7da6c7c63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended" id="i1aab5e673d934b16800bb3fd1724c2d0_STOCKPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1179ec0b-25d4-4114-8810-d4e57dcc175a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1179ec0b-25d4-4114-8810-d4e57dcc175a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_f8c43ffa-955c-4acd-bfc7-b1f591d709ae" xlink:href="pcrx-20220930.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_f8c43ffa-955c-4acd-bfc7-b1f591d709ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_672c7117-8028-467a-9637-7c65da6a1340" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_672c7117-8028-467a-9637-7c65da6a1340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_be56288f-f8f1-4ff0-aa28-81191c2789e7" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_be56288f-f8f1-4ff0-aa28-81191c2789e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_574b6765-4081-4265-9209-efefde858c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_574b6765-4081-4265-9209-efefde858c65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5c728b69-ce2b-4f94-84c8-7c98d96b5c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5c728b69-ce2b-4f94-84c8-7c98d96b5c0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:to="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0e9c4a41-4358-4353-a429-df1872bdeffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:to="loc_us-gaap_EmployeeStockMember_0e9c4a41-4358-4353-a429-df1872bdeffc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended" id="ief68a7c8f4954ba5b88d3ea77eb59e69_STOCKPLANSScheduleofValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_921bfd1d-3177-4703-945d-7169b94129d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_921bfd1d-3177-4703-945d-7169b94129d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_034ca7b0-dc1a-4d63-9b1b-05a10bf120f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_034ca7b0-dc1a-4d63-9b1b-05a10bf120f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc3fd804-3950-4363-a13d-17a0a23b13d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc3fd804-3950-4363-a13d-17a0a23b13d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a7822b06-01f8-492a-ae2e-c5aa8342c9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a7822b06-01f8-492a-ae2e-c5aa8342c9e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:to="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a831d3cf-bd9b-491a-994f-fbdd0d116641_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a831d3cf-bd9b-491a-994f-fbdd0d116641_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6f3b89b2-f823-4b90-ab6a-a8a6a22b7dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6f3b89b2-f823-4b90-ab6a-a8a6a22b7dd9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended" id="iafe03b6a662a41b1a7ef241691c3e0ce_NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c92b7a09-a592-4980-a7a7-6ad7ef89a3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_NetIncomeLoss_c92b7a09-a592-4980-a7a7-6ad7ef89a3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1c785d3a-83d5-49c7-8ce5-974a887eb442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1c785d3a-83d5-49c7-8ce5-974a887eb442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bf5cdf60-42b9-4bd7-8a1c-d3b848c2741b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bf5cdf60-42b9-4bd7-8a1c-d3b848c2741b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6c249e-f860-4c0c-978e-9a094972fb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6c249e-f860-4c0c-978e-9a094972fb9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2dfd32d4-d3ff-467f-8ba0-06480f53feb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2dfd32d4-d3ff-467f-8ba0-06480f53feb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2179e6f5-7220-4407-8141-847d947524d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2179e6f5-7220-4407-8141-847d947524d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85e60b2b-787a-4060-9218-c2114a34e132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85e60b2b-787a-4060-9218-c2114a34e132" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:href="pcrx-20220930.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc078254-5c01-4a1d-a486-129212c60d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:to="loc_us-gaap_EarningsPerShareBasic_cc078254-5c01-4a1d-a486-129212c60d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_407e8d53-235c-449b-9026-506f783cc92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:to="loc_us-gaap_EarningsPerShareDiluted_407e8d53-235c-449b-9026-506f783cc92d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:to="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff9dc9f1-9f4c-4cb6-93bb-05677a9fd776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff9dc9f1-9f4c-4cb6-93bb-05677a9fd776" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb21d508-1d04-427f-b11c-50a8760fd6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb21d508-1d04-427f-b11c-50a8760fd6bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_efd1eadf-5c69-47f6-b069-f657404ba2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_EmployeeStockMember_efd1eadf-5c69-47f6-b069-f657404ba2a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ae86b124-279b-4682-b300-cbf5352bb2b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ae86b124-279b-4682-b300-cbf5352bb2b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_2616b269-aa5d-462a-b316-096eddf38d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_2616b269-aa5d-462a-b316-096eddf38d6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended" id="i9b27131391a041c59c3392902dab858e_NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99b7bf77-a8f6-4cc4-8849-916d6cacdf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99b7bf77-a8f6-4cc4-8849-916d6cacdf80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_25146736-0a8f-491c-a982-537e5a72ea7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_25146736-0a8f-491c-a982-537e5a72ea7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_08c5d877-4fd9-4ace-b404-9f94ba317d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_SeniorNotesMember_08c5d877-4fd9-4ace-b404-9f94ba317d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c76d5ed0-a12f-4ce6-8630-2cc51630b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c76d5ed0-a12f-4ce6-8630-2cc51630b3fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7d8a3bde-74c5-45bc-8a4d-49ea8150252d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_EmployeeStockMember_7d8a3bde-74c5-45bc-8a4d-49ea8150252d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="extended" id="iaaa9aa47e7224d3eb63b96a8b0234d0b_ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1b986f1e-0b0f-4e6f-85ca-48fa62005b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1b986f1e-0b0f-4e6f-85ca-48fa62005b14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e93201de-75ca-454e-9079-d5cc1b4e8404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e93201de-75ca-454e-9079-d5cc1b4e8404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_ba60e456-74b2-439e-8ce4-47e4153cd574" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_ba60e456-74b2-439e-8ce4-47e4153cd574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a55150d5-38d9-4215-83d7-276c8b19d142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a55150d5-38d9-4215-83d7-276c8b19d142" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_6225727d-4eee-4d4b-ac5c-e4665005baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_GainLossOnContractTermination_6225727d-4eee-4d4b-ac5c-e4665005baaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_e2f6a1e6-5572-4759-b13c-decd5184805e" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_e2f6a1e6-5572-4759-b13c-decd5184805e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_dc0f81d7-08a1-4238-9b02-5b92855e9c4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_dc0f81d7-08a1-4238-9b02-5b92855e9c4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember_cc65d9e1-e2bc-4d22-b1c0-c88cff7889cc" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:to="loc_pcrx_AcquisitionRelatedFeesMember_cc65d9e1-e2bc-4d22-b1c0-c88cff7889cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_fe829559-2662-48cc-a081-cd5a77a2b685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:to="loc_us-gaap_OtherRestructuringMember_fe829559-2662-48cc-a081-cd5a77a2b685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9bd2b776-338f-4f7d-9160-de0aa63fa834_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9bd2b776-338f-4f7d-9160-de0aa63fa834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_52a4cc79-1bf4-4a56-9ac2-a0a9c2fc3e89" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_52a4cc79-1bf4-4a56-9ac2-a0a9c2fc3e89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_5edadb27-5baf-402d-91ec-62bcdc574d26" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_5edadb27-5baf-402d-91ec-62bcdc574d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7494467c-0009-4160-b1f5-ffde578070d8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7494467c-0009-4160-b1f5-ffde578070d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_3c1657ad-06f3-4b07-bae7-a177d85b9680" xlink:href="pcrx-20220930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_3c1657ad-06f3-4b07-bae7-a177d85b9680" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails" xlink:type="extended" id="idaef2222b5684b349d7df52e38f36824_ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_08b1e06e-0b9d-4767-946a-76038f668239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_08b1e06e-0b9d-4767-946a-76038f668239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bddfc7c6-8569-4f62-bd9e-30b028bea778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bddfc7c6-8569-4f62-bd9e-30b028bea778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_326c4a45-064c-4a8a-9859-13a44eb31ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_LitigationSettlementExpense_326c4a45-064c-4a8a-9859-13a44eb31ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f614a8f4-7b87-4be4-8b9a-3f513a7796cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f614a8f4-7b87-4be4-8b9a-3f513a7796cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_5dc42f79-69de-4252-beb2-e268f70ebf73" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:to="loc_pcrx_FlexionAcquisitionMember_5dc42f79-69de-4252-beb2-e268f70ebf73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_2246c636-439a-4349-b742-e74af12c06c9" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_2246c636-439a-4349-b742-e74af12c06c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8a3ca363-9941-4fc0-bc14-fe64f2336eba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8a3ca363-9941-4fc0-bc14-fe64f2336eba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember_73ade575-2cfc-4633-b849-c64bf4aeef48" xlink:href="pcrx-20220930.xsd#pcrx_LegalFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:to="loc_pcrx_LegalFeesMember_73ade575-2cfc-4633-b849-c64bf4aeef48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_879b1e74-c869-4c1d-8475-4ff7860776cb" xlink:href="pcrx-20220930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_879b1e74-c869-4c1d-8475-4ff7860776cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ia188da72996f488db8470b005cdec732_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_2a06bf39-3f22-4c3b-8906-044fb52f8b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_2a06bf39-3f22-4c3b-8906-044fb52f8b04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_f45130ed-725a-48ff-90a9-d66cadab1a0b" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_f45130ed-725a-48ff-90a9-d66cadab1a0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_f87a89cd-8774-49ab-b87b-2a2bfec4502e" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_f87a89cd-8774-49ab-b87b-2a2bfec4502e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_728b3f77-7fa8-4214-853a-f524d848a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_728b3f77-7fa8-4214-853a-f524d848a88d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:to="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9a61521a-ca49-429d-b079-584711eda102_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9a61521a-ca49-429d-b079-584711eda102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_6e692e06-8fb4-4de2-9495-9de00a3680b5" xlink:href="pcrx-20220930.xsd#pcrx_FortisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:to="loc_pcrx_FortisMember_6e692e06-8fb4-4de2-9495-9de00a3680b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember_e7994228-1f98-49d2-bad8-20077edf4ae5" xlink:href="pcrx-20220930.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:to="loc_pcrx_HongKongPharmaTainuoLtdMember_e7994228-1f98-49d2-bad8-20077edf4ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:to="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_77863609-85a2-450f-bf33-63673a19d188_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:to="loc_dei_EntityDomain_77863609-85a2-450f-bf33-63673a19d188_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:to="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_a3656c38-37e8-42b7-809f-d873dad157b2" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_a3656c38-37e8-42b7-809f-d873dad157b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>pcrx-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_fc5e0df1-4238-4a3a-ba5c-c5668c168cce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e80b84f-80ad-4eae-9bdc-023b336a2f45_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54f39b74-de2f-483e-8dd8-5c6c4bb43a7e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_07028d64-f096-4200-b070-fed8d4c166e6_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a61c6d09-e66e-461e-956f-8ea88eabb442_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_2f1dbb23-b41b-4a11-a5ee-0cf52ef87965_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_d7272bdd-712b-43b2-b39f-00563d46c3c1_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer two</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Two [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerTwoMember" xlink:to="lab_pcrx_MajorCustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c34af65f-4386-43f2-a5c5-e9e044d05ac0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentSecondaryCategorizationAxis_8f418288-0949-4c85-ae68-4d1ca06d7c06_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentSecondaryCategorizationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Secondary Categorization [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentSecondaryCategorizationAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentSecondaryCategorizationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Secondary Categorization [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentSecondaryCategorizationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentSecondaryCategorizationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentSecondaryCategorizationAxis" xlink:to="lab_us-gaap_InvestmentSecondaryCategorizationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_4fc50ad2-4e66-4374-88ae-be4f3777a919_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_a823acf2-f5b4-48a4-8355-2ebe8c813428_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_dee8750b-5c8a-40bb-b7f1-7e4b1d8d2050_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_86b7866d-2aaa-4adc-8238-c1e76555adab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0e7e42f1-6260-4ecb-bc3a-59acbae475fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a16b9c6c-9c73-4583-9629-90c3148fe35b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsideration_77e27b96-0dc6-4831-8567-92cc44e8a2fe_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_label_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsideration" xlink:to="lab_pcrx_ContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_92d5ff06-fbee-465e-83d9-83f75ba53da6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_dbb121b4-a7df-49b5-ae4a-87165e772165_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_29653428-d3fd-4249-bd55-65202637a0b4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f5b7f790-ccdd-42de-a33a-f70708e4f540_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_922401cd-f884-4d2c-a1d7-8bad50abbed9_terseLabel_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_label_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_documentation_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:to="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8624d020-191d-43e6-94ec-5d6fc3a150f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_ff0de890-70f0-4266-a81f-e7b3995adb3c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2d9d2087-853b-4593-9cb4-c2e0e1dd5fa3_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_b4fdbdbc-a0d6-4c76-bf46-1d7bf888aeae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9cf022b1-fb62-4017-962c-7a43eeb46136_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_280147c4-6a51-4dfe-bc13-2684006f4087_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9a7a117d-c6af-4c90-aa12-c27614859f1e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_261cbf35-dd0d-4e75-8600-a5f0f57cc002_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_65266556-4fbe-45c4-98b6-7a642b424645_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issued in private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_99c5b2a1-8c37-4b6e-a099-bfdc3a30702e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f19caa76-9509-434c-8a27-c51f87157d68_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_f8a510df-49b2-41fa-b91a-5e19517d5afa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f4636e6a-ecbd-41e7-b57b-f7206dbd8f64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cb263616-5953-4b93-82ce-64f5b40e620f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NumberOfLeases_f07cd09b-fac3-48a9-b28b-1bf341c60121_terseLabel_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of embedded leases</link:label>
    <link:label id="lab_pcrx_NumberOfLeases_label_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leases</link:label>
    <link:label id="lab_pcrx_NumberOfLeases_documentation_en-US" xlink:label="lab_pcrx_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NumberOfLeases" xlink:to="lab_pcrx_NumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6fa9281c-0033-431f-b1fc-f37007d853f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_34fbfadf-c289-4950-bf2e-f7d9c7e3b2cc_terseLabel_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_label_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options, employees</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_documentation_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options (employee and board of director awards)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:href="pcrx-20220930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:to="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_85010321-c5c1-40f6-8e8c-fca775efec42_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_9911c4fc-f4a8-4128-8416-6e6f4627cf24_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7b843fbb-972d-4399-a7ca-509eed59c235_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5ff49915-f704-4596-8b97-fe60f401d497_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9f91a8a3-96b4-4b74-9ed1-6e6802744b7d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_48683195-fa63-491c-a451-77523351d2ed_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income&#8212;basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_95179e5b-5bcc-460d-82c8-bea5fcfcd2c3_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b6e4d7fa-3b6b-4b43-95f3-dd70e7825f46_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b0a34981-112f-499f-9339-48694f66b706_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4832f457-7094-42e8-b3c5-cb124fda84bc_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_1ce92c86-a1ac-4392-ab60-0179f4fd6dd8_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_2887e5de-f4de-49c5-8a4a-5979f74ca735_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_a74be170-4df7-4cc0-a93e-6755167c208a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma basic net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d5052547-c750-49ad-b226-217e3848a1e5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_239e4e3d-9ac0-45b2-91bb-acf6adf3aebd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_c4c1d88e-b4f8-4678-8bc9-7c661b24a16d_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_9b21c92c-decf-44bf-a6c2-7f3608d3a3e4_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_593af6a2-8ae9-424a-95e0-63a705b9e402_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_172bb288-082a-4b81-96e8-964fe930c70a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_48d64923-ff3d-4296-9a8d-402af3e06f5b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_402e7330-b68d-461f-8ee0-407d3db847d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8aa552b7-aaf5-4fcb-8b0b-7a0f25e9911c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value (Level 2)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_1652d683-0e64-480b-871b-e709d9d68139_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentDiscountRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentDiscountRate" xlink:to="lab_pcrx_DebtInstrumentDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4988bba4-48f5-48a1-9df3-9eaf30975a84_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4356e471-3810-4f19-8474-fb666c53fc09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationMember_761ee317-e651-4a55-911a-6a5d11442ec9_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationMember" xlink:to="lab_pcrx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_7e1d52fb-c0c2-4e86-9103-03a90fd2532e_totalLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition-related charges (gains) and other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Charges, Product Discontinuation, And Other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Charges, Product Discontinuation, And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:to="lab_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6e231e65-6261-495c-9b8d-40dd07c0a768_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_5242f001-f4c7-44ca-a2f1-c3240db39ec8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7327fcbe-191f-485d-a800-ba593a647659_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_a57a0371-4e2c-4db8-9e4a-2568a9d88843_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative licensing and milestone revenue</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_label_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue [Member]</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_documentation_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:to="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a98bfd98-3808-4fb9-b585-3ada1b18ca84_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b72d8cbd-1aee-484a-8885-f08b2b748416_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_8505b84d-be2b-43ea-9acf-5c229716a894_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of convertible debt securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_693e4dce-d251-4944-a248-36a3b9a678de_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average ESPP purchase options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_dc6bf1c9-67fa-4aac-9484-e92fe85d4cfa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of investment</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4250b509-fddf-4364-8c63-2e939be1c8b9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsBySecondaryCategorizationDomain_47e07eb3-fde5-4b37-b32f-dd9d5da7f67a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsBySecondaryCategorizationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Secondary Categorization [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentsBySecondaryCategorizationDomain_label_en-US" xlink:label="lab_us-gaap_InvestmentsBySecondaryCategorizationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Secondary Categorization [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsBySecondaryCategorizationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain" xlink:to="lab_us-gaap_InvestmentsBySecondaryCategorizationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_bf8207ed-02b7-44a3-aff9-83945d210380_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2020-06 convertible notes if-converted method adjustment</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:to="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2d1007ec-f93d-4c85-9ec0-132a54f14807_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_08a12fe4-b346-4b05-86e7-ea4b85025d5f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2f8fe84f-ecde-44bf-b282-a478b456d917_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_628c38e3-fdf3-4984-8558-eb49155e467b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbded569-39f4-4422-84d3-2f4e705d5aa4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_3e09ffe6-2801-4ce8-a470-ced30f222b1c_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_3e7b9c43-ced6-401f-a3b9-b66538f4b60a_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_d585e7e7-6ee3-49fe-940e-53ba79d0ce6d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0403bc9a-8602-4961-b2db-a27473c0d36d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_56a01b50-4879-409a-8969-e63b45178cdf_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 3 and thereafter</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_fb59eef9-26fb-4fde-8942-6cdac69bb34d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cb4cb465-0919-48b8-b584-0b017c1886d8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ceaaf720-febe-4de8-8885-47ffab91fa74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_44f05127-fd20-47bf-bff6-8c805471a619_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_94424b1c-b65c-4fc1-abe9-a2c6bdf51478_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_d05ba459-4ea9-4967-bf03-1e53e45b9ec6_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a71c3bff-739c-4844-b027-4ea22984ef85_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1a414aa8-14dc-4616-b7a7-495de09a7870_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6baf1cee-0e6c-464e-84bf-31ab035b8949_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_019b7685-7c2f-4b4e-8730-188eb70482e4_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_13e6ddd0-9201-43e8-9563-9757957d0ca3_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchasing period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_01a2ebeb-2b7a-4965-a609-289abe38df97_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fb844555-99b9-485f-b933-94876d169dfb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_e5c1d06a-cb81-4509-8b36-d5daea50bee6_verboseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationCurrent" xlink:to="lab_pcrx_ContingentConsiderationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_66abf5d2-1ad4-4bda-8388-46260c497fe5_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2a7fda8a-05de-4a7a-82cb-ae7bf0b31dc1_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3872e1a6-d01b-40b9-8213-b52d5c97bffb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c0190338-db3a-4719-8acd-64019716ec82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_092738a7-f651-4d24-887c-4bc2439b9617_terseLabel_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of major customers</link:label>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_label_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Major Customers</link:label>
    <link:label id="lab_pcrx_NumberOfMajorCustomers_documentation_en-US" xlink:label="lab_pcrx_NumberOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of major customers of the reporting entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NumberOfMajorCustomers" xlink:to="lab_pcrx_NumberOfMajorCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e0c30614-d879-4290-99e9-6c5d2d46204e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fixed assets summarized by major category</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_490fd04f-8c00-4734-9ef7-5702d6353723_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Shares Issued Under Employee Stock Purchase Plans</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from shares issued under Employee Stock Purchase Plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:to="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_6d468ae8-2e38-403d-a8a7-e63fb4900627_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized (Loss) Gain From Available For Sale Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a43a4dca-d9c7-4d3d-9ff5-ea3f202a8d8c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_28d276a2-24c6-41e1-978c-662f5d6665b5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_56c64149-e47d-4119-b971-6996cdfa1fd6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (Per Share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_480ff5f0-97af-45d3-9e7e-c8879b3750ef_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_93bcf026-35f7-49a1-9883-aa6223f5124a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_270d1b7a-e34f-4fb5-b090-2b7f1ed34319_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_9d2c3bea-6da1-4f9b-aa11-9d88a92f1599_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5216e081-4c94-42a7-bdb2-84d94f59c8d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7f367549-01a8-4965-99db-8a01b0643424_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dd0fb4ca-a261-4920-a4a5-7d66ea95bd8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_fb407777-a1b3-4508-ab6a-4b9bb8cf958a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0d36d008-11d0-49ce-932e-d0c4df646b26_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b30d87d0-ccb4-4404-b9fd-340efe0d2d4e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9dce0f23-a745-4d0c-96a5-68acf01267cc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_2e54dace-3964-4e24-9c1e-9a4bb186e0c2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_d1598fe3-fa1e-400b-a9c0-a197573cbce6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_TELABioMember_476a8c28-4704-49b3-a37b-ea6a6136525e_terseLabel_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio</link:label>
    <link:label id="lab_pcrx_TELABioMember_label_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio [Member]</link:label>
    <link:label id="lab_pcrx_TELABioMember_documentation_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember" xlink:href="pcrx-20220930.xsd#pcrx_TELABioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_TELABioMember" xlink:to="lab_pcrx_TELABioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_2a76afca-ba36-410c-87fc-3114afb2ed8f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_15ed87fa-60e9-48e1-8427-62bb621be2a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_4d639f81-b16c-44d3-9378-1339b2765b75_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_adae8d38-c3da-4e6d-a89d-625896be36f2_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_de6b8c0c-2cb9-4fc4-9b55-0bbbee0d2f77_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_d9f90ab5-22c8-4915-8905-af8260a206ed_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_98e5036f-3194-4425-96fb-da8808619d2a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_2cc40b00-f33e-4523-9a62-a95e49b0eb6e_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of offering periods for ESPP</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FortisMember_53a2dd1f-87a6-480c-b18f-de859efafc25_terseLabel_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:label id="lab_pcrx_FortisMember_label_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis [Member]</link:label>
    <link:label id="lab_pcrx_FortisMember_documentation_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember" xlink:href="pcrx-20220930.xsd#pcrx_FortisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FortisMember" xlink:to="lab_pcrx_FortisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_3701941a-234f-4b01-bfaf-64641774d1ce_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_4100baa9-09b0-47d1-8911-d2e5b9bde48b_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_f511446d-4e0a-4b02-8c9b-a20966680ec6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_0fb12415-f907-43da-8e9f-4474820d3bc1_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, maximum, value</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_label_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:to="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_5b4c9d79-148d-4f3c-8c1f-65c9573d9643_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt, net</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9c141fbf-6c09-49df-aef7-a06c01b49f98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_d7dc4b0a-470c-406e-a26c-1c43da93629f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2c5d4276-2a06-403c-abb3-31ee477a5f88_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e1a9b77f-8381-4715-8f71-8acbc63c4e6f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b710095b-7f73-4377-bdef-08e3b9da85b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_d4401233-d53d-4ba3-892b-4592a7091356_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma diluted net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fa947a4a-b778-462d-b5f2-6e0ac1bae6c6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_6a13a7d8-1f8f-4119-a0ea-883a40df2fd1_terseLabel_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income per share:</link:label>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="pcrx-20220930.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_65993837-01da-4c18-bfdd-70ff41e72ffe_terseLabel_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments for EXPAREL agreed in connection with acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreed Milestone Payments for Sale of Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:href="pcrx-20220930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_41a1753d-29f3-442f-82dc-b503c58e5201_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_7168f334-212c-40b3-b115-a91190876532_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f090ca1-a3b5-47a2-97d0-084ce42fa313_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_89549abe-7c24-4da2-8258-6e04044e0e4c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41634cd6-cb49-4df1-847c-121e324bec83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1b3c7176-88ac-4d02-976f-bdf703f6cbfe_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_bc6f9783-f6d0-422c-bf2b-75c442f81129_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_2b11f344-5924-405e-a324-615678ab86c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_dbf2216d-da89-49af-968a-5b7104351bfe_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_30638b4e-91f2-450a-8de0-7c1894235c7d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_c38ec1f5-fd5d-4907-bfa0-55daf2895d63_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_b06716f5-7ef9-4197-9aa4-dbb61d659bf6_terseLabel_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_label_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_documentation_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stages at which milestone payments for products are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:href="pcrx-20220930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:to="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_53ea8d7d-9d73-40eb-91b9-ce72d4153de1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce2cc6e4-e24d-4995-97f0-f1cc7c04cf7f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_32863ed1-1b81-46eb-b35c-9fd8dbffe7f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ceeb7a76-6b0e-43f9-aa5d-249cb1e25b0c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_1e8a0dab-090a-48ea-a626-e58013704f6a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_7b718040-0061-404c-9237-47ae9e8c00c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8da57e24-0cfa-49c6-a553-567fb41bf3b9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_a378b902-aa90-4c62-a1a6-bf4622696b1d_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_01fb7718-efb7-4176-b279-ab94f14f8aec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_72c6f535-2976-4ca3-8cd6-37d40ef292a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss) gain on investments, tax benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f809e591-d545-44f7-8af9-b2ab4f80212a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES ASSUMED</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_8201374b-3a6b-40ff-8d68-aaf0720ad488_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5b740c1e-3eaa-40a2-9e25-2e7e50025799_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_47584499-f5d7-4793-b4e8-d710d1d1f2ef_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_40258ec6-98bb-43ac-920d-b22f8a310e5d_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:to="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_658ef6ae-2526-42c0-bdfb-e8705103b81b_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets:</link:label>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_bb0cd26c-8eda-4dec-89ad-39eb8e4c0318_terseLabel_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When annual net sales collected reach $500.0 million</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_label_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_documentation_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:href="pcrx-20220930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:to="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_e2047eff-2134-4ea0-b575-137a2d5a72a3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_52ef8baf-ba7d-4b88-92c0-95128f7d2390_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of operating lease not yet commenced, payments due</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:href="pcrx-20220930.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:to="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_3a9657e5-c78d-401a-8cd3-809b344b3f67_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_39523fda-37cc-416a-9d1f-e0979705a725_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_7f09c4c0-1284-4cb0-9e15-4896b7bd016e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_526a8e50-f00b-4f0f-9272-df4be944684f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_af6f4760-0147-4d90-b81a-00d8995d1781_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_cd4a3540-1287-453a-89e4-e1f88419cc36_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_ce58c16b-59d9-4158-b11e-48b198792685_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_d0b443bf-da05-436b-a9cb-14778cc8266f_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (remaining three months)</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_df88f12f-81fb-4d6e-a895-e78ad6762fea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_d7bdab72-eba1-4060-b6fc-8975cfd5c8a7_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_bcf5f2d7-4fd5-488a-a345-e0668d03a3cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_6878228a-9cd7-4a6e-8b76-e9998c5fba60_terseLabel_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_label_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_documentation_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:href="pcrx-20220930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:to="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LargestCustomerMember_d07b6ec4-d46f-4a00-8449-26fadd5aace3_terseLabel_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest wholesaler</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_label_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember" xlink:href="pcrx-20220930.xsd#pcrx_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LargestCustomerMember" xlink:to="lab_pcrx_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_03e33f38-5466-4945-8aa0-d5d62d4113a2_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_b37542a1-9034-4769-9819-fb026f426982_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate of common stock per $1,000 of principal amount of Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_a8a9bc6a-6a7b-4d66-b722-9ea0a65d568a_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of payments in next fiscal year</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:to="lab_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5c665289-8be6-4c0e-aae3-a2a4883ae4e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5cbc4128-2e81-4fc3-8b91-e3edba5a5d48_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_5587295c-5c48-4e17-8cd0-a600c65a5ba0_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty revenue</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0bdcfd20-ce96-4da5-9bb2-ba0203d488ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_fa5eadd4-4581-4f36-ad3b-faa13ba207dd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_62585f87-2796-4cd3-9b1b-816040fb3f20_terseLabel_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of products (in products)</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_label_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_documentation_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:to="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_72277d0b-acc0-4196-bf5f-4fc3a9144603_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c8c74e95-10ce-43b5-bb48-659ee4943dd7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_14688814-fe73-4744-909a-d5caf5538a2e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_740c396d-d754-41ad-baee-2a1c194e9770_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_a60c9cf6-b5a9-4ac0-a6e2-ecb74e941387_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_3a3f6fbb-fa56-4c09-932e-b7099b1377f7_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing sale price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_4c4bb2a0-cad0-40f6-b95c-aa356fbc2975_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_abbfd7c8-500a-428e-8d2a-ac9f8bca899f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_6962b3fd-d1b8-4628-be82-07d8f5c1c281_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3da9f822-1cc6-49c2-94f5-94ce75d51228_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_4d3eb504-d3d1-4d0c-bdcb-3284da6a97f4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_2da0e41a-a4eb-465a-acd8-64f773da35af_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_877d904d-fe99-4083-a02f-05d76b37293e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_ed0d8dae-c76b-4650-be49-31f54e51c8ed_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_label_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleNotesReceivableMember_documentation_en-US" xlink:label="lab_pcrx_ConvertibleNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleNotesReceivableMember" xlink:to="lab_pcrx_ConvertibleNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c04cdcb1-6d64-4421-b7d4-6c0ba160b965_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_ac5a068d-3bab-472f-9c7b-7083c6689b56_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of term loan</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_label_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Debt</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:to="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4613f2d7-1d32-48fb-be40-ffd04c379a31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_871d38c6-c261-4eed-bc10-22fd484baba3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_83366600-b89f-4bcc-95e3-4503ae90afc0_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5fd526f6-a498-485d-81ec-ecee489eaa86_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_0299fe7f-ab0b-4d3c-8b91-aff57e4cb894_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_67880fce-c644-4537-a561-261b28ce193c_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent value rights (CVRs)</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_label_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</link:label>
    <link:label id="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:to="lab_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_27d0c6f6-3099-41f3-96c8-b8b534fdd41d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_08e01e76-5f26-4708-a82f-3666f825df78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLEXION ACQUISITION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_61802780-d593-4f9b-ac47-07556274c555_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balloon payment to be paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_91e1d292-bbcd-4da9-b2ea-877ba9bb304c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_c9fd2594-10d8-4015-a932-5b7ca761b1bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_86bc49da-4fdf-46c2-a59a-d33815f911e2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a30d967a-1fd1-4ddf-96f3-bebda4f2a84b_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7b6f1cac-f361-4ff2-b311-91c622c72f5f_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_9b98cc2b-eacd-4222-85fe-dcf8bf42d0d8_totalLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b17eacd2-1e80-4a85-8930-da9e73a47c85_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from customers to total revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_33e18469-6733-4ab2-9625-572daaa0cf13_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e50e4198-45ad-4ae0-b490-b627d53912ac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0d35a4cd-87d8-43a8-ab6b-7ae940d56a23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_bd5e2420-2388-473f-a42b-251ea0d5c094_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0b2ccc5c-7ee2-4e15-8fe4-58c59fae348d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_e4a62599-764e-43f9-ab69-3ac46891e802_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisition-related charges</link:label>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_label_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition And Integration Related Costs</link:label>
    <link:label id="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition And Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:to="lab_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f79806b0-0b97-45f3-8032-451cab298a24_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f57b15b3-e35e-4fbc-ac98-802d5277bc4d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7c567d3d-f391-43e6-86e9-75088f2ca3bf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2553a4fe-c802-428e-a512-aa264f056789_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net (loss) income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_eba8bf1a-1310-4d34-9e11-7fdcba797548_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_109ad4cd-d3c1-4bfb-8b45-43aa6a761157_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2ebd4b88-7236-4ebf-9fd8-c59edb150fc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_08b80f26-1f41-4aff-91f1-8b462f0a91b1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1c9af9a7-0509-4c0a-ad76-2d78f58970b8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_808ab699-a9de-4d58-96ad-c49b101d95c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_afd408ea-51ec-4dfe-83eb-c27be8b402c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_664bd0a9-afe8-4923-a9f9-aba2241aaceb_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_7c974cca-a8bd-4ea6-a463-ed8c9e07e9c9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_864e22c4-6cfc-454b-bb60-174e1687a485_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2f97fc77-7115-4014-9db0-265800a2a12b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_99076c5e-39e5-4b67-9491-7b039ba8575e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_05ff5758-12a8-4c64-8909-60100b6555da_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity attributable to parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d3ea7c07-763f-4529-b3c2-8d1323f0156b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_1f13a13a-efce-4b7c-9f26-f62cfafc5d38_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread one on variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread One On Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread One On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:to="lab_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1e4daf07-ac24-416e-a390-ba4b129d7342_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_98580ef6-51f9-44fa-8fdd-801f6e6c114d_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, maximum</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_pcrx_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_8ec672e0-113f-4d0b-afda-068d6c946f54_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_73e0603a-dba0-4062-9c87-cc6e13272c10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1615f28e-5bf7-494a-8660-cde9545d0835_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b5efbe10-6485-4217-9524-9d84d6f68150_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_9dcc39d0-4a1e-46eb-97b2-8a07de5fa399_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_51226e15-8aa5-45ea-b594-fc5ef4796ac7_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, percentage of principal amount for computation of redemption price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:to="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_196baaec-19ca-4866-9c46-34ab0597a683_totalLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_011efb35-239c-42ec-9a3c-06b62346fcc5_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_008df242-7e15-449b-941a-faf6287e5a51_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_82db9426-c319-4582-906b-67abe0ab55a7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_445140c1-14e0-406d-977d-d772f4121770_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense, net of sublease income</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9c6676e6-797e-4dc7-ae13-0fef3a0607d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0065cc58-0730-4440-8dda-8dd821523af6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized stock-based compensation in consolidated statements of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1604f309-25f1-4329-b140-36c49deb7efb_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb6daa43-3fe0-4781-ab47-75fb911075e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss (Note 11)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_0723b569-e4c6-41f3-8827-4eb0ab3c6340_terseLabel_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent:</link:label>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_label_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Member]</link:label>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_documentation_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember" xlink:href="pcrx-20220930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LongTermInvestmentsMember" xlink:to="lab_pcrx_LongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_56dd54ec-b545-400c-9d84-b31be63898a2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_459b63e0-d858-4650-a121-884d36d5fbf9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of operating lease expense and other operating lease information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b3f54498-300f-4b0f-aba2-2be1472b9b20_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_4fbee63f-f882-4bf8-8abb-a1f677a9dbe0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4450a5fc-f2b8-44ff-95ad-3c961e1e9886_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_77961d09-915a-4e89-9fd5-c0a5f2b71c1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_12d544e6-6f45-4ce8-83fa-eea63f415075_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9052311e-2814-4e4d-b825-1586a6aadf7e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LegalFeesMember_d6fc7e22-19cf-4133-866d-c18aa8827433_terseLabel_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:label id="lab_pcrx_LegalFeesMember_label_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees [Member]</link:label>
    <link:label id="lab_pcrx_LegalFeesMember_documentation_en-US" xlink:label="lab_pcrx_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember" xlink:href="pcrx-20220930.xsd#pcrx_LegalFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LegalFeesMember" xlink:to="lab_pcrx_LegalFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_424e0904-e915-4a5b-856c-37576da65c51_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_434760ab-649b-48a3-b078-24438cf708a6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d628e1cb-0878-4652-8365-e9df270201e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7e875a39-424f-40e8-9eef-46283e02644b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of key assumptions used in the valuation of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fd3f7f12-aab0-49fb-8699-7383b14f4234_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_649dc5de-13d8-4f90-b822-05210de4c9b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_4860fc5f-f7be-471e-9475-1803a96cb762_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration to MyoScience, Inc. securityholders</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f8322ff5-77d0-4c70-b0ec-ed262e99bd7e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d43d9b13-d72b-4b54-8c77-e5c90a0198ec_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_4c598d84-c102-4524-ab2e-c11b77a64ae7_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_01514bd6-2de3-4c81-abee-e3a4c12f9f9d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_e621ff53-625b-479f-8d51-0df8bb9d7cba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on investment</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_308621cc-cae4-4a9c-b4c8-83a4c067d5de_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_84d71446-6912-4c56-aafa-85a2b71fd7dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_c67a67f8-11ab-4431-88f2-ecaacd1217ee_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_3d25dd26-d700-4690-a70a-fc29d2689218_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_94dca46f-1259-4acc-931d-9115a8003fcc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited pro forma summary of operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_48b7a43c-4c04-4cac-ade9-7effc77a6646_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_eb81161b-2769-4d9a-91d3-d340263e564b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1dfaa178-f479-44af-9575-25fa1daa6912_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_adffb669-b779-44f9-a2d1-e2fbd0ee2343_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_4a5b845e-0b6e-4bee-b50b-f09977515965_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum milestone payment to be received</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_label_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments to be Received, Maximum</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_documentation_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments to be Received, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:to="lab_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1a7e8e9f-147d-434b-83aa-1ea52c7a2d52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_76bd5537-f560-4f20-9fcc-a1f89d814134_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e025c312-3b00-4554-bcc8-a4f62772ea38_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9fea2874-2726-46c2-81ae-c4223589ede9_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_8c7cb55c-0acc-4bf7-8a70-934ec9baeba7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_8d27d80f-e18b-476d-83e1-eea2e8c430ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fce419d4-5bc6-4ce6-a45a-a0c8002fadaf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7ecd03ab-b579-4848-abcf-a56409b54215_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b863664b-71cb-4ad6-a40c-032a24821139_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_79dc1b8e-461b-4818-b5d6-01a7ed01294d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_957b2c55-833b-4764-aeaa-e3e137ad13da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c247e912-1305-4468-8805-eb09f0048f25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_8af67b4a-c80e-47b8-a2c5-bbd82718975e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_bd13fd3d-3584-45d2-9489-a8b1402378b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_95e8dd92-92eb-4555-979b-84216e7902ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_62ac3fb1-dace-4513-852b-a26895eb32c1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_57e905ce-d3dc-4ea7-9a2d-90e913322f90_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_01d757e3-0bee-4b15-8bb1-9f8889dedc0c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1305c34b-90ea-4717-bb11-9cf092c62399_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_04668a64-d1c9-497b-a0cb-07ac1a61a62e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_480c87d0-764b-4924-8ba7-1327926780da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the company's stock option activity and restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_e584129c-27f6-4a61-9a5d-e5aacd0d9c76_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from conversion of 2022 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d9ba7fdc-3e04-4359-9aa3-ef5e5e1c6eb5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d754892a-33e1-42b1-aa8f-b99d8cab4e8f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_d845e7fe-334b-4489-80bc-255bd988b941_terseLabel_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc.</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_label_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc. [Member]</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_documentation_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to SkyePharma Holding, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember" xlink:href="pcrx-20220930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SkyePharmaHoldingIncMember" xlink:to="lab_pcrx_SkyePharmaHoldingIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_773e7404-e926-465d-aa58-9e27c6be0298_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_efbb8225-ad41-4302-81a3-c4d0dbafcced_terseLabel_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_label_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_documentation_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:href="pcrx-20220930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:to="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_969a37b4-405e-4a9e-9cac-463330208c1f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_ecd85a91-76db-416e-8e73-992307ae9a0e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of diluted securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_faa5bac5-1cf4-4c15-8b74-20fa1d9b1f21_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0a957158-2b59-4b31-8c31-d4facca3908f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0dda5fe5-d78f-4965-bcd5-097fbc4d8380_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6d242bd8-9527-40cf-a83e-2200ae758584_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded in connection with the acquisition</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_646ab7ef-86b3-493f-9907-98955c072e3b_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases not yet commenced</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_e99f75fb-542b-4b69-aa77-66147bb44d1c_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 1</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 1</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4d919714-4fb1-4ab4-9d5a-733229dab97f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_5f270f8d-81b8-4b72-a6e8-b95892723abe_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment penalty, percent, year 2</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 2</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty, Percent, Year 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:to="lab_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f3cd4035-606e-45fd-afe7-8ef2c4fd9cfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3982fabc-7da8-4759-bcae-57edadd6e393_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a4bddd1f-7967-4bb3-820d-8e6bdc61b31f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_2b059835-bcae-4cc0-a8e4-c1b8ed7b86cb_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government bonds</link:label>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_f63e7559-d605-4f6c-ab96-a0356ee0a9e5_terseLabel_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for basis of presentation and principles of consolidation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:href="pcrx-20220930.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_704118a2-722a-4137-862a-852ec192e015_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_df4240bc-80c1-4420-bfd3-69667bdf5d86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b6fc2081-017d-4a3f-83bd-de9bf80ee2d6_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_d2ee9ad3-59b9-4570-91cc-aae9fec68c34_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_afb43c93-ad75-4228-baa9-d58da138afc9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_309fdb47-e31f-49f4-9f75-cdc03ce91e0a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_01d47930-42d1-49a2-8569-1ffef23ef062_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_28ca269a-38c3-4156-a1d3-4c28697b3132_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_34e3b9c8-2760-46bc-8801-4aa77301d4e9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_a8971ebc-b2a0-43c1-ac84-1cff27688080_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6c9b8600-3644-418c-a33c-66ed2ef8938f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_0c831314-280b-487f-b008-e318cfcfabc0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_25d1015d-9382-45c1-9c19-1dd1136fbb32_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, realized loss</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_e3cdfe56-50b2-4678-a57c-b68570110d2c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_82bcfdf0-0232-4718-bc8c-2c8cbd2a7680_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bb7b79a6-cfe9-4c3e-bec6-ffbb70becc6b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_baacbbc4-cb34-41af-964b-09de5957fba4_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0bbf3631-c2ff-4e76-81e7-93bbcf96267e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_91697e5f-e108-43dc-a7e4-224737ec0b02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dc8070fd-7fd9-40f6-8e42-7c73070c415e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term of options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_11778d3c-4d42-447c-ab1e-c17f065e765f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5db3af69-c111-4da2-a42f-498257e159a2_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_819fbc78-7f69-444b-96f0-eaafba17df3e_terseLabel_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate</link:label>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_label_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate [Member]</link:label>
    <link:label id="lab_pcrx_FederalReserveBankOfNYRateMember_documentation_en-US" xlink:label="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Reserve Bank Of NY, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember" xlink:href="pcrx-20220930.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FederalReserveBankOfNYRateMember" xlink:to="lab_pcrx_FederalReserveBankOfNYRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_7111abfb-ceee-4809-abdb-d3132dd69858_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5baad3-95ce-450d-bef7-60771bb36608_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_e0427cbe-01dc-4939-b3c4-c00db710e8e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of short-term investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_a77c6b57-25e7-45c5-8d63-d29ee634f7fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_43b0b133-7951-4b8d-b0b2-ff718b9e23b2_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fe9f135e-1751-41df-af7e-35a675df8cb1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001; 250,000,000 shares authorized; 45,864,319 and 44,734,308 shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c24ac8f0-3984-4a67-9940-c6f5b20b7d70_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_5dadd223-743b-485e-b361-98ac941eb395_terseLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related fees</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Fees [Member]</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedFeesMember_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedFeesMember" xlink:to="lab_pcrx_AcquisitionRelatedFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ac8837e3-cec4-49c0-9580-0952209d8c3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_02dea6c2-962b-4876-b302-dda95abb7481_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_6f5ef7a6-c332-44c4-a1d4-77960e04332b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_470e9527-b180-434d-abcf-1b4e239d3ff9_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_a3d7e384-0b2e-423a-a7b0-dafe40d7b3fe_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_75be2aa4-5c2e-4934-85bc-d7a904245db9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_139ea589-907b-4381-9e1b-3df8e3e91c74_terseLabel_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquisition Related Charges (Gains) And Other</link:label>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_label_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</link:label>
    <link:label id="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:href="pcrx-20220930.xsd#pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:to="lab_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_6e4416f0-369e-4251-9d3e-1b509a55b335_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price of notes into common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4996efeb-d114-468d-bb0f-a37fd4a1b0a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_39f71970-8164-4102-bf26-6e2084f5cb27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS ACQUIRED</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_8451df1e-07ee-4204-94d5-511164639093_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationNoncurrent" xlink:to="lab_pcrx_ContingentConsiderationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_64924a51-7cd7-465f-848f-91b1982b37f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_e612f02b-025a-4b0a-8468-9ff68b7d986a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_90125b1b-8d2e-43d8-b3db-e1a721dd68f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_00f52d0b-b71c-410a-a1c5-fc7b958eebb8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_83f5b395-48ee-4ecd-819b-1c4ba234d5cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_76c184be-2e63-4072-8200-40ee8458e7a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31164b92-0b4f-4c0e-9ddf-41c69eea123d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb4d7005-4bad-4634-85e6-839add24cc7a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f80cfc9-47b7-4d15-96d6-290079903217_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_748401de-6a30-4c45-9e50-6099cbe758c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_ac728062-63e9-49c4-b3df-6ba9a3ca895f_terseLabel_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine liposome injectable suspension</link:label>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_label_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine Liposome Injectable Suspension [Member]</link:label>
    <link:label id="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember_documentation_en-US" xlink:label="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bupivacaine Liposome Injectable Suspension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:href="pcrx-20220930.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:to="lab_pcrx_BupivacaineLiposomeInjectableSuspensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_63a5d659-a480-4a7c-a3a8-408e57ce19d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_58f4c061-7581-4385-8abc-3fd160e556cb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_1fcf1842-2640-4530-b352-bb691c28fe3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bc3bb5e5-58c7-4b36-a09b-559aeda31502_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_4bd5ce2b-e618-4d24-bf27-b0597e9711c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e4443471-7fa3-4944-b745-a2b8372c2b13_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_77456b24-6e7d-4f7c-a189-b2f5bc5b4002_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares)</link:label>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_label_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</link:label>
    <link:label id="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_documentation_en-US" xlink:label="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:to="lab_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_bdbd270a-ba10-4d5f-ae2c-2974a0860b5a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_63cd8a7e-7e65-4382-8dc1-26c6aadd518a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_72177bb6-355e-4e79-b7ee-41569564bc5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7cae7088-8c92-4d63-a816-45aba7465ba5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7ec5a9a2-c0bd-402c-bf21-f272f3aaacd2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed4d8b12-8c04-4154-b3fb-32f2279b3453_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_e50dfcd5-5686-4a21-bf92-c37c8cf9fc3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e3adbf8b-1339-4eee-84a0-a1471cb0fe1e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_950cadaf-79ac-45be-b041-5811f6f76c61_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9f99a011-c6b4-42c3-8979-e551842cd11f_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_1df7a516-e219-4240-a703-fd084b0eb894_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying amount and fair value of the long-term debt</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_52ff15c1-b333-41c2-9eb1-a222869b7783_terseLabel_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_label_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MyoscienceAcquisitionMember" xlink:to="lab_pcrx_MyoscienceAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_85f2f401-2034-45ab-befd-871ccdc899cd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_db2df9bc-6652-457b-a195-095cc9abf074_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_750e44db-da62-4d9c-8288-30840db01f83_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_8ad97979-78a8-4c9f-9c01-354fd5372680_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_db2d8a6f-df93-471a-a6cd-f848295f3186_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_7d69abbb-73ff-48cd-992a-6d7948f9f808_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_416ba65c-6d95-4fbd-b34b-d265236180aa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_d4c31126-bc26-4e4c-a48a-8b64273b4567_terseLabel_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and other assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_label_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_documentation_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:href="pcrx-20220930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:to="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_81a55b96-a4a8-4418-b837-c07ee36b1427_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6ccbfbbc-fd27-41bf-8a89-d9d48249b80b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of fixed assets and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_d0017c78-1d26-4fd3-b2b3-e3da9b23ba57_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, ESPP (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_932cc050-cd7f-4785-a368-0e556d2138c1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_d6e5d5a6-6e39-41b7-8844-4602fbe1297b_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_50b47ddd-509e-4a42-a004-adf033bc757d_terseLabel_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_bdf106a4-23ad-4340-b0aa-12187fc680c7_negatedLabel_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of equity investment</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_label_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_documentation_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:to="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_9a325bac-4add-4e1e-9612-fadf5545848e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b3ef8735-036c-4deb-8972-dd44023469e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_8cd33a76-60e4-48b3-aa45-4eff61e3a012_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_df18d174-9bbd-42a8-8faa-42ccfe6e0754_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized identified assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1efd4b37-1f7f-4ef1-989a-f729606657cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_48e5b732-68d6-4927-86ab-0ef3881f34df_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_59f5e4cc-e2bc-40a0-9ed4-4335c4f5a971_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_dc7a9485-2af5-4bf0-ba84-a664f2109948_terseLabel_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP increase to shares allowed to be sold</link:label>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_label_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</link:label>
    <link:label id="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_documentation_en-US" xlink:label="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:href="pcrx-20220930.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:to="lab_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_51e0b1f3-09b3-4597-b5f8-d654d287dee6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_71ec24c4-c72d-466c-8ff9-1b8dee95fc4f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1465ec6c-ed94-465c-85a5-e9091ebcccb4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e19bcb88-37d8-4d26-912d-fe1ac69e8b87_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_8dde6110-6f20-4148-a217-25e208422f6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for operating lease liabilities, net of lease incentive</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_57433972-9f5d-4068-9b0e-f8eaee0cd227_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets acquired as part of business combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7831ed2f-9a38-4e93-a54e-8ec13ee938d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments and accretion</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2bff4e1d-c9d3-4b5a-80e0-d2dc282c5273_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_51eec9f0-2769-45da-865f-9ddd16d927f6_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8034f25d-0daa-4300-8171-2979ce7ecf2e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount payable to holders of the CVRs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cf3d293b-708b-4f9d-8227-61990cc309e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5e33c2ef-e9ee-4f04-8589-569448b00c58_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c1126d4b-1eda-4908-a71b-82ab0e8eaed9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_77aa63e3-6bf2-4c3e-9f97-1ead2122cb30_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted net (loss) income&#8212;diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9105e7e7-eb92-4c7d-b3e8-304c48a70c4f_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b6b44156-8c10-4cb8-9a40-1d853b158b24_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_5a8ca8ae-254f-4bb6-bd54-6b56609b99f9_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, net of debt discount and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0dfa88fc-7bed-43a5-a662-31969c05acc8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2a544fa3-bedb-4312-8bca-a7415de886b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8af4cc97-6641-4882-ab76-a2debc91b6b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_63fab7a6-be5a-4d93-88fa-729005f45e66_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_fcb78fcb-7d03-4586-aa06-2f3133188fcf_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3c0c2f9d-ae83-4a64-af19-341fb7f6241d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_e9269edc-e6d9-416d-9951-1efdee84c72c_terseLabel_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third largest wholesaler</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the third largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember" xlink:href="pcrx-20220930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThirdLargestCustomerMember" xlink:to="lab_pcrx_ThirdLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_fb2e9638-718d-451b-8b34-5bcf9ecffdf9_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms Prior to February 3, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:to="lab_pcrx_DebtRedemptionTermsPriorToFebruary32023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_d22c759c-0dda-4952-90e5-44c19a2f99ef_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_75185cc0-f2eb-4193-b8b4-c99434dd972b_terseLabel_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three largest customers</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_label_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers [Member]</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_documentation_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember" xlink:href="pcrx-20220930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThreeLargestCustomersMember" xlink:to="lab_pcrx_ThreeLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fba0fba-4427-470e-a581-bc1693ba5b49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_acca37f2-6fb0-4ab7-a6e0-5a5a9a78da2b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1a236a6f-581b-4f07-aa06-459ff9f15f8f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_02de4ea1-50cc-49d1-9c59-0dc8820a9d82_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_0b1cfe7d-5659-4eb0-a172-eeb2ea73f52d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_5c113afb-509b-4c75-93f3-25d707ebaea2_negatedTerseLabel_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Contingent Consideration</link:label>
    <link:label id="lab_pcrx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents earnout and milestone payment made which is associated with the acquisition of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration" xlink:href="pcrx-20220930.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_PaymentOfContingentConsideration" xlink:to="lab_pcrx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_bf121008-73fe-461f-8943-74848f987753_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4a56ddba-1d61-498d-b6ed-debd0ca6827c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_363223a8-84b9-4e72-95f9-2d4ac69623ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_b0fceb21-a4bd-440a-ac64-12626172d027_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_101b9049-84aa-4ce8-b272-964c14bfd4e0_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cd20dc7d-28b2-4a0e-87ff-77eada61958a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_75cd83cf-18e5-4712-b0a5-72a5c5401777_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_34ff5178-b585-4b0f-9022-f9758d2a769b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_205cd415-83bc-4a83-a077-cd6ae9683b14_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_fbf570d4-73a1-4e0e-b81d-c16e093a3f56_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_c9241236-eeba-4347-8907-6b068f4fb857_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_9fe531ec-8e47-4061-a85e-36c50f748664_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_6208d635-a196-4609-9c07-91d4281d2677_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:to="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_65fac380-a214-4f0d-8b89-d5dfe525621e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_2f4719a3-ef41-431e-ae77-9add59ee98ae_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of percentage of revenue comprised by the three largest customers</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_117449f0-5007-4e5c-8049-0c2d7875c990_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_f4ff4810-77d6-418a-a1b5-adeac79349b2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_998f0c49-807c-465b-8913-be7e59bcc52c_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount (premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_01c6c5df-4e36-41cc-95d1-34ef5d74486c_terseLabel_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition</link:label>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_label_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_FlexionAndMyoScienceAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion And MyoScience Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:to="lab_pcrx_FlexionAndMyoScienceAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_0db78f23-3257-408c-8515-c2654ff3df2c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_cf4eb436-ee72-47c0-b306-ce8b8813bfba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9370004-0bf1-4d9d-ac47-7018f33bc1de_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_5d0c2e1f-c970-419e-bc95-2d4dab673670_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9a6d5834-862c-4fef-9818-a96710bf3e77_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4cdc5771-42fe-4c9a-8ce1-76ef53c86a02_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_df413fba-c72d-4520-97c0-dbd5db6caa2b_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, conversion premium (in shares)</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:to="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_347df6a7-114b-41cf-a7db-c327e426d7b7_terseLabel_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual net sales threshold</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:href="pcrx-20220930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_42378045-b516-422f-b245-8bf0bc8aaeb6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_76c60e53-c1fc-440b-899a-f47b17d63b41_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_54e7df52-1997-4526-ae99-b2eaf0382567_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_7ef6fddf-e5e5-44ed-91a4-6a3229b1423d_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerFourMember_68933608-4378-4776-9c2b-9aed70fb11a1_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer four</link:label>
    <link:label id="lab_pcrx_MajorCustomerFourMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Four [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerFourMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerFourMember" xlink:to="lab_pcrx_MajorCustomerFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6fd114e4-04ed-41be-85f5-2a31f9f94126_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d9f64eea-5c48-4138-a256-338bd7733fdc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b73d40d5-3fd2-4262-9c42-545501635cdc_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT AND FINANCING OBLIGATIONS</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_e8a4fa65-8195-45f9-a985-b0dcfc2e3dfa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_929fb78d-c5a2-4f7c-9bee-7e354373a3cd_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal agency bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1757e994-160f-4f11-89c4-cca24ad0945a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_8b474f36-85ab-46f5-9705-204d495c6d76_terseLabel_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_label_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Assets and Unfavorable Lease Obligation</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_documentation_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:href="pcrx-20220930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:to="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e3a6d47a-493d-4e4d-9d23-b6ad9a7b2229_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_46517b7d-1b76-424b-8aaf-c1efcded513f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid in capital, other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3ca96510-901d-49c4-9248-cbc076a0cf44_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_7072532a-2c30-4ae4-b263-1daf107cdfc0_totalLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets acquired</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_014dd5fb-c979-4c4c-89c4-c6c7af17b939_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d82438b4-b696-4230-b576-7663d838dfc8_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_872cd64f-b182-4c6c-88c9-1e0811b6dfed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5a4da37a-4edc-4009-9cd7-c97204f0a02b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c7060703-60bd-49eb-ab86-d3cd7036c16b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_386643bb-4475-4b6c-8f87-3159a5517008_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b8def7cd-854e-4c8e-9178-bc8fb9639ff7_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_4445b139-5e18-4c6c-bade-e2913a3a9fe7_terseLabel_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition</link:label>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_label_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_FlexionAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_FlexionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionAcquisitionMember" xlink:to="lab_pcrx_FlexionAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e48de3f5-6cb1-4bb8-873a-a3ab1ed729fb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_8ec4d8b7-cda7-40ee-ad83-05b5088496af_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_4d76810d-07e8-40c2-b585-07ad96d6b396_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_b2e32d7e-21f2-4ef1-a313-84f494a857dc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_30642765-a899-4f47-a3bb-18fdbe6dc558_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_2891c343-831a-4032-8ff1-a815f4b7e220_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2567420e-7f27-4207-b364-e5d99cbe9b50_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ZILRETTAMember_3426d740-3700-4471-9028-1c028fa8a664_terseLabel_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA</link:label>
    <link:label id="lab_pcrx_ZILRETTAMember_label_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA [Member]</link:label>
    <link:label id="lab_pcrx_ZILRETTAMember_documentation_en-US" xlink:label="lab_pcrx_ZILRETTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZILRETTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember" xlink:href="pcrx-20220930.xsd#pcrx_ZILRETTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ZILRETTAMember" xlink:to="lab_pcrx_ZILRETTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_1d4c2eec-83b8-4dcd-b794-365f0e51d597_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_77f9542a-0499-4bd6-aab6-bd6d378596e3_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentVariableRate" xlink:to="lab_pcrx_DebtInstrumentVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2fe086dc-be24-4969-bc3c-1350b85750dd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_193f80e6-ea58-4f24-8f6a-79be51925af8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_7a08d768-1402-4283-9e64-b84e0a7f4049_terseLabel_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd.</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_label_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_documentation_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:href="pcrx-20220930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:to="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_11bcedc0-6874-4cfe-919a-062303549f2f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9e3c341a-1249-4372-89e9-ad7c3bd9136d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_5dae4530-8413-4100-8bc5-96737c917391_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_05aff29d-e7f2-40bf-b849-f5d79c6e3ef0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b89d814f-6d27-4d9f-a1e6-51c58db78f2a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6a570d2-71da-456e-947e-097833040718_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7f23cd3e-0452-4f54-bda0-6b525c8e405a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Useful Lives</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a7e1def9-024e-47e3-aad8-c9ed136677dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ccc2d33b-0b9a-469a-b588-6d9fb2ea4b44_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_1bb38c39-3855-40ac-995e-4d9c9ace0071_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_d8a5b121-b79a-4fd7-aba1-b8ebdabf38b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of the Company's debt and financing obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_9dada5f5-7cb6-47fa-af69-d4675eb79a19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation from:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_686c9557-fbf4-4387-8689-3a1db7fc0518_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_c961c3e8-8eab-45df-9090-0ac9b79db816_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_6d7691e7-bb62-4154-873e-ebba5daf1e1d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b24883be-d159-490f-a746-a748fe49e1be_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_bd153cae-c780-45a7-b96d-08c82fd168b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_19f2c67b-01db-4a9d-a11e-b2d09a8d87fa_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of principal amount of notes</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Market Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt market price, per $1,000 principal amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentMarketPrice" xlink:to="lab_pcrx_DebtInstrumentMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d8ae59ec-81e9-4468-9818-c8192111fd46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of investments without readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_1091ccfe-ff06-4c25-8831-50349e22a191_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_e62de404-71bb-42af-863c-4c7fce155364_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread two on variable rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Two On Variable Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Two On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:to="lab_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8b32839a-5dd1-4063-bf64-ec90b82f6073_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_06983322-cf38-4f4b-bd25-89ee47bf3607_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest and other (Note 6)</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_23fb4e91-586e-4986-b790-d81b13638ae0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest and other (Note 6)</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_78a96059-7453-47e5-b2ac-84fa295b7c11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_cdeb58cf-f685-4ef8-bbec-81c5cbfe3152_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_bbd4340d-30b5-4d58-bea7-a97761ce60ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity and debt investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_19da27b9-131f-4562-b351-048b6ba7860e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_07780f6b-2ce1-4019-bdc1-fea5b569c12d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_73874079-c58e-4867-85b0-45530f1b3cd2_terseLabel_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, payment terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_label_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_documentation_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms" xlink:href="pcrx-20220930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AccountsReceivablePaymentTerms" xlink:to="lab_pcrx_AccountsReceivablePaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_9fab505a-bf54-44c3-8a9e-809500963983_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_f281dd53-035a-4f70-bef8-329b45a92e38_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information regarding the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_ba75a17d-17d4-4d3d-8557-8bd532af38bc_terseLabel_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement period - convertible debt conversion request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_label_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Period - Convertible Debt Conversion Request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_documentation_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of trading days in a settlement period for convertible debt conversion requests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:href="pcrx-20220930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:to="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_d5e21286-546d-4369-871b-580de9a01fc4_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from development and commercialization of ZILRETTA</link:label>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_label_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Development And Commercialization Of ZILRETTA</link:label>
    <link:label id="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Development And Commercialization Of ZILRETTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:to="lab_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_43761fb4-ed9e-404a-873e-1975ac60ac78_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f5e46ba7-e593-4acc-a9b5-f5089e379f27_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_83e5560d-a315-4eb8-8971-1f9b97e9ced8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_d6744e8f-231d-443f-8457-c541f09f2fe7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d281a603-211d-4791-9447-efa1f5362cb3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_IoveraMember_f4709bf9-a81e-4375-adf8-95a59f813cde_terseLabel_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176;</link:label>
    <link:label id="lab_pcrx_IoveraMember_label_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:label id="lab_pcrx_IoveraMember_documentation_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember" xlink:href="pcrx-20220930.xsd#pcrx_IoveraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_IoveraMember" xlink:to="lab_pcrx_IoveraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_f846f771-a786-4809-93b2-feb44843bf54_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ec519a78-1060-4876-8ede-d2fe5d4c8222_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_4b37d990-bae8-440b-b12e-629817f3060e_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt, amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ae27f7ba-fab9-4724-823e-ade102cff6cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share based compensation arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_241064d7-f1a1-4fb7-9d01-52353d809df2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_df96463c-c250-453b-a34f-9379a8bdee54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income before income tax, domestic and foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1e214d8b-de0c-4473-8ae4-1dcb427ac9b3_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b827a1-5eb4-415d-a94f-a6ffa173190c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9011ca79-e737-487e-8121-c8705f02cb8f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e41b11ba-9384-4c7e-b30a-84b01b2c5b67_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_63ad9ced-4656-4be5-962a-84fb42f5ff4d_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identification of the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_8c883b42-0ef0-4caf-8de4-73fb2954bf3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a732eebc-5aa5-4ff5-afe0-92001eb6a4db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_694836bb-eae8-4022-9e37-4f0f2de86539_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net (loss) income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_db6d66f6-1035-4954-8bdc-d90dbccbd5cd_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4e91d3f1-36e3-4ece-ac65-46065cf93849_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_91222a8f-09d1-4f59-beb9-3371bd3997fc_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_b33981fa-1298-49be-81a1-afabc5cd55c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_02864b87-e621-497d-a70b-548306a572c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a0c025b5-cd0f-456c-99dd-8d0e26d98405_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e887c081-7e37-4abf-86ae-a2201c75a584_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_510134e0-c600-4fd7-a90b-54175f30d9fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquisition expenses</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_ef39c6eb-da49-47f2-903d-658c7836babd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. agreement dissolution costs</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnContractTermination" xlink:to="lab_us-gaap_GainLossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f4955eb6-d911-4084-ab69-b0f6e0bc1564_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_0d7be921-8d01-44d2-b866-863140cb2d5f_terseLabel_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second largest wholesaler</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember" xlink:href="pcrx-20220930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SecondLargestCustomerMember" xlink:to="lab_pcrx_SecondLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_e6938457-aa10-4dca-88c9-488dfc2763fe_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk by major customer</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_45de4fbd-b722-4a6b-9b89-3192311afb97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_bf09de20-59ce-496b-8bbe-4874586d99ac_terseLabel_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Success of Regulatory Milestones</link:label>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_label_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Success Of Regulatory Milestones [Member]</link:label>
    <link:label id="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Success Of Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:to="lab_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_2fd66d48-bebe-41ce-b3c7-5fda5a53c209_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_6d52fcfe-60d8-42af-859e-4d788ab26662_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a28189c6-e278-4d7b-953c-6fd033199f12_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1779e805-bc9d-4f00-b142-31cb6c800758_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_2bf3eaa0-5f86-4a95-8651-9c8de96cc6a3_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_890428c6-5c1d-48b3-bdf2-d5aee0ee8034_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c9754c92-e305-43e6-8bfd-6480eff962e1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_8c9fb7d0-a33e-4934-8809-d92a18104259_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_fb84cd34-bf40-4c04-b72a-1cdb080b0506_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_42c169ff-9d36-4dd9-9b8f-e468374e9aad_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_d50d4c37-b34a-4b03-bf01-dd71bc98eed1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_1b19345c-1cb1-4524-b255-b8376e79eeb3_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer three</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Three [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerThreeMember" xlink:to="lab_pcrx_MajorCustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_344cf7e3-f0c9-4f73-baf0-01b0ffbe48dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ba220817-236a-43f8-956b-2cd64446794c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_037ea73f-6591-4958-b4a4-127cee33eb71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_997c4559-ae9d-40d4-947c-5aa3706412b0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_3234d9de-18ca-4f1c-a965-afd68295ebb0_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_1051fe1b-daf0-44f9-853f-332498e4fa1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c1af47c4-b0ad-4be4-80bd-3ed2252dafbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_38ab2f4c-d7c4-46a8-9a70-7d9b0fcd09d0_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_55dbcdc7-e8f8-492f-903c-9f6f43126b23_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, third period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_64016790-1716-4601-9d80-13366c99cb63_terseLabel_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026</link:label>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_label_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026 [Member]</link:label>
    <link:label id="lab_pcrx_TermLoanBFacilityDue2026Member_documentation_en-US" xlink:label="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Facility Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_TermLoanBFacilityDue2026Member" xlink:to="lab_pcrx_TermLoanBFacilityDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_7a91f4f4-3ace-42c0-82d3-c53c5d596747_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, second period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c06d2654-33ca-4337-8282-8e92f467c332_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8526dcef-1729-42ac-b479-197ffd7381d6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_50f675e4-8011-4415-a812-4d5156e98a57_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_7cdad495-ea3a-4086-be77-b2d71f6d0a8c_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, fourth period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e940ae4d-386c-4e78-9c09-a0bc6de79ab7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_a08ea3f7-1051-4f70-93ff-09e1c5559e00_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, first period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_8239bc21-7938-43ae-8efb-4c62313849d1_terseLabel_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_label_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfCustomers_documentation_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConcentrationRiskNumberOfCustomers" xlink:to="lab_pcrx_ConcentrationRiskNumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_fcbe0be9-18f8-4510-b5f3-af10729b975e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_98e0db9d-e16c-4254-9d98-ff7064278c43_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_030ad9cd-9fb3-429c-9b2f-7d035b1b3b81_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_6e76cbff-d5e6-4af2-bcd3-c026ab59acd8_terseLabel_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, In-The-Money Stock Options, and Common Stock</link:label>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_label_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Money Stock Options, And Common Stock [Member]</link:label>
    <link:label id="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_documentation_en-US" xlink:label="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Money Stock Options, And Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:href="pcrx-20220930.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:to="lab_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_db7b5743-66a1-4766-8e69-a897ea739a8e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate on total debt (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_e137a8e4-951d-4b70-8131-d252ff0b3658_terseLabel_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd.</link:label>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_label_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd. [Member]</link:label>
    <link:label id="lab_pcrx_HongKongPharmaTainuoLtdMember_documentation_en-US" xlink:label="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hong Kong Pharma Tainuo Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember" xlink:href="pcrx-20220930.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_HongKongPharmaTainuoLtdMember" xlink:to="lab_pcrx_HongKongPharmaTainuoLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_d95f68f2-96e8-4972-bd30-c8dde9f2f243_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated settlement fees</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c7dc8e46-526f-4b0c-a42d-ccdfd626c792_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_69f7ef39-84d0-4154-a0e3-bfc44e44da83_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of total interest expense recognized related to the Notes</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the amount of interest rate expenses related to convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:href="pcrx-20220930.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:to="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e46002eb-7ec0-4cf1-8cdc-36664ecb4916_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_651b9434-c645-4ebf-8764-b1e9d0cefc63_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_80cf53ea-2df2-4e7c-bfce-9fec1fd9f69e_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4575319f-0dd2-4e1a-98d8-4ef462781c57_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8c4bc3be-0d2c-4458-a046-e219c0e8de43_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_fe2b7d31-e20a-4e14-a38b-f4cd04e4db8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Term loan B facility maturing December 2026</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_725ec76e-c755-4b3a-a3ee-1c77a8eaa9ea_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34e7a34f-578f-4645-a68d-416a17cb266c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (Per Share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_cdf5c9f4-2a93-4a83-a1d8-59bd55cec423_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, premium on common stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Obligation Premium on Common Stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:to="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0c899260-1e73-4e43-b02f-bf3a79254b6a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ffc385-17d3-40e2-87c1-bf41a2cb3bdb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_4d43fadb-cb56-4870-8f55-87cce9e463a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_75a72260-7da3-4f88-b329-cce898ca954e_terseLabel_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency adjustments</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_label_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_documentation_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:to="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_6881e9bd-0c03-4e6d-949e-8cf42390772c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_34a91fe5-1074-42fc-83b3-862df33e7762_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_c8da86a7-0d32-4abc-ae12-c6626afae150_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5c9ffe08-26fe-4142-9b9c-39524a3d1d24_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cc02ae4a-6fcd-477f-b4d6-8e9efe74acac_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerOneMember_2e6e5ef6-c378-4288-972c-ad4e7edc3c64_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer one</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer One [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerOneMember" xlink:to="lab_pcrx_MajorCustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a3f7fc53-15c8-46f9-a8c8-c5a68826eef7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_f26460e2-7e37-47aa-ad3a-59a73e248717_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b18397d5-c157-474c-b043-084f41750949_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_5e71b67d-fac6-4dec-bcdf-c46a61bc7fdc_negatedLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related charges (gains) and other</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:to="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6103ee5d-acfd-4db7-a5b9-8595067d6b09_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6376db7c-091e-4bd4-ab30-10a041093da1_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_212158a6-85e1-415d-826a-7e656e2339f4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_f55a31b5-e2c7-406b-a57f-31805062f9f1_terseLabel_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion</link:label>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_label_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_pcrx_FlexionTherapeuticsIncMember_documentation_en-US" xlink:label="lab_pcrx_FlexionTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionTherapeuticsIncMember" xlink:to="lab_pcrx_FlexionTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2de67e8b-2f51-404c-af0a-0bf83f78a971_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1ec0701f-9204-42a9-b8d3-343dfd56f124_totalLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4845cd79-321f-42f6-bb3a-38858826e225_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_6b1bc0f0-36f7-4e26-8ef8-5e6a60ec36bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_10a0ab86-1e6a-4243-a273-51ecf4558714_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_76b9daf3-3355-49b5-9980-73b7e735d989_terseLabel_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:href="pcrx-20220930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:to="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9826404e-99f6-423c-af75-faeb4d4d2cd7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_81d4f08f-6981-4a0f-80f7-793588480109_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of investment</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9f88d53d-2c96-4e80-8000-344aeeb69516_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_39f76830-069d-47ae-b4bd-a4c863c62e94_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_d896475b-de63-41a4-ad5b-ae2c33452c1c_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_86e861b0-0fe4-4bbf-81bf-62591fad722b_terseLabel_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:href="pcrx-20220930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:to="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7e702cc5-7ea9-4836-a458-5b486b7ef35c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computation of basic and diluted net income (loss) per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1d9f35e9-74e8-464e-b632-585d370e9062_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets recorded in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_99fb9a51-aade-40b3-bc74-18b6c03f7cef_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_37cf6ce8-74b3-46c7-a1e6-21065629435b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_fe02f212-b31a-4c4f-aa01-94af30dbbb3d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Major Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_53754700-155f-47b8-a564-5a2850ba2a04_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_label_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:to="lab_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_197cd155-4730-4c86-a1d2-af36c676477f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 Retrospective [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>pcrx-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1c5d19df-1e21-4c6b-b8fd-7f41d40e2091,g:640aecaa-1b23-468f-9231-460bc1f6b9d8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CoverPage" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d21ebdc9-5188-4327-bfd0-fb15479f7e47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentType_d21ebdc9-5188-4327-bfd0-fb15479f7e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_0f70d11a-17bf-4924-a08b-90518b1d6402" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentQuarterlyReport_0f70d11a-17bf-4924-a08b-90518b1d6402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_37f04496-3dc7-4baa-a313-2f44ef8d785a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentPeriodEndDate_37f04496-3dc7-4baa-a313-2f44ef8d785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4e61df57-6f68-48d2-aa36-09d9c70ce789" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentTransitionReport_4e61df57-6f68-48d2-aa36-09d9c70ce789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7555049a-b374-4d6c-b445-4ec4da7d1a32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityFileNumber_7555049a-b374-4d6c-b445-4ec4da7d1a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2ee16cf5-797c-4047-a9a7-37942fcf60bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityRegistrantName_2ee16cf5-797c-4047-a9a7-37942fcf60bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ab3ecbda-b271-4aea-ac21-cfe8cb487b50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ab3ecbda-b271-4aea-ac21-cfe8cb487b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4797f1dd-beac-4df2-850d-246d6d13763c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityTaxIdentificationNumber_4797f1dd-beac-4df2-850d-246d6d13763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f429d2f3-150a-47d7-ba07-8a9941b6937f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityAddressAddressLine1_f429d2f3-150a-47d7-ba07-8a9941b6937f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_300fe51d-d388-4688-a938-b3a580f1b6e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityAddressCityOrTown_300fe51d-d388-4688-a938-b3a580f1b6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3621dbbb-e0a8-46b1-8e2b-9213667fe2ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityAddressStateOrProvince_3621dbbb-e0a8-46b1-8e2b-9213667fe2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7a322586-c8b4-452f-afb4-680c8aaa0511" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityAddressPostalZipCode_7a322586-c8b4-452f-afb4-680c8aaa0511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8557dde3-0af6-4d8f-b15d-2d4b25f49cc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_CityAreaCode_8557dde3-0af6-4d8f-b15d-2d4b25f49cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a86281a7-0902-4b36-a8f0-d0603d248d8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_LocalPhoneNumber_a86281a7-0902-4b36-a8f0-d0603d248d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e32189d3-ba0c-47cf-a5ab-479549b9b241" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_Security12bTitle_e32189d3-ba0c-47cf-a5ab-479549b9b241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7159b796-76a9-4bd3-ae46-3a1720865a2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_TradingSymbol_7159b796-76a9-4bd3-ae46-3a1720865a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9f5edcd7-f6a5-4111-b00b-78d24e4bf7f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_SecurityExchangeName_9f5edcd7-f6a5-4111-b00b-78d24e4bf7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0822706c-af31-473b-b0de-c2a33268e55c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityCurrentReportingStatus_0822706c-af31-473b-b0de-c2a33268e55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f7808ae2-3412-45e3-b4f5-f78db06ab434" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityInteractiveDataCurrent_f7808ae2-3412-45e3-b4f5-f78db06ab434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_fe6b2dd1-cede-42c5-80db-731886a8f1d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityFilerCategory_fe6b2dd1-cede-42c5-80db-731886a8f1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1fd2a17e-8027-4951-b0db-1067fd366521" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntitySmallBusiness_1fd2a17e-8027-4951-b0db-1067fd366521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_38c965b9-d104-4830-ad2d-34fd7debdb8c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityEmergingGrowthCompany_38c965b9-d104-4830-ad2d-34fd7debdb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_278a0587-2308-42a7-926e-8d76f8e20a01" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityShellCompany_278a0587-2308-42a7-926e-8d76f8e20a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_88a5f1cf-2129-4e83-8457-989e0dab3453" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_88a5f1cf-2129-4e83-8457-989e0dab3453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c6c76e6e-0d9a-4ae4-985b-510d5ce4a58b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_EntityCentralIndexKey_c6c76e6e-0d9a-4ae4-985b-510d5ce4a58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_db8fd98c-0ecd-4a30-9058-63db32a501b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_CurrentFiscalYearEndDate_db8fd98c-0ecd-4a30-9058-63db32a501b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_562a1bb8-555a-456f-a4fb-671b74d31348" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentFiscalYearFocus_562a1bb8-555a-456f-a4fb-671b74d31348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_bc81242b-5786-421c-8d41-274778ea08ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_bc81242b-5786-421c-8d41-274778ea08ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1660e6d3-7ff4-4a8f-bb6d-9fdab10f2da5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ebe4be1c-aac5-440f-acba-39e4451ff2f9" xlink:to="loc_dei_AmendmentFlag_1660e6d3-7ff4-4a8f-bb6d-9fdab10f2da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e12283e2-e4cc-4902-a6ec-e54be3b9ac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e12283e2-e4cc-4902-a6ec-e54be3b9ac9f" xlink:to="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34ed6308-c546-4a12-b224-cd58aa8f2230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34ed6308-c546-4a12-b224-cd58aa8f2230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e187f99d-8b5e-4c84-a308-057d557360cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_ShortTermInvestments_e187f99d-8b5e-4c84-a308-057d557360cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0abe0dfd-82dd-4900-8a96-dbaf640db7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0abe0dfd-82dd-4900-8a96-dbaf640db7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8603b99a-6e1b-4a71-85f8-3bdee5703bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_InventoryNet_8603b99a-6e1b-4a71-85f8-3bdee5703bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c51775e6-f312-40ed-8a4f-f12762e8c9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c51775e6-f312-40ed-8a4f-f12762e8c9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a30d8c70-2e7a-4bc4-a929-bb7ed4c7f7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_780e526d-df92-4407-b920-59c998f3a15b" xlink:to="loc_us-gaap_AssetsCurrent_a30d8c70-2e7a-4bc4-a929-bb7ed4c7f7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_06845560-908f-4bf9-b9fd-f39846edb6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_LongTermInvestments_06845560-908f-4bf9-b9fd-f39846edb6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d2e043a1-f956-4e44-bfdb-82cac0274a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d2e043a1-f956-4e44-bfdb-82cac0274a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c749008-d4ff-418d-a753-c8e4c419dec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c749008-d4ff-418d-a753-c8e4c419dec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0621b793-442f-472c-a781-93375a61e962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_Goodwill_0621b793-442f-472c-a781-93375a61e962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7647c22a-9dd4-4578-8701-5a37e1421615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7647c22a-9dd4-4578-8701-5a37e1421615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_1876570a-0aff-4bc7-9f33-89a6c5800fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_1876570a-0aff-4bc7-9f33-89a6c5800fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_7912ed26-a3a2-4e95-a531-8252e80902a9" xlink:href="pcrx-20220930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_7912ed26-a3a2-4e95-a531-8252e80902a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5ec27b0e-4c9e-4648-af4d-48a6785fa382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb3eabfe-d07e-45ac-a5ca-12608e0c3fed" xlink:to="loc_us-gaap_Assets_5ec27b0e-4c9e-4648-af4d-48a6785fa382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e12283e2-e4cc-4902-a6ec-e54be3b9ac9f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a34c25d3-d28d-4ce4-8d36-c5660d860761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_AccountsPayableCurrent_a34c25d3-d28d-4ce4-8d36-c5660d860761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ff6c3818-5d0d-42f4-affb-d90afa1733c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ff6c3818-5d0d-42f4-affb-d90afa1733c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_935c3c53-5d49-4df5-ab5f-3044b34de072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_935c3c53-5d49-4df5-ab5f-3044b34de072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_ad3ca54e-a8ad-43c1-ba36-7ffec4eae09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_ad3ca54e-a8ad-43c1-ba36-7ffec4eae09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_277bbea6-16f8-4702-aaaa-1f50e90becd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_SecuredDebtCurrent_277bbea6-16f8-4702-aaaa-1f50e90becd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6abcc5fd-9daf-442a-9ce6-39e53518b861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_TaxesPayableCurrent_6abcc5fd-9daf-442a-9ce6-39e53518b861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_250758f7-e903-4dcd-a335-18f1b9ee4a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d272c1bf-aef2-4811-95bd-87f205054aa2" xlink:to="loc_us-gaap_LiabilitiesCurrent_250758f7-e903-4dcd-a335-18f1b9ee4a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_fcf9eb69-d56b-4051-b255-06062fd94456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_fcf9eb69-d56b-4051-b255-06062fd94456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_5a08ae3f-535b-4047-99e4-2a2697b992a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_SecuredLongTermDebt_5a08ae3f-535b-4047-99e4-2a2697b992a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3c21ee12-ea73-418f-96e6-a517671db88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3c21ee12-ea73-418f-96e6-a517671db88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_5dca48d0-7118-4575-93b6-c8d7500a8e65" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_5dca48d0-7118-4575-93b6-c8d7500a8e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2d965d1b-7be3-4769-ad7a-92396209ef9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2d965d1b-7be3-4769-ad7a-92396209ef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_16ff72f7-9fb0-41fc-91a8-37418c2962a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_Liabilities_16ff72f7-9fb0-41fc-91a8-37418c2962a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2887e1c5-0e4c-4cf9-b3de-89b3d9066b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2887e1c5-0e4c-4cf9-b3de-89b3d9066b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e663f094-9a10-40bf-a016-efbb63fc0d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_PreferredStockValue_e663f094-9a10-40bf-a016-efbb63fc0d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_00c8a87a-5137-4776-8fc6-c514e1a46ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_CommonStockValue_00c8a87a-5137-4776-8fc6-c514e1a46ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_61fda8fb-1b9f-4221-ba56-6971f4713b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_61fda8fb-1b9f-4221-ba56-6971f4713b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_45eccecf-3266-4951-bda4-b3eff0544210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_45eccecf-3266-4951-bda4-b3eff0544210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45a30597-f06b-407c-b351-f42e860c7170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45a30597-f06b-407c-b351-f42e860c7170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68ba9634-a45e-4e0c-9055-50ff9f3b0f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cee83d58-0661-4b1b-aaca-3bd83a46dba7" xlink:to="loc_us-gaap_StockholdersEquity_68ba9634-a45e-4e0c-9055-50ff9f3b0f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7a5d7d6e-9528-437d-9b3f-7a11543b65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40ff3791-82e8-4103-8768-3a4570b56947" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7a5d7d6e-9528-437d-9b3f-7a11543b65a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_03955346-8d94-408d-b0e4-2bd8ea98ae74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_03955346-8d94-408d-b0e4-2bd8ea98ae74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4537cea9-8204-4f17-891b-1c214c7857e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4537cea9-8204-4f17-891b-1c214c7857e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6e2ededa-133d-407a-9bfa-f1c690fc9ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6e2ededa-133d-407a-9bfa-f1c690fc9ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6b35d6a3-db40-4c3a-843f-dfcdd1d267bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6b35d6a3-db40-4c3a-843f-dfcdd1d267bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b6dd1b34-3620-4218-be1a-7a7960862be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b6dd1b34-3620-4218-be1a-7a7960862be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_afc2c83f-7cac-4b4e-b3dd-d117a9607fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_afc2c83f-7cac-4b4e-b3dd-d117a9607fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_fdcc3a9f-83d5-4020-935a-4fed36e9f4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_CommonStockSharesIssued_fdcc3a9f-83d5-4020-935a-4fed36e9f4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_94491e15-41c7-4e85-a981-7f8e2fcbbeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e0c8b59f-dd16-4b70-aabc-5e2e3a412213" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_94491e15-41c7-4e85-a981-7f8e2fcbbeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fcfa5e06-7c85-4f2b-b1eb-d98522d043e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fcfa5e06-7c85-4f2b-b1eb-d98522d043e8" xlink:to="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:to="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_eacdb13c-ded4-43b7-b24d-9cfa6111c03c" xlink:to="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5fdf9232-9eb4-41c2-be77-6c4c31e4a8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_us-gaap_ProductMember_5fdf9232-9eb4-41c2-be77-6c4c31e4a8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_15ee0040-0964-4ced-8091-bd6702b4d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_us-gaap_RoyaltyMember_15ee0040-0964-4ced-8091-bd6702b4d4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_27fdb789-6c37-4889-bbd3-772279e8a379" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b5a18f5e-f2ae-4ce6-9676-e042bb77c4fc" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_27fdb789-6c37-4889-bbd3-772279e8a379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_54316ed1-254a-4bb2-9540-9cf19cdc8df8" xlink:to="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20b75d39-fe90-40e0-a88f-7b054959be1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_e139afa8-41ff-44fe-b4db-5e2edc8b688f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20b75d39-fe90-40e0-a88f-7b054959be1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_6b2dd32c-fa2e-488c-baa9-c6ef7286da90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_CostOfRevenue_6b2dd32c-fa2e-488c-baa9-c6ef7286da90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5938644d-f8cb-44ba-879f-05690561f80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5938644d-f8cb-44ba-879f-05690561f80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_86594ac2-81af-49e7-b4d6-c8d033e610b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_86594ac2-81af-49e7-b4d6-c8d033e610b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_72edaed1-87aa-45da-9a2d-d65c12c72c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_72edaed1-87aa-45da-9a2d-d65c12c72c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_24deaf06-bee0-4317-829a-56526dbd6f1d" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_24deaf06-bee0-4317-829a-56526dbd6f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3e0b2fd4-d80a-4cdd-9a4d-423c6da083af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_03b55a58-fde4-403e-9056-e08c54ee853e" xlink:to="loc_us-gaap_CostsAndExpenses_3e0b2fd4-d80a-4cdd-9a4d-423c6da083af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5afaab75-a73c-411e-bccc-e9c57a8ae4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_OperatingIncomeLoss_5afaab75-a73c-411e-bccc-e9c57a8ae4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d9f4f437-86c3-4fce-b249-cd1d2d055a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d9f4f437-86c3-4fce-b249-cd1d2d055a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_385beb3f-d2ed-466c-84c0-c9df64a61d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_InterestExpense_385beb3f-d2ed-466c-84c0-c9df64a61d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bc8236e3-482f-4f8a-ac8e-afd20f30fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bc8236e3-482f-4f8a-ac8e-afd20f30fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b5d15642-068e-4ae8-98b6-7807f94204c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_744ad266-e368-481f-811c-395a4fc75500" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b5d15642-068e-4ae8-98b6-7807f94204c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a03e8354-ad6b-433d-b5bf-d527ecd145dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a03e8354-ad6b-433d-b5bf-d527ecd145dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f48159d8-0966-49b8-8a91-0616ec43094d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f48159d8-0966-49b8-8a91-0616ec43094d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5beac764-5d74-46b9-b8cd-8f3a0ac8fe56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_NetIncomeLoss_5beac764-5d74-46b9-b8cd-8f3a0ac8fe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a8acd37b-005f-4063-96b7-c51c7793e64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:to="loc_us-gaap_EarningsPerShareBasic_a8acd37b-005f-4063-96b7-c51c7793e64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_772a3f7c-0e2a-4546-aba8-b4758620b282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38be9b7c-6ea3-4ca3-ac39-4c195ca2b7d9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_772a3f7c-0e2a-4546-aba8-b4758620b282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3df86085-0862-4e9d-8d4f-1e7aeffd1708" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44d7009a-6551-451b-a790-2ea5b60b5db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44d7009a-6551-451b-a790-2ea5b60b5db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89a95aab-2a43-4614-b17d-341705d85662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b98f6e43-fec1-481d-86b0-a62630c3f6c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89a95aab-2a43-4614-b17d-341705d85662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4b8c8900-48d7-4134-a142-3f0146d222c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7b08ebf2-e310-460f-bc90-30f0cb7dbbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4b8c8900-48d7-4134-a142-3f0146d222c3" xlink:to="loc_us-gaap_NetIncomeLoss_7b08ebf2-e310-460f-bc90-30f0cb7dbbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3ec96ccb-0d6b-4df6-8636-eb343751c19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4b8c8900-48d7-4134-a142-3f0146d222c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3ec96ccb-0d6b-4df6-8636-eb343751c19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d0d00d48-11b2-417d-b624-92f1ea64bed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3ec96ccb-0d6b-4df6-8636-eb343751c19e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d0d00d48-11b2-417d-b624-92f1ea64bed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f0a8256b-f3c9-4bbc-8823-9350aeddb6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3ec96ccb-0d6b-4df6-8636-eb343751c19e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f0a8256b-f3c9-4bbc-8823-9350aeddb6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e645560c-ba26-4ed0-8f40-c1201808cd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3ec96ccb-0d6b-4df6-8636-eb343751c19e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e645560c-ba26-4ed0-8f40-c1201808cd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_17cb872e-fe0a-49ca-9d71-63589f57e753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4b8c8900-48d7-4134-a142-3f0146d222c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_17cb872e-fe0a-49ca-9d71-63589f57e753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_89617905-6cbb-4130-9853-ac354af3165a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_89617905-6cbb-4130-9853-ac354af3165a" xlink:to="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e11e2be0-f983-4544-a3ee-4e850afd4949" xlink:to="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66960e49-1756-4935-b455-b2402adfa51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_CommonStockMember_66960e49-1756-4935-b455-b2402adfa51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9de760b3-c6cc-4898-af47-d9579e0f7577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9de760b3-c6cc-4898-af47-d9579e0f7577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4bcaa71e-6e15-4fc8-828b-0d31e4d8ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_RetainedEarningsMember_4bcaa71e-6e15-4fc8-828b-0d31e4d8ee25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_23d328a3-719f-46b0-8955-5cef7b88926a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_64decca4-1019-4ab5-a313-68cedbeba2cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_23d328a3-719f-46b0-8955-5cef7b88926a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_aa719aa8-5977-4985-bd16-78e01e401b1d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a1482bf6-243f-4495-b43c-87f6fd15ddd9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_02fd676e-c1f4-4aaf-afcd-0156730de1a9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a1482bf6-243f-4495-b43c-87f6fd15ddd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4dad78fd-9141-4e2b-9bf7-71ff9e71bba8" xlink:to="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3d4c2020-1eaa-4b34-a48b-7372cae97300" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_92d9f16c-8063-4a0f-8e5f-2f5cd3c0c504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_SharesOutstanding_92d9f16c-8063-4a0f-8e5f-2f5cd3c0c504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a2c53495-6d0c-4637-bb2a-5eea5173db07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockholdersEquity_a2c53495-6d0c-4637-bb2a-5eea5173db07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fef9fb8-5ec2-433f-a186-5bbbe4207e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fef9fb8-5ec2-433f-a186-5bbbe4207e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_38118e15-512a-4c5d-9145-aee964c0da47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_38118e15-512a-4c5d-9145-aee964c0da47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e840c5ea-47c5-46bb-808a-3c670536432a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e840c5ea-47c5-46bb-808a-3c670536432a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3229d75a-79ba-49cf-95ee-9f07524b97fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3229d75a-79ba-49cf-95ee-9f07524b97fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_34e98481-cdeb-4787-b08d-6cada68fe1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_34e98481-cdeb-4787-b08d-6cada68fe1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_606604cf-8f64-4af7-9824-3d8dde7968fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_606604cf-8f64-4af7-9824-3d8dde7968fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_555377c5-4999-4ad3-8f32-c593df390d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_555377c5-4999-4ad3-8f32-c593df390d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c2d39816-f3b8-47f8-ad07-a51e71377de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c2d39816-f3b8-47f8-ad07-a51e71377de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f13b3eb-67cd-4f7c-8def-b925a918cc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2f13b3eb-67cd-4f7c-8def-b925a918cc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a70d2cb2-8b01-40c7-b843-2f62ef3620b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a70d2cb2-8b01-40c7-b843-2f62ef3620b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a93b3460-bea5-475c-aaf3-addbabab287d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_NetIncomeLoss_a93b3460-bea5-475c-aaf3-addbabab287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ef93ca46-94d1-4bf9-97e7-b792aa824d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_SharesOutstanding_ef93ca46-94d1-4bf9-97e7-b792aa824d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a2aeeb57-209f-4d9c-ad83-f2625a9e25cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_StockholdersEquity_a2aeeb57-209f-4d9c-ad83-f2625a9e25cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_40ffe941-87d4-4120-ad24-d394436a6830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fb33531b-c437-4a73-b18d-3a67316c6795" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_40ffe941-87d4-4120-ad24-d394436a6830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ee0f8006-9305-4cb1-b7ae-0fc892f8baed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee0f8006-9305-4cb1-b7ae-0fc892f8baed" xlink:to="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_713d6ac8-279e-4fe8-bc05-1dae341d07d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_0532ea2f-80c5-4824-a6b3-8138c842a899" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_0532ea2f-80c5-4824-a6b3-8138c842a899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_95cf7239-6867-426b-88a7-5e888f1613b8" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_42e92e45-9f7c-4d3c-876b-54f115b436fd" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_95cf7239-6867-426b-88a7-5e888f1613b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5fb549f7-34c6-4a23-94ee-952f754c5fa1" xlink:to="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4654591-abd7-420b-8c16-8b5fdf2adec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_NetIncomeLoss_e4654591-abd7-420b-8c16-8b5fdf2adec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89d76513-6211-4dea-aa0f-cd124d809197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89d76513-6211-4dea-aa0f-cd124d809197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d0b29577-c11b-45c7-9251-319427dfec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d0b29577-c11b-45c7-9251-319427dfec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_cd3766bb-abe0-4163-a2be-364290f20567" xlink:href="pcrx-20220930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_cd3766bb-abe0-4163-a2be-364290f20567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_cd7d4fc9-52ba-4e46-9f6b-f2fa16b7531f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_cd7d4fc9-52ba-4e46-9f6b-f2fa16b7531f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_badadc86-d8b2-4b0a-92b6-9f05ee8ca09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_badadc86-d8b2-4b0a-92b6-9f05ee8ca09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9fe4801d-b556-4a6a-aa89-39b48bf5101c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_ShareBasedCompensation_9fe4801d-b556-4a6a-aa89-39b48bf5101c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a73193a-424b-483f-82aa-ab01755a04e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a73193a-424b-483f-82aa-ab01755a04e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_006462db-4b49-43e6-81f4-38e1cc7b2634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_AssetImpairmentCharges_006462db-4b49-43e6-81f4-38e1cc7b2634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f1e8d00b-c32d-4665-9432-9743583769cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aa7380ce-5d1f-4f2b-8a7a-7cc980ee4fa8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f1e8d00b-c32d-4665-9432-9743583769cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f39a440-1249-439e-bc39-393eb4068b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f39a440-1249-439e-bc39-393eb4068b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a7961da2-87ce-40e9-bba6-5e743ecdb807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a7961da2-87ce-40e9-bba6-5e743ecdb807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9d579089-2284-4419-893a-ef92e4b76f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9d579089-2284-4419-893a-ef92e4b76f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a2cd2114-e37a-4b8c-ba19-3ec87172a3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a2cd2114-e37a-4b8c-ba19-3ec87172a3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d7e1660-1756-48ec-8b76-ed54dfbd196c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d7e1660-1756-48ec-8b76-ed54dfbd196c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6fb7fea1-d2ea-4566-bf4b-c562945c6e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_GainLossOnInvestments_6fb7fea1-d2ea-4566-bf4b-c562945c6e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_ef757c43-3856-4e7c-8ca8-8b1c7d60db77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3909655-5443-4257-ab38-686c4759f19e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_ef757c43-3856-4e7c-8ca8-8b1c7d60db77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b60f269d-963f-461a-b6da-1a1984a9f62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3096ab30-d02f-4d87-a5c6-446fdea83683" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b60f269d-963f-461a-b6da-1a1984a9f62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_baada919-3efd-4cae-8539-a765c8f39bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_baada919-3efd-4cae-8539-a765c8f39bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_de175858-764a-4f72-876d-f5259c8730ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_de175858-764a-4f72-876d-f5259c8730ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_78eeb371-8a4d-4eef-b657-2de8e4fcafb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_78eeb371-8a4d-4eef-b657-2de8e4fcafb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PaymentOfContingentConsideration_363d3c3e-4ff3-493a-8652-7f01bf818b01" xlink:href="pcrx-20220930.xsd#pcrx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_pcrx_PaymentOfContingentConsideration_363d3c3e-4ff3-493a-8652-7f01bf818b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_a35b09cc-0468-491c-83d8-a22186ea52a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_a35b09cc-0468-491c-83d8-a22186ea52a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_de1db03d-80db-46af-9a97-fcf81b8a657a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_de1db03d-80db-46af-9a97-fcf81b8a657a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_255f14ff-6503-4c7f-a4cf-0a777e76ceaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_9764c5c1-5e60-46c7-81eb-4e71835d3a9a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_255f14ff-6503-4c7f-a4cf-0a777e76ceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_27cb8953-5434-4279-90f5-9a996604a3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_27cb8953-5434-4279-90f5-9a996604a3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4093e830-f6de-4922-bdba-7733fe2c9aca" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_4093e830-f6de-4922-bdba-7733fe2c9aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_e499402a-1568-4b7f-a26d-94862c0acdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_e499402a-1568-4b7f-a26d-94862c0acdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_92cf7e05-5d94-485a-8ad5-268805b68203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_92cf7e05-5d94-485a-8ad5-268805b68203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0cbf8d89-e507-46f4-abb7-16bd5e41a6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0cbf8d89-e507-46f4-abb7-16bd5e41a6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4d16520-0ad8-4f06-a215-1bb68eccc2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59582b96-d0d0-4f7d-998a-df906bd19ef9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4d16520-0ad8-4f06-a215-1bb68eccc2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f72c9385-943f-4c91-bd93-1a7a06360796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f72c9385-943f-4c91-bd93-1a7a06360796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9d30368-3493-4453-9aae-5785a133bcea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9d30368-3493-4453-9aae-5785a133bcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a6b7721-3497-4fbc-9633-5c53c894432c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a6b7721-3497-4fbc-9633-5c53c894432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cd4d22e8-a5a1-4303-a076-4fb9eb894f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:to="loc_us-gaap_InterestPaidNet_cd4d22e8-a5a1-4303-a076-4fb9eb894f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6bd22674-2aeb-4891-93fe-8aef5e5b8bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_9b117e22-74c0-4bb9-aa69-839cac149f13" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6bd22674-2aeb-4891-93fe-8aef5e5b8bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_933e8790-a469-4656-9437-c905dd9586a0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_c31fc94d-dbf4-440a-b653-c2abb1959952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_c31fc94d-dbf4-440a-b653-c2abb1959952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_348cbfff-75b5-41b4-b243-0dfbe3ae624b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97abb4be-6176-4c71-bade-67232bc251fd" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_348cbfff-75b5-41b4-b243-0dfbe3ae624b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3f38b157-ba18-4378-a800-0c7e3f402082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_60999de3-5a1c-46d7-888e-cbfb984f1f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3f38b157-ba18-4378-a800-0c7e3f402082" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_60999de3-5a1c-46d7-888e-cbfb984f1f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_75cdb4da-7d13-4472-a116-04fd50972501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_599a11e4-e126-471b-8134-b72f5d769f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75cdb4da-7d13-4472-a116-04fd50972501" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_599a11e4-e126-471b-8134-b72f5d769f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUE" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c70c4bc9-c819-40dc-a62a-f9aeb1a1d78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a4e5aa2c-5cd9-4c5d-8084-6d67d4e6862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c70c4bc9-c819-40dc-a62a-f9aeb1a1d78e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a4e5aa2c-5cd9-4c5d-8084-6d67d4e6862c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITION" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITION"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_af2bc133-869f-43c3-ae7b-57c1b11652e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_468cce87-b4ed-4114-b204-96d6a8e70d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_af2bc133-869f-43c3-ae7b-57c1b11652e5" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_468cce87-b4ed-4114-b204-96d6a8e70d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIES" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4e06a6d9-13d1-4cec-8b82-af255a3091f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_64c4a1fb-bd32-42fa-a289-b8ab34f305ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4e06a6d9-13d1-4cec-8b82-af255a3091f4" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_64c4a1fb-bd32-42fa-a289-b8ab34f305ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a54c0097-607c-4cdc-a43d-173769b4816d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_03410aad-06c3-4e7c-8056-608dfd72095d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a54c0097-607c-4cdc-a43d-173769b4816d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_03410aad-06c3-4e7c-8056-608dfd72095d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASES" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_70130786-8108-46b7-bb0f-d8ff00b3b374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_0b087b43-01a0-4d10-8d83-e21f84597180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70130786-8108-46b7-bb0f-d8ff00b3b374" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_0b087b43-01a0-4d10-8d83-e21f84597180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3907a153-b990-4446-891d-3522d16252fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4e517894-3269-4bf0-8ddb-d908acac8ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3907a153-b990-4446-891d-3522d16252fe" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4e517894-3269-4bf0-8ddb-d908acac8ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBT" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6297e42d-2ae3-49fd-be95-5051b197cb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_a782ea03-bc59-4476-9651-7ab7693ecd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6297e42d-2ae3-49fd-be95-5051b197cb39" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_a782ea03-bc59-4476-9651-7ab7693ecd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6aed0484-f873-486e-b026-8681af893eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_d250aa7c-22a3-4c83-96cf-31853c1ca3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6aed0484-f873-486e-b026-8681af893eab" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_d250aa7c-22a3-4c83-96cf-31853c1ca3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ff631d65-eec0-4b6b-b7cc-c7291fea42cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_481a4fd7-f1e7-4504-b00b-764afbbe7e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ff631d65-eec0-4b6b-b7cc-c7291fea42cf" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_481a4fd7-f1e7-4504-b00b-764afbbe7e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANS" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ae1d13c6-9b57-40cc-aafc-e10e681b04ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_321d0554-7fa2-46ea-9c53-899647039c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ae1d13c6-9b57-40cc-aafc-e10e681b04ab" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_321d0554-7fa2-46ea-9c53-899647039c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f1c803e6-c49e-4d00-8b42-df72bc33fdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_631e051b-451c-4c1c-9284-3313d3573734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1c803e6-c49e-4d00-8b42-df72bc33fdc2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_631e051b-451c-4c1c-9284-3313d3573734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXES" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8c3f7f18-9c16-4647-8617-2a1ea0b74f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_239a2632-bcf6-42ed-a64f-34083284182c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c3f7f18-9c16-4647-8617-2a1ea0b74f61" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_239a2632-bcf6-42ed-a64f-34083284182c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHER"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c1f6bd3-8e58-4881-8487-077e73035333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_87085b12-1dbc-4e99-bbcf-6173c09002a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6c1f6bd3-8e58-4881-8487-077e73035333" xlink:to="loc_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_87085b12-1dbc-4e99-bbcf-6173c09002a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="pcrx-20220930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_103377e5-ff50-4c56-87d4-707901c51871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fb08fee4-23bc-4b85-85f4-7f1807396533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_103377e5-ff50-4c56-87d4-707901c51871" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fb08fee4-23bc-4b85-85f4-7f1807396533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_50c37c89-b60e-4049-8c63-913657c7621d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_b6b787c4-11db-454d-a1af-ef2c60774838" xlink:href="pcrx-20220930.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50c37c89-b60e-4049-8c63-913657c7621d" xlink:to="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_b6b787c4-11db-454d-a1af-ef2c60774838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_8591ed68-b5f1-4089-8ca1-91d2b01fddf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50c37c89-b60e-4049-8c63-913657c7621d" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_8591ed68-b5f1-4089-8ca1-91d2b01fddf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4d9312f7-3648-41ed-9c06-7e97fb9b5289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50c37c89-b60e-4049-8c63-913657c7621d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4d9312f7-3648-41ed-9c06-7e97fb9b5289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4d5d90be-d070-4d63-8c52-2bb28b8078e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_92d53b5b-2d27-4d8f-aa16-629b8fab8ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d5d90be-d070-4d63-8c52-2bb28b8078e8" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_92d53b5b-2d27-4d8f-aa16-629b8fab8ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUETables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5a1cd989-2656-48ed-9475-9478c758ea6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_47c8f9fc-ce2b-4c85-a699-1c0deab12e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5a1cd989-2656-48ed-9475-9478c758ea6f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_47c8f9fc-ce2b-4c85-a699-1c0deab12e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9fda04bd-b488-45ba-89fd-3ea1a81f0822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5efb4f06-edc8-4a46-919c-d6b99cfee22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9fda04bd-b488-45ba-89fd-3ea1a81f0822" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5efb4f06-edc8-4a46-919c-d6b99cfee22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_a7f79482-f09e-4d59-bab9-725ddc93eec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9fda04bd-b488-45ba-89fd-3ea1a81f0822" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_a7f79482-f09e-4d59-bab9-725ddc93eec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_df66b8ba-564c-405d-81e9-bcfb2a01f216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0ad9651b-399e-41ad-842b-08bddf47f195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_df66b8ba-564c-405d-81e9-bcfb2a01f216" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0ad9651b-399e-41ad-842b-08bddf47f195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a6334c76-d1e6-44aa-bdb4-74906284be80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fdfed696-24d6-4d91-bd39-d370eed3e135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a6334c76-d1e6-44aa-bdb4-74906284be80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fdfed696-24d6-4d91-bd39-d370eed3e135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f3a3ef9e-20c9-43dc-bb05-1994a372ecdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_6b246822-e286-4799-88ef-65e03954da52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3a3ef9e-20c9-43dc-bb05-1994a372ecdf" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_6b246822-e286-4799-88ef-65e03954da52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_dbe6e754-3e3b-43ab-8457-9a8a988845e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3a3ef9e-20c9-43dc-bb05-1994a372ecdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_dbe6e754-3e3b-43ab-8457-9a8a988845e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_a87991d7-f39a-4f08-aff8-178d7dff3f37" xlink:href="pcrx-20220930.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3a3ef9e-20c9-43dc-bb05-1994a372ecdf" xlink:to="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_a87991d7-f39a-4f08-aff8-178d7dff3f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f59e7a6e-b101-4bc1-ad14-995c3bc31772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_8a2f33a1-a768-460d-8448-b0b2f1aeae04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f59e7a6e-b101-4bc1-ad14-995c3bc31772" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_8a2f33a1-a768-460d-8448-b0b2f1aeae04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b0ddcd61-c598-461e-aa05-fbc9c296101a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6667da15-adce-45b1-b6af-5acdfb6259fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b0ddcd61-c598-461e-aa05-fbc9c296101a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6667da15-adce-45b1-b6af-5acdfb6259fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_6b9fba8d-966d-4c08-aa3a-ebc04d819f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b0ddcd61-c598-461e-aa05-fbc9c296101a" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_6b9fba8d-966d-4c08-aa3a-ebc04d819f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_f0b5a695-271e-49e9-84ad-476a707e2d96" xlink:href="pcrx-20220930.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b0ddcd61-c598-461e-aa05-fbc9c296101a" xlink:to="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_f0b5a695-271e-49e9-84ad-476a707e2d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_56b15a11-0964-4671-b378-82fe23cd5dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_56b15a11-0964-4671-b378-82fe23cd5dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_11c4af25-4c41-4171-9082-402948b5a856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_11c4af25-4c41-4171-9082-402948b5a856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_39cf69e5-4a91-4a49-859f-7c102eb8dba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_39cf69e5-4a91-4a49-859f-7c102eb8dba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_02dc0855-0d1d-488e-96a1-737570ca2c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_02dc0855-0d1d-488e-96a1-737570ca2c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_5e19dc79-b997-418e-829e-d3262d852652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b556905c-3993-4a64-8164-074f62482f8e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_5e19dc79-b997-418e-829e-d3262d852652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a1a9c532-92e8-4942-a68c-21cdad9c7c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c3b66d8a-23e4-4897-b3d7-a652424f57ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a1a9c532-92e8-4942-a68c-21cdad9c7c78" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c3b66d8a-23e4-4897-b3d7-a652424f57ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fe5a5585-0a59-41e5-a028-66b471496fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b6ef9d74-e62f-41bc-b0e1-126f2bdaee7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fe5a5585-0a59-41e5-a028-66b471496fe4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b6ef9d74-e62f-41bc-b0e1-126f2bdaee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ba64c313-ac06-4c3a-bc26-b88786f26e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fe5a5585-0a59-41e5-a028-66b471496fe4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ba64c313-ac06-4c3a-bc26-b88786f26e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9424aef2-1357-4134-b0ca-f34745f4646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fe5a5585-0a59-41e5-a028-66b471496fe4" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9424aef2-1357-4134-b0ca-f34745f4646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_388d8c7c-3f4d-4c1c-942e-7ec9b96fcb86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ce730cc2-4832-49a9-9c81-4398c1f20973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_388d8c7c-3f4d-4c1c-942e-7ec9b96fcb86" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ce730cc2-4832-49a9-9c81-4398c1f20973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_fe151188-980e-43ca-afd4-0104f9caa809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_388d8c7c-3f4d-4c1c-942e-7ec9b96fcb86" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_fe151188-980e-43ca-afd4-0104f9caa809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_882f5242-14ce-414d-82e8-894c7672e776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d82ff92c-eb6f-4279-885c-dd28fb150004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_882f5242-14ce-414d-82e8-894c7672e776" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d82ff92c-eb6f-4279-885c-dd28fb150004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e08b0e98-ac17-473f-883f-d770679a8a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_1773b254-0737-4a40-8dd2-f12adf667292" xlink:href="pcrx-20220930.xsd#pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e08b0e98-ac17-473f-883f-d770679a8a01" xlink:to="loc_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock_1773b254-0737-4a40-8dd2-f12adf667292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9ef49172-40ec-4ab5-a74c-dc1298e84776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9ef49172-40ec-4ab5-a74c-dc1298e84776" xlink:to="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0e5598c9-fe8f-4865-94f7-b22ec88b49a6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_f4c5dd73-ebd4-45db-bb2e-d46d50bf84b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_44688351-a4cd-43e5-ba41-4ed66301c930" xlink:to="loc_us-gaap_SalesRevenueNetMember_f4c5dd73-ebd4-45db-bb2e-d46d50bf84b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a02b9fd5-abdc-4a77-8867-68be27780992" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_23a11b14-5fcb-465f-9385-2f0d04533d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_477e4dc1-1fec-4cc4-8029-f286a926fb55" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_23a11b14-5fcb-465f-9385-2f0d04533d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6cb47e8a-c2ac-4edd-873c-ce6b3b96ca4f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_ca51b347-9ed4-435a-9964-772fb138c1b6" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_ca51b347-9ed4-435a-9964-772fb138c1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bdd12bb0-bc37-4da2-b48e-ee40e9d11375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f240a59d-5ff0-41df-b452-b00eb9a1075c" xlink:to="loc_us-gaap_NumberOfReportableSegments_bdd12bb0-bc37-4da2-b48e-ee40e9d11375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_07e8479c-1a3c-45a8-83c6-c325af3f6287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07e8479c-1a3c-45a8-83c6-c325af3f6287" xlink:to="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e032be29-c3d4-4632-954c-49c13a043070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_6119e160-5bd9-4bd8-aff8-554ca338c85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6d793ae-999e-4ad8-aa31-19d430a78c1a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_6119e160-5bd9-4bd8-aff8-554ca338c85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_af3c424c-f488-4ce3-b1c2-654fb795308a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d000ca65-26b0-4b57-91b3-7f520ef7cfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cb96714-bbf4-407a-866c-73649eeb6178" xlink:to="loc_us-gaap_SalesRevenueNetMember_d000ca65-26b0-4b57-91b3-7f520ef7cfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_37b4eb8a-d933-4d76-bcf9-a335d6d4b5a7" xlink:to="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_56c8ee61-066a-441a-bb09-3dd1dcb51c92" xlink:href="pcrx-20220930.xsd#pcrx_LargestCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_LargestCustomerMember_56c8ee61-066a-441a-bb09-3dd1dcb51c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_4e2bdfb7-97ef-4b9f-8575-6a2ab7430550" xlink:href="pcrx-20220930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_SecondLargestCustomerMember_4e2bdfb7-97ef-4b9f-8575-6a2ab7430550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_e91360f6-7291-4bbe-84de-33ba56ce39c7" xlink:href="pcrx-20220930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_ThirdLargestCustomerMember_e91360f6-7291-4bbe-84de-33ba56ce39c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_2e31fa55-0d58-4248-bb63-3fc406018c32" xlink:href="pcrx-20220930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_69d9981d-b407-4e36-b9de-5e95ee319f7a" xlink:to="loc_pcrx_ThreeLargestCustomersMember_2e31fa55-0d58-4248-bb63-3fc406018c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_71a5da81-81ad-42f0-aa03-b3af785fb417" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfCustomers_38a4d688-9a2e-46f5-8eee-41624da97715" xlink:href="pcrx-20220930.xsd#pcrx_ConcentrationRiskNumberOfCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:to="loc_pcrx_ConcentrationRiskNumberOfCustomers_38a4d688-9a2e-46f5-8eee-41624da97715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_36d943ad-6e63-4e4c-bf68-9285b87d74a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_32355c79-62d0-46b7-bcde-8e7a0fdd86ea" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_36d943ad-6e63-4e4c-bf68-9285b87d74a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6946459a-bdde-4d77-995a-a7ec9d8a4abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6946459a-bdde-4d77-995a-a7ec9d8a4abb" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_814b32a7-2d4d-4f60-ae4d-5bd8ffc79422" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_29c2c404-52e7-4230-aa05-ea49c8767927" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c31268f3-b4a1-4c58-9c10-2051ab73d430" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_29c2c404-52e7-4230-aa05-ea49c8767927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9bec4144-53c7-4ded-b778-c8f011813325" xlink:to="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0f47fd28-2a81-4812-80a3-c523e09e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:to="loc_us-gaap_RetainedEarningsMember_0f47fd28-2a81-4812-80a3-c523e09e2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5ea36f07-7f74-498d-ac83-632891348221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9295474c-9d93-4fb7-a201-d44704d6e0d3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5ea36f07-7f74-498d-ac83-632891348221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d7727766-a007-400b-a53f-89e74b30fd3b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c1368621-de2a-4492-964b-52e17b14346e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_LongTermDebt_c1368621-de2a-4492-964b-52e17b14346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a0cf249c-69fa-476e-b03d-f55e43a8f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_StockholdersEquity_a0cf249c-69fa-476e-b03d-f55e43a8f3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_638e5407-3415-45a4-a2bc-bb0e756e76b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_46d54332-660c-4074-983a-ec66973ac9dc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_638e5407-3415-45a4-a2bc-bb0e756e76b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e68bfc9-0d35-4a41-990f-076678be524e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e68bfc9-0d35-4a41-990f-076678be524e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:to="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c634d4e0-a8d4-4f89-8615-97259c2dc313" xlink:to="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25aa7fb9-ac72-459f-8032-44b294b4de92" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:to="loc_srt_MinimumMember_25aa7fb9-ac72-459f-8032-44b294b4de92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5be45341-96c0-442e-b615-b812ff707e8e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cbfdd51a-1a90-461d-aebf-cb16572f20de" xlink:to="loc_srt_MaximumMember_5be45341-96c0-442e-b615-b812ff707e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8b4ad17c-85f5-445b-b4d9-6e34df1310e3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_643487a6-4141-455b-b6a0-a73e867292a6" xlink:href="pcrx-20220930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0043f5df-dec4-4d30-af33-64fef423d260" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_643487a6-4141-455b-b6a0-a73e867292a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#REVENUEScheduleofDisaggregatedRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a5b9338c-7936-452a-a3fb-6f78dfdd0d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a5b9338c-7936-452a-a3fb-6f78dfdd0d2e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:to="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4b582c3e-0104-488e-8c27-0b36e0d6cee7" xlink:to="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_9f34918f-7af3-4cca-8bce-b42498ee3184" xlink:href="pcrx-20220930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_9f34918f-7af3-4cca-8bce-b42498ee3184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ZILRETTAMember_afc11824-73ca-4d53-a179-04305322a875" xlink:href="pcrx-20220930.xsd#pcrx_ZILRETTAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_ZILRETTAMember_afc11824-73ca-4d53-a179-04305322a875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_9f6dca69-bee6-4649-94fb-bb2ed61f03c1" xlink:href="pcrx-20220930.xsd#pcrx_IoveraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_IoveraMember_9f6dca69-bee6-4649-94fb-bb2ed61f03c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a146b6e1-90c4-4a15-99c5-ee6821f276d8" xlink:href="pcrx-20220930.xsd#pcrx_BupivacaineLiposomeInjectableSuspensionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_pcrx_BupivacaineLiposomeInjectableSuspensionMember_a146b6e1-90c4-4a15-99c5-ee6821f276d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_32920de7-a66f-4795-93e8-8a07a1329f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e374f46-8402-4749-9429-f89e722b89bb" xlink:to="loc_us-gaap_ProductMember_32920de7-a66f-4795-93e8-8a07a1329f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac38b1fe-6395-41ae-b983-68ff296c4b2d" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7155b007-d17a-4141-b991-00f521839c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc0165d-51c9-4c01-b752-8701fe6617de" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7155b007-d17a-4141-b991-00f521839c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ef5b43f-142f-41af-87b4-1df6e4fe9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ef5b43f-142f-41af-87b4-1df6e4fe9f1b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11588a33-2c72-4756-8db6-e9a0ac3b1173" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_f131c6f4-0ef0-486a-becc-12de505ba01a" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_78040cbb-2b1d-4c67-a8ca-43240a61bb25" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_f131c6f4-0ef0-486a-becc-12de505ba01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4d845c78-5057-41f9-ac46-3a1e764bc30e" xlink:to="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_a103336f-771c-4797-bd81-30c1d8901236" xlink:href="pcrx-20220930.xsd#pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_21f9018d-837c-40fc-a5bb-c14106e815f7" xlink:to="loc_pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember_a103336f-771c-4797-bd81-30c1d8901236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ab2eb2aa-627b-4562-bfbd-dbfed1c75dd2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0cb59b4d-c1f1-430f-8394-f94f324a3cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0cb59b4d-c1f1-430f-8394-f94f324a3cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd164e77-6875-4bd0-828c-e8b2d1e4e0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd164e77-6875-4bd0-828c-e8b2d1e4e0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_9da09fc9-1be5-4816-a71a-84556413a8e8" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt_9da09fc9-1be5-4816-a71a-84556413a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_82a26660-1073-4173-952d-a214cf0dd5c1" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration_82a26660-1073-4173-952d-a214cf0dd5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_746bd66c-bb19-4a9c-ae97-dc71b794ad7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c3a13433-9e53-45cd-80ee-126ef15fd0a6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_746bd66c-bb19-4a9c-ae97-dc71b794ad7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d9ba7f98-036e-4e35-9d61-93c5344f0a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d9ba7f98-036e-4e35-9d61-93c5344f0a2e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_287157a4-6c42-4a87-b49e-25b6758fdc6a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_94213e65-f6d7-4455-ac98-416ac53ed1d0" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1f06621-319f-411e-98c1-7dbf9a1488e8" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_94213e65-f6d7-4455-ac98-416ac53ed1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f256b5e-f136-4ab7-ba23-f177cbd4f83c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a69ca027-c422-4795-ae72-5112e1799716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a69ca027-c422-4795-ae72-5112e1799716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_31fd06f9-8f5d-4ef7-8f47-73d019243ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_31fd06f9-8f5d-4ef7-8f47-73d019243ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_39d3c6ef-0ad0-4ee6-96b8-a44d217ba164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_39d3c6ef-0ad0-4ee6-96b8-a44d217ba164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_89d475a8-a81f-4539-b390-578166745fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_89d475a8-a81f-4539-b390-578166745fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_14e0290b-4acd-45ff-97c6-845f3be0e91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_14e0290b-4acd-45ff-97c6-845f3be0e91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_343fff01-e76c-4e6e-8944-cd0b53f57c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_343fff01-e76c-4e6e-8944-cd0b53f57c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d03e9602-6718-4377-b501-1473d44d881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_d03e9602-6718-4377-b501-1473d44d881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_bdf96c99-37e3-45f2-9e75-c11e5bdc04f7" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_bdf96c99-37e3-45f2-9e75-c11e5bdc04f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_890b7c08-fdf9-4304-89e0-479dbfd535dd" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_890b7c08-fdf9-4304-89e0-479dbfd535dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0dbd24be-6f33-4929-8810-d1505be68424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0dbd24be-6f33-4929-8810-d1505be68424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cc38bbe6-91fe-4b42-a419-21e2dda7ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cc38bbe6-91fe-4b42-a419-21e2dda7ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7bb2b47c-8d5a-4631-ab05-f75626fca2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7bb2b47c-8d5a-4631-ab05-f75626fca2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_e0f2b891-a775-483d-8462-db98935fc8c7" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_ff24c70d-cedf-480d-8552-7c513e2fe2cc" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_e0f2b891-a775-483d-8462-db98935fc8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_baea198f-a7e0-48e0-8a34-d679744008a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_69e9f0e7-8aef-4ee0-b8e6-313f66b9b6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_69e9f0e7-8aef-4ee0-b8e6-313f66b9b6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_112a21ae-759c-4827-8922-ebcb20533d6c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_112a21ae-759c-4827-8922-ebcb20533d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_5a0f5334-66e1-4f39-b921-1bff151eb02c" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses_5a0f5334-66e1-4f39-b921-1bff151eb02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3dd929e8-34ef-4941-b2f2-96bcdde2a5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_3dd929e8-34ef-4941-b2f2-96bcdde2a5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_7559d2db-6c4c-42f9-9edf-8e1d1ace93c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_7559d2db-6c4c-42f9-9edf-8e1d1ace93c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_4ffb84f6-d806-41c6-bc86-bfecf9c5d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_4ffb84f6-d806-41c6-bc86-bfecf9c5d880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6e7507c6-894b-4d36-9f57-f1353e582f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6e7507c6-894b-4d36-9f57-f1353e582f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_843e23e6-7562-4f6a-adaa-6c20034320e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_843e23e6-7562-4f6a-adaa-6c20034320e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_109bb9c4-a749-4465-86c1-9385548497e3" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities_109bb9c4-a749-4465-86c1-9385548497e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b10df527-124f-4262-a867-544aef5cf6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b10df527-124f-4262-a867-544aef5cf6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_db4ad5e9-c8a9-44c7-a8e8-d19c93a00995" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets_db4ad5e9-c8a9-44c7-a8e8-d19c93a00995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fb5c88d1-a952-4b7a-8325-d5beca16e069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_Goodwill_fb5c88d1-a952-4b7a-8325-d5beca16e069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1f8c6d31-eb66-474b-9bfe-8b0d912055ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_1f8c6d31-eb66-474b-9bfe-8b0d912055ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d50436cf-ecf3-453f-a23e-b76d8739fe80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d50436cf-ecf3-453f-a23e-b76d8739fe80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_a29b9a83-9e6a-4c05-9c3b-fd656e1ba59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9d621226-c5c3-4843-96a4-05a624e50d23" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_a29b9a83-9e6a-4c05-9c3b-fd656e1ba59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FLEXIONACQUISITIONScheduleofProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d06973f-9302-44e3-a4ca-cb5e885f5fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6d06973f-9302-44e3-a4ca-cb5e885f5fbd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ffd45766-1bfa-4bb8-8ec5-73fd437918ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_f18bcfde-ccea-4113-b18a-0aa606441824" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dffc1ae5-a8ff-4a9c-b38f-e04330c472d5" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_f18bcfde-ccea-4113-b18a-0aa606441824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_659af1dc-bfbd-4a03-b919-c42761f8a843" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a3253de3-0c75-4bc9-8d3a-c9b6c1c3cd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a3253de3-0c75-4bc9-8d3a-c9b6c1c3cd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75a462f9-0fd0-4d36-81f4-4fa0d456c8de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_75a462f9-0fd0-4d36-81f4-4fa0d456c8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b641b9f-f0d6-44cf-9fe4-a847a3b981a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b641b9f-f0d6-44cf-9fe4-a847a3b981a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_ecdd5cb1-423c-4d35-a3c4-6e1d33f51414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47bb4c96-f3e0-4533-a6b9-6130b6d4c095" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_ecdd5cb1-423c-4d35-a3c4-6e1d33f51414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2b6c84c9-a072-42d8-b4cb-8c3ee68b7400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_04afd79c-fcb7-4ae9-8f7f-d5f16fad5013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2b6c84c9-a072-42d8-b4cb-8c3ee68b7400" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_04afd79c-fcb7-4ae9-8f7f-d5f16fad5013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0529e907-8538-432b-a72b-87466adea01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2b6c84c9-a072-42d8-b4cb-8c3ee68b7400" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0529e907-8538-432b-a72b-87466adea01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cde2b6bf-dc44-46f7-8e93-954859399419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2b6c84c9-a072-42d8-b4cb-8c3ee68b7400" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cde2b6bf-dc44-46f7-8e93-954859399419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f87437b2-9877-4558-b61c-ec4f2276f559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2b6c84c9-a072-42d8-b4cb-8c3ee68b7400" xlink:to="loc_us-gaap_InventoryNet_f87437b2-9877-4558-b61c-ec4f2276f559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSSummaryofMajorCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cb8beeb3-c17c-4e19-8dc3-fe87466cc7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cb8beeb3-c17c-4e19-8dc3-fe87466cc7b4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3140f5a2-744b-48cc-8bdd-06f9b36357e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a25cbdef-9136-420c-b3b2-3711bba1809a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a25cbdef-9136-420c-b3b2-3711bba1809a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_28f9b212-fe87-4d81-b9f3-af839450ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_28f9b212-fe87-4d81-b9f3-af839450ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_a43c6479-c76a-4cde-a2d0-eb635c3724c2" xlink:href="pcrx-20220930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_a43c6479-c76a-4cde-a2d0-eb635c3724c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0f7b35a6-7662-4758-95f3-c70849df5444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0f7b35a6-7662-4758-95f3-c70849df5444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cf416231-076f-4fa5-a945-000e76c4805d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c73e7938-5d58-4ba2-b366-a3460a4d3e68" xlink:to="loc_us-gaap_ConstructionInProgressMember_cf416231-076f-4fa5-a945-000e76c4805d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea44aea4-f8fd-4a84-af04-ac4d95996b86" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9d90aebc-dac6-4741-a84f-a3194a8e0559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9d90aebc-dac6-4741-a84f-a3194a8e0559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ce669e-270c-4849-9425-01f58f0a78bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ce669e-270c-4849-9425-01f58f0a78bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bcb6a049-249e-44f4-932a-1b63664b21b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_087e78f0-4006-4932-aa0d-8bf84f8705fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bcb6a049-249e-44f4-932a-1b63664b21b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FIXEDASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_207abed7-9145-461d-a810-a0a1f8771b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_207abed7-9145-461d-a810-a0a1f8771b1d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c5b7cdf-25a1-48f5-8e27-0dc114b47e5d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_312bf808-1e28-4432-b226-e31ca6bda3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:to="loc_us-gaap_ConstructionInProgressMember_312bf808-1e28-4432-b226-e31ca6bda3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_978cf778-e456-413f-a070-e6fa5c0dd12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afea242a-ab8a-4be6-bd97-6650ae67c64c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_978cf778-e456-413f-a070-e6fa5c0dd12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:to="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e3f3496e-efb3-4cd9-801c-e9397ff6be72" xlink:to="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_07f13088-d48e-48d1-aa2a-a9c98719bc78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d44ee082-ec56-435c-bb6c-401b6b45b3e8" xlink:to="loc_srt_EuropeMember_07f13088-d48e-48d1-aa2a-a9c98719bc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_720f2fad-3178-4bf8-aa69-c93ea446bad8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f769ec07-1c87-46ed-b5fc-803f4a0e817e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_Depreciation_f769ec07-1c87-46ed-b5fc-803f4a0e817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_c228dc53-569d-4c98-bf90-b79cf13101a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_InterestCostsCapitalized_c228dc53-569d-4c98-bf90-b79cf13101a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_93154c9a-93fd-40db-829f-e548a3d234cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_93154c9a-93fd-40db-829f-e548a3d234cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_2c675a74-ddbc-4d93-abaf-a1c34f6baed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a8baff51-ee48-47c7-a446-36c406b880b5" xlink:to="loc_us-gaap_AssetRetirementObligation_2c675a74-ddbc-4d93-abaf-a1c34f6baed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7037f078-4d05-4ffb-b831-4a43a6152d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7037f078-4d05-4ffb-b831-4a43a6152d81" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:to="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_492f3bdb-1df2-4c0d-8b00-ce74e68f6a22" xlink:to="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f701a7df-c304-4027-a9f5-0eed0d576480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c94b35a-0401-4db6-82ff-288a94c9fb02" xlink:to="loc_srt_MaximumMember_f701a7df-c304-4027-a9f5-0eed0d576480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79f73bc1-d3d3-46ff-8266-b7741a58ec27" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_22ad1a6b-c13f-4634-bf66-e317e97a8b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_22ad1a6b-c13f-4634-bf66-e317e97a8b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfLeases_f63b2902-4386-440d-9112-4943fc431f9b" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_pcrx_NumberOfLeases_f63b2902-4386-440d-9112-4943fc431f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fbd688d7-cc1a-4918-8e78-bc29f6cc9ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fbd688d7-cc1a-4918-8e78-bc29f6cc9ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_f18e7e32-8bf9-4492-a549-83f8993a65d3" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f956fa53-06c2-49f1-a7cb-b1d1cc8367f3" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_f18e7e32-8bf9-4492-a549-83f8993a65d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6d9636e1-8964-4401-97d7-8a5bb7c4a882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6d9636e1-8964-4401-97d7-8a5bb7c4a882" xlink:to="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5933bd80-6268-42fd-a4c1-4878511c2372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:to="loc_us-gaap_OperatingLeaseCost_5933bd80-6268-42fd-a4c1-4878511c2372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_9b359ab5-c888-4e3c-8fb0-9707e02decaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:to="loc_us-gaap_VariableLeaseCost_9b359ab5-c888-4e3c-8fb0-9707e02decaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_49777e72-ffc3-477d-b83f-e48fc6338e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:to="loc_us-gaap_SubleaseIncome_49777e72-ffc3-477d-b83f-e48fc6338e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_960eaa6b-af09-4588-9074-b3d8e099a666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_481559b1-2557-4063-a39c-4eb7d7997c4e" xlink:to="loc_us-gaap_LeaseCost_960eaa6b-af09-4588-9074-b3d8e099a666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c243476a-1e59-4f9f-a8a8-53902af9aba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6d9636e1-8964-4401-97d7-8a5bb7c4a882" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c243476a-1e59-4f9f-a8a8-53902af9aba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_fb3ffd7c-5964-424e-a4bd-28f31362eb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c243476a-1e59-4f9f-a8a8-53902af9aba7" xlink:to="loc_us-gaap_OperatingLeasePayments_fb3ffd7c-5964-424e-a4bd-28f31362eb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f277f3eb-b27f-4f68-be4f-ce917079a9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c243476a-1e59-4f9f-a8a8-53902af9aba7" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f277f3eb-b27f-4f68-be4f-ce917079a9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d19d8eab-3abd-410b-bc50-18bb8f2ffbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6d9636e1-8964-4401-97d7-8a5bb7c4a882" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d19d8eab-3abd-410b-bc50-18bb8f2ffbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_57dabae5-b1ab-4f1e-bf0b-9fc07d5f06ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6d9636e1-8964-4401-97d7-8a5bb7c4a882" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_57dabae5-b1ab-4f1e-bf0b-9fc07d5f06ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_351bf624-6cfc-498b-9bc1-dae0b6b6d628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_351bf624-6cfc-498b-9bc1-dae0b6b6d628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_48bb5d0a-01d4-4ade-bb9d-0e1d81748fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_48bb5d0a-01d4-4ade-bb9d-0e1d81748fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d4c06ac0-7660-4077-9954-d62cec6e670c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d4c06ac0-7660-4077-9954-d62cec6e670c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0eaa9d6d-045c-4cef-8b4e-3b4cefa00391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0eaa9d6d-045c-4cef-8b4e-3b4cefa00391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d96796be-e778-4ed4-965b-c0bbf5100a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d96796be-e778-4ed4-965b-c0bbf5100a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6e4546ad-a41d-4660-a37e-db9c666cd542" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6e4546ad-a41d-4660-a37e-db9c666cd542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd68f02a-3dd5-4cc4-a348-738b9a2e20fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd68f02a-3dd5-4cc4-a348-738b9a2e20fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aed327ab-95fd-4679-8d2c-96d4eb10bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aed327ab-95fd-4679-8d2c-96d4eb10bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f9c77d3e-3562-4a2a-a303-239751de893c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28fa0610-599c-4aec-80ce-a31e9d62068a" xlink:to="loc_us-gaap_OperatingLeaseLiability_f9c77d3e-3562-4a2a-a303-239751de893c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_721ee280-7eb2-4c4c-898b-6bd17d71dd21" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_721ee280-7eb2-4c4c-898b-6bd17d71dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_86ad7f7e-2684-4f9a-8d0e-cc675e088acf" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_86ad7f7e-2684-4f9a-8d0e-cc675e088acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_d1b1f19f-e88a-4793-8ebf-189f4b86df84" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_d1b1f19f-e88a-4793-8ebf-189f4b86df84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_a1979d86-fd70-423d-a688-5e7d472bef7a" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_a1979d86-fd70-423d-a688-5e7d472bef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_bd4bd49e-fa17-41ec-9a13-bc599536088c" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_bd4bd49e-fa17-41ec-9a13-bc599536088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_acebf69f-e4ee-4806-8760-0f433ccd0081" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_acebf69f-e4ee-4806-8760-0f433ccd0081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cfed7c83-340c-4322-883e-52cfd40eca07" xlink:href="pcrx-20220930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e4c99af-badb-42bb-9fd0-bf4e93aca9fc" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cfed7c83-340c-4322-883e-52cfd40eca07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ec9329e5-9cd3-413c-bd72-5cd461ed907b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ec9329e5-9cd3-413c-bd72-5cd461ed907b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:href="pcrx-20220930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:href="pcrx-20220930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_634a37c6-f0ef-4a3c-8224-422fb61228e0" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_7c9d94b8-017b-4867-a143-a56a51b68feb" xlink:href="pcrx-20220930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_03170a42-0785-4c52-bc9f-4be4072e2b50" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_7c9d94b8-017b-4867-a143-a56a51b68feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7545a29c-e502-43a3-b3b1-9097168d7124" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_7988475e-396c-4fd3-82c9-9414494eda25" xlink:href="pcrx-20220930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31880cff-222a-466c-94f6-e658fc452f8c" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_7988475e-396c-4fd3-82c9-9414494eda25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d5dccf2c-5f6e-44bc-91d6-d1032d594c54" xlink:to="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5503ad20-3247-4520-8b5a-5efa328b79b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_Goodwill_5503ad20-3247-4520-8b5a-5efa328b79b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_77ea99ba-0a05-4708-a978-733575a11ea0" xlink:href="pcrx-20220930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_77ea99ba-0a05-4708-a978-733575a11ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_77b0c698-2ffc-4b21-9a8a-ea5992cd9c40" xlink:href="pcrx-20220930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_77b0c698-2ffc-4b21-9a8a-ea5992cd9c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a1f2fa06-3968-4bfc-8124-56fed2f8be7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a1f2fa06-3968-4bfc-8124-56fed2f8be7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3f6cf294-02d6-4b27-a715-874a54b9aa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3f6cf294-02d6-4b27-a715-874a54b9aa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d313b451-407d-49c4-86aa-5bab621035c3" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_d313b451-407d-49c4-86aa-5bab621035c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_642143cf-6b6c-4add-84ba-06d1a3575c9b" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_642143cf-6b6c-4add-84ba-06d1a3575c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_0be08b87-46dd-49aa-9b62-ccdc7bc01781" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3_0be08b87-46dd-49aa-9b62-ccdc7bc01781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_db3102b3-008c-478e-9875-2e1a0636f549" xlink:href="pcrx-20220930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1852e1ed-0201-4ce5-b38d-043b3114e96d" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4_db3102b3-008c-478e-9875-2e1a0636f549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcb96e25-5333-4074-b300-b9f6dc48de5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcb96e25-5333-4074-b300-b9f6dc48de5b" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0f83baee-5350-4461-b62d-235b4ada9e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_340c97e9-7b94-47bb-bc58-08990a3e1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_340c97e9-7b94-47bb-bc58-08990a3e1e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_717db851-3add-4584-9877-1388a44f4b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_717db851-3add-4584-9877-1388a44f4b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_598eb1dc-08a7-446c-af5e-bbb4da1941dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_58d043bb-d9ae-470e-b249-ee87d7094bec" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_598eb1dc-08a7-446c-af5e-bbb4da1941dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1bb969e0-35d1-4fc3-97df-4bf794992dad" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eed05fff-dc91-4bd6-b87e-c878431b6df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eed05fff-dc91-4bd6-b87e-c878431b6df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9b380db7-25c2-4b40-8a72-c74b51964cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9b380db7-25c2-4b40-8a72-c74b51964cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861aa2-a232-489a-b87f-39509bf48307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d6861aa2-a232-489a-b87f-39509bf48307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c5b2f6cf-2ad9-4922-b774-db9aaf8f2115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c5b2f6cf-2ad9-4922-b774-db9aaf8f2115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80cd189b-9031-48af-94c7-4ca705317e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80cd189b-9031-48af-94c7-4ca705317e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0095a02-f4f0-4256-b412-6c73fb090009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0095a02-f4f0-4256-b412-6c73fb090009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29024124-50e9-4cf1-98a8-796b5be4da3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29024124-50e9-4cf1-98a8-796b5be4da3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66b2353c-ef41-4513-bde1-eaa6f0ada95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_f1926d02-4ef8-45ab-9f6b-4cb9de0dccd4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66b2353c-ef41-4513-bde1-eaa6f0ada95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTCarryingValueofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTCarryingValueofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dc8782d8-0745-469f-8dec-e67dd76d7073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dc8782d8-0745-469f-8dec-e67dd76d7073" xlink:to="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:to="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_83dd7a6e-619e-44ed-b307-e690f0b32c13" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_1ecf0d83-5ece-4fe9-9ced-13ab2721b2fa" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_1ecf0d83-5ece-4fe9-9ced-13ab2721b2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8055bbf4-6173-4a58-bb34-62e9e622529b" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8055bbf4-6173-4a58-bb34-62e9e622529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_aaf12adb-9ccd-4703-9032-3be530985420" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_aaf12adb-9ccd-4703-9032-3be530985420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_e8b8865a-e8c4-4c56-b164-75b4f8143679" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b7adeb5-3c1f-479f-b33c-36480a3df650" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_e8b8865a-e8c4-4c56-b164-75b4f8143679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_09b0301d-ae2d-47b5-8ae6-8af6ec4716a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_88f1aa57-e50f-4bdb-9688-456fa83bc077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:to="loc_us-gaap_SecuredDebtMember_88f1aa57-e50f-4bdb-9688-456fa83bc077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_52ddce6f-4dfc-4365-96fb-64f581131795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d493831e-7c57-40c4-a3a4-18194d0b793d" xlink:to="loc_us-gaap_UnsecuredDebtMember_52ddce6f-4dfc-4365-96fb-64f581131795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_90ab0586-3c0d-43d2-84c0-186bb019de3b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ed36707a-5c3e-4086-a879-25e999619a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:to="loc_us-gaap_LongTermDebt_ed36707a-5c3e-4086-a879-25e999619a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b83a1f8-f838-4e7d-b192-17de8734c18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_92efdeb6-80fc-4af0-a94d-6ed3cdd3fdad" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b83a1f8-f838-4e7d-b192-17de8734c18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1fe44fe6-41f4-451a-8217-1b1677f5ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1fe44fe6-41f4-451a-8217-1b1677f5ac9e" xlink:to="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd4f0c1c-8162-47d3-b05b-3ff759b736e1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_243e2306-d852-4b90-94ce-daeea1b6e952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:to="loc_us-gaap_SecuredDebtMember_243e2306-d852-4b90-94ce-daeea1b6e952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_27a8cc9e-2d48-4f05-a702-91d1c6c0fa04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6b0b7b50-92b7-479b-9ba6-33af10f2a1eb" xlink:to="loc_us-gaap_UnsecuredDebtMember_27a8cc9e-2d48-4f05-a702-91d1c6c0fa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8253e303-112c-4b7c-b2ab-881748ac5dc9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_299f9227-cb3a-495a-8eea-84fad34698b1" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_299f9227-cb3a-495a-8eea-84fad34698b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_9a7fe566-ab33-46f3-8c76-3f940870a454" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_9a7fe566-ab33-46f3-8c76-3f940870a454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3bd5f16e-ed99-41c8-a291-cd8f052e6ba5" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_3bd5f16e-ed99-41c8-a291-cd8f052e6ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_30c55544-1860-4526-8d43-b50b6247b635" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_30c55544-1860-4526-8d43-b50b6247b635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_4f423ea7-9a84-4802-85c6-c51072e0b8e2" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDueMay2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8d9ea008-2b7d-4a87-8386-23cf7e147f06" xlink:to="loc_pcrx_ConvertibleSeniorNotesDueMay2024Member_4f423ea7-9a84-4802-85c6-c51072e0b8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_16f9f2b0-2d00-4192-aead-bf8742dee97c" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_69b4fb19-b746-402f-8f30-69eeb6f04e1f" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsPriorToFebruary32023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:to="loc_pcrx_DebtRedemptionTermsPriorToFebruary32023Member_69b4fb19-b746-402f-8f30-69eeb6f04e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_b36d38f4-dca7-4a1f-af1c-093f8006a457" xlink:href="pcrx-20220930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_b10e8faf-2fd2-4b17-817d-d159596340a9" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_b36d38f4-dca7-4a1f-af1c-093f8006a457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_3c331813-e2b8-4385-834f-f14811ec465f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_7630a19e-4a54-407f-a0e3-3a2b34f0d513" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_85093d73-44b4-45b2-96fb-089ada929485" xlink:to="loc_srt_ScenarioForecastMember_7630a19e-4a54-407f-a0e3-3a2b34f0d513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fb12dceb-3ef3-4ef8-b0de-10aa034453b6" xlink:to="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_9e9615c6-490c-4285-8d1c-b3c26be11079" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_15ddd6a4-7a12-40a6-9b4d-ce39b289bf6f" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_9e9615c6-490c-4285-8d1c-b3c26be11079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8e10b2ff-07a9-41ec-a5f7-f0f352b152ad" xlink:to="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_523c16a0-a1a5-4407-bd46-31aca42dc779" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bb29c89a-06b2-4bc4-a87a-76f25488fac1" xlink:to="loc_srt_MinimumMember_523c16a0-a1a5-4407-bd46-31aca42dc779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e967d2d5-f0c2-4235-a99f-f410a7446439" xlink:to="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6cc5343c-1572-4484-a03e-4ae120c023a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_6cc5343c-1572-4484-a03e-4ae120c023a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_44627667-36f4-48d8-8423-c2ca10954d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_us-gaap_BaseRateMember_44627667-36f4-48d8-8423-c2ca10954d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FederalReserveBankOfNYRateMember_f336e865-ccd9-4a49-bf6b-d4233c27319a" xlink:href="pcrx-20220930.xsd#pcrx_FederalReserveBankOfNYRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1c7fbe56-e3f1-4833-8e59-48ac42fdbd36" xlink:to="loc_pcrx_FederalReserveBankOfNYRateMember_f336e865-ccd9-4a49-bf6b-d4233c27319a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0fe4c912-16b6-43a0-aa7b-186e9968592f" xlink:to="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_57b341a6-a126-48a5-9d1c-3bb11c019b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3b5cd108-91be-4967-b2be-dbd0a3b3e48e" xlink:to="loc_us-gaap_CommonStockMember_57b341a6-a126-48a5-9d1c-3bb11c019b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ab5bcaa-eafa-406e-ba0c-f05e72af0e45" xlink:to="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentDiscountRate_01f364d2-82f6-4c2d-80d5-90749891ef41" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentDiscountRate_01f364d2-82f6-4c2d-80d5-90749891ef41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9a0f54db-59ec-4155-b967-e8a94b9fe6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9a0f54db-59ec-4155-b967-e8a94b9fe6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_402b228c-5920-407b-b579-1dfa87df918e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_402b228c-5920-407b-b579-1dfa87df918e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_abfcd1a5-534c-4d70-be3c-9bca74ffcba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_abfcd1a5-534c-4d70-be3c-9bca74ffcba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2dcc6202-5285-4078-9a31-4bd172f743f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2dcc6202-5285-4078-9a31-4bd172f743f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_9629e6c4-e351-4587-9494-0436bf299e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_9629e6c4-e351-4587-9494-0436bf299e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_4f387deb-0489-4598-aef8-93183d3e39c4" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear_4f387deb-0489-4598-aef8-93183d3e39c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_bc01488c-7c45-494b-8e02-bf2773dceba2" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1_bc01488c-7c45-494b-8e02-bf2773dceba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_e974c985-5c25-4236-a17b-50794d3b7035" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2_e974c985-5c25-4236-a17b-50794d3b7035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_d9f40953-5699-46db-82df-9014bdc8e2da" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter_d9f40953-5699-46db-82df-9014bdc8e2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_6e3d13af-c13b-4c72-a8af-0722d9592ebb" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximum_6e3d13af-c13b-4c72-a8af-0722d9592ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_ea699bf7-a337-4c38-aa8b-421a54a70ac6" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue_ea699bf7-a337-4c38-aa8b-421a54a70ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentVariableRate_c4ffe987-5899-460a-83b1-a7a1ccb72167" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentVariableRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentVariableRate_c4ffe987-5899-460a-83b1-a7a1ccb72167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5bdb396b-d3b6-4e10-97f1-ad7c686b2d5f" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate_5bdb396b-d3b6-4e10-97f1-ad7c686b2d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_990a5f9e-667d-4c69-b323-616ebcfcc621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_990a5f9e-667d-4c69-b323-616ebcfcc621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_517a9700-ab6a-46ae-9956-d2e5824e80b3" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentBasisSpreadOneOnVariableRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate_517a9700-ab6a-46ae-9956-d2e5824e80b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c341df3b-3b63-431b-a463-52037f9f446e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c341df3b-3b63-431b-a463-52037f9f446e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c8dd947-83e2-4078-abeb-cb408e92e1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c8dd947-83e2-4078-abeb-cb408e92e1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3725e643-a18f-4f7e-bc20-4cb2bd5f2ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3725e643-a18f-4f7e-bc20-4cb2bd5f2ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_610c450f-1e6f-4302-8a29-f771a6988c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_610c450f-1e6f-4302-8a29-f771a6988c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c28e2856-d276-4eb2-86d6-cea120012760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_RepaymentsOfDebt_c28e2856-d276-4eb2-86d6-cea120012760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1af22507-80c4-4769-86df-45b4c71112df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_1af22507-80c4-4769-86df-45b4c71112df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4bfb0e6e-ef57-49be-84fd-32ba98e10e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4bfb0e6e-ef57-49be-84fd-32ba98e10e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3bc4014c-20c3-4408-bb24-7f9373827b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_3bc4014c-20c3-4408-bb24-7f9373827b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_c599416e-a0bb-403b-8dfc-e38b69d321ad" xlink:href="pcrx-20220930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_c599416e-a0bb-403b-8dfc-e38b69d321ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b47005e9-af0b-499e-92fa-0a9d60b9221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_b47005e9-af0b-499e-92fa-0a9d60b9221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ef227095-0fe3-47e5-a3b9-6322644b5d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ef227095-0fe3-47e5-a3b9-6322644b5d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_ef8cc080-1775-41d3-a290-1f8609df3bd6" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_ef8cc080-1775-41d3-a290-1f8609df3bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_d4c5e2bb-e187-4021-9e93-a1ab209fb2e0" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_d4c5e2bb-e187-4021-9e93-a1ab209fb2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_cf0b557f-15dc-4fdf-96ad-5ff0221231c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_SharePrice_cf0b557f-15dc-4fdf-96ad-5ff0221231c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_dd41b501-bfb1-48c6-9423-a6d5481279d0" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_dd41b501-bfb1-48c6-9423-a6d5481279d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_0c25f3d5-ea6d-4596-9ddf-970c7effbc53" xlink:href="pcrx-20220930.xsd#pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount_0c25f3d5-ea6d-4596-9ddf-970c7effbc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_6d88a081-b9bd-47f6-b789-43bd5105d98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_6d88a081-b9bd-47f6-b789-43bd5105d98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4e2ec0b2-eb57-4ed9-bf1a-e5a1bb2ba980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_LongTermDebt_4e2ec0b2-eb57-4ed9-bf1a-e5a1bb2ba980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_83e97267-c73d-46bb-bd0c-83d1598f5099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_83e97267-c73d-46bb-bd0c-83d1598f5099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_2069fa28-c929-4486-bf69-6ae78c60634a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_2069fa28-c929-4486-bf69-6ae78c60634a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_341fda8c-319e-4296-8560-932b4ef6c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_341fda8c-319e-4296-8560-932b4ef6c63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c5def754-9321-4c8f-9d1e-00534a610bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_224096db-6e45-4e1a-af63-d32b0a6b2700" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c5def754-9321-4c8f-9d1e-00534a610bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0944448f-4993-482e-80e8-216cbc8e8fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0944448f-4993-482e-80e8-216cbc8e8fce" xlink:to="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_94c4f551-692f-4dbd-8fa9-09f9594f1222" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e88afe72-53f7-431f-84e0-23606a64f25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:to="loc_us-gaap_SecuredDebtMember_e88afe72-53f7-431f-84e0-23606a64f25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_fa6f6878-e4a4-43b9-b433-59bed3966b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e76ecd8a-cd04-43d3-a227-b2555320d956" xlink:to="loc_us-gaap_UnsecuredDebtMember_fa6f6878-e4a4-43b9-b433-59bed3966b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6e79aa7-05a8-42f8-a2ef-f2c36dd88409" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_8bf2a745-6f7c-4ab2-ab6b-4081b23ebdf4" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_8bf2a745-6f7c-4ab2-ab6b-4081b23ebdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8ec5217e-5475-4f01-a4df-fe9b01afb568" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8ec5217e-5475-4f01-a4df-fe9b01afb568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_cc96f6ff-e9e1-44aa-9614-d1c6d886d491" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_336f7b04-30dd-46ff-ada0-368cafc3ea6a" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_cc96f6ff-e9e1-44aa-9614-d1c6d886d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2c06285d-e77c-4c21-9c12-3e3ee9c2f8b0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c19ca16-67be-44e8-a4e3-0218503bf272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c19ca16-67be-44e8-a4e3-0218503bf272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e2399298-5b04-43d3-a4cf-e5d2b965abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e2399298-5b04-43d3-a4cf-e5d2b965abbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f9dd7767-4d33-454b-9e7f-d1874bb598e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f9dd7767-4d33-454b-9e7f-d1874bb598e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5bd03111-6944-4d3d-a394-790cc5605ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5bd03111-6944-4d3d-a394-790cc5605ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_004f5688-6d51-4b1e-aaf7-018841385b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f00020c8-bd11-44ed-81e5-d00431f7ef68" xlink:to="loc_us-gaap_LongTermDebt_004f5688-6d51-4b1e-aaf7-018841385b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#DEBTScheduleofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d8afc9ad-e66f-46b0-b6d4-6e7318319ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d8afc9ad-e66f-46b0-b6d4-6e7318319ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_86b62601-ffa9-4258-8dc8-25fee5e3869c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_86b62601-ffa9-4258-8dc8-25fee5e3869c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_75e0d16a-cc60-4130-ad32-ac8df498fdac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_75e0d16a-cc60-4130-ad32-ac8df498fdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4a285e42-b12f-4ff3-8c3d-84b73998691b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_InterestCostsCapitalized_4a285e42-b12f-4ff3-8c3d-84b73998691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_55f9d41c-cfb0-4cc6-87d9-8fcf16dc4017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_InterestExpenseDebt_55f9d41c-cfb0-4cc6-87d9-8fcf16dc4017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_facafff8-8299-49a1-931f-32698e05ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93ebb531-fddf-40f2-9b44-5c6c5fc2b255" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_facafff8-8299-49a1-931f-32698e05ec10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fb4d25a2-b11b-4152-87fc-df71c5532a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fb4d25a2-b11b-4152-87fc-df71c5532a1a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4773d62d-eb3e-4fb2-a9f1-34cd397961a0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_8bce753b-5bf3-408a-aaf5-1862d8f580c5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_84805b4d-3437-4ada-b007-df89d0ec4e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_84805b4d-3437-4ada-b007-df89d0ec4e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_700104b2-dbb0-471d-b4a9-74aac3297349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_709c668c-00ed-4ba3-9d13-0768a4ee1758" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_700104b2-dbb0-471d-b4a9-74aac3297349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0b2f0e64-5d35-4f9d-9936-5ee3796a50b8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9bc1a444-d532-48a8-8169-18be61f86187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9bc1a444-d532-48a8-8169-18be61f86187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8effdeec-ce5e-4f0f-bc4b-613066b04c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8effdeec-ce5e-4f0f-bc4b-613066b04c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_75397cd2-9a03-4e49-9e60-184e8e483976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3125bbc-30d6-4758-9880-e326bf01d759" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_75397cd2-9a03-4e49-9e60-184e8e483976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_030cd867-9f9e-408b-96c2-414c8b70cab8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TermLoanBFacilityDue2026Member_9dad1ed5-930a-4579-b154-d96510547077" xlink:href="pcrx-20220930.xsd#pcrx_TermLoanBFacilityDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_TermLoanBFacilityDue2026Member_9dad1ed5-930a-4579-b154-d96510547077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_a7cfb44d-db3f-4fe6-8fcb-e7c3d49a3e93" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_a7cfb44d-db3f-4fe6-8fcb-e7c3d49a3e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2024Member_1fc727d1-4263-414d-b996-c8a226a91bd2" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleSeniorNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9c787216-916c-44c4-a07d-8072fdceeb85" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2024Member_1fc727d1-4263-414d-b996-c8a226a91bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbe54963-deb0-4188-baaa-710f9a299062" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0792ed48-d4bd-4c2e-990f-b4dd77ac0f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:to="loc_us-gaap_SecuredDebtMember_0792ed48-d4bd-4c2e-990f-b4dd77ac0f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_0327b1d9-defa-4995-a292-6398b2282d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2f18bd6-c09a-491d-9370-b4de4ff9df21" xlink:to="loc_us-gaap_UnsecuredDebtMember_0327b1d9-defa-4995-a292-6398b2282d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0d8ae462-f1a7-436d-969e-6d95b07cd165" xlink:to="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8ac0e156-c00b-40b6-8d83-3aa72e254735" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_beb7502e-eb70-4ec0-ad9a-4ae1c6c242bf" xlink:to="loc_srt_MaximumMember_8ac0e156-c00b-40b6-8d83-3aa72e254735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a7f5a839-6bd9-49f5-a2ca-023b2568cfb9" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_433377fe-48d5-4d28-b024-7caa5aeac310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_433377fe-48d5-4d28-b024-7caa5aeac310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_97ece78e-f366-4749-9859-6a0435748089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_9fe0fbd5-0cb0-4a26-9c89-58a306532892" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_97ece78e-f366-4749-9859-6a0435748089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_df5b98f1-bb53-472c-b6b2-1ab87fdf4325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_f5405d55-1abb-4ad5-aaa8-bd2cbf0ebcaf" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_df5b98f1-bb53-472c-b6b2-1ab87fdf4325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a60c0056-a040-4b73-8d7b-624f2ee5303c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a60c0056-a040-4b73-8d7b-624f2ee5303c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_29de3d4a-1fcc-428d-b620-6ad1f3044a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentFairValue_29de3d4a-1fcc-428d-b620-6ad1f3044a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8a54532e-524b-40c3-9026-f1fa4e647853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_SharePrice_8a54532e-524b-40c3-9026-f1fa4e647853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_51e7043a-3cf6-4f19-83fe-5e9f44e76366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_51e7043a-3cf6-4f19-83fe-5e9f44e76366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_2f4011b0-c488-4be5-b809-af64e1675a1f" xlink:href="pcrx-20220930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_15b8a398-6b04-4bb8-bcd7-e23419448c01" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_2f4011b0-c488-4be5-b809-af64e1675a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b7a1a9f5-7c27-43e8-b27d-423f9c071119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b7a1a9f5-7c27-43e8-b27d-423f9c071119" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_da6beaef-6c17-4caf-8390-3af06e9340e9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ba69c8df-f416-4bca-85ac-4325b3c6579c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:to="loc_us-gaap_EquitySecuritiesMember_ba69c8df-f416-4bca-85ac-4325b3c6579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleNotesReceivableMember_f3e3298f-5a2e-48e1-8c2d-a08eb70403b5" xlink:href="pcrx-20220930.xsd#pcrx_ConvertibleNotesReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_77dc7217-26b8-4b31-8f98-0fca2728da8f" xlink:to="loc_pcrx_ConvertibleNotesReceivableMember_f3e3298f-5a2e-48e1-8c2d-a08eb70403b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_98dd6117-86c9-4861-b012-7e2cd24455cb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5a5b7f99-0315-4f1e-aec4-a4703241b5d5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_740ee3e3-f17b-457c-a484-e9216f2ef900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_740ee3e3-f17b-457c-a484-e9216f2ef900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_e33f9e4d-6d2e-4f78-9935-983310956159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_e33f9e4d-6d2e-4f78-9935-983310956159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_848f5a58-c766-4e73-a62f-e4a791403534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_848f5a58-c766-4e73-a62f-e4a791403534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_ce38ef61-16ae-4751-b8fd-e5fe6443136c" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_ce38ef61-16ae-4751-b8fd-e5fe6443136c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_6b8004a4-3893-4ee2-aad9-f3db56e4af79" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss_6b8004a4-3893-4ee2-aad9-f3db56e4af79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_859c86b6-62cc-465c-b83d-aeb3ea8a2dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c4be4acf-789c-450d-ab49-c0a7c41528fd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_859c86b6-62cc-465c-b83d-aeb3ea8a2dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_86e0d751-879d-48f8-8705-6001dab1afab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86e0d751-879d-48f8-8705-6001dab1afab" xlink:to="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b60cefa7-0bd5-40de-9623-62fa1a1a755e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAndMyoScienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:to="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_3b6bf089-8b40-4a92-9ec1-580b59cc4ce4" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:to="loc_pcrx_FlexionAcquisitionMember_3b6bf089-8b40-4a92-9ec1-580b59cc4ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_af082403-bfa6-43aa-882a-ef1dd6c04d06" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_FlexionAndMyoScienceAcquisitionMember_0ee5bd19-a01e-48e4-b1bd-a6fa0dfd7efe" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_af082403-bfa6-43aa-882a-ef1dd6c04d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_4a7b785d-43c8-44c8-8b3f-33c26685b489" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886985b9-0f1a-40d9-9b11-7bd3616c2abf" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_4a7b785d-43c8-44c8-8b3f-33c26685b489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b43c0ee-d29b-40f8-b3a2-314e59d73409" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_1c43cfd5-6282-40c6-a753-73d44bcaa8d4" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9597d32e-e7a8-4872-b642-dcd0387ae98d" xlink:to="loc_pcrx_ContingentConsiderationMember_1c43cfd5-6282-40c6-a753-73d44bcaa8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81e64660-5a4b-4236-ab0a-ec67a6dbd1d7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_f70d809c-0569-4c2a-8060-f0d968d23e01" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_463b471d-6715-44ec-bed7-663654fc818f" xlink:to="loc_pcrx_ContingentConsiderationMember_f70d809c-0569-4c2a-8060-f0d968d23e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_049a1a55-3855-4ee3-8c37-acc0969d37fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1b39672d-2534-483d-b921-b4387c2a84b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_70bbcf6f-4058-4a04-baff-f7b014bb6bb8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1b39672d-2534-483d-b921-b4387c2a84b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_77976b2c-c83b-4814-9241-10021b7b03aa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_89cab4ae-a33d-434a-88a2-1bafd70b0c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_89cab4ae-a33d-434a-88a2-1bafd70b0c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_cdc663d9-97d7-4717-be85-d98a824a5075" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember_cdc663d9-97d7-4717-be85-d98a824a5075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_069deea0-02b5-4454-b460-602a2050df2e" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a60f15b3-bed9-4ea0-a97a-57c17f48f19c" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_069deea0-02b5-4454-b460-602a2050df2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6c2bc36b-6753-4615-9b49-a7b42bc94d89" xlink:to="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d2777ccc-bb33-45bb-840f-6c7d29340a99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_03861c55-7d13-4431-8ada-5fd4f112ca73" xlink:to="loc_srt_WeightedAverageMember_d2777ccc-bb33-45bb-840f-6c7d29340a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b6648349-fe76-4652-9fa0-23f11c1465e2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_0fc2333f-1a04-4767-b000-73f25186fbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_62892665-ebf7-4b48-b113-299c394fa5c2" xlink:to="loc_us-gaap_AccountsReceivableMember_0fc2333f-1a04-4767-b000-73f25186fbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b7f849fe-149c-4364-8e4c-cd6d43602afc" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_514a6b53-1038-4068-a703-1fd7f5942c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f2589be4-4a80-413f-9cf0-5a2ca07be054" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_514a6b53-1038-4068-a703-1fd7f5942c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_726785e9-fdef-4ef8-85db-3340f513ef24" xlink:to="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_d5ec6bf0-f965-4976-8929-cda0c9980c8a" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerOneMember_d5ec6bf0-f965-4976-8929-cda0c9980c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_3e7f5e1f-eb9a-4474-bfef-fe7d505612d3" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerTwoMember_3e7f5e1f-eb9a-4474-bfef-fe7d505612d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_830cc24e-5965-47bc-8fa5-1144a8213c5a" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerThreeMember_830cc24e-5965-47bc-8fa5-1144a8213c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerFourMember_cd4134e0-d8cb-4c7b-81e6-a70dde9b1966" xlink:href="pcrx-20220930.xsd#pcrx_MajorCustomerFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_651f6aec-9ada-4593-bc1a-964fd6c18860" xlink:to="loc_pcrx_MajorCustomerFourMember_cd4134e0-d8cb-4c7b-81e6-a70dde9b1966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9dc4c4e0-1690-4d03-ae6d-1150b6d660da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember_b1ba6f98-ab33-4b1f-b778-b130d19b7be9" xlink:href="pcrx-20220930.xsd#pcrx_TELABioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6338ea50-f8c9-4d27-ab2b-1ab781ada9e5" xlink:to="loc_pcrx_TELABioMember_b1ba6f98-ab33-4b1f-b778-b130d19b7be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6ec893ff-f478-485f-b194-c573c55ce78c" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_aaeba590-d132-4591-9c7d-e931c91ad4ad" xlink:href="pcrx-20220930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments_aaeba590-d132-4591-9c7d-e931c91ad4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_2b849009-3742-4141-b5fa-4cc4ed04245e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_2b849009-3742-4141-b5fa-4cc4ed04245e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_20eeea29-2dd5-4b3e-b319-35960735d637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_20eeea29-2dd5-4b3e-b319-35960735d637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_844d6800-cce8-4e8f-b6f0-2ecc3f94d754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_844d6800-cce8-4e8f-b6f0-2ecc3f94d754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_542a3101-b673-44d0-bda5-7c742dfa60c6" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_542a3101-b673-44d0-bda5-7c742dfa60c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_715210dd-067d-46d4-a8df-3d4b6abdf2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_715210dd-067d-46d4-a8df-3d4b6abdf2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_094aa23a-e92e-4373-848d-72e14956f321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_094aa23a-e92e-4373-848d-72e14956f321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_b6e791e0-9945-4e89-bca0-7288f557e801" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsideration_b6e791e0-9945-4e89-bca0-7288f557e801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_2f2009ba-1b90-4448-a470-c75654506db1" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_ContingentConsiderationCurrent_2f2009ba-1b90-4448-a470-c75654506db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_4dc07b75-9c4c-48ce-9e32-37b5b7ba88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_InterestReceivable_4dc07b75-9c4c-48ce-9e32-37b5b7ba88f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NumberOfMajorCustomers_f08cbcc7-a277-4a3e-a804-37ab1d500d50" xlink:href="pcrx-20220930.xsd#pcrx_NumberOfMajorCustomers"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_pcrx_NumberOfMajorCustomers_f08cbcc7-a277-4a3e-a804-37ab1d500d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0e75bd31-496d-43c5-8c5a-316b4fbe32bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0e75bd31-496d-43c5-8c5a-316b4fbe32bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_87ff19fd-acf2-417c-ad07-f7bbdb4614b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9b49dd7c-2e72-4c42-a4e0-363e05e12818" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_87ff19fd-acf2-417c-ad07-f7bbdb4614b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1d8b44fe-fcd2-43da-ac77-af4fb34c00f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1d8b44fe-fcd2-43da-ac77-af4fb34c00f3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3d962cb-0087-4e69-be56-72c8eb24d335" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_325162a4-4dbc-4772-9951-ae13c101f654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f73ab0f-6068-48f4-8c02-af4b91f4d121" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_325162a4-4dbc-4772-9951-ae13c101f654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a904ced9-814a-49a9-b967-9a40af10027a" xlink:to="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1f2c951-f260-49d7-ac4d-c2e21649c2f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:to="loc_srt_MinimumMember_b1f2c951-f260-49d7-ac4d-c2e21649c2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e68d77b-79a1-4d41-bbe8-8a18bce68ed4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5cfaef13-fc70-447e-ba7a-894cb3e4832f" xlink:to="loc_srt_MaximumMember_9e68d77b-79a1-4d41-bbe8-8a18bce68ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9726cc8-f14f-4ef1-ab04-45b6f72112ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_1743e412-2cf8-4cc1-a8e1-92ad1bcda609" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:to="loc_pcrx_FlexionAcquisitionMember_1743e412-2cf8-4cc1-a8e1-92ad1bcda609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_71da25b5-53a1-44f7-b532-2d94e6038e87" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3555e03-3edb-4f31-81b9-fceaf04f2633" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_71da25b5-53a1-44f7-b532-2d94e6038e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50dd7218-abdc-4f92-a06e-a7e08f33d37d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_cd9a2734-e678-49eb-802c-ddbcfcb6ef24" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_80606865-41ad-4c50-b02a-08035ee29454" xlink:to="loc_pcrx_ContingentConsiderationMember_cd9a2734-e678-49eb-802c-ddbcfcb6ef24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_6dc604c9-11c3-49c3-beec-c8e95a15d8d6" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_92e01283-6750-439a-a679-d4158a217b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_92e01283-6750-439a-a679-d4158a217b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_e5051ec6-c963-4eec-bee6-73f702372142" xlink:href="pcrx-20220930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3b9a1a78-0087-4587-bbe8-7ff131afcd1f" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_e5051ec6-c963-4eec-bee6-73f702372142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2f9fac09-905f-4a51-b40d-456963a22f32" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a5ee4375-e6b4-4a12-8b88-bc49458cfaff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_36f8546f-d30c-48d7-be28-62beaab58b26" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a5ee4375-e6b4-4a12-8b88-bc49458cfaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cd18291c-91c5-4162-b8a3-e7ce6ad1b625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cd18291c-91c5-4162-b8a3-e7ce6ad1b625" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_625b8b37-d4fc-4e04-87bc-1ba4a3cf9a16" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_8000602b-4a64-4579-877c-8d4338b14085" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5bb1dbee-2ba2-4534-8935-edce01901659" xlink:to="loc_pcrx_ContingentConsiderationMember_8000602b-4a64-4579-877c-8d4338b14085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a9f702c6-359f-4522-b9dd-22b3abcd0b11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_0d12ec05-f01f-4fd4-aebb-be2fb0a95b5b" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_0d12ec05-f01f-4fd4-aebb-be2fb0a95b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_84c25df2-6304-4c2e-ab01-fc27896ab007" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12fa2182-cbb2-453b-af81-e0b910fa9f47" xlink:to="loc_pcrx_FlexionAcquisitionMember_84c25df2-6304-4c2e-ab01-fc27896ab007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c2809f56-27f3-4be7-84f0-24490aadc86c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ca223685-86a9-4879-b1e4-3b0b953acb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ca223685-86a9-4879-b1e4-3b0b953acb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_dea3088d-fcc8-43c7-ba48-970d166edce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_dea3088d-fcc8-43c7-ba48-970d166edce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ec519dc4-2d85-448c-a389-306ecadc0bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_895abaa1-df6a-44bc-918c-6b53c2521883" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ec519dc4-2d85-448c-a389-306ecadc0bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_68b3e163-0cf2-450c-b454-a07259218341" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_pcrx_ContingentConsideration_68b3e163-0cf2-450c-b454-a07259218341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_1fa0f64d-0725-4b5a-9a4c-0550da9b7f67" xlink:href="pcrx-20220930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_588a567d-8527-4da8-b399-82b1951104f8" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_1fa0f64d-0725-4b5a-9a4c-0550da9b7f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d7009690-4ffa-498c-8d0b-730c5bbdb7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d7009690-4ffa-498c-8d0b-730c5bbdb7b9" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a074fbb2-84ac-4fa7-ae18-950a4cfcb785" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_90fb6c87-08b3-4909-a4eb-9d8c3f33c8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_90fb6c87-08b3-4909-a4eb-9d8c3f33c8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_64398be9-128e-4c12-af12-e197016ab03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_CommercialPaperMember_64398be9-128e-4c12-af12-e197016ab03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_30182b49-380d-4321-97ea-422ac81d6e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_30182b49-380d-4321-97ea-422ac81d6e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_04f466eb-9ae3-4186-b54d-63e39fae96e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_04f466eb-9ae3-4186-b54d-63e39fae96e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_9cd19ba0-820a-4395-a571-d52b0c36685f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5a1a6bc9-4453-4392-aba7-5af9c1b33c27" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_9cd19ba0-820a-4395-a571-d52b0c36685f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentSecondaryCategorizationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:to="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsBySecondaryCategorizationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentSecondaryCategorizationAxis_82d0572d-9336-4137-9dd6-6b04094e1477" xlink:to="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_630287ff-8968-40a3-90d7-a66e5cfa7665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_630287ff-8968-40a3-90d7-a66e5cfa7665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember_ffb1817c-3160-468c-8263-ef446358bf78" xlink:href="pcrx-20220930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsBySecondaryCategorizationDomain_b9df2194-34f6-447c-a33a-28b72d3b939a" xlink:to="loc_pcrx_LongTermInvestmentsMember_ffb1817c-3160-468c-8263-ef446358bf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_04dc5e46-3cab-4ca1-a71e-4600114f3c2d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8784f4cb-ea20-4140-84fd-4d9c0aae6cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8784f4cb-ea20-4140-84fd-4d9c0aae6cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e89580b2-092e-4db6-aed7-8955336cde43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e89580b2-092e-4db6-aed7-8955336cde43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1ecb9425-49bb-4413-a304-c279b8075f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1ecb9425-49bb-4413-a304-c279b8075f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4dd4a921-2bd4-4a71-94d9-e8532bc37e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c3e82335-4452-46ae-81ca-e77a46ea3ce3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4dd4a921-2bd4-4a71-94d9-e8532bc37e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_080aede5-6b8a-4fdc-929a-9d27e6ebf1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_080aede5-6b8a-4fdc-929a-9d27e6ebf1e3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05887bba-a8e7-4b51-98df-fdfc71673caa" xlink:to="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_27027696-0179-4bc6-9770-17154e32bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_27027696-0179-4bc6-9770-17154e32bd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b42a58a-53d3-4a1c-996f-548f08a5f309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b42a58a-53d3-4a1c-996f-548f08a5f309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_39cc9ec7-9398-4f8f-a4b9-65b69ce75c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ed749625-84bd-498f-978f-71a1da27cb32" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_39cc9ec7-9398-4f8f-a4b9-65b69ce75c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d4f6e929-bf89-4c2b-894e-d5255c14b0d9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0eda7d5c-aab3-4f7b-9ffe-4b56f59bef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_StockholdersEquity_0eda7d5c-aab3-4f7b-9ffe-4b56f59bef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bab2ee40-5073-42c3-aa8c-765bbd85c774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bab2ee40-5073-42c3-aa8c-765bbd85c774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c3c3ac8-e41c-454f-b75e-6a12dd44aa76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c3c3ac8-e41c-454f-b75e-6a12dd44aa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_09055654-99d1-43ce-bc35-e661a211adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_33f7ec53-456b-4b36-a3fd-2751a437fcf9" xlink:to="loc_us-gaap_StockholdersEquity_09055654-99d1-43ce-bc35-e661a211adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b8bebb12-7396-44b8-90cb-19c2130d3f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_dd4f9381-34c7-4eff-b529-ce09aa437c4e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b8bebb12-7396-44b8-90cb-19c2130d3f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4e84fcf5-0354-4e2f-ac9a-6829d6ed1527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e84fcf5-0354-4e2f-ac9a-6829d6ed1527" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56cf565a-f2ed-4b8c-8faa-c4738f3065c9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_33bc6f4a-6275-4d20-a823-81a17495e37e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_CostOfSalesMember_33bc6f4a-6275-4d20-a823-81a17495e37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0a31cae4-802c-4833-b0e0-50641454f306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0a31cae4-802c-4833-b0e0-50641454f306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_adc5ac9b-9e92-4424-ba6b-abe095a4728d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3733ed10-dfcf-4bf9-8579-3ec80ed09e7e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_adc5ac9b-9e92-4424-ba6b-abe095a4728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_270924b2-1888-42e8-bdb2-9a2af0cac89c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2700b915-c524-4d7d-93a6-bb1c419c4ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2700b915-c524-4d7d-93a6-bb1c419c4ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4516ab62-aab1-454a-909a-d63ee8f0aaa6" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_8540f693-a005-4f7a-99cb-f5723fde2d93" xlink:href="pcrx-20220930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_8540f693-a005-4f7a-99cb-f5723fde2d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_538dba40-6925-44b4-922e-76ccc80a7517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_us-gaap_RestrictedStockExpense_538dba40-6925-44b4-922e-76ccc80a7517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_0117c204-37c4-42b5-b945-593bf12ce619" xlink:href="pcrx-20220930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_0117c204-37c4-42b5-b945-593bf12ce619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9a1b54a7-6429-43db-a08c-bfaa273d7450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_76424f07-d947-4cd3-85a7-26cdd2b21251" xlink:to="loc_us-gaap_ShareBasedCompensation_9a1b54a7-6429-43db-a08c-bfaa273d7450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_22c1d6b5-ccd2-4d45-b15e-1092ace0b3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_22c1d6b5-ccd2-4d45-b15e-1092ace0b3a5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:to="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_994c14bb-21a9-4f8b-8bc3-dc846c24b0b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a637ad4c-040f-4548-b819-d7a7da6c7c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8211a3fe-7872-4336-be09-d5bd60a39420" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a637ad4c-040f-4548-b819-d7a7da6c7c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e02ee39-1ac4-495d-8139-08002a6a489e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f538b90c-249d-450c-a3d0-ff51cc831700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f538b90c-249d-450c-a3d0-ff51cc831700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e9b7a689-b054-41e8-9be6-5ec04757879a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e9b7a689-b054-41e8-9be6-5ec04757879a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0de3fd85-e412-4dfa-97e3-ceb21d28de69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0de3fd85-e412-4dfa-97e3-ceb21d28de69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cde08a3-18a4-443b-815e-530bd4003b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5cde08a3-18a4-443b-815e-530bd4003b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86857074-c478-4536-92da-d2587454d473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86857074-c478-4536-92da-d2587454d473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2e3e2184-92cb-4f97-b842-42159f57e287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_decdcd38-65a0-4690-ba29-650e2c588261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2e3e2184-92cb-4f97-b842-42159f57e287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_850931a9-9965-4c68-b4ac-efa20b9ddfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_850931a9-9965-4c68-b4ac-efa20b9ddfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19a47c15-794e-4b8c-9e27-3d01517f0066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19a47c15-794e-4b8c-9e27-3d01517f0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f834de3c-96de-4e58-89d5-5c4d1c190bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f834de3c-96de-4e58-89d5-5c4d1c190bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_13064b2b-0b12-4ae6-9e7a-6fadbed5de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_13064b2b-0b12-4ae6-9e7a-6fadbed5de17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ae79ee47-c919-4796-99d0-f59fce46d3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ae79ee47-c919-4796-99d0-f59fce46d3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e4e39d1e-22d1-4cc5-bb28-ab3301f3f65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1c765e47-e523-4074-9bde-5e2afb348db9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e4e39d1e-22d1-4cc5-bb28-ab3301f3f65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c604ae09-f497-4546-8d0f-96428f4866bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c604ae09-f497-4546-8d0f-96428f4866bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2cfbafb-b711-4a18-a926-53307ade3594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2cfbafb-b711-4a18-a926-53307ade3594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bb3bd9b0-0b3c-4d45-b8ee-a9bff49d5cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bb3bd9b0-0b3c-4d45-b8ee-a9bff49d5cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_53dbb2c4-1616-450d-b1c2-0a5483aa6737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_53dbb2c4-1616-450d-b1c2-0a5483aa6737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_851fd7f7-7f0c-4218-97cf-262fb0ea9e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cf46e540-aa58-4704-9012-6824858d1446" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_851fd7f7-7f0c-4218-97cf-262fb0ea9e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0417eb64-87e3-4a3b-8bd1-b4223117c155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfa15801-0ec0-4b33-a448-53f83238aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfa15801-0ec0-4b33-a448-53f83238aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb04141e-0891-4b99-bb4c-d5761cceeca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb04141e-0891-4b99-bb4c-d5761cceeca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0f61c540-a090-4f62-aedb-0cb2f4acf68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0f61c540-a090-4f62-aedb-0cb2f4acf68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_22441cde-956b-4ac2-88c2-c25b7d5f0afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_22441cde-956b-4ac2-88c2-c25b7d5f0afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70c5bcff-6e57-4996-93b0-06eeaa0abf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_278764cc-9b64-4293-a7ca-3433cbe93217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70c5bcff-6e57-4996-93b0-06eeaa0abf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fd3fb632-3fc3-40db-9366-6a2c4dddc2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fd3fb632-3fc3-40db-9366-6a2c4dddc2b8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:to="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_223ac4a1-b6e5-4b3a-8eba-44fa2be4f756" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0e9c4a41-4358-4353-a429-df1872bdeffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99b4f269-54e2-4a53-af49-fb3fb72ae5e5" xlink:to="loc_us-gaap_EmployeeStockMember_0e9c4a41-4358-4353-a429-df1872bdeffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8629221-365b-43f2-a364-53ffac6b42bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1179ec0b-25d4-4114-8810-d4e57dcc175a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1179ec0b-25d4-4114-8810-d4e57dcc175a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_f8c43ffa-955c-4acd-bfc7-b1f591d709ae" xlink:href="pcrx-20220930.xsd#pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease_f8c43ffa-955c-4acd-bfc7-b1f591d709ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_672c7117-8028-467a-9637-7c65da6a1340" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_672c7117-8028-467a-9637-7c65da6a1340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_be56288f-f8f1-4ff0-aa28-81191c2789e7" xlink:href="pcrx-20220930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_be56288f-f8f1-4ff0-aa28-81191c2789e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_574b6765-4081-4265-9209-efefde858c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_574b6765-4081-4265-9209-efefde858c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5c728b69-ce2b-4f94-84c8-7c98d96b5c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a6ea197-c6dd-4707-a052-3045ebde6f9c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5c728b69-ce2b-4f94-84c8-7c98d96b5c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4b677c7a-d1f1-4daa-b133-573133de435c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4b677c7a-d1f1-4daa-b133-573133de435c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:to="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a831d3cf-bd9b-491a-994f-fbdd0d116641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6f3b89b2-f823-4b90-ab6a-a8a6a22b7dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa714dcb-1f60-481a-95da-25e9741a2d61" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6f3b89b2-f823-4b90-ab6a-a8a6a22b7dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f678f4a2-cd38-4b67-b173-ce15596f079e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_921bfd1d-3177-4703-945d-7169b94129d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_921bfd1d-3177-4703-945d-7169b94129d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_034ca7b0-dc1a-4d63-9b1b-05a10bf120f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_034ca7b0-dc1a-4d63-9b1b-05a10bf120f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc3fd804-3950-4363-a13d-17a0a23b13d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cc3fd804-3950-4363-a13d-17a0a23b13d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a7822b06-01f8-492a-ae2e-c5aa8342c9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29926546-12ec-4f46-983c-d993337d6461" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a7822b06-01f8-492a-ae2e-c5aa8342c9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ab1fcab5-008a-40ff-87f4-c3e8f7f3d492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ab1fcab5-008a-40ff-87f4-c3e8f7f3d492" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:to="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ec4b7e62-3e76-4c8f-a67f-50edcf88ff65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff9dc9f1-9f4c-4cb6-93bb-05677a9fd776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff9dc9f1-9f4c-4cb6-93bb-05677a9fd776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb21d508-1d04-427f-b11c-50a8760fd6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb21d508-1d04-427f-b11c-50a8760fd6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_efd1eadf-5c69-47f6-b069-f657404ba2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1a7ccdf-fa20-4557-8492-0e156f8fa9ab" xlink:to="loc_us-gaap_EmployeeStockMember_efd1eadf-5c69-47f6-b069-f657404ba2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae86b124-279b-4682-b300-cbf5352bb2b2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_2616b269-aa5d-462a-b316-096eddf38d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_61999a68-1e4a-47a9-87ee-e1946640ab25" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_2616b269-aa5d-462a-b316-096eddf38d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_ecd488e4-3e6f-49b0-aeeb-76392525c883" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c92b7a09-a592-4980-a7a7-6ad7ef89a3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_NetIncomeLoss_c92b7a09-a592-4980-a7a7-6ad7ef89a3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1c785d3a-83d5-49c7-8ce5-974a887eb442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1c785d3a-83d5-49c7-8ce5-974a887eb442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bf5cdf60-42b9-4bd7-8a1c-d3b848c2741b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_3b96f819-96e5-42c1-97f8-a6bcd766babc" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_bf5cdf60-42b9-4bd7-8a1c-d3b848c2741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6c249e-f860-4c0c-978e-9a094972fb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_65fe148e-afc9-4672-b0f1-827b163367fc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6c249e-f860-4c0c-978e-9a094972fb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2dfd32d4-d3ff-467f-8ba0-06480f53feb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2dfd32d4-d3ff-467f-8ba0-06480f53feb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2179e6f5-7220-4407-8141-847d947524d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2179e6f5-7220-4407-8141-847d947524d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85e60b2b-787a-4060-9218-c2114a34e132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_07f1e105-92c3-4644-ae66-acb2ac9570d5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85e60b2b-787a-4060-9218-c2114a34e132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:href="pcrx-20220930.xsd#pcrx_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_ee235bc8-5625-486a-8481-3bdb34caf1f4" xlink:to="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc078254-5c01-4a1d-a486-129212c60d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:to="loc_us-gaap_EarningsPerShareBasic_cc078254-5c01-4a1d-a486-129212c60d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_407e8d53-235c-449b-9026-506f783cc92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract_8028ba63-4edb-48d6-acf0-c885a76df958" xlink:to="loc_us-gaap_EarningsPerShareDiluted_407e8d53-235c-449b-9026-506f783cc92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0e9c4928-c4ac-4ba8-a7ee-5c5cde1f8ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0e9c4928-c4ac-4ba8-a7ee-5c5cde1f8ced" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2c8602a9-6dc3-43f9-abcd-d35b4cd7e485" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_25146736-0a8f-491c-a982-537e5a72ea7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_25146736-0a8f-491c-a982-537e5a72ea7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_08c5d877-4fd9-4ace-b404-9f94ba317d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_SeniorNotesMember_08c5d877-4fd9-4ace-b404-9f94ba317d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c76d5ed0-a12f-4ce6-8630-2cc51630b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c76d5ed0-a12f-4ce6-8630-2cc51630b3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7d8a3bde-74c5-45bc-8a4d-49ea8150252d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_99fad7bf-477b-4a4a-bc28-9f6b65c1b3f1" xlink:to="loc_us-gaap_EmployeeStockMember_7d8a3bde-74c5-45bc-8a4d-49ea8150252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_99df7054-1cce-4bde-a37c-380a58da9f15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99b7bf77-a8f6-4cc4-8849-916d6cacdf80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da6eec1-f92e-47ae-9a69-b0d793863503" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99b7bf77-a8f6-4cc4-8849-916d6cacdf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_69d2bfd2-290e-4626-a398-dbb70ebf8a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_b3af591b-ecf8-45e0-b51f-c2cfec392c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69d2bfd2-290e-4626-a398-dbb70ebf8a2e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_b3af591b-ecf8-45e0-b51f-c2cfec392c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1546579a-0817-4275-b1f2-5e30d3b5c35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_b3af591b-ecf8-45e0-b51f-c2cfec392c35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1546579a-0817-4275-b1f2-5e30d3b5c35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_96967e60-fd87-40fe-aa97-57288f482f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_b3af591b-ecf8-45e0-b51f-c2cfec392c35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_96967e60-fd87-40fe-aa97-57288f482f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4325b2c9-ce37-40c7-a579-6343d8007270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_b3af591b-ecf8-45e0-b51f-c2cfec392c35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4325b2c9-ce37-40c7-a579-6343d8007270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_55828aa6-0ea0-4f9b-ad15-a8bd3b9eca05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69d2bfd2-290e-4626-a398-dbb70ebf8a2e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_55828aa6-0ea0-4f9b-ad15-a8bd3b9eca05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_18fdc7cc-3e23-4f14-840c-910b5b46349c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69d2bfd2-290e-4626-a398-dbb70ebf8a2e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_18fdc7cc-3e23-4f14-840c-910b5b46349c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8dee715c-c42c-46a8-a8dd-7c4ef00c6f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8dee715c-c42c-46a8-a8dd-7c4ef00c6f2c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_dc0f81d7-08a1-4238-9b02-5b92855e9c4b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedFeesMember_cc65d9e1-e2bc-4d22-b1c0-c88cff7889cc" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:to="loc_pcrx_AcquisitionRelatedFeesMember_cc65d9e1-e2bc-4d22-b1c0-c88cff7889cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_fe829559-2662-48cc-a081-cd5a77a2b685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c65746b-5018-4fc6-b6e7-65d8f1b9591e" xlink:to="loc_us-gaap_OtherRestructuringMember_fe829559-2662-48cc-a081-cd5a77a2b685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bd2b776-338f-4f7d-9160-de0aa63fa834" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_52a4cc79-1bf4-4a56-9ac2-a0a9c2fc3e89" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_52a4cc79-1bf4-4a56-9ac2-a0a9c2fc3e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_5edadb27-5baf-402d-91ec-62bcdc574d26" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f754ddbe-9fa1-4d4a-9234-f1a5f5028726" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_5edadb27-5baf-402d-91ec-62bcdc574d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7494467c-0009-4160-b1f5-ffde578070d8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_3c1657ad-06f3-4b07-bae7-a177d85b9680" xlink:href="pcrx-20220930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_28152297-a98d-4e98-b6a6-f296974a278a" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_3c1657ad-06f3-4b07-bae7-a177d85b9680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_06781bb6-e025-4efd-8833-264e98d89297" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1b986f1e-0b0f-4e6f-85ca-48fa62005b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1b986f1e-0b0f-4e6f-85ca-48fa62005b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e93201de-75ca-454e-9079-d5cc1b4e8404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e93201de-75ca-454e-9079-d5cc1b4e8404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_ba60e456-74b2-439e-8ce4-47e4153cd574" xlink:href="pcrx-20220930.xsd#pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts_ba60e456-74b2-439e-8ce4-47e4153cd574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a55150d5-38d9-4215-83d7-276c8b19d142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a55150d5-38d9-4215-83d7-276c8b19d142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_6225727d-4eee-4d4b-ac5c-e4665005baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_us-gaap_GainLossOnContractTermination_6225727d-4eee-4d4b-ac5c-e4665005baaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_e2f6a1e6-5572-4759-b13c-decd5184805e" xlink:href="pcrx-20220930.xsd#pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d95b03c1-45c5-40cf-88b0-6b4555d76609" xlink:to="loc_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther_e2f6a1e6-5572-4759-b13c-decd5184805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd80e19a-a00f-477f-84b3-bb46999e6551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd80e19a-a00f-477f-84b3-bb46999e6551" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f614a8f4-7b87-4be4-8b9a-3f513a7796cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionAcquisitionMember_5dc42f79-69de-4252-beb2-e268f70ebf73" xlink:href="pcrx-20220930.xsd#pcrx_FlexionAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:to="loc_pcrx_FlexionAcquisitionMember_5dc42f79-69de-4252-beb2-e268f70ebf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_2246c636-439a-4349-b742-e74af12c06c9" xlink:href="pcrx-20220930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d6dfae37-a694-4026-b313-b6ba685a25a3" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_2246c636-439a-4349-b742-e74af12c06c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8a3ca363-9941-4fc0-bc14-fe64f2336eba" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LegalFeesMember_73ade575-2cfc-4633-b849-c64bf4aeef48" xlink:href="pcrx-20220930.xsd#pcrx_LegalFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6324c21a-263d-483e-ab66-747c7db7fa2e" xlink:to="loc_pcrx_LegalFeesMember_73ade575-2cfc-4633-b849-c64bf4aeef48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b153e3bc-16b2-42a0-bfbe-cd0afc8cec8d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_879b1e74-c869-4c1d-8475-4ff7860776cb" xlink:href="pcrx-20220930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61a384dd-9d85-4570-8e10-ab75df80f5bf" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_879b1e74-c869-4c1d-8475-4ff7860776cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60bcf69e-89f7-41ba-a024-4f9374b7c666" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_08b1e06e-0b9d-4767-946a-76038f668239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_08b1e06e-0b9d-4767-946a-76038f668239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bddfc7c6-8569-4f62-bd9e-30b028bea778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bddfc7c6-8569-4f62-bd9e-30b028bea778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_326c4a45-064c-4a8a-9859-13a44eb31ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_38834e18-64e7-4680-a23c-6e4524656f8b" xlink:to="loc_us-gaap_LitigationSettlementExpense_326c4a45-064c-4a8a-9859-13a44eb31ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0779757c-daa7-4b60-89e5-b7f694f3f474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0779757c-daa7-4b60-89e5-b7f694f3f474" xlink:to="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:to="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9a61521a-ca49-429d-b079-584711eda102" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_6e692e06-8fb4-4de2-9495-9de00a3680b5" xlink:href="pcrx-20220930.xsd#pcrx_FortisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:to="loc_pcrx_FortisMember_6e692e06-8fb4-4de2-9495-9de00a3680b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_HongKongPharmaTainuoLtdMember_e7994228-1f98-49d2-bad8-20077edf4ae5" xlink:href="pcrx-20220930.xsd#pcrx_HongKongPharmaTainuoLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8d98bbaa-a341-4498-ab08-199f3f2044ea" xlink:to="loc_pcrx_HongKongPharmaTainuoLtdMember_e7994228-1f98-49d2-bad8-20077edf4ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:to="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_77863609-85a2-450f-bf33-63673a19d188" xlink:to="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionTherapeuticsIncMember_a3656c38-37e8-42b7-809f-d873dad157b2" xlink:href="pcrx-20220930.xsd#pcrx_FlexionTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cf5c1dcf-5b91-412e-9bfc-08ae37c0abc7" xlink:to="loc_pcrx_FlexionTherapeuticsIncMember_a3656c38-37e8-42b7-809f-d873dad157b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1571d9f7-f669-405c-a10e-c0baf8da09f6" xlink:to="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_2a06bf39-3f22-4c3b-8906-044fb52f8b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_2a06bf39-3f22-4c3b-8906-044fb52f8b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_f45130ed-725a-48ff-90a9-d66cadab1a0b" xlink:href="pcrx-20220930.xsd#pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA_f45130ed-725a-48ff-90a9-d66cadab1a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_f87a89cd-8774-49ab-b87b-2a2bfec4502e" xlink:href="pcrx-20220930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum_f87a89cd-8774-49ab-b87b-2a2bfec4502e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_728b3f77-7fa8-4214-853a-f524d848a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7525ec29-a9c8-4f47-8d60-81a0940342e7" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_728b3f77-7fa8-4214-853a-f524d848a88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pcrx-20220930_g1.jpg
<DESCRIPTION>PACIRA BIOSCIENCES LOGO
<TEXT>
begin 644 pcrx-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !     %$2  0    !
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #% ?0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ^P^&.GV8_>-/.?]IMH_2M6U\-V-G_J[6'\5W?SHYBCD;,9-:UG;R''[M_\
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MN7^1\RLXHK;#P^[_ (!_,GXJ_P""DW[<_@<-<ZWXR^+NCHO+->Z,UO&OUWP
M55\$_P#!?[]K+P3>+(/BI-JT0ZP:EH]A<(_U)A#C\&%?T[$9%> _M7?\$O\
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MMX=OI'@666TEMI(Y4P)(V210=RDX)&5ST)KT:O&O^">/P.A_9N_8;^%?@N*
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MH'_]EK^6FOZL/^"P%I]M_P""8?QO3^[X5NI/^^0&_I7\I]?LGAO+_8:J_O\
MZ(^VX7?^SS7G^B/V\_X-'-/\OX;_ !NNL?Z[4M)BS_N171_]GK]A*_)3_@TJ
MM-G[.OQ;N/\ GIXCM(\_[MMG_P!FK]:Z^!XQE?.*[\U_Z2CY[.W?&U/E^2"O
MB/\ X.)=*;4_^"2/Q*91DVEQI,_T U.U!_\ 0J^W*^0_^"\MI]M_X)*_&-/[
MMC8R?]\ZC:-_2O.R.5LRP[_OP_\ 2D<V7NV*IO\ O+\S^7NOWB_X-,=/\O\
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M,-T/<H>#['FG:^Q.VY]]33);0M)(RQQQ@LS,<*H'4DU_+G^W[\==8_X*M?\
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M5C1%R=N:]HK\BXBS)8_,*F)A\+=EZ)67W[_,^,S/%+$8F56.W3T6@445YO\
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M%OO^44_QH_[ T?\ Z505YV3_ ._T/\<?_2D<N!_WBG_B7YG\M5?T*?\ !JW
M(_\ @G+XB?O)X\OB?PLK 5_/77]#'_!K!_RC=US_ +'J_P#_ $DL:_8./_\
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M@XK[4_X+^_\ !$B$V.L?'CX/:*L+P*UYXQ\/6,.U'4<OJ-O&HX(&3,BC!&9
M 1(6_%JN3(\/DN/H+$X:A"_5.*;3[?Y/J8Y?3P.(IJK2IQ\U9:,^VO!/_!)[
M]L3_ (*":Q8^*M:T/Q+JT&L0)=P>(O&&N!8Y()0'1T,TC2M&RL&'EHPQTK[L
M_9 _X-3_  SX5O;35OC7XVF\4RQ,'?0?#P>TL7_V9+IL3.I_V%B/ ^:O+?\
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M?B)X-TVW6W\/B_\ [4T,1_ZK[!=J+B%8S_$L8D\K/K$:V?\ @CK^V5_PP_\
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M?$\:Y7]3S*4XKW:GO+U>Z^_7T:/"SW">PQ3:VEJOU_$*_EY_X+L?!Z;X,_\
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MJRODW_@NA<?9O^"3_P 9F]=+MD_[ZOK8?UKS<G_Y&%#_ !Q_]*1RX'_>*?\
MB7YG\N-?T,?\&L!S_P $WM<_['N__P#2.QK^>>OZ#O\ @U4O/._X)W>*(O\
MGCX\O0?QL; U^P<?_P#(I?\ BC^I]IQ%_N?S1^F3#<,'D'@@]Z_GQ_X. /\
M@C\/V0?'$WQ<^'6F;/ACXHO,:E86T?[OPO?2'A0H^[:RL3L_AC<^7\H,0/\
M0=6)\2/AQH?Q?\ ZQX7\3:7:ZUX?UZUDLM0L;E=T=S"XPRGN/8@@@X(((!K\
MIX?SRKEF*5:&L7I)=U_FNC_1L^1R['SPE7GCMU7=?UL?QN)(T3JRLRLIR"#@
M@U_1'_P0,_X*ZK^VQ\+U^&OC[4E;XK>$+4>5<SR?O/$]@@ %QD_>N(^%E'5@
M5D&<N$_(#_@K/_P30US_ ()K?M'3:*WVK4/ OB%I+SPKJ\B_\?-N"-UO*P&/
MM$.Y5?&-P*. H<*/GWX0?%SQ%\!?B?H?C+PEJEQHOB3PY=I>V%Y ?FAD4]QT
M96&596!5E9E(()%?LV;9;A<]R]2IM:J\)=GY^71K]4?;XS"TLPPR<7YI_P!?
MB?V.45\V?\$N/^"CGAW_ (*3_LW6OBK3UM]-\5:24LO$^BHY+:;=[<AD!)8P
M2@%HV.> RDED?'TG7X+BL+5P]65"LK2B[-'YY6I3I3=.:LT%%%%<YF%%%8OQ
M(^(6D_"7X>ZYXIU^[2PT/PW83ZGJ%R_W8((8VDD;\%4G'>JC%R?*MQI-NR/R
M _X.K/VU?L]EX/\ @/HMW\UQM\3^)!&W\ +1V=NV#W82RLI_NP-W%7?^#4?]
MD3^R_"_CSXW:I:8FU1QX7T%W7#"&,K->2+ZJTGD(&'0PR#UK\I/VG/CAXF_;
MW_;#\2>,I;6XN_$'Q"UP+I]@A\R2-798;2T3UV1B*(>NT5_4O^Q9^S5I_P"Q
M]^RIX%^&NG>4T?A32HK6XEC&%NKILR7,P'_32=Y'_P"!U^H<0)91D5++8_'4
M^+\Y?C9>:/K,R_V++X85?%+?\W^-EZ'J%%%%?EI\D%8?Q(^&^C_%KP;>:#KU
MG'>Z;?)M=#PR'LZGJK*>01T-;E% '\_7_!QG^R5XL^#6J?#S7]2W:MH.DP2^
M&;/6#%^\DM#(]Q:Q2-ZQL\ZA3T\S(X( _,2OZX/V^?V4]/\ VV/V0_'7PVOX
M[=IO$.FR+ITTP^6SOD_>6LV>HVS*A.,$KN'0FOY*_$&@WOA77K[2]2M9K+4-
M-N)+6ZMY5VR02HQ5T8=F5@01ZBOVW@#,_K& ^K2^*F[?]NO5?C=>B1]WPWBO
M:8;V3WB_P>J_5'].'_!"_P#;+_X;+_X)[^%;S4+K[1XI\%#_ (1?6]S;I))+
M=%$,S9Y)DMVA8L>K^8.QK[$K^=7_ (-JOVS?^&=?VY/^$#U2[\GPW\7(%TO#
MMA(M3BW/9O\ 5]TL  ZM<)Z5_157YQQ;E?U',9QBO=E[T?1[KY.Z]+'S.<X3
MZOBI);/5?/\ R84445\R>4?SZ_\ !U?JOVS_ (*$^$[;_GS\!V8/_ KZ_:OS
M-M9S;7,<@ZQL&'X'-?HE_P '06I?;O\ @IJL>?\ CS\(Z=#],R7#_P#L]?G3
M7]%<,1ME-!?W5^)^F92K8.GZ']FF@7O]I:#8W'7[1;QR9^J@_P!:N5S/P5U+
M^V/@WX2O,[OM6BV<V?7= A_K735_.]2-I-'YK)6=@HHHJ20HHHH *^"/^#B;
M]M?_ (93_8+U#PWI=WY'BOXL/)X>L@K8DBLMH-],!Z>4RPY'(:Z0CI7WO7\Q
MO_!=_P#;:_X;/_;[\0MIEY]I\(^ =WAG1-C9BF$+M]HN%P<'S)R^''WHTB]*
M^LX-RGZ[F,7->Y3]Y_+9?-_@F>QD>#]OB4WM'5_I^)SG_!%G]DA?VR/^"B/@
M30+ZS6\\.^'[C_A)=;1TW1FULV60(X[K).8(C[2U_4J!@5^3_P#P:I?LJ_\
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MV2_C?X@^'_C73SI_B'PY<F"=02T4ZD;HYHF(&Z*1"KJV!E6' .0/[!J^!/\
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M_/!I5NX;![CSIPB@]"L$RGK7ZB7]_!I5C-=74T5O;6T;2S2RN$2)%&69B>
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M^33?Z?J?KYKG[;_P7\,V+7.H?%SX96=N@R7F\3V2#]9*^;_VA_\ @X:_9C^
MUE,MEXPNO'^J1J=EEX9LVN0Q[9GDV08)[B0D>AKX4T7_ (-)?'$\ZC4?C%X4
MM8^[6VC7%PP_!G3^=>S_  I_X--/AKH<L,GC3XI>,O$6W!>+2K*WTJ-SZ9?S
MVQUZ$'Z5G'+>&Z+YJN)E/RC%K]/U1$<+E<-9U7+R2M^A\B_MQ?\ !RS\8OVC
M[*\T'X=VL/PF\-7&Z-I[&<W&M7"'UNB%$.<9_<JKC)'F$5\[?L2?\$LOC9_P
M45\8QW/AO0;^#0+RY+ZAXLUD/%I\>YLR/YK?-<2<DE8]S$GG )8?O[^SY_P1
M0_9F_9NN(+K1OA?HVKZG;MO6^\0,^KRANS!9RT:$=BB+CK7U-:VL=C:QPPQQ
MPPPJ$CC10JHH&  !P !Q@5VRXSP>"I.AD]#E_O2W];7;?S?R-Y9Y1H0]G@J=
MO-_UK\V5?#'A^W\)>&M/TJT7;:Z9;1VD(]$C4(OZ 5>HHK\Y;;=V?,GP_P#\
M'%FKMI?_  24^(T:MM-[=Z3!]1_:5LQ_]!K^9^OZ\OVNOV1_!_[;GP8N? /C
MN'4;CP[>74%W-%97;6LCO"V]!O7G&>H]J^78O^#;?]E&.+:W@[Q [?WF\27F
M?T?'Z5^C<)\58++,$Z%=2<G)O1)]$NK78^FR?-Z&%H.G4O>]]%Y+S/C3_@T<
MU/ROB/\ &ZSS_K]-TF;'^Y+=#_VI7[=U\X_L4?\ !*OX0_\ !/SQIKFN?#73
M];TV[\16:6-XEWJDEW$T:/O7"OG# ]\]":^CJ^7XDS*CC\PGBJ%^65M]'HDO
M/L>3FF*AB,3*M3V=M_2P5^>G_!SEJG]G_P#!+^\ASC[=XGTV#ZX,LG_LE?H7
M7D?[9_[$W@7]O7X4VG@OXA6^J76@V>IQ:LL5C>O:.\T<<L:[F7DKME?Y?7![
M"N/)\53PV.I8BK?EC)-VWT,<%6C2KPJ3V3N?R-U^V_\ P:-:IYO@/XY6>[_4
MW^CS[?\ ?CO%_P#9*^F4_P"#;C]E!8]I\&^(&/\ >/B2]S_Z'BO;OV'_ /@F
M7\*_^">5]XHF^&=CK.GCQ<MLNH17FI27B'[.93&4W\J?WSYYYX]*^^XCXQP&
M/R^IA:*DI.UKI6TDGW?1'T6:9WA\1AI4H)W=MUYKS/H*BBBOR\^3"BBB@#\)
M_P#@Y'_X)4_\*F\97'[07@/3=GAGQ)= >+[."/Y=,U"5L+>@#I'<,0'STF(.
M3YP"_DO7]E'Q"^'^B_%?P+J_AGQ'IMMK&@Z]:26&H65PNZ.ZAD4JZ-WY!/(P
M1U!!KXDL?^#;+]E*TMECD\)^)+IAUDE\1W88_P#?+J/TK]0X>XZI8;"+#X]2
M;CHFDG=>=VM5MZ6/K,MX@A2H^SQ%VULUV^_H?%G_  ;R?\%DE^&][IOP"^*>
MK;= O)1#X.UF[D^73)6/&GRL?^6+L?W3'[C'9]QD\O\ <:OA$_\ !MW^R>5_
MY$O7A[_\))>\?^1*^ROA%\-+?X._#?2/#%GJ6N:Q9Z+ +:"ZUB\:\O7C!.T2
M3-\TA484,V6P!DD\U\IQ+C,MQ=?ZU@5*+E\2:25^ZLWOU7S[GCYI6PM:I[7#
MW3>Z:_'<^(/^#C;]MK_AES]A6Z\(Z5>>1XJ^+;R:';A&Q)#IX4&^E^AC9(/7
M_2<C[M?SV_ KX2:E\??C3X3\#Z.N=3\7:O:Z1;';N"//*L88_P"RN[)/8 U_
M3W^V'_P22^#G[>'Q1L_%GQ,L?$6MZAIU@FFV=O%K4]K:6L2N[G9'&5PS,Y+,
M22<+V KF?V>_^"&'[._[+WQR\/\ Q"\'^&]8L_$/AF22:Q^T:S/=6ZN\3Q;F
M20G) <D>C 'M7T/#_%&7Y9ESHQ4G5=VW96YNBWO9:=.[/2RW-L-A,,Z:3YW=
M[:7Z==CZF^&W@#3/A/\ #O0?"VBP?9='\-Z=;Z78PC_EE!!&L4:_@J@5M445
M^=RDY/F>Y\RVV[L****D HHHH *K:UHUKXBT>[T^^MXKNQOH7M[B"5=R31NI
M5D8=P02"/>K-%%[:H#^1/]N#]FZZ_9#_ &M_B!\-[D2;?"NL36UH\GWI[1CY
MEM*?=X'B?_@5<_\ LY_'76_V8_CMX3^('AV3R]8\(ZG#J5N"Q59MC9:)\<[)
M$W(P[J[#O7],?[5W_!&;X"_MJ?&JX\?>/O#NJ:AXBNK.&RF>UU6>SCE6($(S
M+&1EPI"Y)Z*H[5YU_P 0WG[)_P#T)>O?^%)??_'*_8J''^7RPT:>*C)R<4I:
M*S=K/JM&?;4^(L,Z2C53;M9Z*WGU/L+X#_&G0_VC/@QX7\=^&[C[3H?BS38=
M3LV)&Y4D0-L<#HZ'*LO565@>117#_LQ_L/>%/V/_ (6Q^"O >K>+M,\,6UU+
M=6MC/JINDLC*=SI$9%9E0ON?;G&YW/5C17Y-B(T?:R]C)\MW:ZUMTOYGQU2,
M.9\CTZ7['LE%>>^,_P!K?X4_#CQ"VD>(OB;\/=!U99/*-EJ/B*SM;@/TV^7)
M(&S[8S7=:7JMKKFFP7EC<V]Y9W2"2&>"021RJ>0RL,@@^HK*5*<4I232>VA$
MHR2NT6****S)"BLG0O'FA^*-;U73-,UK2=1U+09$AU*TM;N.:?3G<;D69%):
M-F ) 8 D#-:U.46G9AJMPHHK&\??$7P_\*?"USKGBC7='\-Z+9#-QJ&J7L=G
M:P#_ &I)"%7\33C%R=EN"3;LC9HKA?@S^T_\-_VBX[IO /CWP?XT^P_\?*Z+
MJ\%\UOZ;UC8E<^X&:[JG4ISA+EFFGV>A4HN+M)6"BBFRRK#&SNRJB@LS,<
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M[V>[  &Z::5&DE<X&7=BWO7MFG:?;Z1I\%I:PQ6]K:QK##%$H5(D4855 X
M   Z5\:Z!_P7E^ CV$%GXDF\?>#O&S1@3^$-2\&ZHVKPS=X@L<#1L<@@'> <
M<XZ5]C:+JL>O:/:7T*S)#>0I.BS1F.1590P#*V"K8/((R#Q49A1QT&GC%+6]
MG*^O=IO?U08BGB(ZUT]>]RU7QG_P<$J'_P""0_Q=W -\FE'D?]1>RK[,KX__
M ."]>@7_ (H_X)._%BPTNQO=2OKA-+$5M:0-/-)C5K,G"*"3@ DX' !/05>1
MNV8X=O\ GA_Z4AX#_>:?^)?FCZI\ #'@/1/^O"#_ -%K6O63X#5D\#:*K*RL
MMC "&&"#Y:]16M7FS^)G++<\&_X*D#/_  3=^.W_ &(NK_\ I))7Q1^P9\<O
MV ;CX!_!K0=:TOX)W'Q.?0M%L+T7'@Q)+Z35S!"C[YFM3NF-QG+ESELG=CFO
MM[_@IKIESK7_  3N^-UG9V]Q>7=UX(U:*&"",R22NUI( JJ,DDGC KYA_8R_
MX*P_!CX-_LB_"OPGX@T_X@6_B'POX2TK2M1B3P#J<GE74%I%%*H=8"&PZM\P
M)SU[U]3E<:DLME&G&<GS_8=G\/7W7=?<>OA5)X5J*DWS?9=NG71GZ(44V"9;
MB!)%SMD4,,C!P?:G5\H>.?&/_!?V*SG_ ."7GC1-0ADN+%M6T(7$2-M:2,ZO
M:;U![$KD9[9J'_@FA\5-4_9]^*7B_P#9-\=7EQ/K7PSB_M'P'J-VQ+^(O"DC
M$6V&( :6UX@?  PH50?+=JN_\%[="O\ Q)_P3#\;6FFV%]J5XVHZ*ZV]G;O<
M3.%U6U9L(@+'"@G@=JW/^"H?[,WB#QOX9\+?&+X9VID^,7P.O6UW0XHLJ^OV
M1&+[27*@DK<0;PH )W?*-OF,:^HP<Z<\NIX2J[*<YV?\LDJ?*_1W:?D[]#UJ
M,HRPT:,]I2EKV=HV?IT?D[]#F/\ @WO18_\ @DW\-E50JK=ZT  .!_Q.+VOM
M*OC_ /X(/:5<Z+_P2_\  ,-UI-]H<K7NM2BPO(FCFMD?5[QT5@P!^ZR\XY'-
M?8%>7GCOF-=_WY?^E,Y,?KB:G^)_F4_$>O6_A;P]?ZI=%EM=-MY+J8J,D(BE
MFP/H#7P#_P $I_V:/#O[<'PXF_:>^,V@Z7X\\=?$[4;RXTBVUR!+^R\)Z7!=
M2P6]G:0R QICRV;S NX[@2=Q<M^@6K:7;ZYI5U8W4:S6MY$T$T9Z.C JP_$$
MBOS>_8^_:;_X<R>"=0^!OQZTGQ1I7@?POJEY+X)^(%GH]QJ6D:KID\[SK%.U
MNCO#<H\K90J0-V. JM)U97&I+"UJ>%_BMQT7Q./O<R75Z\MTM6O),UPO,Z4X
MTOCNMMVM;I?.US[]^&GP$\#_  7O]6NO!_@[POX5N->:-]2DT?2X+%K]HPPC
M,OE*N\J&8 MG&X^M=97D7[*'[<?P[_;:L=:OOAS?:SJ^EZ&\,<NH76B7FG6U
MR90Y'DM<11F7&P[MH^7*Y^\,^NUY&)IUH5''$)J76][[=;Z[''5C.,K5+W\]
MPK\A/A;\5OV3_AM^WA^U;#^T1:?#6?5KKQXLFC_\)+X;&J2K"(/WGEL8)-BE
MR,@$9/.*_7NOS!_9S_;)\#_L7_MK_M5P_$32O&4#>*/':WFER6GA&^U"*YA2
M#8SK)%$PQN]^>HS7N9 I.&(4%*3Y5I%VE\<=G9_/38]#+KN-1)-Z+9V>Z\G^
M1][?LDZS\+_$GP!T/4_@S;>&[7X<ZAY\NEKH.GK86+$3R),4A5$"GSEDW?*"
M6!/O7I%>>_LR_M)>%?VI_AJ?$W@^/68]'CNY++;J>D7&ES>8@4MB*9$8K\XP
MP&"<C.0<>A5X>*C)5I*::=WH]7\WI=]]$>?534VG?Y[_ # \CBOR?_X)_>(?
M@C^S[=^)_@Y^U5X-\-Z1\<-?\0ZA<:IXC\;:+'<67CY)KAFBN(+^9&C\O:ZJ
M(V95!R1\[.!^KEU<"TMI)65V6-2Y"+N8X&>!W/M7YW_MC?\ !3W]G+]KG]FW
MQ9\.+KPWXR\9>/M:TRXMM,\"7/@C45UR'4&1E@9=T!2%TD*GS5D.W'&2-I]G
M(_:S4Z$82E&3C=PT<;7L[[6U=T[)V6JM<[LOYY*5-1;3M=K=;V?IWO\ >C]"
M/#WA^Q\):!8Z3I=G;:?IFF6\=I:6MO&(X;:&-0B1HHX554  #@  5<KQW_@G
MQ\-?%WP=_8B^%OA?QY-)-XNT/P[:6FI!Y1,\$BH,0LX)#&-=L98$@E,@D<U[
M%7BXB"A5E!2YK-J_?7?YG!4CRS:3OKOW"BBBL2 HHKQ_]BC]K_3_ -MSX5ZG
MXTT70=4T?P_#KM[H^EW%[)&_]M16SB)KR+82!$T@D0 G.8F]JUC1G*FZJ7NQ
MLF_6]OOL_N*5.3BYK9?J>P4445D2%?"]T/\ CHYMO^R"'_T]M7W17Q+=>&]2
M/_!PQ;ZO_9]]_9/_  HPVOVW[._V?SO[99O+\S&W?MYVYSBO7REV]M?_ )]R
M_0[,']O_  L^VJ***\@XS\V?^"S/P N_VF?V\/V<?">BZE>:'XNFT+Q7J7A;
M5+>?R3INL64%I>6<KM@_()8%5N"0&)'(%<[^WC^V7'^VU_P;\?%+7-2L?[%\
M<^';C3?#_C+0Y$,<NC:Q;:Q8I/&4.2JLP$B DX5PI.Y6Q]!?M9:'?WG_  6%
M_9)OX;"^GL+/3/&"7-U%;.\%L7T^/9YC@;4W$$#<1D\#DBOF'_@O7^RAXH^$
M6A_$#X@?#G0;[7/"WQRTVT\/_$#1;")W-OJ-K<Q7&G:PL<:L208F@?H/W@/+
M2DC[S*ZE*I/ X>H[.-I1?FJLN:+]4KKS275GT&#E&4J%.6ZLT_\ M]W7S2^]
M>9^KFD?\@JU_ZY)_(58JOI0VZ7;9X_=+P?H*L5\&SY\\"_X*A_M2ZA^QA^P7
M\1_B)H_EC7-%T](-+9T#K%=W,T=M#(5((8(\ROM/!"8/!KE/V*_^"7WPP^#/
MP9TFZ\5>$M!\??$;Q!9QW_BKQ1XDLH]6U'5K^90\Y\V<.RQ[R55%P-JJ6W-E
MCZ)_P4%_977]M?\ 8U\??#$7,-G=>)].VV-Q-GRH+N&1)[=GP"=GG11[L G;
MG&37S7\"?^"S'A7X ?#/2/!?[3.E^+?A'\3O#-M'I6H+>^'[V^L-=DB0)]KL
MY[6*5)(Y<;L< ,2 6 #'Z#!TZ]3 .G@KN?.^91^)QLN71:M)\U^S:OT/2HQJ
M2P_+0OS7U2W:LK>;5[_@?;?PV^%_AOX-^#[;P]X1\/Z+X7T&S:1[?3=*LH[.
MT@,CM(^R*,!5W.S,< <L:W:XWX _';0?VE/A5IOC+PRNJKHNK&7[,=1TZ;3[
MAQ'(T98PS*KJK%25) RI![UV5>'6C-3:J7YKZWWOUOYGGSYE)J6_4***XG]I
M'XZZ=^S+\"?%/C[5M/UC5M-\*6#W]Q::5;?:+R=5Q\L:9 SSR20JC+$@ FE3
MIRG)0@KMNR]6$8N345NSMJ*Y?X(_%BS^.WP>\+^---LM4TVP\5:9;ZK;VNI0
M>1=V\<T8=4E3)"N V#@D>A(P:*4XN,G&6Z%*+3LSJ****D04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!1\2Z&OB?PYJ&FR7%W:QZA
M;26S3VLIBGA#J5+1N.5<9R&[$ U@? ?X(>&_V;/@[X=\">$;$:;X<\+V26-C
M!NW,%7DL[?Q.[%G9CRS,Q/6BBK]I+D]G?2][>?\ 397,[<O0ZVBBBH)"BBB@
? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>pcrx-20220930_g2.jpg
<DESCRIPTION>PRODUCT PIPELINE
<TEXT>
begin 644 pcrx-20220930_g2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" <Z"$X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!\C_"L^BBR"R-#_A*;_P#Y^&_[Y'^%'_"4W_\ S\-_WR/\*SZ*+(+(T/\
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M_P 37(45Z'L*?\J^XZ_9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
MOU'_ /$UR%%'L*?\J^X/9P['7_\ "^O%O_09F_[]1_\ Q-'_  OKQ;_T&9O^
M_4?_ ,37(44>PI_RK[@]G#L=?_POKQ;_ -!F;_OU'_\ $T?\+Z\6_P#09F_[
M]1__ !-<A11["G_*ON#V<.QU_P#POKQ;_P!!F;_OU'_\31_POKQ;_P!!F;_O
MU'_\37(44>PI_P J^X/9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
MOU'_ /$UR%%'L*?\J^X/9P['7_\ "^O%O_09F_[]1_\ Q-'_  OKQ;_T&9O^
M_4?_ ,37(44>PI_RK[@]G#L=?_POKQ;_ -!F;_OU'_\ $T?\+Z\6_P#09F_[
M]1__ !-<A11["G_*ON#V<.QU_P#POKQ;_P!!F;_OU'_\31_POKQ;_P!!F;_O
MU'_\37(44>PI_P J^X/9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
MOU'_ /$UR%%'L*?\J^X/9P['7_\ "^O%O_09F_[]1_\ Q-'_  OKQ;_T&9O^
M_4?_ ,37(44>PI_RK[@]G#L=?_POKQ;_ -!F;_OU'_\ $T?\+Z\6_P#09F_[
M]1__ !-<A11["G_*ON#V<.QU_P#POKQ;_P!!F;_OU'_\31_POKQ;_P!!F;_O
MU'_\37(44>PI_P J^X/9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
MOU'_ /$UR%%'L*?\J^X/9P['7_\ "^O%O_09F_[]1_\ Q-'_  OKQ;_T&9O^
M_4?_ ,37(44>PI_RK[@]G#L=?_POKQ;_ -!F;_OU'_\ $T?\+Z\6_P#09F_[
M]1__ !-<A11["G_*ON#V<.QU_P#POKQ;_P!!F;_OU'_\31_POKQ;_P!!F;_O
MU'_\37(44>PI_P J^X/9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
MOU'_ /$UR%%'L*?\J^X/9P['7_\ "^O%O_09F_[]1_\ Q-'_  OKQ;_T&9O^
M_4?_ ,37(44>PI_RK[@]G#L=?_POKQ;_ -!F;_OU'_\ $T?\+Z\6_P#09F_[
M]1__ !-<A11["G_*ON#V<.QU_P#POKQ;_P!!F;_OU'_\31_POKQ;_P!!F;_O
MU'_\37(44>PI_P J^X/9P['7_P#"^O%O_09F_P"_4?\ \31_POKQ;_T&9O\
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M7_QFOF.BC^R<#_SYA_X"O\@^HX;_ )]Q^Y'TY_P^4_:8_P"BJZK_ ."^R_\
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M ,)1?_\ /RWY#_"C_A*+_P#Y^6_(?X50HH O_P#"47__ #\M^0_PH_X2B_\
M^?EOR'^%4** +_\ PE%__P _+?D/\*/^$HO_ /GY;\A_A5"B@"__ ,)1?_\
M/RWY#_"C_A*+_P#Y^6_(?X50HH O_P#"47__ #\M^0_PH_X2B_\ ^?EOR'^%
M4** +_\ PE%__P _+?D/\*/^$HO_ /GY;\A_A5"B@"__ ,)1?_\ /RWY#_"C
M_A*+_P#Y^6_(?X50HH O_P#"47__ #\M^0_PH_X2B_\ ^?EOR'^%4** +_\
MPE%__P _+?D/\*/^$HO_ /GY;\A_A5"B@"__ ,)1?_\ /RWY#_"C_A*+_P#Y
M^6_(?X50HH O_P#"47__ #\M^0_PH_X2B_\ ^?EOR'^%4** +_\ PE%__P _
M+?D/\*/^$HO_ /GY;\A_A5"B@"__ ,)1?_\ /RWY#_"C_A*+_P#Y^6_(?X50
MHH O_P#"47__ #\M^0_PH_X2B_\ ^?EOR'^%4** +_\ PE%__P _+?D/\*/^
M$HO_ /GY;\A_A5"B@"__ ,)1?_\ /RWY#_"C_A*+_P#Y^6_(?X50HH O_P#"
M47__ #\M^0_PH_X2B_\ ^?EOR'^%4** +_\ PE%__P _+?D/\*/^$HO_ /GY
M;\A_A5"B@"__ ,)1?_\ /RWY#_"C_A*+_P#Y^6_(?X50HH O_P#"47__ #\M
M^0_PH_X2B_\ ^?EOR'^%4** +_\ PE%__P _+?D/\*/^$HO_ /GY;\A_A5"B
M@"__ ,)1?_\ /RWY#_"C_A*+_P#Y^6_(?X50HH O_P#"47__ #\M^0_PH_X2
MB_\ ^?EOR'^%4** /2**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH XWQI_R'6_W%K)K6\:?\AUO]Q:R:ZH[(W6P44450PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#>TG_D1M5_ZYR_^BZ^5:^JM)_Y$;5?^
MN<O_ *+KY5KNR_[1T87J%%%%>D=@4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIO\ E$!\7/\ L6=?_P#262OP-K]\IO\ E$!\7/\ L6=?_P#262OP-KU>$/\
MF(_Q_H=^0_\ +W_$%%%%?9GT(4444 %%%% !1110 4444 %%%% !1110 5Z]
M_P $_O\ D^WX,_\ 8\:-_P"ET->0UZ]_P3^_Y/M^#/\ V/&C?^ET-<N-_P!W
MJ?X7^1CB/X4O1G]'GC[_ )"$/_7/^IK!K>\??\A"'_KG_4U@U_/)^4A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!Z11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXWHV4;!(RIP2*["K*"BBB@ HHHH **_'+]FV=[G_ (.9/%C2.SL-0UA06.2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .S_9[_ .2P:/\ 6;_T3)7E/_!03_DXZ[_Z
M\;?_ -!KU;]GO_DL&C_6;_T3)7E/_!03_DXZ[_Z\;?\ ]!J<+_OO_;OZDT?]
MX^7ZGB5%%%>\>D%%%% !17YG_"O_ (*9_%#2/'FF:GXFU@:OX56]2'4K9=,M
MEVQ/][:8T1PX7<R MABASD!J^XOVM_B=J/PV_9C\2^)_#=[%#J%I:Q2V5TJ)
M.@WRQKO 8%6^5CC((Z5P4,QI5J<JD;^[N<U/%0G%R70].HKYT^ G[0'BKQG_
M ,$_]9\<:GJ$=UXGT_2]6N([S[-&FZ2 3-$QC50G&U1C: 0O.3DGQ+]FCXG_
M +2G[5&B:G?^'OB'X?LX=*G6WF&HZ?;1LS,NX;=EHXQCU(HEF$%R)1;<E=6M
M_F#Q45RV3=]3[XHKXHT#]O;XC_LY_%J#PG\9]'LYK6Y*L-2M(Q%)&CD 2J5_
M=2Q+@@@!6!W9)*[3]IVMW%?6L<\$B30S*'CD1@RNI&001P01WK;#XJ%:_+NM
MT]T:4JT:FVZ)**_.SX^_M_\ Q4_X6SXQN/!NL?9/!_AS45L0HTZUE10&,:LS
M.C.1(T;D<]".E?=?P4^),/Q@^$GA[Q-!Y>-9L8KB14!"Q2D8D09Y^5PR_P#
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M@#MJ*\M_9<_;4^&/[:.AZKJ/PT\4Q>);71)TMKXBRN;1[=W7<F4GCC?! .&
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M\/O^"EOP-^)_P<UGX@:5\0M,'@_0+U=.OM3O[:YTZ.*Y9598@MQ'&SL58$!
M<\^AH ]THKP']G[_ (*C_ /]J/QO#X;\$_$?2]3UZY5FM[&YM;K3IKK;@E8A
M<Q1^8V#G:F6(5B!A6(]^H **^9_B;_P6+_9H^$7B632=8^+.ARWL7W_[*M;K
M5X5/'!EM(I8\C/(W9!!!Y!KUSX _M.^ /VI?"\VL_#[Q7I/BG3[600W#V<AW
MVSD;@LD; .A(Y 91GGTH [RBN;^*WQ@\+? OP7<^(O&7B'2/#.AVG$E[J-TE
MO%NP2$!8C<YP=J+EF/ !->!>#?\ @M!^S'X\\86^A:?\5M+%_=3""(W>FWUE
M;LY8*,SS0)$!D]2^.^<4 ?4-%?(O_!4__@I5X(_9$^#WC'PG%XP32OBSJGAN
M:;P_8Q6MS)-&\V^*.;S8XVCB=2&=?,9>4'&#S\#_ /!&+_@JMI?PC\4^/=1_
M:#^-OC>XAGM;.VT*TUJ?5==AD8O,T\BA5F$3*%A'(7<)#C.#0!^V5%9B^,=,
M'@\>();V&TT;['_:#W=V?LT<-OL\PR2>9M\L!.3OQM .<8KYN\5?\%J/V8/!
MWBF71[OXM:3-=PR>4TECI]]?6I.<<7$$#PL,_P 0<C'.<<T ?4E%<Q\(?C1X
M4^/W@>W\2^"_$&F>)="NF:..\L)A+'O4X9#CE6'=2 1D<5@_M"_M:_#;]E+0
M$U+XA^,=%\+P2JS0QW4I:YN0H)/E0(&EDZ?P*>>.IH ]!NKJ.RMI)II$BAB4
MO)([!510,DDG@ "ODW]D7_@LU\*OVV/V@9/AWX*TCQV=02"YNDU&^TZ"&PEA
MA(!D!$[2J&RNW?&I^8 A3Q6=\:_^"K7P@^+G['7Q>U/X8>/]+USQ!H7A.]N(
M;1HKBRNT=XWACE6&>-)'5)&4L54A<IN*AU)^,/\ @UU^%)O_ (L?%/QP\+*N
MDZ3::%!,P<!S<S-/(JG[AQ]DB+=QO3H&.0#]EJQ/B#\2O#GPE\,2ZWXJU_1?
M#.C6[*DM_JU]%96L;,0JAI)&5022 ,GDFMNOR/\ ^#HOXP;;3X4^ 8+J?YGO
M/$%];!\1G 2"V<KW;FZ /8%NNXX /TR^&_[5?PO^,GB(Z1X0^)'@+Q5JPB:X
M-EH_B"TOK@1K@,_EQ2,VT9&3C R/6N^K^;K]A33=6_9"_P""F_P5_M=GM)[Z
M_P!$G:16\H):ZS9PD;BW0+%>[7_W7':OZ0;JZCLK:2::1(H8E+R2.P544#))
M)X  H Y_XE_&/PC\%M'CU'QCXJ\.>$]/FD\J.YUG4X;"&1_[H>5E!/MFL[X7
M?M)?#OXX:A=6G@KQ]X+\7W5C&)KF'1-<MM0DMT)P&=8G8J">,GC-?@W_ ,%&
M/VA-=_X*C_M<^.-8T*X_XMW\+](OYM+N3'(]M!86RG_2&VIN#WMP(U3<HV^?
M"K$+&SCWO_@UW^%SZE\;?BCXU(Q'HNAVVB*2S#>;N?SC@8VG'V)<\Y&Y>#N.
M #[F_;)_X+3_  <_8C^,_P#P@?B6+Q9K/B""&*:_31+&&>/2_,57C69I9HSN
M,;*^$#?*PSU KV[]K7]JSPI^Q=\#M3\?^,FO_P"Q],>.$0V,(FNKN61@J11J
MS*I8G^\R@ $DC%?"?Q#_ &>/V)/VM?\ @I=>R:AX_P#$&M_$Z^U=8[[PK!YQ
MT6_N[:,(\32?9"&&(LNJ7.,JPX&15#_@Z"^*Z:3\"/AKX)2X83Z[KD^L2PHP
MYCM8/*!;O@M=\=B5/4KP ?;_ .PU^W+X0_X* _"&]\:>"[+Q!I^F:?JLNC30
MZS;Q07"SQQ0RD@122*5*SI@[O7@8KV:ODC_@AO\ "X_"[_@F;\/%E&+O7UNM
M;G^8E3Y]Q(8L9 (_<B'/;.2"00:]!_:#_P""F?P*_9:\5/H?CCXC:1I.LPQB
M26QA@N+^> $[0'2WCD*-_LM@XYQCF@#W:BO(/V</V^/@[^UQ.8/A[X_T/Q!?
MK&TIT_<]K?B-3M9_LTZI-L!QEMF.5YY&>[^*WQ@\+? OP7<^(O&7B'2/#.AV
MG$E[J-TEO%NP2$!8C<YP=J+EF/ !- '245\IZ5_P6]_9;UC7!I\7Q7LDG9F4
M//HVI0094$G]Z]N(P.#@[L'@#.17<?M@?\%#OA=^QIX(LM0\5^*]/L[[Q'87
M%UX=@2WN+Q=5:.-67!MT?;&Q>,;V(4[N#P: /=**_!C_ ()1?\%1]3\%?M;W
MOB'X]_&_QZ/",>C7<D5MJ%[J6JV5U?22Q*D?V:(2*@"-,ZD(%7RP!C(%?N-\
M*/BIH7QO^'&C^+?#%ZVH^']?MEO+"Z:VEMS<1-]U]DJJZ@]MRCB@#H:*^9_B
M;_P6+_9H^$7B632=8^+.ARWL7W_[*M;K5X5/'!EM(I8\C/(W9!!!Y!KU']GG
M]KWX9?M8:/+>_#OQKH?BE+>-);B"UFVW5HK_ '3+;N%EBS@@;T'((Z@T >CT
M5Y?^T]^V;\,_V,] T[4_B5XIM_#-IJ\K061:UN+J2Y=0"P6."-W(4,N3MP-P
MR>:YSXF?\%*_@=\'/ 'AGQ+XF^(.F:/IGC'3H]7T99K:Y-Y?6<BEXYQ:B,W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_##X:Z3J$MO<W<%K/$</$]^P*=^A.:B^"7_(Z'_KW?\ F*\U^.O_ "5G6O\
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MNBCZK+^=A[%_S,^B_ GA#P#IGBNTGT:^MY=20MY*+>^83E&#?+GGY2:^5O\
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M\/?^"='BG0O'5]X$3Q=\2_%%@VD:9(I2VDBL+>7S)5-VT;M$FZZSM16WMMR
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M (*_>)K/6YUL] TZ^TC1[B:0%/(MEMK8SNQ7<<!GE8$ G;CC/%?NY\(?VD/
M/[0%SK$?@;QAX=\7_P!@R117\FCWT=Y#;M*I=!YD9*'(!^Z3RK \@B@#MJ_*
M#_@Z,^*OV7P1\*?!$5T?]-OKW7+JV';R8T@A<_7S[@#@]&Z=_P!7Z_!#_@XM
M^)DGQ#_X*+'P^ODHG@[0;#2QEU4&28-=EF8GY>+E!R0 %![Y(!K_ +!_[8O[
M7'[(/[.FF>&/AS^SU>:]X6OY7UJVU2Z\#:W=OJ0N0KK,)894C="@3:RK@J%Y
M/6OU._X)G?'KXQ?M'? G4O$7QI\$VW@#Q -9EL[#2X]'N],D>S2*$B=X[F62
M3YI'E4<*,1Y .<U<^$G[8'[/OPC^%/AGPI9_&_X0/:>&-)M=)@9/%NG1JR00
MI$I"^>=HP@XR<>IKTO\ X:)\"2_![4?B!;>+O#VI>"=)MI[NZUO3[Z.]LXXX
M03*1)"6#%=I!5<G(QC/% 'XJ?\%X_@7=?LA?\%#-$^)?A19],3QCY7B>TN4#
MJ(-7MIP9RC9Y;<()C@C!GZ#@FIJNN>._^#@K_@H1ID$=A>^'OA]H"K')L/F)
MX=TL,6D=Y-NUKJX92%&#EM@^Y&S"+QAJWCO_ (. /^"B46GZ:9]"\"Z*KI;R
MO'YL7AS2E(WS/@+ON)W PI.2[JNX)&679_X(#_%[4/V7/^"BVN_"[Q%OT[_A
M+H;K0+RUFE,*P:I8N\D>X,.6&RYB4'!W3@#D[2 ?</\ P6G.A_LC?\$C+WP/
MX4M[;0=*OY].\,:=;P1A<IYOVB4<8!=X[>8NQ!+%G)Y.:^'_ /@C#_P2H7]N
MCPC>>)_B)?ZM'\*]!U.:+3]&MIV@.KZ@T40FEW#E8T01*67EF&T,-C ^U_\
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M /W]PK8Q\RQ/@ 9(_>Z@ HHHH **** "BBB@#TBBBB@ HHHH **** "BBB@
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MS+^Q5_P5J^$7[=7C*]\+^&;C7]!\8V$<LTWA_P 16 LKX)&^R3;M=XV93@E
MY< Y*C#8]R^,7QK\)?L^> ;WQ1XV\0Z5X8T"P4F:]U"X$29P2$0'EY&P=L:
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M_P"/Z?\ ZY_UKRWQ=_R->I_]?<O_ *&:O#_&RJ/QLSZ***[3J"BBOFS]K/\
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M"DGL%%%%44=?\$O^1T/_ %[O_,5YK\=?^2LZU_UU7_T!:]*^"7_(Z'_KW?\
MF*\U^.O_ "5G6O\ KJO_ * M3A_]X?H13_BOT.2HHHKTCK"BBO!_VKO^"A'@
M_P#9#\<:'X<UO1?%^OZQK]K)>6]MH-E%=.L:$C+*\L9YVMC:#PC9QBIE-15Y
M$N22NSWBBOEKX;_\%=_A;XY\>:9X=U.P\;>![[6)1!9OXDTE;6&9R0JC>DD@
M4%FQN;"C')'%?4M*%2,]8L(R4M@HKYQ_:V_X*C?#7]CCX@VWA?Q#%XAUC6I;
M47<T&BV\$_V%&/R"8R31A68 L%&3MP2 &4GZ+MYQ<VZ2*'"R*& ="C 'GD$
M@^Q&:(SC)M)[ I)NR'T44591V?[/?_)8-'^LW_HF2O*?^"@G_)QUW_UXV_\
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MQB_X-W?V=OBMXIDU2QM_&'@CSY'EEM/#VIQK:NSD$X2YAF\L YPL951G &
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MBBB@ HHHH **** .-\:?\AUO]Q:R:UO&G_(=;_<6LFNJ.R-UL%%%%4,****
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M5\6"XOY;#P[KMO9V2()Y(H7"F"0EGACC8DMGYL8&W%0]R7N=-^T=/HO[6/\
MP7P^$=IX ":K<_#33X[_ ,6:MIDD;QPI!*\@C=PV&"&6*)N<@W&S&1BOTB;X
M3>&9/BC_ ,)LV@Z7)XN&G)I":P]NK7D5FLDD@@20C<B%Y78A<;B1G.T8X#]D
MC]A'X8?L0>'+JP^'GAR/2Y=1"B^OYI6N+V^VDE1)*Q)P-QPHPHSTKYU_:R_;
MR\8_M,?$O6/@'^S#&^H>,+=A;>*_&^]4TOPA;LVR3RILDM<@[@2H++M81AY
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGQ!_T1;1_P#PI)/_ )'H_P"(KGQ!_P!$6T?_ ,*23_Y'H_L7&?R_BO\ ,/\
M7C)O^?O_ )++_(_:&BOQ>_XBN?$'_1%M'_\ "DD_^1Z/^(KGQ!_T1;1__"DD
M_P#D>C^Q<9_+^*_S#_7C)O\ G[_Y++_(_:&BOQ>_XBN?$'_1%M'_ /"DD_\
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M /"DD_\ D>C_ (BN?$'_ $1;1_\ PI)/_D>C^Q<9_+^*_P P_P!>,F_Y^_\
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M)M*_\'\G_P 8IP_X.2];(_Y)/I7_ (/I/_C%+^RL5_+^*#_6[*O^?G_DLO\
M(_5^BORD3_@Y&UIE_P"23Z7_ .#Z3_XQ3D_X.0M:9L?\*HTO_P 'TG_QBC^R
ML5_+^*'_ *VY7_S\_P#)9?Y'ZLT5^52?\''>M,V/^%4Z7_X/I/\ XQ3_ /B(
MUUK_ *)5I?\ X/9/_C%+^R\3_+^*'_K9E?\ S\_\EE_D?JE17Y7C_@XQUHG_
M ))7I?\ X/9/_C-/7_@XLUHC_DE>F?\ @]?_ .,T?V7B?Y?Q0_\ 6O+/^?GX
M2_R/U-HK\M5_X.*-98?\DLTS_P 'K_\ QFGI_P '$>LM_P TLTS_ ,'K_P#Q
MFC^R\3_+^*#_ %JRS_GY^$O\C]1Z*_+P?\'#NLD?\DMTS_P>/_\ &:</^#AC
M62?^27:9_P"#Q_\ XS1_9>)_E_%#_P!:<M_Y^?A+_(_4&BOS"7_@X3U@C_DE
M^F_^#Q__ (S3D_X.#M8;_FF&F_\ @[?_ .,TO[,Q'\OXH?\ K1EO_/S\'_D?
MIW17YD)_P<$ZPW_-,--_\';_ /QFGC_@X#U<G_DF.F_^#M__ (S1_9F(_E_%
M!_K1EO\ /^#_ ,C]-**_,U?^"_\ JY/_ "3+3?\ P=O_ /&:D_X?\ZO_ -$S
MT[_P=O\ _&:7]FXC^7\4/_6;+OY_P?\ D?I=17YIC_@OMJY'_),]._\ !T__
M ,9IT?\ P7RU=_\ FFFG?^#I_P#XS1_9V(_E_%#_ -9<N_G_  ?^1^E5%?FR
MG_!>O5W/_)-=._\ !R__ ,9IZ_\ !>;5R?\ DFVG?^#E_P#XS1_9V(_E_%#_
M -9<N_G_  ?^1^D=%?F^O_!>+5F/_)-M._\ !R__ ,9J:V_X+OZDLH,OPUL7
M3NJ:VRD_CY)_E2_L[$?R_BA_ZR9?_/\ @_\ (^YO';FWUI28YV$Q2)"D3/EC
MTS@' ]SQ5'^S[C_GA-_WP:^)KO\ X+P:CYH\KX:62(S!0'UQF(_$0#^52+_P
M73U5O^:<Z?\ ^#A__C5:K!XA+X?Q1HN)LO\ Y_P?^1]J_P!GW'_/";_O@T?V
M?<?\\)O^^#7Q:O\ P7-U4G_DG6G_ /@X?_XU3O\ A^7JO_1.M/\ _!P__P :
MH^JXC^7\4'^LV _G_!_Y'VA_9]Q_SPF_[X-']GW'_/";_O@U\8C_ (+C:J3_
M ,DZT_\ \'#_ /QJI/\ A^!JG_1.[#_P;O\ _&J/JN(_E_%#_P!9<!_/^#_R
M/LK^S[C_ )X3?]\&C^S[C_GA-_WP:^-U_P""WVJ$?\D\L/\ P;O_ /&J='_P
M6YU1_P#FGEA_X-W_ /C5'U6O_+^*'_K)@?Y_P?\ D?8W]GW'_/";_O@T?V?<
M?\\)O^^#7QZG_!;/4W/_ "3VP_\ !N__ ,:IX_X+7:F3_P D^L/_  ;O_P#&
MJ7U:O_+^(?ZQX'^;\'_D?7_]GW'_ #PF_P"^#1_9]Q_SPF_[X-?(7_#ZO4_^
MB?V'_@V?_P"-4Y/^"T^IM_S3^P_\&S__ !JCZM7_ )?Q'_K%@?YOP?\ D?7?
M]GW'_/";_O@T?V?<?\\)O^^#7R.O_!:+4V_YD"Q_\&S_ /QJI%_X+-ZFW_,@
MV/\ X-7_ /C5'U:O_+^(_P#6'!?S?@_\CZT_L^X_YX3?]\&C^S[C_GA-_P!\
M&ODT?\%F-3)_Y$*Q_P#!J_\ \:IR_P#!934R?^1"L?\ P:O_ /&J/JU?^7\1
M_P"L."_F_!_Y'UA_9]Q_SPF_[X-']GW'_/";_O@U\IC_ (+'ZD1_R(=C_P"#
M5O\ XU3A_P %B]2(_P"1#LO_  :M_P#&J7U>M_+^(?ZP8/\ F_!_Y'U5_9]Q
M_P \)O\ O@T?V?<?\\)O^^#7RLO_  6)U%O^9$LO_!JW_P :IZ?\%@]1;_F1
M;+_P:-_\:H]A6_E_$?\ ;^#_ )OP?^1]3?V?<?\ /";_ +X-']GW'_/";_O@
MU\NI_P %?=1<_P#(C67_ (-&_P#C=._X>\ZC_P!"-9?^#-O_ (W1["M_+^(_
M[>P?\WX/_(^QO!T#PZ-.'1E)<X##'\(J+[/)_<?_ +YKY"3_ (+ 7412.3P#
M;N\F<,NL%0N!Z>2<_G0O_!7/42/^1'LO_!FW_P ;J/JU:]["6>83^;\'_D?7
MOV>3^X__ 'S1]GD_N/\ ]\U\BI_P5NU%_P#F2++_ ,&;?_&Z>G_!6C46;'_"
M$V7_ (,V_P#C='U>MV*_MW"?S?@_\CZW^SR?W'_[YH^SR?W'_P"^:^2_^'L>
MH_\ 0E67_@R;_P"-T[_A[!J'_0E6?_@R;_XW1]7K=@_MS"?S?@_\CZR^SR?W
M'_[YH^SR?W'_ .^:^3U_X*O:@1_R)5G_ .#)O_C=/7_@JSJ#?\R79_\ @R;_
M .-T?5ZW8?\ ;>%_F_!GU;]GD_N/_P!\T?9Y/[C_ /?-?*J_\%5-08_\B99_
M^#)O_C=*/^"J-^3_ ,B99_\ @R;_ .-TO85>P?VWA?YOP?\ D?5/V>3^X_\
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MSPF_[X-']GW'_/";_O@UXLO_  4>O6_YE2U_\#V_^(IR_P#!1J]8?\BK:_\
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M3_R+5M_X&M_\13O^&];S_H6K;_P,;_XBCVE3^4/[8H_U<TO^$?O_ /GRN_\
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M<%_PB.J_] S4/_ 9_P#"C_A$=5_Z!FH?^ S_ .%>@#]MVZ(_Y%Z#_P ##_\
M$4Y?VVKHC_D7H/\ P+/_ ,11]=J_R_B']LTOZN>>_P#"(ZK_ - S4/\ P&?_
M  H_X1'5?^@9J'_@,_\ A7H8_;8NB?\ D7H/_ L__$4O_#:MU_T+\'_@6?\
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M;$G9_ET"(#WNR?\ V2E2QM2%;VW+TMN*.;4XU/:>5CXJ_P"%8>)?^A>US_P
ME_\ B:/^%8>)?^A>US_P E_^)K[7_P"&O+C_ * </_@4?_B:</VNK@C_ ) <
M/_@4?_B:[O[:J_R?B=/]O0[?F?$W_"L/$O\ T+VN?^ $O_Q-'_"L/$O_ $+V
MN?\ @!+_ /$U]MC]K:X(_P"0)#_X$G_XFG+^UG<-_P P2'_P)/\ \31_;=3^
M3\0_MV'8^(O^%8>)?^A>US_P E_^)H_X5AXE_P"A>US_ , )?_B:^WA^UC<$
M_P#($A_\"3_\33O^&KKC_H"P_P#@2?\ XFE_;E3^3\1_V[#L?#__  K#Q+_T
M+VN?^ $O_P 31_PK#Q+_ -"]KG_@!+_\37W$/VJ[@C_D"P_^!)_^)IP_:GN"
M/^0-#_X$G_XFC^W*G\GXA_;D.WYGPW_PK#Q+_P!"]KG_ ( 2_P#Q-'_"L/$O
M_0O:Y_X 2_\ Q-?<J_M2SG_F#1?^!)_^)IP_:CG)_P"0-%_X$G_XFC^W*G\G
MXC_MN/8^&/\ A6'B7_H7M<_\ )?_ (FC_A6'B7_H7M<_\ )?_B:^Z1^T_.3_
M ,@>+_P(/_Q-+_PTY/\ ] B+_P "#_\ $T?VY4_D_$/[;CV/A7_A6'B7_H7M
M<_\  "7_ .)H_P"%8>)?^A>US_P E_\ B:^[!^TS.1_R"(O_  (/_P 33E_:
M7G(_Y!$7_@0?_B:/[<J?R?B']MQ['PC_ ,*P\2_]"]KG_@!+_P#$T?\ "L/$
MO_0O:Y_X 2__ !-?>"_M)S$?\@F+_P "#_\ $TY?VD9B?^03%_X$'_XFE_;M
M3^3\1_VTNQXI-X1U8_\ !)_XJ:5_9>H_VI=>'-<CAL_LS_:)F:VD"JJ8W$D]
M !S7X:_\,Q?$K_HGOCC_ ,$-U_\ $5_1PO[1\FSG2$W=B+GC_P!!H_X:+F_Z
M!47_ '_/_P 377E/$M7 ^TY::?.[[F^!XA6&YK1OS.Y_./\ \,Q?$K_HGOCC
M_P $-U_\11_PS%\2O^B>^./_  0W7_Q%?T<C]HF8X_XE4?\ W_/_ ,33Q^T)
M,1_R"X_^_P"?_B:]?_7RM_SY7W_\ [_];G_(OO?^1_.'_P ,Q?$K_HGOCC_P
M0W7_ ,11_P ,Q?$K_HGOCC_P0W7_ ,17]'J_M!3,?^09'_W_ #_\33A\?YB?
M^09'_P!_S_A2_P!?:W_/E??_ , ?^MS_ )%]_P#P#^<#_AF+XE?]$]\<?^"&
MZ_\ B*/^&8OB5_T3WQQ_X(;K_P"(K^D#_A?DW_0-C_[_ !_PH_X7Y-_T#8_^
M_P ?\*/]?:W_ #Y7W_\  #_6Y_R+[_\ @'\W_P#PS%\2O^B>^./_  0W7_Q%
M'_#,7Q*_Z)[XX_\ !#=?_$5_2$/CU,1_R#8_^_Q_PIR_'>5O^8;'_P!_C_A1
M_K[6_P"?*^__ ( ?ZVO^1??_ , _F[_X9B^)7_1/?''_ ((;K_XBC_AF+XE?
M]$]\<?\ @ANO_B*_I&7XZ2M_S#H_^_Q_PI1\<92?^0='_P!_C_A1_K[6_P"?
M*^__ ( _];'_ "+[_P#@'\W'_#,7Q*_Z)[XX_P#!#=?_ !%'_#,7Q*_Z)[XX
M_P#!#=?_ !%?TD_\+ND_Z!R?]_C_ (4X?&N0C_D'I_W^/^%+_7ZM_P ^5]__
M   _UL?\B^__ (!_-I_PS%\2O^B>^./_  0W7_Q%'_#,7Q*_Z)[XX_\ !#=?
M_$5_2:OQID(_Y!Z?]_C_ (4J_&:1O^7!/^_I_P */]?JW_/E??\ \ /];)?R
M+[_^ ?S8_P##,7Q*_P"B>^./_!#=?_$5ZM^PE^SO\0-#_;:^$-[>^!?&-G9V
MGC/2)IYY]%N8XH46]B+.S% %4 $DG@ 5^_2_&.0G_CP3_OZ?\*!\9'S_ ,>"
M_P#?[_ZU9UN.JM2G*G[%:IK?O\B:G%$I1<>1:^?_  #4\<VTD]_"4C=\1\[5
M)[FL3^S[C_GA-_WP:M-\87)XL%'UF_\ L:7_ (6[)_SXI_W]_P#K5\#9GS',
MBI_9]Q_SPF_[X-']GW'_ #PF_P"^#5Q?BU(P_P"/%/\ O[_]:@?%N0M_QY)_
MW]_^M19AS(I_V?<?\\)O^^#1_9]Q_P \)O\ O@U='Q8D)_X\D_[^_P#UJ=_P
MM63_ )\D_P"_G_UJ+,=T4/[/N/\ GA-_WP:/[/N/^>$W_?!K1_X6E)_SYI_W
M\_\ K4H^)\A'_'FG_?S_ .M19A=&;_9]Q_SPF_[X-']GW'_/";_O@UI+\4';
M_ES7_OY_]:G+\378_P#'HO\ W\_^M2"Z,O\ L^X_YX3?]\&C^S[C_GA-_P!\
M&M8?$IR?^/1?^_G_ -:E_P"%CO\ \^B_]_/_ *U S(_L^X_YX3?]\&C^S[C_
M )X3?]\&MD?$1R/^/5?^^_\ ZU.7X@N1_P >J_\ ??\ ]:@#$_L^X_YX3?\
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MPL!O^?5?^_G_ -:@##_L^X_YX3?]\&C^S[C_ )X3?]\&MS_A8#?\^J_]_/\
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MPL!O^?5?^_G_ -:@##_L^X_YX3?]\&C^S[C_ )X3?]\&MS_A8#?\^J_]_/\
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MPL!O^?5?^_G_ -:@##_L^X_YX3?]\&C^S[C_ )X3?]\&MS_A8#?\^J_]_/\
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M&'A#W]-79?CYGV6#RW%83,:^95Z]Z/O/E3E+[U;2WE<_%_\ X.*_#F@^'_\
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M:?'4,M#AUJ2HQUJ2D,>.E2#I48Z5(.E Q\=/3[U,CIZ?>H+)$^]3Z8GWJ?0
M\=*>G2F#I3TZ5,ADB=*>G6F)TIZ=:DLI:!_R^_\ 7W)_2M2LO0/^7W_K[D_I
M6I5K8!R]JE3[M1+VJ5/NU+W+0Y.M/'6F)UIXZTADE%%% #T^[3XZ8GW:?'04
MB2.G#K38Z<.M)[%$E/'2F4\=*@!Z=*DCJ-.E21T#6X]/O4E*GWJ2@LDJ2HZD
MH <G2A?OFA.E"_?- #AUJ2HQUJ2@M$E/3[M,IZ?=H&)'3TZTR.GIUK,!XZU)
M48ZU)04AXZ5(GW:C'2I$^[04)'3J;'3J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /YF?^"=_P#RD ^!G_90= _].5O7](?_  4E_P"4>OQQ_P"Q
M$UK_ -(9J_F\_P""=_\ RD ^!G_90= _].5O7](?_!27_E'K\<?^Q$UK_P!(
M9J^HSO\ WFE_74_*N!O^19B_G_Z2S^5JBBBOJ#\L"OUJ_P"#4G_DIWQE_P"P
M7IG_ *-N*_)6OMC_ ((J_P#!37PE_P $V_B3XVO?&F@^(]8TGQ;IUO DNBK#
M+<6TL$C,H,4LD:LC"1LMY@*E!\K;B5X,SI3J8:4(*[?^9[_"^*I8;-*5:O+E
MBF[OY-'O'_!U1_R<C\+O^Q:G_P#2IJ_*^OWJ_P"(I#]G_P#Z%#XQ?^"K3?\
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MU:=OEM\C\FOCM_R6_P 9?]AR]_\ 2AZY2OWJ_P"(I#]G_P#Z%#XQ?^"K3?\
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M1TX=:;'3AUI/8HDIXZ4RGCI4 /3I4D=1ITJ2.@:W'I]ZDI4^]24%DE25'4E
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M1>!/#TDBJLNYB<!1<=?:BY7(SSZI*]"N_ .A6K@2'R21D SXS^=1?\(;X?\
M^?@?^! I7#D9PB=*%^^:[P>#_#X_Y>!_X$"C_A#_  ^#_P ? _\  @47#D9P
MHZU)7;#PAX?'_+P/_ @4[_A$] _Y^%_[_BBY2BSBZ>GW:[+_ (1;0?\ GX7_
M +_BE'AG00/^/A?^_P"*+CLSBXZ>G6NQ'AC01_R\+_W_ !2CPWH0_P"7A?\
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M_B@#F**Z?^Q=%_Y^$_[_ (H_L71?^?A/^_XH Z&BBB@ HHHH **** "BBB@
MHHHH **** "BBD/WA0 M%-_Y:4P_>% $M%0C^*D/W13L!/159_NTDE.P%JBJ
M4O\ 6FOUHY1V+]%9S_=II^Z*:@.QIT5D?P?C3>]/D#E-FBL0]/QI#UHY Y3<
MHK!?I39.II^S#E.@HKG#]RF-WI^R\PY3IJ*Y;O2=S1['S'R'545RG\'XTP_=
MI^Q\Q\AUU%<=WIDG6G[#S#D.THKB'ZTP_=H]AYAR'=45P7\?X5&_W:?U?S'[
M,]!HKSQ^M-/6G]6\P]EYGHM%></UIK_=I_5?,/9>9Z317F)^\?I4;]*?U3S'
M[+S/4J*\K?I^%,;H*/JGF'LO,]7HKR>3J:CI_5-+W'['S/7**\??O3&Z"G]3
M\Q^P\SV!^M)7C$O6F24?4O,/8>9[517B7\-1]Z?U'^\'L/,]QHKPL=*;)3^H
M_P![\ ]AYGNU%>!]J8_6CZA_>_ ?U?6USW^BOGS^#\:8/OU7]G_WOP']6\SZ
M&HKYV;M]:8_>C^S_ .]^'_!#ZMYGT917S:_2FGK3_L[^]^'_  1_5?,^E**^
M96ZBFOWI_P!F_P![\/\ @A]5TW/IRBOF%^E02=#3667^U^'_  1_5/,^I:*^
M69*@DZ&G_9?][\/^"'U3S/JVBOD\]*C/6C^R_P"]^'_!']4\SZTHKY(?[U14
MUE7][\/^"/ZGYGUY17R _6H9?ZT_[)_O?A_P0^I^9]BU'7QV>M1T_P"R/[_X
M?\$/J?F?9%%?&<G4U"_2G_9']_\ #_@C6"\SZT\=_P#,&_["D'_LU;U?"_B3
M[UE_U]Q_UJ])1_9']_\ #_@C^H_WOP/MJBOB(]#4+]:K^QO[_P"'_!#ZC_>_
M ^XZ*^%W[U'3_L73X_P_X(_J'][\#[LHKX/E[U%_'^%/^Q/[_P"'_!%]1_O?
M@?>M%? []Z@?K1_8G]_\/^"5_9_][\#[_HK\^G^[4?\ '^%5_87]_P##_@A_
M9_\ >_#_ ()^@[]*;7YZOTJ)^M']A?W_ ,/^"-9=?[7X?\$_0^BOSL/W14;_
M 'J?]@_W_P /^"/^S?[WX?\ !/T7HK\X7Z5%+_2G_8'_ $\_#_@A_9O][\/^
M"?I'17YK'[PIK_>IKA__ *>?A_P1K++_ &OP_P""?I717YFR5"_>G_J__P!/
M/P_X(_[+_O?A_P $_1S7O^1TT'_MX_\ 0!6Y7Y::C_R&+#_MI_Z#4YZTUP]?
M_EY^'_!#^R_[WX?\$_42F/UK\O)*JW'6G_J[_P!//P_X)7]D_P![\/\ @GZF
M45^5C]:ADZ&FN'+_ /+S\/\ @A_9/][\/^"?JS17Y1=ZB?I3_P!6_P#IY^'_
M  0_LG^]^'_!/UBHK\F'ZU#+_6C_ %;_ .GGX?\ !&LI_O\ X?\ !/UMHK\C
M'^]455_JS_T\_#_@C_LC^_\ A_P3]6O''72?^PE#_P"S5M5^/^M_>@_Z[+_6
MEG^Y^-'^K/\ T\_#_@A_9']_\/\ @GZ_T5^.\O>HZK_5?_I[_P"2_P#!&LGO
M]O\ #_@G[&45^-\G4U"_2FN%_P#I[_Y+_P $?]C?W_P_X)^RU%?C%)T-124_
M]5O^GO\ Y+_P0_L;^_\ A_P3]GCUHK\6Y>]0/UH_U5_Z>_\ DO\ P2O[$_O_
M (?\$_:NBOQ.DZ&H7ZU7^JG_ $]_\E_X(?V)_?\ P_X)^V]8OP\_Y$^T_P"!
M_P#H;5^+,W2J-A_QYI^/\S5?ZI?]/?\ R7_@A_8G]_\ #_@G[G4U^E?AN_2H
MGZT?ZI?]/?\ R7_@E?V%_?\ P_X)^Y=%?A5)T-02=33_ -4/^GO_ )+_ ,$/
M["_O_A_P3]W**_!^HKC^E/\ U0_Z>_\ DO\ ]L-9#?[?X?\ !/WEHK\$9*BD
MZFC_ %0_Z>_^2_\ VP_[ _Z>?A_P3]\7Z4VOP)DJ%^]5_J=_T^_\E_\ M@_L
M#_IY^'_!/WC\'?\ ,5_[",W]*V:_GWM_^6G_ %T:D?[M-<&W_P"7W_DO_P!L
M-</_ /3S\/\ @G]!-%?SXR5#)T:G_J9_T^_\E_\ MA_ZO_\ 3S\/^"?T*4Q_
MO5_/'+_2H)_O'Z57^I?_ $^_\E_^V#_5[_IY^'_!/Z(J*_G3E[U7FZT_]2O^
MGW_DO_VQ7^KO_3S\/^"?T:45_.%+UJK+_2J7!%_^7W_DO_VQ7^K?_3S\/^"?
MTCU&>M?S8W-5I.AJEP-_T_\ _)?_ +8/]6O^GGX?\$_H_P!9_P"1LT7_ +;_
M /H K8K^9R;_ %E5Y?N'ZU7^HG_3_P#\E_\ MBUPQ?\ Y>?A_P $_IKHK^8N
M>JW\-4N K_\ +_\ \E_^V#_5C_I[^'_!/Z>:*_E_GZBJEUW^E7_J!_T__P#)
M?_MBEPM_T]_\E_X)_4717\M<G2HZ:\/[_P#+_P#\E_\ MA_ZK?\ 3W_R7_@G
M]3%1GK7\M=%/_B'W_41_Y)_]L'^JW_3W_P E_P""?U*45_+711_Q#[_J(_\
M)/\ [8/]5O\ I[_Y+_P3^I2BOY:Z*/\ B'W_ %$?^2?_ &P?ZK?]/?\ R7_@
MG]2E1U_+?11_Q#[_ *B/_)/_ +8/]5O^GO\ Y+_P3^I"BOY;Z*/^(??]1'_D
MG_VP?ZK?]/?_ "7_ ()_3MX5ZZG_ -?\O]*UJ_ESHH_XA]_U$?\ DG_VP?ZK
M?]/?_)?^"?U&45_+G11_Q#[_ *B/_)/_ +8/]5O^GO\ Y+_P3^HRFOTK^76B
MC_B'W_41_P"2?_;!_JM_T]_\E_X)_4117\N]?J)_P2._X*X_\@SX5_%34_[M
MKX?\074GX):W+G\ DA]E;L:\W-."J^%H.M1G[2VZM9V[K5W./&\.U*-/VE.7
M-;=6M^K/U"?I3:<_2FU\2?.A1110 U^E-IS]*;0 4444 (_W:FT7_D,6O_79
M/YBH7^[4VB_\ABU_Z[)_,4 :OC[_ )"$/_7/^IK!K>\??\A"'_KG_4U@T %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'I%%%% !1110 5\J_MU_\%D_@E_P3Z\3KX>\8:GJ^L^*S
M ER^A>'[1;N\MXW(VM*7>.*,E3N"O(&*X8+AES]55_.W\2?BE_P[I_X+X^-O
M&GQ@\&W'B/1YO%.IZG%#<;;A_P"S+]Y3:WEOORDAB@D4!,@ QM'E&3Y0#]</
MV%/^"TOP3_X*!^-G\+^$KKQ#H?BKRVFM](\06*6]Q>HBLSM$T4DL;;57<1O#
M8.<<''UI7S#^RQ\8_P!F7_@H%\4-/^+WP\D\+:Y\1O#5I);O>?9VL=?T^*6)
M(W2YA8)))&%;RU=P\8)<1ORV? OB;_P6&^(G@G_@ME9?LW6WA[P7)X'EU/3M
M/EOI;>Y.K'[3IL-TSK()Q$-KS8 ,1^5>N3D 'Z-T5\'_ /!<;_@J#X^_X)G^
M%_AU>^!-(\'ZM+XNNKZ"\&O6MS.L:P) R>7Y,\6"?-;.<]!C'?&_X*C?\%<_
M'G[&?['7P6^(O@WP]X1N=6^)\,%U>6VM17%S;V:26*7!2,12PL2&D W%NB].
M<@ _0FBOS,_8V_X+5_&/]M/]M'PYIN@_!&XL?@'K^HW6EKXE;3;^XEC>*&9U
ME:^ 6U0DQJ6A,9*@E=Y/S4O[0O\ P6>^,7Q*_;7\2? _]ECX6Z%X\U_P0]S%
MK5YXA=HHS):RF&Z\M3<6RI'',T<8D>3YVR%4AD8@'Z95\*Z]_P %M]/T;_@J
M;'^S4/AW>R[M4@TC_A(SK*KB>2W28G[+Y)^0;MN?-R<9VC.*^:_@!_P6@_;$
M^)O[=-G\$=5^$_PCA\3:9JBQ>(=*5IK&Y@M(W1KIH9Y-0>)F6!F=3&LV5&Y4
MD48/HGC?]OR]TC_@X4L?A'#\,?A$X26UTT^,)M 9_%8BFT9;ME2]$HVKF4QA
M=A&S([T ?IQ_RTIA^\*^!O\ @I]_P6BO?V2OCSHWP9^%'@^V^(GQ:UD0H]M/
M*QM=-FN /LL#11D22S.&5RF^,+&\9W'?\NI^QS^WQ^T=>?M1^'_A1^T7\$=+
M\%:AXQT^\U#1M<T"\$UABV4O)'(%GN4W8VC_ %P92R90B0$/J!]R#^*D/W17
MP1^T9_P4V^//BW]H?QE\,OV:_@0/'%YX$NEL-6\2Z_<^1I27059)(%!E@3(1
MAC=<!R6SY> "W)_L)_\ !:/XB^.OVV7_ &??V@/AYH7@7QW+/):P3:;*\$$%
MPD#W"Q2))+,'$L83RI(Y2K[UV[@ZFF@-K_@I5_P5F^(/['?_  4)^%OPB\,:
M'X-O= \:VFEW.H7>J6US+>1_:]2GM'$1CGC1=J0@C<K?,W/ Q7Z#25^*W_!=
MG_E-M^S]_P!@OP[_ .GZ]K]J9*8SX@_X*A_\%G;'_@FM\8O"GA.X^'UWXO\
M^$AT[^U+JZCUA;'[%#Y[1 (AAD\U_D<X+1CA1GDE?MI^M?FM_P %P?V[;O\
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M7Z4VG/TIM !1110 C_=J;1?^0Q:_]=D_F*A?[M3:+_R&+7_KLG\Q0!J^/O\
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M:AX3\=)J5[I?B"W9@LL<0DM(H[? 9F^_G:,*P=5R ?M%17PK_P %!_BEX_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#TBBBB@ HHHH *^>?$"?LV_P#!4KPOJ7AK
M4#X$^*4>A37-G<6CL/[2T:19%CF:,_+<VV65!YD93<-N&((KZ&KX2_:2_P"#
M=3]G']HWQ]>>)!9>+? ^HZG<27=\OAG4TBM[N:1V=W\JXBG2/);[L011@84<
MY /S ^%'PKTG]DS_ (.!O"'@[X$^([GQ#H6F>,[*P,ZSK,T5I*J#4[5I!A91
M#$URA/7]WW=>?6OVK;N+P%_P=-:-JFLR1Z;IU[XA\/207%PP2-U?2K2W4Y[
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M2I:BN/Z4RD5I*BDZFI9*BDZF@H@DJ%^]325"_>M *=O_ ,M/^NC4C_=I;?\
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M^NR?S%0O]VIM%_Y#%K_UV3^8H U?'W_(0A_ZY_U-8-;WC[_D(0_]<_ZFL&@
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MIX?OOB7I&D:!XYNX&EU73=,E\VULG+L4C5][AB(]@8AV!;=@XQ7;44 ?'_\
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MYVPHV]:^RZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*;)U-:+:)D?ZS_QW_P"O2-H6[_EK_P"._P#UZ:F@NC,/W*8W>M7^P/E_UO\
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M3_A ?^GO_P A?_7JO;0[ASQ.:?K37^[73-\/\G_C[_\ (7_UZ:?A[D?\??\
MY"_^O35>'<.>)RQ^\?I4;]*ZO_A7'/\ Q^?^0?\ [*FM\-<C_C]_\@__ &55
M[>GW'[2)RC]/PIC=!76M\,]P_P"/W_R#_P#94A^&.1_Q_?\ D'_[*CV]/N'M
M(G)2=34==@WPPW?\OW_D'_[*F_\ "K/^G[_R!_\ 94_K%.VXU4B<:_>F-T%=
MF?A1G_E__P#('_V5(?A-D?\ '_\ ^0/_ +*J^LT^Y7M8]SA9>M,DKMY/@_D_
M\A#_ ,E__LJ:WP>S_P Q#_R7_P#LJ?UFGW#VL>YP_P##4?>NZ_X4YQ_R$?\
MR7_^RI!\&.?^0C_Y+_\ V5/ZS2[A[6/<X,=*;)7>?\*5Q_S$O_)?_P"RI&^"
MF[_F)_\ DO\ _94_K5+N'M8]SS[M3'ZUZ"/@=_U$_P#R6_\ LJ1O@7D_\A/_
M ,EO_LJ:Q5+N5[:%]SSO^#\:8/OUZ)_PHCC_ )"G_DM_]G2#X#?-_P A7_R5
M_P#LZKZW2[_F/VT.YYRW;ZTQ^]>D'X Y_P"8K_Y*_P#V=-;X 9_YBW_DK_\
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M5?\ ;F!_G_!_Y#68X?\ F_!_Y'QI)U-0OTK[/;_@DD6_YGX_^"+_ .Z*8?\
M@D8S#_D?S_X(O_NBFL\P/\_X/_(K^TL-_-^#_P CXLDZ&HI*^U6_X)"LW_-0
M#_X(?_NBF-_P2!+?\U!/_@A_^Z*K^W<#_/\ @_\ (/[2PW\WX/\ R/B>7O4#
M]:^VG_X(_,W_ #4$_P#@@_\ NBF-_P $>&8_\E"/_@@_^Z*/[=P/\_X/_(O^
MT\-_-^#_ ,CXBDZ&H7ZU]P-_P1S9O^:AG_P0?_=-,;_@C:S'_DHA_P#"?_\
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MU\)_/^#_ ,C\XI>]5YNM?I W_! %W_YJLW_A+?\ W74;_P#!OR[_ /-5V_\
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M'14GV.;_ )Y2?]\FC['-_P \I/\ ODT 1T5)]CF_YY2?]\FC['-_SRD_[Y-
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MN_\ OA?_ (JG[&?8.278Z.BN;/Q0L!_RQO/^^%_^*I#\4M/'_+&\_P"^%_\
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MU2M_*'L*G8],\RF>?[5YK_PU/X?_ .?/6?\ OU'_ /'*C_X:G\/_ //GK/\
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M[/ZT?;O]G]:^>3_P4;\$#_F%^*O_  &M_P#X]33_ ,%(/ Z_\PKQ7_X#6_\
M\>H_LS%?R,/JE;^4^B/MW^S^M'V[_9_6OG7_ (>2>!O^@5XK_P# 6W_^/4T_
M\%*/ P_YA7BS_P !;?\ ^/T_[+Q?\C#ZI6_E/HS[=_L_K1]N_P!G]:^<3_P4
ML\"C_F$^+?\ P%M__C]-;_@IEX$7_F$^+?\ P%M__C]']EXO^1A]3K?RGTC]
MN_V?UH^W?[/ZU\V'_@IOX#!_Y!/B[_P%M_\ X_3?^'G?@+_H$>+_ /P%M_\
MX_3_ +*Q?_/MC^IU_P"5GT-KOBG^QC:?N/,^U7*6_P!_&W=GGI[5=_M+_8_6
MOE7Q;_P4L\"WC:=MTGQ:/)O8I6S:V_(&>G[^M!_^"H/@%!_R"/&'_@+;?_'Z
M/[*Q?_/MA]3K_P K/IK^TO\ 8_6C^TO]C]:^8F_X*D?#]?\ F#^,?_ 2V_\
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MK_L?K1_:O^Q^M?*1_P""M7PY7_F"^-O_  #M?_DBF'_@K?\ #@?\P7QO_P"
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M_P#'O_K5\.^'?^"SWPNT[[=OT'Q\?/O))5VV5IP#CK_I/6KY_P""VGPJ _Y
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MJ8W_  79^$:?\R[\1O\ P LO_DJC^PLP_P"?3'_9F*_D9]R_\)!_TR_\>_\
MK4?\)!_TR_\ 'O\ ZU?"[?\ !>#X1+_S+GQ'_P#!?9?_ "74;?\ !>CX0+_S
M+GQ)_P#!?9?_ "73_L',/^?3'_9F*_D9]V?\)!_TR_\ 'O\ ZU(?$>#_ *G_
M ,>_^M7P@_\ P7Q^#T?_ #+?Q*_\%]E_\EU"W_!?;X.@G_BF_B7_ ."^R_\
MDNG_ &!F/_/IA_9>+_D9]T7OCDVFKV5K]F#?:_,^;S/N;1GICFKG_"2?],?_
M ![_ .M7Y\:E_P %Z_@_<:[I]P/#GQ)V6OF;P=/LLG<N!C_2ZN-_P<#?!I1_
MR+7Q-_\ !=8__)='^K^8_P#/EC_LK%_\^V???_"2?],?_'O_ *U'_"2?],?_
M ![_ .M7P __  <'?!E/^99^)W_@NL?_ ),IG_$0K\%\?\BQ\3__  76/_R9
M3_U>S+_GRP_LK%_\^V?H!_PE'_3'_P ?_P#K4?\ "4?],?\ Q_\ ^M7Y]/\
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M^%@G_GU'_?S_ .M7.44 ='_PL$_\^H_[^?\ UJ/^%@G_ )]1_P!_/_K5SE%
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M?_6H_P"%@G_GU'_?S_ZU<Y10!T?_  L$_P#/J/\ OY_]:C_A8)_Y]1_W\_\
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MTJ.I).E1U:*"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "O?_V
M/V__ !-^PI\3?MMEYNJ>%-4=5UK16DPET@X\V//"3*.C=_NGCIX!16&)PU+$
M4G1K*\7NC*M1A5@Z=173/Z6?@A\<O#/[1OPQTSQ=X1U*+5-%U1-R.O#PN/O1
M2+U213P5/3Z8-=77\_/[ 7[?WB;]A7XF?;;$RZGX4U1U76M%:3"72#CS8\\)
M,HZ-WZ'CI^['P.^.7AG]HSX9:;XN\(ZE%JFBZHFY'7AX7'WHI%ZI(IX*GI],
M&OQCB#A^KEU6ZUIO9_H_/\S\^S3*YX2=UK![/]&==1117SIY(U^E-IS]*;0
M4444 (_W:FT7_D,6O_79/YBH7^[4VB_\ABU_Z[)_,4 :OC[_ )"$/_7/^IK!
MK>\??\A"'_KG_4U@T %%%>'_ /!1+]LBU_83_92\0^/Y+:'4-3M_+L='L92P
M2\O9CMC5B.=B@-(W()2)@""10![A17Y[?!G_ ((W_P##4/@K3/'/[4/BWQWX
MW\>:_'_:,VAMJTEKIGAQ9OWBVD<*@,CQ[V#!&6-6)55(7>_OO[(G_!/D?L7?
M$W4+GPM\1_&VH?#Z]TH64/@W6KHWUIIMPK0^7<V\K-F+"),I0+AO.7)Q&HH
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M5" 2H)R1G(_9J_X*"_!K]K_49[+X=^/M(\0:C;1F5[!DEL[TQ@X+K!<)'*R
MXRRJ0-RY(W#(![)17E_Q1_;1^&'P3^)-QX2\6>+K'0-=M/#Y\4S17D,T<,6G
M"9H/.,^SR<F52@CW^8QP IR,\[^SI_P4I^!W[6'CBX\-> ?B#IFMZ];*7^PR
M6UQ937"@,6,(N(X_/VA&+>5NV@9. 0: /<J*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /2**** "BBB@ K\,?C_\ \K6]A_V,F@_^F.SK]SJ_#?X^
MZ?</_P '6^FX@F/F^(-#E3"'YT70[7<P]0-K9/;:?2@"S_P<%>)_%WA[_@L=
M\%F\$ZQ)HOBD^%=+M]'O-J2"RN;C5=1A$@5P4S\R\D=AZ"N9_P""P/\ P2GU
M/_@G3\*_"?QP\/\ Q@^(WBKQX?$":?JVMZEJ!BOEGECN)4NK>53YT9'E[6!E
M=B7W!L$@=E_P7;M);_\ X+G?L[001R333:;X:CCCC4LTC'Q!?   <DD]J^G/
M^#H"WDF_X)KVC(CLL7C+3WD*KD(ODW2Y/H,D#ZD4 >(?\%2OAIIW[=G_  1)
M^'_[2WB^]U4?$7P;X<L60V1BM['49;W4;&TN6GAV-TP[IY31@,YR",*,W_@W
MH_X)7?#OXI_#+P;^T-J>J^,!XS\->(KL6MC!>6ZZ4YA&Q"\9@,I/SDG$H!('
M&,@^RZ9\"M>_:3_X-D]*\'^%].NM7UZ^\(6EW9V5MCSKMK74H[LQH/XF(@("
MCECA1R17D7_!OQ_P4H\._!OP-X;_ &;M5\&>/F\<ZAXENY);F&PB^PZ?!,%*
MR3EI%E3#X5@8\ ,IW$G;0!\__M6?MI^&?^"B7_!2/Q?X>^.WQ:\2?"_X!>$K
MF\T_3]/TB*XO!??99Q%& D$,R>?,X:X,TL4BHJ>6"<1FJ/P8_:K\#?\ !.W_
M (*(_#Z#]FSXQ^-_B%\&O$EW96OB/2=4M9X-HFG\F:,QS16\<LJ@^;'*L494
MOL+$;RV[\3?@@O\ P2&_X*B^+?$_Q:^"=E\6?@OXSN-0DTV:ZTR#5K>.RN+F
M.Y$\(G4Q"]ME7RF27RR09,,$D60_3_[,W[?O[,W[3O[2/@;PY\&_V+K"^DOM
M9MX[[Q!=>"M(T]?#*AMYO UM'<<Q85QEXO9@0,@'C7_!Q)XD\7:%_P %<_A(
M/ ]_-8>*YO!=A9Z+,D_E&UN[G4M3MUD1\@1OEUP_8JI_AKZC_8A_X)._%+_@
MFAX?^,/Q*A^(\GQ*^(?B7P->+:Z3!8RG[5K4:O- QFFE8W!WHJ*SQJ3YSY
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MMG:8XR<8<&OKW]E#XWWG_!23_@E]XW\!K*TOQ!\/:(=$G1W -^XB+64S.V%
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M) / /V#=>\4>(?\ @N9\3=0\7?#>'X3Z]J_PV^V7^@P:U;ZJDDGVS3E6Y::
M+&SN,D\9&3GDFM#_ ()0_L[>"O'7[:?[67C/7/#NFZSXATGXF:IIMA<7T(G%
ME$U[<2/Y:-E5=F"_/C< N 0"P/O'[+O_  3.E_9Q_;!U;XPWWQ.\2^.]:\1>
M%GT#51KELC3W-PUW#,+A)495CB6*WBB6 1X7!._^$?(?[&G[&NL_M ?M2?M3
M>*O WQ,\0_"?Q[H7Q2U?3HM8T^W6^M[NRENYWDMY[5W5)!N0,K;@5;D[L+@
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M_ EKX?\ V7/AYX\N-9,/QN\ ZWIH\)W=A;;KO7M0=XUFM8X5QE79?/P%R/(
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MQ-\,_!7CG4)M5U+PU%X?M=2\FYG_ -<]M/,_[@G"A66/>JHHWMM!'8?LD?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /2**** "BBB@ HHHH **** "BBB@ HHHH
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M1!)T-125+)T-1258$,O>H'ZU/+WJ!^M!H0R=#4+]:FDZ&H7ZUH!6FZ51L/\
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MF<9Q7S&M[6KHELNB7^?=GYUC\?4Q=3GGMT78****\@X1K]*;3GZ4V@ HHHH
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M13_S!]*_\!(_\*T]U&ZCGEW#F9F?\(%HA_YA&E_^ D?^%(? &B'_ )@VD_\
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MK%7^9_>'M9]V<E_PR]\/C_S(O@K_ ,$EM_\ $4?\,N_#P_\ ,B>"O_!';?\
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MG ']A+X1-_S2SX9_^$O9?_&J:?V#?A"?^:5_#+_PE[+_ .-5Z#]KE_YZ2?\
M?1IAO)L_ZV3_ +Z-/ZW7_G?WL/;U/YG]YYI>?\$_/A+<:I:3+\,/ADD4&_S(
M_P#A%[/]YD8'_+/L:M']@;X/'_FE/PO_ /"6LO\ XU75ZOJES'XGTA%N)PDG
MG;E$APV$&,BM7[;-_P ]9/\ OHT?6Z_\[^]A[>K_ #/[SSX_L!?!P_\ -)_A
M=_X2MC_\:I/^'?\ \&_^B3?"W_PE+'_XU7H7VV;_ )ZR?]]&C[;-_P ]9/\
MOHT?7*_\[^]A[>K_ #/[SSH_\$^_@V?^:3?"S_PE+'_XU2'_ ()[_!ENOPD^
M%?\ X2=C_P#&J]#^W3?\]I?^^S1]NF_Y[2_]]FG]<Q'\[^]A]8J_S/[SSO\
MX=Y_!<_\TC^%7_A)V/\ \:I/^'>7P7_Z)%\*?_"3L?\ XU7HOVZ;_GM+_P!]
MFD^VS?\ /63_ +Z-'US$?SO[V/ZQ5_F?WGG?_#O+X+_]$B^%/_A)V/\ \:I#
M_P $\?@OG_DD?PJ_\).Q_P#C5>B_;9O^>LG_ 'T:8;Z;/^ME_P"^S1]<Q'\[
M^]A]8J_S/[SSS_AWA\%_^B2?"K_PD['_ .-4?\.\/@O_ -$D^%7_ (2=C_\
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MKX-?]$G^%?\ X2=C_P#&J],L?AZNF64-M;&WM[>W18HHHH]B1(HP%4#@
M"J']I7'_ #WF_P"^S1_:5Q_SWF_[[-9U*U2I\<F_5D2J3E\3N:;>"I2/]='^
M1I/^$'E_Y[Q_D:S'U.Y _P"/B;_OLTW^U+G_ )^)_P#OX:R(-7_A!Y?^>\?Y
M&C_A!Y?^>\?Y&LK^U+G_ )^)_P#OX:/[4N?^?B?_ +^&@#4;P-*P_P!?'_WR
M:3_A!)?^?B/_ +Y-93ZI<@?\?$__ '\--_M6Z_Y^)_\ OX: -;_A!)?^>\?Y
M&C_A!)O^>\?Y&LG^U;K_ )^)_P#OX:/[5NO^?B?_ +^&@#6;P'*1_P ?$?\
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M$ F_Y^(_^^31_P (!-_S\1_]\FLC^UKK_GYN/^_AH_M:Z_Y^;C_OX: -?_A
M)O\ GXC_ .^31_P@$W_/Q'_WR:R/[6NO^?FX_P"_AH_M:Z_Y^;C_ +^&@#7_
M .$ F_Y^(_\ ODT?\(!-_P _$?\ WR:R/[6NO^?FX_[^&C^UKK_GYN/^_AH
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M\//V1/VE/"'PL\2:7XOOO$?C2&TGLY=,M+>2T@6YNI+6,RO)/&P_>1N3M5L
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MBNP61<3Q'>'_ );?^.+_ (4/XCO!_P MO_'%_P *I1T24^6/8+(N?\))>_\
M/;_QQ?\ "F'Q->Y_UW_CB_X54J,]:2C'L%D7F\3WP'^O_P#'%_PIO_"4W_\
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M$/\ R!%_\33#\8?$>?\ D(_^2\7_ ,37.U&>M7[&G_*ON#DCV.E?XQ>(P/\
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M.M>=0_MU>$)?V)/^%]FR\0Q^#O['.M?9&MXO[2,08H$\L2F/>6X \S;SRPH
M]HHKX9T/_@OC\-]:\.Q:X?A;\?;3PR\9F?7)?"D+Z=#$,AI&ECN6&P$$$@&O
MJ3]FO]JCP%^UW\/%\3_#[Q#:>(-*$GDSF,-'-9R[0QBEC<!XW (X(YSD9'-
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MO%VG^(]1TW4=7@T6*+1;1+F=9I4D=696= $Q$V3G.2H )- 'KU%%% !1110
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M;>>V#1)'-#,)9 I8[E957<#U(%<O_P ',G_)XGP2_P"P8W_I:*])_P"#J?\
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MQ#XW\??\%UH=&T#P[IWCC6/#\NCVOAOP_K["32[XFRANO+9'DB3RC-+(6!<
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MR"K8X="R'D;MP('G/[9/_!9+X*?L5>.'\+Z_J&M>(/$]J%:\TOP_:)<RV&X
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M96OPN3]A+1KCX<P"'4+B0_\ "5^?,)K[^U%4!Q*VU?DV[3$  HC8=6+D_9-
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M]DJY^#GPD\067Q*^('Q/OM/M-,TO0R\\D:17<-T\LC!-B8$ 4J[(0'+'Y4;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ](HHHH **** "ORI_
M;I_X(N_M!?%O_@IQK7[07PD\<?#;PW<2SZ?>:0^KSW!N[&>VL+>U8M%]BGA8
M$PL1DD889&17ZK44 ?#/['?P'_;Q\&?M&^'=2^,_QJ^&?BWX:VWVG^V-)TFQ
MACO+O=:S+!L9=+@(VW!A<_O5^5#U^Z?#O%W_  0>^+G[+G[4FK?$/]D?XJ:%
M\/+/5H'0:3KGFR)9K(?WEMS!<1SP _-'YL99"%Y+*)*_5>B@#\SOV;/^"&WC
M_P 7_M;Z5\<OVGOBE8_$;QCHMU#=VNF:5;DV#20$F ,[Q1*L2':XAC@1=^[)
M.3N^C/\ @KU_P3ZN?^"CO[)$O@S1KO2--\5Z7J=OJ^B7FIM(EM%,FZ.1)'C5
MW"M#+*.$8;@AQP"/J6B@#\^O^",7_!'?Q#^P#H?Q+D^)^I^%O$^K>/+>VTF-
M-(N+BX@@TZ)) \;/-%$V9#(H*A2 L*8/) ^:OV5/^#9WQ]\(_P!LCPMXE\5^
M+? FJ?#/PGXA_MF&QBN+JZO[V.&0201RPO;1PYD,<(E^<C ; <  _LU10!XC
M^W]^PMX5_P""A_[.%_\ #WQ5/>:>IN8]2TO4[3!FTJ^C5UCG"'Y9%VR2(R-]
MY)' *-M=?A#X._\ !,;]OW]F'X?V_@7X?_M&?#VS\$VK.MO%>Q/<3V:.<%83
M-I\SQJ% *HDJJK%L8)+']6TZ424 ?*?PX_8D^)?A[_@G)\3/A7XQ^)]Q\2OB
M#X_TC7+9-=UF:?[-:37UH\$4(+&1TMXV(.%7C<^U.@KG?^"*7_!.;QC_ ,$W
M/@)XK\->-]7\,ZMJNO\ B ZG$=#FGFMXH!;0QKN>:*)MY9'R F  IW')"_9E
M*_WJ?4!IZ5\%_P#!4_\ X(OG]N'XG:'\4/A]XOE\ ?%;0O(1=0>25;>X6 L\
M$@:+][!<1OM*RIT"_=R 1]Z'I34ZT=0/S+D_8(_X*%_%+3;?0/&G[4_A30M!
M\R,2WGAJW9-22, JS"2&RM)68 ]#. QY)! ->L_\%A/V$OC3^W=\&?"_PX^&
M_B+P7I/A6TE%YK\_B/4;N.]U6:(*MNG[FVD4HIWR.6.6?RR NSYOMR2D3K1U
M _.;]N?_ (()Z1\8_P!B7X<?#SX:7>AZ3XO^&($-GJVK1_98M7BEYNS<O!#)
M)N>3]ZN 0&W _>W#O?B'_P $R_''[4W_  2C\/?!#XI^*]&C^('A6.$V6O:3
M)-=V4TEH9([0S>;'%(^;9A'(<;M^9,L?E/VX_P!ZA>AJNH'P)_P2F_8'_:@_
M8W\4:5H_Q(^+7A36?A5X;TNZM=,\.:0TMVQFFD1QNDFM875$*EE^=]N2BJJN
MU4_V)/\ @DQ\0?V<O^"J7Q1^.>OZ[X.N/"OC*ZUVYTVST^YN9=07[=J"W$2S
M(\"1IMCW;BLCX8 #(.X?H-1VI@>*_M]?L.>%O^"A'[.M]\/_ !3/>:>IN(]1
MTO4K3!FTN]C5UCF"GY77;)(C(?O)(X!1MKK\*?!__@F=^WM^S+X"@\#> /VB
M/A]9^"[5F$$5Y$]Q/9HW!6$S:?,\:A0"$2555BV,$EC^JM,?[U T?+?PX_8J
M^)/A[_@G3\2OA;XO^)MQ\2/B!X]TG6[9-<UB:?[-:S7UH\$4(+&1TMXV(.%7
MC<VU.@KF_P#@B[_P3N\8?\$Y?@-XI\-^-=6\-ZKJNO:^=2B.B33S6\<(MX8Q
MN>6*)MY97R F  IW') ^R1]RFT!U/SY_8I_X)._$#]G/_@J?\4?CEK^N>#KC
MPMXRNM=N=-L]/N+F74%^W:@MQ$)E>!(TVQ[MQ61\, !D'<*G[>W_  2!\>?M
M9?\ !2OP#\8-%\1^$=.\*>'5T@ZC!?27 U$-:7DDT@AC2)HW!0I@M*GS%@0
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MI?\ !.3X)^(M/\3:AH6K>,/%>J+=7USI/F-;1VT2;+>$22(COM+3.254 S$
M<;F^OHZ'Z4#Z'YR_M7?\$6?&O_#7L_QM_9T^(MM\/?%NKW4NI:E;:D\GV?[9
M(=TCQLD<FZ*=\M)#*CKN9L94B->I^!7[%_[8FL_'#PKXA^,G[1&EW7A[PQJ4
M=]-H_A>-K=-81,GR)_*M[161B<,'$@QVX&/N\=:#UH$(>E?GY_P4K_X(^>(O
M^"@7[;?A#QF^MZ#IO@'3O#D.AZM&;J:/5PR7%Y*9+=! \38^T1D;W&2K C'7
M] STIJ=:"I'Y7_%?_@C?^U/^T7IWASP%\0_C_P"'M=^%GAB:/[(?*F_M!D55
M3?)$(%$\JKN"F:YD(R<,-S5]&_MO?\$RI_BI_P $Y=(^!'PIGTC1X= N;-K.
M37;J41M'"SM(TDD44C&1V=F.$ RQ^Z,"OL22FTUN+H?,GP'_ ."?%E8?\$T]
M'_9^^)K6>M6ZZ8]EJDNE3R+'YANWN8Y()&56S'(8V4LF"T8RI&0?DOX4_P#!
M)S]K_P#8XTW7/#GP6^._@O3_  ?JMW)/Y&IPNLG3:LBQO9W*PRLOWC$XR57D
MX&/U+/6D/2K$?&O_  3)_P""1]E^PCXJUOQMXA\4S>.OB)XC@:"YU"2$I%:H
M\GF2["Y:1Y)&"EY&()QT&3GQWXS_ /!%3XE?"K]JS4/BM^S/\1]%\$:AK$TL
MT]CK0?9:&8EYT1Q#.LL3.%(CDCX]3M%?I8.E))0!\L?L$_L7?$SX%?$#Q9X]
M^,'Q4NOB-XU\5V\5CY4(9--TVWCD>0+$I"A<LY(6..-$W/@,6S7B_P#P2E_X
M) >)?V/;/XHZ?\5+OP3XGT7Q_IMMI1L-+FN+F.:)3/YPF\V&+;D2(%V[B<L<
MKM&?T*?K41ZT%K8_/W_@G-_P2L^*G_!/3]K'7[_2_''AW5_@[KD<L,]A++.N
MJ7 52UK(\(A\D31N2I=9,,C.=HW!5_0*D/2EH$QLE$=$E$=-;E#3UI#TI3UI
M#TIR 2.B2B.B2F VHSUJ2HSUI(!'^[3*>_W:95#6XUNHIU-;J*=0.1&>M(_W
M:4]:1_NT"0RFR4ZFR4T6-'6@]:!UH/6K 1_NTRGO]VF4 -;J*=36ZBG4 1GK
M43_=J4]:B?[M #*;)3J;)0!B^+_^87_V$(OZUJ5E^+_^87_V$(OZUJ4 (_W:
M1.E*_P!VD3I6@T$E-ITE-I#D1TC_ ':6D?[M,D$^[224J?=I)*"QM1GK4E1G
MK0,1_NTRGO\ =IE4@&/UI*5^M)5 1GK2/]VE/6D?[M #*#THH/2@:"HSUJ2H
MSUH'(R-:_P"1GTC_ +;?^@"M.LS6O^1GTC_MM_Z *TZ"1C]:C?K4C]:C?K30
M$1ZTC_=I3UI'^[5F@RF/UI],?K0 E1GK4E1GK5@-?I3:<_2FT/8:W,;Q=]_3
MO^OV+^M:-9WB[[^G?]?L7]:T:E%D9ZTU^E./6FOTJP&TQ^M/IC]: $J,]:DJ
M,]: &OTIM.?I3:L!C]:2E?K24P(SUK*\)?\ (MVW_ O_ $(UJGK65X2_Y%NV
M_P"!?^A&@#1J.>I*CGH ADJ&II*AH+6PC_=K3\%^"[[QYKD=C8Q[G;EW/W(5
M[LQ]/YT_P;X+OO'FMI8V,>YVY=S]R%>[,?3^=?2WP_\ A_8_#O0UL[-=SMAI
MYV'SSMZGV]!V_,GDQ.)5)66YA6KJ"LMP^'_P_L?AWH:V=FNYVPT\[#YYV]3[
M>@[?F3NT45X<I.3NSS&VW=C7Z4VG/TIM(1C>#O\ F*_]A&;^E;-8W@[_ )BO
M_81F_I6S0 4444 %,?[U/IC_ 'J $HHHH **** "HSUJ2HSUH Q]9_Y&S1?^
MV_\ Z *V*Q]9_P"1LT7_ +;_ /H K8H **** (Z*** "BBB@ J,]:DJ,]: "
MBBB@ HHHH *CJ2HZ "BBB@#%\*]=3_Z_Y?Z5K5D^%>NI_P#7_+_2M:@ HHHH
M *:_2G4U^E #:*** &OTIM.?I3: "BBB@!K]*;3GZ4V@ HHHH 1_NU-HO_(8
MM?\ KLG\Q4+_ ':FT7_D,6O_ %V3^8H U?'W_(0A_P"N?]36#6]X^_Y"$/\
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MNFI#"4,,8MV4QA(S&A5=N%V+C&!71T4 <UX]^#7A#XJ^&XM&\4>%/#?B32(
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M5^BCF879GMI,C=T_.D72) >J?F?\*T:*.=A=F<=(D)ZI^9_PI#H\A'5/S/\
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M?_?;?_$UV>MS:?%]D^V!3NN46#*DXEYV]/QJ[E*/;S#VDCSYOA=J!'^NL_\
MOMO_ (FA?A;J '^NL_\ OMO_ (FO0=R>E&Y/2G]9F'M9'GS?"W4&_P"6UG_W
MVW_Q--_X57J'_/:S_P"^V_\ B:]#W)1E*/K,P]K(\Z_X51J/_/:R_P"^V_\
MB:1OA/J)'^NLO^^V_P#B:]&RE&4H^LS#VDCSE?A/J('^NLO^^V_^)H;X3:B?
M^6UE_P!]M_\ $UZ-E*,I1]9F/VLCS?\ X5+J/_/:R_[[;_XFFGX1:D3_ *^Q
M_P"^V_\ B:]*RE&4H^LS#VTCS1_A%J6W_7V/_?;?_$TS_A4.I?\ />Q_[[;_
M .)KTYC'CFFYBI_6IA[:1YBWP?U,G_7V/_?;_P#Q-)_PI[4_^>]C_P!]O_\
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M_*D9H<\X_*CZW4#VTCQX_ K5R?\ CXT[_OX__P 12-\"=7(_X^-._P"_C_\
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M/_'UI/\ W]D_^(KWGS+?V_(TF^W]/T-'UVJ'UF9X*_[-NN'_ )>M*_[^R?\
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M+_NK_P!\&F_:M*_NK_WP: ,.BMW[3I7]U?\ O@T?:=)]$_[X- '$>%>NI_\
M7_+_ $K6K5TR^\/R?:/LRQC$["7$3#,G&[M5K[5I![)_WPW^% &!16_]IT?T
M3_OAJ/M6D>B?]^V_PH P*:_2NA-UI']U/^^&_P *0W6C_P!U?^^&H YVBNA^
MUZ-_=3_OVU'VO1O[J?\ ?MJ .<?I3:Z1KO1L<JG_ '[:D^V:*/X4_P"_;4 <
MY171_;-%_NI_W[;_  H^UZ)_=3_OVU '-/TIM=,;O1!_"G_?MJ3[9H?]U/\
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M )@W_84@_P#9JWJ^=_%WBK5'_LS.HWYQJ$1&;A^.OO6Q_P );JO_ $$M0_\
M A_\:/J<NX_J[[GN%%>&-XNU7=_R$]0_\"7_ ,::WB[5MO\ R$]0_P# E_\
M&CZG+N+V#[GNM%>$?\)?JW_04U'_ ,"7_P :C_X3'5_^@IJ/_@2_^-'U.7</
M8/N>]T5X$_C+5P?^0KJ7_@2_^--;QEK&W_D*ZE_X$O\ XU7U&7<KZL^Y[_17
MS[_PF>L?]!74O_ I_P#&F?\ ":ZS_P!!;4__  *?_&CZC+N'U9]SZ%HKYX?Q
MMK(_YBVI_P#@4_\ C3?^$VUG_H+ZG_X%/_C5?4)=P^K/N?0[]*;7SR_C;6<?
M\A?4_P#P*?\ QJ$^-]:S_P A?5/_  *D_P :GZC+N/ZJ^Y]&45\XOXXUH?\
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M_&#P=X^\6IK7ACPU97MQI>GII5E:K9LFHQPIB2*)96"QL5^=VSU.3S7ZB/\
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MA_:^^(/[%G[(&@^)_AMKB>'M>U+Q?:Z3-=M8V]X?L[V=[,RA)T= 2T$?.W.
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MV_\ !"?Q_P"/X[6'3]3N-"FL=8L8BQ2SO89HUD52>=C I(O)(25026!KB/\
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M R-9_P"1DTG_ +;?^@"M*LW6?^1DTG_MM_Z *TJ (ZBG^_\ A4M13_?_  H
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MI3J:_2@!M%%% #7Z4VG/TIM !1110 U^E-IS]*;0 4444 (_W:FT7_D,6O\
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M\)OV6_B)KWBOP)X270_$'B9&CU*\_M&[NFN%:3S6 6:5U0%\'Y .@["JC_\
M!/+X-I^THGQ?B\$6EM\0TN3>?VK;WMU &F:,QM*T"2B!G96;<QC)8DL<MS0"
M/9J***!L8_6E_P"6=(_6E_Y9TT4-IJ_?-.IJ_?--;@(_6FGI3GZTT]*&!"_6
MHCUJ5^M1'K5 -;J*4]*1NHI3TH*D,J,]:DJ,]: 0U^E(GWJ5^E(GWJM;%"4Q
M_O4^F/\ >I@,?I3J:_2G4 1TQ^M/IC]: &O]VF4]_NTR@".FM]\4ZFM]\52
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M2FT 8W@[_F*_]A&;^E;-8W@[_F*_]A&;^E;- !1110 4Q_O4^F/]Z@!****
M"BBB@ J,]:DJ,]: ,?6?^1LT7_MO_P"@"MBL?6?^1LT7_MO_ .@"MB@ HHHH
M CHHHH **** "HSUJ2HSUH **** "BBB@ J.I*CH **** ,7PKUU/_K_ )?Z
M5K5D^%>NI_\ 7_+_ $K6H **** "FOTIU-?I0 VBBB@!K]*;3GZ4V@ HHHH
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M>EM_WTW^%-/P[O2?]9;?]]-_A3]K#N'/$YY^E.K>;X<7Q'^LM?\ OIO\*/\
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MUJ?V?-_SS:@"&BIO[/F_YYM1_9\W_/-J (:8_P!ZK/\ 9\W_ #S:FMILY/\
MJVH KT5/_9LX_P"6;4G]G3_\\VH AHJ?^S)_^>;4?V;/_P \VH @J,]:M?V=
M/_SS:FG2[C/^J:@#G]9_Y&S1?^V__H K8JGJOA^\F\2:5*MO(8X?.WMV7*@"
MM/\ LNX_YY-0!!14_P#9=Q_SR:C^R[C_ )Y-0!4HJQ_95Q_SR?\ *C^R;C_G
MD] %>BK']DW'_/)J/[*N/^>3T 5ZC/6KG]E7'_/)Z8=(N<_ZEZ *U%6?[(N?
M^>+T?V1<_P#/%Z *U%6?[(N?^>+T?V1<_P#/%Z *U1U=_LBY_P">+TS^Q;K_
M )XO0!5HJU_8UT/^6#TG]C77_/!_RH YSPKUU/\ Z_Y?Z5K5!X=\,W]J;_S+
M65?,O))%R/O*<8-:/]AW9_Y8/0!5HJW_ &%=_P#/!Z3^P[O_ )X/0!5IK]*N
M?V'=_P#/!Z1]"NR/]0] %*BK?]@WG_/!Z/[!O/\ G@] %)^E-J\^@7A'_'N]
M-_X1^\_Y]Y* *=%7/^$?O/\ GWDH_P"$>O?^?=Z *+]*;5]_#UZ1_P >[TW_
M (1V]_Y]Y* *5%7?^$=O?^?>2C_A';W_ )]Y* *+_=J;1?\ D,6O_79/YBIV
M\.7NW_CVDJ72M O(=3MW:WD"I*I)/89H L^/O^0A#_US_J:P:Z;QEI5QJ%[$
MT,32!4P2.W-8_P#PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U
M??\ /M)1_P (U??\^TE %&BKW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M
M)1_PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (
MU??\^TE %&BKW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24
M 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (U??\^TE %&BK
MW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24 4:*O?\ "-7W
M_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (U??\^TE %&BKW_"-7W_/M)1_
MPC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S
M[24 4:*O?\(U??\ /M)1_P (U??\^TE %&BKW_"-7W_/M)1_PC5]_P ^TE %
M&BKW_"-7W_/M)1_PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U
M??\ /M)1_P (U??\^TE %&BKW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M
M)1_PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (
MU??\^TE %&BKW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24
M 4:*O?\ "-7W_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (U??\^TE %&BK
MW_"-7W_/M)1_PC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24 4:*O?\ "-7W
M_/M)1_PC5]_S[24 4:*O?\(U??\ /M)1_P (U??\^TE %&BKW_"-7W_/M)1_
MPC5]_P ^TE %&BKW_"-7W_/M)1_PC5]_S[24 4:*O?\ "-7W_/M)1_PC5]_S
M[24 =U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% #6;!I-YH?K24 +N-&\TE% "[Z-])10
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MH_M23T3\JK44 6/[3D]%_*L_PIXHN-;T""ZE6(22[LA5('#$>OM5BL7X>?\
M(GVG_ __ $-J .B_M.3T7\J1M4D Z+^504U^E %C^UI?1/RH_M:7T3\JJT4
M6O[6E]$_*C^UI?1/RJK10!:_M:7T3\J/[6E]$_*JM% %E]7E Z)^5-_MF;_8
M_*JS]*;0!%X?\776J?;?,6'_ $>[D@7:IY5<8SSUYK0_MJ7T3\JYOP=_S%?^
MPC-_2MF@"W_;4OHGY4?VU+Z)^55** +?]M2^B?E36UR8'I'^7_UZK4Q_O4 7
M/[=F](_R_P#KT?V[-Z1_E_\ 7JE10!=_MV;TC_+_ .O1_;LWI'^7_P!>J5%
M%W^W9O2/\O\ Z],.OSYZ1_E56HSUH ;J'C.[M=<T^V58?+NO,WDJ<C:N1CFM
M#_A()_2/\JYG6?\ D;-%_P"V_P#Z *V* +W_  D$_I'^7_UZ/^$@G](_R/\
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M3_C6510!J-XRN@/NP_\ ?)_QI/\ A-+O^[!_WR?\:RGZ4V@#7_X32[_NP?\
M?)_QH_X32[_NP?\ ?)_QK(HH UF\:W8'W8/^^3_C3?\ A-[O^[!_WR?\:R7Z
M4V@#8_X3>[_NP?\ ?)_QH_X3>[_NP?\ ?)_QK'HH V&\<7@'W(/^^3_C4FG^
M,[N[U"")EAVR2*IPIS@GZUA/]VIM%_Y#%K_UV3^8H Z3Q1XBGT:ZC2(1D,FX
M[@3W^M9?_"=7G]V#_OD_XU+X^_Y"$/\ US_J:P: -G_A.KS^[!_WR?\ &C_A
M.KS^[!_WR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V?^$Z
MO/[L'_?)_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^[!_W
MR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V?^$ZO/[L'_?)
M_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^[!_WR?\ &L:B
M@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V?^$ZO/[L'_?)_P :/^$Z
MO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^[!_WR?\ &L:B@#9_X3J\
M_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V?^$ZO/[L'_?)_P :/^$ZO/[L'_?)
M_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^[!_WR?\ &L:B@#9_X3J\_NP?]\G_
M !H_X3J\_NP?]\G_ !K&HH V?^$ZO/[L'_?)_P :/^$ZO/[L'_?)_P :QJ*
M-G_A.KS^[!_WR?\ &C_A.KS^[!_WR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\
M_NP?]\G_ !K&HH V?^$ZO/[L'_?)_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^
M[!_WR?\ &C_A.KS^[!_WR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_
M !K&HH V?^$ZO/[L'_?)_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\
M&C_A.KS^[!_WR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V
M?^$ZO/[L'_?)_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^
M[!_WR?\ &L:B@#9_X3J\_NP?]\G_ !H_X3J\_NP?]\G_ !K&HH V?^$ZO/[L
M'_?)_P :/^$ZO/[L'_?)_P :QJ* -G_A.KS^[!_WR?\ &C_A.KS^[!_WR?\
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MI@8I+HUIXAM)]0C8$*0T"R&0$$@$%>I'K7XX?\&G/_)QOQ7_ .Q;MO\ TJH
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M* "BBB@ J.I*CH **** ,'QW_P P;_L*0?\ LU;U8/CO_F#?]A2#_P!FK>H
M**** "BBB@ HHHH **** "BBB@!K]*;3GZ4V@ HHHH **** "BBB@ HHHH P
M]>_Y'30?^WC_ - %;E8>O?\ (Z:#_P!O'_H K<H *8_6GTQ^M "4444 %%%%
M !1110 4444 8/CCKI/_ &$H?_9JVJQ?''72?^PE#_[-6U0 4444 %%%% !1
M110!&>M%!ZT4 %%%% !6+\//^1/M/^!_^AM6U6+\//\ D3[3_@?_ *&U &U3
M7Z4ZFOTH ;1110 4444 %%%% #7Z4VG/TIM &-X._P"8K_V$9OZ5LUC>#O\
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M>JZCI%S8V>K/'>,-]L\R+YJ,J;P5S\K*3U&0#AO^#<S_ )2D?'W_ +!>H_\
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M  5 ^&?B+7O''C?Q%I'A[P7<G1-)T_21%YPFD0W#R,\J.JQAI5.T+N<EOF3
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M0!X9_P $H/\ E8W^/W_85\8_^G<5S/Q,T*[_ ."PW_!>?7_ACX[U[4K;X?\
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M!C>#O^8K_P!A&;^E;-8W@[_F*_\ 81F_I6S0 4444 %,?[U/IC_>H 2BBB@
MHHHH *C/6I*C/6@#'UG_ )&S1?\ MO\ ^@"MBL?6?^1LT7_MO_Z *V* "BBB
M@".BBB@ HHHH *C/6I*C/6@ HHHH **** "HZDJ.@ HHHH Q?"O74_\ K_E_
MI6M63X5ZZG_U_P O]*UJ "BBB@ IK]*=37Z4 -HHHH :_2FTY^E-H **** &
MOTIM.?I3: "BBB@!'^[4VB_\ABU_Z[)_,5"_W:FT7_D,6O\ UV3^8H U?'W_
M "$(?^N?]36#6]X^_P"0A#_US_J:P: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#TBBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z11110 4444 %
M%%% !1110 4444 %%%% !112$\T +12%L&FF7!Z4 /HIGG=>.E(9\#I18"2B
MHS<>WZTC7..WZT[,"6BH&O-O\/ZT->[3]W]:+,+$]%5C?X'W?UI#J.!]S]:.
M5CLRU15/^U>/N?\ CU']K<_ZO_Q[_P"M3Y6%F7**H_VSQ_J__'O_ *U!UG'_
M "S_ /'O_K4<K"S+U%4&UO _U?\ X]_]:D.NX_Y9?^/?_6HY&%F:%%9W]O\
MR_ZK_P >_P#K4T^(L#_4_P#C_P#]:G[.069IT5E_\)+S_J?_ !__ .M2?\)-
MU_<]/]O_ .M1[.0<K-6BLG_A*./]1_X__P#6I#XIP/\ 4?\ C_\ ]:G[*0^5
MFO16/_PEG/\ J/\ Q_\ ^M33XOQ_R[_^1/\ ZU'LI=@Y6;5%8C>,=I_X]_\
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M "8_^QIK?&S;_P PS_R8_P#L:?U6KV#V4^QWWET;*\__ .%X<?\ (,_\F?\
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MBO\ ,/JE;M^1]$FW![TGV4>IKYT?]O/C_D5?_*G_ /:JC/[>V#_R*G_E3_\
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M9A_S[_&/^8_[*Q7\OXK_ #/T"_LA?^>A_*C^R$_OFOSY;_@N!M_YIC_Y<?\
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M#C_YZG]*/["C_P">I_2OS-;_ (."-I_Y))_Y=/\ ]QU$W_!PCM_YI%_Y=/\
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M^>S?I7Y.-_P<K[?^:+?^7?\ _<5)_P 1+7_5%O\ R[__ +BH_P!4LV_Y]?\
MDT?\Q_V%COY/Q7^9^LG_  C<7_/9OTII\,Q'_ELWZ5^3O_$2U_U1;_R[_P#[
MBII_X.5LG_DBW_EW_P#W%3_U1S;_ )]?^31_S#^PL=_)^*_S/UD_X1B+_GLW
MZ4?\(Q%_SV;\A7Y-_P#$2M_U1;_R[_\ [BH_XB5O^J+?^7?_ /<5'^J.;?\
M/K_R:/\ F']A8[^3\5_F?K)_PC$7_/9OR%'_  B\9_Y;-^0K\F_^(E;_ *HM
M_P"7?_\ <5'_ !$K?]46_P#+O_\ N*C_ %1S;_GU_P"31_S#^PL=_)^*_P S
M]9/^$7C_ .>S?D*3_A$XO^>S_D*_)S_B)6_ZHM_Y=_\ ]Q4W_B)2_P"J+_\
MEW?_ '%1_JCFW_/K_P FC_F']A8[^3\5_F?K+_PB<7_/9_R%)_PB<?\ SV;\
MA7Y-_P#$2E_U1?\ \N[_ .XJ/^(E+_JB_P#Y=W_W%1_JCFW_ #Z_\FC_ )A_
M86._D_%?YGZLZ9\/[?3C<;;IV\^=ICD#Y2<<59_X1&'_ )[M^0K\D-*_X.._
M[,-S_P 6;W_:+AY_^1MQMW8X_P"/+VJW_P 1)_\ U1?_ ,N[_P"XJ/\ 5'-O
M^?7_ )-'_,/["QW\GXK_ #/UD_X1&'_GNWY"C_A$8?\ GNWY"OR;_P"(D_\
MZHO_ .7=_P#<5'_$2?\ ]47_ /+N_P#N*C_5'-O^?7_DT?\ ,/["QW\GXK_,
M_63_ (1&'_GNWY"AO"$)'^O;\A7Y-_\ $2?_ -47_P#+N_\ N*D;_@Y.W#_D
MC'_EW?\ W%1_JCFW_/K_ ,FC_F']A8[^3\5_F?K)_P (=#_SW?\ (4?\(=#_
M ,]W_(5^3]C_ ,')$,E["MS\')8K<NHE>+Q4)'1,\E5-HH8@9P"PSZCK7Z(_
M WXY>&?VC?AEIOB[PCJ46J:+JB;D=>'A<?>BD7JDBG@J>GTP:\_'Y+C<%%3Q
M-/E3\T_R;.7%9?B,.E*M&R?H_P CTX^#(3_R\-^0I/\ A"H?^?A_R%<\_2FU
MY9Q'1_\ "%0_\_#_ )"C_A"H/^?A_P A7.44 =$W@F C_CX?]*3_ (0BW_Y^
M7_2N<?I3: .E_P"$(M_^?E_TH_X0B#_GY?\ (5S5% '2MX&@(_X^7_(4ZS\&
M0VMW'*+AV,;A@,#G!S7+O]VIM%_Y#%K_ -=D_F* .LUOPY'K4Z.\K(47;@8J
ME_P@EO\ \_$GY"JOC[_D(0_]<_ZFL&@#J/\ A!+?_GXD_(4?\();_P#/Q)^0
MKEZ* .H_X02W_P"?B3\A1_P@EO\ \_$GY"N7HH ZC_A!+?\ Y^)/R%'_  @E
MO_S\2?D*Y>B@#J/^$$M_^?B3\A1_P@EO_P _$GY"N7HH ZC_ (02W_Y^)/R%
M'_""6_\ S\2?D*Y>B@#J/^$$M_\ GXD_(4?\();_ //Q)^0KEZ* .H_X02W_
M .?B3\A1_P ();_\_$GY"N7HH ZC_A!+?_GXD_(4?\();_\ /Q)^0KEZ* .H
M_P"$$M_^?B3\A1_P@EO_ ,_$GY"N7HH ZC_A!+?_ )^)/R%'_""6_P#S\2?D
M*Y>B@#J/^$$M_P#GXD_(4?\ ""6__/Q)^0KEZ* .H_X02W_Y^)/R%'_""6__
M #\2?D*Y>B@#J/\ A!+?_GXD_(4?\();_P#/Q)^0KEZ* .H_X02W_P"?B3\A
M1_P@EO\ \_$GY"N7HH ZC_A!+?\ Y^)/R%'_  @EO_S\2?D*Y>B@#J/^$$M_
M^?B3\A1_P@EO_P _$GY"N7HH ZC_ (02W_Y^)/R%'_""6_\ S\2?D*Y>B@#J
M/^$$M_\ GXD_(4?\();_ //Q)^0KEZ* .H_X02W_ .?B3\A1_P ();_\_$GY
M"N7HH ZC_A!+?_GXD_(4?\();_\ /Q)^0KEZ* .H_P"$$M_^?B3\A1_P@EO_
M ,_$GY"N7HH ZC_A!+?_ )^)/R%'_""6_P#S\2?D*Y>B@#J/^$$M_P#GXD_(
M4?\ ""6__/Q)^0KEZ* .H_X02W_Y^)/R%'_""6__ #\2?D*Y>B@#J/\ A!+?
M_GXD_(4?\();_P#/Q)^0KEZ* .H_X02W_P"?B3\A1_P@EO\ \_$GY"N7HH Z
MC_A!+?\ Y^)/R%'_  @EO_S\2?D*Y>B@#J/^$$M_^?B3\A1_P@EO_P _$GY"
MN7HH ZC_ (02W_Y^)/R%'_""6_\ S\2?D*Y>B@#J/^$$M_\ GXD_(4?\();_
M //Q)^0KEZ* .H_X02W_ .?B3\A1_P ();_\_$GY"N7HH ZC_A!+?_GXD_(4
M?\();_\ /Q)^0KEZ* .H_P"$$M_^?B3\A1_P@EO_ ,_$GY"N7HH ZC_A!+?_
M )^)/R%'_""6_P#S\2?D*Y>B@#J/^$$M_P#GXD_(4?\ ""6__/Q)^0KEZ* .
MH_X02W_Y^)/R%'_""6__ #\2?D*Y>B@#J/\ A!+?_GXD_(4?\();_P#/Q)^0
MKEZ* /2**** "BBB@ HHHH **** "BBB@ HHHH *0_>%+2'[PH :?O4T_>%.
M/WJ:?O"GU 0?Q4A^Z*4?Q4A^Z*: :>E))2GI2250QDO]::_6G2_UIK]:!H:_
MW::?NBG/]VO'/@9^WW\'_P!ICXL>(/ W@3QQIWB3Q/X7CDFU&UM8)PB1I*L3
MR1S,@BF0.Z*6B=Q\R\\BJ0SUW^#\:;WIW\'XTWO5#&_P?C2'K2_P?C2'K0 U
M^E-?O3GZ4U^]- ,/W*8W0T\_<IC=#5@,[T@_BKQK]HO_ (*&?!C]D[7AI?C[
MQ]I.A:KY:3&P6*:\NT1_NLT,"2.H.."0..>E;'[-7[8_PT_:_P!*U.\^''BR
MR\31:.T2WRQ0S02VOFAC'OCE1' 8(^"1U1AU4@-;E+<]+[4T_=IW:FG[M44,
M[TQ^OXT_O3'Z_C3 8_6F'[M/?K3#]V@",??J-^E2#[]1OTJEN4A'ZTT]:<_6
MFGK5#8U_O4Q^E/?[U,?I30$?<U&_2I.YJ-^E6,9)TIK=!3I.E-;H* $DZFHZ
MDDZFHZI;%="*3H::W04Z3H::W05117EZU&_6I)>M1OUI@,/W:9WIY^[3.],!
MH^Z:CE_I4@^Z:CE_I5 1=J8_WJ?VIC_>IK<KJ1=J:?O'Z4[M33]X_2K*&'K3
M'[T\]:8_>@"&2FR=33I*;)U-4MBB$_?IK]Z<?OTU^]4+H-DJ ]*GDJ ]*J)8
MU^M0R_UJ9^M0R_UI@-;M]*BJ5NWTJ*J0^HQ_O5%4K_>J*FBQC]:@DJ=^M025
M0#3UJ.I#UJ.K C?O4,E3/WJ&2F-&3XD^]9?]?<?]:O251\2?>LO^ON/^M7I*
M"R,=#43]:E'0U$_6K ADZ&F4^3H:95=!D4O]:C[U)+_6H^]6"W(W^[4+_>J9
M_NU"_P!Z@L@?I3#W^E/?I3#W^E: 1/TJ)_O5*_2HG^]0-$;=!43]ZE;H*B?O
M5=BR%^E0R]ZF?I4,O>J B[TQ^]/[TQ^]4AH@?K4,G0U,_6H9.AJBS-U'_D,6
M'_;3_P!!J>H-1_Y#%A_VT_\ 0:GIH!C]:K7'6K+]:K7'6K-"!_O5 _2IW^]4
M#]*I ,/?Z5$_2I3W^E1/TJ@(G^]4$E3O]ZH)*!HADZFHZDDZFHZT+*6M]8/^
MNZ_UI9^U)K?6#_KNO]:6?M36X%>7O4=22]ZCJRD12=#44E2R=#44E-%$#_=J
M%^M3/]VH7ZU8$,O]:A?K4TO]:A?K36YH0O\ =J"3J:G?[M02=35@5INM4K#_
M (\T_'^9J[-UJE8?\>:?C_,U8$DE0R=34TE0R=30:%:7^M0/WJ>7^M0/WK1;
M 1U#<=:FJ&XZTRUL5Y*A?O4TE0OWH&0OUJ!_NU._6H'^[6@%2WZR?]=#2/TI
M;?K)_P!=#2/TJD4B)^M5Y?\ 5FK#]:KR_P"K-4459>]02_>-3R]Z@E^\:T J
MR_UJO-]ZK$O]:KS?>K0U6Y6E^_5:3J:LR_?JM)U-4BBG<=:KR]*L7'6J\O2M
M5L4BG-_K!]35:;[OXU9F_P!8/J:K3?=_&M$:(K7']*K?\LZLW']*K?\ +.M%
ML403??JG==_K5R;[]4[KO]:T*17E_K3*?+_6F5:+"BBBJ **** "BBB@ HHH
MH **** "BBB@ HHHH **** "O?\ ]@#]O_Q-^PI\3?MMEYNJ>%-4=5UK16DP
MET@X\V//"3*.C=_NGCIX!16&)PU+$4G1K*\7NC*M1A5@Z=173/Z6?@A\<O#/
M[1OPQTSQ=X1U*+5-%U1-R.O#PN/O12+U213P5/3Z8-=77\_/[ 7[?WB;]A7X
MF?;;$RZGX4U1U76M%:3"72#CS8\\),HZ-WZ'CI^['P.^.7AG]HSX9:;XN\(Z
ME%JFBZHFY'7AX7'WHI%ZI(IX*GI],&OQCB#A^KEU6ZUIO9_H_/\ ,_/LTRN>
M$G=:P>S_ $9UU%%%?.GDC7Z4VG/TIM !1110 C_=J;1?^0Q:_P#79/YBH7^[
M4VB_\ABU_P"NR?S% &KX^_Y"$/\ US_J:P:WO'W_ "$(?^N?]36#0 4456UG
M6;3P[I%UJ&H75M8V%C"]Q<W-Q*(H;>)%+.[NQ 554$DDX !)H LT5\/6G_!7
MOQ5\;-;U=_@1^SYXP^+GA72+Q[ ^(GU:+1;*\E3[_D^9$Y889",[6P^2J]_?
MOV.?VQ;#]KOPQK<O_"+>*O _B+PM?#3]9T'Q!9FWN[*0KN1@>CHPS@\'Y3D
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MZTRGR_UIE6BPHHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ'-'J"Z@VL7.H:9JYMF$MW*ZNMJ+2"X624^:6?8IW@\@>I_M:?\ *MI\+_\
M?TS_ -'ST ?KGJ.HV^CZ?/=W<\-K:VL;3333.$CA11EF9CP  "23P *^(/\
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M!;F^TN33(_#=E8QQ3V2K(9;6ZMPAN$F$L: /$N'![#+?&O[-;Z+XKN?B+?\
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MW,@V%_(R55 V[9SZ[^Q7_P $XO#?[$OQ/\>:_H-^+JU\6K:6VGV/V/RCHUM
MK Q>9YC&9I"59G(4DIG!))KZ/?K33UJAL\)_9W_8GA^!7[2_Q7^)EUXBE\0:
MK\2[N.2*)K,VXTBW0N1 #YC"7@QC<54@1# &36C^UM^SAXN^/MOX?G\&_%?Q
M-\+=4\/RS2"7381<VNH>9Y8Q<P%T$H0(VP%L R$X/%>QO]ZF/TIH#Y.^'?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!Z11110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@"O15G[8@_A-'VQ?[IH K459^UQ_W3^5'VN/^Z?RH K459^UQ_W3^5'VN/\
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MK_:\/_/-OR%-.L0 _P"J;_OD4 9=%:G]LV__ #R;_OD4?VS;_P#/)O\ OD4
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M (2*V_YXM_WR*/\ A(;4_P#+!O\ OD4 8M1UO?\ "06O_/!O^^13?^$DM/\
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M^%_QH_X3*P_Y]7_[X7_&@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\:
M.8HKI_\ A,K#_GU?_OA?\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_Q
MH_X3*P_Y]7_[X7_&@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HK
MI_\ A,K#_GU?_OA?\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3
M*P_Y]7_[X7_&@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\
MA,K#_GU?_OA?\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y
M]7_[X7_&@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#
M_GU?_OA?\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[
MX7_&@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#_GU?
M_OA?\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[X7_&
M@#F**Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#_GU?_OA?
M\:/^$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[X7_&@#F*
M*Z?_ (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#_GU?_OA?\:/^
M$RL/^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[X7_&@#F**Z?_
M (3*P_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#_GU?_OA?\:/^$RL/
M^?5_^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[X7_&@#F**Z?_ (3*
MP_Y]7_[X7_&C_A,K#_GU?_OA?\: .8HKI_\ A,K#_GU?_OA?\:/^$RL/^?5_
M^^%_QH YBBNG_P"$RL/^?5_^^%_QH_X3*P_Y]7_[X7_&@#H:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 8_6DI7ZTE !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !4=25'0 4444 8/CO\ Y@W_ &%(/_9JWJP?
M'?\ S!O^PI!_[-6]0 4444 %%%% !1110 4444 %%%% #7Z4VG/TIM !1110
M 4444 %%%% !1110!AZ]_P CIH/_ &\?^@"MRL/7O^1TT'_MX_\ 0!6Y0 4Q
M^M/IC]: $HHHH **** "BBB@ HHHH P?''72?^PE#_[-6U6+XXZZ3_V$H?\
MV:MJ@ HHHH **** "BBB@",]:*#UHH **** "L7X>?\ (GVG_ __ $-JVJQ?
MAY_R)]I_P/\ ]#:@#:IK]*=37Z4 -HHHH **** "BBB@!K]*;3GZ4V@#&\'?
M\Q7_ +",W]*V:QO!W_,5_P"PC-_2MF@ HHHH *8_WJ?3'^]0 E%%% !1110
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M)=5_:9\=_":]\-ZW-:Z%X#\':FNGS6%B@B"W=Q&LA^T1EF5"3N'F+)\X#JM
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M/6B@ HHHH *Q?AY_R)]I_P #_P#0VK:K%^'G_(GVG_ __0VH VJ:_2G4U^E
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MY+ =ZQ/AA\?/ OQNBG?P7XT\)^+DM3MG;1=7M[\0GCAC$[8^\O7U'K7YU_\
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M+$[B2U 'I?\ P0B_Y13_  L_[BW_ *>+ZO>=<_:T^%?ACQFWAS4OB9\/M/\
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M\ K'(ZL0>V!737_C'2-*\(S>(+K5=.MM!MK-M0FU*6Y1+2*V5/,:=I2=@C"
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M ()#>,=0\=_\$V?A)J&J7#W5V-':T\UV+,T<$\L$8).2<1QH/PKZ0H ****
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MI?LZQ^)H?V?? J>-)!+XQ7P]IZZ]( </?BVC^TGD \R[^H'TK\^?^"YVJ/\
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MS1?^V_\ Z *V* "BBB@".BBB@ HHHH *C/6I*C/6@ HHHH **** "HZDJ.@
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M;\ Z#<:E=Z/X7M!9VLVH2))<R(&+9=D1%)^8]%'TH ^>_@+_ ,$Q_P#AG/\
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MWT;5]-L[NST]M-TO3A=6;6\$.!OD9%8[V<AG_>, "%7/O-% 'DW["WP(U?\
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M;30W4^FR226LA>YEE&QI$1B-L@ZJ.0?K7L]%% !1110 4444 %%%% !1110
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M ,(3?>D7_?='_"$WWI%_WW0!D45K_P#"$WWI%_WW1_PA-]Z1?]]T 9%%:_\
MPA-]Z1?]]T?\(3?>D7_?= &116O_ ,(3?>D7_?='_"$WWI%_WW0!D45K_P#"
M$WWI%_WW1_PA-]Z1?]]T 9%%:_\ PA-]Z1?]]T?\(3?>D7_?= &116O_ ,(3
M?>D7_?='_"$WWI%_WW0!D45K_P#"$WWI%_WW1_PA-]Z1?]]T 9%%:_\ PA-]
MZ1?]]T?\(3?>D7_?= &116O_ ,(3?>D7_?='_"$WWI%_WW0!D45K_P#"$WWI
M%_WW1_PA-]Z1?]]T 9%%:_\ PA-]Z1?]]T?\(3?>D7_?= &116O_ ,(3?>D7
M_?='_"$WWI%_WW0!D45K_P#"$WWI%_WW1_PA-]Z1?]]T 9%%:_\ PA-]Z1?]
M]T?\(3?>D7_?= &116O_ ,(3?>D7_?='_"$WWI%_WW0!D45K_P#"$WWI%_WW
M1_PA-]Z1?]]T 9%%:_\ PA-]Z1?]]T?\(3?>D7_?= &116O_ ,(3?>D7_?='
M_"$WWI%_WW0!V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_!_[Y7_"C_A*M0_Y^#_WRO\ A6?10!H?\)5J'_/P?^^5_P */^$JU#_GX/\
MWRO^%9]% &A_PE6H?\_!_P"^5_PH_P"$JU#_ )^#_P!\K_A6?10!H?\ "5:A
M_P _!_[Y7_"C_A*M0_Y^#_WRO^%9]% &A_PE6H?\_!_[Y7_"C_A*M0_Y^#_W
MRO\ A6?10!H?\)5J'_/P?^^5_P */^$JU#_GX/\ WRO^%9]% &A_PE6H?\_!
M_P"^5_PH_P"$JU#_ )^#_P!\K_A6?10!H?\ "5:A_P _!_[Y7_"C_A*M0_Y^
M#_WRO^%9]% &A_PE6H?\_!_[Y7_"C_A*M0_Y^#_WRO\ A6?10!H?\)5J'_/P
M?^^5_P */^$JU#_GX/\ WRO^%9]% &A_PE6H?\_!_P"^5_PH_P"$JU#_ )^#
M_P!\K_A6?10!H?\ "5:A_P _!_[Y7_"C_A*M0_Y^#_WRO^%9]% &A_PE6H?\
M_!_[Y7_"C_A*M0_Y^#_WRO\ A6?10!H?\)5J'_/P?^^5_P */^$JU#_GX/\
MWRO^%9]% &A_PE6H?\_!_P"^5_PH_P"$JU#_ )^#_P!\K_A6?10!H?\ "5:A
M_P _!_[Y7_"C_A*M0_Y^#_WRO^%9]% &A_PE6H?\_!_[Y7_"C_A*M0_Y^#_W
MRO\ A6?10!H?\)5J'_/P?^^5_P */^$JU#_GX/\ WRO^%9]% &A_PE6H?\_!
M_P"^5_PH_P"$JU#_ )^#_P!\K_A6?10!H?\ "5:A_P _!_[Y7_"C_A*M0_Y^
M#_WRO^%9]% &A_PE6H?\_!_[Y7_"C_A*M0_Y^#_WRO\ A6?10!H?\)5J'_/P
M?^^5_P */^$JU#_GX/\ WRO^%9]% &A_PE6H?\_!_P"^5_PH_P"$JU#_ )^#
M_P!\K_A6?10!H?\ "5:A_P _!_[Y7_"C_A*M0_Y^#_WRO^%9]% &A_PE6H?\
M_!_[Y7_"C_A*M0_Y^#_WRO\ A6?10!H?\)5J'_/P?^^5_P */^$JU#_GX/\
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M\ _M<>&O^&-/!OQA\=:QHO@S1?$/AG3=?O+B^N5M[:U:[MHYA$I9B2VZ3:J
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M)\+"ZLO%UHWAZ*;9J$<X7R6>\MSN 53S VT[C\QXP ?L=17@7P$_X*@? O\
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M 'O;IT,D-M'(\89>07 !!7^\,_?7P$_:(\$?M1?#J#Q9\/\ Q+IOBGP]<2O
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MA6(5020I..#0!UU>*:O_ ,%$O@YH7[6,/P.N?&2)\4IWCC31%TR]<[I+<7*
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M -A*'_V:MJL7QQUTG_L)0_\ LU;5 !1110 4444 %%%% $9ZT4'K10 4444
M%8OP\_Y$^T_X'_Z&U;58OP\_Y$^T_P"!_P#H;4 ;5-?I3J:_2@!M%%% !111
M0 4444 -?I3:<_2FT 8W@[_F*_\ 81F_I6S6-X._YBO_ &$9OZ5LT %%%% !
M3'^]3Z8_WJ $HHHH **** "HSUJ2HSUH Q]9_P"1LT7_ +;_ /H K8K'UG_D
M;-%_[;_^@"MB@ HHHH CHHHH **** "HSUJ2HSUH **** "BBB@ J.I*CH *
M*** ,7PKUU/_ *_Y?Z5K5D^%>NI_]?\ +_2M:@ HHHH *:_2G4U^E #:***
M&OTIM.?I3: "BBB@!K]*;3GZ4V@ HHHH 1_NU-HO_(8M?^NR?S%0O]VIM%_Y
M#%K_ -=D_F* -7Q]_P A"'_KG_4U@UO>/O\ D(0_]<_ZFL&@ KGOBO\ %70/
M@?\ #C6/%OBG4%TGP]H%LUW?W;1/*((EZG8BL['I@*I))X%=#7SC_P %=?\
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M]]+33? ][\(K/Q'=:Y!>^#9P^_1XCIEU<_9&$L<;J%FAC<#8F-J@ +Q76?\
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MNWK=[^U'_P %C?@Y\$]8U*\@\&"YT32OLT("^3)J=ZJ7-PO.2YB,2@G 'E#
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M,7[,WAG3_$/@G6+LW-]I!U6ULQ80S%1>V4BW$J;HG)>2)H]QCPHP#&I?]>J
M"BBB@ HHHH **** "BBB@ HHHH 8_6DI7ZTE !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4=25'0 4444 8/CO\
MY@W_ &%(/_9JWJP?'?\ S!O^PI!_[-6]0 4444 %%%% !1110 4444 %%%%
M#7Z4VG/TIM !1110 4444 %%%% !1110!AZ]_P CIH/_ &\?^@"MRL/7O^1T
MT'_MX_\ 0!6Y0 4Q^M/IC]: $HHHH **** "BBB@ HHHH P?''72?^PE#_[-
M6U6+XXZZ3_V$H?\ V:MJ@ HHHH **** "BBB@",]:*#UHH **** "L7X>?\
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MQ6MM%\OQ]JVD#0KK5/MDY\VR#QN(O)+^2/FBC.X(&^7KR<@'R3^UCIUO<_\
M!=O]EUI((9&/A_7"2R D[+*^9/\ OEN1Z'D5-_P5@_Y/1_8S_P"Q^D_]#LJ^
ML/%?[-'@GQO\=O"WQ+U/1?M/C;P7;W%KHVI?;)T^QQ3QO'*OE*XB?<DCC+HQ
M&[C! I_Q2_9O\%?&GQOX-\1^)]$75-9^']\^I:!<-<S1BPN&V9DV(ZI(?D3
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MCT:TU"RF6XLK^%+BWE7[LL;J&5A[$$&K5<]\*/A7H7P0^'&C^$O#%DVG>']
MMEL["U:XEN#;Q+]U/,E9G8#MN8\5T- !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 >D4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 Q^M)
M2OUI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HZDJ.@ HHHH P?'?_ #!O^PI!_P"S5O5@^._^8-_V%(/_ &:M
MZ@ HHHH **** "BBB@ HHHH **** &OTIM.?I3: "BBB@ HHHH **** "BBB
M@##U[_D=-!_[>/\ T 5N5AZ]_P CIH/_ &\?^@"MR@ IC]:?3'ZT )1110 4
M444 %%%% !1110!@^..ND_\ 82A_]FK:K%\<==)_["4/_LU;5 !1110 4444
M %%%% $9ZT4'K10 4444 %8OP\_Y$^T_X'_Z&U;58OP\_P"1/M/^!_\ H;4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJI1_G?X%KQ^S+_H%A]\C]@O^&L/AC_T/_A#_ ,&L/_Q5'_#6'PR/_,_^$?\
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M,HO_ (JORW3[M.3K1_J[2_G92\9<?_T#P^]GZC_\-)?#P_\ ,Z^&/_!E%_\
M%4?\-(?#W_H=?#'_ (,HO_BJ_+L=:DJ?]7J7\[+_ .(QX[_H'A][/U!_X:/^
M'W_0Z>&/_!E%_P#%4?\ #1WP^/\ S.GAC_P91?\ Q5?F".E/CI?ZO4OYV6O&
M''?] \/O9^G?_#1GP_\ ^AT\,_\ @RB_^*I?^&C?A^/^9S\,_P#@RB_^*K\Q
MD^]2R4?ZOTOYF6O%_'?\^(?>S].?^&B_ !_YG/PS_P"#&+_XJC_AHGP ?^9S
M\-?^#&+_ !K\RT^[3TZ5/]@4OYF5_P 1=QW_ #XA][/TQ'[1/@ _\SEX:_\
M!C%_\52_\-$> ?\ H<?#7_@QB_\ BJ_,Z+_6&I1UH_L"E_,RUXMXW_GQ'[V?
MI9_PT/X"_P"AQ\-_^#&+_P"*I1^T)X"8?\CCX;_\&,7^-?FJ_P!VGQ?ZL4GD
M-/\ F9:\6<:_^7$?O9^D_P#PT'X#/_,X>'/_  81?XTG_#0'@+_H</#G_@QB
M_P :_-V.C_EI2_L*G_,REXKXW_GQ'[V?I%_PO_P'_P!#AX<_\&,7^-+_ ,+^
M\!_]#?X<_P#!A%_C7YO5(/\ 5TO["I_S,T_XBKC/^?$?O9^B>I_&KX>ZI]G\
M[Q?X>_T>=9X\:E&/G7.._O5L?'SP(?\ F;O#O_@PC_QK\W;CI'_UT%6HOOTO
M[$I_S,K_ (BGC/\ GS'[V?HQ_P +[\"_]#=X=_\ !A'_ (TO_"^/ W_0W>'?
M_!A%_C7YT'K4E+^PZ?\ ,RO^(HXS_GS'[V?HG_PO?P-_T-OA[_P81_XTO_"]
MO Q_YFWP]_X,(_\ &OSN3[M/CI/)::^TRUXG8M_\N8_>S]#O^%[>!_\ H;/#
MW_@?'_C1_P +U\#_ /0V>'__  /C_P :_/,=:<OWS2_L6G_,REXFXM_\N8_>
MS]"_^%Y^"/\ H:_#_P#X'Q_XT?\ "\_!'_0U^'__  /C_P :_/D=*=_!^-']
MBT_YF4O$O%_\^8_>S]!!\<O!)/\ R-?A_P#\#X_\:7_A=_@K_H:M _\  ^/_
M !K\^XO]8*FI/)H?S,M>).+_ .?,?O9]^GXW^"3_ ,S5H'_@='_C1_PNWP3_
M -#3H/\ X'1_XU\!4]/NTO['A_,R_P#B(^*_Y\Q^]GWU_P +L\$G_F:=!_\
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MQ7\(_P#0Q:-_X&)_C7Q6.E/3I1_9D.[*7'&(_P"?<?Q/M'_A:_A'_H8M&_\
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M1X?_ .?^U_\  @?XT>?X?'_+_;?^! _QKR=/O4LE'LD'U^78]7\_P_\ \_\
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M877<5(^=48$$=UQR,$U]-?\ !$S_ )'+Q_\ ]>5G_P"ARUG?\%JO^2N^#?\
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M]H3]C/X@?LS,LOB71\Z5(_EQ:I9/]HLY&P#@L,&,Y. )%4MM;:"!FNX\,?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"F_[#%I_[/7@YM_R-\/\OS9^N>'G_)NLW]:G_IN!^65%%%?8'\W'[-_L4?\
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MK4@Z5&W;ZU(.E06A\='_ "THCH_Y:4&BV)4^[3Y*8GW:?)2>QJBO+_Q^V_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOK4@Z5&W;ZU(.E06A\='_+2B.C_EI0:+8E3[M/DIB?=I\E)[&J*\O_'[;_\
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M1_K7C>T?N?\ F'_$OW#/\]7_ ,#C_P#('Y3_ /#IWXR?] K1_P#P:1?XT?\
M#IWXR?\ 0*T?_P &D7^-?JMN-&XT?ZUXWM'[G_F'_$OW#/\ /5_\#C_\@?E3
M_P .G?C)_P! K1__  :1?XT?\.G?C)_T"M'_ /!I%_C7ZK;C1N-'^M>-[1^Y
M_P"8?\2_<,_SU?\ P./_ ,@?E3_PZ=^,G_0*T?\ \&D7^-'_  Z=^,G_ $"M
M'_\ !I%_C7ZK;C1N-'^M>-[1^Y_YA_Q+]PS_ #U?_ X__('Y4_\ #IWXR?\
M0*T?_P &D7^-'_#IWXR?] K1_P#P:1?XU^JVXT;C1_K7C>T?N?\ F'_$OW#/
M\]7_ ,#C_P#('Y4_\.G?C)_T"M'_ /!I%_C1_P .G?C)_P! K1__  :1?XU^
MJVXT;C1_K7C>T?N?^8?\2_<,_P ]7_P./_R!^5/_  Z=^,G_ $"M'_\ !I%_
MC1_PZ=^,G_0*T?\ \&D7^-?JMN-&XT?ZUXWM'[G_ )A_Q+]PS_/5_P# X_\
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M]J?^]^E'VI_[WZ4O]8,3V7W?\$K_ (A!D?\ -4_\"7_R)^?J_P#!.KXG ?\
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M!:4__AD'QM_SZ67_ (%I7T]_:]Q_ST_\='^%(=7N,?ZS_P ='^%']IUO(?\
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M_@'CJ_LY^*!_R[VW_@0M _9R\4 _\>]K_P"!"U[%_P )#>?\]O\ QQ?\*/\
MA(;S_GM_XXO^%+ZW,?\ J[A>[^__ (!X_P#\,Z^)_P#GWMO_  (6GK^SOXF
M_P"/>V_\"%KUW_A(;S_GM_XXO^%'_"0WG_/;_P <7_"CZW,K_5_"KJ_O_P"
M>-:7^SAXHM/M&^WM?WDS.N+A>AJU_P ,\^)M_P#Q[VW_ ($+7J&D^*[^Z^T[
MY\^7<.B_(O &,=JM_P#"0WG_ #V_\<7_  H^MS'_ &!AN[^__@'DO_#/7B7_
M )X6W_?]:>/V??$@'^HMO^_ZUZI_PDE[_P ]O_'%_P */^$DO?\ GM_XXO\
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M_8]#S_KY' _\*2U__GA!_P!_EI3\$]?Q_J(/^_RUWO\ PDU[_P ]_P#QQ?\
M"D_X26]_Y[_^.+_A1]8D5_9-'S.#3X)Z\#_J8/\ O\*5O@IKW_/&#_O\*[O_
M (26]_Y[_P#CB_X4?\)+>_\ /?\ \<7_  H]O(?]E4?,X9/@MKP/^I@_[_+3
MS\&==*_ZF#_O\*[;_A);W_GO_P".+_A33XGOL_Z__P <7_"I]M(?]F4?,XM/
M@SKH_P"6,'_?X4[_ (4UKG_/&#_O\*['_A*+[_GO_P".+_A1_P )1??\]_\
MQQ?\*/;2'_9E'S.._P"%-:Y_SQ@_[_"E?X.:X?\ EC!_W^%=A_PE%]_SW_\
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M;_QQ?\* *G_"%7W]V/\ [[H_X0J^_NQ_]]U;_P"$AO/^>W_CB_X4?\)#>?\
M/;_QQ?\ "@"I_P (5??W8_\ ONC_ (0J^_NQ_P#?=6_^$AO/^>W_ (XO^%'_
M  D-Y_SV_P#'%_PH J?\(5??W8_^^Z/^$*OO[L?_ 'W5O_A(;S_GM_XXO^%'
M_"0WG_/;_P <7_"@"I_PA5]_=C_[[H_X0J^_NQ_]]U;_ .$AO/\ GM_XXO\
MA1_PD-Y_SV_\<7_"@"I_PA5]_=C_ .^Z/^$*OO[L?_?=6_\ A(;S_GM_XXO^
M%'_"0WG_ #V_\<7_  H J?\ "%7W]V/_ +[H_P"$*OO[L?\ WW5O_A(;S_GM
M_P".+_A1_P )#>?\]O\ QQ?\* *G_"%7W]V/_ONC_A"K[^['_P!]U;_X2&\_
MY[?^.+_A1_PD-Y_SV_\ '%_PH J?\(5??W8_^^Z/^$*OO[L?_?=6_P#A(;S_
M )[?^.+_ (4?\)#>?\]O_'%_PH J?\(5??W8_P#ONC_A"K[^['_WW5O_ (2&
M\_Y[?^.+_A1_PD-Y_P ]O_'%_P * *G_  A5]_=C_P"^Z/\ A"K[^['_ -]U
M;_X2&\_Y[?\ CB_X4?\ "0WG_/;_ ,<7_"@"I_PA5]_=C_[[H_X0J^_NQ_\
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M3?ZP?4U6F^[^-69O]8/J:K3?=_&M$:(K7']*J/\ =JW<?TJH_P!VM%L40/\
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M.B_\ABU_Z[)_,4 =!XM_X_(_]S^M95:OBW_C\C_W/ZUE4 %%%<[\6OBOX?\
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M^"4?[-?C[P[!?^--9\/:$M]XBTRTC,VH:L]Q;6Z"\2,?-+(IA?<B L3<DJN
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MN/V:)4ANA')':264/B-08'1XT^R6T>Z'<<N@9B+A 2 J5]_?\' WB"[\6?\
M!*WX3:IJ$OGW^I>)='N[F78%\R631[]G;"@ 9))P !0!]?W?_!3WX"V_Q1TO
MP7_PLC1IO$VL*&MK*WAN)\,4WB.1TC*12X_Y9R,KYPNW<<5^>OCG_@N[J?\
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MT*C?>_&HW[U(WWOQJ-^]:+8".H;CK4U0W'6F6MBO)4+]ZFDJ%^] R%^M0/\
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M=\*/^#@K]H6R\3Z[I6AZAXGT31+'2&OG$(NY5TZP=X5D;Y0Q !"E@6(  )%
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M8;*QAA(V4^52V!];_LV_'C2_VG/@7X9\>:-;WEGI_B6S%REM=J%GM6#%)(I
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MR\ ^TPQ1VD=AY;RF/YHTBG!_>H#O&X-QM^N!_%2'[HIH#\@+_P#X)M_M5_\
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MWCS]IJ#PCX&\,>&?)A_X1_2IDN'N;='WO!$L4LP42L#ODEG++O&U2 %7L/\
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MA[_A;-WXA@O7T?1K^""VAM%=F4&2:X,>] VTXE.=HP6ZGW3]@']G[Q1\%O\
M@G5X2^'OBBSATKQ38Z/=VEU;&X29+:2::=U!DB+*<"1<E21UQFOHD_<IC=#5
M@?G=_P $%OV&/BG^Q<?BK_PLOPO_ ,(W_P ))_9']F_\3*TO/M/D?;O-_P"/
M>63;M\Z/[V,[N,X.*'_!(S]@?XK?LQ_MH?%;QAXY\,+H>@>(;2Z@TVX_M.TN
M6NFDODF7"0RNRC8I/SA>H'6OT=[T@_BIK<I;GQM_P6]_95\>_M??LH>'_#7P
M[T'_ (2'6K'Q;;ZG/;?;;>TV6Z6=Y&S[IY$4X>6,8!S\W3 .-H_L2Z[\3/\
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M[U2&B!^M0R=#4S]:ADZ&J+*MS_Q\P_\  OY4E+<_\?,/_ OY4E- ,?K4,O\
M6IGZU#+_ %JS0A?[U0/TJ=_O5 _2J0##W^E1/TJ4]_I43]*H")_O5!)4[_>J
M"2@:(9.IJ%^E32=34+]*T+*]]T3_ *Z"FS]J=?=$_P"N@IL_:FMP*\O>HZDE
M[U'5E(BDZ&HI*EDZ&HI*:*('^[4+]:F?[M0OUJP(9?ZU"_6II?ZU"_6FMS0A
M?[M02=34[_=J"3J:L"M-UJ"U_P!0M3S=:@M?]0M6 Z2H)^AJ>2H)^AH-"HWW
MOQJ-^]2-][\:C?O6BV CJ&XZU-4-QUIEK8KR5"_>II*A?O0,A?K4#_=J=^M0
M/]VM *Z=6_WC4;]*D3JW^\:C?I5(I$3]:KR_ZLU8?K5>7_5FJ**LO>H)?O&I
MY>]02_>-: 0OTJG-]ZKC]*IS?>K0U6Y6E^_5:3J:LR_?JM)U-4BBG<=:B?[E
M2W'6HG^Y6JV*14F_U@^IJM-]W\:LS?ZP?4U6F^[^-:(T16N/Z54?[M6[C^E5
M'^[6BV*('^]56Z[_ %JT_P!ZJMUW^M:%(KR_UIE/E_K3*M%A1115 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !117N/["G["GBG]N;XIKI&D*VGZ!I[
M))K6M21EH=.B)Z#IOF;!")GG!)(4,PQQ&(IT*;K5G:*W9G5JPI0=2H[)!^PI
M^PIXI_;F^*:Z1I"MI^@:>R2:UK4D9:'3HB>@Z;YFP0B9YP22%#,/W:_9^_9^
M\+?LQ?"S3O!_@_3ET_2-/7))PTUW*0-\\SX&^1L#)]@  H !^S]^S]X6_9B^
M%FG>#_!^G+I^D:>N23AIKN4@;YYGP-\C8&3[  !0 .UK\9XAXAJ9C4Y8Z4UL
MOU?G^1^>YKFL\7.RT@ME^K"HSUJ2HSUKYL\D*DJ.I* (Z*** "K.B_\ (8M?
M^NR?S%5JLZ+_ ,ABU_Z[)_,4 =!XM_X_(_\ <_K656KXM_X_(_\ <_K650 5
MSOQ:^%'A_P".GPVUGPAXJTY=6\.^(+9K._LVE>(3Q-U&]&5U/ P58$$9!%=%
M10!\@?\ #A7]D_\ Z)3_ .7-K'_R77I7QS_X)H? W]I/PSX7TGQIX L=9M?!
MEC'IFCR"]NK:YM+6- B0&XAE2:2-0.%D=ADENI)KW6B@#QCX0?\ !/+X+_ #
MQOHGB/P7X TCPWK7AZSN+&RNK&2:-O*GQYOFC?MG=L >9*'<!0 P  IOQ,_X
M)V_!;XR^(/'.K>*? .E:YJ?Q'6R77KJZFG>6X^R1>3;M$V_-LRQ_+NM_++8&
MXD\U[310!X_^R_\ L"_"#]C&:_F^&O@?3O#5UJ<8AN;L3SW=U+&&W>7YT[R2
M!-V#M#8)5<CY1BQ^TY^PS\)OVR;2TB^)7@G2_$SV"F.VN7>6VN[="P8HD\+I
M*JD@$J&P>>.37K%% 'BO[-'_  3J^"O['NMR:G\.O .E^'M4EA>W:_,T]Y=^
M4Q#,@FGDD<*2JY ..!76_!K]F3P1^S]XA\8ZKX1T3^R;_P ?ZO+KVOR_;+B?
M[?>R,SO+B5V$>6=CMC"J,\"N]HH *^:_C+_P2!_9O^/WC>Y\1^)_A=I4^L7K
M;[B>QOKS3!.V "S):S1H6.!EBN2<DG)-?2E% 'D-]^P7\([S]G2]^$T?@NQT
M[X>ZE/\ :;S1],N;C3TNI/,63=))!(DKG<B9RYR$4'A0!U7C7]G?P5\0_@5-
M\,]6\/65QX$GTV/2#HZ;H(([6-56.)#&59 @1-I0@KM!!!%=I10!^<7_  4!
M^"'A7X8?MD_L)^ -'T>%/!^FZEKFEP:7=2/>Q?93'IZF%S.SM(A4E2')X..E
M?2?P?_X),?L[_ ;XH0>,O"WPPTBP\16EP;NVN9;NZNTM)<DAXHII7CB*DY4H
MHVX&W&!CZ*HH \T_:<_8\^&G[97A*TT3XE^$['Q186$QN+3S9);>>T<XW>7/
M"Z2H&PNX*P#;1D' KB_AI_P2U^ /P<U+PW?>&?AKI&CZAX2U :KIM[!<W/VI
M+@(4#2S&0O. I.$F9U!9B "Q)]_HH X+5/V9/!&L_M%:=\6;G1/,^(&DZ0=!
MM-5^V7 \JR+R.8O)#^2?FED.XH6^;KP,/^+/[-?@GXY>+O!NO>*=#75-7^'^
MI?VOH%R;F:%M/N?E^<"-U#CY%^5PRG:.*[JB@#YR^.W_  22_9W_ &E?B)>^
M+/&/PUL-1\0:DWF7=Y;ZE>Z>UT^ -[K;S1JS8498C)Y).2:]/M?V7?A[IWP$
MOOA?9^$M&T[P#J5A-IESHUC#]E@EAF4K+S&58.V23(&\S<=V[=S7?44 <OX%
M^"WA?X;_  AL/ 6DZ/;1^#]-TX:1!I=P6NX3:;-GDOYQ=I%*D@[RV03G->"V
M'_!%G]E[3O''_"0Q_"'0FO\ [0+GRI;R\EL=X8,!]D:8V^S(&4\O:1D$8)!^
MHJ* .7^*WP7\,_&WX4ZIX(\3:6E_X6UFU%E=V"2R6RR0C!"!HF5T VC[K#I5
MSP/\.-%^''PWT?PCH]@EMX<T'38='L;)W:=8K2&)88XBTA9G C4+ER2<<DDU
MN44 <1^SS^SEX,_93^%]IX,\ Z-_8/AJQEEF@L_M<]UL>5R[G?,[N<L2>6X[
M5I?&#X1>'OCW\,]8\'>+-/\ [5\.:_!]EO[3SY8//CR#MWQ,KKR!RK UTM%
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M\$OO@+^SM\:!\0O!?PYTS0?%J+,L-Y#=W3QVHE4I)Y,#RM#$2A9<QHI"LP&
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M-OV,O!UYH/PT\+VWAG3-1NOMETB7$]U+<2[0H+RSN\A  P%+87)P!DY]+HH
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M+_W\%']FZ?\ \]5_[^BG_K!C.Z^X?]J5_(_/9O\ @E[X_;_F+^#_ /P*N?\
MXQ3&_P""7/Q ;_F+^#__  +N?_C%?H9_9MA_SV7_ +^"C^S;#_GLO_?P4_\
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M#K]K;#P[H,'G^3=QMOF9Y,7"G#GJ/;Z58_L31_\ GY3_ +_"C_77,^Z^X/\
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M#T?_ )^4_P"_XH Y:BNG_L'1O^?I/^_ZT?V#HW_/TG_?]: .8JSHO_(8M?\
MKLG\Q6]_8.C?\_2?]_UJ6ST728;N-H[E&D5P5'G Y.>.* &>+?\ C\C_ -S^
MM95=-JEE:7,JFXD",!@ N%XJK_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3
MIO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_\]U_[^B@##HK<_LG3?\ GNO_
M ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_11_9.F_\ /=?^_HH PZ*W/[)T
MW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_\]U_[^B@##HK
M<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_11_9.F_\ /=?^
M_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_
M\]U_[^B@##HK<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_1
M1_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^
M>Z_]_11_9.F_\]U_[^B@##HK<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^
MR=-_Y[K_ -_11_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B
M@##HK<_LG3?^>Z_]_11_9.F_\]U_[^B@##HK<_LG3?\ GNO_ ']%']DZ;_SW
M7_OZ* ,.BMS^R=-_Y[K_ -_11_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3
MIO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_\]U_[^B@##HK<_LG3?\ GNO_
M ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_11_9.F_\ /=?^_HH PZ*W/[)T
MW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_\]U_[^B@##HK
M<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_11_9.F_\ /=?^
M_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^>Z_]_11_9.F_
M\]U_[^B@##HK<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^R=-_Y[K_ -_1
M1_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B@##HK<_LG3?^
M>Z_]_11_9.F_\]U_[^B@##HK<_LG3?\ GNO_ ']%']DZ;_SW7_OZ* ,.BMS^
MR=-_Y[K_ -_11_9.F_\ /=?^_HH PZ*W/[)TW_GNO_?T4?V3IO\ SW7_ +^B
M@#8HHHH **** "BBB@ HHHH **** "BBB@ SFC.*:G2B2@!=U&:92O\ >H =
MNHW ]Q49Z4U.M/J!-N [TA8$=14<E(O?Z4=0';QZBC</45"_WJ%Z&BP$V\>H
MHWCU%04O\'XT^4";>/44GF#U'YU#3'^]18:U+7F#U'YTGF+ZC\ZKK]PTVBP=
M2UYJC^(?G1YJG^(?G5-^E$=%@L7/.7^\OYT><O\ >7\ZHGK2'I1RCL7O/0_Q
M+^=+YR#^)?SK.3K2OTI\NH6+_GI_?7\ZC^T1_P!]/SJE5<]:'&P6-7ST_OK^
M='VB/^^G_?59O\'X4RGR!8U?M,8_C3_OJD^U1_\ /1/^^A62_2D3[U'(%C7^
MU1_\]$_[Z%'VJ/\ YZ)_WT*QSUI#THY L;/VN(_\M$_[Z%'VJ,?\M$_[Z%8L
M=#]*.0.4VOM<7_/2/_OH4V2[BQ_K(_\ OH5BCK22_P!:.0.4V?M<7_/2/_OH
M4GVR+_GK'_WT*PSTIJ?>I^S&XV-_[9$/^6L?_?0I/ML/_/6/_OH5A24VCV8<
MNAO_ &Z'_GK%_P!]"C[=#_SVB_[[%<Z_WJ:>E5[)"Y3I/MT/_/:+_OL4?;X!
M_P MHO\ OL5S8Z4DE'LD%CI/M\'_ #VB_P"^Q1_:$'_/>'_OL5S-,?[U'LD5
MR'4_VC;_ //>'_OL4?VC;_\ />'_ +[%<H>E+1[)"Y#JO[2MQ_RWA_[[%']I
M6Y_Y;P_]]BN3DHCH5)#Y#J_[2M_^>\/_ 'V*/[2M_P#GO#_WV*Y-_O4T]*;H
MI!R'5?VG;'_EX@_[^"C^TK?_ )[P_P#?8KCTZT^CV"#D.M_M*W_Y[P_]]BC^
MT[;_ )^(/^_@KDJ8_P!ZA44PY#L/[4MO^?B#_OX*3^U;;_GX@_[^"N.?[M,I
M^P7<?(=HVJVN/^/F#_OX*C_M6V_Y^(/^_@KC9*;1[!=P=.QVG]K6O_/S;_\
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MR^6O_?Y?\:\VILE'U9=P]DCT+4=>L3Y'^F6O^N7_ );+_C5C_A(+#_G]M/\
MO\O^->67W_+'_KJM//6CZLNX>R1Z:WB"PS_Q^VG_ '^7_&D_X2&P/_+[:?\
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MDVFC_F(67_?]?\:/^$GTW_H(6/\ W_7_ !KQ^2FT_J:[A[!=SV'_ (2C3/\
MH(V/_@0G^-,;Q3IF?^0C8_\ @0G^->.GK4;]Z/J:[A[!=SV7_A*M,_Z"-A_X
M$)_C1_PE6F?]!&P_\"$_QKQ:CM1]37<:H+N>T_\ "5:9_P!!&P_\"$_QH'BO
M2]I_XF5A_P"!"?XUXM3.QH^IKN#PZ74]@O/%>E_VI:?\3*P_C_Y>$]/K5O\
MX2W2O^@EI_\ X$)_C7A-W_Q_VW_ _P"534?4UW%[!=SW#_A+=*'_ #$]/_\
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M]\0]<M-/L-8\5Z2E[>06"NMM'+N96\L.S,%RN0"S$9ZGK7XV?\%H?VT/C_\
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M.OAIIW@W]F/2O$WA:R\/6D.F:M-X\T^U?481& )C$[JT>[KM89&<'.,UO?\
M!P[?7>I_L0_">XU"Q_LR_N/B/H\ES9^<LWV24V%^7CWKP^UB1N'!QD4 ='XT
M_:0_;K^!'ANY\3>)OA%\&?'.AZ4OVJ_L/".H7L.H_9TYD\L322;FQTV1N>#\
MC=*^D_V(/VS_  I^WE\ ;#Q]X2^TP6\LSV5_8W./M&F7D84R0.1D'Y71@1]Y
M)$. 20/7J_.__@CUY/AS]OO]M#P[HB0GPQ8^+[>XB6WQ'!8W+SZ@)8DC^JLO
M'RK]G  &0* -S_@KM_P5?\9?L'?$OPEX8^'WAC1/%.HS:3/XD\21:E;SR?9-
M-6=88WB,,J%"66XW.RLJA5."-V/MKX=?$#2OBMX"T?Q+H5W%?Z-KUG%?V5Q$
MZNLL4BAE.5)'0\X/7-?GC_P3\\"67_!33XS?M3_&+Q%;?\4MX]BE^&7ATJ
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MA[XO^*O%7_!5+]JOPOJGB/6]3\.:"VCOI>F7=[)/:Z86A;=]GC8E80VXE@@
M8@$Y(& #[6HK\H?V ?AM\>_^"@_A;XDP:G\??'/@OP'X7\9ZKIEI<Z1J,TFO
M7UYNAD$;W,CEHK2",Q;(XRNXRR#@<U[M_P $E?C!\1-&^.WQS^!'Q%\8:G\0
M)?A)?VG]BZ]J(#7ES:7'FMB>0EG=L")AO9V&]UW;54  ^Z**_*[]EO1_$O\
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MZEO)1YLZM+,QD8+([(NX\*B@!0 !ZA0 4444 %%%% !1110 4444 =I1110
M4444 %?//B!/V;?^"I7A?4O#6H'P)\4H]"FN;.XM'8?VEHTBR+',T9^6YMLL
MJ#S(RFX;<,017T-7PE^TE_P;J?LX_M&^/KSQ(++Q;X'U'4[B2[OE\,ZFD5O=
MS2.SN_E7$4Z1Y+?=B"*,#"CG(!^8'PH^%>D_LF?\' WA#P=\"?$=SXAT+3/&
M=E8&=9UF:*TE5!J=JT@PLHAB:Y0GK^[[NO/N7Q0MTN?^#LVV61$D4:OIC@,N
M0&7PU;D'Z@@$>X%?I1^PY_P2>^"W_!/J[FU'P%X?NI?$MU:BSN-?U>[-YJ$L
M7!*@X6*(,1EO*C3=@9R%4"AJ7_!);X;:O_P427]IBXU7QG)XY66.<:=]MMQI
M >/3UL$/EB#SN(U5_P#7??'/R_)0!\._\';%O&W@?X'2E$,J7VLHKE?F53'9
M$@'T.U<_0>E>+_\ !QUX>U2/X>_LLZJZ9T6;P0;2%P!\MPD=H\@/&1E'BQD\
M[6QT-?J]_P %#_\ @F'\/_\ @I?X?\,:?X[U/Q;I2>$[B>XLI=!NX()&,RHK
MJ_G0RJ1^[4C !&.M=Q\9?V,? '[0G[-$7PH\9Z2=?\*V]C;V<!G8"ZMF@C$<
M5Q'*H!2=0/O*!G+ @JS*0#D/VG?VHOAI;_\ !-[QE\1+77]%O?A]J?A"\&FW
M-NZ"'4!+;R116T2-M'FNY$0B;!#Y1@I! _.S_@VS^&&N:A^PQ^TA?P:?<2P>
M)D_LK3-J'-Y<16-SO1.QYN8AP>K5[UI'_!KK^S?IOBF'4)M4^*.H6D;;FTRX
MUJV%K,-N,,T=JLV,\_+(#GOCBOO+X*? [PE^SE\-]/\ "'@?0-/\->&]+#"V
ML;-"$0L2S,2269F))+,2Q)R2: /R!_X-+O%^F:-K'Q[T^[OK:VO)[31-0CBE
M<*6MX&U!9I>>-J&>(,>WF+7F/PJ^+7ASXY_\'-=CXI\):K;:YX>U3Q5)]CO[
M<-Y-R(]+>)F0D#<N]& 8<, ""003^@'QK_X-Q/V<?C9\6[OQ<8/&'A5M0N_M
MEUI.@:A!;:9,Y(9P(W@D:)6(.5B= -QV[>,=G\+_ /@AY\#O@C^U+X/^*WA2
MW\1:'J?@FT2UL-(M;F!=+F9;:2W\^<>3Y\LQ$A=G,V6< G(RI /@SXD_\K9-
MO_V%=._]1F"L+]O7Q';?!C_@YC\-^)O&4T-EX;;5_#UY;W,J QP6_P!B@@\U
MN.BW"2$MS@+GM@?ICJ7_  29^&VK_P#!1!?VE[C5?&4GCE98YQI_VRW&D!X]
M/6P0^6(/.XC57_UWWQS\OR5N_MZ?\$R/A3_P45T/3K?X@:;J$6J:,KIIVM:3
M<BVU"S1R"Z!F5T="0#MD1P#D@ DY?4#XJ_X.F_C3X3OOV1/ O@RW\0:7<^*;
MOQ=;:Y'IL$XEG^PQV%[&UPP7.U"UQ"%+8W[CMR%;'SA_P47\/ZI>_P#! C]E
M/4H$W:187@BO" "4EDANO))[XPDHSTR5'4BON?0/^#;3]G3P[\)->\,1OX[G
MO-?\I9?$$^IV\FJVT4<R3>5#_H_V=%9HU#-Y.\KD;L$U]1^!OV)_A_X4_9$T
M[X'WVE'Q5\/[#2UTE[36]EQ)>1*V\/(RJ@$H?#JZ!"CJK)M*@@Z@?F'^QY_P
M2T^(/[6?[%WA?Q#H'[='CNV\'ZCX?AL]0\/VPO)]/\/@6R"?2Y%_M-$"0*WE
ME3&BE #M"L*]G_9V_80\+?L-?\$HOVJ;'PK\5]%^+EOKGAC7_M6HZ7;PPP6$
M\&D3QM;,([B<>8I;+ L"-RC:.IT=6_X-=_V=+[5UN8M<^*ME"&W&TAUFS,)&
MXG&7M&?&./O9P.N>:^J_AA_P3Q^&_P &/V/?$WP1\*VFJ:-X.\6:=J%AJ$L=
MX9KYS>P&":822AU\S81MRI4;5^4C@G4#X?\ ^#533X(_V6OB9=+!$MS-XJCB
MDF"#S)$2TB*J6ZD*7<@=M[>IK]3EZ&O"/V!/^">7@C_@G'\,]8\*^![[Q+J=
MGK>J'5;FXURZAGN/,,4<013%%$@0"/(^7=EFRQ& /=UZ&JZ@?A]_P6:OH?A7
M_P %VOA%XI\8R0VGA"";PSJDES+%YD45A!J)^T%U526VF.8E<$X(XY K[Y_X
M+>?&_P (^&O^"5_CN>\U;3;J'QK86UEH AGCE_M:6:6)XW@^;$BJ@,Q92<(A
M89XS[/\ MG_L+?#G]O;X:0^&?B'I#WD-E-]IT^_M)/(O],D. S0RX. P #*0
M5;"Y4E5(^6?A_P#\&T/[.'@KQA'JMY-\0O$]M&^\:5JNL0BR/S!@#]G@BE(&
M,8,G()SD\TP/$_\ @F/^QKX'_:0_X(GVW@OXMZC;>%=/\<^-+S4?"VHW%U':
MSI>I%Y<4EOYN%D<K!=@H,[HA+C'WE\4^-C_M _\ !OQXH\)CPW\9-)\?_#[Q
M,?-L]$NSN@NHHB6<?8Y'D:W1@Z9EMI1N+*"QP ?UL_:>_P""=WPO_:P_9UT7
MX6>(-'GTSP?X;N8;O2;719OL/]G20PRP1^7@%<".:0;64CG.,BOG/X,?\&WO
M[.?P@\=6VMW8\:^-Q:-O33O$>HV\MBS8."\<%O"7&2#M9BIP,@C((-'A_P#P
M<S>(#\0_V.O@AXGAMWM[35=3:ZV.X+0F>R65$/J<!N0,<>XK[A_8_27Q5_P2
MV^%^F:+<VKZQJ'PJTZWL5\U>9AI4,7?C"R,JMG@$X-=_^U?^R/X&_;7^#T_@
MGX@Z4VJ:*]S'>PF.4PSV=Q'D+-%(.4<*SKGNKLIR&(KQK]@G_@CK\*_^"=GQ
M)U3Q9X*U'QIJNMZKICZ1)+KE_!,L=N\L,K*JPP1#.^",Y.3U]: ZGX]_\$:/
MV:/$G[3'Q!\:^$_#7[1?B3X!^)5CM98M-TIKA+CQ.(_M/F?+'=VY9K8#.T[R
M!.Y 4*Q/WE\!_P#@C+;?!_\ X*!>"?&WC?\ :G'Q!^(6F70U*+1M8LP-;UE(
M(2  \U_+,4C0J20C808X&"/<OVMO^"$/P%_:Z^)^H^,=2L_$7A/7M98RZA-X
M:NX;2.^G+;GN'CDAD3S7).]@HWDEFRY+'7_8C_X(M_!?]A'XD1>,/"R>*=8\
M46L,MO;ZCK>HK,]NDH*OM2&.*/)4E<E"<$T%/8_//]E'Q?IOP0_X./OB!+X[
MU&PT8ZEXEUZVT^>[PD9DO'=K- V,*SQ2(H)QDMC)+<^Z?\'2GQ1\.V_[-GP_
M\%O<VS^++OQ*NMQ6ZLAF@L8K6ZA=V&=ZJ\LT84XVL8GYRE?7'[<O_!*/X0_\
M% =5LM4\;:=J=CX@T^W:TBUG1;E;6]:(G(1RR.D@4Y*[U;;N;'4UYC^SO_P;
MX_L[?L^>-8-?DT_Q+X[O+*036L7BB^BN;6WD!!#>3###')C!XE5UY/&0" #Y
M(_;J_;H^*_[ G["7[-/PI\'7?_"'^(M>\%VE]K&I[4%W:J(XU6U0R#;$0S-Y
MC8R"@ 8#=GR#_@KO^R'X^_9J_9W\':I\0/VI-=^+][XJU=+BS\+7=W<SVB1^
M1.QU&W,MU(K(FY(PRPIQ=8! X/[%?MK?\$__ (:_\% /!%AHOQ#TNZG?1I6G
MTO4K&X-O?::SE/-$;X*E9!&JLKJRG"G 959?F;2/^#:K]G72/!.K:5)=?$._
MO=3V"+5[C5X/MNFA9(W(@"6ZP?-Y94F2)SMD?!!P5?49Y=\:_P#E5KL_^P#H
MW_I]M:]K_P"#>.P@L_\ @F+X9DBABBDNM7U.6=D0*9G%RR!F(ZG:BKD]E Z
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M!#/Y&K:O-'YB!O+==/DVL,]&'8]17V[_ ,%XO^44GQ4_[A'_ *>+&NH\!_\
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MBBB@ HHHH **** ,GP[UO_\ K\D_I6E6;X=ZW_\ U^2?TK2H >>E,IYZ4R@
MHHHH **** "BBB@ J,]:DJ,]: "I*CJ2@".BBB@ JSHO_(8M?^NR?S%5JLZ+
M_P ABU_Z[)_,4 =!XM_X_(_]S^M95:OBW_C\C_W/ZUE4 %>!?\%2? VL_$K_
M ()\?%?0_#VE7^MZSJ&ANEK86,#3W-TP=&VQQJ"SM@'"@$GL*]]HH \5_P""
M<G@O5OAW^P;\(]%UW3KS2-8T[PM8Q7=E=Q&*XM9/)4F.1#\R.,X*L 5.00""
M*^?_ /@X#^%'BSXM?LC^"H/!_A3Q)XPOM'\?Z?JES8Z'ITM_=);I:7RM)Y<8
M+8#2(,XP"XS7W510!\+:_P#\%2?C'\3-'N]'^&W[)WQIMO%=U PLKGQ9IPT;
M3;9RRJ'>6;"' 8G:6&=H[9(Y+2OV3/'_ /P3W_X):_&&Z2TUCXC_ !\^+4EQ
M/K4NA65SJDTUW>N8<QK%&&(ABFFG,C*!YK/RP*+7Z+44 ?!/[-W_  ;\_ 'P
MY\"/"MI\0_ O_"1>.$T^-M;O_P"W-1MA+=-\SJ$@NA$ A;8"HPP0'J:Y[X$?
MLA7O_!-/_@K-%!\.? _BE_@C\6?#BV,YTZWNM4L_#NH0E2K7-PY=XD+(Q#22
M$?Z6^.% 3]%Z* .3^/>G7&L? SQI:6D$UU=W6A7T,,,*%Y)G:W<*JJ.2Q)
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ME\2=95IO",#W>N:9J:I:;UEM^0]L\1AVLH!5DEW$@J!^O]?-'_!+W]C7Q/\
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M^P/_ "['_OMO\::KQ'[5'$4R3[YKNO\ A#K#_GV/_?;?XTQO!]@6_P"/8_\
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M_%4'X(^'?^@4W_?^;_XJCZ_3[,/K4#P&F/\ >KZ _P"%(^'/^@4W_?\ E_\
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MW<>%)^3L/>LKR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
M#:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5 #:*=Y#_W&_*CR'_N-^5
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MZ7_R!]T_\/J#_P!$V'_A0?\ W-1_P^H/_1-A_P"%!_\ <U?"U%'_ !#WA_\
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M_<U'_#Z@_P#1-A_X4'_W-7PM11_Q#WA__H'_ /)Y_P#R0?\ $8N+_P#H,_\
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MFE_\D6O$CB/_ *"/_)(?_(GUR/\ @J3D_P#(C?\ E9_^T4O_  ]&_P"I&_\
M*S_]HKY('6I*C_5#*/\ GS_Y-+_,T7B-Q%_T$?\ DD/_ )$^M1_P5#R/^1'_
M /*S_P#:*5?^"H&[_F1__*S_ /:*^3!TI\=2^$<I_P"?7_DTO\R_^(B\0_\
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M7=_S)_\ Y5?_ +37S-#]VECJ7PUEO_/O\9?YEKCC._\ G_\ ^2P_^1/IH?\
M!1/)_P"1/_\ *K_]IIP_X*'Y_P"90_\ *K_]IKYE'6I5[_2H?#>6_P#/O\9?
MYFG^NV=?\_O_ "6'_P B?2P_X*&9'_(H?^57_P"TTY?^"A.X?\BC_P"53_[3
M7S2.E/3I4_ZN9=_S[_&7^9HN-<Z_Y_?^2P_^1/I,_P#!0G!_Y%'_ ,JG_P!I
MIW_#P7_J4O\ RJ?_ &FOFL_>%2U+X=R[_GW^,O\ ,T7&><_\_O\ R6/_ ,B?
M2 _X*"9/_(I?^53_ .TTH_X*!9'_ "*7_E4_^TU\WI]ZG)]VI?#N7_\ /O\
M&7^9:XRSC_G]_P"2Q_\ D3Z/7_@H!N/_ "*?_E4_^TTX?M^Y/_(I_P#E3_\
MM5?."=:>.M3_ *O9?_S[_&7^8_\ 7'./^?W_ )+'_P"1/HW_ (;Z_P"I4_\
M*G_]JIP_;WR/^14_\J?_ -JKYTIXZ5+X?R__ )]_C+_,O_7#-_\ G]_Y+'_Y
M$^B!^WOD_P#(J?\ E3_^U4H_;UR?^15_\J?_ -JKYV'WC3D^]2_U?P'_ #[_
M !E_F7_K?F__ #]_\EC_ /(GT4?V\,#_ )%7_P J7_VJC_AN_P#ZE;_RI?\
MVJOGM_NTM1_8& _Y]_B_\S3_ %NS;_G[_P"2Q_R/H%_V]-L\:?\ "*_ZS//]
MI],?]LJD'[=F6Q_PBW_E2_\ M5?.DO\ Q^V__ OY59'^LJ7D.!_D_%_YE_ZV
M9K_S]_\ )8_Y'T*/VY\G_D5__*E_]JH;]N;:?^17_P#*E_\ :J^?QUI7ZU/]
MA8'^3\7_ )E_ZUYK_P _?_)8_P"1] #]N7(_Y%?_ ,J7_P!JI5_;BW?\RQ_Y
M4?\ [57@"?=I\=3_ &'@?Y/Q?^97^M6:?\_?_)8_Y'OP_;@R?^18_P#*C_\
M:J7_ (;=_P"I9_\ *C_]JKP-/O4^E_8F"M\'XO\ S+_UIS3_ )^_^2Q_R/>C
M^VW@?\BS_P"5'_[52K^VWN'_ "+/_E1_^U5X,WW!0G2I_L3!?R?B_P#,O_6C
M,_\ G[_Y+'_(]Z7]MC<?^1:_\J'_ -JI?^&U?^I:_P#*A_\ :J\'3K3ZC^QL
M'_)^+_S+_P!9LS_Y^?A'_(]RNOVV_LWE_P#%,YWN$_Y"/3/_ &RJ8_MH\?\
M(M_^5#_[77@.J?\ +O\ ]=U_K5L_=%+^QL'_ "?B_P#,M<2YE_S\_"/^1[FO
M[:&[_F6__*A_]KIP_;.R?^1;_P#*A_\ :Z\+CIPZU#R?!_R?B_\ ,I<29E_S
M\_"/^1[G_P -E_\ 4N?^3_\ ]KIP_;(R/^1=_P#)_P#^UUX=3QTI/*,)_)^+
M_P REQ'F/_/S\(_Y'MW_  V/_P!2[_Y/_P#VNE'[8V3_ ,B[_P"3_P#]KKQ&
ME3[U3_9&$_D_%_YE_P"L68_\_/PC_D>W?\-A_P#4N_\ D_\ _:Z=_P -@?\
M4O?^3_\ ]KKQ*I*G^R<)_+^+_P S1<09A_S\_"/^1[6/VO<C_D7O_)[_ .UT
MB_M?9/\ R+W_ )/_ /VNO&$^[34ZTO[*PO\ +^+_ ,RUG^/_ .?GX1_R/:Q^
MUYD_\B__ .3W_P!KJ.Q_;#^VVJR?\([MW9X^WYQSC_GG7C8ZU!H?_(+B_'^9
MJ?[+PO\ +^+_ ,REGV/_ )_P7^1[D/VMLC_D7_\ R>_^UTH_:TX_Y '_ )/?
M_:Z\:'2G#[IJ?[,PU_A_%_YE?V[COY_P7^1[&/VM,G_D ?\ D]_]KIW_  UE
M_P!0#_R>_P#M=>-)]ZGTO[,PW\OXO_,O^W,=_/\ @O\ (]C/[5^!_P @'_R>
M_P#M=*G[5N\?\@'_ ,GO_M=>//\ =IT'W/QJ7EN&_E_%_P"8UG>-_G_!?Y'L
M _:LR?\ D _^3O\ ]KI1^U5D_P#(!_\ )W_[77CZ_?-.'6E_9N&_E_%_YE?V
MWC?Y_P %_D>O_P##5'/_ " O_)W_ .UTX?M29'_("_\ )W_[77D/\?X5(GW:
MEY=A_P"7\7_F7_;.,_G_  7^1ZI9?M8?;#-_Q(-OE2&/_C^SG'?_ %=3C]J+
M)_Y ?_D[_P#:Z\7T3[UY_P!?+_TJ^GWJ7]GX?^7\7_F4LYQG\_X+_(];/[4&
M!_R _P#R=_\ M= _:@R/^0'_ .3O_P!KKR8]*!TJ?J&'_E_%EK-\7_/^"_R/
M6E_:=R/^0)_Y.?\ V%.7]IK<?^0)_P"3G_V%>3)TIZ=:7U"A_+^+*_M?%_S_
M (+_ "/5_P#AIC_J"_\ DY_]A0?VE\'_ ) O_DY_]A7E=*_WJCZC0_E_%EK-
M<5_-^"_R/5!^TKD?\@7_ ,G/_L*7_AI7_J"_^3G_ -A7EB?=I:/J-#^7\65_
M:F*_F_!?Y'J0_:4R?^0+_P"3G_V%/;]I#:?^0-_Y-_\ V%>5I]\?6I'ZU+P5
M'M^92S/$_P WX+_(]*G_ &FO)O+>+^Q,^?NY^V?=P,_W*G_X:,X_Y __ )-_
M_85Y%>_\AG3_ /MI_P"@UH?P?C2^I4>WYE?VGB?YOP7^1Z:/VC,G_D#_ /DW
M_P#84K?M%8'_ "!__)O_ .PKS%/O4Y_NTG@Z/;\RO[2Q/\WX+_(]._X:&_ZA
M'_DU_P#84X?M!Y'_ ""?_)K_ .PKS2GI]VI^J4NQ?]H8C^;\%_D>CK^T+N/_
M ""/_)K_ .PIP_:"R?\ D$_^37_V%>:)UIXZT?5*78/[0Q'\WX+_ "/2#^T%
M@_\ ()_\FO\ ["E'Q_R/^03_ .37_P!A7FQZT\=*CZK2[%_7Z_\ -^"/1U^/
MVXG_ (E73_IY_P#L*</CUD_\@K_R9_\ L*\XB^\:D3[U'U6EV+6.K_S?@CT,
M_'K!_P"05_Y,_P#V%+_PO?\ ZA?_ ),__85YV_WJ?4?5Z?8/KU?^;\$>@_\
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M0?\ ^1__ +&N('WC2CK2]E'L'MZG<[9OC!@_\@__ ,C_ /V-*/B_D?\ (/\
M_(__ -C7$OUIPZ4G2B7[:?<[9?BYN'_(/_\ (_\ ]C2CXLY/_'A_Y'_^QKBT
MZ4]/O4G3B'MI]SL3\6<'_CP_\C__ &-+_P +7_Z</_(W_P!C7&O]ZGTO9Q+]
MK/N=>/BQD?\ 'A_Y'_\ L:5?BKD_\>/_ )&_^QKCD^[3DZTG"(>UEW.P_P"%
MI_\ 3C_Y&_\ L:/^%I_]./\ Y&_^QKDJ*3@B_:2.O'Q0R/\ CR_\C?\ V- ^
M*.3_ ,>/_D;_ .QKDQTI%ZFERH/:2.N'Q/R?^/+_ ,C?_8TI^)N!_P >7_D;
M_P"QKDT^]3G^[2Y4/GD=7_PLS_IR_P#(W_V-'_"R^/\ CR_\C?\ V-<K2_P?
MC2Y5<KF9U2_$O)_X\O\ R-_]C2CXD9/_ !Y_^1O_ +&N43K3QUI60U)G5'XB
MX'_'G_Y%_P#L:0?$;(_X\_\ R+_]C7,GI0GW:5BKLZA?B'N_Y=/_ "+_ /6I
M!\1,G_CS_P#(O_V-<W'2)]ZD4=/_ ,+!_P"G3_R+_P#6H_X6#_TZ?^1?_K5S
M=%(9TG_"P?\ IT_\B_\ UJ/^%@_].G_D7_ZU<W10!TG_  L'_IT_\B__ %J/
M^%@_].G_ )%_^M7-T4 =)_PL'_IT_P#(O_UJ/^%@_P#3I_Y%_P#K5S=% '2?
M\+!_Z=/_ "+_ /6H_P"%@_\ 3I_Y%_\ K5S=% '2?\+!_P"G3_R+_P#6H_X6
M#_TZ?^1?_K5S=% '2?\ "P?^G3_R+_\ 6H_X6#_TZ?\ D7_ZU<W10!TG_"P?
M^G3_ ,B__6H_X6#_ -.G_D7_ .M7-T4 =)_PL'_IT_\ (O\ ]:C_ (6#_P!.
MG_D7_P"M7-T4 =)_PL'_ *=/_(O_ -:C_A8/_3I_Y%_^M7-T4 =)_P +!_Z=
M/_(O_P!:C_A8/_3I_P"1?_K5S=% '2?\+!_Z=/\ R+_]:C_A8/\ TZ?^1?\
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MO_UJ/^%@_P#3I_Y%_P#K5S=% '2?\+!_Z=/_ "+_ /6H_P"%@_\ 3I_Y%_\
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M]8\&WF2SV3RN-.53V<OXCDE:\;M.*D[[+;9L^1/VHM6\.:[^T)XMO?"7E?\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?CG7[*?M7?\FP_$/\
M[%O4/_2=Z_&NOV4_:N_Y-A^(?_8MZA_Z3O7[UXF_[[EW^*7YTS^/O '_ )%N
M=?X(?^DUC\:Z***_5C\,"OU-_P""6_\ R9UHG_7Y>?\ H]J_+*OU-_X);_\
M)G6B?]?EY_Z/:OS7Q4_Y$\?^OD?RD?MW@'_R4D_^O4O_ $J!\F_"71(/$'_!
M5NZ@N8TDCC\:ZK<@,N0'BDN94/U#(I'N!7TS_P %:O&M[X6_9AM[.SF>$:[K
M$-E=%21OA$4LI7(/=HTSV(S7R5IOQ+MOA#_P4IU7Q!>[5LK+QOJ,=R[/M$,4
MMS-"\A.#]U9"V.^W&1G(^[/V\_@%>_M(?LZWFE:,L=QK-A<1:IIT32[%N)$#
M*4W=,M')(%SQN*Y('(^?X@G"AG668G$Z4N2&KV33U?RO%L^OX0I5,7PQGF"P
M.M=U*FBW::5E\[227<_*/PIXENO!GBG3=8L7$=]I-U%>6[G^&2-PZG\P*_7;
M]L*PMO$G[)?CP3PI+"=!N+I%D0-AXXS+&V#D95E4@]B 1R*_._X&?L"?$/XA
M?%NRTG6/">L:+H]I>)_:MY?PM;0K K_O/*<X$K$ A?++9)!R%RP^Z/\ @HW\
M7++X7?LLZ_;S2K_:'B:(Z190;B&E,G$C<<X6+>2>F=H/WA73QOB:&-S? 4<%
M)3J*6O*[V3<6M5Z-^2U.+PMP6*RSAW-\5F<'3I2A9<R:NU&:E9/O>,?-Z;H\
M$_X(W_%GR-1\5>")Y !.JZS9(>/F7;%/[$D&#CKA3U[8G_!5[X$7<G[07AG6
MM)M#--XXB33MB@#S;V)EC4%C@ LCQ*,_\\SS@<?/W[)'Q:_X4E^T5X5\0/+Y
M5G!>K!>DMM46TN8I2>QVJY;GNHZ=:_6SQW\,-*^(NH^';G4[>.=_#6J)JUIO
M0-MF2.1%/X%PP]T4]0",>)L3+(.)(YI!>Y5@[KNTK6^]1;.G@?!1XMX*ED52
M5JE"I&S[1<KI_<ZD5Z'$_$W7;3]D']C^[>TF'_%):$EC8/,I?SK@(L,)8+@G
M=*REL8ZD\#D>"_\ !&?PW;P> /&FKA%^UW.H0V9?'(2.,N #GUE/0=AG.!B/
M_@L9\7/[.\)>&?!-M-B74IVU6]1)\,(H\I$KH.JN[.1GC=!T)'&)_P $;/B?
M#;W_ (O\'3RQK-<+%JUFFTAI-O[N;GIQF' Z_>//./)P^65EPAB<:]9UI*3\
MXQE_G=^A]!C,]PLO$7!98K*GAX2A'LIR@W_Z3RQ]=#U']J[_ ()S77[4OQ;E
M\3W'CH:5$MK%9VME_8WVC[/&@)(W^>N<NTC?=&-V.<9/<_L9_LFW/[)'AG6M
M);Q.OB*SU2Z2[B']G?9#;2!-C_\ +63=N C],;#USQ\W?\%-OV./%GBKXNMX
MX\*:!>:Y8ZG9PQZBECNGNH[F/]T&\D98J8A$,Q@@;&+!>K>$_#;_ ()_?%GX
MEZC!%'X2O]&@E/SW6L*;&. 9(W,KCS#TZ*C''.,5W87 /'Y'3IU\TA&C97@X
M0]UKI?F4KI]=W\SRL?FRRGBFM6PF15*F)YI6J*K5:FI:<W+R.-FGMJHO1/0]
MO\0&V?\ X+)P/:W$%PC7T._RF+>5(--571CTW!E.0"<9QP00/=?^"H/Q5U7X
M6?LP2?V1/):W'B#4HM(DN(G*20Q/'+*^TC^\(MA]G-?%O[&_A"Z^'O[??A[0
M+YH7O=#UJ[T^X:%BT;21)-&Q4D D94XR!QVKZL_X+$?\FS:'_P!C/;_^DMW6
MN:X&E#/\KPLGSQC3@K]^5RL[?*YAD&:UZO"&>X^*]E.=6K*R>L>91NK^5VKZ
M?(_-NOJ7X*?\$H/'/Q+T2TU37=0L/"-E>P>='#/$\]\N3\H>$;0F5Y.7W#@%
M<YQY%^Q]!9W/[4G@%;\Q"V&MVS?O'VKO#@ISD?QA>._3G-?HS_P4-T?QYK?[
M.\L7P_.J_P!I)?PR7T>F,1=S6@5]RQ[?G)\SRB0G)4,.1D'ZCB_B+&83&X?+
M<'*--U=YRU2UMUT^_P CX/PZX,R[,,LQ>=9C"594-%2@VG)VOJUK]WF]=CG/
MV0/^">)_91^*%UXD'C$ZZ+G3I-/-L-*^RX#R1ONW><^<>7TQWZ\5Y#_P6C0#
M6?AXV!N,-^"<<D!K?'\S^=7/^"6_[*OC?X<_$>]\9>(='FT+39M-FTZ*WOU:
M"\D=I8FW>2PW*G[MN6QGC (.:J?\%H_^0M\._P#KCJ'\[:OD<M=3_7*DJN(5
M>233DDH_8EI:.FA^BYU&BO#7$2P^">$BY1:A*4I/^)#WKR2>I\/4445^X'\L
MA1110 4444 %%%% !1110 4J?>I*5/O4 /HHHK,J)-%]RGIUID7W*>G6H>YL
M*WWQ4HZ5$WWQ4HZ5$C6)(GW:</NFFI]VG#[IK-FJ'Q=JDJ.+M4E9LV'CI3TZ
M4P=*>G2H>QHAZ=:?3$ZT^H-T24]/NTRGI]VLS4?'3AUIL=.'6H9LAZ]_K4@Z
M5&O?ZU(.E2]C1#DZU(GWJC3K4B?>J#5#Z=)3:=)61<1\/W:>.M,A^[3QUJ#9
M#GZ4Y.U-?I3D[5F;HE_@_&G)]VF_P?C3D^[4/<M"U*GWJBJ5/O5#-5L2'[HH
M3K0?NBA.M2:+8>.M25&.M25F:H>.E/CI@Z4^.H>YH/3[U/IB?>I]0]C1$E.7
M[AIM.7[AJ#9#H*D'6HX*D'6H-@/6GI]VF'K3T^[69H20_>IR?>IL/WJ<GWJE
MEH?3QTIE/'2I-4,N.D?_ %T%64ZU6N.D?_70593K69H+)4K_ ':BDJ5_NU#W
M+6PZ'[M+'20_=I8ZAFBV'#K4J]_I40ZU*O?Z5#V-APZ4].E,'2GITJ#5"G[P
MJ6HC]X5+4/<TB*GWJ<GW::GWJ<GW:AFD1R=:>.M,3K3QUJ2R2GCI3*>.E0]R
MP'WC3D^]31]XTY/O4C0F?[M+2/\ =I:S-2&7_C]M_P#@7\JLC_656E_X_;?_
M (%_*K(_UE0]S0E'6E?K2#K2OUJ30<GW:?'3$^[3XZ@L>GWJ?3$^]3ZGH:#F
M^X*$Z4-]P4)TJ30>G6GTQ.M/K,T(=4_Y=_\ KNO]:MG[HJIJG_+O_P!=U_K5
ML_=%+J6MA8Z<.M-CIPZUG(T1)3QTIE/'2I9:%I4^]24J?>J2Q]25'4E0:Q'I
M]VFIUIR?=IJ=:74TB/'6H-#_ .07%^/\S4XZU!H?_(+B_'^9J#1%X=*</NFF
MCI3A]TU'4H$^]3Z8GWJ?2-![_=IT'W/QIK_=IT'W/QJ&4A5^^:<.M-7[YIPZ
MTBA_\?X5(GW:C_C_  J1/NU,C0I:)]Z\_P"OE_Z5?3[U4-$^]>?]?+_TJ^GW
MJDM#CTH'2@]*!TJ&:(>G2GIUIB=*>G6D4/I7^]24K_>K,U0Y/NTM(GW:6@H5
M/OCZU(_6HT^^/K4C]:F1:*=[_P AG3_^VG_H-:'\'XUGWO\ R&=/_P"VG_H-
M:'\'XU)0)]ZG/]VFI]ZG/]VD]BR6GI]VF4]/NU!H-3K3QUIB=:>.M  >M/'2
MF'K3QTK,T'1?>-2)]ZHXOO&I$^]06M@?[U/IC_>I]9C"E3K24J=:#05OOBG4
MUOOBG5/092\._=O?^ON3^E:<=9GAW[M[_P!?<G]*TXZDL/\ EI3J;_RTIU!H
M/'2A>_UH'2A>_P!:S-!R=:?3$ZT^@!TE*GW:22E3[M3T+6P#[QI1UI!]XTHZ
MU(Q7ZTX=*:_6G#I2>QH/3I3T^]3$Z4]/O5+ '^]3Z8_WJ?2-!$^[3DZTU/NT
MY.M2P'T444F:#QTI%ZFE'2D7J:0#T^]3G^[34^]3G^[28Q:7^#\:2E_@_&IZ
ME@G6GCK3$ZT\=:12'GI0GW:#TH3[M+J4/CI$^]2QTB?>J2NP^BBBD4%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!^.=?LI^U=_R;#\0_P#L6]0_])WK\:Z_
M93]J[_DV'XA_]BWJ'_I.]?O7B;_ON7?XI?G3/X^\ ?\ D6YU_@A_Z36/QKHH
MHK]6/PP*]Z^ '_!1+QQ^SG\.H/#&BZ?X9O-.MI9)8VO[69Y5+L68925!C)/:
MO!:*X<?EN%QU+V.+@IQO>S[GJ91G6.RNO]9R^JZ<[6NNSZ?@C3\;^+KOQ_XS
MU?7;_P K[=K5[-?W'E+M3S)7:1MHYP,L<#->_?LS_P#!2_Q?^S_X5A\/WUC;
M>*M#LD*6<=S.T-S:#C:BR@-F,<X5E)&0 P4!:^;J*SQ^3X+&T%AL534H+9=K
M=FM5\C?*>(\SRS%O'8"LX5'>[76^KNG=/775/4^X=4_X+1W<UH19?#RWMY^S
MSZTTR#@_PB!#UQWKY1^.7Q\\3?M$^,SKGB>]%S<B,10PQKL@M4'\,:9.T$\G
MN2>37&45Q95POE>6S=7!45&7>[;^]MV^1Z>?\=Y]G5)4,RQ#G!.]K1BK^:BD
MGY7V"OI_PI_P5I^)GA7PS8:9_9_A"_%A;I;BYNK.X,\P4 !G*3JI; YPH^E?
M,%%=N8Y1@L?&,<934U':_0\S)N(LSRF4IY;6E3<M';K;:_H=K\??CYK_ .TA
M\07\2>(FM/MIMX[6.*UB,<,$:9PJ@DGEBS')/+'M@#GO!?C35?AUXJL=;T2^
MGTW5=-E$UM<PG#1MT^A!!(*D$$$@@@D5ET5U4L)1IT5AH12@E:UM+=K'!7S#
M$UL2\;5J-U6^;FOK?>]^_P"1]E> ?^"R/B71]*$/B/PCI6N7*' N+2\:P+K@
M?>4I*"V<G(VCG&T=:?XV_P""RGB+5=*GBT#P=I>CW,B[8[BZO6O?)/=@H2,$
M^F>,]0>E?&5%?,_ZB9#[3VOU=7]96^Z]OP/M_P#B*_%BH^P^N2MM\,.;_P "
MY>;YWN=?X,^..O\ @KXT1>/HI;>\\1)?2ZC))<Q9CGFEW&0LJ[>I=N%QUXQ7
M>?M*?MX^,?VI?!EGH6OV/AVSL;*]6_7^SK>:-WD5'C&XO*_&)&X '6O%**]V
MIE&#J5X8F=-.<-(OLO(^6H<19G1PE7 TZTE2JN\XWTDWNWYNRN/MKF2SN$EB
M=XI8F#HZ,59&'(((Z$5]@?"G_@L'XF\)>%XK'Q/X9M/%-W -BWT=[]AEE4 8
M,B^6ZLW7E0H/'&<D_'E%99KD> S."ACJ:FEMNFO1II_B;\/\59MDE257*ZSI
MN6^S3[74DT[=':Z/J7XC_P#!6+Q_XI\9Z3J&AVFG^'M-TMS(VG%FN4U!B,$3
MO\C,@YPJ;,9R22 1Y=^T[^U[XE_:ON-&D\166AV;:&LRP?V=#+&'$NPMNWR/
MG_5C&,=3UKRNBL<%PWEF$G"KAJ,8RA=)]=;WUW>[WN=&9\;9[F-*I0QN)E.%
M1IRB]G:UM%HK66BL@HHHKW#Y8**** "BBB@ HHHH **** "E3[U)2I]Z@!]%
M%%9E1)HON4].M,B^Y3TZU#W-A6^^*E'2HF^^*E'2HD:Q)$^[3A]TTU/NTX?=
M-9LU0^+M4E1Q=JDK-FP\=*>G2F#I3TZ5#V-$/3K3Z8G6GU!NB2GI]VF4]/NU
MF:CXZ<.M-CIPZU#-D/7O]:D'2HU[_6I!TJ7L:(<G6I$^]4:=:D3[U0:H?3I*
M;3I*R+B/A^[3QUID/W:>.M0;(<_2G)VIK]*<G:LS=$O\'XTY/NTW^#\:<GW:
MA[EH6I4^]452I]ZH9JMB0_=%"=:#]T4)UJ31;#QUJ2HQUJ2LS5#QTI\=,'2G
MQU#W-!Z?>I],3[U/J'L:(DIR_<--IR_<-0;(=!4@ZU'!4@ZU!L!ZT]/NTP]:
M>GW:S-"2'[U.3[U-A^]3D^]4LM#Z>.E,IXZ5)JAEQTC_ .N@JRG6JUQTC_ZZ
M"K*=:S-!9*E?[M125*_W:A[EK8=#]VECI(?NTL=0S1;#AUJ5>_TJ(=:E7O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_C5?4-%'^M^=?]!,_O#_ (ASPQ_T T__  $^7O\ AT?\*_\ GOXK_P# ^/\
M^-4?\.C_ (5_\]_%?_@?'_\ &J^H:*/];\Z_Z"9_>'_$.>&/^@&G_P" GR]_
MPZ/^%?\ SW\5_P#@?'_\:H_X='_"O_GOXK_\#X__ (U7U#11_K?G7_03/[P_
MXASPQ_T T_\ P$^7O^'1_P *_P#GOXK_ / ^/_XU1_PZ/^%?_/?Q7_X'Q_\
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M?\.C_A7_ ,]_%?\ X'Q__&J^H:*/];\Z_P"@F?WA_P 0YX8_Z :?_@)\O?\
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M_P!!,_O'_P 0[X9_Z J?_@)\Q_\ #IKX6D_Z_P 5?^!\?_QJG?\ #I_X7?\
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M\;H'_!-_X>C_ ):^(O\ P,3_ .-U[U11_K%F?_/^7WC_ -3,C_Z!8?<>#?\
M#N+X>C_EMXA_\#$_^-TO_#N7X>_\]O$'_@8G_P ;KWBBE_K#F?\ S_E]X_\
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M //F/W'G _9"\( _Z_5?_ E/_B:7_AD3PC_SWU7_ ,"4_P#B:]&HH_M/%_\
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M%A_RVU'_ ,"%_P#B:[.BE]?Q'\[#^R<'_P ^U]QQO_#,?A;_ )[:A_X$+_\
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MK _9\\- _P"OO?\ P(7_ .)JQX._YBO_ &$9OZ5LT?7*_P#,P_L["_R(Y_\
MX9^\-_\ />]_\"%_^)H_X9^\-_\ />]_\"%_^)KH**7UNM_,Q_V=AOY$8 ^
M'AL?\M[S_P "%_\ B:!\!/#:G_7WG_@0O^%;],?[U'UNM_,P_L_#?R(Q/^%#
M>'#_ ,M[O_P(7_"E/P&\.$_ZZ\_[_K_A6S12^M5OYF/ZAA_Y$8X^ _AT?\M[
MS_O^O_Q-'_"B/#O_ #WO/^_Z_P#Q-;%%'UJK_,P^HX?^1&./@3X=!_U]W_W_
M %_PI3\#_#I_Y;W7_@0O^%:]1GK1]9J_S,?U'#_R(QI_@;X7:]MR]U<"5=WE
MJ;E1NXYXQSQ4_P#PI+P[C_7W/_@0O^%0ZS_R-FB_]M__ $ 5L4?6:O\ ,'U*
MA_(C-'P1\.@_\?%U_P!_U_PI3\$_#Q'^ON?^_P"O^%:-%+ZS5_F']2H?RHS_
M /A3/A[_ )^+C_P(7_"E'P;\/@?\?%Q_W_7_  JW11]8J_S!]3H?RHJ#X->'
MA_R\7'_@0O\ A2CX-^'_ /GXN?\ O^O^%6J*/K%3^8?U2C_*BK_PIOP__P ]
M[C_O^O\ A2_\*?\ #X_Y;S_]_P!?\*LU&>M+V]3N'U2C_*B(?"#P^I_U\_\
MW_7_  IP^$>@#_EXG_[_ *_X4^BCV]3N/ZK1_E1&?A%H!/\ Q\7'_?\ 7_"E
M_P"%2Z"/^7F?_O\ K_A3Z*/;5.X?5:7\J&?\*FT#_GXF_P"_Z_X4#X4Z /\
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MQ^QAV+Y^'>AG_EZD_P"_Z_X4#X>Z$!_Q]/\ ]_U_PK.?I3:/:2[A[&'8T_\
MA7NA9_X^G_[_ *_X4H^'VAC_ )>G_P"_Z_X5ET4<\NX>RAV-0_#_ $,_\O3_
M /?]?\*7_A -#_Y^G_[_ *_X5D/TIM+GEW'[.'8VAX"T0?\ +TW_ '_7_"E'
M@71%_P"7IO\ O^O^%8E%'/+N'LX=C:/@;1#_ ,O3?]_U_P *<G@?17< 7+,2
M< "=>?TK"?[M3:+_ ,ABU_Z[)_,4<S#DCV-JX\ Z/;, \KQ9' :8#/YU&/!>
MB#_E[/\ W_6D\??\A"'_ *Y_U-8-',Q\D>QT'_"&Z)_S]_\ D=:7_A#M$_Y^
MO_(ZUSU%+F8<D3HAX0T4?\O7_D=:0>#]%'_+U_Y'6N>HHNPY$=$/"&B@_P#'
MW_Y'6@^$M&(_X^__ ".M<[11=ARHZ/\ X1/1O^?O_P CK1_PBFC8_P"/K_R.
MM<Y11=CY4=(/"NC#_EZ_\CK0/"^C#_EZ_P#(ZUS=%%V%D=,?#.CG_EZ'_?\
M6D'AG1P/^/H?]_UKFJ*0['3CPWHZ_P#+T/\ O^M)_P (UHX/_'T/^_ZUS-%
M'3_\(YI'_/V/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'
M_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0
M_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!
MT_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/
MT/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/
M^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%%
M'3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'
M_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0
M_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!
MT_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/
MT/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/
M^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%%
M'3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'
M_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0
M_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/T/\ O^M<Q10!
MT_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/^_ZT?\([I'_/
MT/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%% '3_\([I'_/T/
M^_ZT?\([I'_/T/\ O^M<Q10!T_\ PCND?\_0_P"_ZT?\([I'_/T/^_ZUS%%
M'I%%%% !1110 45F^,/%-KX'\):IK5]Y@LM'LY;ZX,:[F$<2%VP.YPIXK\W_
M /B*K_9Z_P"A.^,W_@ITW_Y/H _3*BOS-_XBJ_V>O^A.^,W_ (*=-_\ D^OT
MJTK5(-<TNVO;5_-MKN)9X7VD;T8!E.#R.".M %BBBL[Q9XNTKP#X9OM:UW4]
M/T71],A:XO+^_N4MK:TB499Y)'(5% ZDD 4 :-%<Y\+OC%X1^.'AIM9\%^*?
M#GB_1UF:V:^T34H=0MEE4 M&9(F9=P#*2,Y&X>M='0 4A^\*6OSP_P""R/\
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ME_K0-$+_ 'JBJ5_O5%6A93UO[T'_ %V7^M+/]S\:36_O0?\ 79?ZTL_W/QH
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M6GJM_#5F>JW\-6AD$_454NN_TJW/U%5+KO\ 2M31%:3I4=22=*CJT4%%%%4
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M@[7YVL"!\0^$_P#@X,^-GQ3\#6FG^#/A-H?BCQU$LMYJLFG:7J%W96ENK,%
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MOND;^#D8!!%4MRD?H1_P4._X*C>)?V<?CYH'PD^&/@NT\8^/]>@@F!O)'-O
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M44 (_P!VIM%_Y#%K_P!=D_F*A?[M3:+_ ,ABU_Z[)_,4 :OC[_D(0_\ 7/\
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MXH^(7Q%^'?[$-YJEU>> /B5XJ\3:=:W]W]A0W&C7MY!!#++]GD "NIE9O*8
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MF[XE^%?B?81Z=J_B?QQJFI)+:7,$J7MK/:VD0N8_+9P@=HY2$?#K@945S/\
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M#(H ^5/^";W[$\/[4.L?%WX9?%7QOXT\=?#'X)^,;SPUHWAB?4I;.TNGCGG
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M?-\1].72O'G]E0)KUNDT,RB\50LKAH<Q8=@7VH2J[]H)QFO!_'7[-'C;6?\
M@LIX,^*UMHOF> =)^'<FA76J?;(!Y5Z;F\<1>27\X_++&=P0K\W7@X /%O\
M@HYI^G_\$O?V%-"^&7PBG\7Z/;_$?Q<FEH+"Y.H:G86LR9NULA(=YD<HH5 R
MG?<.0ZDBOG#XJ?##PSX#\"+K?P#_ &?_ -MOP)\9]*F2[L/$U]X>O'34YS*O
MFM?#SY%8-$9UQ'$JL92&5E)%?I%_P4K_ &+=0_;:^ EEI'AW6K7PYXT\*ZS;
M^(_#FI7,9:&&]@#A5D(5F$;!SDA6P51MK;<'SRR_:/\ VS]8T)-)'[.'@72/
M$!0AO$%[XZMYM'#G.#]CB)N<#(R/,.=K<\C !Y7_ ,%8OB?J&MV7[,.F_%.^
MUSP)\*O'LS_\+'BTR[GM%6X-M;.EC<[06$ =I@5))(1S\K1JU>.>%_V&OV</
M&/\ P5O^&_A_X.6=EXW\!0Z-=:SXJ@TO7[C4=.T"6&-S9SI>1SEM[7"PAHVE
M<?./E ;CV?\ X*=>'M>^*?\ P4E^ WA_X?VOA36?B?8>'M3O[W1?%]I]K\+Q
MZ;,KQ&64X$C,7CN$Q&A<[8R0@'S7]$^,_P 5/^":'COP#IGCCX3?LY:'X*^)
MWB6U\.W5[\,8Y]+>"[G8K'-)!)&&E"1AB<*W0#>I95(!O? N:X/_  7I^/4,
M$WEF3P#IK+O!:/>%L0K,H(W8W'N#@GD9KY:_9Y^&_P #]<\5:KX?_:RU;X@>
M"_VFO[;EC_X235=<O+-&+3EX9M.N(O\ 1(HL2*/WF5^8LA"L OVOX)_9D^(O
MA3_@JQ\8?BE;:381^&_%'@>VTW0M2NKN-H)=0C6V BEB1_/50T+$MLQMZ')Q
M7E?[57A;]J7]NWX!W?PB\5_L]^!?#TNJW-N9?&LOC"UN]/T\I,K&XM[,*URC
M^7N3.XMAG_O;: .7_P""\'[*/@#7/B5\&?%]UH/F^(O&OCK3/#6M7?VZY7[9
MI^"/)V"0(G'\:*K_ .U7;?\ !4']DSX?_L;_ /!&OXO^&/AOH'_".:'?:AIF
MJ3VWVZYO-]R^IZ;$S[YY)'&4AC& <?+G&2<]Q_P43_88\9?$_P#90^%>F?#V
M2W\1^,?@MJ^E:M8VNHS+;+X@%G#Y3(SLP5)'(1\LX7AAG)!%+]L7P5\<OVY?
M^"8GQ/\ #6K?">V\&?$#6M2L8=%\,Q>)K/4&FM(+S3YVEDN]T< 8E+D[25PJ
M*.6/(!7_ &1/^"2W@F'X<6'C?Q;K_B_Q9\0/'OA>>U\0:M<:FPBNK;4;,QS6
MBP8,8@19?D!!PT:'@ *.9_X)0?';_AEC]DOXT?#SQS?"XNOV8-7U*.YF5=B7
M&FGSKB%TZN?,DCNMH()VF,#/W1]O?!G0+OPG\'_"FEW\7D7^FZ/9VMS%N#>7
M+' BNN5)!P01D$BOS(_X*X?LZ:\W_!0OPQHG@_5A;V_[5UA:^&/%%K&V+FVB
MT^[LGDNU/&U?LR1KR&RL5PN#N  !])_\$/?A?J.A_L@W?Q#\1)_Q5?QIU^]\
M9:DY/59I2L0')^5E4RC))_?G)[#[)JKHFC6OAS1K33[*%;>RL(4M[>)?NQ1H
MH55'L  *M4 %%%% !1110 4444 %%%% 'I%%%% !1110 5Y=^V3^R+X5_;E_
M9]UCX;^,I-6M]#UEX)7GTRX6"[MY(95E1HV='3.5P0R,,$\9P1ZC10!Y/^Q3
M^QUX9_80_9^TWX;^$;[7=1T/2[BXN8I]8FBFNV::5I&#-%'&F 6.,(./6L']
MN/\ X)R?"S_@H7X6TW3?B+HT\]QHLC2:?J=A-]FO[/<,.BRX.4;@E&!4E5.,
M@5[M10!^>OPB_P"#9C]FOX7^,+?5M0_X3WQO';,'73M?U>'[&S#."RVL$#,,
MX.UF*G&"""0?N_4_AQH&L?#JX\(W&C::_A:ZTUM'ETD6ZK9M9-$83;^4 %$7
MEG9M QMXZ5MT4 ?!?PI_X-S_ -G[X,?M"Z#\1-#NOB#%>^&=5M=9TW2I=8AD
MT^VN+>5)8CS!Y[*'C!(:8YR1TP!T?[:'_!!KX#_MN_%:Z\;:W#XJ\*^)=28/
MJ5WX;OXK<:FX4*'ECFAFC#X RR*I8\L2237VC10!\*^ /^#>']GSX6_%7X=>
M,?#_ /PF^F:Q\.;^WU.WV:M')'K%S!<_:8I+L/"Q)#!5Q"8@54 CO7I'[='_
M  27^&__  4%^*W@_P 7>-M6\9V-]X,B\BTM]'O+>"WN$\X2D2B2"1SDC'RL
MO'OS7U%2'[PH 3_EI7S+_P %$O\ @E=\/O\ @IBW@[_A.]8\9:3_ ,(5]M^P
M_P!@W=M!YOVK[/YGF^=!-G'V9-NW;C+9SD8^FO\ EI3#]X4^H'S]^W!_P33^
M&'[?WPKT7PKXUM-4LX_"[[M&U/2;A(M0TQ2$5XXY)$D4I(L:!U=6!V*>&56'
M)?%W_@D'\.OC5^Q%X&^ VL^(_B ?"7@&_CU#3K^/4+7^U)6C2YC2.61[=HS&
MJ73J L:X"1@' .?JT?Q4A^Z*: \W\'_LO^&O W[*5I\'K1]3?PI9^&O^$6$L
MLZF\EMC;F!G9PH7S64EB0H7<>% P*X']@#_@FYX'_P"";_A'Q!HW@?5?%>JV
MOB6\CO;IM=N;>>2-T0H AAAB &#SD'ZU]"/]VDDIC/@OXZ?\&Y_[.OQF\=ZC
MKUO!XN\$/J4_GR6/AJ^M[:PB8@[A%#+;RK&I/.Q,*O10HXKU_P#88_X)6?"?
M_@GIJ.I:AX%MM<NM;UBT6QN]3U>_^T7$D(</L"HJ1*"P4G:@SM%?24O]::_6
MF-'R'^V3_P $2_@;^VK\0+CQ9KMAKGAOQ)>JHO+_ ,.745HU\P)/F2I)%)&T
MAS@OMW$ 9/ JG^R!_P $./@A^QA\6-,\<:"/%NO^)-&67[!<Z[J22K:/(K1M
M((X8HD9MCLHWJP&=P 8!A]C/]VFG[HJD,C_@_&OD[]M7_@C-\%_VZ?B*?%WB
M:W\0Z#XIGA2&\U/0+U+>745142,S++'+&S(B; P0-M."2%3;]8_P?C3>]4,^
M$]+_ .#>+]G[P_<>$;G3W\<V5]X3OA?O=QZM$TNM.K0LHNM\++M!B.! (O\
M6R?[.WU[]O[_ ()D> _^"C1\)_\ ";ZMXNTO_A#OMGV+^P[JW@\W[3Y'F>9Y
MT$N<?9TV[=O5LYXQ]&'I^-(>M %;3]-AT;2[>SMD\NWM8UAB3).U%& ,GD\
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M+WJ+^/\ "I9>]1?Q_A5DC'[U _6IW[U _6@T(7^[4?\ '^%2/]VH_P"/\*T
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MMYA&V>4;?FX]?HH **** "BBB@ HHHH **** "BBB@#TBBBB@ HHHH ****
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MK_\ 9UZ1YE'F4?7*W?\ (/;3[GFC?L]Y'_(7_P#)7_[.D/[/.?\ F+_^2O\
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M1K_\I?\ ]MII_8"W'_D;/_*7_P#;J^DOM?M1]K]OUH_M7%?S?@O\A_7:W?\
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M^S^M'V[_ &?UH_MG&?S_ (+_ "#Z_7_F_!'R3_P["Y_Y'?\ \HW_ -OIK?\
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M%?S?@O\ (^!F_P""*A;_ )J2?_"=_P#NFHV_X(FEO^:E'_PG?_NFOOO^V?\
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MX2'_ -VU^L/_  F0_P"?<_\ ??\ ]:C_ (3(?\^Y_P"^_P#ZU'^MV;?\_?\
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M_P#?S_ZU'_"P1_SZG_OY_P#6H YSR'_N-^5'D/\ W&_*NC_X6"/^?4_]_/\
MZU'_  L$?\^I_P"_G_UJ .<\A_[C?E1Y#_W&_*NC_P"%@C_GU/\ W\_^M1_P
ML$?\^I_[^?\ UJ .<\A_[C?E1Y#_ -QORKH_^%@C_GU/_?S_ .M1_P +!'_/
MJ?\ OY_]:@#G/(?^XWY4>0_]QORKH_\ A8(_Y]3_ -_/_K4?\+!'_/J?^_G_
M -:@#G/(?^XWY4>0_P#<;\JZ/_A8(_Y]3_W\_P#K4?\ "P1_SZG_ +^?_6H
MYSR'_N-^5'D/_<;\JZ/_ (6"/^?4_P#?S_ZU'_"P1_SZG_OY_P#6H YSR'_N
M-^5'D/\ W&_*NC_X6"/^?4_]_/\ ZU'_  L$?\^I_P"_G_UJ .<\A_[C?E1Y
M#_W&_*NC_P"%@C_GU/\ W\_^M1_PL$?\^I_[^?\ UJ .<\A_[C?E1Y#_ -QO
MRKH_^%@C_GU/_?S_ .M1_P +!'_/J?\ OY_]:@#G/(?^XWY4>0_]QORKH_\
MA8(_Y]3_ -_/_K4?\+!'_/J?^_G_ -:@#G/(?^XWY4>0_P#<;\JZ/_A8(_Y]
M3_W\_P#K4?\ "P1_SZG_ +^?_6H YSR'_N-^5'D/_<;\JZ/_ (6"/^?4_P#?
MS_ZU'_"P1_SZG_OY_P#6H YSR'_N-^5'D/\ W&_*NC_X6"/^?4_]_/\ ZU'_
M  L$?\^I_P"_G_UJ .<\A_[C?E1Y#_W&_*NC_P"%@C_GU/\ W\_^M1_PL$?\
M^I_[^?\ UJ .<\A_[C?E1Y#_ -QORKH_^%@C_GU/_?S_ .M1_P +!'_/J?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C]:2E?K24 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1U)4=
M!1110!@^._\ F#?]A2#_ -FK>K!\=_\ ,&_["D'_ +-6]0 4444 %%%% !11
M10 4444 %%%% #7Z4VG/TIM !1110 4444 %%%% !1110!AZ]_R.F@_]O'_H
M K<K#U[_ )'30?\ MX_] %;E !3'ZT^F/UH 2BBB@ HHHH **** "BBB@#!\
M<==)_P"PE#_[-6U6+XXZZ3_V$H?_ &:MJ@ HHHH **** "BBB@",]:*#UHH
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MG_@BW^SI^UE\%?B/\1+K]HKQ'XAU71+F&*#1H=6\5#6_/G\UB\\"B23R8]@
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M(/\ @GY\&[J\F>XN&\(Z<C2/]Y@D"HN?4[5'/4]3S0![?1110 4444 %%%%
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M^)/QG^/_ (>33_%^K0&+27NM0L]4FGFNY6DO+D20S2^4RA$C!)W,L\@SC(8
M_4/3-,M]%TVWL[.WAM+2TC6&""&,1QPQJ %15' 4   #@ 5/110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 Q^M)2OUI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ#\??$WQ(^!_Q>UKX+:]XYF6Y\26L>BV^N:9JLP,C&8VT[*JREI7;<2V"\A
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M* ,6BMC_ (0R?_GK%^O^%'_"&3_\]8OU_P * ,5^E-K;;P7.1_K8OU_PI/\
MA"+C_GK#^O\ A0!BT5M?\(1<?\]8?U_PH_X0BX_YZP_K_A0!AOTIM;K>![AA
M_KH?U_PI/^$%N/\ GM#^O^% &'16Y_P@MQ_SVA_7_"C_ (06X_Y[0_K_ (4
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M\Z3SW_OM^=-HH =Y[_WV_.CSW_OM^=-HH 0W$F?OO^='VB3^^_\ WU3#UHH
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M[]AW]H[1_ACXQA\5W&N:I#;7$]WIUI;O8:3'/(41KF26>-E  WML5\(0>O%
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MP]^+'Q/TCXP:?X#\1^)O*T&/0XK*#Q!;7:_;8B7CEE>V\ITM9SDLQVLA&">
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MQ/M_#DC^./#]M=3+!%KFK:5##I>YF5069)WEC7YLEGC55"L214/_  <)6OP
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M#X[_ .8-_P!A2#_V:MZL'QW_ ,P;_L*0?^S5O4 %%%% !1110 4444 %%%%
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MJ@G 8G"J2/AOX3>!M&^&?_!P7>Z!X>TNQT71=*^&$=O9V-G"L,%M&/(PJJO
M_J236]_P4^-O\6O^"D?[)_PSUA+:^\,SZK>>(+[3IX/,BO)854P^8#PR_NI%
MV]"';<&! H [7X>?\%Q/A%XP\?Z+H6N:%\2OAW%XCD2+3-7\6Z$FGZ9>%\^6
MRS"5]J-QAV 4;@20,D?1/[57[1&D?LG?L[>+OB)K@\RP\+6#70@W%#>3DB."
MW#!6VF69XXPQ!"F0$\ UX9_P7!^&=A\2O^"9_P 1?M<*O<>'XK;6;&0L5-O-
M#<1Y88ZDQ-*F".DAZ'!'SA^W#\3[G]J#]DW]B+P)JEVU])\:-9T&YU^X8YDN
M5A@MTN\AR"P\R[+GU,:\\C(!]0?M.?\ !1?4/V7_ -@/PY\:]5\ I=7^NQ:=
M++X<77#']B^V)O"&Y-N=S(" P\H#=D X&3]15\*?\'%7_*-R_P#^QAT[_P!"
M>N\^-W[>/BKQI^U!:?!?X!:7X?\ $WBO29EF\::_K$4T^A^$+;D&*00R1M+=
M$](UD&"NTY/F>4 >@>,_VT+;X<_MR^%?@UKNAM8P>.M"FU+P_KXO-\=]>0LY
MFL7A\L>6RQ)O#ER&W*H&XXKV^OA/_@NV/^%;_##X0_%NS)MM6^%WQ!L+O[8G
MWX;*4-YZ =6#O#;ADSAE!!S7W90 45\F_M<_MM?$GP[^UQX=^!/P;\-^$;[Q
MQK.@MXCN=4\7SSP:59VHF:,!4A(EF;]U)G8>,K@-APO>_";XG?&K0_@7X\U/
MXM^%_!&C^)O"T%U/IEQX?O9;G3-9CBMS()1'(?.C7>N,.P8@]%QD@'NM8WQ$
M\6_\(#\/]=UW[/\ :_[%T^XO_(W[/.\J-GV;L'&=N,X.,]#7DG_!-7]IS7OV
MR/V*/!?Q(\3VFD6.N>(_MWVF#2XI(K1/(O[BV38LCR.,I"I.7/).,#@>7?LU
M_MF^(_VP/V=OVD!XDT[1;&;P%K&N^&[)M-CEC6>UBMF\MI%D=R9<[MS*0IR,
M*N.0#VC]A']JG_AMC]E/PK\3O["_X1G_ (2;[7_Q+?MOVW[-Y%Y/;?ZWRX]V
M[R=WW!C=CG&3Z[7Y/?\ !*KX]?M*ZU^P3X1\-?!'X;^"Y-)\'_;8KO7_ !I<
MSQV^KW$M_=W#0V4<+HS!%EB4R,VW>'7MFOK7]C7_ (*)ZG^TU^SA\1]2UOPR
M/"/Q1^% N[3Q%H4\<AMX+J**1XG4DY,;F-U*;]RF-N<%'8 ^K**_.;]G#_@H
M_P#M5_MJ_ W3O$_PP^$7@)O[/7R]7U'7IY[.RUBY$L@>'38O/W;4C\K,LDI7
M?YBXR,";X"?\%7OCI^W9X!BA^"OP<T6'Q+H-IL\4ZKXJNY(="MK\,/\ 1K54
M=996= 6VLRF+> V0 [@'Z)UY#^Q;^VEX6_;K^%FH>+O".G^(].TW3M7GT66+
M6K1+:=IHDC=F55=P4Q*N#G.0P(!%<3_P38_;EUK]LKP9XOLO&7A:+P9\0OAW
MK3Z'X@TN&4R0I(,[73))4$K(N-S#,9(8AACF?V+/^"CVK?&;]A'X@_&'QSHM
MA%)\/[[6$GM- @E NK>QA68;5DD<AV5B"2VT8R=HS@ ^NJ*^(/V>/VI_VM_C
M_P"$O"?Q'T[X?_!2X^'7BN>"6/2(=9NTUZWLG8!YVG8_9CM <[0N_.!LR#76
M_M<_MM?$GP[^UQX=^!/P;\-^$;[QQK.@MXCN=4\7SSP:59VHF:,!4A(EF;]U
M)G8>,K@-APH!]2^)->A\+>';_4[A9GM].MI+J584WR,J*6(5>YP.!W-><_L<
M?M<^&_VW_@99?$#PI8Z[I^C7US/:QPZO;QP7(:%RC$B-Y$(R."KGWP00,KX
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MXYQD@'N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCXA^(6I^._$'@_5I?%EO96MG#H,US.L:PM,SM(\T,.#^\4 !6[Y(Z$ _,_\
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M@W0=:C;[%%O_ +0E-GYM[G;_ ,?#^;)ND&&(D89P<5YY_P $??C-X.^$/_!
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MI_%7[=_P&^&7@GX77G@_PY:> +E@D.MW=S##':BW2&*.,Q0S,2H0#YL<#J:
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M&>M25&>M &/K/_(V:+_VW_\ 0!6Q6/K/_(V:+_VW_P#0!6Q0 4444 1T444
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M_&:](TCP)HGA[P;%X<L-&TJQ\/06WV*+2[>TCCLXX-NWR5A4! FWC:!C'&*
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MA%9QW5RX4/.ZQJH:1@J@N<L0HR>!0!\9?\$G_P#D]']LS_L?H_\ T.]KE?\
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M;1?^0Q:_]=D_F* -7Q]_R$(?^N?]36#6]X^_Y"$/_7/^IK!H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /2**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0?I3: )M);1C]I^R[?\ CX?SL!O]9QNZ_A5O-C[?K7*^#O\ F*_]A&;^E;-
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M2>'2;C[-L_U[>;A7_P!9QNZ_A5G?HY_N_DU<7X5ZZG_U_P O]*UJ -_=H_\
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M@[XG^-?"5ZFF^)/#VBO<Z?=M!'.+:7>JA]D@9&(W$@,I&<9!Z4 >Y45\6?\
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M_P#VA_%O[*?_  3I^(OCWP+J2:/XJT-=.6QO6M8KD6YGU*UMW/ERJT;'RY7
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M110 5&>M25&>M &/K/\ R-FB_P#;?_T 5L5CZS_R-FB_]M__ $ 5L4 %%%%
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M/V[/V4- ^($FEKHVI7+RV6I6<;%H8[J%MKF(GGRVX=0<E0VTEBNX@'N=%%%
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M#8/]I34+'PQ\1_V>_$T7V37/ .H2ZO8PR2J98XGE$%Y;[1VAN51MP+9-V1D
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MMX<\=:'XNDLT#:;9VUI%:6]U<-!'>6LT<$#,$D5@R3J<B-AE3\]?L;7XF?\
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M@K6/&G@CXVZ%OGUS1-:UJ]L]4U6[P4FCNXIR8KCYG9ML&"0_S#AE'-_M@?\
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M2=0DU*\B6V6VN'N808(YEAD"S2.V)$;=NPV5XKVJB@#QG]KG_@GU\(?V[?\
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M'&YL?>.<'PC_ ,$[O@YX%_:DU#XTZ7X-2W^)FJ/-)<ZRVIWLI=ID\N0B!YC
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M_P"SEX+_ &4/A+IW@;X?Z)'X>\+Z2\TEM9K<37!1I96ED+2S.\CDN['+,<#
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M[_D=-!_[>/\ T 5N5AZ]_P CIH/_ &\?^@"MR@ IC]:?3'ZT )1110 4444
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M2=GE^;%USUW<>AKW:BB@ HHHH **** "BBB@ HHHH **** "BBB@#TBBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** &NN32;33F;!I/,H ;BC%+OHWT )@TNPT;Z-] !M(I,
M4N^C?0 F*,4N^C?0 F*7:31OHWT &TTF*7?1OH 3%&*=OH\R@!-AHVD4;Z-]
M "8HQ2[Z-] "8HQ2[Z-] !M-&TT;Z-] "8HQ2[Z-] "8IGEGTJ3?3?//M0 W
MRSZ4>6?2G>>://\ :@#$\8Z?/>_V5Y43R>5J,,C[1G:HSDGVK9V'T/Y5G^)/
M$$NC?8/+2-OM5Y';MNSPK9R1[\5I>>?2@!NP^A_*CRSZ4[SS[4>>?:@!OEGT
MH\L^E.\\^U'GGVH ;L([&C8?0_E3O//M1YY]J &^6?2CRSZ4[SS[4>>?:@!O
MEGTHV'T-.\\^U'GGVH C="1T/Y4WRV_NG\JE:X(':F_:F]J &^4Q['\J/*;T
M-/\ M1]!1]J/H* &>4WH:/*;T-/^U'T%'VH^@H 9Y3>AH\IO0T_[4?04GVIO
M:@!OE-Z&CRF]#3OM3>U'VIO:@#%UG3IYO%>C2K$[1P^?YC <)E !GZUL>4WH
M:H:EXBFLO$&FVBK&8[WS=Y(.1M4$8YK1^U-[4 ,\MO[I_*FO"Q/W3^52_:F]
MJ1KQ@>BT 1>0_P#=/Y4>0_\ =/Y5)]M;T6C[:WHM $?D/_=/Y4>0_P#=/Y5)
M]N;T%'VYO04 ,^SO_=-'D/\ W33_ +<WH*/MS>@H C\A_P"Z?RH\A_[I_*I/
MMS>@H^W-Z"@#"\7Z9<7ATSRH9)/*OXI'VKG:HSDGVK6^SO\ W&_*JGB+Q/-H
MYL?+2)OM-W' VX'A6SDCGKQ6A_:+>BT 1?9I/[A_*C[-)_=-2?VB_HM']HOZ
M+^5 $?V=_P"XWY4?9W_N-^52?VB_HOY4?VB_HOY4 1_9W_N-^5'V:3^Z:D_M
M%_1?RH_M%_1?RH @-K)G[C?E1]DD_N-^52G5) >B?E1_:DGHGY4 1?9)/[C?
ME1]ED_N-^52_VH_HM']J/_=6@"'[+)_<;\JRO ^DW-CX7M8IH)(Y%WY5EP1\
M[&MO^U'_ +JUG^%O%4^N:%!=2I$KR[LA0<##$>OM0!;^R2?W&_*FO:2$?<;\
MJG_M1_[JTC:LX'W5H K_ &.7_GFWY4?8Y?\ GFWY5/\ VQ)_=2C^V)/[J4 0
M?8Y?^>;?E1]CE_YYM^53_P!L2?W4H_MB3^ZE $'V.7_GFWY4?8Y?^>;?E4_]
ML2?W4I/[7D_NI^1H @>SE(_U;?E3?L4W_/-_RJPVLR@?=3\C_C2?VW+_ '8_
MR/\ C0!A^%=&NK7^T?,MY4\R^ED3<N-RG&"/:M7[#-_SS;\JKZ#XPN-5^V>9
M'"/L]T\"[0>0N,$\]>:O_P!MR?W4_(T 0?8IO^>;_E1]BF_YYO\ E4_]MR?W
M4_(T?VW)_=3\C0!!]AF_YYO^5-;3YMW^K?\ *K/]MR?W4_(TUM>E!^['^1H
MK_V?-_SR?\J/[/F_YY/^56/[>E_NQ_D?\:/[>E_NQ_D?\: *WV";_GD_Y4?8
M)O\ GD_Y59_MZ7^['^1_QH_MZ7^['^1_QH K?8)O^>3_ )4TZ=/G_5/^56_[
M>E_NQ_D?\::?$,P/W(_R/^- &#JNAW<WB7295MY3'%YV]@O"Y4 9K4_LV?\
MYY/^51:AXVN;36]/MEC@*7?F;B0<C:N1CFKW_"13?W(_R/\ C0!6_LV?_GD_
MY4?V;/\ \\G_ "JS_P )%-_<C_(_XT?\)%-_<C_(_P"- %/^R[C_ )XO^5']
MEW'_ #Q?\JM?\)--_<C_ %_QH_X26;^Y'^1_QH J_P!F7'_/&3_OFC^S+C_G
MC)_WS5K_ (26;^Y%^1_QH_X26;^Y%^1_QH J_P!F7'_/&3_OFF'2[C/^ID_[
MYJ[_ ,)+-_<B_(_XTT^*)P?N1?D?\: *G]E7/_/&3\J/[*N?^>,GY5:_X2B?
M^Y%^1_QH_P"$HG_N1?D?\: *G]EW'_/&3_OFC^R[C_GC)_WS5O\ X2B?^Y%^
M1_QH_P"$HG_N1?D?\: *G]EW'_/&3_OFF?V1<_\ /"3_ +YJ]_PE$_\ <B_(
M_P"--_X2RX_N0_D?\: *?]D7/_/"3_OFC^R+G_GA)_WS5S_A++C^Y#^1_P :
M/^$LN/[D/Y'_ !H Y[PYX=OK8ZAYEK.GF7LCKE?O*<8-:7]CW7_/"7_OFC1?
MB%=ZB;O?%;C[/<O"NT'D+C&>>M7?^$PN/^></Y'_ !H I?V/=?\ /"7_ +YH
M_L>Z_P">$O\ WS5W_A,+C_GG#^1_QH_X3"X_YYP_D?\ &@"E_8]U_P \)?\
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MQH SO[ O?^?6;_OFC^P+W_GUF_[YK1_X3VZ_YY6_Y'_&C_A/;K_GE;_D?\:
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4=25'0 4444
M8/CO_F#?]A2#_P!FK>K!\=_\P;_L*0?^S5O4 %%%% !1110 4444 %%%% !1
M110 U^E-IS]*;0 4444 %%%% !1110 4444 8>O?\CIH/_;Q_P"@"MRL/7O^
M1TT'_MX_] %;E !3'ZT^F/UH 2BBB@ HHHH **** "BBB@#!\<==)_["4/\
M[-6U6+XXZZ3_ -A*'_V:MJ@ HHHH **** "BBB@",]:*#UHH **** "L7X>?
M\B?:?\#_ /0VK:K%^'G_ ")]I_P/_P!#:@#:IK]*=37Z4 -HHHH **** "BB
MB@!K]*;3GZ4V@#&\'?\ ,5_[",W]*V:QO!W_ #%?^PC-_2MF@ HHHH *8_WJ
M?3'^]0 E%%% !1110 5&>M25&>M &/K/_(V:+_VW_P#0!6Q6/K/_ "-FB_\
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MUK[3XV\%V]O=:SIOV.=/L<4\:21-YK((GW)(APCL1NYP0:[N@ HHHH ****
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M\"?%SX<_$30M2BN#J.IWP-O<Q*,^86^W7#I.DBQLAB$8&Y\]%P ?TWU\F_\
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MO$_Q(\!>'-?N=,LDBTS5/$%I9WDK/#'L"Q22!R6W+C YW#'6O//^"Q]W%?\
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M.@ HHHH P?'?_,&_["D'_LU;U8/CO_F#?]A2#_V:MZ@ HHHH **** "BBB@
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MTIM.?I3: "BBB@!K]*;3GZ4V@ HHHH 1_NU-HO\ R&+7_KLG\Q4+_=J;1?\
MD,6O_79/YB@#5\??\A"'_KG_ %-8-;WC[_D(0_\ 7/\ J:P: "O _P#@IQ^U
M5=_L:?L3^-/'.E/"OB"V@CL=&\U X%Y<2+$C[2"K>6&:7:PP1$0>M>^5\>_\
M%W/A3J?Q5_X)J^-1I-M+>7/AV:UUV2*/[QMX)09WQCD)$TDAY'$9/;! ,/\
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MGPNUN;X>+)X:U2[\/6>N^9&'8SPVT%TRJC-LNF,D>9-L4JXV,Y !]3_L_?\
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M_!,W4+6^_P""I'[7_P#PD2J?'B:S;+8R3R%YVT=7E6-8R?X BV61C@&(9.*
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MDCTWQS:R+;R/I]DRR@7TI5VB,+*!YF5SWK]'*^%/^"Q'_)P'['W_ &5O3?\
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MK5_X(">#=*MOAA\:O$*:=:+KEY\3]4TZ>_$0\^2VBBM9(X2_78KS2L!TRY-
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M_'EI\/?&ESX&.N:/=_\ "11:-<-I*Q1:-;1R,UT$\I=KQNI!;.X8ZD5^Q]%
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M?ZQ-'X@N-%N(=+F22Q:-"ERR")]SL -K'/X&C_@XI_9A^)/QY_:[^"U[X)\
M>-/%UCI]AY-W=Z/HMQ>V]FYO58"62-"D?'/S$<<]*_7RB@#B/VF/A?>_&_\
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MZ9\+?^"8WPQ^$7P@^)G@/2H];'A;XI:I/JM_9?:DA73&EV[8K,PI&8HHMJ;
MQ<C:,EAQ7T-10!\AZ'_P1C^'C>(]#N?%WCOXT?$W1?#4ZW.E^'?%WBU[[1[*
M5!B)DA6-&^0#:%+;2N58,"17L'[7'[$7P_\ VU_"^G:?XWTZY>[T.4W&D:M8
M7+6NHZ/*S1LSP2C.TMY29!!!VJ<9 (]<HH ^7_AA_P $K?#'@3XCZ3XGUWXF
M_'/XD7NA7<%]86_B_P 92WUK;S0LSQ-Y:)&&VN0X#Y&Y!Q@L#]0444 %%%%
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M16C_ &$/^>A_*C^PQ_ST/Y4 9U,?[U:G]AK_ ,]#^5(= !/^L/Y4 9=%:?\
MPCX_YZ'_ +YH_P"$?'_/4_\ ?- &916G_P (^O\ ST/Y4?\ "/K_ ,]#^5 &
M949ZUK_\(^O_ #T/Y4A\.*3_ *T_]\T <CK/_(V:+_VW_P#0!6Q5J\\#)=ZI
M9W7VA@;3?A=GWMPQZU;_ .$;'_/4_P#?- &516K_ ,(V/^>I_P"^:/\ A&U_
MYZG_ +YH QJ*U_\ A&%_Y['_ +YH_P"$87_GL?\ OF@#(HK7_P"$87_GL?\
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M^/\ Z]'_  K]/^?EO^^/_KT <S173?\ "OT_Y^6_[X_^O1_PK]/^?EO^^/\
MZ] ',T5TW_"OT_Y^6_[X_P#KT?\ "OT_Y^6_[X_^O0!S-%=-_P *_3_GY;_O
MC_Z]'_"OT_Y^6_[X_P#KT <S173?\*_3_GY;_OC_ .O1_P *_3_GY;_OC_Z]
M ',T5TW_  K]/^?EO^^/_KT?\*_3_GY;_OC_ .O0!S-%=-_PK]/^?EO^^/\
MZ]'_  K]/^?EO^^/_KT <S173?\ "OT_Y^6_[X_^O1_PK]/^?EO^^/\ Z] '
M,T5TW_"OT_Y^6_[X_P#KT?\ "OT_Y^6_[X_^O0!S-%=-_P *_3_GY;_OC_Z]
M'_"OT_Y^6_[X_P#KT <S173?\*_3_GY;_OC_ .O1_P *_3_GY;_OC_Z] ',T
M5TW_  K]/^?EO^^/_KT?\*_3_GY;_OC_ .O0!S-%=-_PK]/^?EO^^/\ Z]'_
M  K]/^?EO^^/_KT <S173?\ "OT_Y^6_[X_^O1_PK]/^?EO^^/\ Z] 'Y(?L
MP?$GQ%??M+?#R"?7]:FAF\3::DD;WTK*ZFZB!!!;!!':OU/_ &M&*?LN?$4@
MD$>&M0(([?Z/)7Y+?LK?\G/_  X_[&G3/_2N*OUH_:V_Y-:^(W_8M:A_Z324
M ?C!_:-Q_P ]YO\ OLT?VC<?\]YO^^S4-% $W]HW'_/>;_OLT?VC<?\ />;_
M +[-0T4 3?VC<?\ />;_ +[-']HW'_/>;_OLU#10!-_:-Q_SWF_[[-']HW'_
M #WF_P"^S5SP?X/U3X@>*++1=%L9]1U34I1#;6T*Y>5C_(#DDG@ $D@"NU^-
M'[)'Q#_9ZT6UU'Q?X;ETFQO)_LT4XNH+A&D*LP0F)VP2%8@'&=I]* //O[1N
M/^>\W_?9H_M&X_Y[S?\ ?9J&B@";^T;C_GO-_P!]FC^T;C_GO-_WV:AHH F_
MM&X_Y[S?]]FC^T;C_GO-_P!]FH:* )O[1N/^>\W_ 'V:/[1N/^>\W_?9J&OH
M#]GS_@F_XZ_:2^&EOXJT34O"UGIUU-+#&E_=3I,3&VUCA(7&,@XYSQTH \%_
MM&X_Y[S?]]FC^T;C_GO-_P!]FM#QYX.NOAWXYUGP_?-"]]H5_/I]PT+%HVDA
MD:-BI(!*Y4X) X[5Z'XW_88^*_PY\!3^)M9\'7MIHUK&)IY1<0220(?XGB20
MR*!W)7Y>^* /+/[1N/\ GO-_WV:/[1N/^>\W_?9J&B@";^T;C_GO-_WV:/[1
MN/\ GO-_WV:AHH F_M&X_P">\W_?9H_M&X_Y[S?]]FH:* )O[1N/^>\W_?9H
M_M&X_P">\W_?9J&B@";^T;C_ )[S?]]FC^T;C_GO-_WV:AHH F_M&X_Y[S?]
M]FC^T;C_ )[S?]]FH:* )O[1N/\ GO-_WV:5-1N-W^OF_P"^S4%*GWJ +/\
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MVE_[[-.2^FQ_KI?^^S4%.3I0!82^FS_KI?\ OLT\7TV?]=+_ -]FJZ=:>.M
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M/^^C3TNY=O\ K)/^^C4%/3[M $\=W+_STD_[Z-/2[EW?ZR3_ +Z-01T]/O4
M3_:Y?^>DG_?1H:ZDX_>/T_O&HZ5NWTH E2ZDQ_K'_P"^C3TNI,_ZQ_\ OHU
MG2GIUH F^U2?\]'_ .^C4GVJ3_GH_P#WT:@J2@"9+J3;_K'_ .^C3X[J3_GH
M_P#WT:A3[M/CH F%U)G_ %C_ /?1I_VJ3_GH_P#WT:@'6I* )6NI-@_>/_WT
M:5+J3'^L?_OHU&WW!0G2@"9+J3=_K'_[Z-/^U2?\]'_[Z-0I]ZGT 3_:I/\
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M_K[D_I6C)0 _S&]3^=/21MO4_G4=/3[M "^8V_J>GK3TD;/4_G4?\?X4Y.M
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M-Y]3244 +O/J:-Y]3244 +O/J:-Y]3244 +O/J:-Y]3244 +O/J:-Y]3244
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MY^)NE6T%CK6GW$4&K%/D74(9&\M'8 ?-*KE!NX)0G).U0/3?^"5/_)F6A?\
M7Y>_^CWH _/3XZ>)F\%_MI>,=82)9WTGQM>WBQ,<"0QWSN%)[9QBOJSXZ?\
M!6SP9\1?@1XDT#2_#GB=-:\0:3-IN+M8$M8#/&8W;S%D9FVAF(^0;B #MSD?
M('[5/_)S_P 1_P#L:=3_ /2N6OU8_;6MXV_9&^(*%$*+H<Y52O PN1@>Q Q]
M* /QJJ6PL)]4OH;:VAEN+FXD6***)"[RNQPJJHY))(  ZU]8_P#!&A W[4.N
M$@$KX7N",CH?M5H/ZU]8?M1_$+X=?LC>)[OXG:UIZ:KXWUFT73M+M 5$TRQ#
M)V$@^6N67?+@D#: "<*P!^8WB#X ^._">C/J.J^"O%NFZ?&-SW5WH]Q#"@QG
M)=D"CCWKDJ_7O]C7]M32/VQM U;R=)FT/5=&*"\L99Q<(8Y-X1TDVKO!V'=E
M!M.!SD$_ 7_!2?X%:/\  3]I>>RT&W6RTO6[&/5XK5,>7:F225'1!_"FZ)B%
MZ ' X % '@EM;27MS'##&\LLK!$1%+,[$X  '))-=HG[,WQ(EM!<+\/O&[0,
M,B0:%=%"/KLQ7Z!_\$S/V3M%^%'P>T[Q[JMM%+XE\1VGVQ+B?!73[1OFC$>0
M-I9-KLWN!G YP=1_X+->$K;XEC3H/"^J7/A@3F)]9^TA)BH)'F+;%,E3P<%U
M;!^Z"-M 'YT7]A/I=]-;7,,MO<V\C12Q2H4>)U.&5E/(((((/2HJ_4C_ (*6
M?LQZ'\9O@1J7C6S@MH?$OABR-_#?+\GVRT3YY(I" =PV;F3/(8  @,V?RWH
M**** "BBB@ I4^]24J?>H ?4E1U)0 Y.E/3K3$Z4].M #QUJ2HQUJ2@"2+M4
MT=0Q=JFCH >GWJ?3$^]3Z 'CI3TZ4P=*>G2@!Z=:?3$ZT^@"2GI]VF4]/NT
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M!Z=:?3$ZT^@"MHO_ "]_]?+_ -*NU2T7_E[_ .OE_P"E7: '1TX=:;'3AUH
MDHHHH <G2GI]ZF)TIZ?>H <_W:6D?[M+0 ]/NTY.M-3[M.3K0!2U'_D.:?\
M]M/_ $&M"L_4?^0YI_\ VT_]!K0H >.E.'W331TIP^Z: !/O5(GWJC3[U2)]
MZ@!]%%% #DZ4].M,3I3TZT #_>I],?[U/H >GW:6D3[M+0 #K4E1CK4E "MV
M^E*G2D;M]*5.E %+P[]Z]_Z^Y/Z5HR5G>'?O7O\ U]R?TK1DH =3T^[3*>GW
M: #^/\*<G6F_Q_A3DZT /'6@]:!UH/6@!Z?=IP^Z::GW:</NF@ 3[U/IB?>I
M] #F^X*$Z4-]P4)TH >G6D/6E3K2'K0!)3O^6=-IW_+.@ CIPZTV.G#K0 K]
M:<.E-?K3ATH =_!^-"?>H_@_&A/O4 2)]ZA_O4)]ZA_O4 /I?X/QI*7^#\:
M!.M/IB=:?0 4]/NTRGI]V@ 'WC2T@^\:6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^3G_B/_ -C3J?\ Z5RU^K?[:O\ R:9\0O\ L!W/_H!H ^'O^",W_)S^N_\
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MZ=:8G2GIUH ?4E1U)0 ]/NT^.F)]VGQT .'6I*C'6I* '-]P4)TH;[@H3I0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>(_%^H7FGL,26T,<5I%,.>'6%$#CGHV>WI7F%>B_\,@_%3_HG7C3_P $\_\
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M)'_0B>+?_!5-_P#$T <,.E/CKN1^R[\2,?\ (B>+/_!7-_\ $TY/V7OB./\
MF1/%G_@KF_\ B: .'3[U/KMU_9@^(^[_ )$7Q9_X*YO_ (FG_P##,/Q&_P"A
M%\6?^"N;_P")H XFG)TKM_\ AF+XC?\ 0C>*_P#P5S?_ !-.3]F/XB@?\B-X
MK_\ !7-_\30!Q*=:>.M=LG[,GQ%!_P"1'\5_^"N;_P")IX_9E^(F?^1'\5?^
M"R;_ .)H XJGI]VNU_X9G^(G_0D>*O\ P63?_$TY?V:/B'M_Y$CQ3_X+)O\
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M ,32K^SUX[W?\B=XE_\ !=+_ /$T <C4E=9_PSWXZ_Z$_P 2?^"Z7_XFI/\
MAGSQU_T)_B3_ ,%TO_Q- '))]VG)UKK5_9^\<@?\BAXD_P#!=+_\33D_9_\
M'(/_ "*'B3_P72__ !- '&W76+_KH*M#K737/[/WCEC%CPAXDXD!/_$NEX_\
M=JP/@%XXS_R*/B/_ ,%\O_Q- '*T]/NUU7_"@_&__0I>(O\ P7R_X4]?@)XW
MV_\ (I>(O_!?+_A0!RL=/3[U=4GP%\;#_F4_$7_@!+_A3E^ WC;=_P BGXA_
M\ )?\* .6I6[?2NK_P"%#^-?^A4\0_\ @!)_A2M\"/&O_0J>(>G_ #X2?X4
M<HG2GIUKJ4^!/C0#_D5/$/\ X 2_X4Y/@5XT!_Y%3Q#_ . $O^% '+U)73?\
M*+\9_P#0J^(/_ "7_"I/^%&>,_\ H5?$'_@!)_A0!S"?=I\==,OP-\9;?^16
MU_\ \ )/\*>GP.\9#_F5M?\ _ &3_"@#F!UJ2NE'P/\ &.?^16U__P  9/\
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M%S6__ .3_"G?\*>\5_\ 0N:U_P" <G^% '.MV^E*G2NB;X/^*O\ H7-:Z?\
M/G)_A2I\'_%0'_(N:U_X!R?X4 <^G6GUT"?"#Q4#_P B[K7_ (!O_A3O^%0^
M*?\ H7=9_P# -_\ "@#E]4_Y=_\ KNO]:NI]VM;4?@_XJD\C'AS6CB92<6;\
M#\JMK\)/% '_ "+VL_\ @(_^% '.QTX=:WT^$GB@?\R]K/\ X!O_ (4X?"7Q
M1G_D7M9_\!'_ ,* ,(=:DK='PG\3Y_Y%_6/_  $?_"G_ /"J/$__ $+^L?\
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MV_PH RT^[3DZUJKX US;_P @C4?_  ';_"G)X!UL'_D$ZC_X#M_A0!S>H_\
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M5Y_SZS_]\&C^PKS_ )]9_P#O@T 5:*M?V%>?\^L__?!H_L*\_P"?6?\ [X-
M%6BK7]A7G_/K/_WP:/["O/\ GUG_ .^#0!5HJU_85Y_SZS_]\&C^PKS_ )]9
M_P#O@T 5:*M?V%>?\^L__?!H_L*\_P"?6?\ [X- %6BK7]A7G_/K/_WP:/["
MO/\ GUG_ .^#0!5HJU_85Y_SZS_]\&C^PKS_ )]9_P#O@T 5:*M?V%>?\^L_
M_?!H_L*\_P"?6?\ [X- %6BK7]A7G_/K/_WP:/["O/\ GUG_ .^#0!5HJU_8
M5Y_SZS_]\&C^PKS_ )]9_P#O@T 5:*M?V%>?\^L__?!H_L*\_P"?6?\ [X-
M%6BK7]A7G_/K/_WP:/["O/\ GUG_ .^#0!5HJU_85Y_SZS_]\&C^PKS_ )]9
M_P#O@T 5:*M?V%>?\^L__?!H_L*\_P"?6?\ [X- %6BK7]A7G_/K/_WP:/["
MO/\ GUG_ .^#0!5HJU_85Y_SZS_]\&C^PKS_ )]9_P#O@T 5:*M?V%>?\^L_
M_?!H_L*\_P"?6?\ [X- %6BK7]A7G_/K/_WP:/["O/\ GUG_ .^#0!5HJU_8
M5Y_SZS_]\&C^PKS_ )]9_P#O@T 5:*M?V%>?\^L__?!H_L*\_P"?6?\ [X-
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M_&CD8^5FM162VNS _=C_ "/^--;7Y@/NQ_D?\:?(PY6;%%8W_"0S?W8OR/\
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M9R1[\5I>>?:O$O&7QEU2;^RLP6'RZC"PPC]L_P"U6U_PNO5?^??3_P#OV_\
M\51]5J#]A(]3\_VH\_VKRIOC=JH/_'OI_P#W[?\ ^*I&^-^K ?\ 'OI__?M_
M_BJ/JM07L9'JWGGTH\\^U>3_ /"\M6_Y]]._[]O_ /%TS_A>NK_\^^G?]^W_
M /BZ/JM0/8R/6_//M1YY]J\C;X[ZN#_Q[Z;_ -^W_P#BZ:WQYU@#_CVTW_OV
M_P#\73^J5!^PF>O>>?2CS_:O'_\ A?FL?\^VF_\ ?M__ (NF_P#"_P#6?^?;
M3/\ OV__ ,71]3J!["9[%Y_M1YY]J\<;]H'65_Y=M,_[]O\ _%TW_AH/6?\
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MQ6C]J/H*^;];_:5UUO%6C/\ 9-)RGGX_=2=T'^W6K_PT[K__ #Z:1_WZD_\
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MP/\ ]#:@#I/[5?\ NK2-JSJ/NK5:FOTH L_VQ)_=2C^V)/[J54HH M_VP_\
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MM2-WNA@7[/<O"N,\A<<]?>KG_"83_P#/*+]?\:Y/PKUU/_K_ )?Z5K4 :_\
MPF$W_/*+]:/^$PF_YY1?K6110!K_ /"83_\ /*+]:1O&,X'^JB_7_&LFFOTH
M UO^$SG_ .>4/Z_XT?\ "9W'_/*']?\ &L>B@#7;QI.!_JHOU_QI/^$WN/\
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MVY_YXP?K_C1_PGMS_P \8/U_QK"HH W?^$]N?^>,'Z_XT?\ ">W/_/&#]?\
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M]?\ &L*B@#=_X3VY_P">,'Z_XT?\)[<_\\8/U_QK"HH W?\ A/;G_GC!^O\
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M@DDX45\6?M6_M2_$OP7_ ,'#_A/P=I?C_P 8V7@^[UK0+6;0(]8G&E2Q3VT
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M6^+O#'A>36Y3;Z<FKZI!9-?R#:"D(E9?,;YEX7)^8>HK,\:?M/?#7X9>*XM
M\2?$/P-X?UVX9$BTW4M>M;2[E9]NT+%(X<D[EQ@<[AZT =P_WJ3M7EO[9W[3
M>D?LF_L\>+/%U_K'AO3M5T_1[ZXT*TUB^2V36+^*VDEAM4#.K2.[(!LC.\YX
MKY6_X)4?\%F;7]K?P9XA?XP>(/A5X$\0V>J0V>DV<6I#3&U*.1!]V*ZN'>1@
M_&4./F QGJ ??1Z4U.M9GC;QWH?PV\.3ZOXBUG2M TJV4M->ZC=QVMO" "26
MD<A1P">3V-8'PL_:+^'WQNNKB'P7XZ\&^+IK1-\\>BZU;7[0KD#+")V(&6'7
MU'K0-DWQ5^//@;X&0V<OC;QGX4\'Q:BSI:/KFKV^GK=% "PC,SKN(W+G&<;A
MZUTT-U'>VL<T,B2PRJ'CD1@RNI&001P017Y(_P#!U+][X$_]S!_[C*_34?%G
MPM\&O@GX<U?Q?XE\/^%-*:SM+=;W6-1AL;<RM""J>9*RKN(5B!G)P?2F@9W5
M(GW:^(?^"SOP.L/VU_V-_#$NA_%CX<^$=#76X-2M]5\0:ZMIH6LJT,JHJW2;
MT9L,SIA6W;6QCK7N/[(UKHG[,'["G@:+Q#X_\,ZIHOAW1(!=>*CJ4:Z5<!CQ
M(ER[[3%N<*KEAN^7@9VBPZ'M;_>IC]*XOQ!^TS\-_"W@O3?$NI_$'P1IWAS6
M5+Z?JMUKMK#97P! )BF9PD@R0/E)ZBNC\*>,=(^('AFSUG0=4T[6]'U!/-M;
MZPN4N;:Y3D;DD0E6&0>0>U (OT5RWQ)^.7@KX,V\<OC#QAX6\*12@%'UC58+
M%7R<#!E=<\\4_P"&GQH\'?&C3IKSP=XL\->++2V8+-/HVJ07\<1.<!FB9@"=
MIZ^A]*!LZ-^M+_RSK$^('Q(\/?"K0&U;Q1KVB^&]*1@C7NJ7L5G;JQ!.#)(R
MKG )Z]C7G_\ PWW\"=G_ "6KX2_^%?I__P >IHH]9IJ_?-4;CQ7I=IX<&L2Z
ME81:285N!?/<(+8QL 5?S,[=I!&#G!R*Y+X=?M2_#+XNZ_\ V9X3^(O@3Q/J
M14L+32=?M+V<@ DG9'(S8P">G8TUN!W3]::>E8?Q*^*OA?X.Z NK>+O$F@^%
MM*:5;=;W5]0BL;<R,"5022LJ[B%8@9R<'TK&\>_M*_#GX66]C+XG\?\ @KPY
M'JD*W%D^J:Y:V:W<39*O&9'&]3@X*Y!Q0P.O?K41ZTEEJ$&KV,%U:SPW-K<Q
MK+#-$X>.5&&596'!!!!!'7-<C\3/V@_ 7P7N88O&/C?PAX3ENEWPIK.LV]@T
MRY(RHE=<CY3T]#Z50'6MU%*>E97A#QQHOQ%T&WU;P_J^EZ[I=R T-YI]U'=6
M\H(!!61"5/!!X/<5JGI05(Y#0/CWX&\6>/[WPGI?C3PGJ7BG3C(+O1K75[>;
M4+7RR%D\R!7,B[20#E1@D9KJ#UK\A_\ @G'J$&D_\%U/CE=74T5M:VU]XKEF
MFE<)'$BZGEF9CP  "23TQ7ZE?#S]H'P'\7]7O;#PGXV\(^*+[3EWW=OI&L6]
M[+:KG;F18G8J,\<@<T CK'Z4B?>J/4]0@TG3YKJZFBMK6V1I9II7"1Q(H)9F
M8\   DD],5PW@S]JCX8?$/Q0-%T#XC^ ]<UC)'V#3_$%I<W/!"G]VDA;@D#I
MU(JUL4=Y4-Y<QV4$DTSI%%$I=W=MJHH&223P !4U>-_$_P#:/^'GQ&^&7CO0
M_#WCSP9KNM0:%J*RZ?IVMVUU=1E;>7<&B1RP(VMG(XVGTI@=M\-OCAX+^-5O
M=R>#O%_A?Q9'I[(MT^C:K!?K;%LE0YB9MI.UL9ZX/I755^4__!LOT^-G_<"_
M]R5?I5\2?C_X$^#5Q!%XO\:^$O"LMTN^%-8UBWL6F7D942NN1P>GH?2@#JJ8
M_6L[PAXVT;XA:##JN@:MIFN:9<@-#>:?=)<P2@@$%70E3P0>#W%95G\:O!VJ
M^.-3\,VOBWPS<^)-$@:ZU'2HM4@>^L(EV[I)H0V^-!YB99@!\Z^HH Z1_NTR
MN1\&?M#^ /B5XCN=%\.>.?!^OZQ9[O/L--UFVNKF#:<-NCC<LN""#D<8KJ+^
M_@TJQFNKJ:*VMK:-I9II7")$BC+,S'@  $DGIB@!U-;[XKS[3/VN/A3K7B&+
M2+/XG?#V[U:=ML=E#XCLY+B0XW8$8DW$XYZ=*Z3XB?%#PU\)-$75/%?B'0_#
M.F-*L O-6OXK* R,"53?(RKN(4D#.>#Z52 WG^[3*J>'?$VG>,O#]IJND:A9
M:KI=_$L]K>6<ZSP7,;<AT=2593V(.*YWP=\>_ OQ$\77N@>'_&GA/7=>TU9'
MO--T_5[>ZN[18W$;F2)'+H%=E4Y PS 'DU1;V.I/6FMU%<?\1/VBOA]\(M3C
ML_%?CKP;X8NY@6C@U;6K:RDD QDA9'4D<C\QZUT?A_Q+IWC#1K;4M)O[+5-.
MN@6@NK2=9X9@#@E74E2,@C@]J""\>E,K!^(OQ=\)_"'3XKKQ9XG\/>&+6X)6
M*;5]2ALHY2,9"M*R@GD=/4>M6_"/C31_B!H4.J:#JVFZWIEP T5W8727,$H(
M!RKH2IX(/![T&A?/6FR4X]:;)36X##TJ"L#XC?&OP;\((87\6^+?#/A=+D[8
M6U?5(+(2GGA?-9<]#T]#5CP3X_T+XEZ$NJ>'-;TC7]-=MBW>FWD=U QP#@/&
M2N<$'KW%6!J/]ZF/TK!'Q;\*R_$1_"2^)O#[>*XXO/?11J,)U!(]H;>8-WF!
M=I!SMQ@@UG>&_P!H3P#XW\6MX?T7QQX0U?7D#,VFV6LVUQ>*%&6)B1R^ .O'
M% &MXLZZ9_U_Q?UK7K(\6==,_P"O^+^M?)'_  68_9J?]HOX:^#8S\0_ O@.
M'2-1G?\ XJO5O[.L[^22-0H5\,#(BJ^!M)P[<CG(4C[+?[U-?[M>>_#O6M"^
M /[-7@__ (23QGH;:5HFAZ?82>(KV_C@L[]E@CC6<2R/MQ*0&'S'.X<FM/Q5
M^T'X"\$>'].U36O&_A#2-,UF)+C3[R]UFWMX+Z-UW(\3NX5U9>05)!'(H).L
MJ.L?4?B9X;T?P.?$]WX@T2U\-K$LQU::^B2Q$;$*K^<6V;22 #G!)%?#W[&?
M_!8:?XT?M*>+?#?Q!OOAMX2\'Z;:75QI6JM>&R^TO'=11Q1F:><QR%HG9_D"
MYV$@8S@ ^]GZTU_NU3MO%.F:EX:BUJWU&QGT:>U6^BOX[A&M9+<KO$RR [3&
M4.X,#C'.<5ROA;]I7X<^//$']D:'X_\ !.LZMR/L5CKEK<7'! /[M'+=2!TZ
MFM#0[.HZS?&WCW0_AKX?DU;Q'K6DZ!I4+*DE[J5W':V\;,<*#)(0H)) '/)-
M9%Q\<?!5IJ&@VDOC#PO'=>*8HY]%A?58!)J\<F/+>V7=F96R,%,@Y&* "^^-
M?@VQ^(,?A*;Q;X9A\52XV:,^J0+J#Y3>,0%O,.4^8?+TYZ5TM?EUXY_Y6&8/
M^O\ L_\ TQ15^G/B#Q%I_A/1Y]1U6^L]-T^U ::ZNYEAAA!( +.Q ') Y/>M
M +3]*A/6N7\"_M > _BK?R6GA?QMX1\2740#20Z5K%O>2(#GDK&[$=#^1JS\
M0OBMX7^$VGPWGBKQ)H'AFTN9?)AGU74(K*.5\$[5:1E!; )P.< U'4LW9*JZ
MMJEMHFEW-[>W$%I9VD33SSSR".."-1N9V8\*H ))/  JMJ'C;1M-\(GQ!<:M
MID&@K;"];4I+I%M! 5#"4RD[-FT@[LXP<YKRO]I7XD>'OBE^Q#\6=2\,Z]HW
MB+3E\):S ;K2[V*[@$@L924WQL5W $9&<\CUJQGH7P_^*OA?XL:=-=^%O$F@
M^);2VD\F:?2M0BO(XGP#M9HV8!L$'!YP16X_WJ^#?^" ?_)O'C7_ +&(?^DT
M5?8GA[XN>$OC)!JVG>$_&?AS6;VVA,=P=)U2&\EL"X959UC<E>0<9QRIH ZM
M^E,/2OAW_@DM^RW_ ,,_^/\ Q[<_\+1\!>.C=QQ0_9/#>K_;WA_>,?/N1QY3
MG;C&&S\WS<<_7^F_&+PCK>LZQIMEXI\.7>H^'E=]5M8-2ADFTP*2&,Z!MT0!
M!SO QB@#H*8_WJYOP-\;?!GQ0U*ZLO#7B[PQXAO+%=US!IFJ07<EN,[<NL;$
MJ,\<]ZZ1_O5H!D:S_P C)I/_ &V_] %:5<I\7O$]SX)T*?6;/2[O7+O2-/OK
MV#3;4$SZA)' 76", ,=[E0HP"<L.#TK\J_VZOVI_VD+;Q#X?UOQ3>:]\+;'Q
M!;RS:/HNCZE-8210JR@FX5'$AEY7/FX(YPB9*T ?KW44_P!_\*Q?A1J4^L_"
MWPW=W4KSW-UI5K--(YRTCM"I9C[DDUM3_?\ PH KS=:['X0?%^X^&^H^3-OG
MTF=LS0CK&?[Z>_J._P"1'C\/[0?@+4/#]_J\'C?PA/I6E2B&]O8]9MVM[.0]
M$DD#[48X/#$&M[2/%&F^(/#T.KV&H6-[I5S#]HAO;>=9+>6+&=ZR*2I7'.0<
M5$X*<>66PW%2C9GVEI.K6^N:;#=VDR7%M.N^.1#PP_S^56*^,?@)^W=X%\->
M-1H-IX\\(:N;F?R9=+MM;MI;I),[24C#EMX/!7'/3KC'V-I.K6^N:;#=VDR7
M%M.N^.1#PP_S^5>%B,/*E+R/+JTG!^18HKS^_P#VLOA9I7Q!_P"$2NOB7\/[
M;Q5YC0_V-+XAM$U#>N<KY!D\S<-K9&W/RGTKT"N<R"BO,K']M3X-ZIXP7P];
M?%KX9W&OO(8ETR+Q18O>,X&XJ(A+OS@$XQTKO?%?BW2O ?AJ]UG7-3T_1M'T
MR%KB\OKZX2WMK2)1EGDD<A44#J20!0!1\<==)_["4/\ [-6U7E_Q&_:8^'&F
M?#GP[XQN?B!X)M_"-_J$;6NN2Z[:IIMR%9D8I<%_+8!OE.&X/'6NJ\+?&GP=
MXY\!W'BK1?%GAG6/#%I')+/K%CJD%Q80I&F]V:=&,:A4^8DMP.3Q0!TU%?F!
MX#_X+Z7.O_\ !5.Z^%FIZG\(K+X(K?7MK#XO-^8_W<5C)-%*;UKG[*1).BH,
M( ?,"@[N3^DWP_\ B+X?^+'A&T\0>%M=T;Q+H-_O^RZEI5['>6ESL=HWV2QL
MR-M=&4X/#*0>0: -FBO+;S]N/X*Z?K\6E3_&#X70:I/((H[.3Q78+<2.6V!0
MAEW$EN ,=>*].M;N*^M8YX)$FAF4/'(C!E=2,@@C@@CO0!)17GFG_M<_"C5O
M".J^(+7XG?#VYT'09EMM3U*+Q'9O::=*V<1S2B39&QP<!B#Q79^%/%NE>//#
M5EK.AZGI^LZ/J<*W%G?6-PEQ;7<3<J\<B$JZD=""0: +AZT5#JFI6^C:?<7E
MY/#:VEK&TT\\SA(X44$LS,> H ))/  K@/!'[8'PE^)OBO\ L'PW\4?AUX@U
MPD@:=IOB2SN[O((4_NHY"_!('3J10!Z+16%\1?B?X:^#_A6;7?%OB'0_"VB6
M[HDNH:O?Q65K$SD*H:65E0$D@ $\DU@>,OVIOAC\.O#.D:UX@^(W@/0M'U^"
M.ZTN_P!1U^TM;;4HI$WQR02/(%D1E^964D$<CB@#O*Q?AY_R)]I_P/\ ]#:H
M[CXH^&;3X?/XME\1:%%X5BM3>OK3W\0T]( ,F8S[O+$>/XMV/>OS/_8]_P""
M\5UXX_;\\2_#/QCJ7PE\._"/2+K5H-*\3/?&T-RL$S"VD-W+<FWD$JC(V(-V
MX%3QR ?J=37Z5E>&/'^A>-_!UOXBT;6M)U?P_=PFY@U.RO([BSGB&<R+,A*,
MO!Y!QP:XSP]^V1\(?&?C%?#FC_%3X;ZKXA:<VRZ79^)K*>]:4-M,8A60ONW<
M8QG/% 'HU%%>2ZO^WS\"O#^I365_\:?A-97ENVR6"X\7Z?')$?1E:4$'ZT >
MM45R?PI^//@?X[V%W=>!_&?A3QE:V$@BNIM"U>WU&.V<C(5VA=@I(Y -8WQ!
M_:_^$OPEULZ9XJ^*/PZ\,ZDI(:TU;Q)9V4XQP?DDD5N/I0!Z+16?X6\6:7XY
M\/VVK:)J6GZQI=ZI>WO+&X2XMYU!()21"589!'!Z@U@:)^T'X"\2^(_$&CZ=
MXW\(7^K^$U=]<L;;6;>6YT94)#FYC5RT(4@@EP,8.: .M?I3:XSX:_M)_#KX
MV:O?:=X-\?>"O%NH:8N^\M=%URVOYK1=VW,B1.Q0;N,D#GBOSY_X+G?L,R?M
M/_M&?"_76^./PO\ A9'IUE]BAM/%6O\ ]FW61=;Y+NQ3_EK(-T8P"G,: N.,
M 'Z0>#O^8K_V$9OZ5LURUOXLTOP-H&O:KK>I6&CZ79W\KW%Y?7"6]O I*@%Y
M'(51D@<GJ16;\,_VI/AE\:M5-CX-^(O@3Q;>A68V^C:_:7\H"X+';%(QP-PS
MQQD>M '=T5^9O_!1K_@NKJG[+?[:7A'P%\/+CX6>*_"-S;VK>)-1FNGO)=,N
M&OIX+BW,L%RL<$D442L1(K%2X+#'!_0?X4_'CP/\=["[NO _C/PIXRM;"017
M4VA:O;ZC';.1D*[0NP4D<@&@#JZY#2_CUX&U_P")][X*L?&?A.]\9:<ADN]!
M@U>WDU.U4!26DM@YE4 .AR5'WE]12?M!_%FV^ OP(\9^-KOR_L_A+1+S5V60
MX63R(7D">I+%0H Y)( YK\PO^#:+X;S?%;Q1\:/CQXE0:AXEU_6?[.COY+=?
MEGE+7E\R/R=SM-;Y Q@ ==W !^M-%?C_ /&3]J#XDZ%_P<DVG@>T^('C2W\%
M/KFD6[>'DUJY&E&.71K9Y%^R[_*PSNSGY?O,6Z\T?\')/[4'Q*^ 'Q]^&<'@
M;X@>-/!UM=:'/<7$&BZU<V,-S(MS@-(D;JKG''S \<=* /V HHHH *C/6O$?
M^"@?[0WQ%_9Q^!UKJ7PK^&]_\3O&FMZM#HMC8012R0:>98Y6%Y<B,9%NC1JK
M$O&N95S(G6OR/_9P_:I_:4T__@M#X5\&?%7XB>+$U*7Q1';ZWX>M=<D.B(LD
M&X0I;1/]GV!&7HIY&22V6H _<;6?^1LT7_MO_P"@"MBOFC_@K1XZUKX:?L0>
M/M<\/:KJ&AZUI^AW3VE_8SM!<VK'RUW1R*0R-@G# @CL:_-?_@FK^RU^T9_P
M4?\ V:]>\>:=^UO\5_"U[I&OS:%#IESK&IW,5P8[>UG\QIUO5* _:,8$38V9
MSSP ?M_17Y-_\$:O^"C/Q=7]MKQ1^SC\8=</C*^TZYU&RMM4FE\ZXL[W3V=9
MHA+M!EA<12$%_F!4<_,17ZD?$+XF^&_A)X<?6/%?B#0_#.DQL$:^U:_BLK96
M() ,DC*N< G&>Q]* -BN1\4?'[P)X'^(6F>$=:\:^$M'\5ZTL;Z=HM[K%O;Z
MA?K([1H8H'<22!G1U&U3DJP'(-'PM_: \!_'**X?P3XV\(^,$M#MG;1-8M]0
M$)XX8PNVW[R]?4>M?FS_ ,'.7P3GTWP5\+_C1HDHL-;\)ZO_ &+-=12%;@+(
M#<VLB]OW4L$N".<SCJ!\H!^JE%>=_LE_'NT_:B_9G\#_ ! LS#M\5Z/;WTT<
M2L$M[@J!/" V3^[F$B=3]SJ>M>B4 %1GK7E>K_MZ? W0-2FL[_XS_">RO+=M
MDL%QXNT^.2(^C*900?K75?"SX[>"/CK8W=UX(\9>%?&-K82"*YFT/5K?4([=
MR,A7:%V"DCD T =517GGC;]KKX4?#3Q5_87B/XG_  \T#6P0#I^I>([.UNN2
M5'[J20/R01TZ@UWFFZE;ZSIT%W:3PW5I=1K-!/"X>.9& *LK#@J0001P0: )
MZ*XCPW^TQ\./&7AG5]:TCX@>"-5T;P_((M4O[/7;6>VTUR<!9Y%<K&2>S$5<
M^%?QV\$?'2PN[KP1XR\*^,;:PD$5S-H>K6^H1VSD9"NT+L%)'(!H ZNHZS?&
MWCW0_AIX=GUCQ'K6D^'])M06FO=2O([6WA !)+22$*. 3R>QKGOA;^T=\//C
MC<W$/@KQYX,\836B[YX]$UNVU!H5R!EA$[%1EEZ^H]: .SHHKX4_X+'?\%9M
M1_8 T;P[8?#ZX^'NO^,KR_:/5])U6=KJXTVV\D21N]O!/'+'O++AGX(Z YR
M#[1\*]=3_P"O^7^E8OPS_:&\ ?&K4;^S\'>./!_BR[TK!OH-&UFVOY+/)('F
M+$[%,E6 W8Y!]*\T_8._;.\(_M5?"K0;JU\6>";WQQJ^C6^O:QH&DZO#<7.E
MO+# 9U: 2-+&D<THC.\94D G)K\T?^#8;Q7I?@CQ;\:]5UK4K#2-+L]*TQKB
M\O;A+>" &:< N[D*HR0.3U(H _:FBN5^%GQU\$_'.PNKKP3XQ\*^,;:PD$5S
M-H>K0:A';N1D*[0NP4D<@&M3QKX]T/X:^'9]7\1ZSI6@:3:@M->ZE=QVMO"
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MP<-&GE.P7U8D]%K4_P"#@[]GKQ[\9?&7PPN_!_@OQ5XLM[.RU"*Y?1M*GO\
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M?MZ>-_%.D_![Q'\2=%\2?;[&P?25F,#VT]U#<1R&6.*;RF78BLLB]=^"0-U
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M[ 'C_P +>*_#6J^%?% UYM1\./K%B]E,MPEI$!Q(H<0R$^6S 8ZD9*8'L?\
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M;_ ";]G'P?X2U73=2U*"]M9;(79LIDFD.UXH&FFGXCW1PJ@4#=EE=F /,_\
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MQ]]D:+]%%?0?_!5'X477QK_X)V?%[P_8[OMDGAV>^@1>LSVNVZ6,>[F':/\
M>[=:^4?^#7[XF6OB3]B/Q5X9#R&_\,^*I9I$9]P6"YMX6C(],O'/Q_LYSR<
M'S?\>?\ E:9L?^QBT+_TR6='_!U-_P G#_"S_L7;G_TIKO?C1^RS\2]7_P"#
MD:P\<VO@#QC<>"3K6D77_"0QZ/.VE+%%H]M'(QN0OE#:\;J06SN&.I%,_P"#
ME/\ 9@^)/QT^-_PTU#P1\/\ QIXRLK/0[FWN)M"T6YU%;:3[0&"R>2C;"001
MNQGG&<&@#]@*_.[QO_P<Q_ ;P)XTU?0[CPM\6;F?1KV:QEFM]+L#%*T4C(63
M=>JVTE<C<H.",@=*9X0_X+-_'CQ'XMTO3[K]A[XN:9;7]W%;S7DLFH^7:([A
M6E;.E@84$DY(Z=17Z*4 <M\$?BWIOQ\^#?A7QOH\&H6VD^+])MM8LX;Z'R;F
M.&>)946102 P##.UF4]59@03^*'C7_E9WB_[':S_ /2&*OUP_;L_:;\6_LG_
M  9MO$W@SX4^)/C#JT^J16#Z)HC2BX@B>.5VN6\N"9]BF-5.(^LJ\BOQ6UNY
M^/\ K'_!3M?VCO\ AESXPQ[=;AUG_A'O["U$Y\N!8O+^U?8^^W.[RN^,=Z /
MU@_X+0?\H]OB5_V ;G_T**ORE_X)P_M6_M3_ ++O[ ?CW5O@_P##_P ,ZW\-
M;'6[Z\U?Q'<P?:[_ $:[%C:^<Z0BZ4F.*%(9=S6[Q@EMQ(!4?HC^T7\5/B'^
MWA_P2Q\>7E_\&_&/@#QEJ5CJ%C:^$[N*:YU*Z6/R662.-H(I6WC=A?*R2AQN
MXS5_X-U?@3XL^"_["GBG1/'OA'7O"U[J?C2]NDT_7=-ELYI[9K"PBWF*50Q1
MFCD7D8.TT >)_P#!N3\ O!_Q5\5^-/CUJGC6Z\6?%9[N:WU+3I$,#Z.]XS22
M7,W/[]K@K)L8?( LG!?(CA_X*?ZE^R=X6_;X\1^)/C]XP\=?%75!96UKI_@'
MP^CQVGA2%+90T<TZSQYDEEW3JB2Q;#*WF(P96/,_L&_LK_%;_@F;_P %C=4T
M/2/ 7CG6?A1XDGET-]<MM%NY=,2QN-D]M,TZAXPT$@C1V=LJ/-R5W&LOXI_L
MV_''_@GQ_P %9O%WQGT_X):Q\<?#OB36M1U;2SI=K-=B-;N;SUYACF>WF@SY
M:M)'M^3*C[I !\Z?LX?&[X?^$_\ @L1\+]<_9ZTWQ7X0\#Z[XFTG1SI>N3;I
MXXKN:.UNXLK-*6B(D+*'E<[L$] *_6'_ (."?#%KK_\ P2L^(%U<;_-T2[TJ
M]MMK8 D;4;> Y]1LG?CUQZ5\#^-_@O\ M(_M+_\ !6?X0?&3QG\$O%'A;2M6
M\5Z'>I!:64MW#H.G6=_&I^V3*O[J14C9V,HCW!MRJH(4?8O_  <H_$NU\'?\
M$[ET24.UWXN\1V5G %3(41;[EV)R !^Y [DEQQU( .T_X-^O$-QKO_!++P#'
M<'=_9MUJEI$V26*"_G<9))Z;R!C   &.*U/^"Z>K>--"_P"":GCJ[\%7UYI\
M\1MEU:2TD$<S::\H2X0-U (90VT@E-XZ$@Z__!%;X3GX/?\ !,CX4V4A+7&K
M::^NRN49-PO9I+F/AB>D4L:Y'#;=PZUY?_P<@&U/_!-JZ2YU^/19'\1V'V>W
M=93_ &U(!*WV4; 0#M5Y@7^7_1^H.#0!^7?B9_V.8O\ @F3 -.&OR_M(/%;B
M1BNH*([CSE,N0S?8OL_EAP,9D)(.!V^N/A58WO\ P33_ ."!FH?$CP[H7_"'
M?%7XHPV]I>:@7N5N3%)>3QVER%:1A'(+*5Y(S&(P&E1BI(PW#_!75_VG/@=^
MSAX6\>_\,@? 76_#6@>&K:[A\47?A^S;7[JPMK57BNIV2\\_>(H4;<80QVKQ
MN(KZ>\#_ !IMO^#@[_@FI\0?"D=A9^"O'NEW,"[9I&GL;>\1_/M95<9D$,JQ
MO$Y*%DW2$*^T9 /S6_9-^*'[&7ASX"36?QI\"?&#Q=\2-5DN7NM7TJ>..WTW
M<S+%]F_TZ(.P39(3/$_[PL,,@ /V?_P:_?'?6=7E^*/PZ:;4;WPEI M]8T?[
M3,6&F-)+*DD87!4>;\CD*0 T;G!+DBA^Q)^U=^U/_P $S?@X/A)KW[*_C?XB
M:7X<O+A-(O-&AN4$"R3R33*TT%M<QSHTLI9'&W +#+#&W[W_ .">_P =_CA^
MT%H7BG6?C%\-+'X86@NH$\.:<#)]MEBV,9FN-[D\-LVGRXNK#:<9H _(+_@A
M-^PYX7_;S^(7C'1/B#>:[>^"O",-KJW]@6NIRVMK?WLCM&LDH0@\1)*F4*OB
M3A@,UWOP?^%,7_!.K_@X9TGP'X"O;^T\+:C>0:?]F-RSM-8WMDDS6\Q8'>J3
M;6&<G]S&V0PR/9/^#:K]F?XB_ OQS\6KSQOX#\8>#;>^L=-AM7UW1[C3OM3B
M2Y+",3(I?:,;MN=NY<XW#)^T;^S5\1=6_P"#B3PGXXM/ ?C"\\%I?:3+)K]O
MH]Q+ID2I9+&Y>X5#&NUE(.YAC\10!\\?\%;?VKM#^,?_  5FE\/_ !<E\3WG
MP:^&-XNG'1_#I7[5+MMQ)*RK+)&GF2W!".X96$*J%)**3XO^U1^T;\!/"OQ.
M\">-?V5/#?Q'^&'B'PW<//>C5KO? [*08GB)N[B7<P,B2*7",FT;>6S]X?\
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MV3X<^.5U<:T/&'A?0I/#]I!'<(+!K=VG)9X]A<R#[1* 0X'(R#@4 8W[,?\
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MP_9U\%>';S]E#Q@\7QHOM=M(_#^F>!_%]QKWVUQ*OF+/%YLZ@,&3"N5WF-0
MRB0']@=,^T_V;;_;/(^V>4OG^3GR_,P-VW/.W.<9YQ0!/1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!Z11110 4444 %%%% !1110 4444 -;J*5_
MNTC=12O]V@!E*_WJ2E?[U/J R2E_@_"DDI?X/PH0#4^]0_WJ$^]0_P!ZFM@
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M ,E:^]Z8_P!Z@!**** "BBB@ J,]:DJ,]: ,?6?^1LT7_MO_ .@"MBL?6?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW/\ WQ_]>F_\(@/^>Y_[X_\ KUD^8WJ?SJ/S&]3^= &U_P (@/\ GN?^^/\
MZ]'_  B _P">Y_[X_P#KUB^8WJ?SH\QO4_G0!>TOX<KIAN?]++_:)VG_ -7C
M;NQQU]JM?\(:/^?@_P#?'_UZX_PM.Y.I?.W%_*!S]*U?.;^\WYT ;?\ PAH_
MY^#_ -\?_7H_X0T?\_!_[X_^O6)YS?WF_.D\UO[Q_.@#<_X0T?\ /P?^^/\
MZ](?!8/_ "\'_OC_ .O6)YC>I_.D>1L=3^= &W_PA(_Y^#_WQ_\ 7H_X0D?\
M_!_[]_\ UZP?,;U/YT>8WJ?SH W6\$!A_P ?)_[]_P#UZ3_A!A_S\G_OW_\
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M]'_OW_\ 7H_X5^O_ #]'_OW_ /7KG/.;^\WYT><W]YOSH Z/_A7Z_P#/T?\
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M\'XT@ZUA_$SXEZ#\&_AYK'BKQ/J=MHWA_0;9[V_O;@D1V\2#)/&23V"@$L2
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MG5Y)P!1110 4444 %%%% &'KW_(Z:#_V\?\ H K<K#U[_D=-!_[>/_0!6Y0
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MU\)[[1/C/\)/%<-KY>@7>@3Z%"8HL1V\MM.9=AQPN4N%VCC(C;&=IP ?=W[
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MQO\ L\^._#.@6?B_4KB\TFT\0PVV+S[59LSO9^<P!:TF2)Y8VP"S)&/F#IL
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M9X!\0ZQJRZJMYJEYH5L^H3A-6O$3-SL\[*HBJ#OR%4 <#%?%7Q5\%7?_  1
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M444 %8OP\_Y$^T_X'_Z&U;58OP\_Y$^T_P"!_P#H;4 ;5-?I3J:_2@!M%%%
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MPKX5/A75;#0[K7H!:W&O11P7+O=)!RR0EI=J$D[PN>#N5?4_V5?^4['[4?\
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M'E7P'_8M\(_LV?LQS_"_PK'+9Z;?6D\5[?/A[F^N)XO*DNI#P#(0%XX "*H
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MX6V?PST;RX\37TP!N+@CES_='HH]*ZFBBO#E)R?-+<\N4FW=A1114B"BBB@
MHHHH P]>_P"1TT'_ +>/_0!6Y6'KW_(Z:#_V\?\ H K<H *8_6GTQ^M "444
M4 %%%% !1110 4444 8/CCKI/_82A_\ 9JVJQ?''72?^PE#_ .S5M4 %%%%
M!1110 4444 1GK10>M% !1110 5B_#S_ )$^T_X'_P"AM6U6+\//^1/M/^!_
M^AM0!M4U^E.IK]* &T444 %%%% !1110 U^E-IS]*;0!C>#O^8K_ -A&;^E;
M-8W@[_F*_P#81F_I6S0 4444 %,?[U/IC_>H 2BBB@ HHHH *C/6I*C/6@#'
MUG_D;-%_[;_^@"MBL?6?^1LT7_MO_P"@"MB@ HHHH CHHHH **** "HSUJ2H
MSUH **** "BBB@ J.I*CH **** ,7PKUU/\ Z_Y?Z5K5D^%>NI_]?\O]*UJ
M"BBB@ IK]*=37Z4 -HHHH :_2FTY^E-H **** &OTIM.?I3: "BBB@!'^[4V
MB_\ (8M?^NR?S%0O]VIM%_Y#%K_UV3^8H U?'W_(0A_ZY_U-8-;WC[_D(0_]
M<_ZFL&@ HHHH **** "BBB@ HHHH **** "BBB@ KYS_ ."LWP(\5_M,_P#!
M/WQ_X(\$:5_;?B?6_P"SOL5E]IAMO.\K4K6>3]Y,Z1KB.-V^9AG;@9) KZ,H
MH YKX,Z!=^$_@_X4TN_B\B_TW1[.UN8MP;RY8X$5URI(."",@D5TM%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>4_MQ6GCO4_V2/'UC\,M
M+;6/'6J:5)IVDVZW<5JRO.1"\JRRR1HK11N\H)8<QC@G"GU:B@#P_P#X)Q?L
MPO\ L?\ [%O@3P+=P0P:S86 NM9$80_Z?.QFG4NI(DV.YC#Y.5C7&!@#W"BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1_Q^_P#D'_[*F_\ "K_^G[_R#_\ 95UV^C(H]M/N'M)''GX69/\ Q_?^0?\
M[*FGX4Y/_'__ .0/_LJ[+(HW#TH]M/N'M)'&'X3Y/_'_ /\ D#_[*AOA/N'_
M !__ /D#_P"RKL]P]*-P]*?MZG</:2.*/PCR/^0A_P"0/_LJ3_A4/_40_P#(
M'_V5=MN'I1D4>WJ=P]I(XA?@_@?\A'_R!_\ 94A^#V3_ ,A'_P E_P#[*NXR
M*-P]*/;U.X_:R.%/P;R?^0C_ .2__P!E2-\&-W_,2_\ )?\ ^RKN]X%&^CZQ
M4[A[67<X)O@ID?\ (3_\E_\ [*D/P2R/^0G_ .2W_P!E7?;AZ4;A3^LU.X>U
MEW//_P#A1W_44_\ );_[*F_\*+_ZBG_DM_\ 9UZ%D4;A1]9J=P]K+N>>GX%Y
M/_(4_P#);_[.D;X$Y/\ R%?_ "6_^SKT/</2C</2CZS4[A[:?<\Z;X#;A_R%
M?_);_P"SIK? +(_Y"W_DK_\ 9UZ/N'I1N%'UFIW#VLNYYN?@!D?\A;_R5_\
MLZ;_ ,,^?]1?_P E?_LZ]*R*-P%/ZU5[A[:?<\S/[/.3_P A?_R5_P#LZA/[
M.V3_ ,AC_P E/_LZ]2WTWS5]/TH^M5>X_;3[GES?LY[C_P AC_R4_P#LZ3_A
MG+_J,_\ DI_]G7J7FJ>WZ4>8OI^E/ZW5[_D'MI]SQ+QK^SOY0TG_ (G&=^I0
MK_QZ=.O^W6S_ ,,W?]1G_P E/_LZ]&UK4[.P^R?:8?,\ZY2*+Y VV0YVGGIW
MYJ]YB^GZ4OK57N/V]3N>4_\ #-7_ %&O_)/_ .SII_9GR?\ D-?^2?\ ]G7K
M&]/3]*-Z>GZ4_K=7O^0>WJ=SR4_LR9/_ "&__)/_ .SI&_9AW?\ ,;_\D_\
M[.O6]Z^GZ4>:OI^E'UNKW_(/;U.YY$W[+VX?\AS_ ,DO_ME-/[+>1_R'?_)+
M_P"V5Z_YJ^GZ4>:OI^E/ZY6[_D'MZG<\?_X98_ZCO_DE_P#;*;_PRK_U'O\
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M6^SRIVCD_=*-SC&3[_6K?]H6O_/+_P <% &=16C_ &A:_P#/+_QP4?VA:_\
M/+_QP4 9U,?[U:GV^U_YY_\ C@I#J-H#_JO_ !P4 9=%:?\ :5I_SR_\<%']
MI6G_ #R_\<% &916I_:=I_SR_P#'!1_:=I_SR_\ '!0!EU&>M;']I6G_ #S_
M /'!2'5+//\ JO\ QP4 <AK/_(V:+_VW_P#0!6Q5N\\0:7#JEI%);[IYM_DM
MY*G;@9;GMQ5O^U;/_GE_XX* ,FBM;^U+,_\ +'_QP4G]IV7_ #Q_\AB@#&HK
M8_M6Q_YXC_OV*/[5L?\ GB/^_8H QZ*V/[5L?^>(_P"_8H_M:Q_YX_\ D,4
M8]1GK6Y_:UC_ ,\?_(8IIUBP_P">/_D,4 8M%;7]LV'_ #P_\ABC^V;#_GA_
MY#% &+16U_;%A_SP_P#(8H_MBP_YX?\ D,4 8M1UO?VQ8?\ /#_R&*;_ &UI
M_P#SP_\ (0H PZ*W/[:T_P#YX?\ D(4?VUI__/#_ ,A"@#B?"O74_P#K_E_I
M6M6KIGB;1[O[1Y-H$\N=HY/W"C<XQD^_UJU_;>F_\^X_[]"@# HK>_MS3O\
MGW_\A+1_;FG?\^__ )"6@#!IK]*Z#^W-._Y]_P#R$M#:[IH'_'O_ .0EH YV
MBNA_MW3/^?8?]^EH_MW3/^?<?]^EH YQ^E-KI&U[2P/^/8?]^5I/^$@TL?\
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M_7?&'B^X2#PQ9WCM-:7D8V23W3")T9X4B9>4<?--#SAJX#_@XP_9L\*_&/\
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M?\%I_BQ\9M#^ 7Q)^(^A0ZA?VZ&QTJ]@M)4F@C_>BZ2VF3:%PW3!!ZBOL?\
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MCNF-TJYD$3+O^48^;..<=37J7_!;[]M+QS^RK\-_!FB^!9QI%]XYN;I)]:!
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M^"='[7OQ3^"?[>FI_ 7XK>)=5\70SW%SIEM=7UR]Y+;7<2O/',DTF9&AFC!
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M (*,_''Q3+<_M 6/[//@+1F5]*@?5$TZYG5BZQ* )X6G?:K-*?-*HS( N"N
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MSM9M1^)G[5WASX5^*Y%DEMO#%GK<5C%:DC(AE:&XBQM(52P68@9.YSG/4_\
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M2_;"\$_LH_#.;[:;?4;9-8$,DGDW&K3XV13;%(\FUA82NXW!3))N ,)KE/\
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M[FP3]9^-_P!DOX5_$_QB_B'Q+\,_A]XAU^3R]^IZGX=L[N\?8 J9EDC+G:
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MMG5C<M+N&9W1/F)9LG*^O_\ !N.UJ_\ P4:\?FQLI=.LCX-U$V]I*Q9[6/\
MM/3]L;$\DJ, YYXK]?\ Q#^RI\+_ !=XU;Q)JWPW\!:GXB9@[:K=^'[2:]+#
M@$S-&7S^-:GAWX+^#O"'CK4_%&D^$_#6E^)M;4KJ.KVFEP07U^"0Q$TZJ))!
ME5/S$\J/2F!^37[-O_*RMXL_["6L_P#IODI/B!_RM"0?]A*P_P#4=AK]6M*_
M9_\  >@?$FY\96'@GPC9>+[PN;C7+?1[>/4I]XP^^X""1MP !RW/>C_A0/@3
M_A:O_"=?\(5X2_X3?_H8?['M_P"U?]3Y'_'SL\W_ %/[O[WW/EZ<4%GYK_\
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M2\@6>"=>NUT8%6''0BJ?@SP!H/PTT0:9X<T32/#^FJ[2"TTVSCM8 [?>;9&
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MOP!M/V6/V8O OP]LQ#M\)Z-;V,\D+,4N+@(#/,"V#^\F,C]!]_H.E? N@?\
M!,?XK?'7_@M]?_&;XD>&XM+^&7@Z]CNO#=PVL07+ZB+&-(M/(19))@QD1;E_
M-"_,&&<D+7Z@4 ?BG^WY_P K+?PJ_P"PIX:_]"%>F_\ !UO_ ,D$^$W_ &'[
MS_TG6OTLUG]G/X>^(OB=:^-M0\">#;[QG9%#;:_<:);2ZG;[!A-ERR&5=H)
MPW&>*G^*_P !? WQYL+2U\<^#/"?C.UL)#+:PZ[I%OJ,=LY&"R+,C!21P2*
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MY^E-H **** &OTIM.?I3: "BBB@!'^[4VB_\ABU_Z[)_,5"_W:FT7_D,6O\
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MJ/I7K-% 'S?_ ,$O?V.?$?[$'P#USPEXFU#1=3O-0\4WVLP3:9)*\7V>81!
MWF1H1)^[.0 0,C#&N5_X+N_\HI_BG_W"?_3Q8U]=5YS^UG^S'H/[9'[/VO\
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MR@C<2 =H!^UZ* /SZ_:&_8?_ &OOVS/V:M0^'WQ%^)'P:TVT\I)-N@6%[O\
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M"3PWX+\/Q/#HOA;3H-,LP^WS'2) @=RH :1L;F; W,S'O734 %%%% !1110
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MW_Y"_P#KTT_#O)_X_/\ R%_]>FJT.Y7M(G+R_>_"HGZUU;_#G<?^/S_R%_\
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M&?\ R4_^SJ5BJ7<KV]/N>4U&>M>L?\,RG_H-?^2G_P!G33^S$V?^0U_Y*?\
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M/6BISI\N?N_K2?V?+_=_6@"&BIO[/E_N_K1_9\O]W]: (:Q?AY_R)]I_P/\
M]#:N@_L^7^[^M9G@[P[=Z3X<M[>>,)+'NW#<#C+$]OK0!=IK]*L?V?+_ '?U
MI&TZ4C[OZT 5J*G_ +,F_N_J*/[,F_N_J* (**G_ +,F_N_J*/[,F_N_J* (
M**G_ +,F_N_J*/[,F_N_J* *S]*;5I]+F(^[^HIO]E3_ -S_ ,>% '/>#O\
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MR'_?8_QH S'^[4VB_P#(8M?^NR?S%76\(7Y'^J'_ 'V/\:DTSPK>VVI02/$
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M]]K_ (T 9E%:?_"'ZA_SQ'_?:_XT?\(?J'_/$?\ ?:_XT 9E%:?_  A^H?\
M/$?]]K_C1_PA^H?\\1_WVO\ C0!F45I_\(?J'_/$?]]K_C1_PA^H?\\1_P!]
MK_C0!F45I_\ "'ZA_P \1_WVO^-'_"'ZA_SQ'_?:_P"- &916G_PA^H?\\1_
MWVO^-'_"'ZA_SQ'_ 'VO^- &916G_P (?J'_ #Q'_?:_XT?\(?J'_/$?]]K_
M (T 9E%:?_"'ZA_SQ'_?:_XT?\(?J'_/$?\ ?:_XT 9E%:?_  A^H?\ /$?]
M]K_C1_PA^H?\\1_WVO\ C0!F45I_\(?J'_/$?]]K_C1_PA^H?\\1_P!]K_C0
M!F45I_\ "'ZA_P \1_WVO^-'_"'ZA_SQ'_?:_P"- &916G_PA^H?\\1_WVO^
M-'_"'ZA_SQ'_ 'VO^- &916G_P (?J'_ #Q'_?:_XT?\(?J'_/$?]]K_ (T
M9E%:?_"'ZA_SQ'_?:_XT?\(?J'_/$?\ ?:_XT 9E%:?_  A^H?\ /$?]]K_C
M1_PA^H?\\1_WVO\ C0!F45I_\(?J'_/$?]]K_C1_PA^H?\\1_P!]K_C0!F45
MI_\ "'ZA_P \1_WVO^-'_"'ZA_SQ'_?:_P"- &916G_PA^H?\\1_WVO^-'_"
M'ZA_SQ'_ 'VO^- &916G_P (?J'_ #Q'_?:_XT?\(?J'_/$?]]K_ (T 9E%:
M?_"'ZA_SQ'_?:_XT?\(?J'_/$?\ ?:_XT 9E%:?_  A^H?\ /$?]]K_C1_PA
M^H?\\1_WVO\ C0!F45I_\(?J'_/$?]]K_C1_PA^H?\\1_P!]K_C0!F45I_\
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MJ:_W:/J?F+V'F?0_G&CSC7SK4='U+S#V'F?1WFM1YK>M?-S]::_W:KZC_>_
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M U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ* -3_A,;_P#YZK_WP/\
M"C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_  H_X3&__P">J_\ ? _P
MK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ* -3_A,;_P#YZK_W
MP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_  H_X3&__P">J_\
M? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ* -3_A,;_P#Y
MZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_  H_X3&__P">
MJ_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ* -3_A,;
M_P#YZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_  H_X3&_
M_P">J_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ* -3
M_A,;_P#YZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_  H_
MX3&__P">J_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/\*RZ
M* -3_A,;_P#YZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_]\#_
M  H_X3&__P">J_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_ 'P/
M\*RZ* -3_A,;_P#YZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\ ^>J_
M]\#_  H_X3&__P">J_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\ GJO_
M 'P/\*RZ* -3_A,;_P#YZK_WP/\ "C_A,;__ )ZK_P!\#_"LNB@#4_X3&_\
M^>J_]\#_  H_X3&__P">J_\ ? _PK+HH U/^$QO_ /GJO_? _P */^$QO_\
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M@?!'[.?A@:UX[\5:'X4TR23RHI]2NT@^T28SLC4G=(^ 3M4$X!.,"O'?@_\
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MPG^ .D3RFWTYX%U'R9@#;SWK*\KLO(S%9QI("<G$C87GY@J1^LE1GK7Y/?\
M!R[H]MX>T?X#6%E"MO9V,.MV\$2_=BC1=,55'L  *_3;X$3O<_ [P;)([222
M:%8LS,<EB;="23ZT CJ7Z4B?>I7Z4B?>JUL4)3'^]3Z8_P!ZF Q^E.IK]*=0
M!'3'ZT^F/UH :_W:93W^[3* (Z:WWQ3J:WWQ5(!7^[3*>_W:95%O8C/6FMU%
M./6FMU%! IZ4RGGI3*#0C/6FR4X]:;)36X##TJ"ISTJ"K 8_WJ8_2GO]ZF/T
MH QO%G73/^O^+^M:]9'BSKIG_7_%_6M>@I#'^]37^[3G^]37^[02,J.I*CH
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M %_R_P!*UJR?"O74_P#K_E_I6M0 4444 %-?I3J:_2@!M%%% #7Z4VG/TIM
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M UW%##=-&IFCAE,L<;X^95<JI8 YP2JDCG Z4 34444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'I%%%% !1110 5^&/Q__P"5K>P_[&30?_3'9U^YU?E5\7?^"9WQ
MG\5?\'!-C\;['PG#-\+UU?2K^36CJUFOEQV^E06\@,!E$^?-B91B,YR#G&2
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MOA?X=_#[PUIG]GMJUM?P7.J^(+6"*06]BQBNF4QDK%&01 -FW>6 =2= )O\
M@WY_Y1D_M _]?=]_Z:DKRO\ X-S/V)?AY^TWJ_Q!\3_$#0;3Q:/!\EE;Z5I6
MI1B?3HI+@2M+-)"V5D?$$:@,-H&[(8[2OU/_ ,$H/V+OB/\ L5?\$Z_C9H_Q
M+T%/#FKZPVH7EK:"_M[QG@&F(GF%H))$ +!@ 6W?(<@ @GX3_P""*>A_M*:'
M:^/O&O[/LGAG6_[$:ULM8\)Z[<LEMK7G+,8Y54O$@>(QDAO.C;YB,E2RLP.V
MU+X>67[#7_!Q9H&@?#G.B:'J/B'3X18H/W,-MJ5O']IMPO3R\S2%!CY,1XY0
M&NT^(W_*T[;?]A/3_P#U&X*]6_X)^?\ !*[XR>*_V\;S]HW]HUK'3?$4-U)J
M%GHUM=0W337)C>"+>T3ND<$$03RU5V8[8\D;&#:GBW_@GG\7-=_X+]0_&J+P
MLB_#%+RUN#K;ZI: ;8M#CMF'D"4W&?/0QC]WUP>%^:F!\^?MV:0/^":7_!=K
MPC\2]+A>T\-^-[Z#7KQ+;,I9+MGM-47:_61B9IMN< SIM*X 7H?V]$/_  47
M_P""[/@3X31J]YX5\ /;VNIQ^2'A9(U^WZ@3GIO39;DMQN10%.?F^JO^"[?_
M  3Z\4?MT_L_^%YO .E+K/C?P;JS26UFUW!:BXL[A MPH>9D0,'CMWY<<1L,
M$D5YU_P0_P#^":OQ1_9S^-?Q&^*GQMTK[#XPU^,V=BUQJD&HW5T9Y?M%[=2/
M#)(@9W6( EMY_>Y"@_. 9G_!7'X[_L[_  R_;>\-ZAXR\ ^(_C9\4-*T2WT^
MV\)I.HT33H?.EN$FFCV,9;EQ,W[MEDC,84LJD(6_//\ X**_%.XNOCMX1\4Z
M5^SM=_LPZMIMLD\%C]C>T34)89M\=U'"UK;H"C8!*QG=@;B< 5^@_P#P4:_X
M)E?'&V_X*&VO[1WP-MM#\5ZO))9W,FD:A/!"]E<V]JEID"=HXI(6BC1L^8'#
MLV!PIKQ3]NW_ ()R?MK?M\:_H/CKQMX5\'?VM&ITJ'PYH^JVMNFA6P"OYS-+
M.RN)'9RV)I7!7@!=H ![#_P=!?&+5_"OP9^&?@NSNY8-*\7ZA?7NHPHHQ=?8
MA;>4K-UP&N=VT<$J"?NBO=OA+_P1^^ WC_\ 89\+^$M2\$Z6M[JV@6=Q<^)K
M6TAAUX7+Q)(TZ711F!WD_(=T>."I&0>D_P""NG_!.>7_ (*(? &RTW1]1M]+
M\7^%+E[_ $:2Y'^C7)= LEO*P!9%<!2& .&1<@C-?,7PS\!?\%&3\(=/^$BV
MG@[PAI&GHNE)XVN-2M[C4ULU5DR)$GE?&P##BW6894AE() -G1_\%A?B9^SK
M\(OCS\-T^('A+Q+\4_&>AZ2UKHG@JRNPNFQ0R2*(IKG(+O([1[$0%PP4[XS\
MA/YV_P#!3OXF1?$75? FLV7[,-Q^S1*D-T(Y([22RA\1J# Z/&GV2V3=#N.7
M0,Q%P@) 5*^_?^"F'_!*_P",WBO]I_P%\;?A'>Z9XP\6>%[73([NTU.2"WFD
MOK#+1WB"8B%HW*)N1I-RN006#$Q^/_MZ_L(_MN_\%"=)T'Q5XY\(>#;>]\/R
M-8:=X2T75;6!K..;<T]V7EN'C.XP0*1]H9N8\( KTT#/7/\ @X&\07?BS_@E
M;\)]4OY?/O\ 4O$NCW5S+M"^9+)I%^SMA0 ,DDX  JS^TI_RK-:;_P!BIX<_
M].=C7?\ _!7+]BKXE?M*_P#!/'X:^ ? OAY?$'BGPYK&EW%_:+J%M;+%%!IE
MW!(XDGDC1@))$& <G=D# .-#X[_L;_$3Q5_P0WL?@YIFA)??$6+P[H=F^E)?
MVZ!9X+VTFGC\YW6'*)')DA]I*':6R,V'0\;_ .")W_!.GX/_ !O_ &!AXF\8
M^"M'\1Z]XKN[^TFOKV+S9K.%)1$BP%B1$P,>X.@#9<C)'%>0_P#!O+XWO/A-
MXT^/]LLSW-EH?A\:D8CNV2RVLDP5MFX#)!8=<]!D5^@O_!(3]G+Q?^RK^PKX
M:\'^.M,31O$MK>7]Q<V2W45R;=9+J1DR\3-&24VM\K' 8 X.0/G'_@C)_P $
M]OBK^R=^T/\ %75/B-X3ATK0O$ED;6QG.HV=Y'??Z2S$;(I78 H<_.HX.#SQ
M0"/@;_@G_P#%_4-8^,'C_P =>(?V<M8_:E\0ZM)'-=2&VDN[?29;AYGEEF@2
MSN(B\Q7Y"RKL$+A."<>[?L6>!_B=9?\ !7+PU\0O#'[.?CGX,>"]=N7M-4TJ
M;1KX:596\MLRSDRO!#&B&0"5$"JB.$ 4@ 'TCP=_P3F_:A_X)A?M$^)=8_9R
MBT'Q_P""/$2@G3=8NH(/-B#2>3#<I)-"3+!YC;98I%#C)(7>T5?3/['^H?MG
M?$/X_:=K7QELO O@/P!96UPMWH&D^1/-J$Q3;"=XDN77:_S\3J.H(.0 #9S'
MQG_X*P_&3X<?%WQ/X>T?]C_XI>*-*T'5;G3K36;<WRP:K%%*T:W,873I%V2!
M=RX=@58')KR;_@N;\4M8^-7_  2B^&'BG7_".J> ]8UGQG:3W6@:B6-UIK?8
MM378^Y$;) #<HIPPR!7ZB/UK\\?^#ES_ ),1\)_]CY9_^F_4::**G[''_!+W
MX/\ C7_@EE%J&L^&++5O%7Q \,2:U>>(KV)9M3LKJ2-I(WMI6YA$9V\)@/M_
M>;PQ!\N_X-A?B%JTS?%CPH]TSZ';BPU:"V;[L%R_FQ2.ONZ1Q!O^N2=,'./\
M!O 7[;UA^P-H7@WX?0>%O&?@#XB: 'L=4?48XM7\,6=P@5[57N)H@H"EPI5)
MMBM\C(0H7[(_X)!_\$Y;G_@GU\%M537KZWOO&GC*6&ZUA;7YK>R6$.(;='QE
MROFR%FZ%G(487<S6X'Y[_P#!"_X'6O[2OPY_:0\"78AV^)_"]I90R2E@D$Y:
MX,$IQS\DHC?H?N]#TK%_9#_;ZG_9M_X)B_'SX97]S_9_BJ*[6ST*%I#'<9U
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M_P#2>.OB[_@NQ^PY\3_VRX/A<WPW\.+XB;PTVJC4$_M&ULVA$_V/RR//DC#
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M8_W:L8RF/]ZGTQ_O4 ,?I3#TI[]*8>E #*8_WJ?3'^]6@&1K/_(R:3_VV_\
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M^NR?S%0O]VIM%_Y#%K_UV3^8H U?'W_(0A_ZY_U-8-;WC[_D(0_]<_ZFL&@
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M(?,$NWAM^0XRK'=AB0<?.W[$MXOC3]@#]O#QKH]K?0>"/&5WXLOO#KW(*&:
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MY-NXYQNQ\J_W5QZW0!^=O_!Q9XOTFX_91\ P1ZGI[SV?Q+TY[B-;E"\ 6SU
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M$=?^#*_#S4-!L=2\%KIL6D?V5>*;B$VT2JD:$N2Q*A%(8G<"H;.X9H ^7?\
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M^M;.VPMO;:?;/)%!%&OW@JRO= ;CRNP@=V^_Z "BBB@ HHHH **** "BBB@
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MX[_]>D71,#_6?^.__7HYD%T9[_>I.U:!T/)_UO\ X[_]>C^PN/\ 6_\ CO\
M]>CF071G'I34ZUIG0LC_ %O_ ([_ /7I%T#!_P!;_P"._P#UZ.9#;1FO]ZF/
MTK4/A_)_UO\ XY_]>D;P[N'^N_\ '/\ Z]-30-HRJ1/NUJ_\(W_TV_\ '/\
MZ](/#6!_KO\ QS_Z]5[2(75C)?[U,?I6P?#&3_K_ /QS_P"O2-X6R/\ 7_\
MCG_UZ/:1!-&-16Q_PB?_ $W_ /'/_KT?\(G_ --__'/_ *]'M(C<D8C]:^>?
M^"EW[!7_  \2^ VD^"O^$K_X0_\ LO7H=;^V?V9_:'F^7;W,/E>7YL6,_:-V
M[<?N8QSD?4#>$<G_ (^/_(?_ ->C_A$OEQ]H_P#(?_UZ:J1'S(\O_9Q^#%O^
MSK\!?"'@6UOIM3@\)Z5;Z8MW+&(WN?+0*7*C(7)!.,G&<9/6NS7[YK<_X1#_
M *>/_(?_ ->D'@[!_P"/C_R'_P#7H]I&X<R,-^M-/2MYO!VX_P#'Q_Y#_P#K
MTA\&9'_'S_Y#_P#KTW4B',CG'ZU$>M=&_@GG_CY_\A__ %Z8? N3_P ?7_D+
M_P"O3]K'N',CG6ZBE/2N@/@/)_X^O_(7_P!>E/@3(_X^O_(7_P!>CVL>XW.)
MS=1GK73?\(#_ -/?_D+_ .O33\/LG_C[_P#(7_UZ/:Q[C4XG,OTI$^]73-\/
M=P_X^_\ R%_]>D'P[P?^/S_R%_\ 7JE6AW'[2)S-,?[U=3_PKK_I\_\ (7_V
M5-/PWR?^/S_R#_\ 94_;0[A[2)RK]*=73M\-<C_C]_\ (/\ ]E2_\*V_Z??_
M "#_ /94>VAW#VD3DZ8_6NM_X5G_ -/O_D'_ .RI&^&.X_\ ']_Y!_\ LJ/;
M0[A[2)R+_=IE=>?A=D?\?W_D'_[*D_X59_T_?^0/_LJ/;0[A[2)QM-;[XKLO
M^%4?]/\ _P"0/_LJ0_";)_X__P#R!_\ 952KP[A[2)Q[_=IE=F?A/D?\?_\
MY _^RI/^%2?]1#_R!_\ 94_;T^Y3JQ.)/6FMU%=L?A#D_P#(0_\ ('_V5(?@
M_D_\A'_R!_\ 94>WI]R?:1.+/2F5W!^$&1_R$/\ R!_]E3?^%._]1'_R7_\
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M_DI_]G2?\,Y?]1G_ ,E/_LZOZW2[_F'MH=SR]^E0GK7JC_LY<?\ (9_\E/\
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MH **** $?[M3:+_R&+7_ *[)_,5"_P!VIM%_Y#%K_P!=D_F* -7Q]_R$(?\
MKG_4U@UO>/O^0A#_ -<_ZFL&@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Z#_A=_@O_ *&_PO\
M^#6#_P"*K?U?6+3P_I5S?7]U;V5E9Q-/<7%Q((XH(U&6=V8@*H )))P *_F,
MK^B7]NW_ ),H^+?_ &)^J_\ I)+7U.<\.QP-2C34^;VC:VM;;S\S\MX,\1*N
M>X;&5Y4%#V$4_BO>ZF^RM\/XFU_PU5\+S_S4CP%_X4%I_P#'*/\ AJGX8?\
M11_ 7_A06G_QROYPHZE3[M?0O@2BO^7K^Y'Y\O';%_\ 0)'_ ,"?^1_1R/VI
M_AB?^:C^ _\ P?VG_P <H_X:G^&/_11O ?\ X/[3_P".5_.;%_JQ3QUJ?]1:
M/_/U_<BEXZ8O_H$C_P"!/_(_HO\ ^&IOAC_T4;P)_P"#^T_^.4?\-2_#(_\
M-1? G_@_M/\ XY7\ZR=*>G6E_J-2_P"?K^Y%KQRQ;_YA8_\ @3_R/Z)_^&H_
MAF?^:B^!?_!_:_\ QRE_X:B^&9_YJ)X%_P#!]:__ !ROYW$Z5+%VJ?\ 4>E_
MS]?W(K_B.&+_ .@6/_@3_P C^A[_ (:@^&G_ $4/P-_X/K7_ ..4O_#3_P -
M?^BA^!O_  ?6O_Q=?SR5*GWJ7^I%+_GZ_N+7C=B_^@6/_@3_ ,C^A;_AIWX:
M_P#10O __@^M?_BZ/^&G?AM_T4+P/_X/K7_XNOY[T^[4B=*3X*I+_EZ_N*7C
M9BO^@6/_ ($_\C^@S_AISX;'_FH7@?\ \'MK_P#%TO\ PTY\-O\ HH7@?_P>
MVO\ \77\^J=:=2_U+I?\_7]Q2\:L4_\ F%C_ .!/_(_H('[37PW/_-0?!'_@
M]M?_ (NE_P"&F?AO_P!% \$?^#VU_P#BZ_G]3[@^E2)]VI_U,I?\_7]Q2\:<
M5_T"Q_\  G_D?O\ ?\-+_#C_ **!X)_\'EK_ /%TO_#2WPY_Z'_P3_X/+7_X
MNOP%IZ?=I?ZF4O\ GZ_N+7C-BO\ H&C_ .!/_(_??_AI7X<_]#_X*_\ !Y:_
M_%T?\-*?#H_\S]X*_P#!Y:__ !=?@;3DZT?ZFTO^?K^XO_B,F*_Z!H_^!/\
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M_P"@>/\ X$_\C]O/^&A/ /\ T/'A#_P<V_\ \72C]H/P$?\ F=_"'_@YM_\
MXNOQ&J2"E_JK3_Y^/[BUXJXA_P#,/'_P)_Y'[;?\- > S_S.WA'_ ,'%O_\
M%T?\+_\  ?\ T.WA'_P<6_\ \77XGITIZ?>J?]5J?_/Q_<4O%/$/_F'7_@3_
M ,C]K?\ A?W@3_H=?"7_ (.+?_XNC_A?W@3_ *'7PE_X.+?_ .+K\6$^[2T?
MZKT_^?C^XI>*.(?_ "X7WO\ R/VG_P"%_>!#_P SKX2_\'%O_P#%T?\ "_/
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M(DU_^?"^]_Y'[#_\+S\$_P#0X>%O_!M!_P#%TO\ PO+P4?\ F</"W_@V@_\
MBZ_'U.M/J?\ 5R'\[^XI>)-=_P#+A?>_\C]?C\;_  4W_,X>%_\ P:P?_%4?
M\+M\%?\ 0W^%_P#P:P?_ !5?D(.E/CH_U<A_._N*7B/7?_+E?>_\C]>?^%U^
M"S_S-_AC_P &L'_Q5'_"ZO!?_0W>&/\ P:P?_%5^14=.I?ZNP_G?W%_\1%K_
M //E?>_\C]<_^%T^#/\ H;O#/_@U@_\ BJ/^%T^#/^AN\,_^#2#_ .*K\CT^
M[3TZ4O\ 5Z'\[^X?_$0Z_P#SY7WO_(_6W_A=/@S_ *&[PS_X-(/_ (JE_P"%
MT>#/^AM\,_\ @T@_^*K\E4Z5*.E3_J_#^=_<4O$*M_SY7WO_ "/UE_X71X,_
MZ&WPS_X-(/\ XJE_X7-X-/\ S-GAK_P:0?\ Q5?DXG2G4O[ A_._N*7B!6?_
M "Y7WL_6'_A<O@[_ *&SPU_X-(/_ (JC_A<G@[_H;/#?_@T@_P#BJ_*".I4^
M[1_8$/YW]Q2X^K/_ )<K[W_D?JU_PN/P=_T-?AO_ ,&<'_Q5'_"X_!W_ $-?
MAO\ \&<'_P 57Y3I]ZIATI/((+[;^XK_ %]K?\^5][_R/U3_ .%Q>#_^AK\-
M_P#@S@_^*H_X7#X//_,U^&__  9P?_%5^5R=:D3K2_L&'\[*_P!?*W_/I?>S
M]3?^%P^$/^AJ\.?^#.'_ .*I?^%O^$/^AI\.?^#.'_XJORTJ2E_8</YV5_KU
M6_Y]+[V?J/\ \+@\(?\ 0T^'/_!G#_\ %4?\+>\(G_F:?#O_ (,H?_BJ_+BI
M4^]2_L.'\PUQS5?_ "Z7WL_4/_A;GA+_ *&CP[_X,H?_ (JC_A;?A+_H:/#W
M_@RA_P#BJ_+\=:DH_L.'\P_]>*O_ #Z7WL_3S_A;?A+_ *&CP]_X,H?_ (JC
M_A;?A(_\S1X>_P#!E#_\57YACK4J=:7]B0_F*_UVJ_\ /I?>?IQ_PMKPG_T,
M_A[_ ,&4/_Q5'_"VO"?_ $,_A[_P90__ !5?F54E+^Q8?S#7&M5_\NE]Y^F/
M_"V/"G_0S^'_ /P8P_\ Q5'_  M3PG_T,WA__P &,/\ \57YI44O[%C_ #%K
MC.K_ ,^E]Y^EO_"T_"G_ $,N@?\ @QA_^*H_X6GX4_Z&70/_  8P_P#Q5?FJ
MGW:>G2E_8\?YBEQE5_Y]+[S]'-6\>>#M6^S>=XGT-?LUPLZ;=2A&67. >>G-
M6_\ A:7A3_H9M _\&,/_ ,57YJW'6/\ ZZ"K-']CQ_F'_KC5_P"?:^\_2'_A
M:'A4_P#,RZ#_ .#&'_XJE_X6?X6_Z&70?_!A#_\ %5^;R?>J>DLGB_M%?ZWU
M?^?:^\_1K_A9_A;_ *&70?\ P80__%4O_"S?"_\ T,FA?^#"'_XJOSDJ5/O4
MGE$5]H?^M]7_ )]K[S]%O^%F^%_^ACT+_P &$7_Q5'_"S?"__0QZ%_X,(O\
MXJOSLH'6E_9$?YA_ZW5/^?:^\_13_A9GA<?\S%H7_@PB_P#BJ3_A9GA<_P#,
MQZ%_X,(O_BJ_/"E3K2651_F*7%E1_P#+M?>?H?\ \+*\,'_F8]#_ /!A%_\
M%4?\+*\,?]#%H?\ X'Q?_%5^>L=.H_LJ/\P_]:ZG_/M?>?H.?B1X8;_F8M$_
M\#XO_BJ/^%B^&/\ H8M$_P# ^+_XJOSZCIU+^RH_S%?ZU5/^?:^\_0/_ (6)
MX9/_ #,6B_\ @?%_C1_PL3PS_P!##HO_ ('Q?_%5^?R=*=1_94?YAKBFI_S[
M7WGZ #XA>&3_ ,S!HO\ X'Q?_%4O_"P?#7_0P:+_ .!\7_Q5? <'W/QI]+^R
MX_S#_P!:*G_/M?>??/\ PL'PU_T,&B_^!\7_ ,51_P +!\-?]#!HO_@?%_\
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MU\0)]VEI?V>NX_\ 6&?\B^\^WO\ A-_#G_0=TC_P-C_QH_X3;P[_ -!S2?\
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M#_Z"ME_X%1_XU\TT]/NTOJZ[C_M&7\I])_VCH9_YBME_X%1TAO=#/_,5L_\
MP*CKYO3K3Z2PZ[C_ +1EV/H.Z3P[<:E:SOJ]J);;?Y8^UQX;<,'BK7V[0_\
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M3_[#T3_G_3_P(2C^P]$_Y_T_\"$KS"BCD'[4]0_L/13_ ,OZ?^!"4?V%HO\
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M#_R^#_O^M<313L+F.V_X1O2/^?S_ ,C+1_PCFD#_ )?/_(ZUQ-*G6D.YVO\
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M6?AB)XO]6*Z[X=? CQQ\7K6XG\)^#?%?BB"S<1W$FD:1<7J0,1D*YB1@I(Z
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MX(S]F_\ !&W]@_2M'^'=M\6/%>FP7VLZTS'0(+J$L-.ME8K]HVN /,D9258
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M#J='3:='2174E3[M+2)]VEJ"P'6I*C'6I*"D/'2G)]ZFCI3D^]0417_WK?\
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M*"T.CIU-CIU =0HHHH&.3I3J:G2G4 %*GWJ2E3[U(!]%%%0!)1110:!1110
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M\%0_&7]J.WT"*]@BMO$OB7[&+OSD5%CFN=OF!C\I^5LCKG@ $D"O/J<G6N/
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M*<GWJ!CZ>GW:93T^[298M%%%,8Y.E/3K3$Z4].M2RQ].CIM.CJ0*VD_\O/\
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MR.CB:%&K*2KI)WMI926EE_>>Y^$J?\$9OVD1_P TZ'_A0:9_\DT]?^"-7[2
M'_).A_X/],_^2:_=>BO2_P!>,?\ R0^Y_P#R1\U_Q _(O^?M;_P*'_RL_"Z/
M_@C=^T>J?\D['_@_TS_Y(IP_X(X?M' _\D\'_@_TS_Y(K]SZ*7^N^._DA]S_
M /DBO^((Y%_S]J_^!0_^5GX:+_P1T_:- _Y)X/\ P?Z9_P#)%.7_ (([?M&
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MXW^6/W/_ .2'_P 08R3_ )^U?_ H?_('XG)_P2*_:%!_Y$ ?^#W3?_DBG?\
M#HS]H3_H0!_X/=-_^2*_:^BC_7+&_P L?N?_ ,D5_P 0:R7_ )^U?_ H?_('
MXJK_ ,$D/V@@O_(@C_P>:=_\D4]?^"2?[00'_(@C_P 'FG?_ "17[3T4O]<<
M;_+'[G_\D/\ X@YDJ_Y>U?\ P*'_ ,@?BY_PZ6_: _Z$(?\ @\T[_P"2*<O_
M  28_:  _P"1"'_@\T[_ .2*_:&BE_KAC?Y8_<__ )(K_B#V3?\ /VK_ .!0
M_P#D#\8O^'3?Q^_Z$,?^#O3O_C]*G_!)SX_ _P#(AC_P=Z=_\?K]G**/]<,;
M_+'[G_\ )%?\0@R;_GY5_P# H_\ R!^-2_\ !*/X^!1_Q0@_\'>G?_'Z<G_!
M*3X^ _\ (B#_ ,'>G?\ Q^OV3HJ?];L9_+'[G_F5_P 0BR?_ )^5?OC_ /('
MXW?\.IOCW_T(@_\ !WIW_P ?IR_\$J/CT!_R(H_\'6G_ /Q^OV/HH_UMQG\L
M?N?^8_\ B$>3_P#/RK]\?_D#\=E_X)6?'D?\R,/_  =:?_\ 'Z<O_!*[X\!O
M^1&'_@ZT_P#^/U^P]%+_ %MQG\L?N?\ F5_Q";*%_P O*GWQ_P#D#\>U_P""
M6'QW!_Y$<?\ @ZT__P"/T]/^"6GQV!_Y$<?^#K3_ /X_7[ T4O\ 6O%_RQ^Y
M_P"97_$)\H_Y^5/OC_\ ('Y #_@EM\=<_P#(CC_P<Z?_ /'Z?_PZX^.O_0CC
M_P '.G__ !^OU\HI?ZUXO^6/W/\ S'_Q"G*?^?E3[X__ "!^0Z_\$N_CF#_R
M) _\'-A_\?IZ_P#!+WXY _\ (DC_ ,'-A_\ 'Z_76BE_K5B_Y8_<_P#,?_$*
MLI_Y^5/OC_\ ('Y&I_P3!^.(_P"9)'_@YL/_ (_3A_P3"^..?^1*'_@XL/\
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M_P#'J<G_  3@^,P_YDX?^#:Q_P#CU?J=12_UDQ7\L?N?^8UX;98OMU/OC_\
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M?]"D/_!I9?\ QZOTQW&C<:7^L&)[1_'_ #*_XA]EW\\_OC_\B?F@O_!/?XO
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M?MO_ (Y7VHTS =:;]H;_ "*/[4J]E_7S'_JOA?YI?>O\CXO3]D7XA ?\B_\
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MKV7]?,?^K>&_FE]Z_P CXXF_9-\?O=PL-!X3=D_;K?C(_P"NE61^RKX]Q_R
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M@#_R"/\ R:A_^+KZ-_M&7U'Y4CZE*!U'Y4?6Y^0?V11[O\/\CYU_X9Y\8?\
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M_P!\"BXN1&8O@/50/^/7_P BI_C2_P#"":K_ ,^O_D5/\:TO^$SO_P"^G_?
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M?]\"@5BM_P (9J7_ #[?^1%_QH_X0S4O^?;_ ,B+_C5G_A,[_P#OI_WP*/\
MA,[_ /OI_P!\"@96_P"$,U+_ )]O_(B_XT?\(9J7_/M_Y$7_ !JS_P )G?\
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M(O\ C3_^$SO_ .^G_? H_P"$SO\ ^^G_ 'P* .SHHHH **** "BBB@ HHHH
M**** "BBB@ I"?F%+2'[PH 0GYJ86.X4X_>II^\*?4 #'GDTA<[1R:!_%2'[
MHIH!"Y]3^=(\A'<_G0>E))5#&R2L/XCU]:1Y6!^\WYT2_P!::_6@:!IGV_>;
M\Z:9WVCYF_.A_NTT_=%-#$^T2;?OOU]:;]IDS]]_^^J3^#\:;WJAB_:I-O\
MK'Z_WC0;J3_GH_\ WT:XSP+^T+X!^*'BK4= \->./"'B+7='WF_TW3-9MKN[
ML=C^6_FQ1N73:Y"G<!AC@\UUYZT .>ZE _UC_P#?1IK7<O/[R3_OHTU^E-?O
M5(!QO)=G^MD_[Z-,:]FP?WLG_?1II^Y3&Z&JL@'?;IL_ZZ7_ +[-(+^?G]]+
M_P!]FH^](/XJ:2N4MR3[?/C_ %TO_?9IIU"?;_KI?^^S6;XG\4:9X)\.WFK:
MSJ-CI&E:=$T]W>WMPD%O:QJ,L[R.0JJ.Y) K-^'7Q5\+_&'PZVK>$?$F@^*=
M*69K<WND:A%?6XD7!9/,B9EW ,I(SD9'K560SH?[1N,_Z^;_ +[-,;4KC/\
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M5Q_R$]0_\"7_ ,::?%^K;C_Q,]1Z?\_+_P"-4.U-/WC]*ODCV*LB\?&&K?\
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M&4W_ ,56$_2HG^]1[*'\J&H1[&^WQ?\ %N!_Q5'B+_P93?\ Q51-\8?%W/\
MQ5/B/_P93?\ Q58+=!43]ZKV4/Y5]Q7)'L;S_&/Q<!_R-7B/_P &<W_Q50R?
M&7Q@,_\ %5^)/_!G-_\ %5@OTJ&7O5>QI_RK[@Y(]CH/^%S^,,_\C7XE_P#!
MG/\ _%4QOC1XQY_XJSQ+_P"#2?\ ^*KG>],?O5*C3_E7W%*$>QT#_&KQD#_R
M-OB;_P &D_\ \54+_&WQF,_\5=XG_P#!I/\ _%5SS]:ADZ&G[&G_ "K[BN2/
M8U-3^-/C%M;T]CXL\3%E\S:3JD^5RHZ?-5G_ (7CXU_Z&_Q1_P"#6?\ ^*KD
M-1_Y#%A_VT_]!J>J5&G_ "K[@]G'L=,_QQ\:@_\ (X>*?_!K/_\ %57G^.GC
M8'_D<?%/_@VG_P#BZYY^M5KCK5>QI_RK[C3V<.QT;?';QON_Y'+Q5_X-KC_X
MNH7^/'C@#_D<O%?_ (-[C_XNN;?[U0/TJE1I_P J^X/9P['4'X\^.>?^*S\5
M]/\ H+W'_P 74;_'OQT!_P CIXL_\&]Q_P#%US![_2HGZ57L*?\ *ON#V<.Q
MU#?'WQUN_P"1T\6_^#>X_P#BZA?X_P#CP?\ ,Z^+O_!Q<?\ Q=<P_P!ZH)*/
M84_Y5]PU3AV.I?\ :!\>C/\ Q6WB[_P<7'_Q=1_\-!^/?^AW\7_^#FX_^+KE
M).IJ.M/84OY5]Q?LX=CH-?\ C[X[E-MN\:^+6VW",N=7N#@\\CYZDF_:%\?C
M'_%<>,/_  <W/_Q=<=K?6#_KNO\ 6EG[4*A2O\*^X/9P['4R?M$?$ 9_XKGQ
MC_X.KG_XNH_^&B?B#_T/7C'_ ,'5S_\ %UR4O>HZOV%+^5?<4J<.R.M?]HOX
M@C/_ !7?C+_P=7/_ ,74;_M&_$(?\SWXS_\ !W<__%UR,G0U%)5*A2_E7W#]
ME#LCK&_:/^(>W_D?/&?_ (.[G_XNHW_:1^(@/_(^^-/_  =W/_Q=<@_W:A?K
M5?5Z7\J^X?LH=D==)^TE\11_S/WC3K_T'+G_ .+J-_VE/B*#_P C]XU_\'EU
M_P#%UQ\O]:A?K36'I7^%?<7[*'9'8-^TM\1]O_(_^-O_  >77_Q=0O\ M,_$
M@9_XN!XW_P#![=?_ !=<>_W:@DZFK^KTOY5]P>RAV1U\O[3GQ)'_ #4+QQ_X
M/;K_ .+JCI7[2_Q'MM/C2/X@>-HT&<*NN70 Y/;?7*S=:I6'_'FGX_S-7]7I
M?RK[D'LH=D=Z_P"T_P#$L?\ -0_'/_@^NO\ XY44G[4'Q+Y_XN)XZ_\ !]=?
M_'*XN2H9.IH^KTOY5]R-/90_E1V,G[4?Q,'_ #47QUU_Z#]U_P#'*A;]J7XG
M<_\ %QO'?_@_N_\ XY7%R_UJ!^]6L-1M\*^Y![*'\J.X_P"&I_B=_P!%&\>?
M^#^[_P#CE0S_ +5/Q/!_Y*/X]_\ "@N__CE<34-QUI_5J/\ *ON1:I4[?"ON
M.V?]JOXHC_FI'C[_ ,*"[_\ CE0M^U=\4>?^+D^/O_"AN_\ XY7#R5"_>G]6
MH_R+[D/V-/\ E7W'</\ M7_%+/\ R4KQ_P#^%#=__'*A;]K'XI[?^2E>/_\
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M /\ ':\OE_K3*I8/#_R+[D5]7I?RK[CU/_AN;XV?]%A^*?\ X5=__P#':/\
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M!H ***I^(/$%AX2T&]U75;VTTS2],MY+N\O+N988+2&-2SR2.Q"HBJ"2Q(
M)- %RBN?^&OQ9\*_&;P\VK^#_$OA_P 5Z2LS6[7NC:C#?6XE4 LADB9EW ,I
M(SD;AZUN75U'96TDTTB10Q*7DD=@JHH&223P !0!)17)_"SX]>!OCG!>2^"?
M&?A3QA'IS(EV^AZO;Z@MJ7R5$AA=MI;:V,XSM/I764 %%%% !17">%/VE_!/
MC?X[>*?AIIFM?:?&W@NWM[K6=-^QSI]CBGC22)O-9!$^Y)$.$=B-W."#7=T
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M"6F:Q$EXC6]Q<J#'9R3/< &WA68@Y^4EL[>:]R^*'[57PO\ @EJZV'C/XD>
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M_8)U'PEXXM?[<T'3]?DL(8))Y8V6*-;:Y0!T8.NV21L;2/E^7IG-1+#]B/\
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MXU>&;R_UGPCX>TJ\U2_ABMO+O[<VD!GGMC%(57SE48 W;&)4ARI#'R[X:?\
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MO"-_XE\%V%I?^(-=\8WTL.F67VA8I(T2& ^=+^ZE4E@>&)&WY1N /1_V1_\
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M965K$(X;:)!A451P  *^)_@_^W+^TA^WIIM_XL^!'@[X1>'OAU;ZA<6%E?\
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MVG_!/3]N^?X<M-_PB*^)-7;P_=Z?"(H'L0K%S$550%%GY9*J!M1AP,BO8_\
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M1E)!4@@@D&H?"'@[2/A]X:L]&T'2M.T31]/C\JUL-/MDMK:V3KM2- %4<G@
M=: .3^ O[,?@G]FOX)V7P]\)Z);6GA>TA>)[:8>>;TR9\UYRV?,9\G=NXP<
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MJF/]?8?]]O\ _$TQO@KJI/\ Q\:?_P!]O_\ $UZA11]<J#]O(\M_X4CJN/\
MCXT__OX__P 33?\ A1^K9/\ I&G_ /?Q_P#XFO5**?UVJ'MYGE/_  HW5O\
MGXT[_OX__P 136^!6KG_ )>-._[^/_\ $5ZQ11]=JA[>9Y(WP%UAO^7G3?\
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MD_\ C=>^44_[1K!]:J'@1_98\0?\_FC?]_9/_C=1_P##+'B#_G\T;_O[)_\
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M?^0EX:_\")__ (U36_8$\8G_ )B7AK_P(G_^,U]>44_[:Q/=?</Z_5/C]O\
M@G]XR)_Y"7AG_P ")_\ XS4;?\$^?&;?\Q/PQ_X$3_\ QFOL2BC^VL3W7W#_
M +0K'Q;??\$[_&\NJV;KJ'ADHF_>WVJ;"Y''_++/Y5/_ ,.\/&O_ $%/"_\
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MMF_X(C?%8G_D8/A[_P"!UY_\BU$__!$#XKLN/^$@^'O_ ('7G_R+7ZG44_\
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M]<,Q[K[A_P!OXONON/QVE_X-\/C._P#S,WPQ_P#!C??_ "'4/_$/3\:-N/\
MA)_AA_X,;[_Y#K]CZ*?^N69=U]P_]8,9W7W'XU2?\&\WQI9O^1G^%_\ X,;[
M_P"0Z@F_X-W/C5)G'BCX7?\ @RO_ /Y#K]F**?\ KGF7=?</_6'&=U]Q^,3_
M /!NM\;&_P"9H^%O_@RO_P#Y#IO_ !#I_&S_ *&CX6?^#*__ /D.OV?HI_ZZ
M9GW7W#_UBQG=?<?C!_Q#I_&S_H:/A9_X,K__ .0Z:?\ @W6^-@_YFCX6_P#@
MRO\ _P"0Z_:&HSUI_P"NN9]U]P?ZQ8SNON/QB_XAUOC9_P!#1\+?_!E?_P#R
M'1_Q#K?&S_H:/A;_ .#*_P#_ )#K]G:*/]=<S[K[@_UBQG=?<?C%_P 0ZWQL
M_P"AH^%O_@RO_P#Y#H_XAUOC9_T-'PM_\&5__P#(=?L[11_KKF?=?<'^L6,[
MK[C\8O\ B'6^-G_0T?"W_P &5_\ _(=)_P 0[7QK_P"AH^%O_@RO_P#Y#K]G
MJCH_UUS/NON#_6+&=U]Q^,O_ !#M?&O_ *&CX6_^#*__ /D.C_B':^-?_0T?
M"W_P97__ ,AU^S5%'^NN9]U]P?ZQ8SNON/Q;T_\ X-[_ (SZEY^SQ-\,!]GF
M:%MVHWW)7KC_ $/I5C_B'=^-7_0T?"[_ ,&5_P#_ "'7[!>%>NI_]?\ +_2M
M:C_77,^Z^X/]8L9W7W'XS_\ $.[\:O\ H:/A=_X,K_\ ^0Z/^(=WXU?]#1\+
MO_!E?_\ R'7[,44?ZZYGW7W!_K%C.Z^X_&?_ (AW?C5_T-'PN_\ !E?_ /R'
M0?\ @W>^-0_YF?X7?^#*_P#_ )#K]F*:_2C_ %US/NON#_6+&=U]Q^-MC_P;
MO?&.2]A6Y\5_#.*W+J)7BOKZ1T3/)53:J&(&< L,^HZU^G_[(_[(_A+]C/X2
MVWA7PK;>DNH:A*H^TZI/C!ED(_)5'"C@=R?4:*\W,N(,;CH*G7E[JZ+3[SCQ
MF:XC$QY*KT\AK]*;3GZ4VO$/."BBB@!K]*;3GZ4V@ HHHH 1_NU-HO\ R&+7
M_KLG\Q4+_=J;1?\ D,6O_79/YB@#5\??\A"'_KG_ %-8-;WC[_D(0_\ 7/\
MJ:P: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920342256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PACIRA BIOSCIENCES,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0619477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5401 West Kennedy Boulevard, Suite 890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tampa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">553-6680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PCRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,882,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920535584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 109,424<span></span>
</td>
<td class="nump">$ 585,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term available-for-sale investments</a></td>
<td class="nump">219,301<span></span>
</td>
<td class="nump">70,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">93,471<span></span>
</td>
<td class="nump">96,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">96,799<span></span>
</td>
<td class="nump">98,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">14,416<span></span>
</td>
<td class="nump">14,771<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">533,411<span></span>
</td>
<td class="nump">866,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Noncurrent available-for-sale investments</a></td>
<td class="nump">17,394<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">193,646<span></span>
</td>
<td class="nump">188,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">69,662<span></span>
</td>
<td class="nump">76,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">157,361<span></span>
</td>
<td class="nump">145,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">581,002<span></span>
</td>
<td class="nump">623,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">155,531<span></span>
</td>
<td class="nump">153,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_EquityMethodInvestmentsAndOtherAssets', window );">Investments and other assets</a></td>
<td class="nump">26,358<span></span>
</td>
<td class="nump">21,987<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,734,365<span></span>
</td>
<td class="nump">2,075,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">12,933<span></span>
</td>
<td class="nump">10,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">76,357<span></span>
</td>
<td class="nump">127,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">8,364<span></span>
</td>
<td class="nump">7,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">350,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="nump">33,872<span></span>
</td>
<td class="nump">24,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">131,526<span></span>
</td>
<td class="nump">521,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes, net</a></td>
<td class="nump">404,151<span></span>
</td>
<td class="nump">339,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">309,848<span></span>
</td>
<td class="nump">335,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">65,401<span></span>
</td>
<td class="nump">71,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">34,204<span></span>
</td>
<td class="nump">57,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">19,112<span></span>
</td>
<td class="nump">19,972<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">964,242<span></span>
</td>
<td class="nump">1,344,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 250,000,000 shares authorized; 45,864,319 and 44,734,308 shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">909,396<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(138,649)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(670)<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">770,123<span></span>
</td>
<td class="nump">730,408<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,734,365<span></span>
</td>
<td class="nump">$ 2,075,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EquityMethodInvestmentsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments and Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EquityMethodInvestmentsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822919942144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">45,864,319<span></span>
</td>
<td class="nump">44,734,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">45,864,319<span></span>
</td>
<td class="nump">44,734,308<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924538864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 167,466<span></span>
</td>
<td class="nump">$ 127,722<span></span>
</td>
<td class="nump">$ 494,868<span></span>
</td>
<td class="nump">$ 382,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">50,678<span></span>
</td>
<td class="nump">34,651<span></span>
</td>
<td class="nump">137,379<span></span>
</td>
<td class="nump">101,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,405<span></span>
</td>
<td class="nump">11,578<span></span>
</td>
<td class="nump">67,292<span></span>
</td>
<td class="nump">40,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">61,283<span></span>
</td>
<td class="nump">47,856<span></span>
</td>
<td class="nump">190,546<span></span>
</td>
<td class="nump">147,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">42,966<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet', window );">Acquisition-related charges (gains) and other</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="num">(13,232)<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">146,177<span></span>
</td>
<td class="nump">96,289<span></span>
</td>
<td class="nump">424,951<span></span>
</td>
<td class="nump">296,626<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">21,289<span></span>
</td>
<td class="nump">31,433<span></span>
</td>
<td class="nump">69,917<span></span>
</td>
<td class="nump">85,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(9,856)<span></span>
</td>
<td class="num">(7,333)<span></span>
</td>
<td class="num">(28,935)<span></span>
</td>
<td class="num">(21,327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(10,598)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(11,369)<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(19,220)<span></span>
</td>
<td class="num">(7,202)<span></span>
</td>
<td class="num">(38,547)<span></span>
</td>
<td class="num">(23,111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">24,231<span></span>
</td>
<td class="nump">31,370<span></span>
</td>
<td class="nump">62,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2,762)<span></span>
</td>
<td class="num">(6,571)<span></span>
</td>
<td class="num">(5,359)<span></span>
</td>
<td class="num">(15,492)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (693)<span></span>
</td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 26,011<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net (loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per common share (in USD per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per common share (in USD per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">44,476<span></span>
</td>
<td class="nump">45,400<span></span>
</td>
<td class="nump">44,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">45,463<span></span>
</td>
<td class="nump">52,220<span></span>
</td>
<td class="nump">45,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 166,560<span></span>
</td>
<td class="nump">$ 126,791<span></span>
</td>
<td class="nump">$ 492,563<span></span>
</td>
<td class="nump">$ 380,392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="nump">2,305<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember', window );">Collaborative licensing and milestone revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924459344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (693)<span></span>
</td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 26,011<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(837)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">$ (758)<span></span>
</td>
<td class="nump">$ 17,632<span></span>
</td>
<td class="nump">$ 25,174<span></span>
</td>
<td class="nump">$ 46,945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822916066240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 619,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 873,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (253,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">19,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">19,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">31,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">47,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">718,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">925,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">619,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">873,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(253,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="num">$ (49,233)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
<td class="num">$ (96,468)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
<td class="nump">$ 47,235<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)</a></td>
<td class="text">Accounting Standards Update 2020-06 Retrospective [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2021</a></td>
<td class="nump">$ 687,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">911,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(224,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">3,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">718,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">925,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="num">$ (49,233)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
<td class="num">$ (96,468)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
<td class="nump">$ 47,235<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">667,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 23,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">23,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">36,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">35,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(837)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">26,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,864,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">770,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">909,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138,649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(670)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2022</a></td>
<td class="nump">756,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">895,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137,956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(605)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">12,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,864,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">$ 770,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 909,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (138,649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (670)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822918908224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 26,011<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">2,895<span></span>
</td>
<td class="nump">12,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation of fixed assets and amortization of intangible assets</a></td>
<td class="nump">61,095<span></span>
</td>
<td class="nump">15,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation', window );">Amortization of debt issuance costs</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">2,107<span></span>
</td>
<td class="nump">17,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss (gain) on disposal of fixed assets</a></td>
<td class="nump">193<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">35,415<span></span>
</td>
<td class="nump">31,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(23,394)<span></span>
</td>
<td class="num">(2,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of investment</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Loss on investment</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">2,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">2,847<span></span>
</td>
<td class="nump">3,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="num">(2,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(568)<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4,681<span></span>
</td>
<td class="num">(825)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and income taxes payable</a></td>
<td class="num">(23,560)<span></span>
</td>
<td class="num">(17,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Other liabilities</a></td>
<td class="nump">623<span></span>
</td>
<td class="num">(1,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,662)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">103,237<span></span>
</td>
<td class="nump">102,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of fixed assets</a></td>
<td class="num">(24,584)<span></span>
</td>
<td class="num">(36,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of available-for-sale investments</a></td>
<td class="num">(319,426)<span></span>
</td>
<td class="num">(513,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sales of available-for-sale investments</a></td>
<td class="nump">152,636<span></span>
</td>
<td class="nump">470,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="num">(32,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchases of equity and debt investments</a></td>
<td class="num">(13,000)<span></span>
</td>
<td class="num">(17,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Sale of equity investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,057<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(236,374)<span></span>
</td>
<td class="num">(87,708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">23,482<span></span>
</td>
<td class="nump">19,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of Term loan B facility maturing December 2026</a></td>
<td class="num">(18,750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration to MyoScience, Inc. securityholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(343,017)<span></span>
</td>
<td class="nump">19,285<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(476,154)<span></span>
</td>
<td class="nump">34,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">585,578<span></span>
</td>
<td class="nump">99,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">109,424<span></span>
</td>
<td class="nump">134,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">23,620<span></span>
</td>
<td class="nump">5,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">4,216<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of common stock from conversion of 2022 convertible senior notes</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed assets included in accounts payable and accrued liabilities</a></td>
<td class="nump">5,486<span></span>
</td>
<td class="nump">4,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible senior notes</a></td>
<td class="num">(156,960)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible senior notes</a></td>
<td class="num">$ (192,609)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents earnout and milestone payment made which is associated with the acquisition of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from shares issued under Employee Stock Purchase Plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139823014670224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The Company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#8217;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#8220;MyoScience Acquisition&#8221;). The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to targeted nerves.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from three products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coronavirus (COVID-19) Pandemic and Global Economic Conditions</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, the Company&#8217;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#8217;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#8217;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139823009454160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of revenues from the Company&#8217;s three largest wholesalers have shifted in the current year with the addition of ZILRETTA sales, which began in November 2021 following the completion of the Flexion Acquisition (as defined below).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span>which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921258592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#176; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#8217;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenues are recorded at the time the products are transferred to the customer.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy and doctors. Payment terms generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzMg_bfd25119-5362-4514-9063-c69b91c15797">zero</span> to 97 days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,560&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921441712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">FLEXION ACQUISITION</a></td>
<td class="text">FLEXION ACQUISITION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, the Company acquired Flexion (the &#8220;Flexion Acquisition&#8221;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total consideration for the Flexion Acquisition was approximately $578.8&#160;million consisting of: (i) $448.5&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $45.2&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $380.2&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the nine months ended September&#160;30, 2022. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is finalizing its valuation of certain tax accounts, and anticipates finalizing the purchase price allocation as the information necessary to complete the analyses is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,970)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,186)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents the finalization of a tax study and pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Summary of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the unaudited pro forma summary of operations for the three and nine-month periods ended September&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Recognition of the income tax benefit resulting from decreasing Flexion&#8217;s existing valuation allowance on deferred tax assets for the three and nine months ended September&#160;30, 2021;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Removal of Flexion&#8217;s interest expense and associated deferred financing cost amortization related to the $85.1&#160;million of debt not assumed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Adjustments to the Company&#8217;s interest income for the cash used to acquire Flexion; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional cost of goods sold related to a step-up value in inventory;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional amortization expense from the acquired developed technology intangible assets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional depreciation of Flexion&#8217;s fixed assets; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Additional lease expense on Flexion&#8217;s right-of-use, or ROU, assets.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all of the above adjustments were adjusted for the applicable tax impact.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921289312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921338656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">FIXED ASSETS</a></td>
<td class="text">FIXED ASSETS<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,646&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, depreciation expense was $5.8 million and $3.8 million, respectively. For the three months ended September&#160;30, 2022 and 2021, there was $1.1 million and $0.9 million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and 2021, depreciation expense was $18.0 million and $9.6 million, respectively. For the nine months ended September&#160;30, 2022 and 2021, there was $2.9&#160;million and $3.0&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $57.4 million and $65.4&#160;million, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $3.1&#160;million and $2.4&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921285584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL and iovera&#176; manufacturing facility in San Diego, California. These leases have remaining terms up to 7.9 years, some of which provide renewal options at the then-current market value. The Company also has two embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis. During the three months ended September 30, 2022, the Company entered into a partial sublease for the former Flexion research and development laboratory in Woburn, Massachusetts which resulted in a $0.4&#160;million ROU asset reclassified to a fixed asset.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease expense, net is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Lease expense, net of sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.46 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921378752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), MyoScience, Inc., or MyoScience, (the &#8220;MyoScience Acquisition&#8221;) in April 2019 and the Flexion Acquisition in November 2021. The balances at September&#160;30, 2022 and December&#160;31, 2021 were $157.4&#160;million and $145.2&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $32.0&#160;million when annual net sales collected reached $500.0&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,097)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2022 was $14.3&#160;million and $43.0&#160;million, respectively. Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2021 was $2.0&#160;million and $5.9&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $14.3&#160;million for the remaining three months of 2022, $57.3&#160;million from 2023 to 2030, $37.4&#160;million in 2031, $7.9&#160;million in 2032 and $2.2&#160;million in 2033.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. During the three months ended June 30, 2022, a triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921404176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan B Facility</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a term loan credit agreement (the &#8220;Credit Agreement&#8221;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#8220;Term Loan&#8221;) was issued at a 3% discount and allows for a single-advance term loan B facility in the principal amount of $375.0&#160;million, which is secured by substantially all of the Company&#8217;s and each subsidiary guarantor&#8217;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $363.8&#160;million after deducting an original issue discount of $11.2&#160;million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $9.4&#160;million commencing June 30, 2022, increasing to $14.1&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $188.0&#160;million due at maturity. During 2022, the Company is required to make three quarterly payments totaling $28.1&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#8217;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are 2% in the first loan year plus an interest make-whole payment, 2% in the second loan year, 1% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the nine months ended September&#160;30, 2022, the Company made scheduled principal payments of $18.8&#160;million in the aggregate.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events of default and other provisions. As of September&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a 75 basis points floor) plus an applicable margin of 700 basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a 175 basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus 50 basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus 100 basis points, subject to certain exceptions, plus an applicable margin of 600 basis points. As of September&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of 9.21%. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its then-outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#8217;s common stock was greater than 130% of the conversion price then applicable for at least 20 out of the last 30 consecutive trading days of the quarter. During the quarter ended&#160;September&#160;30, 2022, this condition for conversion was not met.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $993</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s condensed consolidated balance sheet at September&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $201.3&#160;million principal amount of 3.375% convertible senior notes due 2024 (the &#8220;Flexion 2024 Notes&#8221;), pursuant to the indenture, dated as of May 2, 2017 (the &#8220;Original Flexion Indenture&#8221;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#8220;Flexion Trustee&#8221;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#8220;First Supplemental Flexion Indenture&#8221; and, together with the Original Flexion Indenture, the &#8220;Flexion Indenture&#8221;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#8217;s common stock, or a combination thereof, at Flexion&#8217;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $26.78 per share of Flexion&#8217;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#8220;Notice&#8221;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to 100% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#8217;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $317.40 in cash and (ii) 37.3413 CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#8217;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $192.6&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At September&#160;30, 2022, the remaining principal outstanding is $8.6&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $160.0&#160;million and a conversion premium of $4.8&#160;million through a cash payment of $156.9&#160;million and the issuance of 101,521 shares of the Company&#8217;s common stock, which increased additional paid-in capital by $3.0&#160;million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921232928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions, whereas an equity investment was fully impaired during the three months ended September 30, 2022. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;3.375% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $53.19 per share at September&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at September&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Convertible Note Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, an impairment of an equity investment of $10.0&#160;million was recorded within other, net</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated statements of operations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, the Company sold an equity investment for net cash proceeds of $9.1&#160;million and recognized a realized loss of $2.6&#160;million, which was recorded in other, net in the condensed consolidated statements of operations. The fair value of the divested equity investment was based on a Level 1 input.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Contingent Consideration</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $34.2&#160;million and $57.6&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $425.5&#160;million if certain regulatory and commercial milestones are met. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represented the Company&#8217;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $1.2&#160;million liability. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded gains of $0.5&#160;million and $13.8&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At September&#160;30, 2022, the weighted average discount rate was 14.4% and the probability of success for the remaining regulatory milestone was 20.0%. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $32.6&#160;million and $46.4&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of September&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $43.0&#160;million. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized contingent consideration gains of $0.5&#160;million and $9.6&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized contingent consideration gains of $1.2&#160;million and $2.1&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At September&#160;30, 2022, the weighted average discount rate was 12.8% and the probability of success for the regulatory milestone that has not yet been met was reduced to zero. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $1.6&#160;million and $11.2&#160;million, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.98% to 14.77%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.25% to 13.28%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% to 20%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate, federal agency and government bonds with maturities greater than three months, but less than one year. Noncurrent investments consist of federal agency bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term investments are reported in other comprehensive income (loss). At September&#160;30, 2022 and December&#160;31, 2021, all of the Company&#8217;s short-term and noncurrent investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.&#160;</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term and noncurrent available-for-sale investments at September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,010&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $0.4&#160;million and $0.1&#160;million, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of September&#160;30, 2022, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 33%, 18% and 18%. At December&#160;31, 2021, four wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 30%, 20%, 17% and 11%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the </span></div>Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2022 and December&#160;31, 2021, the Company did not deem any allowances for credit losses on its accounts receivable necessary.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921404176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Net of a $0.3&#160;million and $0.1&#160;million tax benefit for the nine months ended September&#160;30, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921343376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">STOCK PLANS</a></td>
<td class="text">STOCK PLANS<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667,940)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,766)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303,617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,821)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2022 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $25.66 per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92 years</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company&#8217;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional 500,000 shares.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP features two six-month offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2022, 36,729 shares were purchased and issued through the ESPP.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921278224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER SHARE</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE<div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. </span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive. As the Company reported a net loss for the three months ended September 30, 2022, no potentially dilutive securities have been included in the computation of diluted net loss per share for that period.</span></div><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net (loss) income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net (loss) income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net (loss) income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net (loss) income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921289312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense are as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating re</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sults adjusted for certain discrete tax items. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates for the three months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation and valuation allowances recorded against non-U.S. results and deductible capital losses. The three months ended September&#160;30, 2022 also includes benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration. </span></div>The Company&#8217;s effective tax rates for the nine months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation costs and valuation allowances recorded against non-U.S. results and deductible capital losses, offset by benefits related to stock based compensation. The nine months ended September&#160;30, 2022 also include benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921261824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock', window );">ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER</a></td>
<td class="text">ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related charges (gains) and other for the three and nine months ended September&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,557)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges (gains) and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $1.5&#160;million and $10.2&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, respectively</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. The Company recognized acquisition-related costs of $1.0&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to legal fees. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flexion Acquisition</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represents the Company&#8217;s potential achievement of meeting regulatory and sales-based milestones. During the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded $0.5&#160;million and $13.8&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration. See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $0.5&#160;million and $9.6&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September&#160;30, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $1.2&#160;million and $2.1&#160;million contingent consideration gains during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized acquisition-related costs of $0.4&#160;million during the three and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily related to one-time termination benefits fees.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product, which resulted in dissolution costs of $3.0&#160;million for the nine months ended September 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921404176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eVenus Pharmaceutical Laboratories Litigations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#8217;495 patent).</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#8217;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#8217;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#8217;s ANDA submission.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#8217;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#8217;336 patent). eVenus further alleges in the Notice Letter that both the &#8217;495 patent and the &#8217;366 patent are invalid and/or not infringed.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#8217;495 and &#8217;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#8217;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These litigations are in their early stages, and the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Development Foundation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#8217;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#8217;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments and Contingencies</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#8217;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hong Kong Pharma Tainuo Ltd.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $10.0&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of December 31, 2021. The Company was also eligible to receive up to $32.5&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company submitted a letter to HK Tainuo associated with this license agreement seeking a mutual decision to end the licensing agreement. As of September&#160;30, 2022, $10.0&#160;million was recognized as part of acquisition accounting within other liabilities in the condensed consolidated balance sheet related to this matter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822919937232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Concentration of Major Customers</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#176; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Adopted Accounting Pronouncements</a></td>
<td class="text">Recently Adopted Accounting Pronouncements<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span>which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of presentation and principles of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921232928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of percentage of revenue comprised by the three largest customers</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented: </span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921338656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenue</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;ZILRETTA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,560&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921208800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of recognized identified assets acquired and liabilities assumed</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is finalizing its valuation of certain tax accounts, and anticipates finalizing the purchase price allocation as the information necessary to complete the analyses is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(as previously </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">reported) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Recognized at the Acquisition Date <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS ACQUIRED</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,970)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES ASSUMED</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,186)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)  As previously reported in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(b)  Represents the finalization of a tax study and pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Unaudited pro forma summary of operations</a></td>
<td class="text">This pro forma information does not purport to represent what the Company&#8217;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma basic and diluted net loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921338656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of components of inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921297600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of fixed assets summarized by major category</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,646&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924512096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of operating lease expense and other operating lease information</a></td>
<td class="text">Total operating lease expense, net is as follows (in thousands):<div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Lease expense, net of sublease income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,860&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted average remaining lease term and the weighted average discount rate are summarized as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.46 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of operating lease liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock', window );">Schedule of operating lease not yet commenced, payments due</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Operating Lease Not Yet Commenced, Payments Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921313568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of finite-lived intangible assets acquired as part of business combination</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the in-process research and development, or IPR&amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible<br/>Assets, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,097)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years, 5 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,090&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921409376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long-term debt instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s outstanding debt is summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan B facility maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% Convertible senior notes due August 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375% Convertible senior notes due May 2024 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Convertible senior notes due April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The 2022 Notes (as defined below) matured on April 1, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of composition of the Company's debt and financing obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the Term Loan is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan maturing December 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due August 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,627&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due April 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,857&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ScheduleOfInterestExpenseTableTextBlock', window );">Schedule of total interest expense recognized related to the Notes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of interest rate expenses related to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822922488192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of carrying amount and fair value of the long-term debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility due December 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;3.375% convertible senior notes due 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was $53.19 per share at September&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at September&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#8217;s common stock, which assumes no increase in the conversion rate for certain corporate events.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of investments without readily determinable fair value</a></td>
<td class="text">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Convertible Notes Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of key assumptions used in the valuation of contingent consideration</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flexion Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MyoScience Ranges </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Utilized as of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.98% to 14.77%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.25% to 13.28%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% to 20%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of short-term investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s short-term and noncurrent available-for-sale investments at September&#160;30, 2022 and December&#160;31, 2021 (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September&#160;30, 2022 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,010&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2021 Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921402368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables illustrate the changes in the balances of the Company&#8217;s accumulated other comprehensive (loss) income for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrealized (Loss) Gain From Available<br/>For Sale Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss on investments, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Net of a $0.3&#160;million and $0.1&#160;million tax benefit for the nine months ended September&#160;30, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921216464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of recognized stock-based compensation in consolidated statements of operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of the company's stock option activity and restricted stock unit activity</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667,940)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,766)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303,617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,821)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, stock options, valuation assumptions</a></td>
<td class="text">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92 years</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921425488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted net income (loss) per common share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2022 and 2021 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net (loss) income&#8212;basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Adjusted net (loss) income&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU 2020-06 convertible notes if-converted method adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net (loss) income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net (loss) income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921509920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income before income tax, domestic and foreign</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes and income tax expense are as follows (dollar amounts in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822921443520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock', window );">Schedule of Acquisition Related Charges (Gains) And Other</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related charges (gains) and other for the three and nine months ended September&#160;30, 2022 and 2021 summarized below (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flexion contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,837)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoScience contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,557)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuance Biotech Co. Ltd. agreement dissolution costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related charges (gains) and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,232)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822922459760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>product </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ConcentrationRiskNumberOfProducts', window );">Concentration of products (in products) | product</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ConcentrationRiskNumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number Of Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ConcentrationRiskNumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920348976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details) - Concentration risk by major customer - segment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ConcentrationRiskNumberOfCustomers', window );">Number of customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Second largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Third largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Sales Revenue, Net | Three largest customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ConcentrationRiskNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number of Customers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ConcentrationRiskNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911300736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="nump">$ 770,123<span></span>
</td>
<td class="nump">$ 756,636<span></span>
</td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="nump">$ 718,602<span></span>
</td>
<td class="nump">$ 687,168<span></span>
</td>
<td class="nump">$ 619,688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="num">(138,649)<span></span>
</td>
<td class="num">(137,956)<span></span>
</td>
<td class="num">(211,895)<span></span>
</td>
<td class="num">(206,765)<span></span>
</td>
<td class="num">(224,425)<span></span>
</td>
<td class="num">(253,875)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="nump">$ 909,396<span></span>
</td>
<td class="nump">$ 895,151<span></span>
</td>
<td class="nump">942,091<span></span>
</td>
<td class="nump">$ 925,169<span></span>
</td>
<td class="nump">$ 911,368<span></span>
</td>
<td class="nump">$ 873,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Decrease in deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Cumulative Effect, Period of Adoption, Adjusted Balance | Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (96,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924513120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">0 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">97 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AccountsReceivablePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AccountsReceivablePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822919844192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 167,466<span></span>
</td>
<td class="nump">$ 127,722<span></span>
</td>
<td class="nump">$ 494,868<span></span>
</td>
<td class="nump">$ 382,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember', window );">EXPAREL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">132,642<span></span>
</td>
<td class="nump">121,926<span></span>
</td>
<td class="nump">398,854<span></span>
</td>
<td class="nump">366,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_ZILRETTAMember', window );">ZILRETTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">26,494<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">77,546<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_IoveraMember', window );">iovera&#176;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">4,467<span></span>
</td>
<td class="nump">4,182<span></span>
</td>
<td class="nump">10,694<span></span>
</td>
<td class="nump">11,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember', window );">Bupivacaine liposome injectable suspension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">5,469<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 166,560<span></span>
</td>
<td class="nump">$ 126,791<span></span>
</td>
<td class="nump">$ 492,563<span></span>
</td>
<td class="nump">$ 380,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_ZILRETTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_ZILRETTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_IoveraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_IoveraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_BupivacaineLiposomeInjectableSuspensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139823014628272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Narrative (Details) - Flexion - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">$ 578.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt', window );">Retirement of term loan</a></td>
<td class="nump">85.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration', window );">Fair value of contingent value rights (CVRs)</a></td>
<td class="nump">45.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Additional amount payable to holders of the CVRs</a></td>
<td class="nump">$ 380.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">RSUs, In-The-Money Stock Options, and Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822915924432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>ASSETS ACQUIRED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="num">$ (10,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets', window );">Total assets</a></td>
<td class="num">(10,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES ASSUMED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities', window );">Total liabilities</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets', window );">Total identifiable net assets acquired</a></td>
<td class="num">(12,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">157,361<span></span>
</td>
<td class="nump">$ 145,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill</a></td>
<td class="nump">12,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total consideration transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>ASSETS ACQUIRED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">113,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Short-term available-for-sale investments</a></td>
<td class="nump">11,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">32,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">29,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">4,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">23,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">47,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">61,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">810,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES ASSUMED</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">9,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">23,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Lease liabilities</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="nump">1,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="nump">201,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,450<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">252,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,762<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets acquired</a></td>
<td class="nump">557,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">21,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,628<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total consideration transferred</a></td>
<td class="nump">$ 578,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139823014626576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FLEXION ACQUISITION - Schedule of Pro Forma Information (Details) - Flexion - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues</a></td>
<td class="nump">$ 149,048<span></span>
</td>
<td class="nump">$ 456,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,763)<span></span>
</td>
<td class="num">$ (31,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Pro forma basic net loss per share (in usd per share)</a></td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Pro forma diluted net loss per share (in usd per share)</a></td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924406752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 35,602<span></span>
</td>
<td class="nump">$ 36,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">35,026<span></span>
</td>
<td class="nump">35,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">26,171<span></span>
</td>
<td class="nump">27,031<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 96,799<span></span>
</td>
<td class="nump">$ 98,550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822919871104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FIXED ASSETS - Summary of Major Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">$ 295,174<span></span>
</td>
<td class="nump">$ 273,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(101,528)<span></span>
</td>
<td class="num">(85,240)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">193,646<span></span>
</td>
<td class="nump">188,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">118,233<span></span>
</td>
<td class="nump">117,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">61,302<span></span>
</td>
<td class="nump">59,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">14,449<span></span>
</td>
<td class="nump">13,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">2,420<span></span>
</td>
<td class="nump">2,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">$ 98,770<span></span>
</td>
<td class="nump">$ 80,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911137184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="nump">1,085<span></span>
</td>
<td class="nump">881<span></span>
</td>
<td class="nump">2,852<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">193,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">$ 57,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116646717&amp;loc=d3e6290-110844<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920140368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment </div>
<div>lease</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_NumberOfLeases', window );">Number of embedded leases | lease</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net | $</a></td>
<td class="nump">$ 69,662<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 76,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts', window );">Number of leases not yet commenced | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_NumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_NumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920488192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Summary of operating lease cost and other operating lease information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed lease costs</a></td>
<td class="nump">$ 3,440<span></span>
</td>
<td class="nump">$ 2,919<span></span>
</td>
<td class="nump">$ 10,509<span></span>
</td>
<td class="nump">$ 8,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(169)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease expense, net of sublease income</a></td>
<td class="nump">$ 3,811<span></span>
</td>
<td class="nump">$ 3,335<span></span>
</td>
<td class="nump">11,860<span></span>
</td>
<td class="nump">10,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash Flow, Operating Activities, Lessee [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities, net of lease incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,922<span></span>
</td>
<td class="nump">9,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets recorded in exchange for lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">7 years 1 month 9 days<span></span>
</td>
<td class="text">8 years 5 months 15 days<span></span>
</td>
<td class="text">7 years 1 month 9 days<span></span>
</td>
<td class="text">8 years 5 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
<td class="nump">6.95%<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924485408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of maturities of operating lease liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (remaining three months)</a></td>
<td class="nump">$ 3,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">13,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">13,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">12,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">12,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">39,423<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">94,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(20,543)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 73,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822925473040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear', window );">2022 (remaining three months)</a></td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne', window );">2023</a></td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo', window );">2024</a></td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree', window );">2025</a></td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour', window );">2026</a></td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Total future lease payments</a></td>
<td class="nump">$ 2,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924335088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill recorded in connection with the acquisition</a></td>
<td class="nump">$ 157,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14,322<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
<td class="nump">42,966<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Amortization expense, remainder of fiscal year</a></td>
<td class="nump">14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1', window );">Amortization expense, first period</a></td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2', window );">Amortization expense, second period</a></td>
<td class="nump">37,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3', window );">Amortization expense, third period</a></td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4', window );">Amortization expense, fourth period</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember', window );">When annual net sales collected reach $500.0 million | Skye Pharma Holding Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition', window );">Milestone payments for EXPAREL agreed in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition', window );">Annual net sales threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822915897360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 590,090<span></span>
</td>
<td class="nump">$ 590,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(70,088)<span></span>
</td>
<td class="num">(27,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">520,002<span></span>
</td>
<td class="nump">562,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Value</a></td>
<td class="nump">651,090<span></span>
</td>
<td class="nump">651,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">581,002<span></span>
</td>
<td class="nump">623,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">590,000<span></span>
</td>
<td class="nump">590,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(70,057)<span></span>
</td>
<td class="num">(27,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 519,943<span></span>
</td>
<td class="nump">$ 562,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Lives</a></td>
<td class="text">10 years 5 months<span></span>
</td>
<td class="text">10 years 5 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">Acquired IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Value</a></td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911125056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Carrying Value of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 747,870<span></span>
</td>
<td class="nump">$ 1,049,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 343,719<span></span>
</td>
<td class="nump">359,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 395,510<span></span>
</td>
<td class="nump">330,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 8,641<span></span>
</td>
<td class="nump">201,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 157,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822908384800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 02, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>d </div>
<div>payment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>payment </div>
<div>d </div>
<div>segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 07, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 06, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest', window );">Settlement period - convertible debt conversion request</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 695,000<span></span>
</td>
<td class="nump">$ 5,844,000<span></span>
</td>
<td class="nump">$ 2,107,000<span></span>
</td>
<td class="nump">$ 17,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to additional paid in capital, other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue', window );">Leverage ratio, maximum, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate', window );">Basis spread two on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate', window );">Basis spread one on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentVariableRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentVariableRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member', window );">Term Loan B Facility Due 2026 | Minimum | Federal Reserve Bank Of NY, Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0139324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentMarketPrice', window );">Market price of principal amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock', window );">Convertible debt, premium on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Redemption Terms Prior to February 3, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Redemption Terms on or after August 1, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024 | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0373413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount', window );">Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.3413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member', window );">Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear', window );">Number of payments in next fiscal year | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1', window );">Prepayment penalty, percent, year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2', window );">Prepayment penalty, percent, year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter', window );">Prepayment penalty, percent, year 3 and thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026 | Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="nump">$ 14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Balloon payment to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,049,230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,718,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2024 | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentBasisSpreadOneOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread One On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentBasisSpreadOneOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread Two On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt market price, per $1,000 principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 2</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of trading days in a settlement period for convertible debt conversion requests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_SettlementPeriodConvertibleDebtConversionRequest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=pcrx_FederalReserveBankOfNYRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=pcrx_FederalReserveBankOfNYRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsPriorToFebruary32023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsPriorToFebruary32023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822916714448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan B Facility Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 356,250<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(3,578)<span></span>
</td>
<td class="num">(4,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(8,953)<span></span>
</td>
<td class="num">(11,060)<span></span>
</td>
<td class="num">$ (11,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">343,719<span></span>
</td>
<td class="nump">359,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 747,870<span></span>
</td>
<td class="nump">1,049,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 402,500<span></span>
</td>
<td class="nump">402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(6,990)<span></span>
</td>
<td class="num">(7,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(64,718)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 395,510<span></span>
</td>
<td class="nump">330,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 157,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920315328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Schedule of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 9,343<span></span>
</td>
<td class="nump">$ 1,704<span></span>
</td>
<td class="nump">$ 26,724<span></span>
</td>
<td class="nump">$ 5,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">695<span></span>
</td>
<td class="nump">5,844<span></span>
</td>
<td class="nump">2,107<span></span>
</td>
<td class="nump">17,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 6)</a></td>
<td class="num">(1,085)<span></span>
</td>
<td class="num">(881)<span></span>
</td>
<td class="num">(2,852)<span></span>
</td>
<td class="num">(3,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total</a></td>
<td class="nump">$ 9,856<span></span>
</td>
<td class="nump">$ 7,333<span></span>
</td>
<td class="nump">$ 28,935<span></span>
</td>
<td class="nump">$ 21,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate on total debt (in percent)</a></td>
<td class="nump">5.42%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">5.66%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822916266848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($)<br> $ / shares in Units, $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="nump">$ 53.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share)</a></td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares', window );">Debt instrument, convertible, conversion premium (in shares)</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member', window );">Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">$ 15,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">5,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">34,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">343,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">395,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">8,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">343,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">399,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">8,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments</a></td>
<td class="nump">15,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">5,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">34,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Term Loan B Facility Due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2024 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Conversion Premium, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConvertibleConversionPremiumShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_TermLoanBFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822915902352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,259<span></span>
</td>
<td class="nump">$ 12,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Divestiture of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,642)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments', window );">Impairment</a></td>
<td class="num">$ (10,000)<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at September&#160;30, 2022</a></td>
<td class="nump">21,101<span></span>
</td>
<td class="nump">21,101<span></span>
</td>
<td class="nump">18,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,127<span></span>
</td>
<td class="nump">12,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,750<span></span>
</td>
<td class="nump">12,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Divestiture of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,642)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at September&#160;30, 2022</a></td>
<td class="nump">15,877<span></span>
</td>
<td class="nump">15,877<span></span>
</td>
<td class="nump">14,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember', window );">Convertible Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Investments Without Readily Determinable Fair Value Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">4,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Divestiture of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss', window );">Foreign currency adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at September&#160;30, 2022</a></td>
<td class="nump">$ 5,224<span></span>
</td>
<td class="nump">$ 5,224<span></span>
</td>
<td class="nump">$ 4,132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ConvertibleNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822922836608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 19, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments', window );">Impairment of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,394,000)<span></span>
</td>
<td class="num">$ (2,147,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_NumberOfMajorCustomers', window );">Number of major customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Amount of allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_TELABioMember', window );">TELA Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedLoss', window );">Equity securities, realized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember', window );">Flexion And MyoScience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">$ 425,500,000<span></span>
</td>
<td class="nump">46,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="nump">$ 45,200,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Contingent Consideration | Level 3 | Measurement Input, Discount Rate | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Contingent Consideration | Level 3 | Measurement Input, Probability of Success of Regulatory Milestones | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,000<span></span>
</td>
<td class="nump">$ 1,159,000<span></span>
</td>
<td class="nump">9,557,000<span></span>
</td>
<td class="nump">2,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Level 3 | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Level 3 | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,837,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_NumberOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of major customers of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_NumberOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_TELABioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_TELABioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAndMyoScienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920376384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details) - Fair Value, Inputs, Level 3 - Contingent Consideration<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Myoscience Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Flexion Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Flexion Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Myoscience Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Flexion Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Flexion Acquisition | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Myoscience Acquisition | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.1328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920126496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December&#160;31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments and accretion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at September&#160;30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822908285552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 238,010<span></span>
</td>
<td class="nump">$ 70,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,315)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">236,695<span></span>
</td>
<td class="nump">70,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentSecondaryCategorizationAxis=us-gaap_ShortTermInvestmentsMember', window );">Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">220,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">219,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">22,298<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(127)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">22,171<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">169,736<span></span>
</td>
<td class="nump">57,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">168,833<span></span>
</td>
<td class="nump">57,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds | Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">9,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">$ 10,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. federal agency bonds | Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">24,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">24,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. federal agency bonds | Noncurrent:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">17,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">17,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember', window );">U.S. government bonds | Current:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">2,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">$ 1,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentSecondaryCategorizationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentSecondaryCategorizationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentSecondaryCategorizationAxis=pcrx_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentSecondaryCategorizationAxis=pcrx_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822915915424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="nump">$ 756,636<span></span>
</td>
<td class="nump">$ 687,168<span></span>
</td>
<td class="nump">$ 730,408<span></span>
</td>
<td class="nump">$ 619,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">770,123<span></span>
</td>
<td class="nump">718,602<span></span>
</td>
<td class="nump">770,123<span></span>
</td>
<td class="nump">718,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized (loss) gain on investments, tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Net Unrealized (Loss) Gain From Available For Sale Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="num">(917)<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Unrealized Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="num">(605)<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on investments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="num">$ (670)<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="num">$ (670)<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822924499680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 12,682<span></span>
</td>
<td class="nump">$ 10,784<span></span>
</td>
<td class="nump">$ 35,415<span></span>
</td>
<td class="nump">$ 31,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Stock-based compensation from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_Compensationexpensefromstockoptionsemployees', window );">Stock options</a></td>
<td class="nump">6,711<span></span>
</td>
<td class="nump">6,458<span></span>
</td>
<td class="nump">20,038<span></span>
</td>
<td class="nump">19,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock units</a></td>
<td class="nump">5,758<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">14,588<span></span>
</td>
<td class="nump">11,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">789<span></span>
</td>
<td class="nump">685<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">12,682<span></span>
</td>
<td class="nump">10,784<span></span>
</td>
<td class="nump">35,415<span></span>
</td>
<td class="nump">31,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,599<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">4,429<span></span>
</td>
<td class="nump">4,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
<td class="nump">4,761<span></span>
</td>
<td class="nump">3,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="nump">$ 8,116<span></span>
</td>
<td class="nump">$ 26,225<span></span>
</td>
<td class="nump">$ 23,336<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation Expense From Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CompensationExpenseFromEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_Compensationexpensefromstockoptionsemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation expense from stock options (employee and board of director awards)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_Compensationexpensefromstockoptionsemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920106208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning of period (in shares) | shares</a></td>
<td class="nump">6,050,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,034,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(667,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(88,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="num">(24,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding end of period (in shares) | shares</a></td>
<td class="nump">6,303,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price (Per Share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 49.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">60.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">35.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">54.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share) | $ / shares</a></td>
<td class="nump">78.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 52.41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (shares) | shares</a></td>
<td class="nump">955,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">598,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares) | shares</a></td>
<td class="num">(323,821)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(68,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (shares) | shares</a></td>
<td class="nump">1,162,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value (Per Share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 52.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">60.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">50.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">55.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 57.38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911285024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>offeringPeriod </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease', window );">ESPP increase to shares allowed to be sold</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, ESPP (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Weighted average ESPP purchase options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of offering periods for ESPP | offeringPeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">ESPP purchasing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822919816048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Valuation Assumptions (Details) - Employee Stock Option<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">2.84%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">45.14%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822916661408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income&#8212;basic</a></td>
<td class="num">$ (693)<span></span>
</td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 26,011<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">ASU 2020-06 convertible notes if-converted method adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Adjusted net (loss) income&#8212;diluted</a></td>
<td class="num">$ (693)<span></span>
</td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 29,123<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">44,476<span></span>
</td>
<td class="nump">45,400<span></span>
</td>
<td class="nump">44,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of convertible debt securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">45,831<span></span>
</td>
<td class="nump">45,463<span></span>
</td>
<td class="nump">52,220<span></span>
</td>
<td class="nump">45,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Net (loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per common share (in USD per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per common share (in USD per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of convertible debt securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,608<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">1,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Weighted average ESPP purchase options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822915915312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">13,132<span></span>
</td>
<td class="nump">3,102<span></span>
</td>
<td class="nump">3,513<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Weighted average number of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">6,344<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="nump">1,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">5,608<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Weighted average number of RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">1,180<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Weighted average ESPP purchase options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822925542576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 9,230<span></span>
</td>
<td class="nump">$ 25,167<span></span>
</td>
<td class="nump">$ 39,610<span></span>
</td>
<td class="nump">$ 66,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(7,161)<span></span>
</td>
<td class="num">(936)<span></span>
</td>
<td class="num">(8,240)<span></span>
</td>
<td class="num">(4,360)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">24,231<span></span>
</td>
<td class="nump">31,370<span></span>
</td>
<td class="nump">62,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 2,762<span></span>
</td>
<td class="nump">$ 6,571<span></span>
</td>
<td class="nump">$ 5,359<span></span>
</td>
<td class="nump">$ 15,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (in percent)</a></td>
<td class="nump">133.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911229200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Severance-related expenses</a></td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">$ 4,259<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts', window );">Total acquisition-related charges</a></td>
<td class="nump">1,532<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
<td class="nump">10,162<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,394<span></span>
</td>
<td class="nump">2,147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther', window );">Total acquisition-related charges (gains) and other</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="num">(13,232)<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member', window );">Nuance Biotech Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Nuance Biotech Co. Ltd. agreement dissolution costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember', window );">Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(520)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,837)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(523)<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
<td class="num">(9,557)<span></span>
</td>
<td class="num">(2,147)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember', window );">Acquisition-related fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">951<span></span>
</td>
<td class="nump">4,918<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other acquisition expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 985<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition-Related Charges, Product Discontinuation, And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquisition And Integration Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_NuanceBiotechCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=pcrx_AcquisitionRelatedFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822920492480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION&#8211;RELATED CHARGES (GAINS) AND OTHER - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,394)<span></span>
</td>
<td class="num">$ (2,147)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member', window );">Nuance Biotech Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Estimated settlement fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="nump">$ 45,200<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember', window );">Flexion Acquisition | Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">10,200<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 9,557<span></span>
</td>
<td class="nump">$ 2,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=pcrx_LegalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=pcrx_LegalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822911127888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_FortisMember', window );">Fortis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember', window );">Hong Kong Pharma Tainuo Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember', window );">Hong Kong Pharma Tainuo Ltd. | Flexion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA', window );">Proceeds from development and commercialization of ZILRETTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum', window );">Maximum milestone payment to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Milestone Payments to be Received, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Development And Commercialization Of ZILRETTA</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_FortisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_FortisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_HongKongPharmaTainuoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pcrx_FlexionTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>pcrx-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pcrx="http://www.pacira.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pcrx-20220930.xsd" xlink:type="simple"/>
    <context id="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4cb9b12dd08b4498ad442b10cdd5b751_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ic44364ce38c044838833d136327e1683_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaf5db5136edb4258bb25992f7a708439_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i08b07e519ec647d98d89e6ff41f57c17_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i296396fbc9e84eba9ec04154af9e9c1e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5fa65067bcc41bebdf6822950026442_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad8f81f091924fc3a4edff3d54a6825d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i651ac2daa5d14c668a7fe9f65787fa0b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7048adc212324bc0b035c0020bd464ce_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd81ae54732c47849b986c561fdfa792_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2cbfb9a42fd243c890be52ee0d74fd8f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i66278c6f4cce4fd2ad08c5c059665f38_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i869d18b1d1484493b15aac75f097bce8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i01926f9c07cb4651b749c885c0a99ef8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i54aab0893c1f40f491d1e7a3b7a97718_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibc550af62b504ae58f1e161f47a65942_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1472000d14eb451bb7a3794aff155744_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib2c26ed78e9b4b63aed76cbf74cf8f4a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifba08fe64fae4c57bf8911a0904d2df9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i017393d821a848799eb138394bd7839e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib9287e79f6d44d568cf917866e4551b3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icd43125dbda74778b63a9be02be0a13c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9791b8fe7b3a4f12800eef3e3a5c6bf6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifdf819b6879b403cafbbce9b6339e7b0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1421c3f2c2d74fd99b18bfdda0e895a0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iae46cd944c6d419186595743d38a8f81_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa66a357a47d49b68b18893d24be3af3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if6d00233f14343878bcb73daec21f9e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7be9d002e9444fd18292f0d89d043d25_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e11e72269fb497ba643fca620eefeaf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic26efb05ce904daca36d5ba11271c6a9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7a219071ecbb42ac9eb93d05379e1467_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id1cb7d17f0c248e29e06df39baf41859_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic3e655fae2f146fc934fcf31ce6ec541_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7c1bd8c69f7453fb0c4b1269e35f69b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic05e3b6239474b029b08b6f0046dce35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ea53f33c63e42cfb873ac4aa0686769_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ca30657d70a4d3ab6e32635d54c30ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8275aa05c35d448d97c72eaa9bb0a095_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i680c262defe742b6a537fb5624221e69_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia35d775120e64ebf8502bf3e34c34978_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i33df00d3d4b243f9ad70111a564bd482_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedd0cb764acb47c09483deef5d55ead6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib213f4e105874831a0ebdb89ae27881e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10ac36a407c64570801dc9eeb4a4c82d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idad438652c2a484a8de75c3c8971bdef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib3de17f0c49946a488093a9951839714_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i40f13326d7884e5090d68f3d0a570ff2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b3530d8956b418fb81361eeb95b183f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i041c1e3222e444948ec64a03cb444a3e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if31c04f6a8b042bf8a5b262a586ee559_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f778c46a68241c395e54cb6cccc6e03_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iada9dd15075e4cd895a69a423bad73c7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id798a30004274993babf49e9b98be123_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2a7621b4bba342699674426138465e98_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i491f1c40eec747d48c2a3cbf996a653f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idea3269a015844a88e20bfa8a2c5db42_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib4d204d59893479994e548d189f110c0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0e8428c526394e7b892c82c1100eae05_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i785ba673e38b4971a09e28476d230f20_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i40d9bb0c3093491f8fd4cc029445495a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c2f2c9bc8c54a0298a54156ff906c36_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i81faa5db9ab84d9abcedc8d10f6aadd6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i35ee1fd141184820a1033d1e2b620500_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0dcf246ea00f4772961db833e7e6c9c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4cc07e896b4645dfa4efb71cc229b19c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i75e7ecfa4c964440a2946a9bd17bcb30_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if36a483a5fae482eabe15aad4726bdf2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iba56a5bf30fa44d791bf3d27fae3998c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ab43b03e7f045cfa6ba5b01ccc9f663_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a7066383d00444bb7d24779d5fcd386_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i144ecb23bdc84f3ca01452f1878c55ef_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i61b7f09cd3fa46f7bef2e7b988c8c155_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaced5e5f9bc940a892330f204dd2244f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie744a5ac2c014227987bdfeeacecae8c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if4b27bac4a4f40deae2b2f890f8e66b2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifbb8393abab9472ba432b3023d43f876_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3bec708640aa4fe89373e8a8b5097698_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie304082b6d1244319404c24adf4df95d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i54b382af13b04dad89a0b67e8cbed57b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:ZILRETTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ff9b5c1afd24751ac47466df9cf7363_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia0d71636ef1a41278d664b9a58e7b14a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d7b8f126963466480f241a2ea73cd74_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i22145e0671d24d3192e811839a75fcc6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i58db0d23a27d413abf5cf179a882a86e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i57ca564b922e4b24926c90284b7d52f5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i774694031232442bade01c3100051d55_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic9b6428ad6264377b5daa3a69ab1fb5e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:BupivacaineLiposomeInjectableSuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <context id="ifa17d6ce32084dc195161c9e6c47a57c_D20211119-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">pcrx:RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac35326c08e44e7cb67d82dcebbcba61_I20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-19</instant>
        </period>
    </context>
    <context id="i3ddfff3e82c24fcaa16748d8079315ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i083491131603445e901ef44a6b4db810_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea3422a161284fd4968428139893ccc3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8efbe146066f4b189710fe01037a4e39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01ba6850e6cf4817a5abb640bffde50e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iabadf7b6a1224bb3916ef669ce65a34d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if230c3c362c544bea9bc5d678fd8606c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id93a4a3f2486495096df65f35513637d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6aef198937e45468ba17175b8a02cbd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i69260eaa59884a4b80bee5f89c48b5ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if84837eb6c88478cb22b5e730913d7da_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1083fc7b3c5544e99ac79b620bd148fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5850959cee0b45c5999d3d9d0ee56a23_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i452f6f29fd7a4cefaf5db7fc6d5b7fcc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icaea5ef1bea14e64a8f9e557b76fefec_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifd5ea19425754b48a8d743a2a9a4c06f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2fb3d023787140b4a618c948c7de865a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i933d53b6705f4e2d828a014e7a4ef1cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if677311d787345c3a160575158dda8a6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if7c59933724e48839a86397a939f4299_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i7f168810ed0344c59194941cdbda381d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i29b1660ea8f84974983336799383b47d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc5538bd98f04aad8cfd55a06c19a09f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i63a4085601e44fbebf50e56e2d711b28_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6afb0c5544774a4eb8b7b594661ac03b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i80de923b605d461ca51c7f2b04879428_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b3b5083d5dd4003b0ab03be5387f445_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54f78b1e6ad44ec488026a91fa089205_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2518c182890b404d9c0847b899ec72e3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1806dce28b54192bab8601ab3c1447b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if14d12e11ebf4258a8f69637d5c05212_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2987275eeeb04ca68f16c4a37d3f4047_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83f1500ac81e40438b8cf99c85734a41_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2a9fe0493cf0469887c610902f910cc7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if98c89d2075848e490be94b7892ae381_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7972eed61fdd41bfa7003be5de760617_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id3bfdb577e5f40e2a1cc25683f97f802_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0661863911fa4ee69bffbcb43e697fc9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0e2c21af05a4477e9c7bb7850db493fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia67521500add4fed80583b1a16d61ffc_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5d7be76ce2e48f592161d85a4fefa90_I20211230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-30</instant>
        </period>
    </context>
    <context id="i25ab9cb4fb474f0294e6a5ee5da125cb_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9083b4c816cc413aa9ab5d4153e040e9_D20251231-20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="id5c3a50af1fd40f4bf123c711ae0554e_I20261207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-12-07</instant>
        </period>
    </context>
    <context id="i23248a32f20143cdb17ce6c0f3073d59_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib50e0fe6fa704b639d0ebd924808a630_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0685a2f4f2664048921f005c41b7445f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1ff7019c657c48dc88b1a004ea06e6c4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7a1f16b7c4a44c2f9845617ce7eb7a49_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifba3b8babde24b29a32cda10f955ab31_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pcrx:FederalReserveBankOfNYRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i87421aa4628142b0b44a3829fc1f2eca_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7e8761921961454aac57dbb378009c76_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i6e99e58b6bd44e40ab5470c217d31556_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i4512c74066e24feca38c2f9325150125_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsPriorToFebruary32023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i296d96d871454ea38915dae663029fed_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i96d9551dea4644c58fe6c52777f083d4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="ia37f7fd3e4cb4abda635243010c825e3_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="ia1cf140155284958b08b2b1f0924c732_D20211206-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="i7c781235586e428f8b7c97e2da13c07b_I20211206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-06</instant>
        </period>
    </context>
    <context id="i9637107d21ec4490b98079479563d736_I20220107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-07</instant>
        </period>
    </context>
    <context id="i0758a7b3ffcf4223ab706cc6d93df47d_D20170301-20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i95bfbbda29cb41b08ec5f11badc01723_D20170502-20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-02</startDate>
            <endDate>2017-05-02</endDate>
        </period>
    </context>
    <context id="i5680d8d8935c48d2a766d861284f7f24_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2c4eb1feab7a4455a8715a95b460650a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iad677feff1b3471c9fc3894136f1cb76_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if395814f8be54df8ae589815c8b5ea5f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i68b2cb6f7435421fb55a6eb4e5b93ba0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9990062454b491199857f28489640fe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if461dd01e8a747b98348bf5b481bc5ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic5390f0263e84d2991820ff5956b0b46_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:TermLoanBFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i73d52c9f53b64c98807e28bf9ce30a2b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i842c641ed23b47fbae6ff4979db04f5f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i237dd059fd944899a066705c4dd92003_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if76389ec090e4b37a494b0f226302069_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i04816a7095884e6e9859291f3a1985f6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id7032c8982294d0285e1776d6d06b048_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icd6c853b9ab94c81b8a41af53226deb3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b0c51b1b8584e129f7c49e3e49e3733_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6cf9551aa20b403f82af345d31ef1338_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7601e3ac14b4439db842e414e541e541_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9ff74a397bde40f0a00c0186334cb04b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3cd4e8e0384e49248615b7e238b8f37b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if45c48f822014fffa77939a3f9445eee_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ee79fc7c43e4c82a749f7a396f9b49a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if235f229d1e54baa9183a582add02676_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45972db0acf74f51a6a8fe893af05d41_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5c1875ee869245698fc37dffd27e30da_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ConvertibleNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7a2c111588354614880539cfc8ac9953_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pcrx:TELABioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib134093c2a3f489ab847df33ed43d3d9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib75b83d0d5d841d190c5b865d08cd08d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAndMyoScienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief0126ce4313418d8ce64bdcbb8482ca_I20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-19</instant>
        </period>
    </context>
    <context id="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <context id="ia6f13ce1ab564a898d9dac5545791a08_D20211119-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8f7942c168654d229d7c5f4bb6f53cff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if8692b80a10c4971a257a0b3f42d44bb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie699db1e7648442b83c51b5a1a49d064_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1b34aaa056564bd9be196339b6471fcc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i6c3e45d0874045948ab68adfba7d11f7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i29b825b5067840dc9cd04185cca37592_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iba4b68f7ebb74b26a54592d12d2be099_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ac8229fdddc4b69a07f14f03a89a3a3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie856966ca92d41f78bca76f98d68d66a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e57fefd18bb42ddbe9674fd60b5a57f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i06a2e05d68194f6d893829de561923ae_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id902659ce35844918702ed4963f48b60_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iab55c6e18cd7486e97de5fe845e97e9b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib6855240812b48478df36a10542449d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i56063439710147d8a4fccb6b50441d1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4218e46259cf49069b7aa7ce6e397e10_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia5cc90199d454f10b36d87b70479ee68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34b51ea16b9440a08b69736ae59a5c23_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i146ccf9c46794ec58b3fd078eac868ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i54ee273867e240459470219b08af7a1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i256e4a972f804ea4afc1c0c32264da1c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2f12bda689b34c1cb5adb0a61348d595_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5602cffde8af4cd59ea67824357bd7cf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie4ced79204c94980b9c38c4970517274_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i25002d007da945f7b1fd37b64ad6fbb5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i457f0d7ed7f3471fbea7fe35bd757052_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib20bc844b2ac4123acffb7c0cf235838_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0d61d593f234e0aab86db49aa1ab359_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentSecondaryCategorizationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44e9ad15636e471c976e2609f64d7dc1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibf48d4523ea34480aebe47808748c1a3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9fbc9b9c3e414c91b056f6e47ff38cff_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1b779e5e08f8409f8661541db1c36b0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea427b466be34ebbba3f1a1d2684ca8b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic94fe1291d1b4789b165b90d7885e3f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae887f18bb20483e8ff30cc6ed2e8c0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7211501c213a4e7599a5684dd5be37a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib82c2ca1fca444babc5bb300a97a1bc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fad952d06634849a67e5b1217dd68bf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id3320bc9569d4047a853e2db8903a804_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i97c19447cd504d5ab3f69d4b883be660_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8f98a360a3864c079bacf7afbc9066c7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1cc597a5032a411686eef62dd04fb5fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0138beec6b884dd68edbbf43f505701b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5a40479823647ddb96d0a3dbc1e6577_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i129b1978433c487181ff9a7d935fca2a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77aee1ee825a4993985deaa770a072c4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i34f003f3e1a84055b8f4cfecb523624c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iacde86a59c774f04b954ca896a5a70e2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i01e0f3d97cd74e64991c04f3f85804e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i000ca49114364850ace4c02275016d71_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i393b09d63da340a388d84a9a521340e9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i705ca31dbd8c46188969e5de6c1b9bec_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i025386fe742f4458ba40cf3c14ab73ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia380efcf48764d14911365055786a8c1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i97de2860387c4ebb9d4c67d302888d0c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23baf9eae53648b5862c179217f38259_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30c025fee8f64b4a80f4a122c03be02f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf9e30e4f3ae45789d654ae03283e68f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic0115f45cca34fe59169ae1673caf52a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if92e2ee8bc084934add5e4997216b20b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1d19f95d9c4e41ff8e7135be13df1713_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i34432db649744b62b15fef5547cddb1b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8d338010b91c405c9adcfebc639f8496_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9d47dbf4731e40a8817c9b98685f2fad_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iacd2ba2d5b0b4cbd856acd935fe9e469_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i485078b5973a4f38a864235574eace6d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i80aa21cf123146cfa48d76c6340c8f02_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d47a9c9bbe34e8a884b57b4a1b7c7d7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i751881f6186c4a20b2999971312c68ea_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia902e06002164005b91ff53bfc5574a6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i25ec2fd985f1484584f9e9321ebe8636_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i66cdb3b9475d440585c31ef8170080cd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica8d4ccba77d49c585c7d57451c690c9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i033a677bcf7842e8962e783e4ecdff17_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic925042152574d9896e5d11b213d65ef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0529b24441114da8aea1d86d3e46324d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i220fe9ca1ed949bdacf99f33c990cd98_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9c341f2698fe409ab358a241336259db_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f355a2653684c24b57b2f7c5f946633_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c1d51f4133f426395546e41d42a7bf2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20b9602474ee4df3a8cdbf721f6b53ec_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i999eddb8433c487184e9e575bd4a8c32_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i569b3dcd44504f2ebc2b67589ca1ef77_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i92a9bde52b5e4954a236c46394ef2fe1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie8d9d4db1ba04e1288564adf8e895b8c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia097c92a4047403d82b24978021270af_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib01b4d60757d4870804d497766e7943c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7925b0863c1647ce89e8613307298317_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9ddd46a4b60a416c94127599c856aa48_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2f95987401124116b24759ace715aa41_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09fc8460b9894b6cb2fb0b2e035270ae_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i095b5a48440040b98f786b561073678f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i24d0d73926a8453fbff3d3a2959a9f19_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i47e4065f3bf84a769793c677aa707755_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6952928bc30b45c094b9931501de819e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5e6b8329aab94b669b97bbc6cc18e60c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">pcrx:AcquisitionRelatedFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2090540004814f58aec0fe11cbfc0491_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2be6662b540d42b5b071db1e7701ffd5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb5ac33a93d943dfa41d95c7fbb2fa8c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie470b1ec9ebc496c8a8a2b82cee22927_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2c777abcf4b469ebafc9aa977f3f943_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4df205ee98b9479fa0df23571a4898df_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i20ec8193fb584c849fb512a1ebd30246_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie3ee845af90843f89f53ceeb7e4f835b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1904086f824643bbbbb99866420b64c8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icada30aef3ab4b739d33763eef827871_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ied8157b496ab44079fe9f2e4512f3b32_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i80fd88738e5c447e82122a8f75186048_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac64608b237d43f0a6a93d7bdccf7a88_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e41fa8486f34ea58ad7ceac10e1140e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pcrx:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i166df1f4bcd2446d844456bfb7f76005_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4fac746bbf294b19acb69210d7229116_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i17b1073570b241519f375ef761e56fc8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia28ed82e949f407abfcf436c06550157_I20200320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pcrx:FlexionTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="iea1a035c480c4e9cb20e78a99005a535_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:HongKongPharmaTainuoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="product">
        <measure>pcrx:product</measure>
    </unit>
    <unit id="segment">
        <measure>pcrx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>pcrx:lease</measure>
    </unit>
    <unit id="payment">
        <measure>pcrx:payment</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="customer">
        <measure>pcrx:customer</measure>
    </unit>
    <unit id="offeringperiod">
        <measure>pcrx:offeringPeriod</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN18zLTEtMS0xLTk4Njc0_2cd43b58-1367-4370-8bba-1594960846b1">0001396814</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN180LTEtMS0xLTk4Njc0_ceee02a5-5b68-4734-9c9e-7d9567cac98a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN182LTEtMS0xLTk4Njc0_b549eaef-c25b-488f-9d19-3bb3752df78a">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN183LTEtMS0xLTk4Njc0_5d82faad-9981-461d-b65f-052b6b848bd3">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80L2ZyYWc6OGM0OGFiMDRiOTFiNDE1NmFkZDI0ODBiZDQ1ZTk0ZjgvdGFibGU6NjI4M2JkYjZhODhlNDIzYTg2MzVjYTJkMmVlMGI1MjcvdGFibGVyYW5nZTo2MjgzYmRiNmE4OGU0MjNhODYzNWNhMmQyZWUwYjUyN184LTEtMS0xLTk4Njc0_4e8818bb-78e5-4d1d-a061-98d5a4791afe">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy0wLTEtMS05ODY3NA_6319c949-5d0c-4651-ba59-8ba255c6fe96">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006RetrospectiveMember</us-gaap:AccountingStandardsUpdateExtensibleList>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="i144ecb23bdc84f3ca01452f1878c55ef_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzMg_bfd25119-5362-4514-9063-c69b91c15797">P0D</pcrx:AccountsReceivablePaymentTerms>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i95bfbbda29cb41b08ec5f11badc01723_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjcz_65afcda3-91f0-4961-9bc1-f720a8bb37a3"
      unitRef="number">0.0373413</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <pcrx:DebtInstrumentMarketPrice
      contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjY2_a601101f-a4ca-4583-91ea-8c2435ea3e6b"
      unitRef="number">0.993</pcrx:DebtInstrumentMarketPrice>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i5680d8d8935c48d2a766d861284f7f24_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xMzQzL2ZyYWc6NDU2NWZkMzJiYTZiNDMwZjk5MzljYjU1NzRlYTc4ZDUvdGV4dHJlZ2lvbjo0NTY1ZmQzMmJhNmI0MzBmOTkzOWNiNTU3NGVhNzhkNV80Mzk4MDQ2NTExMjU2_8c426b83-c692-40ff-a051-71d0acb10bbc"
      unitRef="number">0.0139324</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV80Mzk4MDQ2NTEzMTk2_4ebfae74-1701-4742-81ef-f0ac018dfa79">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6ZDI4NzM2NzM0ZjNhNDllNjgzZTM5MmYzYTNkZjUxZWUvdGFibGVyYW5nZTpkMjg3MzY3MzRmM2E0OWU2ODNlMzkyZjNhM2RmNTFlZV8xLTAtMS0xLTk4Njc0_188dca1a-7d3a-4ffd-af13-8b72f0f38b4d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8xMjg_7f4ec577-00f1-4cb0-ac09-523060bb8a57">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6ZDMwZmI4MjE2NTUzNDI3NGI0N2EzOGEwZTFlOGY2ZjkvdGFibGVyYW5nZTpkMzBmYjgyMTY1NTM0Mjc0YjQ3YTM4YTBlMWU4ZjZmOV8wLTAtMS0xLTk4Njc0_c4636ab9-edaa-4d73-984f-a43a2b0c3328">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgy_49155740-2729-4892-bcae-05b3281639e4">001-35060</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgz_5dc58a88-74d9-4440-837b-535d5c26bd43">PACIRA BIOSCIENCES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MDM0YjhlNjMzMWFlNDM1ZGIxYTFiYzE0OTRjNmJmODcvdGFibGVyYW5nZTowMzRiOGU2MzMxYWU0MzVkYjFhMWJjMTQ5NGM2YmY4N18wLTAtMS0xLTk4Njc0_ecf82df8-44b1-4dbe-b33b-f5ed02a0f5e7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MDM0YjhlNjMzMWFlNDM1ZGIxYTFiYzE0OTRjNmJmODcvdGFibGVyYW5nZTowMzRiOGU2MzMxYWU0MzVkYjFhMWJjMTQ5NGM2YmY4N18wLTItMS0xLTk4Njc0_ca3b82b2-5e03-43b1-825a-6c2193e8722b">51-0619477</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg1_b2778b44-08a2-456c-a255-1fc0f41d2594">5401 West Kennedy Boulevard, Suite 890</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg2_e45bd0a9-d343-44aa-8d7c-e6dcc4fc0033">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc2_24cf679d-efc2-409c-9362-c7399a875829">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDcz_0ec6f867-7708-49c6-acfd-6cb4b41ee383">33609</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgw_5f05c899-31ab-45c6-b5dc-e500b9146aed">813</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc0_35dbfeae-68d5-4b59-9e69-7513519adb3a">553-6680</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTAtMS0xLTk4Njc0_eda39013-36a5-47c7-a78b-329bf15f366d">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTItMS0xLTk4Njc0_b268756e-dde8-462e-8f8c-96fbec0c7f88">PCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MTdiZWM3MmMyMDU3NDcwNThlYjBmOTE5YTY1NzQ0MWUvdGFibGVyYW5nZToxN2JlYzcyYzIwNTc0NzA1OGViMGY5MTlhNjU3NDQxZV8xLTQtMS0xLTk4Njc0_bb97cb5c-bb8f-4f93-831d-b0eeeacf22e3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDg0_295c65ca-4bc0-4727-88a8-08ec91a1f369">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDc3_e6efa9c2-87cd-4c26-959b-1c8bbdf3d97e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8wLTEtMS0xLTk4Njc0_0c07a61c-10d7-4169-8381-367a05c444a4">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8xLTUtMS0xLTk4Njc0_258339f7-c7e3-4bc3-8629-18298746971f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGFibGU6MGI2ZTAzZjQ2MDMxNGM4Yjg2ZWQwODBjZGY4NDliMzEvdGFibGVyYW5nZTowYjZlMDNmNDYwMzE0YzhiODZlZDA4MGNkZjg0OWIzMV8yLTUtMS0xLTk4Njc0_5a337e07-3424-4cf8-8b8c-7608649e761d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8yMDgx_cb3c7b46-1bec-4139-9832-3b061ac7c459">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i4cb9b12dd08b4498ad442b10cdd5b751_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xL2ZyYWc6MzhjMzYyNTdkNGFmNGMzODg0YTE2ODdmNGQ1ZjMzN2UvdGV4dHJlZ2lvbjozOGMzNjI1N2Q0YWY0YzM4ODRhMTY4N2Y0ZDVmMzM3ZV8xOTg1_17f783fe-adb6-4d1d-b8df-d4e45aeea7e0"
      unitRef="shares">45882088</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMy0xLTEtMS05ODY3NA_c71cedfe-ee49-4473-8cf7-99310d67f3bd"
      unitRef="usd">109424000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMy0zLTEtMS05ODY3NA_e9af60ab-c81b-47a3-ac7c-929248bd0560"
      unitRef="usd">585578000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNC0xLTEtMS05ODY3NA_efc8307b-1727-45bf-999b-8774565281d4"
      unitRef="usd">219301000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNC0zLTEtMS05ODY3NA_fc83da9b-9aac-41d0-9cf9-16f879eb7600"
      unitRef="usd">70831000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNS0xLTEtMS05ODY3NA_82fd73e6-3da8-4202-9913-ac79e835a0ff"
      unitRef="usd">93471000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNS0zLTEtMS05ODY3NA_29b06308-0af2-4a12-910d-7a17d395c605"
      unitRef="usd">96318000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNi0xLTEtMS05ODY3NA_4854d5cd-6fea-41e5-88da-e3116f559808"
      unitRef="usd">96799000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNi0zLTEtMS05ODY3NA_e7aef72e-e35d-4df2-8219-3c2743d55487"
      unitRef="usd">98550000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNy0xLTEtMS05ODY3NA_6df64da6-e1ca-48b0-acf4-de66d5c4bd31"
      unitRef="usd">14416000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNy0zLTEtMS05ODY3NA_9c3a9a36-b743-4a80-a6ba-048c6ddaea9f"
      unitRef="usd">14771000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOC0xLTEtMS05ODY3NA_12925e03-70f4-45df-94bb-e8cddb219509"
      unitRef="usd">533411000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOC0zLTEtMS05ODY3NA_cdfc279d-7673-480a-a988-5a2a03492a9d"
      unitRef="usd">866048000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOS0xLTEtMS05ODY3NA_fae7fcd5-be96-408f-a927-3bb630cb9134"
      unitRef="usd">17394000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfOS0zLTEtMS05ODY3NA_be543947-38db-4630-951a-e6afdcabc270"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTAtMS0xLTEtOTg2NzQ_7ecc2c6d-e70d-49c9-b7da-ab676495d12b"
      unitRef="usd">193646000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTAtMy0xLTEtOTg2NzQ_22ac3beb-7984-42b2-b5cf-94b36aed30df"
      unitRef="usd">188401000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTEtMS0xLTEtOTg2NzQ_ec90c284-d32c-4aa6-aef5-d75951004745"
      unitRef="usd">69662000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTEtMy0xLTEtOTg2NzQ_be93040c-2268-45db-99f7-c0eba2cdf224"
      unitRef="usd">76410000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTItMS0xLTEtOTg2NzQ_870c5155-5a55-4de6-8afa-cfb8881e7688"
      unitRef="usd">157361000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTItMy0xLTEtOTg2NzQ_884cb324-a4f0-45ca-b102-d3b5ac2d6d1e"
      unitRef="usd">145175000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTMtMS0xLTEtOTg2NzQ_880ef663-df53-4ebd-b6f1-1d1e12d09c78"
      unitRef="usd">581002000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTMtMy0xLTEtOTg2NzQ_2d2344c6-6ff6-4ff9-ad47-c1775a7b38e3"
      unitRef="usd">623968000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTQtMS0xLTEtOTg2NzQ_b794e3bb-4989-4bee-9e3c-e39bd9cffa93"
      unitRef="usd">155531000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTQtMy0xLTEtOTg2NzQ_be860b2e-45f8-4f42-a5b9-b57c5ac04be9"
      unitRef="usd">153364000</us-gaap:DeferredIncomeTaxAssetsNet>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTUtMS0xLTEtOTg2NzQ_940570d4-6479-4418-ae33-1c9dce48e902"
      unitRef="usd">26358000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTUtMy0xLTEtOTg2NzQ_ce4c9509-1532-4a83-94a4-4406396d7ae9"
      unitRef="usd">21987000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <us-gaap:Assets
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTYtMS0xLTEtOTg2NzQ_bbac4d92-3325-4e2d-8339-b04d921d9c68"
      unitRef="usd">1734365000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMTYtMy0xLTEtOTg2NzQ_e4706f6f-3e28-40f9-b1c6-5e733a8f678b"
      unitRef="usd">2075353000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjAtMS0xLTEtOTg2NzQ_def3d7d0-ab93-4445-b2f7-1b8b9e35956d"
      unitRef="usd">12933000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjAtMy0xLTEtOTg2NzQ_efe75cb4-34a5-4f08-92ec-f5187f1d8ad9"
      unitRef="usd">10543000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjEtMS0xLTEtOTg2NzQ_e0a4d985-4d5f-4210-bdaa-7bfc4ce779a0"
      unitRef="usd">76357000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjEtMy0xLTEtOTg2NzQ_55dbee0b-e95d-440d-9920-9e1f276019a8"
      unitRef="usd">127555000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjItMS0xLTEtOTg2NzQ_9eb61531-7f1a-44a6-87f2-6de8a3753f00"
      unitRef="usd">8364000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjItMy0xLTEtOTg2NzQ_737d9685-0206-4480-96f0-3659442e3288"
      unitRef="usd">7891000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMS0xLTEtOTg2NzQ_9bf36189-df6b-4795-83ec-4de92de99b5c"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMS0xLTEtOTg2NzQ_f2e16591-8ebf-4375-a95f-5d522fb18127"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMy0xLTEtOTg2NzQ_c065178b-da9c-4c40-852e-96f393620292"
      unitRef="usd">350466000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjMtMy0xLTEtOTg2NzQ_eb2de966-d2d0-4f14-8667-4bed5f3b1a40"
      unitRef="usd">350466000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjUtMS0xLTEtOTg2NzQ_390a8d46-f3a0-4f80-8fac-234db1d5d0ce"
      unitRef="usd">33872000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjUtMy0xLTEtOTg2NzQ_e3cdf087-4db1-41e2-a16c-4eebf67ef638"
      unitRef="usd">24234000</us-gaap:SecuredDebtCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjYtMS0xLTEtOTg2NzQ_30ab4a30-35c2-41c9-9ccf-54f025941f89"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjYtMy0xLTEtOTg2NzQ_eea548f3-52d9-479b-9584-ec39cfade03a"
      unitRef="usd">429000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjctMS0xLTEtOTg2NzQ_d44f7d9d-d427-4c10-905c-9696da9872db"
      unitRef="usd">131526000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjctMy0xLTEtOTg2NzQ_b2363186-6e40-4c75-82fc-ce1a1dc44770"
      unitRef="usd">521118000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjgtMS0xLTEtOTg2NzQ_60e6f9d3-7a75-4713-8cd8-daea7b08b30c"
      unitRef="usd">404151000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjgtMy0xLTEtOTg2NzQ_2ea60384-3a1c-4d91-83f0-3b326e59628f"
      unitRef="usd">339267000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjktMS0xLTEtOTg2NzQ_f06ed714-6717-4fb7-8dcb-5f1320565bbb"
      unitRef="usd">309848000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMjktMy0xLTEtOTg2NzQ_f4545005-d9eb-4d49-a207-52df0e9bbe02"
      unitRef="usd">335263000</us-gaap:SecuredLongTermDebt>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzAtMS0xLTEtOTg2NzQ_c6b7a3fa-a740-4592-995a-1ca642eafdc4"
      unitRef="usd">65401000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzAtMy0xLTEtOTg2NzQ_582c3ff2-1c70-491b-9d90-a2632e4a3700"
      unitRef="usd">71727000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzItMS0xLTEtOTg2NzQ_f0196aa5-566f-486b-8457-ac2a2f0ab134"
      unitRef="usd">34204000</pcrx:ContingentConsiderationNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzItMy0xLTEtOTg2NzQ_ce410278-bf8c-4500-a529-9cce341d6e1a"
      unitRef="usd">57598000</pcrx:ContingentConsiderationNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzMtMS0xLTEtOTg2NzQ_bd600ecc-ae91-4dee-863a-db109ea9aab3"
      unitRef="usd">19112000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzMtMy0xLTEtOTg2NzQ_2ba92397-de2e-48a9-a65d-7edfd6c7ecc3"
      unitRef="usd">19972000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzQtMS0xLTEtOTg2NzQ_e81b6c6d-00a9-4f20-a976-ae464615b3ae"
      unitRef="usd">964242000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzQtMy0xLTEtOTg2NzQ_229ee98c-089b-4796-9ec3-928aaac7cdd0"
      unitRef="usd">1344945000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzUtMS0xLTEtOTg2NzQ_43e7c82c-b79c-4afd-b107-a6d26cf5d166"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzUtMy0xLTEtOTg2NzQ_c8e8cda3-aca6-483f-b3f6-f4a40f09c521"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zMQ_546f60f0-6ab4-49bd-b7a2-a91909853604"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zMQ_ab292bdc-00ed-4c69-ae94-d7fded2ec334"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zNQ_4d959fae-8d3d-4ab4-84b6-e3b899168b71"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV8zNQ_f632aca4-548f-4343-8cdb-d4188ca9bab3"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_751bfd37-6dd5-4828-8f43-cbf266863332"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_ba2bbc4f-97d3-4bfa-ba42-640f2130a2c0"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_d126ea19-01bf-4cba-9f69-24f45687612f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjo4NDY5NmI2YjFlZDA0MWViYmEyODc4Yzc2N2FjYzkwOV81Nw_df5639b3-3a98-430c-8de0-9cd3d9e4e0c9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMS0xLTEtOTg2NzQ_8bfcf65d-e312-474f-8b59-4becc23bd677"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzctMy0xLTEtOTg2NzQ_a4b2a644-28ab-4bbc-98b7-6ecd3060bf8e"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8yOA_063ad3c6-1e4e-41ab-b1ce-70436c9d48bf"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8yOA_6f47748e-68a6-481c-85f7-0d0abdaf5f3f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8zMg_4b894b52-4538-4e4a-b10b-1b9cf4d04c8f"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF8zMg_f6f50fb9-c31a-4651-9674-530619c62721"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF81NA_95af870f-9d1e-417c-b3de-a17b157bd8bb"
      unitRef="shares">45864319</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF81NA_fae7ee35-79f3-4484-b01e-e654f9cfa3db"
      unitRef="shares">45864319</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF82MQ_d7268599-1113-4308-b7be-32794f6ce84d"
      unitRef="shares">44734308</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpmZDljOTQyYTU5NWE0YTExYTBkMjQ3NTQyNzY0ZTAxZF82MQ_f8d05e93-29ce-46af-bb34-5c4e04e681eb"
      unitRef="shares">44734308</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMS0xLTEtOTg2NzQ_97396be6-75f4-43d1-9fd6-5badf95e05b7"
      unitRef="usd">46000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzgtMy0xLTEtOTg2NzQ_14140ab2-2085-4741-b579-0ba37c9ced36"
      unitRef="usd">45000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzktMS0xLTEtOTg2NzQ_0a1849b9-eed5-453d-852a-ba85294f8caf"
      unitRef="usd">909396000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfMzktMy0xLTEtOTg2NzQ_a195295c-13a6-478a-aa18-775701296990"
      unitRef="usd">942091000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDAtMS0xLTEtOTg2NzQ_e0c1ffb0-d25a-4be9-975d-962342c04836"
      unitRef="usd">-138649000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDAtMy0xLTEtOTg2NzQ_708a1c2d-9e36-439b-8b7a-5ba0fe21f227"
      unitRef="usd">-211895000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDEtMS0xLTEtOTg2NzQ_1137743f-952f-4199-a220-291647090bcf"
      unitRef="usd">-670000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDEtMy0xLTEtOTg2NzQ_c854787b-99ee-4c40-bbbf-6c016c61f3ed"
      unitRef="usd">167000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDItMS0xLTEtOTg2NzQ_6fef2e32-976f-4ebc-b062-a11300cad361"
      unitRef="usd">770123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDItMy0xLTEtOTg2NzQ_c893d614-0ac6-4780-b9ba-a337975517d0"
      unitRef="usd">730408000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDMtMS0xLTEtOTg2NzQ_2640360a-a40b-4b2c-a41c-850bcdf2ab43"
      unitRef="usd">1734365000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xNi9mcmFnOjEwOWU5Mjk1ZTMwMjQ0NDE5Yzk2YjVkZTQxYjk0ZTZlL3RhYmxlOjE5YjRiYmEzNTA4MzRiNGI5NzRhYmM3MWJlMjJkYzdhL3RhYmxlcmFuZ2U6MTliNGJiYTM1MDgzNGI0Yjk3NGFiYzcxYmUyMmRjN2FfNDMtMy0xLTEtOTg2NzQ_74df8cab-e143-4196-8354-712af205fac0"
      unitRef="usd">2075353000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy0xLTEtMS05ODY3NA_027d2047-5a31-4a8d-a77d-7deaa9e152e2"
      unitRef="usd">166560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy0zLTEtMS05ODY3NA_4239ab9d-ebb7-4788-b3d5-1904058d1d1d"
      unitRef="usd">126791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy01LTEtMS05ODY3NA_6b5ea118-0be1-4325-bfb1-372190f60e21"
      unitRef="usd">492563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMy03LTEtMS05ODY3NA_9baafae7-baf0-4dc8-8cd1-4de9f174379c"
      unitRef="usd">380392000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08b07e519ec647d98d89e6ff41f57c17_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC0xLTEtMS05ODY3NA_20142d0b-f232-4fcc-b70b-9d5bdaa018c3"
      unitRef="usd">906000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i296396fbc9e84eba9ec04154af9e9c1e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC0zLTEtMS05ODY3NA_48b78d55-3fc2-4cc9-b9f9-939be1ab37ed"
      unitRef="usd">931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5fa65067bcc41bebdf6822950026442_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC01LTEtMS05ODY3NA_1d8e1f74-5c86-4094-8a2e-b316aa0045b5"
      unitRef="usd">2305000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad8f81f091924fc3a4edff3d54a6825d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNC03LTEtMS05ODY3NA_05ab593f-be82-4e13-9a21-bb63a0ee5c2c"
      unitRef="usd">1822000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i651ac2daa5d14c668a7fe9f65787fa0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS0xLTEtMS05ODY3NA_53816db3-e64e-4eb9-bcc7-b1409fcf862b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7048adc212324bc0b035c0020bd464ce_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS0zLTEtMS05ODY3NA_a16d69ab-1674-4092-9bc7-78f01ef71aff"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd81ae54732c47849b986c561fdfa792_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS01LTEtMS05ODY3NA_b1558919-b5cb-4f8e-abcf-936e8f45f206"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cbfb9a42fd243c890be52ee0d74fd8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNS03LTEtMS05ODY3NA_7872caf1-f629-44c9-8487-59bd478024a4"
      unitRef="usd">125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi0xLTEtMS05ODY3NA_219e94e5-723b-480e-82e1-1f8116cfb062"
      unitRef="usd">167466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi0zLTEtMS05ODY3NA_8ddee0aa-f6d2-4262-9891-887b1d9481e0"
      unitRef="usd">127722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi01LTEtMS05ODY3NA_7967caed-ae15-4a66-979e-a2d099fa3f80"
      unitRef="usd">494868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfNi03LTEtMS05ODY3NA_11f0fd00-f260-4400-8486-be0d20a43170"
      unitRef="usd">382339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC0xLTEtMS05ODY3NA_4205f4c3-b7f5-4872-971e-4ece3161d2e6"
      unitRef="usd">50678000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC0zLTEtMS05ODY3NA_b18c5928-be08-4643-b0f8-ffaf7078c74f"
      unitRef="usd">34651000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC01LTEtMS05ODY3NA_5dd31a18-3b95-4c1c-b468-1dee1b8999ac"
      unitRef="usd">137379000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOC03LTEtMS05ODY3NA_15d261cd-86b8-4f65-9f05-a1905ed2cf00"
      unitRef="usd">101248000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS0xLTEtMS05ODY3NA_26fe22a6-e021-4ad8-8f14-f31a688ef160"
      unitRef="usd">19405000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS0zLTEtMS05ODY3NA_981128a2-d9e2-4b0d-b6ec-de0c8c9deb1b"
      unitRef="usd">11578000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS01LTEtMS05ODY3NA_ac47759d-fcd2-4b0a-a671-d69c2a751fa7"
      unitRef="usd">67292000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfOS03LTEtMS05ODY3NA_b7c4e987-0cb1-4870-b9f5-8fe45acae4d5"
      unitRef="usd">40031000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtMS0xLTEtOTg2NzQ_8154ec35-fe70-4b79-b9bc-ecef3084bbcf"
      unitRef="usd">61283000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtMy0xLTEtOTg2NzQ_ab948910-0a0e-404c-a100-57dc4de76491"
      unitRef="usd">47856000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtNS0xLTEtOTg2NzQ_a77a8589-faad-48b8-a93d-655fb6112c9f"
      unitRef="usd">190546000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTAtNy0xLTEtOTg2NzQ_428876e5-017f-404f-aedd-c2a3921e961e"
      unitRef="usd">147191000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtMS0xLTEtOTg2NzQ_fc0b7f35-c39b-48b0-8f23-18e909d94319"
      unitRef="usd">14322000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtMy0xLTEtOTg2NzQ_8713f210-eeb8-4fed-ab52-1c2df4e714e7"
      unitRef="usd">1967000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtNS0xLTEtOTg2NzQ_bcafee84-195b-480e-9a03-3d4092154289"
      unitRef="usd">42966000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTEtNy0xLTEtOTg2NzQ_48e994b2-e4b8-4a08-82c6-ffef6915f7da"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItMS0xLTEtOTg2NzQ_dab47847-f352-4f85-9f9f-626b67df7162"
      unitRef="usd">-489000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItMy0xLTEtOTg2NzQ_e7f0f127-b522-4e0d-bdb5-908ddf4cb00e"
      unitRef="usd">-237000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItNS0xLTEtOTg2NzQ_66c79df4-d0bc-4a4d-947d-738b4b63d6c8"
      unitRef="usd">13232000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTItNy0xLTEtOTg2NzQ_013e5fdf-847e-471f-b256-a01f7f3124ee"
      unitRef="usd">-2256000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <us-gaap:CostsAndExpenses
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtMS0xLTEtOTg2NzQ_46936b31-e495-4cfc-9cfa-73be9d56bea8"
      unitRef="usd">146177000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtMy0xLTEtOTg2NzQ_faabd8bd-f5a7-4663-b638-7ee8b906a0e1"
      unitRef="usd">96289000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtNS0xLTEtOTg2NzQ_9918f075-9883-484c-b779-2f8e4085d706"
      unitRef="usd">424951000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTMtNy0xLTEtOTg2NzQ_8860e540-636d-4e28-ad7f-d40c036d5c01"
      unitRef="usd">296626000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtMS0xLTEtOTg2NzQ_58aaf121-17aa-448f-8b22-e8a04b6252a4"
      unitRef="usd">21289000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtMy0xLTEtOTg2NzQ_29e1eca0-7baf-4a8e-9832-8fb1fa3e85d8"
      unitRef="usd">31433000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtNS0xLTEtOTg2NzQ_0fe1924d-8569-41c1-a134-2eaeec5c4138"
      unitRef="usd">69917000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTQtNy0xLTEtOTg2NzQ_5e774dc4-fb4a-4793-8823-6c5bf62bfb0a"
      unitRef="usd">85713000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtMS0xLTEtOTg2NzQ_5cfdac29-5eea-4a72-80fd-eb515fa9dde6"
      unitRef="usd">1234000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtMy0xLTEtOTg2NzQ_acf01d4c-bcf5-43ad-9155-cdb28750f7cf"
      unitRef="usd">177000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtNS0xLTEtOTg2NzQ_fd305f2f-0b11-429e-b244-61c656ba933b"
      unitRef="usd">1757000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTYtNy0xLTEtOTg2NzQ_8dfd1e0c-af38-448e-b545-5d548bcea1df"
      unitRef="usd">816000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctMS0xLTEtOTg2NzQ_3fa3fb7c-aede-4c8f-9154-b1fc9e898dc2"
      unitRef="usd">9856000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctMy0xLTEtOTg2NzQ_65a44e65-e229-485a-a9e1-89101e7ba152"
      unitRef="usd">7333000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctNS0xLTEtOTg2NzQ_464622ab-74dd-449c-8f8f-32685e4496a0"
      unitRef="usd">28935000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTctNy0xLTEtOTg2NzQ_1612558c-a700-4f9c-bf78-02ccef48ab89"
      unitRef="usd">21327000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktMS0xLTEtOTg2NzQ_beba2856-878b-4e6d-9a4a-dc28e4c316cf"
      unitRef="usd">-10598000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktMy0xLTEtOTg2NzQ_f0a96f6b-dd24-4a40-9d2c-853ded3794e8"
      unitRef="usd">-46000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktNS0xLTEtOTg2NzQ_367f50cc-5f7a-4a99-9ec1-1d387080a23d"
      unitRef="usd">-11369000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMTktNy0xLTEtOTg2NzQ_a402d1d1-d300-496a-a9e8-19fe2dbe0a3e"
      unitRef="usd">-2600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtMS0xLTEtOTg2NzQ_0cdabb0f-ecee-4cfd-8a8f-0f5d1c98c866"
      unitRef="usd">-19220000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtMy0xLTEtOTg2NzQ_c882893b-c3d1-47c0-8b7b-1b2711538272"
      unitRef="usd">-7202000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtNS0xLTEtOTg2NzQ_03e76bb4-4b48-41de-88b1-a01fc2155877"
      unitRef="usd">-38547000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjAtNy0xLTEtOTg2NzQ_a57d55f8-177b-4053-bf5c-111662f4068c"
      unitRef="usd">-23111000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtMS0xLTEtOTg2NzQ_39d9839e-9d87-4d6e-a5cf-a101e9d202d0"
      unitRef="usd">2069000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtMy0xLTEtOTg2NzQ_638474c3-04d3-449a-bfe4-89a16028b021"
      unitRef="usd">24231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtNS0xLTEtOTg2NzQ_e3b71839-9a9d-4e80-ad49-5f912851df60"
      unitRef="usd">31370000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjEtNy0xLTEtOTg2NzQ_6b634c4a-ebcc-4a04-8aa3-f00ac5a876e5"
      unitRef="usd">62602000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItMS0xLTEtOTg2NzQ_f896e5f7-df3b-4760-acd9-dfe022ba7559"
      unitRef="usd">2762000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItMy0xLTEtOTg2NzQ_36f6c8db-c4ea-40bc-8f34-b56f0993c9dc"
      unitRef="usd">6571000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItNS0xLTEtOTg2NzQ_ec3180a1-0491-4d8b-b8df-40d0807d1363"
      unitRef="usd">5359000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjItNy0xLTEtOTg2NzQ_c787b57e-9a00-4433-9513-8ba62019efab"
      unitRef="usd">15492000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtMS0xLTEtOTg2NzQ_f48cc3a8-79e0-4de7-ada5-67044dfae48f"
      unitRef="usd">-693000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtMy0xLTEtOTg2NzQ_f4406619-ff2c-4bb6-be4f-f8668b9be63b"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtNS0xLTEtOTg2NzQ_ab980016-e6e4-42a6-a4a0-e131d31fcc28"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjMtNy0xLTEtOTg2NzQ_1bc06a1d-2d7e-41cb-8e2c-1a838b431bcb"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtMS0xLTEtOTg2NzQ_43ea56d1-d044-47cc-81a6-bb2a748b01f2"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtMy0xLTEtOTg2NzQ_5a5db082-4a01-41ee-a33b-c4ecc55423ca"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtNS0xLTEtOTg2NzQ_3bf2e61f-7940-4899-8b83-a8611f77a766"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjYtNy0xLTEtOTg2NzQ_546617d8-30ef-4bd6-bd0f-d67543772567"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctMS0xLTEtOTg2NzQ_f42ade57-c300-4577-92b8-b2606be0cade"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctMy0xLTEtOTg2NzQ_dc271691-78fb-4ae1-82c7-8c1d172041c7"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctNS0xLTEtOTg2NzQ_99ce4a82-6f88-4fc3-82df-5b8ba1c82e0d"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjctNy0xLTEtOTg2NzQ_8c70a7b4-676a-4389-b46e-21189242e088"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktMS0xLTEtOTg2NzQ_c6d91402-8b7e-4f9e-ab91-f7fb81f16c0e"
      unitRef="shares">45831000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktMy0xLTEtOTg2NzQ_27cabe97-a6dc-4ff2-8110-7299b555803b"
      unitRef="shares">44476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktNS0xLTEtOTg2NzQ_f2686cd9-e94e-4017-a2d1-46dc73377464"
      unitRef="shares">45400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMjktNy0xLTEtOTg2NzQ_17a6e6b6-ed03-4e85-baad-927da9ec59d9"
      unitRef="shares">44151000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtMS0xLTEtOTg2NzQ_6c96ab6f-b17a-47ae-93a4-77c54d54f656"
      unitRef="shares">45831000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtMy0xLTEtOTg2NzQ_3e3e0715-4a81-4437-adb8-03fdb85d5a55"
      unitRef="shares">45463000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtNS0xLTEtOTg2NzQ_b1825366-705e-4e1a-bfcd-cbc539b18706"
      unitRef="shares">52220000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8xOS9mcmFnOjJkMDkxMDYxNzlmNDRlOWViMDU2ZjEzN2RhZjJjZDZiL3RhYmxlOjNlODRjMDhjNjk2ZDQzMDI5MjU4YTk0NThjNTFlMzQyL3RhYmxlcmFuZ2U6M2U4NGMwOGM2OTZkNDMwMjkyNThhOTQ1OGM1MWUzNDJfMzAtNy0xLTEtOTg2NzQ_93417ea0-cf60-43a3-8efd-ffd6759713ba"
      unitRef="shares">45674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi0xLTEtMS05ODY3NA_f48cc3a8-79e0-4de7-ada5-67044dfae48f"
      unitRef="usd">-693000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi0zLTEtMS05ODY3NA_7082ea28-d75f-4608-92a5-5cb89eee3304"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi01LTEtMS05ODY3NA_ab980016-e6e4-42a6-a4a0-e131d31fcc28"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfMi03LTEtMS05ODY3NA_39c82f9d-678e-4e10-baaa-1dd1f1ba2b00"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC0xLTEtMS05ODY3NA_7db55b77-fcc5-4074-af4d-f8a5e0bc124c"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC0zLTEtMS05ODY3NA_00ac5cc0-0c55-4648-bbff-2caeb27ceb24"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC01LTEtMS05ODY3NA_ef4a3ebc-444e-4e40-8b3f-1f4a34a21e8c"
      unitRef="usd">-1056000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNC03LTEtMS05ODY3NA_801a4e53-19b1-47b4-a64e-065d65c1241e"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS0xLTEtMS05ODY3NA_277bd40f-6bdf-4c00-a1cb-72fa63e56913"
      unitRef="usd">98000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS0zLTEtMS05ODY3NA_1d33329a-6e23-4d01-9996-0dabc545d35e"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS01LTEtMS05ODY3NA_0fdc30c7-af27-4917-b57b-ff08af1da920"
      unitRef="usd">219000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNS03LTEtMS05ODY3NA_8f915f9f-9465-454a-99b3-acabd4723b30"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi0xLTEtMS05ODY3NA_61f65872-b638-40c3-aa1e-d059be0687ca"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi0zLTEtMS05ODY3NA_b613faf9-32d9-4d1f-985d-579c64ccee0e"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi01LTEtMS05ODY3NA_6c968823-67e1-44ed-a277-762f57683cf6"
      unitRef="usd">-837000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNi03LTEtMS05ODY3NA_447c7771-4612-477b-96a0-bc1913e273e9"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy0xLTEtMS05ODY3NA_f047dffa-f0ea-4b0f-a29b-6c835363e9e2"
      unitRef="usd">-758000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy0zLTEtMS05ODY3NA_61de0535-71c4-4504-a4b5-e5c84d84a475"
      unitRef="usd">17632000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy01LTEtMS05ODY3NA_88bda21a-74cb-4959-9d4e-9eccb7d64fa8"
      unitRef="usd">25174000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yMi9mcmFnOmRhOGM2ODYyOGY3MjQ0N2FhYmE5NjViOTA4YTE0NDA3L3RhYmxlOmNiMjQ5NzVkNTY5OTQzZGFhZGZmMGE4OWFjMDY1ZmU2L3RhYmxlcmFuZ2U6Y2IyNDk3NWQ1Njk5NDNkYWFkZmYwYTg5YWMwNjVmZTZfNy03LTEtMS05ODY3NA_a6c8ae83-e3e4-4d85-8193-6cb34377f25a"
      unitRef="usd">46945000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i66278c6f4cce4fd2ad08c5c059665f38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0xLTEtMS05ODY3NA_45561305-d797-4639-98f4-2f3c463b2eab"
      unitRef="shares">45802000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i66278c6f4cce4fd2ad08c5c059665f38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0zLTEtMS05ODY3NA_7f775008-7d04-48cb-a00d-01c344badea0"
      unitRef="usd">46000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i869d18b1d1484493b15aac75f097bce8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi01LTEtMS05ODY3NA_b3d74513-11d1-43e9-b107-df666dfa7e3d"
      unitRef="usd">895151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i01926f9c07cb4651b749c885c0a99ef8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi03LTEtMS05ODY3NA_44eea11b-2c9f-493a-8eca-5c13db702a35"
      unitRef="usd">-137956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54aab0893c1f40f491d1e7a3b7a97718_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi05LTEtMS05ODY3NA_73e089b2-93a7-44c6-bcad-060312968aec"
      unitRef="usd">-605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc550af62b504ae58f1e161f47a65942_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMi0xMS0xLTEtOTg2NzQ_142a8c7e-dbaf-45f8-a6f6-71131c0bf24c"
      unitRef="usd">756636000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0xLTEtMS05ODY3NA_edb14acf-c7fd-4ca6-9d75-462188887a33"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0zLTEtMS05ODY3NA_680ed419-a354-4c95-a560-08bfc557d554"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1472000d14eb451bb7a3794aff155744_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC01LTEtMS05ODY3NA_8b6e10ac-e77d-4319-841d-eba2761cbb94"
      unitRef="usd">1563000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNC0xMS0xLTEtOTg2NzQ_5b5a09ca-188a-47fb-aee6-cb2279e5d596"
      unitRef="usd">1563000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id08edb1413cb45ea9a869f11acdb376d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNS0xLTEtMS05ODY3NA_582d0ba7-3db2-4fba-bccb-646e091d9a47"
      unitRef="shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNS0xMS0xLTEtOTg2NzQ_0b1fac5b-24bd-4e85-82a0-1a1687c08a3e"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1472000d14eb451bb7a3794aff155744_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNy01LTEtMS05ODY3NA_5d485064-6e52-48eb-ac30-69a25880d519"
      unitRef="usd">12682000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfNy0xMS0xLTEtOTg2NzQ_bd6ee5dd-41f6-4234-bd7d-8f599268d0bf"
      unitRef="usd">12682000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib2c26ed78e9b4b63aed76cbf74cf8f4a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTEtOS0xLTEtOTg2NzQ_8b885208-d732-4695-8013-ea857f226b8e"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTEtMTEtMS0xLTk4Njc0_aa57b29a-ccc6-429f-a584-844937aa5873"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ifba08fe64fae4c57bf8911a0904d2df9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTItNy0xLTEtOTg2NzQ_7342213b-07c1-409f-b520-01527edc239b"
      unitRef="usd">-693000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTItMTEtMS0xLTk4Njc0_b77313ab-fa37-4bee-a9d4-abc9593f8982"
      unitRef="usd">-693000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i017393d821a848799eb138394bd7839e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMS0xLTEtOTg2NzQ_df9d97ff-d9c9-486b-b6bf-59a1b7f9d869"
      unitRef="shares">45864000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i017393d821a848799eb138394bd7839e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMy0xLTEtOTg2NzQ_1d1a0b87-21a2-4af8-b384-eca0b623e115"
      unitRef="usd">46000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtNS0xLTEtOTg2NzQ_da973955-bca2-459b-9706-937fb0561483"
      unitRef="usd">909396000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9287e79f6d44d568cf917866e4551b3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtNy0xLTEtOTg2NzQ_d952bd0c-5516-4d5c-85d2-bd6225c1204c"
      unitRef="usd">-138649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtOS0xLTEtOTg2NzQ_45ebfce5-3349-45c9-8f0d-055f2e462159"
      unitRef="usd">-670000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOmMwOTJjYzgwYmY1MDQ0NTA4NWE2ZDJmMjE2NjdhYjVjL3RhYmxlcmFuZ2U6YzA5MmNjODBiZjUwNDQ1MDg1YTZkMmYyMTY2N2FiNWNfMTMtMTEtMS0xLTk4Njc0_96530451-1eff-449e-a609-053e0a7a9ab5"
      unitRef="usd">770123000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="icd43125dbda74778b63a9be02be0a13c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0xLTEtMS05ODY3NA_275cad75-bea0-48c8-932a-bbd118cdb1dd"
      unitRef="shares">44437000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icd43125dbda74778b63a9be02be0a13c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0zLTEtMS05ODY3NA_b77584a0-70de-416b-bf13-c8b7279f1534"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9791b8fe7b3a4f12800eef3e3a5c6bf6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi01LTEtMS05ODY3NA_5ee1e3e0-422c-4ce0-9ea1-d04b1b7945fd"
      unitRef="usd">911368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdf819b6879b403cafbbce9b6339e7b0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi03LTEtMS05ODY3NA_fd319940-b6f4-422f-97dd-0cdfca1e7269"
      unitRef="usd">-224425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1421c3f2c2d74fd99b18bfdda0e895a0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi05LTEtMS05ODY3NA_f0bf62ec-f207-43aa-8b92-54e2da6b3f2d"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae46cd944c6d419186595743d38a8f81_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMi0xMS0xLTEtOTg2NzQ_697a9175-af7a-48a4-9159-6a21c7432068"
      unitRef="usd">687168000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0xLTEtMS05ODY3NA_4e0bcc61-07e6-4d04-9748-039124c17ace"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0zLTEtMS05ODY3NA_46e2be08-a740-432d-9378-becbb566273e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS01LTEtMS05ODY3NA_a9b6593d-7605-4da3-8827-4cd10354f023"
      unitRef="usd">3017000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNS0xMS0xLTEtOTg2NzQ_7c61a7e3-afae-437b-a80e-cc48233046c8"
      unitRef="usd">3018000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i18fe1f26eb3a4fb59e75ba0a09a1ce2b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNi0xLTEtMS05ODY3NA_4e5536b2-4371-4032-8ccc-b36655719a3c"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfNi0xMS0xLTEtOTg2NzQ_b796f9b7-2881-4c08-9346-acddca9c041c"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i71c802eb7a7f4ca08bfc6709d93d5f94_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfOC01LTEtMS05ODY3NA_e3200aa0-aad0-4785-9df4-b1fc1472e0a1"
      unitRef="usd">10784000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfOC0xMS0xLTEtOTg2NzQ_2933b380-7327-42f8-bd8a-bdfa31c3925f"
      unitRef="usd">10784000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaa66a357a47d49b68b18893d24be3af3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTItOS0xLTEtOTg2NzQ_667606ed-af36-482e-8424-6e25e21750ae"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTItMTEtMS0xLTk4Njc0_107ad3f0-a8ed-440f-8a18-4e2b1935a53d"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="if6d00233f14343878bcb73daec21f9e8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTMtNy0xLTEtOTg2NzQ_437c2db9-2b95-40a4-9bd9-a33a89c9a818"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTMtMTEtMS0xLTk4Njc0_0b0e7a2e-e02e-4dca-b72b-f51636d20fa7"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMS0xLTEtOTg2NzQ_d454f2bf-85f0-4cdd-84b4-42ccc1ff0334"
      unitRef="shares">44523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMy0xLTEtOTg2NzQ_fbedf440-3910-4024-9818-353a1ac24cad"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e11e72269fb497ba643fca620eefeaf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtNS0xLTEtOTg2NzQ_3a4e3b14-703e-4610-a311-80042d48ed90"
      unitRef="usd">925169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic26efb05ce904daca36d5ba11271c6a9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtNy0xLTEtOTg2NzQ_96c43ee7-4b28-4601-8538-5e11b5ccaaf1"
      unitRef="usd">-206765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtOS0xLTEtOTg2NzQ_78e4ca46-ae47-4763-b1b7-f5f7e748786a"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjAxZjk1NThjZjdiOTQ1ODliNTJhMjNiOTUzN2M3ZDZmL3RhYmxlcmFuZ2U6MDFmOTU1OGNmN2I5NDU4OWI1MmEyM2I5NTM3YzdkNmZfMTQtMTEtMS0xLTk4Njc0_f1d95c97-d275-4ddc-a3d5-46f2df37fd87"
      unitRef="usd">718602000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ic3e655fae2f146fc934fcf31ce6ec541_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0xLTEtMS05ODY3NA_fe211e78-29ba-4ab2-b805-3f8998050450"
      unitRef="shares">44734000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic3e655fae2f146fc934fcf31ce6ec541_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0zLTEtMS05ODY3NA_f8ab6cf7-fad5-4f24-8f45-fe0e49240218"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7c1bd8c69f7453fb0c4b1269e35f69b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi01LTEtMS05ODY3NA_bdaef836-a4d6-43c8-8355-321ea113a91a"
      unitRef="usd">942091000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic05e3b6239474b029b08b6f0046dce35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi03LTEtMS05ODY3NA_ea81fd5c-1f3a-4f4f-a797-33d4aeadbf68"
      unitRef="usd">-211895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi05LTEtMS05ODY3NA_9055d633-7b7f-42e8-a113-a3ef6d39be91"
      unitRef="usd">167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMi0xMS0xLTEtOTg2NzQ_178105d2-74bf-414e-b001-3a9178d996bd"
      unitRef="usd">730408000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3ea53f33c63e42cfb873ac4aa0686769_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy01LTEtMS05ODY3NA_84445427-a4fe-43f2-a660-201596f5ea05"
      unitRef="usd">-96468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ca30657d70a4d3ab6e32635d54c30ce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy03LTEtMS05ODY3NA_3e6a33df-0131-43fb-8dd5-2587d704332d"
      unitRef="usd">47235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8275aa05c35d448d97c72eaa9bb0a095_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMy0xMS0xLTEtOTg2NzQ_eee498f5-91e5-46c8-ac86-1cef868364c3"
      unitRef="usd">-49233000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0xLTEtMS05ODY3NA_463a8ae4-f25c-4535-afe1-3ac29ba7a447"
      unitRef="shares">667000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0zLTEtMS05ODY3NA_ddd774b3-a287-491c-a7fa-e5a4acc17335"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS01LTEtMS05ODY3NA_9f83ff0b-0510-4638-9243-4bce0a72a845"
      unitRef="usd">23497000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNS0xMS0xLTEtOTg2NzQ_f3f78f68-e200-4fce-96d7-ab6ee0516b8b"
      unitRef="usd">23498000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNi0xLTEtMS05ODY3NA_9bd42d6e-c624-4b30-9230-f52aa7c64ab9"
      unitRef="shares">324000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNi0xMS0xLTEtOTg2NzQ_6d1fd590-0671-42d7-83f5-5bf276a2387a"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy0xLTEtMS05ODY3NA_96d9fc1f-f45e-434b-b3f8-a4d66a38f575"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy01LTEtMS05ODY3NA_8033d59d-0c48-4a47-b3d7-6f1b007b5fe6"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfNy0xMS0xLTEtOTg2NzQ_85a2c102-2ebf-475a-8db1-5ff9d2518179"
      unitRef="usd">1821000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOC01LTEtMS05ODY3NA_ce55c182-019d-47fe-8aef-52ec9e634297"
      unitRef="usd">35415000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOC0xMS0xLTEtOTg2NzQ_06c4db17-8616-4628-b476-9ad28804d73c"
      unitRef="usd">35415000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i680c262defe742b6a537fb5624221e69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS0xLTEtMS05ODY3NA_4c5dd3f8-5940-450a-bb10-78e70ab83948"
      unitRef="shares">102000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i5e114f87c771424bb7810b107f6a7f40_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS01LTEtMS05ODY3NA_6baa2190-8861-4776-81c9-a281b514db45"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfOS0xMS0xLTEtOTg2NzQ_a0850176-597d-4865-b8e8-41ec3fafc1e7"
      unitRef="usd">3040000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTItOS0xLTEtOTg2NzQ_055481b6-d5b2-46af-93c0-aeb5ca17dd4b"
      unitRef="usd">-837000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTItMTEtMS0xLTk4Njc0_fb45f5bd-fb22-42f8-a2fc-7ed63febe50d"
      unitRef="usd">-837000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ia35d775120e64ebf8502bf3e34c34978_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTMtNy0xLTEtOTg2NzQ_4b6a0732-c661-47de-8ada-d8bc5f2de645"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTMtMTEtMS0xLTk4Njc0_38fa309b-b344-467d-a249-8a5ebadf0d6e"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i017393d821a848799eb138394bd7839e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMS0xLTEtOTg2NzQ_d0ed6c03-de4d-4924-ae36-cd65047e5855"
      unitRef="shares">45864000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i017393d821a848799eb138394bd7839e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMy0xLTEtOTg2NzQ_9440f5ab-f0c5-4fac-a306-4b2bad464048"
      unitRef="usd">46000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71b5ed4c9c8f472f8bc832211e2ca9da_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtNS0xLTEtOTg2NzQ_f389adbc-0be3-40c1-924d-38825eaf5f26"
      unitRef="usd">909396000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9287e79f6d44d568cf917866e4551b3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtNy0xLTEtOTg2NzQ_ce9d709d-954f-4784-8eef-bbed72623fe5"
      unitRef="usd">-138649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtOS0xLTEtOTg2NzQ_7e86cfa2-42c4-4a0e-b978-d024d6ce1a09"
      unitRef="usd">-670000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjcxZWU2ZmM5MDNmMTQxZmY4MTU3MzU2M2M2MjE4ODZkL3RhYmxlcmFuZ2U6NzFlZTZmYzkwM2YxNDFmZjgxNTczNTYzYzYyMTg4NmRfMTQtMTEtMS0xLTk4Njc0_082446ee-d6fa-411f-bf8c-75c72d2cfe92"
      unitRef="usd">770123000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i33df00d3d4b243f9ad70111a564bd482_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0xLTEtMS05ODY3NA_6a708071-3034-4859-bf23-faa9d8ccad63"
      unitRef="shares">43637000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i33df00d3d4b243f9ad70111a564bd482_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0zLTEtMS05ODY3NA_3e4c0564-0472-4bb6-afcd-2983f76a8d54"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iedd0cb764acb47c09483deef5d55ead6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi01LTEtMS05ODY3NA_08f22ddc-c24d-42c9-8fc9-2f88c9eb24a5"
      unitRef="usd">873201000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib213f4e105874831a0ebdb89ae27881e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi03LTEtMS05ODY3NA_c80662f2-bd89-4e64-a521-aa6740a8fb99"
      unitRef="usd">-253875000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10ac36a407c64570801dc9eeb4a4c82d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi05LTEtMS05ODY3NA_436566be-18f3-4776-b7e9-38cbd9e5e209"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMi0xMS0xLTEtOTg2NzQ_7578b526-cd9c-43b9-a1d1-e2d586ba4ad1"
      unitRef="usd">619688000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0xLTEtMS05ODY3NA_18b8f1df-ae1a-46ba-9c62-5f184ab15955"
      unitRef="shares">553000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0zLTEtMS05ODY3NA_3e95bfbd-f339-4a8e-9e73-59abaf25053e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS01LTEtMS05ODY3NA_3ff60c96-0dff-4052-87c0-2653e538f2ee"
      unitRef="usd">19038000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNS0xMS0xLTEtOTg2NzQ_dfae0da0-5d9e-475e-a44b-7e80ebc27311"
      unitRef="usd">19039000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNi0xLTEtMS05ODY3NA_b8c42b0f-ed73-46e7-b3dc-71bae0f4cbb5"
      unitRef="shares">302000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNi0xMS0xLTEtOTg2NzQ_39de2c73-e5a1-4e38-950e-5ed37402a0ed"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i56972a5601f94b26a9156a919f19b57a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy0xLTEtMS05ODY3NA_d2d18960-528a-4791-9e2f-66c0efb31384"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy01LTEtMS05ODY3NA_0ea78e07-4725-4d1d-8834-a1a8c68bb7f0"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfNy0xMS0xLTEtOTg2NzQ_6f540176-83cf-4775-a8ff-305fe4c2d4ad"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib3de17f0c49946a488093a9951839714_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfOC01LTEtMS05ODY3NA_3d4af7bd-0714-4f00-89e8-1ac491e1371c"
      unitRef="usd">31356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfOC0xMS0xLTEtOTg2NzQ_164d6d2f-6f3f-4a41-848a-e88f4399ed86"
      unitRef="usd">31356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTItOS0xLTEtOTg2NzQ_3ec603d1-4bbd-48e5-b520-661c7cafe8a8"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTItMTEtMS0xLTk4Njc0_7666d12c-67a1-4f10-babe-e7cf44301f54"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i40f13326d7884e5090d68f3d0a570ff2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTMtNy0xLTEtOTg2NzQ_0ea97f98-8e34-4f4b-910c-bc82ec657e78"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTMtMTEtMS0xLTk4Njc0_27fb74d0-a5ef-45bd-a28d-304f0d288fbc"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMS0xLTEtOTg2NzQ_f8092483-2958-47fb-b948-3460b6ace718"
      unitRef="shares">44523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7be9d002e9444fd18292f0d89d043d25_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMy0xLTEtOTg2NzQ_22456cce-98d2-4db3-8b71-12b93b3a1b3c"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e11e72269fb497ba643fca620eefeaf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtNS0xLTEtOTg2NzQ_f7cc36a7-d817-4794-add1-2f2c4d8f2e38"
      unitRef="usd">925169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic26efb05ce904daca36d5ba11271c6a9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtNy0xLTEtOTg2NzQ_253f7a17-3a50-42c0-ae84-3b800ba2ad5c"
      unitRef="usd">-206765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtOS0xLTEtOTg2NzQ_4fd6ebfb-f0db-4b3c-a873-c6505bb16b18"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yNS9mcmFnOjZhZmY3NGVlMjQ0ZDQxOTZhYWQwZTJjYTZlMTM2Y2ZlL3RhYmxlOjIwZmQwMWVkMTVkYTQzMDliYjBiYzA3NWZhMWYzMGFmL3RhYmxlcmFuZ2U6MjBmZDAxZWQxNWRhNDMwOWJiMGJjMDc1ZmExZjMwYWZfMTQtMTEtMS0xLTk4Njc0_9f251368-8854-4529-80d7-4aac1abbc781"
      unitRef="usd">718602000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMy0xLTEtMS05ODY3NA_598976c1-da3c-4529-84d4-da995271b516"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMy0zLTEtMS05ODY3NA_7512137c-72a0-4628-811d-ec00122cad8a"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNS0xLTEtMS05ODY3NA_9c0619a6-530b-46c3-a2e9-5dc52569012b"
      unitRef="usd">2895000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNS0zLTEtMS05ODY3NA_1a51c2c4-7204-4bbc-933e-e1f8036d532d"
      unitRef="usd">12953000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNi0xLTEtMS05ODY3NA_6fe7b167-2f77-4ede-ac5f-284adbd3f28d"
      unitRef="usd">61095000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNi0zLTEtMS05ODY3NA_f5604445-9f7f-4bdc-9f7d-9f3b107f701f"
      unitRef="usd">15478000</us-gaap:DepreciationDepletionAndAmortization>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNy0xLTEtMS05ODY3NA_98ae40db-ef19-41d8-a226-02d7388ec794"
      unitRef="usd">2957000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNy0zLTEtMS05ODY3NA_a26d384c-d459-492a-94c9-d79abecdfaf6"
      unitRef="usd">1976000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfOC0xLTEtMS05ODY3NA_28f6986e-75af-457f-bed3-b4b424aec851"
      unitRef="usd">2107000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfOC0zLTEtMS05ODY3NA_4856ca8a-fe12-48d0-839e-7421a41a5a09"
      unitRef="usd">17245000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTAtMS0xLTEtOTg2NzQ_c6d951fe-65b9-4d06-825a-31493f0fb387"
      unitRef="usd">-193000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTAtMy0xLTEtOTg2NzQ_f0480c2d-70f5-49a8-a8d6-73acc647ed9d"
      unitRef="usd">10000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTEtMS0xLTEtOTg2NzQ_27d2f5a7-b2f1-40c9-b5d5-ee0440da8dfd"
      unitRef="usd">35415000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTEtMy0xLTEtOTg2NzQ_2631c74f-db29-4612-88b8-201b06c4582d"
      unitRef="usd">31356000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTItMS0xLTEtOTg2NzQ_3bc3155f-7765-4633-a5af-a8bfd38b6752"
      unitRef="usd">-23394000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTItMy0xLTEtOTg2NzQ_e7115382-4faa-4b6e-b269-305ac13aedc7"
      unitRef="usd">-2147000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMS0xLTEtMTA0ODM5_0de0fd8f-45e4-4364-8d34-1928623bc536"
      unitRef="usd">10000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMy0xLTEtMTA0ODM5_6692d603-0070-481b-8b27-e1084a0bbf5f"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMS0xLTEtOTg2NzQ_3f03b561-a3cd-481a-8605-54312941d1af"
      unitRef="usd">184000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTMtMy0xLTEtOTg2NzQ_c67759ed-dee8-4615-846d-98c542a21af9"
      unitRef="usd">2641000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTUtMS0xLTEtOTg2NzQ_4263eea1-a2c0-42b8-855e-5632437fdcb3"
      unitRef="usd">-2847000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTUtMy0xLTEtOTg2NzQ_b6d479a2-3852-42c7-b663-eecc1df47d73"
      unitRef="usd">-3070000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTYtMS0xLTEtOTg2NzQ_ad564d06-55e2-4723-aa9f-ed631f94ab63"
      unitRef="usd">-1751000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTYtMy0xLTEtOTg2NzQ_4641ccdf-816e-4b73-af8e-db217dd0f3bc"
      unitRef="usd">2560000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTctMS0xLTEtOTg2NzQ_a7067d85-1ec1-43cd-b6b1-73f9635525ee"
      unitRef="usd">568000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTctMy0xLTEtOTg2NzQ_99972266-978a-4ca9-985c-fd800da7b01c"
      unitRef="usd">-907000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTgtMS0xLTEtOTg2NzQ_b3e300ce-3595-4ed2-906c-b3bf1718bcb7"
      unitRef="usd">4681000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTgtMy0xLTEtOTg2NzQ_1d20b32a-ee3a-4b59-b022-ad26c2f7724d"
      unitRef="usd">-825000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTktMS0xLTEtOTg2NzQ_c4c47a7c-bea1-471f-8ff1-441d226fcf1b"
      unitRef="usd">-23560000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMTktMy0xLTEtOTg2NzQ_a0ac9647-df89-43e9-8105-cd80dde3473e"
      unitRef="usd">-17034000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:GainLossOnInvestments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjAtMS0xLTEtOTg2NzQ_6dd45daa-f81a-446b-b956-0da2ae65f6b2"
      unitRef="usd">-623000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjAtMy0xLTEtOTg2NzQ_79085b06-3fdd-41fe-88a3-b9d8bc37eb25"
      unitRef="usd">1996000</us-gaap:GainLossOnInvestments>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjEtMS0xLTEtOTg2NzQ_a1ca4f12-2ee5-476e-beab-df2d42bee3bc"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjEtMy0xLTEtOTg2NzQ_cb162ed1-8c0d-4256-99dc-be871915961f"
      unitRef="usd">5662000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjItMS0xLTEtOTg2NzQ_e6811549-a38b-4a2f-8a77-f75d79069444"
      unitRef="usd">103237000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjItMy0xLTEtOTg2NzQ_01352289-1065-4508-8738-5fa294982138"
      unitRef="usd">102502000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjUtMS0xLTEtOTg2NzQ_670e5c79-e88f-4cf9-bdcb-b7929b87f584"
      unitRef="usd">24584000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjUtMy0xLTEtOTg2NzQ_149f7b1f-0719-406c-9bc6-01b135889d45"
      unitRef="usd">36700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjYtMS0xLTEtOTg2NzQ_edfa3c0d-4936-4596-be03-853108b0d2d2"
      unitRef="usd">319426000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjYtMy0xLTEtOTg2NzQ_75fea244-75f2-40c9-9a55-5966bcfc4b30"
      unitRef="usd">513492000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjctMS0xLTEtOTg2NzQ_541ac4f5-39fd-432a-bf66-4fcb1164282d"
      unitRef="usd">152636000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjctMy0xLTEtOTg2NzQ_7ac3bc16-1ec7-417e-bf6b-328a802d9666"
      unitRef="usd">470614000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <pcrx:PaymentOfContingentConsideration
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjgtMS0xLTEtOTg2NzQ_dfb9b2f8-7252-43a0-856d-4ca824e99ed8"
      unitRef="usd">32000000</pcrx:PaymentOfContingentConsideration>
    <pcrx:PaymentOfContingentConsideration
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjgtMy0xLTEtOTg2NzQ_19ce2cb5-f7b6-443d-9988-4432e07d510e"
      unitRef="usd">0</pcrx:PaymentOfContingentConsideration>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjktMS0xLTEtOTg2NzQ_827bee79-d549-4ad9-8329-5cb4073bfb2c"
      unitRef="usd">13000000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMjktMy0xLTEtOTg2NzQ_711d3e3a-7515-4c0e-a619-cbb5cda5c7b7"
      unitRef="usd">17187000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzAtMS0xLTEtOTg2NzQ_644f46ca-d7cb-4c29-b5d3-24c91490cc3d"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzAtMy0xLTEtOTg2NzQ_a1918b01-2b73-4558-bd19-1b92def82e61"
      unitRef="usd">9057000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzItMS0xLTEtOTg2NzQ_15b60e0b-bda9-4b53-ab13-6d3726bcfbe9"
      unitRef="usd">-236374000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzItMy0xLTEtOTg2NzQ_2e7bca36-8dca-49db-947a-9dd48fb57b18"
      unitRef="usd">-87708000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzQtMS0xLTEtOTg2NzQ_cf3b01ed-4b09-4021-a656-3bc8cb9933a5"
      unitRef="usd">23482000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzQtMy0xLTEtOTg2NzQ_c7325d77-d8a9-4faf-b459-7b804e9f20a7"
      unitRef="usd">19049000</us-gaap:ProceedsFromStockOptionsExercised>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzUtMS0xLTEtOTg2NzQ_ebce0725-a7d8-4b65-be6f-d25a396f1c46"
      unitRef="usd">1820000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzUtMy0xLTEtOTg2NzQ_dce60bf0-43d9-4b53-9641-b7a214a2c28c"
      unitRef="usd">1574000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i5b3530d8956b418fb81361eeb95b183f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzgtMS0xLTEtOTg2NzQ_f7f220ec-37ba-431f-ac1e-e416cd7fccc6"
      unitRef="usd">156960000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i041c1e3222e444948ec64a03cb444a3e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzgtMy0xLTEtOTg2NzQ_f2b8f70d-a496-4193-99a3-b6e9b3094e47"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="if31c04f6a8b042bf8a5b262a586ee559_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzktMS0xLTEtOTg2NzQ_40f4b23e-e01c-40e8-9db3-b4f0f61829ce"
      unitRef="usd">192609000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i9f778c46a68241c395e54cb6cccc6e03_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfMzktMy0xLTEtOTg2NzQ_f0be64cf-c594-482c-a3a9-1f2af6dfa9bf"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDAtMS0xLTEtOTg2NzQ_ed0adfcc-b069-47cf-9a21-d77450f14bc0"
      unitRef="usd">18750000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDAtMy0xLTEtOTg2NzQ_b8b9aa30-f8f0-4940-b6b3-484693b98c4c"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDQtMS0xLTEtOTg2NzQ_2152d6fb-decc-4d43-8ab0-04c11443ec87"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDQtMy0xLTEtOTg2NzQ_edcaafe5-84a8-4e99-8fa0-42c8c2bb38a1"
      unitRef="usd">1338000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDUtMS0xLTEtOTg2NzQ_435237b7-2871-4fa8-85be-705c754b9da3"
      unitRef="usd">-343017000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDUtMy0xLTEtOTg2NzQ_4e7aae26-36b9-4b51-91ee-a35c475508b5"
      unitRef="usd">19285000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDYtMS0xLTEtOTg2NzQ_3cca62ad-e9ee-42e7-9fda-eef5ba193c62"
      unitRef="usd">-476154000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDYtMy0xLTEtOTg2NzQ_99f4363b-3951-416a-9d3d-1f138767d6b0"
      unitRef="usd">34079000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDctMS0xLTEtOTg2NzQ_30d257eb-94ed-43c8-85a4-c2edff5deb79"
      unitRef="usd">585578000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDctMy0xLTEtOTg2NzQ_f5b7efbf-1b8b-4e5e-aff3-0ffc909b9ee1"
      unitRef="usd">99957000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDgtMS0xLTEtOTg2NzQ_186fada9-ac95-4006-b39d-187baa3ceae4"
      unitRef="usd">109424000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNDgtMy0xLTEtOTg2NzQ_8505d55f-9e13-431b-9922-56ceeb3097f9"
      unitRef="usd">134036000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTUtMS0xLTEtOTg2NzQ_a4e8bcb3-5f39-47af-89ac-01169b78ce49"
      unitRef="usd">23620000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTUtMy0xLTEtOTg2NzQ_9c784ce8-f730-4782-908c-6564dbf2fd4d"
      unitRef="usd">5096000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTYtMS0xLTEtOTg2NzQ_5323232f-6814-449f-bd60-10cea72b6673"
      unitRef="usd">4216000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTYtMy0xLTEtOTg2NzQ_40dc73b9-a3df-4ee5-bbc4-d90c4a896916"
      unitRef="usd">2259000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTgtMS0xLTEtOTg2NzQ_ea0079b5-5393-4a42-9152-c136cf7d67df"
      unitRef="usd">3040000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNTgtMy0xLTEtOTg2NzQ_935ac6cc-30d6-40ac-b4c9-36a3bfa685fb"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNjItMS0xLTEtOTg2NzQ_8af82c68-8224-4b43-8256-f17dc1903547"
      unitRef="usd">5486000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8yOC9mcmFnOjhiZmZhNzgxMmVlMTQzMDU5MmY2Mzg4N2M2OGM3YWQxL3RhYmxlOmM2OGRkZDNiOWEyYzQ5YjFhZGMxZmJkNWJlNjIyMDFiL3RhYmxlcmFuZ2U6YzY4ZGRkM2I5YTJjNDliMWFkYzFmYmQ1YmU2MjIwMWJfNjItMy0xLTEtOTg2NzQ_88bc4cd4-0ddb-43ad-83c2-9e164a2fc3e7"
      unitRef="usd">4719000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfNDIxMw_925f9c80-c50e-4df2-a02d-47c5f5259e89">DESCRIPTION OF BUSINESS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#x201c;Company&#x201d; or &#x201c;Pacira&#x201d;) is the industry leader in its commitment to non-opioid pain management and providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The Company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain and spasticity. The Company&#x2019;s long-acting, local analgesic, EXPAREL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(bupivacaine liposome injectable suspension), was commercially launched in the United States, or U.S., in April 2012 and approved in select European countries and the United Kingdom, or U.K. in November 2021. EXPAREL utilizes the Company&#x2019;s proprietary multivesicular liposome drug delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In November 2021, the Company acquired Flexion Therapeutics, Inc., or Flexion, and added ZILRETTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (triamcinolone acetonide extended-release injectable suspension) to its product portfolio. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of osteoarthritis, or OA, knee pain. For more information, see Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In April 2019, the Company added iovera&#xb0;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience (the &#x201c;MyoScience Acquisition&#x201d;). The iovera&#xb0; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to targeted nerves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from three products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Coronavirus (COVID-19) Pandemic and Global Economic Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since early 2020, the Company&#x2019;s revenues have been impacted by COVID-19 pandemic-related challenges that included the significant postponement or suspension in the scheduling of elective surgical procedures due to public health guidance and government directives. While the degree of impact has diminished during the course of the pandemic due to the introduction of vaccines and therapeutics, as well as the lessening of elective surgery restrictions, certain pandemic-related operational and staffing challenges persist. It remains unclear how long it will take the elective surgery market to normalize or if restrictions on elective procedures will recur due to future COVID-19 variants or otherwise. Direct effects of the pandemic and global economic conditions may negatively impact the Company&#x2019;s business, financial condition and results of operations. Such impacts may include the effect of prolonged periods of inflation on the Company&#x2019;s customers and suppliers and longer lead-times or the inability to secure a sufficient supply of materials. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <pcrx:ConcentrationRiskNumberOfProducts
      contextRef="iada9dd15075e4cd895a69a423bad73c7_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfMTg3Mw_d290964a-15a2-411e-bed6-4b45b27d6cea"
      unitRef="product">3</pcrx:ConcentrationRiskNumberOfProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNC9mcmFnOjlmYTYzZTcxYTFhZDRiZjU4MmMzNjljZDk5Yjg3ZDcyL3RleHRyZWdpb246OWZhNjNlNzFhMWFkNGJmNTgyYzM2OWNkOTliODdkNzJfMjY2OQ_fa3fb813-92ba-499c-b8c5-3f8092f2af17"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc5Ng_8d46b75e-c550-4ad4-925b-0d1faeeb0a96">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2021&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#xb0; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The percentage of revenues from the Company&#x2019;s three largest wholesalers have shifted in the current year with the addition of ZILRETTA sales, which began in November 2021 following the completion of the Flexion Acquisition (as defined below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc4MA_08be6e69-b2f5-4edf-8864-808f14bdaeb3">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681422000021/pcrx-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2021&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at September&#160;30, 2022, and for the three and nine-month periods ended September&#160;30, 2022 and 2021, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2021 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;</pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDgwNA_134ef0eb-999b-4bb5-99f9-1c4587c9837e">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells ZILRETTA primarily to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as Group Purchasing Organizations, or GPOs. The Company sells iovera&#xb0; directly to end users and its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee in the U.S.&lt;/span&gt;&lt;/div&gt;</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc3Mw_8e681b6c-2f70-4b26-87a7-672fc91104a5">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <pcrx:ConcentrationRiskNumberOfCustomers
      contextRef="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfMjk0MQ_f034ad8b-3a0b-43ed-9d96-448f3c39c321"
      unitRef="segment">3</pcrx:ConcentrationRiskNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id798a30004274993babf49e9b98be123_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi0xLTEtMS05ODY3NA_fab1e1c6-f9a8-4c1a-a77f-39fb455286d2"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2a7621b4bba342699674426138465e98_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi0zLTEtMS05ODY3NA_662f42fa-f294-4600-a227-dcd6203dd9e7"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i491f1c40eec747d48c2a3cbf996a653f_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi01LTEtMS05ODY3NA_1b9b481b-6667-4449-8c90-801ec3f76d0f"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idea3269a015844a88e20bfa8a2c5db42_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMi03LTEtMS05ODY3NA_5703d61d-7bbb-4b68-896b-50f8e380686e"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib4d204d59893479994e548d189f110c0_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy0xLTEtMS05ODY3NA_b1cbdba9-7d8a-4bed-9537-af8869189efc"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0e8428c526394e7b892c82c1100eae05_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy0zLTEtMS05ODY3NA_929de998-8181-43b4-850f-0b952ea4212b"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i785ba673e38b4971a09e28476d230f20_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy01LTEtMS05ODY3NA_3e2c64c9-0ff1-42fc-8b1b-8ad931208ff7"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i40d9bb0c3093491f8fd4cc029445495a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfMy03LTEtMS05ODY3NA_2e016874-1383-441f-84d2-973138c354ce"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c2f2c9bc8c54a0298a54156ff906c36_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC0xLTEtMS05ODY3NA_5cae7521-1ba9-49f5-a743-fd9a67dfeb68"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i81faa5db9ab84d9abcedc8d10f6aadd6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC0zLTEtMS05ODY3NA_b15bfc42-c869-437c-a308-5c943576694e"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i35ee1fd141184820a1033d1e2b620500_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC01LTEtMS05ODY3NA_7a8bae87-5353-43b9-ba63-19c33790ad7b"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0dcf246ea00f4772961db833e7e6c9c5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNC03LTEtMS05ODY3NA_78840e1d-e276-4059-b122-7fb52ab40df0"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4cc07e896b4645dfa4efb71cc229b19c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS0xLTEtMS05ODY3NA_f5e3ded8-ca21-4324-bc94-794bf5047afd"
      unitRef="number">0.75</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i75e7ecfa4c964440a2946a9bd17bcb30_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS0zLTEtMS05ODY3NA_4eccc19a-5c71-489b-bae1-a91747b9f879"
      unitRef="number">0.85</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if36a483a5fae482eabe15aad4726bdf2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS01LTEtMS05ODY3NA_a7d017ec-902a-44f9-a07d-40f76927c8ab"
      unitRef="number">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iba56a5bf30fa44d791bf3d27fae3998c_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RhYmxlOjNmMmI3NWIxNjljMjQ1N2Y5MzM2YjNlZDI4NzQwYWFkL3RhYmxlcmFuZ2U6M2YyYjc1YjE2OWMyNDU3ZjkzMzZiM2VkMjg3NDBhYWRfNS03LTEtMS05ODY3NA_8e58fab8-3e96-486d-9bc4-ef7f3b142524"
      unitRef="number">0.85</us-gaap:ConcentrationRiskPercentage1>
    <pcrx:ConcentrationRiskNumberOfCustomers
      contextRef="i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfMzAzOQ_f034ad8b-3a0b-43ed-9d96-448f3c39c321"
      unitRef="segment">3</pcrx:ConcentrationRiskNumberOfCustomers>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc4OQ_b053d4d6-1bf3-4040-8faf-73aec978c5fe">Recently Adopted Accounting Pronouncements&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums were recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations be prepared using the if-converted method instead of the treasury stock method. The Company elected to adopt the new guidance using a modified retrospective method of transition, which applied to transactions outstanding at January 1, 2022. As a result, the Company does not separately present in equity an embedded conversion feature for its convertible debt. Instead, the Company accounts for its convertible debt instruments wholly as debt. In addition, effective on January 1, 2022, the Company did not record interest expense on the previously recorded discount on its convertible debt. The impact on the condensed consolidated balance sheet at January 1, 2022 increased net debt by approximately $64.9&#160;million, reduced accumulated deficit by $47.2&#160;million, reduced additional paid-in capital by $96.5&#160;million and decreased deferred tax liabilities by $15.7&#160;million.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LongTermDebt
      contextRef="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDY0Nw_dd529ce0-c8ec-4bc5-88bc-d60e4179bd15"
      unitRef="usd">64900000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="i4ab43b03e7f045cfa6ba5b01ccc9f663_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDY4Mg_b3d3fd48-1694-40cd-8d06-46800c1204b9"
      unitRef="usd">47200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3a7066383d00444bb7d24779d5fcd386_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDcyNA_c77fe3f4-b21d-46c7-b142-e275ca5a8f57"
      unitRef="usd">-96500000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV8zNy9mcmFnOjc3NGYxYzhlZmUyNjQ4YWM5M2I2NWRjYTJmMDk3NjU3L3RleHRyZWdpb246Nzc0ZjFjOGVmZTI2NDhhYzkzYjY1ZGNhMmYwOTc2NTdfNDc2OQ_49d4a6dc-bd5a-43e3-a431-da73ec83ba87"
      unitRef="usd">-15700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfNDYxNA_3a357851-b691-488f-ab02-69bf2fa20268">REVENUE&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net product sales consist of (i) EXPAREL in the U.S., the European Union, or E.U., and the U.K.; (ii) ZILRETTA in the U.S.; (iii) iovera&#xb0; in the U.S., Canada and the E.U. and (iv) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use. Royalty revenues are from the Company&#x2019;s collaborative licensing agreements. The Company does not consider revenue from sources other than sales of EXPAREL and ZILRETTA to be material sources of its consolidated revenue. As such, the following disclosure only relates to revenue associated with net EXPAREL and ZILRETTA product sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. The Company primarily sells ZILRETTA to specialty distributors and a specialty pharmacy, who then subsequently resell ZILRETTA to physicians, clinics and certain medical centers or hospitals. The Company also contracts directly with healthcare providers and intermediaries such as GPOs. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL and ZILRETTA revenues are recorded at the time the products are transferred to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, service fees, government rebates, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts, statutory requirements and other related information that may become known in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers, specialty distributors, specialty pharmacy and doctors. Payment terms generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzMg_bfd25119-5362-4514-9063-c69b91c15797"&gt;zero&lt;/span&gt; to 97 days from the date of the transaction, and accordingly, there is no significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#x2019;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#x2019;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL and ZILRETTA to its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;ZILRETTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfMjkzOA_4f2d4767-21ec-424d-b105-9c6dfbbb5d0f">P97D</pcrx:AccountsReceivablePaymentTerms>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RleHRyZWdpb246ZTkxN2ZlNGJhOWIzNDZiOWFhMmExOGViNjAyYzExNGRfNDYxMQ_62063e5b-1d23-4afc-8366-febe2c434252">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;ZILRETTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b7f09cd3fa46f7bef2e7b988c8c155_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy0yLTEtMS05ODY3NA_56666266-c01a-4386-a90c-2775a662edf0"
      unitRef="usd">132642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaced5e5f9bc940a892330f204dd2244f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy00LTEtMS05ODY3NA_ac496ac5-9d92-4316-8fa7-5570d14a8a2c"
      unitRef="usd">121926000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie744a5ac2c014227987bdfeeacecae8c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy02LTEtMS05ODY3NA_30e3ae90-cd1f-4cd6-9ea8-a27d7b6f1b8e"
      unitRef="usd">398854000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4b27bac4a4f40deae2b2f890f8e66b2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfMy04LTEtMS05ODY3NA_b486a77f-e084-4a80-a436-d989d449f10e"
      unitRef="usd">366663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbb8393abab9472ba432b3023d43f876_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC0yLTEtMS05ODY3NA_d9fbe22e-9647-4834-a21d-447f5f7eee90"
      unitRef="usd">26494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bec708640aa4fe89373e8a8b5097698_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC00LTEtMS05ODY3NA_0fdeaf72-9ad3-492f-b619-3e95a95ed51b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie304082b6d1244319404c24adf4df95d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC02LTEtMS05ODY3NA_9d85851b-cba3-4932-b841-06aa46fa0192"
      unitRef="usd">77546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54b382af13b04dad89a0b67e8cbed57b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNC04LTEtMS05ODY3NA_ebb5933c-5647-4c13-9eb9-c97bda3af095"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ff9b5c1afd24751ac47466df9cf7363_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS0yLTEtMS05ODY3NA_da6676c4-2e06-4ec2-80f9-bd9d5da4f22f"
      unitRef="usd">4467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0d71636ef1a41278d664b9a58e7b14a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS00LTEtMS05ODY3NA_902604cf-4c4c-4e9e-96d1-f04add597f43"
      unitRef="usd">4182000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d7b8f126963466480f241a2ea73cd74_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS02LTEtMS05ODY3NA_4b4f4d1c-f08c-4d61-be66-921eeec5dcb5"
      unitRef="usd">10694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22145e0671d24d3192e811839a75fcc6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNS04LTEtMS05ODY3NA_4bc012fe-f314-4c0c-95d7-59bceddd8675"
      unitRef="usd">11264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58db0d23a27d413abf5cf179a882a86e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi0yLTEtMS05ODY3NA_a4e15b5f-9cbb-4875-b34a-d009ef3734c9"
      unitRef="usd">2957000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57ca564b922e4b24926c90284b7d52f5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi00LTEtMS05ODY3NA_5753e09a-ecf7-44d7-b216-e0e24d9cfe21"
      unitRef="usd">683000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i774694031232442bade01c3100051d55_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi02LTEtMS05ODY3NA_72a93a79-3791-4fb8-81b2-b0cb0ad7bc3f"
      unitRef="usd">5469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9b6428ad6264377b5daa3a69ab1fb5e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNi04LTEtMS05ODY3NA_14fb4eae-9082-4c18-afb5-db7124d77aaa"
      unitRef="usd">2465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65216f846faf4af9b90980aae2b8f32a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy0yLTEtMS05ODY3NA_2404d1f7-4f08-4204-a060-cb1ce20c9b65"
      unitRef="usd">166560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id39db401bf5943cdb37c18d9f60e12ed_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy00LTEtMS05ODY3NA_9b68710c-adb2-402b-8c67-9ddfcfb6b04b"
      unitRef="usd">126791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a18e970b9754775b8c064d13348cb6c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy02LTEtMS05ODY3NA_26f75266-c27c-4a88-bb81-d7d398189f4e"
      unitRef="usd">492563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i757cb84d9b1f4a009a375db6678f91f0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80My9mcmFnOmU5MTdmZTRiYTliMzQ2YjlhYTJhMThlYjYwMmMxMTRkL3RhYmxlOjRjYTE4YmJjNWI0ZjRiMWU5ZDg3YWYyNzgwZWI1YTMyL3RhYmxlcmFuZ2U6NGNhMThiYmM1YjRmNGIxZTlkODdhZjI3ODBlYjVhMzJfNy04LTEtMS05ODY3NA_8de7ad88-488d-4c58-82de-915f8c78847f"
      unitRef="usd">380392000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1Nw_4f351ae3-8f26-437a-96eb-aac6d9ae775b">FLEXION ACQUISITION&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2021, the Company acquired Flexion (the &#x201c;Flexion Acquisition&#x201d;), a biopharmaceutical company focused on the discovery, development, and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. Upon consummation of the Flexion Acquisition, Flexion became a wholly-owned subsidiary of the Company and was renamed Pacira Therapeutics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The total consideration for the Flexion Acquisition was approximately $578.8&#160;million consisting of: (i) $448.5&#160;million of cash paid to former Flexion stockholders and to settle restricted stock units and in-the-money stock options; (ii) an $85.1&#160;million cash payment to repay Flexion debt that was not assumed by the Company and (iii) $45.2&#160;million of estimated contingent consideration related to contingent value rights, or CVRs, that were issued to Flexion shareholders and certain equity award holders in conjunction with the Flexion Acquisition. The consideration is subject to adjustments based on the achievement of certain potential milestone payments. Up to an additional $380.2&#160;million in the aggregate may be payable to holders of the CVRs if each of the applicable milestones are achieved. No contingent consideration milestones were achieved in the nine months ended September&#160;30, 2022. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the methodology and key assumptions used in the fair value measurements of contingent consideration and for more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is finalizing its valuation of certain tax accounts, and anticipates finalizing the purchase price allocation as the information necessary to complete the analyses is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(as previously &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;reported) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES ASSUMED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)  As previously reported in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b)  Represents the finalization of a tax study and pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Summary of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the unaudited pro forma summary of operations for the three and nine-month periods ended September&#160;30, 2021, as if the Flexion Acquisition had occurred on January 1, 2020. This pro forma information does not purport to represent what the Company&#x2019;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Flexion. The summary pro forma financial information primarily reflects the following pro forma adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Recognition of the income tax benefit resulting from decreasing Flexion&#x2019;s existing valuation allowance on deferred tax assets for the three and nine months ended September&#160;30, 2021;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Removal of Flexion&#x2019;s interest expense and associated deferred financing cost amortization related to the $85.1&#160;million of debt not assumed;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Adjustments to the Company&#x2019;s interest income for the cash used to acquire Flexion; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional cost of goods sold related to a step-up value in inventory;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional amortization expense from the acquired developed technology intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional depreciation of Flexion&#x2019;s fixed assets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Additional lease expense on Flexion&#x2019;s right-of-use, or ROU, assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, all of the above adjustments were adjusted for the applicable tax impact.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNTcy_c426f284-ca53-4043-9636-978cd7cdf4fe"
      unitRef="usd">578800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifa17d6ce32084dc195161c9e6c47a57c_D20211119-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNTk0_4c5c3991-d6af-4e2e-b9d6-5c7cf4146cd2"
      unitRef="usd">448500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfNzE4_c3d6b97b-166d-48cd-8840-91a13438dfbf"
      unitRef="usd">85100000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration
      contextRef="i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfODAy_56b9dda8-6bd5-4a0b-9afd-d12334b0df90"
      unitRef="usd">45200000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMTEzNw_393bd784-cfe8-4d13-9a09-d77d6b4a82e9"
      unitRef="usd">380200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1OA_776feb83-72f0-4bf4-b018-ee2b86e46319">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is finalizing its valuation of certain tax accounts, and anticipates finalizing the purchase price allocation as the information necessary to complete the analyses is obtained, but no later than one year after the acquisition date. The following table sets forth the preliminary allocation of the Flexion Acquisition purchase price to the estimated fair value of the net assets acquired at the acquisition date (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(as previously &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;reported) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Recognized at the Acquisition Date &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,970)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES ASSUMED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)  As previously reported in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(b)  Represents the finalization of a tax study and pre-acquisition expenses that were paid by the Company in 2022, partially offset by the release of estimated reserves.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMi0yLTEtMS05ODY3NA_4b2ebf4a-7b0b-439e-b774-c55422a333f0"
      unitRef="usd">113562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMi02LTEtMS05ODY3NA_5f604f97-6452-4966-8f2d-6b962971fec3"
      unitRef="usd">113562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMy0yLTEtMS05ODY3NA_e8134ba6-2587-4c30-aabc-42a48d339384"
      unitRef="usd">11153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMy02LTEtMS05ODY3NA_e25728e4-5bd8-4c2b-b193-fb778184c8db"
      unitRef="usd">11153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNC0yLTEtMS05ODY3NA_763e8391-5c2f-482b-8638-f8833e9f04d2"
      unitRef="usd">32838000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNC02LTEtMS05ODY3NA_1347a2cb-6e7b-499b-8a43-b1c5f4b7f92b"
      unitRef="usd">32838000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNS0yLTEtMS05ODY3NA_041fe1c6-14d1-4729-8512-a852dcd01362"
      unitRef="usd">29667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNS02LTEtMS05ODY3NA_bda3eea2-0d24-482a-a799-b13bee746465"
      unitRef="usd">29667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNi0yLTEtMS05ODY3NA_748654e3-3d04-45c8-98a2-7f1ba6eb5d4b"
      unitRef="usd">4852000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNi02LTEtMS05ODY3NA_5b720355-55dc-4aab-a84e-b1534acefedd"
      unitRef="usd">4852000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNy0yLTEtMS05ODY3NA_82c8f098-1bb7-49ed-8b65-6bc9acbe8bd9"
      unitRef="usd">23307000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfNy02LTEtMS05ODY3NA_c7494025-b7cb-4d22-9224-f860dc34c30f"
      unitRef="usd">23307000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC0yLTEtMS05ODY3NA_f70c6ee6-2c8b-4080-b49a-7f40438dd50f"
      unitRef="usd">58015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC00LTEtMS0xMDQ0NzE_fff1bc3e-906e-44ab-a181-71a5b7e630ab"
      unitRef="usd">-10970000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOC02LTEtMS05ODY3NA_9472249b-2096-47b1-a482-2074ec1d4765"
      unitRef="usd">47045000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOS0yLTEtMS05ODY3NA_a09d2359-7179-45ac-9c49-b8b7835d7f0f"
      unitRef="usd">6585000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfOS02LTEtMS05ODY3NA_b5dfaec3-57d5-4cda-b4c3-1b287a2b39af"
      unitRef="usd">6585000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTAtMi0xLTEtOTg2NzQ_099ca187-a852-40d2-9fc4-50ffb8b927a2"
      unitRef="usd">480000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTAtNi0xLTEtOTg2NzQ_b4a12310-d4c9-481b-89e3-1721c8398517"
      unitRef="usd">480000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTEtMi0xLTEtOTg2NzQ_7a497b91-94b4-44f3-849c-2822fd0ad306"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTEtNi0xLTEtOTg2NzQ_5b6a21fd-e0ad-4aa2-be8a-3e068705e265"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItMi0xLTEtOTg2NzQ_75ff0aee-7b3d-4fd7-bcaa-48b53992f56b"
      unitRef="usd">820979000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItNC0xLTEtOTg2NzQ_84dbb4ee-adfe-4d11-8a33-164ee0a309f6"
      unitRef="usd">-10970000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTItNi0xLTEtOTg2NzQ_dd57779c-fb33-4baf-a8ee-a854d8f0e306"
      unitRef="usd">810009000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTQtMi0xLTEtOTg2NzQ_b4dca3ba-2a5e-42d0-ad64-ee01a2a71db2"
      unitRef="usd">9794000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTQtNi0xLTEtOTg2NzQ_8c2a65ab-c482-446f-9f71-7f7cc029b595"
      unitRef="usd">9794000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtMi0xLTEtOTg2NzQ_29b5288b-b388-4faf-aa59-dc93def177b0"
      unitRef="usd">22746000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtNC0xLTEtOTg2NzQ_60627291-8de0-4de4-9893-fe1e202bb910"
      unitRef="usd">1216000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses>
    <pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTUtNi0xLTEtOTg2NzQ_f53033e8-c2a1-49a1-a8d0-9aa1262623c5"
      unitRef="usd">23962000</pcrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTYtMi0xLTEtOTg2NzQ_14ebe6e1-fb7c-4eec-b1a6-0a3269cff581"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTYtNi0xLTEtOTg2NzQ_03f878c2-5102-44c5-a9fc-57013d931fc6"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTctMi0xLTEtOTg2NzQ_4252e45d-e29d-4f05-99f5-5aa8e63a4b63"
      unitRef="usd">6585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTctNi0xLTEtOTg2NzQ_e850d648-b6db-4eaf-b232-ed3a033a85ab"
      unitRef="usd">6585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTgtMi0xLTEtOTg2NzQ_cbee7eb2-af6b-47e4-b69a-7722f67512ff"
      unitRef="usd">1187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTgtNi0xLTEtOTg2NzQ_e91596e0-3b36-4473-85fa-e1f2a51b4660"
      unitRef="usd">1187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTktMi0xLTEtOTg2NzQ_08062670-9aa5-4bae-863a-bc91859f97f4"
      unitRef="usd">201450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMTktNi0xLTEtOTg2NzQ_72321e25-6688-40cc-8c18-bce8d85f5adc"
      unitRef="usd">201450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtMi0xLTEtOTg2NzQ_b6cfde94-7495-46a3-b56b-2d728a2fa2c4"
      unitRef="usd">251762000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtNC0xLTEtOTg2NzQ_f3e5bd1d-b2df-4233-83c8-1e7a8aca3b67"
      unitRef="usd">1216000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjAtNi0xLTEtOTg2NzQ_3eb48224-6eda-477c-8772-616784b0f18e"
      unitRef="usd">252978000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtMi0xLTEtOTg2NzQ_6e980571-6e65-472d-b66c-4c4bcd5b7fc7"
      unitRef="usd">569217000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtNC0xLTEtOTg2NzQ_83e54ae3-acf4-4dbb-a466-87cffa09af4f"
      unitRef="usd">-12186000</pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjEtNi0xLTEtOTg2NzQ_80df320b-cca1-4bac-85c3-9acb38cbd351"
      unitRef="usd">557031000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItMi0xLTEtOTg2NzQ_e30e9b2e-da1d-4b04-8766-23668b9defc9"
      unitRef="usd">9628000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItNC0xLTEtOTg2NzQ_64e9e70c-0360-4aad-9df2-64622256cf1b"
      unitRef="usd">12186000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjItNi0xLTEtOTg2NzQ_1b879501-4de6-4011-8b1b-0dede4fa19a8"
      unitRef="usd">21814000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtMi0xLTEtOTg2NzQ_90469655-7d83-41ae-aba7-4df0e1ec33a5"
      unitRef="usd">578845000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i494d0416c7804e05936f5c4b14a63791_D20211119-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtNC0xLTEtOTg2NzQ_63d703f2-b04d-48cb-bd25-6751689631e4"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i3ddfff3e82c24fcaa16748d8079315ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOmY3MzMzOWZjODUzNDQ4YzBhZjk0MTY1MWY5Yjc5MTQ0L3RhYmxlcmFuZ2U6ZjczMzM5ZmM4NTM0NDhjMGFmOTQxNjUxZjliNzkxNDRfMjMtNi0xLTEtOTg2NzQ_31f0e8ad-cc04-4467-9e23-66784c4472df"
      unitRef="usd">578845000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzc1OQ_58d772b8-78ff-4f7a-9115-9f91a3d7473f">This pro forma information does not purport to represent what the Company&#x2019;s actual results would have been if the Flexion Acquisition had occurred as of January 1, 2020, and is not indicative of what such results would be expected for any future period (in thousands, except per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pro forma basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMS0xLTEtMS05ODY3NA_c891465c-537a-4f01-acb9-9aabd0158233"
      unitRef="usd">149048000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMS0zLTEtMS05ODY3NA_2c86f5cb-d7f2-42be-b3e3-580773dda0cd"
      unitRef="usd">456429000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMi0xLTEtMS05ODY3NA_28e3e25f-b2e0-4b74-b688-1301becf4190"
      unitRef="usd">-10763000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMi0zLTEtMS05ODY3NA_8f26c792-dac2-475c-a04e-780acc1f3a22"
      unitRef="usd">-31250000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0xLTEtMS05ODY3NA_07b56102-d80f-43b3-b9c3-70c48a342cd8"
      unitRef="usdPerShare">-0.24</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0xLTEtMS05ODY3NA_3f5f92be-cd73-4c13-97de-e1e6a4dca1b9"
      unitRef="usdPerShare">-0.24</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0zLTEtMS05ODY3NA_445fefa2-f24d-497d-9840-70870bd877c9"
      unitRef="usdPerShare">-0.71</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RhYmxlOjVkZGM1Y2Y2Nzk4ZjQ5ZjhhMjhjNDE2ZmMyMDAwNTZjL3RhYmxlcmFuZ2U6NWRkYzVjZjY3OThmNDlmOGEyOGM0MTZmYzIwMDA1NmNfMy0zLTEtMS05ODY3NA_a618443c-1137-461d-8fd3-44bc91cbb546"
      unitRef="usdPerShare">-0.71</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt
      contextRef="iac35326c08e44e7cb67d82dcebbcba61_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80Ni9mcmFnOmEzZDUxZjJhYThmZTRlZjBhZjdmM2NlZTlkMmZhMTFjL3RleHRyZWdpb246YTNkNTFmMmFhOGZlNGVmMGFmN2YzY2VlOWQyZmExMWNfMzI4MA_eab001a3-68b1-4cb8-af79-75a7e48ce01e"
      unitRef="usd">85100000</pcrx:BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RleHRyZWdpb246MWE4OTg5MmVhM2FhNGE1YThiNmQyZTk4OTMwNDkxZjBfOTg_f1d281d2-b680-4432-ace8-6a463280df8f">INVENTORIES&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RleHRyZWdpb246MWE4OTg5MmVhM2FhNGE1YThiNmQyZTk4OTMwNDkxZjBfMTAx_b2124a30-ae30-4bcc-84f9-c266040838e9">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMi0xLTEtMS05ODY3NA_a5029136-2481-4750-b2ff-6aebea61d3d9"
      unitRef="usd">35602000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMi0zLTEtMS05ODY3NA_18272335-d3a7-499b-817c-e42e04692269"
      unitRef="usd">36337000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMy0xLTEtMS05ODY3NA_c6fb76ef-9fd4-41eb-90bf-73270b5ce14c"
      unitRef="usd">35026000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfMy0zLTEtMS05ODY3NA_7c47a1df-571e-4cf8-8211-3e922b442e50"
      unitRef="usd">35182000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNC0xLTEtMS05ODY3NA_6d570647-4242-4ece-8d5d-33c6b6668aea"
      unitRef="usd">26171000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNC0zLTEtMS05ODY3NA_bb4aef54-2eb8-48c4-9e8b-764a2eb0bc07"
      unitRef="usd">27031000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNS0xLTEtMS05ODY3NA_780982b7-0f75-400b-829e-320117082f47"
      unitRef="usd">96799000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV80OS9mcmFnOjFhODk4OTJlYTNhYTRhNWE4YjZkMmU5ODkzMDQ5MWYwL3RhYmxlOjIwM2IxNjdlN2M1NjRiYzBhYmFkNDE1ZWQyODkxMGYwL3RhYmxlcmFuZ2U6MjAzYjE2N2U3YzU2NGJjMGFiYWQ0MTVlZDI4OTEwZjBfNS0zLTEtMS05ODY3NA_44981186-bbff-49f3-861b-ff66c743a505"
      unitRef="usd">98550000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTAyNg_26549dc8-2e6b-4763-9462-be8515a0db48">FIXED ASSETS&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2022 and 2021, depreciation expense was $5.8 million and $3.8 million, respectively. For the three months ended September&#160;30, 2022 and 2021, there was $1.1 million and $0.9 million of capitalized interest on the construction of manufacturing sites, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2022 and 2021, depreciation expense was $18.0 million and $9.6 million, respectively. For the nine months ended September&#160;30, 2022 and 2021, there was $2.9&#160;million and $3.0&#160;million of capitalized interest on the construction of manufacturing sites, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022 and December&#160;31, 2021, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $57.4 million and $65.4&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, the Company had asset retirement obligations of $3.1&#160;million and $2.4&#160;million, respectively, included in accrued expenses and other liabilities on its condensed consolidated balance sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTAzMw_27fd48a6-09ac-40e6-855b-0d2a621dd14a">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iea3422a161284fd4968428139893ccc3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMi0xLTEtMS05ODY3NA_adbbed56-e125-4fc1-958a-23207c3e0051"
      unitRef="usd">118233000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8efbe146066f4b189710fe01037a4e39_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMi0zLTEtMS05ODY3NA_a999f4a4-ea71-44f5-acac-0f422769839b"
      unitRef="usd">117264000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01ba6850e6cf4817a5abb640bffde50e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMy0xLTEtMS05ODY3NA_bc9152f4-dccd-442a-bb0c-1c8582c430a0"
      unitRef="usd">61302000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iabadf7b6a1224bb3916ef669ce65a34d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfMy0zLTEtMS05ODY3NA_52001e18-1af9-48c2-8ba9-f0498f4949a3"
      unitRef="usd">59740000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if230c3c362c544bea9bc5d678fd8606c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNC0xLTEtMS05ODY3NA_51149f1c-e3f4-456f-999f-48a635a48c50"
      unitRef="usd">14449000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id93a4a3f2486495096df65f35513637d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNC0zLTEtMS05ODY3NA_185c17e3-85fa-4d54-907d-c3976b25240d"
      unitRef="usd">13197000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie6aef198937e45468ba17175b8a02cbd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNS0xLTEtMS05ODY3NA_e2d1b968-a2d4-429b-b42d-3bdf54d5df17"
      unitRef="usd">2420000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69260eaa59884a4b80bee5f89c48b5ee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNS0zLTEtMS05ODY3NA_1490446b-6bc9-47de-bdbd-5ea2cab327a1"
      unitRef="usd">2883000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if84837eb6c88478cb22b5e730913d7da_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNi0xLTEtMS05ODY3NA_c06ef8dd-e98a-4e22-9834-7fe32a1d58aa"
      unitRef="usd">98770000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1083fc7b3c5544e99ac79b620bd148fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNi0zLTEtMS05ODY3NA_d53d187d-d962-439b-a599-b2cb16d71751"
      unitRef="usd">80557000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNy0xLTEtMS05ODY3NA_26b25c63-5638-485d-8c0f-2adf151f6a94"
      unitRef="usd">295174000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfNy0zLTEtMS05ODY3NA_4fe711ef-59b2-4d1e-8682-30c1f9db9f02"
      unitRef="usd">273641000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOC0xLTEtMS05ODY3NA_7a493fb3-995d-4fd5-94e9-95d31138115f"
      unitRef="usd">101528000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOC0zLTEtMS05ODY3NA_893bf161-273c-4d65-a6bd-eea9698ca4ff"
      unitRef="usd">85240000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOS0xLTEtMS05ODY3NA_6e8e31ce-149c-45b1-b343-2270dad8cc84"
      unitRef="usd">193646000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RhYmxlOjZmMTFhZDU5ZWNiYzQ0NjNiYzg3MDQ3MjE1OWJmYWQ0L3RhYmxlcmFuZ2U6NmYxMWFkNTllY2JjNDQ2M2JjODcwNDcyMTU5YmZhZDRfOS0zLTEtMS05ODY3NA_a6fcd261-5f17-4c10-98b5-630d79ffb655"
      unitRef="usd">188401000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTgx_b96cecd9-f0f0-4362-a46e-f8d72c0561d4"
      unitRef="usd">5800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMTg4_a9364c1f-4ee8-46dd-a02e-5a1a062a6ea0"
      unitRef="usd">3800000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i5850959cee0b45c5999d3d9d0ee56a23_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMjU0_7c80cd79-af11-4cce-bb0c-d20ea0f3dd7c"
      unitRef="usd">1100000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i452f6f29fd7a4cefaf5db7fc6d5b7fcc_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMjYx_13fd66cf-0e8c-4c62-97e7-41ad56f97550"
      unitRef="usd">900000</us-gaap:InterestCostsCapitalized>
    <us-gaap:Depreciation
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfMzk0_5591fda7-35a9-4b44-8947-5db70d451ec0"
      unitRef="usd">18000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDAx_6044ebc0-6e37-4dca-b466-d4714f67334e"
      unitRef="usd">9600000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="icaea5ef1bea14e64a8f9e557b76fefec_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDUx_96b87ff8-6f35-401d-b03f-07ed2933bf09"
      unitRef="usd">2900000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ifd5ea19425754b48a8d743a2a9a4c06f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNDU4_0df09384-8c19-4e1f-8758-12c36024ea2a"
      unitRef="usd">3000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2fb3d023787140b4a618c948c7de865a_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNjg0_3a1652a8-a9c4-413a-918c-cb9b7c223877"
      unitRef="usd">57400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i933d53b6705f4e2d828a014e7a4ef1cb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNjkx_872c6b22-6661-4e8a-87a5-b9771f8e1a96"
      unitRef="usd">65400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetRetirementObligation
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNzc1_5900e075-7f0b-4368-85c3-c9dd8a6dece4"
      unitRef="usd">3100000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81Mi9mcmFnOjkxZTM3ZDc3ZWIwMzRiMDY4YTg0MDc5OWU1MDliZDBkL3RleHRyZWdpb246OTFlMzdkNzdlYjAzNGIwNjhhODQwNzk5ZTUwOWJkMGRfNzgy_e133b885-57a7-441d-8fb0-f6aac71dea4e"
      unitRef="usd">2400000</us-gaap:AssetRetirementObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxMg_2ecf274d-4aff-452f-944f-3032805a0e43">LEASES&lt;div style="margin-bottom:10pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases all of its facilities, including its EXPAREL and iovera&#xb0; manufacturing facility in San Diego, California. These leases have remaining terms up to 7.9 years, some of which provide renewal options at the then-current market value. The Company also has two embedded leases with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England for the production of EXPAREL and ZILRETTA. A portion of the associated monthly base fees has been allocated to the lease components based on a relative fair value basis. During the three months ended September 30, 2022, the Company entered into a partial sublease for the former Flexion research and development laboratory in Woburn, Massachusetts which resulted in a $0.4&#160;million ROU asset reclassified to a fixed asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease expense, net is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Lease expense, net of sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to net the amortization of the ROU asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.46 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if677311d787345c3a160575158dda8a6_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxMA_a7b9cb97-0e3c-49db-85e1-3fa189396ddb">P7Y10M24D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <pcrx:NumberOfLeases
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAwNg_0b702aec-5ef5-4bc5-a3c0-c626e25b6119"
      unitRef="lease">2</pcrx:NumberOfLeases>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if7c59933724e48839a86397a939f4299_I20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMzEwOA_c597f283-2c66-44c7-865d-0690fbc95480"
      unitRef="usd">400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxNw_31da7188-284d-437d-91fe-5041aeffd6ca">Total operating lease expense, net is as follows (in thousands):&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Lease expense, net of sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.46 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy0yLTEtMS05ODY3NA_951d2207-b015-4089-b217-6c4455b860f7"
      unitRef="usd">3440000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy00LTEtMS05ODY3NA_792f8a63-b150-47ba-b20f-920d63ff6690"
      unitRef="usd">2919000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy02LTEtMS05ODY3NA_06036bca-2830-4413-b33c-7d9782c2699c"
      unitRef="usd">10509000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfMy04LTEtMS05ODY3NA_2b740ff0-82c0-4eb5-a158-f98ec4150885"
      unitRef="usd">8762000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC0yLTEtMS05ODY3NA_ad2f7d07-1708-40bf-8e25-f2887dfc2d92"
      unitRef="usd">540000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC00LTEtMS05ODY3NA_fae66da2-d791-4576-94ef-a380256bfcef"
      unitRef="usd">416000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC02LTEtMS05ODY3NA_12f5ecaf-f8cb-4d5e-a3c0-a986a54af993"
      unitRef="usd">1520000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNC04LTEtMS05ODY3NA_29bdfa49-b4a5-40d7-acf0-87d9d30c7b38"
      unitRef="usd">1318000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS0yLTEtMS0xMDE0ODY_89f525e5-e92c-4815-9e5e-01d21170cf5a"
      unitRef="usd">169000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS00LTEtMS0xMDE0ODY_1691e1e1-2522-41ce-a3d2-2b8c7dab452c"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS02LTEtMS0xMDE0ODY_9a54fbe1-6d0e-43e3-9da9-4f6864e6a5b0"
      unitRef="usd">169000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS04LTEtMS0xMDE0ODY_4a1dc761-61b2-4171-a116-a2b8895f6dae"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS0yLTEtMS05ODY3NA_0bc58605-d4e2-40b8-87a3-577bc34ebcca"
      unitRef="usd">3811000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS00LTEtMS05ODY3NA_f1f3e55e-c32c-47b6-b9c0-dd81f46d6304"
      unitRef="usd">3335000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS02LTEtMS05ODY3NA_2f92c005-c16b-4d16-8dba-973e7b04bcb4"
      unitRef="usd">11860000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjVhMjExMGY2YjIyMjQ4YzhiNTJiYzRlY2FiNzgwMTFmL3RhYmxlcmFuZ2U6NWEyMTEwZjZiMjIyNDhjOGI1MmJjNGVjYWI3ODAxMWZfNS04LTEtMS05ODY3NA_f0ad5bf0-7d47-4530-834e-7ee2c5d205d5"
      unitRef="usd">10080000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfMy0yLTEtMS05ODY3NA_d7f23489-7a94-4f64-8b21-838cf9ba1161"
      unitRef="usd">9922000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfMy00LTEtMS05ODY3NA_6d20102f-787d-4d45-81f8-3ef8e9ee4cca"
      unitRef="usd">9868000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfNC0yLTEtMS05ODY3NA_33349104-229e-4fad-be21-7228519bcd4d"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmNiOGFlODBlMDU2MzRmZTliMzFlYTkwNGI3NjRmYmI2L3RhYmxlcmFuZ2U6Y2I4YWU4MGUwNTYzNGZlOWIzMWVhOTA0Yjc2NGZiYjZfNC00LTEtMS05ODY3NA_67c54181-7b2b-488c-9781-b9aa60682f9e"
      unitRef="usd">212000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMi0yLTEtMS05ODY3NA_5bc5595a-9ce4-4de1-a914-37037a39efed">P7Y1M9D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMi00LTEtMS05ODY3NA_79355077-a586-4ad9-98b6-bd0506530343">P8Y5M15D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMy0yLTEtMS05ODY3NA_48ee7a42-97e5-4774-a562-dc9a1f4444a2"
      unitRef="number">0.0695</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id1cb7d17f0c248e29e06df39baf41859_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFhYjYxNzI0NTJjZTRlY2I4MTZmZTliMWE5OWRjYWJiL3RhYmxlcmFuZ2U6YWFiNjE3MjQ1MmNlNGVjYjgxNmZlOWIxYTk5ZGNhYmJfMy00LTEtMS05ODY3NA_4ad66491-2509-4a96-84d7-9c21b9585a46"
      unitRef="number">0.0688</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAxNQ_ca6f4f3a-ca51-428a-991f-3f97047e0faa">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMS0yLTEtMS05ODY3NA_09edfd84-abba-4d37-aa21-cf3ea70fffeb"
      unitRef="usd">3261000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMi0yLTEtMS05ODY3NA_94f7e753-d968-456b-9b53-1fff487e26b7"
      unitRef="usd">13304000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfMy0yLTEtMS05ODY3NA_24392524-8f3a-4094-b0c4-870443796138"
      unitRef="usd">13435000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNC0yLTEtMS05ODY3NA_de87ee91-5191-4a41-b68f-69e5b3bed670"
      unitRef="usd">12575000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNS0yLTEtMS05ODY3NA_b3a2287c-ccc7-44d9-b944-f5b2c156624e"
      unitRef="usd">12310000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNi0yLTEtMS05ODY3NA_9985daa4-97e5-41b6-857e-69bc692e3944"
      unitRef="usd">39423000</pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfNy0yLTEtMS05ODY3NA_7bc2eff6-591c-4d9c-b759-61be76a71ea3"
      unitRef="usd">94308000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfOC0yLTEtMS05ODY3NA_a8677b26-295b-4799-9bef-239baa0d49a1"
      unitRef="usd">20543000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOmFkYTBlZjYwZDY0MzQ5ZWY5YTUxMTI1Mzc2NzA3ZWI1L3RhYmxlcmFuZ2U6YWRhMGVmNjBkNjQzNDllZjlhNTExMjUzNzY3MDdlYjVfOS0yLTEtMS05ODY3NA_b8bd0f9b-246a-40f5-aa98-cb3b1a82def4"
      unitRef="usd">73765000</us-gaap:OperatingLeaseLiability>
    <pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMjAwOA_e4ba772a-48bf-4532-8323-10365b64328f">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company has entered into one lease agreement not included above as the Company has not yet taken possession of the property. When the lease commences, the future lease obligations will be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RleHRyZWdpb246OTg2NDcxNDIyYWMwNDdiNmJiYzJiZmMzYmNhYWY2NmJfMTU4NA_a925d230-f7f9-405a-ac5e-5bcd6aaa48e3"
      unitRef="segment">1</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMS0yLTEtMS05ODY3NA_62d6802e-c54a-4cee-b425-cbed12d344a1"
      unitRef="usd">81000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMi0yLTEtMS05ODY3NA_664772ef-9691-4a5f-8af9-d7b1040557b7"
      unitRef="usd">492000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfMy0yLTEtMS05ODY3NA_9664ed4b-d6b4-4076-b2bc-3c8c9f7e711f"
      unitRef="usd">493000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNC0yLTEtMS05ODY3NA_ba1a4132-0619-4959-b31f-40c51981d4e7"
      unitRef="usd">503000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNS0yLTEtMS05ODY3NA_3fae7996-f418-4d8f-b068-9202d5ca5bf2"
      unitRef="usd">505000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNi0yLTEtMS05ODY3NA_1630fb23-3191-405c-89fc-adc69c47514e"
      unitRef="usd">443000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81NS9mcmFnOjk4NjQ3MTQyMmFjMDQ3YjZiYmMyYmZjM2JjYWFmNjZiL3RhYmxlOjEwNWQzZjBlNjBlOTRmZTc5ZWQ1ZGRmMjY4OWVjNTdjL3RhYmxlcmFuZ2U6MTA1ZDNmMGU2MGU5NGZlNzllZDVkZGYyNjg5ZWM1N2NfNy0yLTEtMS05ODY3NA_39d602ab-ecae-476c-ba33-5b0b30ce1be3"
      unitRef="usd">2517000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjc0Mg_324de568-187e-4b01-b75c-d3f5a12f64d1">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#x2019;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#x201c;Skyepharma Acquisition&#x201d;), MyoScience, Inc., or MyoScience, (the &#x201c;MyoScience Acquisition&#x201d;) in April 2019 and the Flexion Acquisition in November 2021. The balances at September&#160;30, 2022 and December&#160;31, 2021 were $157.4&#160;million and $145.2&#160;million, respectively. The increase was due to measurement period adjustments associated with the Flexion Acquisition. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. The final Skyepharma milestone payment of $32.0&#160;million when annual net sales collected reached $500.0&#160;million was achieved in the fourth quarter of 2021 and paid during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net, consist of the in-process research and development, or IPR&amp;amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2022 was $14.3&#160;million and $43.0&#160;million, respectively. Amortization expense on intangible assets for the three and nine months ended September&#160;30, 2021 was $2.0&#160;million and $5.9&#160;million, respectively. The increase in amortization expense in the current year is a result of the amortization of ZILRETTA for osteoarthritis knee pain acquired as part of the Flexion Acquisition in November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assuming no changes in the gross carrying amount of these intangible assets, the future estimated amortization expense on the finite-lived intangible assets will be $14.3&#160;million for the remaining three months of 2022, $57.3&#160;million from 2023 to 2030, $37.4&#160;million in 2031, $7.9&#160;million in 2032 and $2.2&#160;million in 2033.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets for impairment whenever an event or change in circumstances arise that indicate the carrying amount of an asset group is at risk of not being recoverable. During the three months ended June 30, 2022, a triggering event was identified for the ZILRETTA asset group due to a reduction in the near-term projected cash flows from the ZILRETTA product. The Company completed an impairment assessment through a recoverability test at June 30, 2022 by comparing the net carrying value of ZILRETTA asset group against the undiscounted net cash flows expected to be generated from ZILRETTA. It was determined that the ZILRETTA asset group was recoverable and not impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfNDcy_993a0c4e-0bb5-4d6c-a57c-4247d2586396"
      unitRef="usd">157400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfNDc5_7c13ee47-8e9b-42a0-9660-e0341fc6e91e"
      unitRef="usd">145200000</us-gaap:Goodwill>
    <pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition
      contextRef="i7f168810ed0344c59194941cdbda381d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfOTgw_8c2d18a6-8bde-4540-be9f-4071aae32596"
      unitRef="usd">32000000</pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition>
    <pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition
      contextRef="i7f168810ed0344c59194941cdbda381d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTAyMw_1efd1a89-5be3-44f2-8fd7-efa2a2ed914a"
      unitRef="usd">500000000</pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjczNw_86543ee2-4c99-4eb4-abdd-8710ec691953">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net, consist of the in-process research and development, or IPR&amp;amp;D, and developed technology from the Flexion Acquisition and developed technology and customer relationships from the MyoScience Acquisition and are summarized as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible&lt;br/&gt;Assets, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years, 5 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS0yLTEtMS05ODY3NA_5bd2e98c-3925-4f75-aaa9-c2f5805b442c"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS00LTEtMS05ODY3NA_a5d42153-8aa9-43a5-8382-3fe73aeb0853"
      unitRef="usd">70057000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3b0cd632a10f4bd68f9d63c852c5b012_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS02LTEtMS05ODY3NA_0ba96514-ae36-43c5-88cf-9d37d10edf50"
      unitRef="usd">519943000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i29b1660ea8f84974983336799383b47d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMS04LTEtMS05ODY3NA_9ea47be4-12ab-4b2b-9c56-2f20707dc121">P10Y5M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi0yLTEtMS05ODY3NA_3a5cf9ec-9386-4bae-b414-f855a228e11a"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi00LTEtMS05ODY3NA_27add85a-ca4b-43f5-bae5-9343f20fddbc"
      unitRef="usd">31000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icc5538bd98f04aad8cfd55a06c19a09f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi02LTEtMS05ODY3NA_775cd507-b1f0-4979-8722-e3edc9ddfef0"
      unitRef="usd">59000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i63a4085601e44fbebf50e56e2d711b28_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMi04LTEtMS05ODY3NA_b468c229-a721-48c6-a578-d9a74e947daa">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy0yLTEtMS05ODY3NA_3689234b-d007-4ef7-b6d8-7826467b3850"
      unitRef="usd">590090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy00LTEtMS05ODY3NA_330024b3-ea13-4f62-9f6c-7c26b928e747"
      unitRef="usd">70088000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMy02LTEtMS05ODY3NA_8de301e7-3745-42fb-b568-351cef6184b4"
      unitRef="usd">520002000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6afb0c5544774a4eb8b7b594661ac03b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNC0yLTEtMS05ODY3NA_18d747b9-a09f-48fb-8723-7f3b8b958342"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6afb0c5544774a4eb8b7b594661ac03b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNC02LTEtMS05ODY3NA_00e8160d-2c77-4b7c-862f-3e0899155d44"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS0yLTEtMS05ODY3NA_61a57b4d-8554-4711-bde8-11d1ceaaf3df"
      unitRef="usd">651090000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS00LTEtMS05ODY3NA_62b8633e-e9c1-40cd-8780-ed54b15f218d"
      unitRef="usd">70088000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfNS02LTEtMS05ODY3NA_4027e51f-b6de-4b48-ad5e-5e4f1815157b"
      unitRef="usd">581002000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i80de923b605d461ca51c7f2b04879428_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC0yLTEtMS05ODY3NA_42631f1e-e02f-4811-8158-d438a5c36a75"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i80de923b605d461ca51c7f2b04879428_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC00LTEtMS05ODY3NA_849fdbd2-0542-4e12-bab9-753419260c9d"
      unitRef="usd">27097000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i80de923b605d461ca51c7f2b04879428_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC02LTEtMS05ODY3NA_10ecb8f6-6112-4c5f-ba2e-3cc8c3fbdb23"
      unitRef="usd">562903000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1b3b5083d5dd4003b0ab03be5387f445_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOC04LTEtMS05ODY3NA_afa10849-c731-4173-975e-88ee0766a88b">P10Y5M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS0yLTEtMS05ODY3NA_f6fe965a-5966-42db-9aea-5a923a476e89"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS00LTEtMS05ODY3NA_2384ea58-7ce1-4cd1-b4c1-683286f8dcc4"
      unitRef="usd">25000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i54f78b1e6ad44ec488026a91fa089205_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS02LTEtMS05ODY3NA_15b4ac84-e512-4d59-b6e4-2c9aafd0dffa"
      unitRef="usd">65000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2518c182890b404d9c0847b899ec72e3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfOS04LTEtMS05ODY3NA_3954018d-14cf-413e-8d27-b73ef8fd84dc">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtMi0xLTEtOTg2NzQ_60617c2d-85ef-4540-9ee8-22331e167afa"
      unitRef="usd">590090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtNC0xLTEtOTg2NzQ_ed150737-3350-4662-ac32-984e2192c05a"
      unitRef="usd">27122000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTAtNi0xLTEtOTg2NzQ_a6f10238-b162-49cc-8ad8-8ecc8620136d"
      unitRef="usd">562968000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTEtMi0xLTEtOTg2NzQ_ce0b9fec-a3cf-445c-b24c-d7dc1b03c316"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i300f2c6b6c214515a7791ff25f4f7bdf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTEtNi0xLTEtOTg2NzQ_4127a9f4-a129-4fe7-8995-03f756d4dda7"
      unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItMi0xLTEtOTg2NzQ_05bb0522-e664-4386-a7b8-e1846d06b94f"
      unitRef="usd">651090000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItNC0xLTEtOTg2NzQ_9f83046a-9182-453e-8232-e216e46b5ce1"
      unitRef="usd">27122000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RhYmxlOjY4YmNlMzdlNmQ1MjQwNjViNjM3YzZjZmY4MTliYWYxL3RhYmxlcmFuZ2U6NjhiY2UzN2U2ZDUyNDA2NWI2MzdjNmNmZjgxOWJhZjFfMTItNi0xLTEtOTg2NzQ_d0061cd8-fe95-4d0b-a252-9651918c3cd9"
      unitRef="usd">623968000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTQ5MA_785b5b8f-1d5c-4b3a-ae1b-d8986ec8695e"
      unitRef="usd">14300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTQ5Nw_56b8787d-3575-405e-83f8-6dca14053ac4"
      unitRef="usd">43000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTU5Nw_579c85b0-05bb-4b38-8367-f5450276a608"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTYwNA_52d5dbb3-3001-42f4-a97a-7378454c82f4"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMTk3OQ_a3ba780d-9c55-46f6-a3b5-ea787b571927"
      unitRef="usd">14300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjAxNw_b69b4d10-7d61-4a01-aaa5-889cae60fe53"
      unitRef="usd">57300000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjAzOQ_133cd6c7-08fc-4f87-ae52-571bb759cadc"
      unitRef="usd">37400000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjA1MQ_5661c951-4f21-4575-8294-272f63cba1e3"
      unitRef="usd">7900000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV81OC9mcmFnOmQwY2I4NzlkYzQyMTQzY2I5YjI2MDQzOTU1ZjYzMDExL3RleHRyZWdpb246ZDBjYjg3OWRjNDIxNDNjYjliMjYwNDM5NTVmNjMwMTFfMjA2Ng_9b9edc63-6e5c-4204-9a73-cca205587641"
      unitRef="usd">2200000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTM_9bcbf378-12a1-4b73-a42a-2d13365cf2f6">DEBT &lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s outstanding debt is summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan B facility maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% Convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375% Convertible senior notes due May 2024 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Convertible senior notes due April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The 2022 Notes (as defined below) matured on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loan B Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into a term loan credit agreement (the &#x201c;Credit Agreement&#x201d;) with JP Morgan Chase Bank, N.A., as administrative agent and the initial lender. The term loan issued under the Credit Agreement (the &#x201c;Term Loan&#x201d;) was issued at a 3% discount and allows for a single-advance term loan B facility in the principal amount of $375.0&#160;million, which is secured by substantially all of the Company&#x2019;s and each subsidiary guarantor&#x2019;s assets. Subject to certain conditions, the Company may, at any time, on one or more occasion, add one or more new classes of term facilities and/or increase the principal amount of the loans of any existing class by requesting one or more incremental term facilities. The net proceeds of the Term Loan were approximately $363.8&#160;million after deducting an original issue discount of $11.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the Term Loan is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan matures on December 7, 2026 and requires quarterly repayments of principal in the amount of $9.4&#160;million commencing June 30, 2022, increasing to $14.1&#160;million commencing December 31, 2025, with a remaining balloon payment of approximately $188.0&#160;million due at maturity. During 2022, the Company is required to make three quarterly payments totaling $28.1&#160;million. The Company is also required to make mandatory prepayments of principal from (i) the Company&#x2019;s excess cash flow (as defined in the Credit Agreement) existing in any fiscal year and if the Senior Secured Leverage Ratio (as defined in the Credit Agreement) for such fiscal year exceeds certain predetermined limits (ii) net proceeds (as defined in the Credit Agreement) of non-ordinary course assets sales and casualty events and (iii) debt issuance proceeds (other than permitted debt under the Credit Agreement). Prepayment penalties for the Term Loan are 2% in the first loan year plus an interest make-whole payment, 2% in the second loan year, 1% in the third loan year and nothing thereafter. Prepayment penalties generally do not apply to mandatory prepayment obligations under the Credit Agreement, such as prepayments due in connection with excess cash flow. During the nine months ended September&#160;30, 2022, the Company made scheduled principal payments of $18.8&#160;million in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan requires the Company to, among other things, maintain (i) a first lien net leverage ratio, determined as of the last day of any fiscal quarter, of no greater than 1.75 to 1.00 and (ii) liquidity, at any time, of at least $150.0&#160;million. The Term Loan also contains customary affirmative and negative covenants, financial covenants, representations and warranties, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;events of default and other provisions. As of September&#160;30, 2022, the Company was in compliance with all financial covenants under the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company may elect to borrow either term benchmark borrowings or alternate base rate borrowings. Term benchmark borrowings bear interest at a variable rate per annum equal to the Adjusted Term SOFR Rate (as defined in the Credit Agreement) (subject to a 75 basis points floor) plus an applicable margin of 700 basis points. Alternate base rate borrowings bear interest at a variable rate per annum determined using a base rate (subject to a 175 basis points floor) equal to the greatest of (i) the Prime Rate (as defined in the Credit Agreement) in effect on such day, (ii) the NYFRB Rate (as defined in the Credit Agreement) plus 50 basis points or (iii) the Adjusted Term SOFR Rate (as defined in the Credit Agreement) plus 100 basis points, subject to certain exceptions, plus an applicable margin of 600 basis points. As of September&#160;30, 2022, borrowings under the Term Loan consisted entirely of term benchmark borrowings at a rate of 9.21%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2025&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and August 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. The 2025 Notes mature on August 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its then-outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert the 2025 Notes at any time prior to February 3, 2025, only if certain circumstances are met, including if during the previous calendar quarter, the last reported sales price of the Company&#x2019;s common stock was greater than 130% of the conversion price then applicable for at least 20 out of the last 30 consecutive trading days of the quarter. During the quarter ended&#160;September&#160;30, 2022, this condition for conversion was not met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#x2019;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#x2019;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the 2025 Notes had a market price o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $993&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; pe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#x2019;s option).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; scheduled trading day immediately before the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#x201c;make-whole fundamental change&#x201d; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the 2025 Notes are currently classified on the Company&#x2019;s condensed consolidated balance sheet at September&#160;30, 2022 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#x2019;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2024 Assumed from the Flexion Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Flexion Acquisition, on May 2, 2017, Flexion issued an aggregate of $201.3&#160;million principal amount of 3.375% convertible senior notes due 2024 (the &#x201c;Flexion 2024 Notes&#x201d;), pursuant to the indenture, dated as of May 2, 2017 (the &#x201c;Original Flexion Indenture&#x201d;), between Flexion and Wells Fargo Bank, N.A., as trustee (the &#x201c;Flexion Trustee&#x201d;), as supplemented by the First Supplemental Indenture, dated as of November 19, 2021, between Flexion and the Flexion Trustee (the &#x201c;First Supplemental Flexion Indenture&#x201d; and, together with the Original Flexion Indenture, the &#x201c;Flexion Indenture&#x201d;). The Flexion 2024 Notes have a maturity date of May 1, 2024, are unsecured, and accrue interest at a rate of 3.375% per annum, payable semi-annually on May 1 and November 1 of each year. Upon the Flexion Acquisition, the principal was assumed and recorded at fair value by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion of the Flexion 2024 Notes, at the election of each holder thereof, each Flexion 2024 Note was convertible into cash, shares of Flexion&#x2019;s common stock, or a combination thereof, at Flexion&#x2019;s election, at a conversion rate of approximately 37.3413 shares of Flexion common stock per $1,000 principal amount of the Flexion 2024 Notes, which corresponded to an initial conversion price of approximately $26.78 per share of Flexion&#x2019;s common stock. As a result of the Flexion Acquisition, and in connection with the Notice (as defined below), holders of the Flexion 2024 Notes became entitled to certain Flexion Acquisition-related conversion and repurchase rights, as discussed below. In addition, as a result of the Flexion Acquisition and as discussed in more detail below, any future conversion rights are subject to the occurrence of any future events giving rise to such conversion rights under the Flexion Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 6, 2021, as a result of the Flexion Acquisition and in accordance with the Flexion Indenture, Flexion provided a Fundamental Change Company Notice and Offer to Purchase (the &#x201c;Notice&#x201d;) to the holders of the Flexion 2024 Notes and offered to repurchase for cash all of the outstanding Flexion 2024 Notes, at a repurchase price in cash equal to 100% of the principal amount of the Flexion 2024 Notes being repurchased, plus accrued and unpaid interest thereon to, but excluding, January 7, 2022, subject to the terms and conditions set forth therein. The offer to purchase expired at 5:00 p.m., New York City time, on January 6, 2022, as scheduled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any holder that did not exercise its repurchase right in accordance with the terms of the Notice retained the conversion rights associated with such holder&#x2019;s Flexion 2024 Notes under the Flexion Indenture. For conversion of Flexion 2024 Notes in connection with the Fundamental Change and the Make-Whole Fundamental Change (each as defined in the Flexion Indenture) resulting from the Flexion Acquisition, each $1,000 principal amount of the Flexion 2024 Notes was convertible into (i) $317.40 in cash and (ii) 37.3413 CVRs, based on the conversion rate of 37.3413, prior to 5:00 p.m., New York City time, on January 7, 2022. Alternatively, holders could retain their Flexion 2024 Notes and such Flexion 2024 Notes would remain outstanding subject to their existing terms, including with respect to a holder&#x2019;s right to receive interest payments on the Flexion 2024 Notes and exercise any future conversion rights that may arise under the Flexion Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 7, 2022, following the expiration of the offer to purchase, the Company accepted the $192.6&#160;million aggregate principal amount of Flexion 2024 Notes that were validly tendered (and not validly withdrawn). No Flexion 2024 Notes were converted in connection with the Notice. At September&#160;30, 2022, the remaining principal outstanding is $8.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes. The 2022 Notes accrued interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and October&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. In July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, the 2022 Notes matured and the Company settled the remaining outstanding principal balance of $160.0&#160;million and a conversion premium of $4.8&#160;million through a cash payment of $156.9&#160;million and the issuance of 101,521 shares of the Company&#x2019;s common stock, which increased additional paid-in capital by $3.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Upon the adoption of ASU 2020-06 effective January 1, 2022, the Company eliminated the convertible debt discounts associated with the 2022 Notes and the 2025 Notes that were originally recorded as offsets to the embedded conversion features recognized in equity. Effective January 1, 2022, the Company will not record interest expense on the previously recorded discounts on convertible debt. The deferred financing costs previously allocated to the conversion features have since been re-allocated to the outstanding debt, slightly increasing the future annual amortization of deferred financing costs. For additional information regarding the adoption of ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTk_4f2bbf78-d5fc-4b5e-a4dc-cb4fe7a574e4">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s outstanding debt is summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan B facility maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% Convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375% Convertible senior notes due May 2024 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Convertible senior notes due April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The 2022 Notes (as defined below) matured on April 1, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMi0xLTEtMS05ODY3NA_f4d55a67-6836-409b-948d-85394f19d81e"
      unitRef="usd">343719000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMi0zLTEtMS05ODY3NA_85e61040-cfca-4f07-88f3-918758c4bfdb"
      unitRef="usd">359497000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjhiMThmYjc3MTA4NTRiYzk5ZDFkOWEwM2MxNDY2MDdhXzQ_3d6ae893-6641-44fa-a647-212382a7c6e2"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0xLTEtMS05ODY3NA_dca54da7-a4d6-4890-8f64-ccadcf5ee898"
      unitRef="usd">395510000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfMy0zLTEtMS05ODY3NA_d55033ab-244d-4fed-b88a-04bc406a1ba2"
      unitRef="usd">330627000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83f1500ac81e40438b8cf99c85734a41_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOmFmOWYzZmZmNDkzZDRhMDg4ZGNkM2E1MjM3MDFjZDdhXzQ_a8ed2b34-4a0d-481e-ab51-91bf61ce2d21"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2a9fe0493cf0469887c610902f910cc7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0xLTEtMS05ODY3NA_96c6c115-ea21-468c-87e4-16e7b62429f1"
      unitRef="usd">8641000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if98c89d2075848e490be94b7892ae381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNC0zLTEtMS05ODY3NA_ef5ee70a-030d-4328-9618-b5bb09676c7c"
      unitRef="usd">201249000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7972eed61fdd41bfa7003be5de760617_I20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjJmODExNzFhODhkNTRjMzc4Y2MwOTVhYWMwMzY5ZWYxXzQ_a02f333e-a2c6-439d-b41f-15074634341a"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0xLTEtMS05ODY3NA_10dde62a-7ce0-4f13-8a5d-a646b7acf1f8"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNS0zLTEtMS05ODY3NA_5c3a08c5-2b38-4ea2-82ec-b7e55137625a"
      unitRef="usd">157857000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0661863911fa4ee69bffbcb43e697fc9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNi0xLTEtMS05ODY3NA_2c3a670a-057f-4b96-b50b-a0e7ab82d09c"
      unitRef="usd">747870000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0e2c21af05a4477e9c7bb7850db493fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjkwOGQ1MzliODU4MDQ1NWE4ODExMmRlMTRjYTVmODIyL3RhYmxlcmFuZ2U6OTA4ZDUzOWI4NTgwNDU1YTg4MTEyZGUxNGNhNWY4MjJfNi0zLTEtMS05ODY3NA_66ccc359-28af-43e7-b264-d41440611d8b"
      unitRef="usd">1049230000</us-gaap:LongTermDebt>
    <pcrx:DebtInstrumentDiscountRate
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDU5_2a6cc4a6-5eea-4401-9bc6-98c25d05ce5d"
      unitRef="number">0.03</pcrx:DebtInstrumentDiscountRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTUx_d4a17cdb-5f16-4e4a-b274-9ad79392f513"
      unitRef="usd">375000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia67521500add4fed80583b1a16d61ffc_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTYz_d889d885-d911-4ae5-8a94-7f1365de3690"
      unitRef="usd">363800000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ib5d7be76ce2e48f592161d85a4fefa90_I20211230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTAxMg_8e7277d6-6f7f-43e3-a491-98f200d7ef1e"
      unitRef="usd">11200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NDQ_daaf9fbc-5b71-4e18-b2d7-1698febf65bf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the Term Loan is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan maturing December 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due August 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMi0xLTEtMS05ODY3NA_61aef715-13d8-4429-8e01-72d15af0d30d"
      unitRef="usd">356250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMi0zLTEtMS05ODY3NA_b639ff8d-6c0d-4007-9b48-9cbb7ee637eb"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMy0xLTEtMS05ODY3NA_87c6e8cd-b990-4522-a06a-a0e4c0f86806"
      unitRef="usd">3578000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfMy0zLTEtMS05ODY3NA_4101073d-ad73-47f2-a6cf-c0e2d1026701"
      unitRef="usd">4443000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNC0xLTEtMS05ODY3NA_717487aa-9fbf-48c0-9082-a9da358a231b"
      unitRef="usd">8953000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNC0zLTEtMS05ODY3NA_7ee4e531-55db-4ceb-9a37-7f67bc114f73"
      unitRef="usd">11060000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNS0xLTEtMS05ODY3NA_e7d5bf03-3708-492e-83ea-2b8f03bbaa57"
      unitRef="usd">343719000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f79191a39814bf2ae0a7e0d2f2ad7d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjM3MDczNTQ4Y2U1YTRkMzNhZjU2NjRiOWU4YTU0NzVhL3RhYmxlcmFuZ2U6MzcwNzM1NDhjZTVhNGQzM2FmNTY2NGI5ZThhNTQ3NWFfNS0zLTEtMS05ODY3NA_0fc828be-eecb-4192-b1df-2c39d34d73c6"
      unitRef="usd">359497000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i25ab9cb4fb474f0294e6a5ee5da125cb_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTE5Nw_8ff63b5d-bc5e-4a43-b853-840e6a1f3bf4"
      unitRef="usd">9400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i9083b4c816cc413aa9ab5d4153e040e9_D20251231-20251231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI0MA_0c06cb46-9e1d-4a51-8289-de79b17096ad"
      unitRef="usd">14100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
      contextRef="id5c3a50af1fd40f4bf123c711ae0554e_I20261207"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMyMw_f46043f0-5293-4442-bcd2-f78f0f1dbbe8"
      unitRef="usd">188000000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NjA_270e8c7f-5106-4f29-aebe-c2518d93becf"
      unitRef="payment">3</pcrx:DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i23248a32f20143cdb17ce6c0f3073d59_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQyMg_3e6df71b-25a6-4c4e-ba5f-d44873cf50ad"
      unitRef="usd">28100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTk4Mg_b4b9e685-cff4-46e2-ad42-ca15bd4239ac"
      unitRef="number">0.02</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear1>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjA0NQ_057cea9e-92c0-46b4-839c-b715290913ea"
      unitRef="number">0.02</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear2>
    <pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter
      contextRef="ie1806dce28b54192bab8601ab3c1447b_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjA3Mw_09580f33-3d57-4246-86c0-659d2a705d7c"
      unitRef="number">0.01</pcrx:DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ib50e0fe6fa704b639d0ebd924808a630_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjM2NQ_986c2f30-5e20-4a89-899d-82096e0eaa6b"
      unitRef="usd">18800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <pcrx:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjU0Ng_c37d4b45-2b2f-4fcd-88a5-955274aacc9d"
      unitRef="number">1.75</pcrx:DebtInstrumentCovenantLeverageRatioMaximum>
    <pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue
      contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMjYwMA_9e4ddde0-f403-4372-a9dd-871af6d492e3"
      unitRef="usd">150000000</pcrx:DebtInstrumentCovenantLeverageRatioMaximumValue>
    <pcrx:DebtInstrumentVariableRate
      contextRef="i1ff7019c657c48dc88b1a004ea06e6c4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzEyNg_e082a61c-9061-4ce2-94f3-48fd1fd59bb6"
      unitRef="number">0.0075</pcrx:DebtInstrumentVariableRate>
    <pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate
      contextRef="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzE3OA_4654ac98-b95c-4b1e-8a0d-2216866e50c3"
      unitRef="number">0.0700</pcrx:DebtInstrumentBasisSpreadTwoOnVariableRate>
    <pcrx:DebtInstrumentVariableRate
      contextRef="i7a1f16b7c4a44c2f9845617ce7eb7a49_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzMxMg_84f83c0b-d14e-40a4-a470-bdd43149c702"
      unitRef="number">0.0175</pcrx:DebtInstrumentVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifba3b8babde24b29a32cda10f955ab31_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzUwMQ_5769a119-3b5f-436f-94bf-a4788df425c9"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pcrx:DebtInstrumentBasisSpreadOneOnVariableRate
      contextRef="i338f4ca3f9ff4f95bd42ed90cb75ab9d_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzU5Ng_3c4b117d-18bc-4e57-b802-887afee878d1"
      unitRef="number">0.0100</pcrx:DebtInstrumentBasisSpreadOneOnVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i87421aa4628142b0b44a3829fc1f2eca_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzY3Mw_e400cd67-7ace-43ea-91b1-2e4b828815ca"
      unitRef="number">0.0600</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i0685a2f4f2664048921f005c41b7445f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzc5Mg_5a5a95df-7204-4ada-bea0-f72fcac35000"
      unitRef="number">0.0921</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7e8761921961454aac57dbb378009c76_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzg5MA_fcc7a22d-4cd4-42f0-af5d-f3a0627f1e8b"
      unitRef="usd">402500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e8761921961454aac57dbb378009c76_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMzkzMA_2e6157c1-f3dd-4a7e-8797-81d8da8b7c04"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e8761921961454aac57dbb378009c76_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDExNQ_5c8c7217-372a-4a0b-9261-b881a8b324fc"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOmM2NjI5ODg4OTgzZTRjODlhMmUwZTA4Mjc1YjBlMzA2XzQ_867f9643-0b08-416d-b35d-187a86c6b623"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0xLTEtMS05ODY3NA_f119127c-ddfa-4dfa-804d-4fff94d5e74f"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMi0zLTEtMS05ODY3NA_37b4f31b-8273-47f1-9cd1-263eb5e652df"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMy0xLTEtMS05ODY3NA_e3dbfda8-d177-4e65-a4e1-9d49f5789079"
      unitRef="usd">6990000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfMy0zLTEtMS05ODY3NA_4f4664bf-8ec9-4cda-b540-010345022d8f"
      unitRef="usd">7155000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNC0xLTEtMS05ODY3NA_9ea6e470-8926-4729-b886-23d773ce8d5b"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNC0zLTEtMS05ODY3NA_f18f3ea6-4ac2-4a67-bd88-b0a1f54b04c2"
      unitRef="usd">64718000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNS0xLTEtMS05ODY3NA_6a18f560-2297-4a3c-a70b-2ef3fbe2cb94"
      unitRef="usd">395510000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie3477014ac1d43d3b9fabdfc51d7be9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOjcwMzg1Y2VjMDlkNjQ2MmQ5MWRmYmUzNDkyYjI3ZjVkL3RhYmxlcmFuZ2U6NzAzODVjZWMwOWQ2NDYyZDkxZGZiZTM0OTJiMjdmNWRfNS0zLTEtMS05ODY3NA_1c779abb-f3db-451f-aa01-da5557aa0d89"
      unitRef="usd">330627000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i6e99e58b6bd44e40ab5470c217d31556_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDM5NA_d7868f01-c8bf-4ad5-9b95-51d8a3fbbeb3"
      unitRef="usd">390000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i4512c74066e24feca38c2f9325150125_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDU2Mg_9f7d13ac-177b-40ad-89c4-e561ff2dce9d"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4512c74066e24feca38c2f9325150125_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDYxOQ_497ca9a8-c2ab-4182-81c8-9a55c6ee632e"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDcwOA_68f1c5ae-7430-442a-8687-6c24010793fc"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNDk5MA_0fc22ef9-7582-4fac-af0d-7b8c699d02bf"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTA0Ng_7a50acef-8b46-4a17-9165-c1b2d08104ad"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ifa82e6023b434f65a88a08b11596f848_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTA2NQ_75942f6c-eba7-4267-b5af-bb880e72aff3"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:SettlementPeriodConvertibleDebtConversionRequest
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNTU1NQ_639bfc3f-7c44-4f00-951d-4bcd7f966ab1">P40D</pcrx:SettlementPeriodConvertibleDebtConversionRequest>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i296d96d871454ea38915dae663029fed_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjAyNA_2e8150ad-cecb-4b22-84d0-718ef6380c92"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock
      contextRef="i296d96d871454ea38915dae663029fed_I20200731"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjI4MA_4daaa3e7-6d12-428a-b1a4-b7bd0c66b929"
      unitRef="number">0.325</pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock>
    <us-gaap:SharePrice
      contextRef="i296d96d871454ea38915dae663029fed_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjMxMg_724373f2-d10c-4c3d-82ef-3e7e8bfb436a"
      unitRef="usdPerShare">54.17</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i96d9551dea4644c58fe6c52777f083d4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNjk0OA_9e169c85-e48f-4295-9015-e7eb2933e64e"
      unitRef="usd">402500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzUyMA_7e1cd91d-be18-4aa1-ad72-a91200dd5265"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzU4Nw_e739f416-1880-4136-8fd8-17c841dcf4f6"
      unitRef="segment">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzY0Mw_76fffc71-016b-45a3-a0c4-146e926314e7"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="i3a1c497822ad4738ae8220ea99059a4c_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfNzkyMw_b3dbe66f-935f-41aa-b11b-9a06288512e3"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTIwNw_5a4a8aac-8605-4d56-a155-767f462ec3fd"
      unitRef="usd">201300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTIzMA_e3e50d9b-8d77-422a-8d72-1417f7d632ed"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id2a8e26c520b4b6e9ba3eeb3b6c50842_I20170502"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfOTgxNQ_0d850760-c040-42a5-b1e0-05a118a05348"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia37f7fd3e4cb4abda635243010c825e3_I20170502"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTAzOTk_26a9a71d-9c22-440f-9576-8927ccf88ee2"
      unitRef="usdPerShare">26.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="ia1cf140155284958b08b2b1f0924c732_D20211206-20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTEyNjg_e11378bc-e120-470d-8f63-080ac0293101"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i7c781235586e428f8b7c97e2da13c07b_I20211206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTIwNTc_3b32df81-b54c-408b-96d0-d09207eb66d3"
      unitRef="usdPerShare">317.40</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount
      contextRef="i7c781235586e428f8b7c97e2da13c07b_I20211206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTIwNzc_403ce07e-805d-4f11-aaba-2958287f148c"
      unitRef="shares">37.3413</pcrx:DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i9637107d21ec4490b98079479563d736_I20220107"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI2MDk_1b512ec4-d4cf-419d-9e66-af1e648b9697"
      unitRef="usd">192600000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:LongTermDebt
      contextRef="i2a9fe0493cf0469887c610902f910cc7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI4MzE_1fe01cfc-db42-4851-bcdc-9dcb12908c27"
      unitRef="usd">8600000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0758a7b3ffcf4223ab706cc6d93df47d_D20170301-20170331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI5Mjk_c6cdce10-0bbc-403c-b37b-760a477ea5f2"
      unitRef="usd">345000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTI5NjU_0f579970-94e9-43dd-9dab-2f05f48feb0d"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifed1318b63d84407bb0fd3fbbc2b0117_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMwNjk_5ca5567d-c36c-4bf1-b4bd-5e0badbdc44c"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i4512c74066e24feca38c2f9325150125_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMyNjM_ef5b5892-dc81-4713-9cd0-8bb6724b2c4d"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="iaa99b3647bd046478936f9f397bd4753_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTMzNjg_eaa1c0f4-93d7-450e-857a-0926f9c7bc76"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0wLTEtMS05ODY3NC90ZXh0cmVnaW9uOjU4MGM5MTEyMGE3MDRlNGU4NjA4YzVhNGU5MWNhY2M0XzQ_48dfc21c-765a-4755-8a33-f39c4e38dc4d"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0xLTEtMS05ODY3NA_3a56883a-1491-42c5-ab80-87fccfea52ac"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMi0zLTEtMS05ODY3NA_613ad293-4bf3-480d-8667-bec843fae50c"
      unitRef="usd">160000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMy0xLTEtMS05ODY3NA_ddc09c96-bea5-48df-9b39-7059e56ad55c"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfMy0zLTEtMS05ODY3NA_4e51cc8a-3b96-4f79-8bc5-ea09758cb307"
      unitRef="usd">223000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNC0xLTEtMS05ODY3NA_96bbbeff-66e6-493f-a3e0-4d585408df68"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNC0zLTEtMS05ODY3NA_52fe98c2-7ff7-4f6d-bc45-a6759aab7bf3"
      unitRef="usd">1920000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="id3bfdb577e5f40e2a1cc25683f97f802_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNS0xLTEtMS05ODY3NA_2f0a0a66-9e18-4ed1-b4c8-ed044dd69547"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ife796b99e35c4aa0a9cb4319f90bb90d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmU5ZDA5ZDEyMjMwODQ3NzNhMzk2MzUyODA5N2FiZGJlL3RhYmxlcmFuZ2U6ZTlkMDlkMTIyMzA4NDc3M2EzOTYzNTI4MDk3YWJkYmVfNS0zLTEtMS05ODY3NA_78a7f441-18d4-48db-993c-390cbf3d0baf"
      unitRef="usd">157857000</us-gaap:LongTermDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM1OTc_edc06d3f-8399-49e1-8074-2489eb63ee5a"
      unitRef="usd">160000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2Mjg_325b3fc1-0f00-4617-b099-58dc1d985496"
      unitRef="usd">-4800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5b67e779ef8b4a1aa82b7b7b533b8a63_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2NTc_23cbc4dc-c2ee-4ffc-98ab-2dc178286b13"
      unitRef="usd">156900000</us-gaap:RepaymentsOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM2ODA_4078d907-1d61-46f8-bf8c-060e6d440378"
      unitRef="shares">101521</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ie21eeb52e35c4d75ada8775b18e4e3c7_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTM3Njc_db832f0e-4e4d-4b38-9ee4-2a0db6c2099a"
      unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <pcrx:ScheduleOfInterestExpenseTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RleHRyZWdpb246ZDZlODAwNDUxM2RjNDUwNzk1OTUwNDMzZDc0ZDk3ZDdfMTQ2NTE_57aba889-b404-4f94-9f30-c7f709c411e9">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi0xLTEtMS05ODY3NA_87dbcdac-d8be-438e-bc63-7959233bf614"
      unitRef="usd">9343000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi0zLTEtMS05ODY3NA_cdef4db2-1d94-46b2-a867-c923e731a5e1"
      unitRef="usd">1704000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi01LTEtMS05ODY3NA_27cf3704-456c-478c-812b-6fef2d22dcf9"
      unitRef="usd">26724000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMi03LTEtMS05ODY3NA_7544d7b9-3220-438c-9c9d-8404224c53f9"
      unitRef="usd">5122000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy0xLTEtMS05ODY3NA_e5b378c4-839e-4023-b68f-96fcb0c5208e"
      unitRef="usd">903000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy0zLTEtMS05ODY3NA_dfe5caed-a1cc-4dcb-9868-49141465f8fa"
      unitRef="usd">666000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy01LTEtMS05ODY3NA_8658bc71-7a36-43fd-991a-047de89f9af5"
      unitRef="usd">2956000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfMy03LTEtMS05ODY3NA_35734f52-be88-4324-87b2-702a2fe2a6f1"
      unitRef="usd">1976000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC0xLTEtMS05ODY3NA_cc658a76-188c-4bb1-84ce-848f9a063109"
      unitRef="usd">695000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC0zLTEtMS05ODY3NA_a1c39ebf-9554-42b8-be65-914817b1d10a"
      unitRef="usd">5844000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC01LTEtMS05ODY3NA_aae4c268-2377-42c6-8b40-c27f42d62d4c"
      unitRef="usd">2107000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNC03LTEtMS05ODY3NA_fdc8e976-9f4d-43dd-be5f-fd391abb529e"
      unitRef="usd">17245000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestCostsCapitalized
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS0xLTEtMS05ODY3NA_2c204b5a-0415-4420-bbbe-19fc20ce8eba"
      unitRef="usd">1085000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS0zLTEtMS05ODY3NA_17e70936-c82a-4c32-b514-87f5f1714904"
      unitRef="usd">881000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS01LTEtMS05ODY3NA_f669d51a-484a-4c4e-95bb-ec946d7f3a61"
      unitRef="usd">2852000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNS03LTEtMS05ODY3NA_439bd56e-c44f-4ae2-95ad-fab49f91022c"
      unitRef="usd">3016000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestExpenseDebt
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi0xLTEtMS05ODY3NA_5ce88246-df83-4a88-a0bc-dfa2d03b2df5"
      unitRef="usd">9856000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi0zLTEtMS05ODY3NA_da94f298-4eb6-4660-a333-844295d1b3bc"
      unitRef="usd">7333000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi01LTEtMS05ODY3NA_8b50af27-e9ad-432f-bad9-712f5f7373b0"
      unitRef="usd">28935000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfNi03LTEtMS05ODY3NA_9741c4df-5d87-4fa0-b804-f34246fdd443"
      unitRef="usd">21327000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC0xLTEtMS05ODY3NA_9cbd2f3e-54ad-4d7c-a71c-28b3140ed0c8"
      unitRef="number">0.0542</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC0zLTEtMS05ODY3NA_5f3bdd41-b318-45ef-986d-7169f753de11"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC01LTEtMS05ODY3NA_0f7d72ec-0e32-4818-b676-a0f9ce1a28b5"
      unitRef="number">0.0566</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82MS9mcmFnOmQ2ZTgwMDQ1MTNkYzQ1MDc5NTk1MDQzM2Q3NGQ5N2Q3L3RhYmxlOmM0MmRhZGRhOGE1NTQ2MTc4NjU0M2FhYTMzNDhlNWNhL3RhYmxlcmFuZ2U6YzQyZGFkZGE4YTU1NDYxNzg2NTQzYWFhMzM0OGU1Y2FfOC03LTEtMS05ODY3NA_25fa9700-be49-40cc-8351-f4c4b0e920ac"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg0Nw_c3cfa7c2-6de7-4db5-a98a-4a7fc227b566">FINANCIAL INSTRUMENTS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#x2019;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#x2019;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amounts of convertible notes receivable without readily determinable fair values have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions, whereas an equity investment was fully impaired during the three months ended September 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility due December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;3.375% convertible senior notes due 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was $53.19 per share at September&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at September&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#x2019;s common stock, which assumes no increase in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity and Convertible Note Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds strategic investments in clinical and preclinical stage privately-held biotechnology companies in the form of equity and convertible note investments. The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022, an impairment of an equity investment of $10.0&#160;million was recorded within other, net&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2021, the Company sold an equity investment for net cash proceeds of $9.1&#160;million and recognized a realized loss of $2.6&#160;million, which was recorded in other, net in the condensed consolidated statements of operations. The fair value of the divested equity investment was based on a Level 1 input.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recognized contingent consideration related to the Flexion Acquisition and the MyoScience Acquisition in the amount of $34.2&#160;million and $57.6&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. The Company&#x2019;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rates used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company completed the Flexion Acquisition, which provided for contingent consideration related to CVRs that were issued to Flexion shareholders and certain equity award holders which could aggregate up to a total of $425.5&#160;million if certain regulatory and commercial milestones are met. The Company&#x2019;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2030, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represented the Company&#x2019;s potential achievement of meeting the regulatory and commercial milestones. For the period from the date of the Flexion Acquisition through December 31, 2021, the Company recorded an additional $1.2&#160;million liability. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded gains of $0.5&#160;million and $13.8&#160;million, respectively, primarily due to adjustments to near-term forecasts for the earnout period of the contingent consideration. These adjustments were recorded as acquisition-related gains in the condensed consolidated statements of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At September&#160;30, 2022, the weighted average discount rate was 14.4% and the probability of success for the remaining regulatory milestone was 20.0%. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the Flexion Acquisition was recognized in the amount of $32.6&#160;million and $46.4&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#x2019;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of September&#160;30, 2022, the maximum potential remaining milestone payments to be paid are $43.0&#160;million. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized contingent consideration gains of $0.5&#160;million and $9.6&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, due to the reduced probability of meeting the contingent consideration milestones by December 31, 2023, the expiration date for achieving the milestones. The Company recognized contingent consideration gains of $1.2&#160;million and $2.1&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. At September&#160;30, 2022, the weighted average discount rate was 12.8% and the probability of success for the regulatory milestone that has not yet been met was reduced to zero. As of September&#160;30, 2022 and December&#160;31, 2021, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $1.6&#160;million and $11.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Flexion Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;MyoScience Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.98% to 14.77%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.25% to 13.28%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% to 20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available-for-Sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate, federal agency and government bonds with maturities greater than three months, but less than one year. Noncurrent investments consist of federal agency bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#x2019;s short-term investments are reported in other comprehensive income (loss). At September&#160;30, 2022 and December&#160;31, 2021, all of the Company&#x2019;s short-term and noncurrent investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term investments had an &#x201c;A&#x201d; or better rating by Standard&#160;&amp;amp; Poor&#x2019;s.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s short-term and noncurrent available-for-sale investments at September&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2022 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, there were no investments available for sale that were materially less than their amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2022 and December&#160;31, 2021, the interest receivable recognized in prepaid expenses and other current assets was $0.4&#160;million and $0.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term available-for-sale investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;As of September&#160;30, 2022, three wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 33%, 18% and 18%. At December&#160;31, 2021, four wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 30%, 20%, 17% and 11%. For additional information regarding the Company&#x2019;s wholesalers, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. EXPAREL and ZILRETTA revenues are primarily derived from major wholesalers and specialty distributors that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the &lt;/span&gt;&lt;/div&gt;Company&#x2019;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2022 and December&#160;31, 2021, the Company did not deem any allowances for credit losses on its accounts receivable necessary.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg1MQ_c9217aae-a3f7-4d9e-973d-9b02aa9f2a2d">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility due December 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;3.375% convertible senior notes due 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was $53.19 per share at September&#160;30, 2022 compared to a conversion price of $71.78 per share. Therefore, at September&#160;30, 2022, the conversion price was above the stock price. The maximum conversion premium that could have been due on the 2025 Notes is 5.6&#160;million shares of the Company&#x2019;s common stock, which assumes no increase in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Relates to the Flexion 2024 Notes. For more information, See Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC0yLTEtMS05ODY3NA_08f3df14-fd2b-497c-9139-352ae45bb94b"
      unitRef="usd">15877000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC00LTEtMS05ODY3NA_40b67c6a-9820-4259-b986-35a52c0ef9ec"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC02LTEtMS05ODY3NA_e194b0bb-ef5a-4499-a3a0-f76312180c7b"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNC04LTEtMS05ODY3NA_ac1be9e0-a84a-4a20-ae51-e9305acbaf9b"
      unitRef="usd">15877000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS0yLTEtMS05ODY3NA_709f01cb-c26c-45b2-bbfb-64acb8a5a0c0"
      unitRef="usd">5224000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS00LTEtMS05ODY3NA_95b3727b-54fd-4b39-805a-ebc6aee9aa63"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS02LTEtMS05ODY3NA_8c569659-5f14-4de8-9a1e-94aef5e4afd5"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNS04LTEtMS05ODY3NA_205543e8-64e4-4176-9b6f-496bd72ea494"
      unitRef="usd">5224000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2c4eb1feab7a4455a8715a95b460650a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy0yLTEtMS05ODY3NA_0a7d180e-bc05-4b97-966c-b7c8fc2f2882"
      unitRef="usd">34204000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib2fab0244e854bc2a5e7b09ccf5d6d57_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy00LTEtMS05ODY3NA_96c0f6ea-9232-4cac-9a97-4639443b90d0"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iad677feff1b3471c9fc3894136f1cb76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy02LTEtMS05ODY3NA_04d01265-3464-4f01-9c5b-e367b4e8ff36"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if395814f8be54df8ae589815c8b5ea5f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfNy04LTEtMS05ODY3NA_0e88fce0-c92a-40f2-a071-725a6c37a945"
      unitRef="usd">34204000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i68b2cb6f7435421fb55a6eb4e5b93ba0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtMi0xLTEtOTg2NzQ_feb15e17-8081-48cc-a3f1-d0fe28f5286b"
      unitRef="usd">343719000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if9990062454b491199857f28489640fe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtNC0xLTEtOTg2NzQ_46125c7b-3141-4e51-af6c-20bcb403667e"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if461dd01e8a747b98348bf5b481bc5ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtNi0xLTEtOTg2NzQ_30a28cc3-a741-4560-9317-142e84304c57"
      unitRef="usd">343781000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic5390f0263e84d2991820ff5956b0b46_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTAtOC0xLTEtOTg2NzQ_adf78bdd-19e1-4c9a-8e81-4e11a171f3b2"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2987275eeeb04ca68f16c4a37d3f4047_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpkNjMzNTA4YjhiNjg0NTNkOWVhMDdiMmJmNDQ3MTkyMl83_1d1c39db-1b31-41ac-9e7b-0df7fcf28b49"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i73d52c9f53b64c98807e28bf9ce30a2b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtMi0xLTEtOTg2NzQ_6cded9e5-5846-4083-bd7f-5a4fc6ce6b9d"
      unitRef="usd">395510000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i842c641ed23b47fbae6ff4979db04f5f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtNC0xLTEtOTg2NzQ_9801d90f-1dfe-490b-ae2e-9ef4227ed481"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i237dd059fd944899a066705c4dd92003_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtNi0xLTEtOTg2NzQ_1487ec93-91f8-42ea-8043-925dea00dfce"
      unitRef="usd">399481000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if76389ec090e4b37a494b0f226302069_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTEtOC0xLTEtOTg2NzQ_29b70f9b-75e7-4625-bd05-abc5b2598f91"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04816a7095884e6e9859291f3a1985f6_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItMC0xLTEtOTg2NzQvdGV4dHJlZ2lvbjpiMjg1ZDAzN2Q0ODA0MzhhYjY3NjgwMzk4ODdiZmI2ZF83_70951b1f-f6d8-4678-bec0-a543da366bca"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id7032c8982294d0285e1776d6d06b048_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItMi0xLTEtOTg2NzQ_2ae6e206-e2b3-45f5-a0de-d6ab026e4289"
      unitRef="usd">8641000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icd6c853b9ab94c81b8a41af53226deb3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItNC0xLTEtOTg2NzQ_cea8e03e-5aac-4d40-8235-8a80d4b8daab"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7b0c51b1b8584e129f7c49e3e49e3733_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItNi0xLTEtOTg2NzQ_dce5d80d-1d17-4271-be2e-1f520be21e12"
      unitRef="usd">8649000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6cf9551aa20b403f82af345d31ef1338_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ1MmYzOGM1ZDM5NDQ5ZGM5NTMyYzg5NjY3ODBmZTljL3RhYmxlcmFuZ2U6NDUyZjM4YzVkMzk0NDlkYzk1MzJjODk2Njc4MGZlOWNfMTItOC0xLTEtOTg2NzQ_56c837eb-e2fb-43a7-8264-c1433e2d8dcb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SharePrice
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTk4NA_f1b98404-48f1-4096-bfe9-278773ce6a59"
      unitRef="usdPerShare">53.19</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="if14d12e11ebf4258a8f69637d5c05212_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjAzNw_5dca8cb7-1e8e-422e-83da-ebe4dde90851"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConvertibleConversionPremiumShares
      contextRef="i7601e3ac14b4439db842e414e541e541_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5NA_c55da7f8-0c22-4914-8f43-6cd8bb07919d"
      unitRef="shares">5600000</pcrx:DebtInstrumentConvertibleConversionPremiumShares>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg2Nw_d28fb059-251a-45aa-8359-38b3d10db797">The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Convertible Notes Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9ff74a397bde40f0a00c0186334cb04b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0yLTEtMS0xMDY4NzM_0b1773ed-7545-4faa-bf64-292e61bc7319"
      unitRef="usd">12802000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i3cd4e8e0384e49248615b7e238b8f37b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS00LTEtMS0xMDY4NzM_ea57a0a3-efb9-4cb1-91d6-f705584f47b8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="idad438652c2a484a8de75c3c8971bdef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS02LTEtMS0xMDY4NzM_6bbf947c-2c9f-4333-a1e2-b15fc24aa485"
      unitRef="usd">12802000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0yLTEtMS0xMDY4NzM_ee8f00fc-fc02-4589-a14e-a79ce31c4ec2"
      unitRef="usd">12967000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi00LTEtMS0xMDY4NzM_d63b98dc-9d27-48a4-a576-e5ec6b962083"
      unitRef="usd">4220000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi02LTEtMS0xMDY4NzM_25bbbc23-74e3-4970-9dd9-b2fcc3e48f77"
      unitRef="usd">17187000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0yLTEtMS0xMDY4Nzc_5e351037-c8c4-401f-8949-b86fe48cf1de"
      unitRef="usd">-11642000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy00LTEtMS0xMDY4Nzc_01f316d1-9f50-4f53-84b4-9eaac1b49c73"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy02LTEtMS0xMDY4Nzc_5078bd6c-8ea7-4f8b-8ec9-6fc4e9db43d4"
      unitRef="usd">-11642000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="if6ba663c30a8471aad99e22f97f9eb7c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0yLTEtMS0xMDY4NzU_c91c2298-4a10-4025-a08d-c9d65212f70a"
      unitRef="usd">0</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="i2208a26e59bf4d999510aff3269356e0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC00LTEtMS0xMDY4NzU_e035b4fc-434c-4e06-9132-e0a95824a9d4"
      unitRef="usd">-88000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC02LTEtMS0xMDY4NzU_e6cc9372-a02b-40af-beb7-34dc84744732"
      unitRef="usd">-88000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i3ee79fc7c43e4c82a749f7a396f9b49a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0xLTEtMS05ODY3NA_59515b43-48b0-46d1-8146-7d808d7bcc5b"
      unitRef="usd">14127000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if235f229d1e54baa9183a582add02676_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS0zLTEtMS05ODY3NA_f1935459-c272-4767-a781-60a691f9324c"
      unitRef="usd">4132000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMS01LTEtMS05ODY3NA_022d6134-4cc5-4b6e-8251-bc2c3d0c4b91"
      unitRef="usd">18259000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0xLTEtMS05ODY3NA_d8536d83-0eb2-47ca-b174-4722093ee1bd"
      unitRef="usd">11750000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi0zLTEtMS05ODY3NA_10ef47e7-ec9d-4551-9af8-51af0046f218"
      unitRef="usd">1250000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMi01LTEtMS05ODY3NA_b49f4743-90cf-472f-83e7-65ec9015d2e3"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
      contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0yLTEtMS0xMDMzMzk_76557da4-53c3-4dd0-9e88-7fa400d171e9"
      unitRef="usd">-10000000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
      contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy00LTEtMS0xMDMzMzk_e2121338-6335-4835-9d00-b899e99f0a23"
      unitRef="usd">0</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy02LTEtMS0xMDMzMzk_67e042a3-9e23-4186-8aca-c859234d4336"
      unitRef="usd">-10000000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="i5cc47b76f66f49d5b0e916857021a4ab_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0xLTEtMS05ODY3NA_9fe495ce-622a-426d-a310-b87f049e30fc"
      unitRef="usd">0</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="if45c48f822014fffa77939a3f9445eee_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy0zLTEtMS05ODY3NA_90391213-ecff-44d0-85b2-24f4a5143ff5"
      unitRef="usd">-158000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfMy01LTEtMS05ODY3NA_df386d98-7161-4735-a8b5-f7538317316c"
      unitRef="usd">-158000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i45972db0acf74f51a6a8fe893af05d41_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0xLTEtMS05ODY3NA_f15bc591-6c1a-4735-bf1c-5dcf7a691472"
      unitRef="usd">15877000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5c1875ee869245698fc37dffd27e30da_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC0zLTEtMS05ODY3NA_ed31cc61-3464-40f9-ae0c-8f83bdb1871f"
      unitRef="usd">5224000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmUzMjQxMmMyY2NiNzRhYzhiNDdjNzU5MGYyNDczY2EwL3RhYmxlcmFuZ2U6ZTMyNDEyYzJjY2I3NGFjOGI0N2M3NTkwZjI0NzNjYTBfNC01LTEtMS05ODY3NA_45f1cf46-47b4-4612-9e33-ed22327d6f80"
      unitRef="usd">21101000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTA5OTUxMTY0MTYxNQ_7dbd6263-7824-44ad-af16-b3d8dc165abf"
      unitRef="usd">-10000000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMTA5OTUxMTY0MTYxNQ_e51c3db9-4362-4e7a-9fed-78eb0e88b5e2"
      unitRef="usd">-10000000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i7a2c111588354614880539cfc8ac9953_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5OTAyMzI2OTI1Mw_7bd7628a-4067-4255-8d40-a3387f4bd56f"
      unitRef="usd">9100000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="i7a2c111588354614880539cfc8ac9953_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjE5OTAyMzI2OTIzOQ_8ed9e0bc-0917-4b74-9341-712815f5bee2"
      unitRef="usd">2600000</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib134093c2a3f489ab847df33ed43d3d9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMjk5Mw_2050a007-80f2-45f1-baff-66fc5794ab59"
      unitRef="usd">34200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib75b83d0d5d841d190c5b865d08cd08d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfMzAwMA_381bc02c-6a21-440b-9d8f-98ddf8adf1b6"
      unitRef="usd">57600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ief0126ce4313418d8ce64bdcbb8482ca_I20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDE1NA_0a5ce8d8-b618-48d1-891e-222b06b8ff58"
      unitRef="usd">425500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <pcrx:ContingentConsiderationPaymentTerm
      contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDM1OQ_ce587eb8-a265-49c5-8c00-f7fa836969c0">P60D</pcrx:ContingentConsiderationPaymentTerm>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDU0NQ_12fff21a-bd1a-47ea-8c2e-d94a2b7a9d75"
      unitRef="usd">45200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia6f13ce1ab564a898d9dac5545791a08_D20211119-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDc3NA_2f4a5174-e4eb-4a99-b5ba-1a88aa98321a"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDg0Ng_d4293afe-f3f7-4847-8fd6-658b2f05b358"
      unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNDg1Mw_05687c1c-1617-452a-8a4d-3e82e81fb03d"
      unitRef="usd">13800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8f7942c168654d229d7c5f4bb6f53cff_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTE0Mg_41830fa6-93e0-45a5-b874-2dfa36981871"
      unitRef="number">0.144</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="if8692b80a10c4971a257a0b3f42d44bb_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTIyMw_360ecd6f-bd62-44b3-8dc1-6eedf2c811fe"
      unitRef="number">0.200</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie699db1e7648442b83c51b5a1a49d064_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTM0OA_48a9548d-cc79-43bd-9c13-80d7a3142192"
      unitRef="usd">32600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1b34aaa056564bd9be196339b6471fcc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTM1NQ_638dac1e-f6e9-442a-a0b9-9bcea4db27ec"
      unitRef="usd">46400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <pcrx:ContingentConsideration
      contextRef="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTU2OQ_ee71eef4-c236-4ab8-bcb4-0f357a1976c8"
      unitRef="usd">100000000</pcrx:ContingentConsideration>
    <pcrx:ContingentConsiderationPaymentTerm
      contextRef="i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTc4Nw_73fc7db8-6bae-4a7c-af84-2068173be0d1">P60D</pcrx:ContingentConsiderationPaymentTerm>
    <pcrx:ContingentConsiderationCurrent
      contextRef="i6c3e45d0874045948ab68adfba7d11f7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTkyMA_3d7b309e-7f75-479a-89f9-151a12ea8b43"
      unitRef="usd">43000000</pcrx:ContingentConsiderationCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTk4MQ_1cb442ec-7aa4-430f-9794-7c6e05040dc0"
      unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNTk4OA_66ae55e7-a445-49b4-a84b-4b1a08c06412"
      unitRef="usd">9600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjIxMg_b12aeecb-b184-4236-a979-adca3ce170ae"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjI1Mw_16b97e36-5cee-4791-81de-aa5259f735b8"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iba4b68f7ebb74b26a54592d12d2be099_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjM1OQ_86cb5260-bfb0-4915-a945-0529a27b34ce"
      unitRef="number">0.128</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8ac8229fdddc4b69a07f14f03a89a3a3_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjQ2Mw_0d240e60-9ffe-4636-a7d8-f7f6a25fd7d1"
      unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6c3e45d0874045948ab68adfba7d11f7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjU5Nw_dd820756-f251-4a54-9875-a22bc82c432e"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie856966ca92d41f78bca76f98d68d66a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfNjYwNA_11a8270a-2676-4a45-a3a4-0e0dd93efe5f"
      unitRef="usd">11200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg2OA_23e8183d-5baf-4e72-b48d-f71f4b17eb27">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Flexion Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;MyoScience Ranges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Utilized as of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.98% to 14.77%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.25% to 13.28%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% to 20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i9e57fefd18bb42ddbe9674fd60b5a57f_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOmI5MmVmY2VjYzA3MjQwNWRhMDRhMGNkMWUwYTU4Y2E3XzQ_34b26783-5e28-4daf-86e8-3b6c67901f2f"
      unitRef="number">0.1398</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i06a2e05d68194f6d893829de561923ae_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOmI5MmVmY2VjYzA3MjQwNWRhMDRhMGNkMWUwYTU4Y2E3XzEw_b6511be9-1f19-413d-9378-3e908531fc9d"
      unitRef="number">0.1477</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id902659ce35844918702ed4963f48b60_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjE0ZmQ2NDdlOWUwODQzMWFiZDZmNzUzNTJmNDAyZjM2XzQ_4250cc1e-8de8-4523-a132-0dee497cb9f8"
      unitRef="number">0.1225</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iab55c6e18cd7486e97de5fe845e97e9b_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMS00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjE0ZmQ2NDdlOWUwODQzMWFiZDZmNzUzNTJmNDAyZjM2XzEw_1c5d3601-126a-4dc0-9d62-856cca3ecfa6"
      unitRef="number">0.1328</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ib6855240812b48478df36a10542449d4_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOjdkNmVmYmMyMDNmNzRiMTM5NGYwZTBkNDcyZTE5ZjkzXzQ_135bf32c-de16-4501-a15c-180a77297a08"
      unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i56063439710147d8a4fccb6b50441d1a_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi0yLTEtMS05ODY3NC90ZXh0cmVnaW9uOjdkNmVmYmMyMDNmNzRiMTM5NGYwZTBkNDcyZTE5ZjkzXzEw_dee7ab6b-9191-4a96-92d8-d0de7043e3b4"
      unitRef="number">0.20</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4218e46259cf49069b7aa7ce6e397e10_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmQ0MTRlOGZkMDVjMjQyYzE5MjYwYjI1NDY4YjQ1ZDg2L3RhYmxlcmFuZ2U6ZDQxNGU4ZmQwNWMyNDJjMTkyNjBiMjU0NjhiNDVkODZfMi00LTEtMS05ODY3NC90ZXh0cmVnaW9uOjcyZmVjMmQxYzk5MjRiY2JhZTA0MTNjZDcxOGZjZmM2XzQ_262d1571-4c83-44e6-ae33-e0882ba1c967"
      unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg3MA_e28a83f4-a64d-4b05-9fa6-5848f691af45">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia5cc90199d454f10b36d87b70479ee68_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfMS0yLTEtMS05ODY3NA_4bfc0f16-f7d3-400e-bc24-c0d1a5ddf124"
      unitRef="usd">57598000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i34b51ea16b9440a08b69736ae59a5c23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfMy0yLTEtMS05ODY3NA_fc0d0db2-cf13-4615-8aa1-4847f80d83ea"
      unitRef="usd">23394000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i146ccf9c46794ec58b3fd078eac868ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjQ5MjhjNDYwOTgxMjQzZWQ5ZGUxNDQxZDdmMjhhOWZjL3RhYmxlcmFuZ2U6NDkyOGM0NjA5ODEyNDNlZDlkZTE0NDFkN2YyOGE5ZmNfNi0yLTEtMS05ODY3NA_d711fee8-4dac-41aa-a12c-b28159677c7e"
      unitRef="usd">34204000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTg3Mg_c83ec8ee-dd2b-4e8c-9866-01cf31632a93">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s short-term and noncurrent available-for-sale investments at September&#160;30, 2022 and December&#160;31, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2022 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2021 Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i54ee273867e240459470219b08af7a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi0yLTEtMS05ODY3NA_2536e05b-c0d6-459f-b2fe-6eccdf7c24d0"
      unitRef="usd">22298000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i54ee273867e240459470219b08af7a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi00LTEtMS05ODY3NA_581aa6ea-5b25-4a29-ba7f-8f8497420a48"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i54ee273867e240459470219b08af7a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi02LTEtMS05ODY3NA_9feed586-b87a-460d-8630-1663870cbb66"
      unitRef="usd">127000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54ee273867e240459470219b08af7a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMi04LTEtMS05ODY3NA_d7714a65-e525-453b-b66d-02bae1ed9b96"
      unitRef="usd">22171000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy0yLTEtMS05ODY3NA_c6c1d942-c2ad-4151-9ae7-8c554901554e"
      unitRef="usd">169736000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy00LTEtMS05ODY3NA_e97c726f-271c-4c5e-af00-867cbe477fd1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy02LTEtMS05ODY3NA_d8007898-e681-456e-8143-c62cc171567f"
      unitRef="usd">903000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i256e4a972f804ea4afc1c0c32264da1c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMy04LTEtMS05ODY3NA_e65f92e8-c371-4945-9e60-3dc0306fa4ab"
      unitRef="usd">168833000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC0yLTEtMS05ODY3NA_1c5093f6-d021-4956-ad2d-8ba010ab8725"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC00LTEtMS05ODY3NA_825cbc67-89b9-4de1-ae02-1db9ef776cdf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC02LTEtMS05ODY3NA_bd61f160-f4e7-46e9-bf95-85177e25f6c0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5426ccd0ccd746bb977427a4e5d6e7f6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNC04LTEtMS05ODY3NA_324f6cb2-fdaf-466a-b3c2-77c48092324c"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS0yLTEtMS0xMDI0OTk_c609eaae-4111-4217-a9f5-b6a9d2768246"
      unitRef="usd">24474000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS00LTEtMS0xMDI0OTk_df0b11f6-0825-481f-9200-37b94db550cb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS02LTEtMS0xMDI0OTk_74c900ce-87f0-44d6-abbf-21f17feff287"
      unitRef="usd">160000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f12bda689b34c1cb5adb0a61348d595_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS04LTEtMS0xMDI0OTk_9b3de95b-9e67-4b51-99a7-235d7846acfa"
      unitRef="usd">24314000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS0yLTEtMS05ODY3NA_8aeb062c-71ef-4d0b-b741-f84dee938ac0"
      unitRef="usd">2006000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS00LTEtMS05ODY3NA_6e2fd76e-5cfc-4e25-9f16-b402e0fe6174"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS02LTEtMS05ODY3NA_cd92ad49-d776-4946-9565-534e717915a5"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5602cffde8af4cd59ea67824357bd7cf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNS04LTEtMS05ODY3NA_ad5347f2-8099-4e4b-aa02-a532405f7d94"
      unitRef="usd">1983000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie4ced79204c94980b9c38c4970517274_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi0yLTEtMS05ODY3NA_03d93a7f-ca96-4d96-a867-b5d67fcb310d"
      unitRef="usd">220514000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie4ced79204c94980b9c38c4970517274_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi00LTEtMS05ODY3NA_1c5e0fd1-532f-4e1e-8399-56a05b6098a3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie4ced79204c94980b9c38c4970517274_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi02LTEtMS05ODY3NA_fa61bd72-8c2b-4bb4-8ef9-00fa38f6eff5"
      unitRef="usd">1213000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie4ced79204c94980b9c38c4970517274_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfNi04LTEtMS05ODY3NA_a192566d-75e0-4a8a-a67a-8efa460cb5fe"
      unitRef="usd">219301000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtMi0xLTEtMTAyNTU4_bd5d5906-dd16-4e86-95ac-717a26736bbf"
      unitRef="usd">17496000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtNC0xLTEtMTAyNTU4_f66e1704-4da1-484a-afd4-06dd68fb9b87"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtNi0xLTEtMTAyNTU4_75e30efc-caf5-4477-834e-a520fb704a34"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25002d007da945f7b1fd37b64ad6fbb5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTEtOC0xLTEtMTAyNTU4_012c1a23-a3f4-4d13-a0b5-19d337e6910b"
      unitRef="usd">17394000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItMi0xLTEtOTg2NzQ_85e898c4-1857-4735-a4a7-286548e98fa1"
      unitRef="usd">238010000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItNC0xLTEtOTg2NzQ_b74e0442-b0a9-43cd-be42-2118ac1077a7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItNi0xLTEtOTg2NzQ_057a29ea-3939-464c-bf57-a6ac8fa1a83f"
      unitRef="usd">1315000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOmRkMGY1ZjQxMzRhNjQ4YjdiNTlkMWExOTM2NTQyYTgxL3RhYmxlcmFuZ2U6ZGQwZjVmNDEzNGE2NDhiN2I1OWQxYTE5MzY1NDJhODFfMTItOC0xLTEtOTg2NzQ_96f0b099-4428-46e7-99bd-d8dc5133c44b"
      unitRef="usd">236695000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi0yLTEtMS05ODY3NA_434614f7-e826-4c08-afe3-3f01eaaccd18"
      unitRef="usd">3182000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi00LTEtMS05ODY3NA_946bb407-c516-45ce-83ef-2228c5bbead0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi02LTEtMS05ODY3NA_538285e2-bf06-4fd1-9f68-a0f5681ae00e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i457f0d7ed7f3471fbea7fe35bd757052_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMi04LTEtMS05ODY3NA_9238a0e9-2183-4423-b559-21b0a0c8782e"
      unitRef="usd">3182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy0yLTEtMS05ODY3NA_0a792f2b-bc38-49a7-bd0c-8fc1f1ab1880"
      unitRef="usd">57533000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy00LTEtMS05ODY3NA_d642c9e3-6a42-42e0-9660-8e19a3029484"
      unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy02LTEtMS05ODY3NA_fb99cb52-981a-4e7f-a356-b995675d00d0"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib20bc844b2ac4123acffb7c0cf235838_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfMy04LTEtMS05ODY3NA_282adb9b-550e-4b7e-83d0-eed4d120edf6"
      unitRef="usd">57611000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC0yLTEtMS05ODY3NA_e3fbd6b4-96e7-4ce5-9d06-4db5731d27ec"
      unitRef="usd">9936000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC00LTEtMS05ODY3NA_b1db1714-363c-4a0b-823b-60a125af9009"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC02LTEtMS05ODY3NA_43b3ccf0-a110-477f-b476-1cd0358d38a4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic0d61d593f234e0aab86db49aa1ab359_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNC04LTEtMS05ODY3NA_76c1eefd-4bd7-4cf8-b026-24315ffe0581"
      unitRef="usd">10038000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi0yLTEtMS05ODY3NA_c4e49f66-9a9d-41d1-b3ac-05ad34527d98"
      unitRef="usd">70651000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi00LTEtMS05ODY3NA_827cbb33-b86a-403f-b1d7-eb3c6930a91e"
      unitRef="usd">182000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi02LTEtMS05ODY3NA_604ddefe-cd36-4228-ba32-84bf6acf3316"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RhYmxlOjA4NDE4ZDhhMTlhYTRmMjJhMjA1MWU2NTZlN2M5OTQ5L3RhYmxlcmFuZ2U6MDg0MThkOGExOWFhNGYyMmEyMDUxZTY1NmU3Yzk5NDlfNi04LTEtMS05ODY3NA_f61643d3-d95b-49a2-889d-8b0f07785a84"
      unitRef="usd">70831000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InterestReceivable
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODQ5OA_e3e5b3bb-072c-42e2-8896-74d947c78138"
      unitRef="usd">400000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODUwNQ_aad8704a-51f4-4dd3-bc0c-22e40fac2a4b"
      unitRef="usd">100000</us-gaap:InterestReceivable>
    <pcrx:NumberOfMajorCustomers
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODkwNA_849215b0-a20d-44b0-9314-7e10a5df5b72"
      unitRef="customer">3</pcrx:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i44e9ad15636e471c976e2609f64d7dc1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk4OA_d97ec081-244c-46b6-90ab-231b74ad0374"
      unitRef="number">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibf48d4523ea34480aebe47808748c1a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk5Mg_dd963209-21ee-4111-9d1c-d5813e312738"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9fbc9b9c3e414c91b056f6e47ff38cff_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfODk5OQ_fee73592-3050-448a-88c5-90f870577298"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <pcrx:NumberOfMajorCustomers
      contextRef="icca7decc11a044ac9d282030bd53ffc8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTAxMA_c8d8adf5-c19b-47f9-956a-102c2e66bdf1"
      unitRef="segment">4</pcrx:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1b779e5e08f8409f8661541db1c36b0e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTA5NA_91607487-9ecb-46a2-aa70-773718e417e8"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iea427b466be34ebbba3f1a1d2684ca8b_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTA5OA_1bae2840-9495-4e9d-8dff-9d5b942b4e72"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic94fe1291d1b4789b165b90d7885e3f7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTEwMg_e2339398-ae15-409f-9b5f-122c6a0e24fa"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iae887f18bb20483e8ff30cc6ed2e8c0e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTEwOQ_30d722fb-2bcd-4b70-b8fd-8a62d6b4ae7e"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTc2Mg_2500a1ab-0507-4288-b69f-7463779bd886"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV82Ny9mcmFnOmU4NzU0NmI5NjRhMjQ2OGRiNmJiNDBiOWJkMGM1NThjL3RleHRyZWdpb246ZTg3NTQ2Yjk2NGEyNDY4ZGI2YmI0MGI5YmQwYzU1OGNfOTc2Mg_70c7b89e-42a1-40ad-a0bf-6995fa48c738"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMjYw_663dd376-4ce3-4510-9322-012b30b489a8">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables illustrate the changes in the balances of the Company&#x2019;s accumulated other comprehensive (loss) income for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Net of a $0.3&#160;million and $0.1&#160;million tax benefit for the nine months ended September&#160;30, 2022 and 2021, respectively.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMjUx_b4b4f12a-6343-43d9-a513-6d246f98530d">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables illustrate the changes in the balances of the Company&#x2019;s accumulated other comprehensive (loss) income for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Unrealized (Loss) Gain From Available&lt;br/&gt;For Sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on investments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Net of a $0.3&#160;million and $0.1&#160;million tax benefit for the nine months ended September&#160;30, 2022 and 2021, respectively.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i7211501c213a4e7599a5684dd5be37a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS0yLTEtMS05ODY3NA_9edcbb54-8f06-4342-add3-114b266c5764"
      unitRef="usd">139000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib82c2ca1fca444babc5bb300a97a1bc6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS00LTEtMS05ODY3NA_8fb1b801-84e6-436a-9dfb-9b5d257be498"
      unitRef="usd">28000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbb25cb8377a4ebfa948f9a21858c7f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMS02LTEtMS05ODY3NA_f178a2b2-7023-4d5c-837f-f0d3cddb23ce"
      unitRef="usd">167000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6fad952d06634849a67e5b1217dd68bf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMi0yLTEtMS05ODY3NA_cb1a45a3-d3f7-4872-a510-048ee2917de6"
      unitRef="usd">-1056000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMi02LTEtMS05ODY3NA_44062d97-dbd8-4ee2-a212-79e18e1a639d"
      unitRef="usd">-1056000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id3320bc9569d4047a853e2db8903a804_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMy00LTEtMS05ODY3NA_ef900075-e1e4-45c1-9158-8ce2f1a9c4a9"
      unitRef="usd">219000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6f6d97b734ae430194ee5348b923e7db_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfMy02LTEtMS05ODY3NA_7258c2d3-dcb9-443a-9310-404fe08f88b4"
      unitRef="usd">219000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i97c19447cd504d5ab3f69d4b883be660_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS0yLTEtMS05ODY3NA_30888000-3f4c-41d5-ac8a-2d6f8d11a5ee"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f98a360a3864c079bacf7afbc9066c7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS00LTEtMS05ODY3NA_59ac8e8a-bc5d-44e9-a90b-69dc6e45d5c6"
      unitRef="usd">247000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2f6cf2d4b22477f8fbb04b11fea5c1b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmQ5NzRjZmU0YjExYzRhOTViOWI4YWY3N2U5OTU0ODBiL3RhYmxlcmFuZ2U6ZDk3NGNmZTRiMTFjNGE5NWI5YjhhZjc3ZTk5NTQ4MGJfNS02LTEtMS05ODY3NA_210c12ac-7967-4803-a09b-04f1487dfbd4"
      unitRef="usd">-670000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1cc597a5032a411686eef62dd04fb5fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS0yLTEtMS05ODY3NA_e2354012-db7a-4bc1-872d-f898db9455b4"
      unitRef="usd">319000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0138beec6b884dd68edbbf43f505701b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS00LTEtMS05ODY3NA_fd780a4d-d8f3-4eb6-babf-31c1c3288cf3"
      unitRef="usd">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10ac36a407c64570801dc9eeb4a4c82d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMS02LTEtMS05ODY3NA_1a60de53-245d-4184-80a7-1ceb64ca55eb"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie5a40479823647ddb96d0a3dbc1e6577_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMi0yLTEtMS05ODY3NA_454f5756-196c-4a30-9936-a65d93ec21e1"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMi02LTEtMS05ODY3NA_2146b305-4e9d-4b14-9712-828c966e0b41"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i129b1978433c487181ff9a7d935fca2a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMy00LTEtMS05ODY3NA_206ecf26-f299-4714-b2e3-4d8ba17eb8e4"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2be481d279c645fa94fba08d2b651abb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfMy02LTEtMS05ODY3NA_1f75251f-0258-4f3d-947c-61cd5f4a3552"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i77aee1ee825a4993985deaa770a072c4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC0yLTEtMS05ODY3NA_35cd8ca8-fbcb-479f-bba7-4f06bc47f689"
      unitRef="usd">151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34f003f3e1a84055b8f4cfecb523624c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC00LTEtMS05ODY3NA_1b72bfb6-b15e-40e7-94df-0a2b6ffd2abc"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a219071ecbb42ac9eb93d05379e1467_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RhYmxlOmEwY2VmYzk4NGQ2MDQ5MTJiMjQ2MzIwMWViNzRiMTRjL3RhYmxlcmFuZ2U6YTBjZWZjOTg0ZDYwNDkxMmIyNDYzMjAxZWI3NGIxNGNfNC02LTEtMS05ODY3NA_ddf97450-3d98-4de6-a2bf-7630145332b3"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMTA5OTUxMTYyODk1Ng_17b82061-d5bc-4e63-8f02-84d616865284"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83MC9mcmFnOmMzNzRjMGY1OWFmYzQ5ZTY4MDFhNzRiYjk4OTJhNzIyL3RleHRyZWdpb246YzM3NGMwZjU5YWZjNDllNjgwMWE3NGJiOTg5MmE3MjJfMTA5OTUxMTYyODk3MA_5389ac49-041f-4e3e-a80a-965de723f371"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI4OQ_f9a5c1ce-acaa-4152-b56e-8d3c4d09499e">STOCK PLANS&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2022 wa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $25.66 per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.84%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company&#x2019;s stockholders approved the Amended and Restated 2014 Employee Stock Purchase Plan, or ESPP. The ESPP was amended to increase the number of shares of common stock that may be sold under the ESPP by an additional 500,000 shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP features two six-month offering periods per year, running from January 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#x2019;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2022, 36,729 shares were purchased and issued through the ESPP.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI5Mw_cbda036f-bc0c-4f9d-a60e-082541a4a61e">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iacde86a59c774f04b954ca896a5a70e2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi0yLTEtMS05ODY3NA_e8ffa5d0-7077-469e-b56a-1909c5010a73"
      unitRef="usd">1599000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i01e0f3d97cd74e64991c04f3f85804e8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi00LTEtMS05ODY3NA_2694632f-34b4-4fb1-b89d-d8f9e315826f"
      unitRef="usd">1512000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i000ca49114364850ace4c02275016d71_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi02LTEtMS05ODY3NA_5b6d7d78-4000-427b-87fb-4e968eebdc71"
      unitRef="usd">4429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i393b09d63da340a388d84a9a521340e9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMi04LTEtMS05ODY3NA_50059a5c-8a9a-4be0-98b6-72a96afa631a"
      unitRef="usd">4429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i705ca31dbd8c46188969e5de6c1b9bec_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy0yLTEtMS05ODY3NA_817c005f-c8f9-449e-812d-ea9fb71bf07c"
      unitRef="usd">1783000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i025386fe742f4458ba40cf3c14ab73ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy00LTEtMS05ODY3NA_264e6f0b-51f8-4ae2-8f72-4fa4f9dc4e2b"
      unitRef="usd">1156000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia380efcf48764d14911365055786a8c1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy02LTEtMS05ODY3NA_7c0c791c-4b61-449e-b7fc-4a459ed98408"
      unitRef="usd">4761000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97de2860387c4ebb9d4c67d302888d0c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMy04LTEtMS05ODY3NA_16b0b961-c979-4823-8960-0ad5f4ab1af5"
      unitRef="usd">3591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i23baf9eae53648b5862c179217f38259_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC0yLTEtMS05ODY3NA_c0ca3f57-4f63-45d2-bbbf-6fcb85b5aa44"
      unitRef="usd">9300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i30c025fee8f64b4a80f4a122c03be02f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC00LTEtMS05ODY3NA_6e89040c-7a69-4ef5-b010-82dcb478ddda"
      unitRef="usd">8116000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icf9e30e4f3ae45789d654ae03283e68f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC02LTEtMS05ODY3NA_e1b8708c-7446-4a0f-a9d4-bcc86d5be07d"
      unitRef="usd">26225000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic0115f45cca34fe59169ae1673caf52a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNC04LTEtMS05ODY3NA_0854f6db-615e-4c78-b0b8-7c1ac5b65f4a"
      unitRef="usd">23336000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS0yLTEtMS05ODY3NA_6021cca4-4689-4d2d-b8c1-e5adcf77760c"
      unitRef="usd">12682000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS00LTEtMS05ODY3NA_b6b2c336-8480-4fb8-9d08-3fe1b5d9b4da"
      unitRef="usd">10784000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS02LTEtMS05ODY3NA_2d828605-477c-4b2c-9276-40ae07ff353c"
      unitRef="usd">35415000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfNS04LTEtMS05ODY3NA_e09fb60c-c743-4bbe-b6d6-a37f243d7d97"
      unitRef="usd">31356000</us-gaap:AllocatedShareBasedCompensationExpense>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC0yLTEtMS05ODY3NA_98ce7a31-eb76-472c-95fb-05c17bc44341"
      unitRef="usd">6711000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC00LTEtMS05ODY3NA_ca19ac33-bf63-4bad-8777-94f6de62e2b9"
      unitRef="usd">6458000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC02LTEtMS05ODY3NA_1ed1936d-59ca-40b0-85d7-d8bbc404264b"
      unitRef="usd">20038000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOC04LTEtMS05ODY3NA_182b431f-7436-443c-8e5f-68e9395a4c5d"
      unitRef="usd">19507000</pcrx:Compensationexpensefromstockoptionsemployees>
    <us-gaap:RestrictedStockExpense
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS0yLTEtMS05ODY3NA_ed6899ca-5689-4a86-b9a8-108fbe5a189c"
      unitRef="usd">5758000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS00LTEtMS05ODY3NA_1db0c542-98f5-4393-8649-4c4188601a7e"
      unitRef="usd">4126000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS02LTEtMS05ODY3NA_900da4ea-23eb-42e7-b8d6-6c0328ffed93"
      unitRef="usd">14588000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfOS04LTEtMS05ODY3NA_8754003d-06af-4aa2-9635-47bb62aebe6e"
      unitRef="usd">11164000</us-gaap:RestrictedStockExpense>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtMi0xLTEtOTg2NzQ_31d76e60-9651-4bd9-88e6-4809913f01ff"
      unitRef="usd">213000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtNC0xLTEtOTg2NzQ_0ce04107-d725-4fff-b92e-034bf722f1f6"
      unitRef="usd">200000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtNi0xLTEtOTg2NzQ_a7d08432-60c2-4dad-be9d-579453a3c090"
      unitRef="usd">789000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTAtOC0xLTEtOTg2NzQ_4146dc9b-cf57-4c0f-84eb-dceabb35c824"
      unitRef="usd">685000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <us-gaap:ShareBasedCompensation
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtMi0xLTEtOTg2NzQ_30a25427-084f-49f0-9b3a-4f9145cb8ba2"
      unitRef="usd">12682000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtNC0xLTEtOTg2NzQ_e969c70f-c17a-4876-9d41-1cb82bbce7a1"
      unitRef="usd">10784000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtNi0xLTEtOTg2NzQ_1727aea1-17e5-47ec-a4c7-3d7503f31548"
      unitRef="usd">35415000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjNhNTE5MTk4OTRkZDRjZWY4YmRjOTNmMWMwZDg2ZGMzL3RhYmxlcmFuZ2U6M2E1MTkxOTg5NGRkNGNlZjhiZGM5M2YxYzBkODZkYzNfMTEtOC0xLTEtOTg2NzQ_53a4697f-893f-4893-add7-7db46671058e"
      unitRef="usd">31356000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTMwMA_f5789c39-85c9-41dc-823e-696c45580b07">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(667,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMS0yLTEtMS05ODY3NA_2602f0c3-2383-40a9-8d37-a28be193f7b9"
      unitRef="shares">6050540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iaf5db5136edb4258bb25992f7a708439_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMS00LTEtMS05ODY3NA_117b1d8c-bfc0-427d-b0da-1ec8bd1f4eb5"
      unitRef="usdPerShare">49.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMi0yLTEtMS05ODY3NA_9fd6fb09-031e-41b3-a60b-56c603c70936"
      unitRef="shares">1034230</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMi00LTEtMS05ODY3NA_d86776ce-75eb-467a-9126-4ce7f831c776"
      unitRef="usdPerShare">60.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMy0yLTEtMS05ODY3NA_24e63625-bae7-43dc-b842-df261528ad98"
      unitRef="shares">667940</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfMy00LTEtMS05ODY3NA_6649c8cf-5d8e-4394-99a6-4f93ee6f42c4"
      unitRef="usdPerShare">35.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNC0yLTEtMS05ODY3NA_0860cde3-81dd-47f3-9c70-646515946fb3"
      unitRef="shares">88766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNC00LTEtMS05ODY3NA_f50acb23-720e-48f7-a561-b9cb1c875bb7"
      unitRef="usdPerShare">54.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNS0yLTEtMS05ODY3NA_1840a118-6b39-423f-893b-d1f82374481d"
      unitRef="shares">24447</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNS00LTEtMS05ODY3NA_17f8671f-dde1-46dc-947b-fb9a5a72df4e"
      unitRef="usdPerShare">78.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNi0yLTEtMS05ODY3NA_507659eb-f892-45b7-8e8b-b6195b92e14b"
      unitRef="shares">6303617</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic44364ce38c044838833d136327e1683_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjEzZDVlODNkMmY2OTRkYmJhNWI4NGFlMTc3ZDBmNzZhL3RhYmxlcmFuZ2U6MTNkNWU4M2QyZjY5NGRiYmE1Yjg0YWUxNzdkMGY3NmFfNi00LTEtMS05ODY3NA_97c5c529-fee8-468d-95ff-d805b1a08ce8"
      unitRef="usdPerShare">52.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if92e2ee8bc084934add5e4997216b20b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMS0yLTEtMS05ODY3NA_d661c0c5-c4c2-408d-ac2b-50b55679b152"
      unitRef="shares">955277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if92e2ee8bc084934add5e4997216b20b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMS00LTEtMS05ODY3NA_d7bcc0ab-d152-4a11-ba3f-937a709e86c2"
      unitRef="usdPerShare">52.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMi0yLTEtMS05ODY3NA_8d2168fa-07e2-4142-84c7-88dc5ef15322"
      unitRef="shares">598699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMi00LTEtMS05ODY3NA_ad87ae40-759b-49cf-81e0-9d5eb7210df2"
      unitRef="usdPerShare">60.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMy0yLTEtMS05ODY3NA_2abed545-45eb-4f04-93a0-b3e7475fde56"
      unitRef="shares">323821</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfMy00LTEtMS05ODY3NA_e5e2fa12-cf1a-4d77-b3da-3eef36ef4a53"
      unitRef="usdPerShare">50.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNC0yLTEtMS05ODY3NA_584d2728-aa82-44ae-8b4f-6a3058490a1e"
      unitRef="shares">68000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNC00LTEtMS05ODY3NA_0de38d49-8bf1-4770-b7d4-053a2ff7b3d2"
      unitRef="usdPerShare">55.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1d19f95d9c4e41ff8e7135be13df1713_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNS0yLTEtMS05ODY3NA_768333a8-d61d-4da5-a137-e90f1dc97920"
      unitRef="shares">1162155</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1d19f95d9c4e41ff8e7135be13df1713_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOjJkMTFhZWViNjllZTQyZDI5N2UwNTRkN2Y0N2M1ZjdlL3RhYmxlcmFuZ2U6MmQxMWFlZWI2OWVlNDJkMjk3ZTA1NGQ3ZjQ3YzVmN2VfNS00LTEtMS05ODY3NA_81719d5c-6113-4867-a6fe-6b347af7d3cb"
      unitRef="usdPerShare">57.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfNDE1_0ae30215-4420-4b76-bbbe-a7efd721994a"
      unitRef="usdPerShare">25.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTI5NQ_d59b3076-b0cd-46fb-8e86-3af44d85cd04">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.84%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.14%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMS0yLTEtMS05ODY3NA_089d71ff-40bd-4318-a952-494457fef1be"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMi0yLTEtMS05ODY3NA_c2cad05f-2ba6-4814-b15d-b5902972d6b8"
      unitRef="number">0.0284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfMy0yLTEtMS05ODY3NA_b6a2b57a-8773-4b1c-b45f-13d5bb9e9453"
      unitRef="number">0.4514</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RhYmxlOmQ5MTVlOGI2OTM5MzQyMTRiMTZlM2E2NDgwODcwNGQzL3RhYmxlcmFuZ2U6ZDkxNWU4YjY5MzkzNDIxNGIxNmUzYTY0ODA4NzA0ZDNfNC0yLTEtMS05ODY3NA_5563e5bc-5885-42fa-9276-c3f86898e3be">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease
      contextRef="i8d338010b91c405c9adcfebc639f8496_D20220601-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfODUw_d936f06f-cdcf-42c3-a119-298f8c3c96d9"
      unitRef="shares">500000</pcrx:EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfODc5_b2c869e9-238c-4da9-8638-5ff48be3243f"
      unitRef="offeringperiod">2</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTMxMg_aa8105f1-e68b-4c21-a5d0-0027a4c3e568">P6M</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTA3MA_d4444e1b-389e-4f83-aa85-81dabcd716d8"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83My9mcmFnOjdmMjcxMmMyYzBkNjRmNTZiZTkzNjU0ZmY3NTg0OGY5L3RleHRyZWdpb246N2YyNzEyYzJjMGQ2NGY1NmJlOTM2NTRmZjc1ODQ4ZjlfMTIzNg_0db1077c-3a23-4db6-8b96-cf6f9f5a93b8"
      unitRef="shares">36729</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE4MA_c83b397a-7a7e-4a44-bc50-e515692f800c">NET INCOME (LOSS) PER SHARE&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2020-06 was adopted on January 1, 2022 and requires the Company to use the if-converted method to calculate the number of potentially dilutive shares for convertible debt. Under the if-converted method, adjustments are made to the diluted net income (loss) per common share calculation as if the Company had converted the convertible debt on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible debt on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period. For additional information regarding ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Prior to January 1, 2022, the Company used the treasury stock method to calculate dilutive shares on its convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive. As the Company reported a net loss for the three months ended September 30, 2022, no potentially dilutive securities have been included in the computation of diluted net loss per share for that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and nine mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended September&#160;30, 2022 and 2021 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net (loss) income&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Adjusted net (loss) income&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (loss) income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE4NA_746bb5a7-ca0e-4e5a-b4a9-9739f390b7ca">&lt;div style="margin-bottom:9pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per common share for the three and nine mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended September&#160;30, 2022 and 2021 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net (loss) income&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Adjusted net (loss) income&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 convertible notes if-converted method adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net (loss) income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy0xLTEtMS05ODY3NA_f48cc3a8-79e0-4de7-ada5-67044dfae48f"
      unitRef="usd">-693000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy0zLTEtMS05ODY3NA_58e41d88-49e3-4553-a922-6e7edc184d51"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy01LTEtMS05ODY3NA_ab980016-e6e4-42a6-a4a0-e131d31fcc28"
      unitRef="usd">26011000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMy03LTEtMS05ODY3NA_b27bb123-5ef1-4d14-94df-0ec585974a2c"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC0xLTEtMS05ODY3NA_7f6a41dd-888d-4b87-b012-e04be4de452f"
      unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC0zLTEtMS05ODY3NA_c5d19f7e-80ac-4d11-8118-059c7e15ec74"
      unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC01LTEtMS05ODY3NA_c3eee492-eb81-4c3f-9b31-d007a0467e29"
      unitRef="usd">3112000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNC03LTEtMS05ODY3NA_c18c47fb-20e9-4101-aed1-d26bd9b22049"
      unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi0xLTEtMS05ODY3NA_78475df2-f864-4809-ab58-a0f2c5beaef0"
      unitRef="usd">-693000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi0zLTEtMS05ODY3NA_7cfe59e1-8dcd-4b33-b9b1-93b8bec7c602"
      unitRef="usd">17660000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi01LTEtMS05ODY3NA_f8f9105b-da1d-4772-8a9d-44f3933fc485"
      unitRef="usd">29123000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfNi03LTEtMS05ODY3NA_5775ff02-b4e7-4642-a614-a7380066e56c"
      unitRef="usd">47110000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtMS0xLTEtOTg2NzQ_4407822d-33c6-400a-b1bc-0fa19ff776e9"
      unitRef="shares">45831000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtMy0xLTEtOTg2NzQ_debdcd64-f87d-46e9-b518-a58f7b098000"
      unitRef="shares">44476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtNS0xLTEtOTg2NzQ_79fd11b2-2233-4e2b-a250-1d17610ba7d3"
      unitRef="shares">45400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTMtNy0xLTEtOTg2NzQ_55b6875f-3769-4d18-a06e-9f8410d6fe53"
      unitRef="shares">44151000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9d47dbf4731e40a8817c9b98685f2fad_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtMS0xLTEtOTg2NzQ_f6503e27-2741-4f30-bfa4-00eeac74b17a"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="iacd2ba2d5b0b4cbd856acd935fe9e469_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtMy0xLTEtOTg2NzQ_7b1050f6-801e-4681-a9d6-681196149b51"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i485078b5973a4f38a864235574eace6d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtNS0xLTEtOTg2NzQ_e59ca6a8-9459-4304-82e8-853a409ce4a8"
      unitRef="shares">5608000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i80aa21cf123146cfa48d76c6340c8f02_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTUtNy0xLTEtOTg2NzQ_be692cde-2011-46e8-8f60-cf87de9abd2c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7d47a9c9bbe34e8a884b57b4a1b7c7d7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtMS0xLTEtOTg2NzQ_7e2560a3-f25f-4fcd-a79a-f4f05a389bcb"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i751881f6186c4a20b2999971312c68ea_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtMy0xLTEtOTg2NzQ_cf6b861f-b886-4403-b805-c916b64fa163"
      unitRef="shares">827000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i34432db649744b62b15fef5547cddb1b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtNS0xLTEtOTg2NzQ_39bd860d-33fb-4632-8d86-7bb04dacc0cf"
      unitRef="shares">937000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia902e06002164005b91ff53bfc5574a6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTYtNy0xLTEtOTg2NzQ_5ed96083-e3e8-4e75-8dd7-22c96f95e1a4"
      unitRef="shares">1132000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i25ec2fd985f1484584f9e9321ebe8636_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctMS0xLTEtOTg2NzQ_e59e8317-bca1-452b-bf9f-6863235f1dc7"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i66cdb3b9475d440585c31ef8170080cd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctMy0xLTEtOTg2NzQ_dd02afe8-ec61-4aa0-904f-79f7a504ff83"
      unitRef="shares">160000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i63b3461ea63d4b4983ff4b102ad203b9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctNS0xLTEtOTg2NzQ_ea6f0861-e9df-4021-982b-99fbae4e5b8c"
      unitRef="shares">272000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ica8d4ccba77d49c585c7d57451c690c9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTctNy0xLTEtOTg2NzQ_3a34400e-efa4-4794-8930-a3c5d2bfa68d"
      unitRef="shares">337000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtMS0xLTEtOTg2NzQ_316e2c6c-8f1f-4abc-826a-19a4839a6033"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtMy0xLTEtOTg2NzQ_0bbd62e0-2b01-4a7e-94e3-7ed744217cd4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtNS0xLTEtOTg2NzQ_cb06d0d3-4a6b-428e-8c32-de137b9385ff"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTgtNy0xLTEtOTg2NzQ_62ee3eaa-9ce9-4b3d-becc-0e29bf216332"
      unitRef="shares">51000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i033a677bcf7842e8962e783e4ecdff17_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktMS0xLTEtOTg2NzQ_b3559c5f-59ea-4139-a2be-6edb9266ff3c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic925042152574d9896e5d11b213d65ef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktMy0xLTEtOTg2NzQ_bf732e85-2b03-474c-855d-cf5ed786a7be"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1ad62e49feb74d9790e16943cb6fcc07_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktNS0xLTEtOTg2NzQ_448c8115-569c-4c47-b2c1-666270be371e"
      unitRef="shares">3000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0529b24441114da8aea1d86d3e46324d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMTktNy0xLTEtOTg2NzQ_b13193d6-1005-427c-bbb7-8100a64025c0"
      unitRef="shares">3000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtMS0xLTEtOTg2NzQ_17397c47-ab7c-4fa9-b3d6-89bdedd4dbe4"
      unitRef="shares">45831000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtMy0xLTEtOTg2NzQ_503d1b5f-24bd-4493-8fdb-75bf3dd98423"
      unitRef="shares">45463000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtNS0xLTEtOTg2NzQ_a67da67e-2eb0-4eb8-bbbc-d3fc5707b5b7"
      unitRef="shares">52220000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjEtNy0xLTEtOTg2NzQ_7a567812-a2c2-4df5-8dd8-4c130b74ce5e"
      unitRef="shares">45674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtMS0xLTEtOTg2NzQ_d49999db-89d8-492e-b3d9-f2a9026b1a4f"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtMy0xLTEtOTg2NzQ_dbaa5452-1c05-4ac5-a0ef-a579224e063f"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtNS0xLTEtOTg2NzQ_efa7b3ac-15fa-47dd-ba84-61f1b68a1c36"
      unitRef="usdPerShare">0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjMtNy0xLTEtOTg2NzQ_93829c9d-a33b-4645-bb00-25e29169e51f"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtMS0xLTEtOTg2NzQ_219c9acd-aea1-40d8-ab80-9996efa18d41"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtMy0xLTEtOTg2NzQ_5132e1d3-4682-4076-b75f-3ddd23138ea9"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtNS0xLTEtOTg2NzQ_80c81a89-ab19-4e84-80c2-5984a7b81ee8"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOjVlM2JmNDFhNzUwNjQxZDY5OTM0YzM5N2ZmMjRhNGZjL3RhYmxlcmFuZ2U6NWUzYmY0MWE3NTA2NDFkNjk5MzRjMzk3ZmYyNGE0ZmNfMjQtNy0xLTEtOTg2NzQ_e25312bd-9e80-45b8-84f0-402d20b91550"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RleHRyZWdpb246ZjJmMmY4YzE4NjEyNDc2MjljOTNhNjFjNjA1NzA5YTNfMjE3NA_c4fedaf1-65b6-4d2f-aab7-a525556ca4d9">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding stock options, RSUs and convertible senior notes that were excluded from the diluted net (loss) income per common share calculation because the effects of including these potential shares were antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i220fe9ca1ed949bdacf99f33c990cd98_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi0xLTEtMS05ODY3NA_1ade277b-9159-4a94-a0a6-83939e234194"
      unitRef="shares">6344000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9c341f2698fe409ab358a241336259db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi0zLTEtMS05ODY3NA_ef76dbca-dfc3-4998-99b0-ee23ff27897d"
      unitRef="shares">2707000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f355a2653684c24b57b2f7c5f946633_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi01LTEtMS05ODY3NA_dc3fe9b3-56d0-41e4-9d40-11fa4b5bd026"
      unitRef="shares">2439000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6c1d51f4133f426395546e41d42a7bf2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMi03LTEtMS05ODY3NA_f23e2024-92df-4a3c-90e2-2b8e75e53ecd"
      unitRef="shares">1895000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i20b9602474ee4df3a8cdbf721f6b53ec_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy0xLTEtMS05ODY3NA_425c6c0f-d9c7-45c6-a392-9d8ceda57bd6"
      unitRef="shares">5608000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i999eddb8433c487184e9e575bd4a8c32_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy0zLTEtMS05ODY3NA_adf22000-df46-4614-975d-a88373bfbdbb"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i569b3dcd44504f2ebc2b67589ca1ef77_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy01LTEtMS05ODY3NA_25cd9a55-69e8-49a3-b3b1-735f36e92db7"
      unitRef="shares">797000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i92a9bde52b5e4954a236c46394ef2fe1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfMy03LTEtMS05ODY3NA_9ca1b545-df30-4baa-869e-8a666099130f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie8d9d4db1ba04e1288564adf8e895b8c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC0xLTEtMS05ODY3NA_14bcb732-a8b3-4fd0-96c5-133e33545aba"
      unitRef="shares">1180000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia097c92a4047403d82b24978021270af_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC0zLTEtMS05ODY3NA_6e4b5234-cd9c-4aa0-ad3b-f347a461c521"
      unitRef="shares">369000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib01b4d60757d4870804d497766e7943c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC01LTEtMS05ODY3NA_85519894-414d-4f97-85cf-55709f69512d"
      unitRef="shares">277000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7925b0863c1647ce89e8613307298317_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNC03LTEtMS05ODY3NA_8bc3c88b-81cc-4ed5-b835-7f8a3d97f528"
      unitRef="shares">132000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9ddd46a4b60a416c94127599c856aa48_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS0xLTEtMS05ODY3NA_ae92843a-327e-4f54-9031-88bcb7a03a7c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2f95987401124116b24759ace715aa41_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS0zLTEtMS05ODY3NA_34bee8c1-ff7d-441f-8318-43a9db5798cf"
      unitRef="shares">26000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i09fc8460b9894b6cb2fb0b2e035270ae_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS01LTEtMS05ODY3NA_7e89dd14-25fd-46f7-9ad3-f3c311f552d6"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i095b5a48440040b98f786b561073678f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNS03LTEtMS05ODY3NA_98628323-0228-4b32-a2cb-ff3190933c04"
      unitRef="shares">9000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi0xLTEtMS05ODY3NA_e1cb18b9-20a2-4598-b53a-cfb2fd825195"
      unitRef="shares">13132000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi0zLTEtMS05ODY3NA_ce93f604-94f8-483f-b1d4-84f69ba675bb"
      unitRef="shares">3102000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi01LTEtMS05ODY3NA_ad79f8aa-27be-4437-9e97-85f574ecfd3b"
      unitRef="shares">3513000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83Ni9mcmFnOmYyZjJmOGMxODYxMjQ3NjI5YzkzYTYxYzYwNTcwOWEzL3RhYmxlOmViNzE0OTNlNzM4ZTQzNzQ5Y2U2YjRmMWJhMzlhMGMwL3RhYmxlcmFuZ2U6ZWI3MTQ5M2U3MzhlNDM3NDljZTZiNGYxYmEzOWEwYzBfNi03LTEtMS05ODY3NA_e6dd6089-c754-4f08-88c2-a28a106cee23"
      unitRef="shares">2036000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RleHRyZWdpb246MWZiZmJmZjhjZDIyNGY3ZjgxYWYyZDY5NTJhNGE0MjlfODk4_d2f4c00d-864d-4e92-9fe9-d92ef1f7b650">INCOME TAXES&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes and income tax expense are as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax expense represents the estimated annual effective tax rate applied to the year-to-date domestic operating re&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sults adjusted for certain discrete tax items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates for the three months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation and valuation allowances recorded against non-U.S. results and deductible capital losses. The three months ended September&#160;30, 2022 also includes benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration. &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s effective tax rates for the nine months ended September&#160;30, 2022 and September&#160;30, 2021 include non-deductible executive compensation costs and valuation allowances recorded against non-U.S. results and deductible capital losses, offset by benefits related to stock based compensation. The nine months ended September&#160;30, 2022 also include benefits for a first quarter Skyepharma milestone payment and a fair value adjustment for Flexion contingent consideration.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RleHRyZWdpb246MWZiZmJmZjhjZDIyNGY3ZjgxYWYyZDY5NTJhNGE0MjlfOTAy_ab739fc0-5b38-4293-aecc-0ccc8a365e51">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes and income tax expense are as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy0xLTEtMS05ODY3NA_b414c296-59cd-46f7-af44-d95d6e6d2ea0"
      unitRef="usd">9230000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy0zLTEtMS05ODY3NA_b4e9f9dd-7945-412f-bb5b-d342061878b5"
      unitRef="usd">25167000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy01LTEtMS05ODY3NA_6d914667-b9a9-49da-8994-4a19264b3839"
      unitRef="usd">39610000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfMy03LTEtMS05ODY3NA_cc9d2d3d-a335-4563-bc95-9008eba9e209"
      unitRef="usd">66962000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC0xLTEtMS05ODY3NA_b216657a-de9a-4779-9840-30a439f9dd58"
      unitRef="usd">-7161000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC0zLTEtMS05ODY3NA_62f805eb-52c0-4579-bc27-9bde70054749"
      unitRef="usd">-936000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC01LTEtMS05ODY3NA_757ea225-92fb-4fd7-80b5-9a17a562db33"
      unitRef="usd">-8240000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNC03LTEtMS05ODY3NA_a3fad465-5b04-4b52-a6fb-f8183ffc546f"
      unitRef="usd">-4360000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS0xLTEtMS05ODY3NA_e41c11d9-47e9-42e7-a2eb-bdb254fb823c"
      unitRef="usd">2069000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS0zLTEtMS05ODY3NA_5f15d572-6fb1-4765-aadf-00b5f188b25f"
      unitRef="usd">24231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS01LTEtMS05ODY3NA_adf83c9d-fc8d-4703-9949-32ef20f4b85e"
      unitRef="usd">31370000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNS03LTEtMS05ODY3NA_b4b081f5-382b-4a30-a74f-9f058262cb6c"
      unitRef="usd">62602000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy0xLTEtMS05ODY3NA_bf34d959-61f6-4370-ba42-b61049a4151b"
      unitRef="usd">2762000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy0zLTEtMS05ODY3NA_21614968-eeb1-4625-9db9-2f0a6c0d4974"
      unitRef="usd">6571000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy01LTEtMS05ODY3NA_6474c640-f42d-4c02-b19d-10c42584959a"
      unitRef="usd">5359000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfNy03LTEtMS05ODY3NA_508f62fc-4e6a-43d1-b815-3883bcb26b24"
      unitRef="usd">15492000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC0xLTEtMS05ODY3NA_89f13f35-f983-4f5e-b432-e1f154aa715e"
      unitRef="number">1.33</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC0zLTEtMS05ODY3NA_6199770a-7d12-4507-a4b2-7f9b43d54e7e"
      unitRef="number">0.27</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC01LTEtMS05ODY3NA_cbeb762d-11b4-4740-afd0-50dc670b33ac"
      unitRef="number">0.17</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV83OS9mcmFnOjFmYmZiZmY4Y2QyMjRmN2Y4MWFmMmQ2OTUyYTRhNDI5L3RhYmxlOmExNTVjNGJkMzc5YTQ2NmM5ZDA3MjRhMGU0MzBkZGYxL3RhYmxlcmFuZ2U6YTE1NWM0YmQzNzlhNDY2YzlkMDcyNGEwZTQzMGRkZjFfOC03LTEtMS05ODY3NA_638bdaee-8fd9-45c6-a754-7878bf615dd2"
      unitRef="number">0.25</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjQ1Mw_2ceb7844-3df7-44df-97d6-e46ac39601de">ACQUISITION&#x2013;RELATED CHARGES (GAINS) AND OTHER&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition-related charges (gains) and other for the three and nine months ended September&#160;30, 2022 and 2021 summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Flexion contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoScience contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nuance Biotech Co. Ltd. agreement dissolution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges (gains) and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized acquisition-related costs of $1.5&#160;million and $10.2&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022, respectively&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, primarily for severance, legal fees, third-party services and other one-time charges related to the Flexion Acquisition. The Company recognized acquisition-related costs of $1.0&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; primarily related to legal fees. See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flexion Acquisition&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2021, as part of the purchase price consideration related to the Flexion Acquisition, the Company recorded contingent consideration of $45.2&#160;million, which represents the Company&#x2019;s potential achievement of meeting regulatory and sales-based milestones. During the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded $0.5&#160;million and $13.8&#160;million gains, respectively, due to a decrease to the fair value of its contingent consideration. See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoScience Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $0.5&#160;million and $9.6&#160;million contingent consideration gains during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September&#160;30, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $1.2&#160;million and $2.1&#160;million contingent consideration gains during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30,&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information regarding the method, key assumptions used in the fair value measurements of contingent consideration and more information regarding the changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized acquisition-related costs of $0.4&#160;million during the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; primarily related to one-time termination benefits fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nuance Biotech Co. Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#x2019;s intellectual property against the risk of a generic product, which resulted in dissolution costs of $3.0&#160;million for the nine months ended September 30,&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock>
    <pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjQ1NA_495735b4-25f0-4b33-8666-e2452253a429">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition-related charges (gains) and other for the three and nine months ended September&#160;30, 2022 and 2021 summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Flexion contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoScience contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nuance Biotech Co. Ltd. agreement dissolution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquisition-related charges (gains) and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi0xLTEtMS05ODY3NA_c03c4d8a-34a6-4ab2-bdab-72e6fba9419e"
      unitRef="usd">194000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi0zLTEtMS05ODY3NA_8f5bfdcd-e913-4f3b-afe3-0623c23a208f"
      unitRef="usd">445000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi01LTEtMS05ODY3NA_8066dd08-df7e-474f-b252-1dd43c7132f4"
      unitRef="usd">4259000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMi03LTEtMS05ODY3NA_ee51238c-8ed9-4055-923d-2457ec125632"
      unitRef="usd">445000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i24d0d73926a8453fbff3d3a2959a9f19_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy0xLTEtMS05ODY3NA_6250704a-2db9-4b2c-a470-c4ae2a96934e"
      unitRef="usd">905000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i47e4065f3bf84a769793c677aa707755_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy0zLTEtMS05ODY3NA_09f4b465-255d-4fbf-93af-8508fe0109a6"
      unitRef="usd">951000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i6952928bc30b45c094b9931501de819e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy01LTEtMS05ODY3NA_840d1358-a451-4f3b-9b24-b60f82c10856"
      unitRef="usd">4918000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i5e6b8329aab94b669b97bbc6cc18e60c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfMy03LTEtMS05ODY3NA_fe253f41-a693-4ae7-b661-776b2be5e539"
      unitRef="usd">958000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2090540004814f58aec0fe11cbfc0491_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC0xLTEtMS05ODY3NA_971eb3e5-a214-49cf-8e19-fc05166aecac"
      unitRef="usd">433000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2be6662b540d42b5b071db1e7701ffd5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC0zLTEtMS05ODY3NA_50d8a3ba-bdd3-41f2-891d-1465c4f6b52e"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ieb5ac33a93d943dfa41d95c7fbb2fa8c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC01LTEtMS05ODY3NA_15403090-cfe9-457f-a61e-c987379ddf35"
      unitRef="usd">985000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie470b1ec9ebc496c8a8a2b82cee22927_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNC03LTEtMS05ODY3NA_fbd71147-7676-42d8-b1ae-7fa7c10d5124"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS0xLTEtMS05ODY3NA_0a04327d-5081-4a0b-abba-b2f40b509b10"
      unitRef="usd">1532000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS0zLTEtMS05ODY3NA_0109cdc2-b78c-4ba4-bc21-93326312869b"
      unitRef="usd">1396000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS01LTEtMS05ODY3NA_6baaf6cb-d4ad-4a0a-82e3-215fa64ca5a8"
      unitRef="usd">10162000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNS03LTEtMS05ODY3NA_6171a192-8ff4-4fea-a523-09879d997ae8"
      unitRef="usd">1403000</pcrx:BusinessCombinationAcquisitionAndIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia2c777abcf4b469ebafc9aa977f3f943_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi0xLTEtMS05ODY3NA_e9fd30aa-f30e-4813-9e7c-81191714b430"
      unitRef="usd">520000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi0zLTEtMS05ODY3NA_493dd91e-7cc0-4827-8df1-b83efab6d068"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4df205ee98b9479fa0df23571a4898df_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi01LTEtMS05ODY3NA_66399573-1a41-4740-afd8-7848f0a30caa"
      unitRef="usd">13837000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i083491131603445e901ef44a6b4db810_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNi03LTEtMS05ODY3NA_2b3f0d0e-ad73-4974-8bcd-ba490aaa0336"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy0xLTEtMS05ODY3NA_17003a7c-bc8f-49cd-971b-304fbbb21e15"
      unitRef="usd">523000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy0zLTEtMS05ODY3NA_dad17bad-dce1-407d-8d51-5bb7f5898f63"
      unitRef="usd">1159000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy01LTEtMS05ODY3NA_62cb3ded-d041-45d4-81f5-f95badb45368"
      unitRef="usd">9557000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfNy03LTEtMS05ODY3NA_84eb16c8-921a-4e68-991b-1075b1d970fd"
      unitRef="usd">2147000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnContractTermination
      contextRef="i20ec8193fb584c849fb512a1ebd30246_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC0xLTEtMS05ODY3NA_6c48c803-f495-4c25-96c9-d81c91d8d706"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="ie3ee845af90843f89f53ceeb7e4f835b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC0zLTEtMS05ODY3NA_3f583b90-1f11-479c-97e6-3be125e590f3"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="i1904086f824643bbbbb99866420b64c8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC01LTEtMS05ODY3NA_4ad9c8be-e252-4313-92f0-b0c11ad27cce"
      unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination
      contextRef="icada30aef3ab4b739d33763eef827871_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOC03LTEtMS05ODY3NA_e79f43aa-659c-41eb-b23a-4e1afbde06a2"
      unitRef="usd">-3000000</us-gaap:GainLossOnContractTermination>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS0xLTEtMS05ODY3NA_0485a940-7bad-48f8-8234-176fe73fcb89"
      unitRef="usd">489000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="ibaac43bcaafd447981243bb544ae0e10_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS0zLTEtMS05ODY3NA_a5bad508-d2fc-460c-8e08-b5ec63b33c1c"
      unitRef="usd">237000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS01LTEtMS05ODY3NA_1977bd66-078d-44ce-8f0c-5d7efae9ca84"
      unitRef="usd">-13232000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther
      contextRef="i7a889c4eb3c4491cbf628c9d34303230_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RhYmxlOjk1ZWRhNzI1NmQyYjQ2YjdiYTg4YTA5ZmJhYzBmYzBjL3RhYmxlcmFuZ2U6OTVlZGE3MjU2ZDJiNDZiN2JhODhhMDlmYmFjMGZjMGNfOS03LTEtMS05ODY3NA_10e6cefd-3c07-47fe-b863-2b952c20219e"
      unitRef="usd">2256000</pcrx:AcquisitionRelatedChargesProductDiscontinuationAndOther>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ied8157b496ab44079fe9f2e4512f3b32_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjkz_237f49da-0175-4beb-ab3d-da14b14ad297"
      unitRef="usd">1500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i80fd88738e5c447e82122a8f75186048_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMzAw_0a996a61-87f7-4bf8-a7ee-9503887a38d5"
      unitRef="usd">10200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iac64608b237d43f0a6a93d7bdccf7a88_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTA5OTUxMTYzMDYxNA_811208b5-0267-472d-bedf-1efba4e59b61"
      unitRef="usd">1000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i7e41fa8486f34ea58ad7ceac10e1140e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTA5OTUxMTYzMDYxNA_8c856c36-6d74-42e6-b533-5d4b8a4103f1"
      unitRef="usd">1000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3f9b40559caf4ae8afe076917f9752ae_D20211119-20211119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfNjcz_1f2234c7-86c3-4c78-bdfc-78c22fb8eea5"
      unitRef="usd">45200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6284fbc559434e6e9a6b636edeead928_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfODI5_573d30b5-976f-4b32-a59a-8672e1221aa2"
      unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2d80999d718b4dce93b9bc7256cf5b5c_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfODM2_5acc3703-93e5-4c97-940e-ac68e32505b2"
      unitRef="usd">13800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iafad33d5e079486ebaa0d06400f206e2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTMwMQ_5f1aa970-0a9c-48ac-bd16-295ea897e28d"
      unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i759d65caabbc4901840a18f37bb7abd2_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTMwOA_a28a2d85-497d-4c97-b9b5-26e87f761a65"
      unitRef="usd">9600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTQwOQ_f612f751-4325-4ba0-8193-a65a85f78eb3"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMTQ1MA_4110949e-df46-4674-bbce-05c031092df7"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i29b825b5067840dc9cd04185cca37592_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjE5OTAyMzI1OTIwMA_2317926e-026b-4d53-91e1-cfe2e580b53b"
      unitRef="usd">400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="icd8429408bb54469b9d1d01aecb68f2d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjE5OTAyMzI1OTIwMA_baa594d8-947d-404f-891c-8867d11aa056"
      unitRef="usd">400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LitigationSettlementExpense
      contextRef="i166df1f4bcd2446d844456bfb7f76005_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84Mi9mcmFnOjM2ODAyNTBhMWY4NzRkZGNhNmQxMWE4YzgwNzgxZjUzL3RleHRyZWdpb246MzY4MDI1MGExZjg3NGRkY2E2ZDExYThjODA3ODFmNTNfMjMzMQ_086abb12-629f-400b-98d3-80da7c466d65"
      unitRef="usd">3000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfODk2Mw_79f3d744-d1a3-49da-b770-7436303e0314">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoScience Milestone Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#x201c;Pacira CryoTech&#x201d;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#x201c;Fortis&#x201d;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#x201c;Merger Agreement&#x201d;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#x2019; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;eVenus Pharmaceutical Laboratories Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the Company received a Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted to the FDA an Abbreviated New Drug Application (ANDA) with a Paragraph IV certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,033,495 (the &#x2019;495 patent).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company filed a patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (21-cv-19829) asserting infringement of the &#x2019;495 patent. This triggered an automatic 30-month stay of final approval of the eVenus ANDA. On January 6, 2022, eVenus filed an Answer with counterclaims to the Complaint, alleging the &#x2019;495 patent is invalid and/or not infringed through the manufacture, sale, or offer for sale of the product described in product described in eVenus&#x2019;s ANDA submission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company received a second Notice Letter advising that eVenus submitted to the FDA an amendment to its ANDA with a Paragraph IV Certification seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (133 mg/10 mL) in the U.S. prior to the expiration of the &#x2019;495 patent. In the Notice Letter, eVenus also advised that it submitted a Paragraph IV Certification to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL (266 mg/20 mL and 133 mg/10 mL) in the U.S. prior to the expiration of U.S. Patent No. 11,179,336 (the &#x2019;336 patent). eVenus further alleges in the Notice Letter that both the &#x2019;495 patent and the &#x2019;366 patent are invalid and/or not infringed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, the Company filed a second patent infringement suit against eVenus and its parent company in the U.S. District Court for the District of New Jersey (22-cv-00718) asserting that the 133 mg/10 mL ANDA product will infringe the &#x2019;495 and &#x2019;336 patents and that the 266 mg/20 mL ANDA product will infringe the &#x2019;336 patent. This filing triggered a second automatic 30-month stay of final approval for the 133 mg/10 mL ANDA product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These litigations are in their early stages, and the Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research Development Foundation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to an agreement with the Research Development Foundation, or RDF, the Company was required to pay RDF a low single-digit royalty on the collection of revenues from certain products, for as long as certain patents assigned to the Company under the agreement remain valid. RDF has the right to terminate the agreement for an uncured material breach by the Company, in connection with its bankruptcy or insolvency or if it directly or indirectly opposes or disputes the validity of the assigned patent rights. The Company&#x2019;s U.S. Patent No. 11,033,495 was issued on June 15, 2021. Thereafter, RDF asserted that the issuance of that patent extends the Company&#x2019;s royalty obligations under the agreement until 2041. The Company believes that the royalty period under the agreement was set to end on December 24, 2021 with the expiration of its U.S. Patent No. 9,585,838. Because of the disagreement over the interpretation of the agreement, in December 2021, the Company filed a declaratory judgment lawsuit in the U.S. District Court for the District of Nevada (21-cv-02241). The lawsuit seeks a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;declaration from the court that the Company owes no royalties to RDF with respect to its EXPAREL product after December 24, 2021. During the pendency of the lawsuit, the Company will continue to pay royalties to RDF under protest, however, the Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pediatric Trial Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the U.K.&#x2019;s withdrawal from the E.U., the agreed pediatric plan is applicable in the U.K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#x201c;PLAY&#x201d;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and U.K. to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency, or MHRA, are still reviewing the Type II variations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hong Kong Pharma Tainuo Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Flexion Acquisition, in March 2020, Flexion entered into an exclusive license agreement with Hong Kong Tainuo Pharma Ltd., or HK Tainuo, and Jiangsu Tainuo Pharmaceutical Co. Ltd., or Jiangsu Tainuo, a subsidiary of China Shijiazhuang Pharmaceutical Co, Ltd., for the development and commercialization of ZILRETTA in Greater China (consisting of mainland China, Hong Kong, Macau and Taiwan). Under the terms of the agreement, HK Tainuo paid Flexion an upfront payment of $10.0&#160;million during the year ended December 31, 2020 which was recorded in other liabilities as of December 31, 2021. The Company was also eligible to receive up to $32.5&#160;million in aggregate development, regulatory and commercial sales milestone payments under the exclusive license agreement. HK Tainuo was responsible for the clinical development, product registration and commercialization of ZILRETTA in Greater China. The Company was solely responsible for the manufacture and supply of ZILRETTA to HK Tainuo for all clinical and commercial activities. The terms related to product manufacturing and supply, including pricing and minimum purchase requirements agreed to in the license agreement, were to be covered by a separate supply agreement, which had not yet been finalized as of June 30, 2022. Unless terminated earlier in accordance with its terms, the license agreement was scheduled to continue in effect in perpetuity or as long as HK Tainuo or Jiangsu Tainuo continued to sell ZILRETTA in Greater China. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company submitted a letter to HK Tainuo associated with this license agreement seeking a mutual decision to end the licensing agreement. As of September&#160;30, 2022, $10.0&#160;million was recognized as part of acquisition accounting within other liabilities in the condensed consolidated balance sheet related to this matter.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i4fac746bbf294b19acb69210d7229116_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfMTczNw_a5c68a0c-4a58-4328-825b-148b105331da"
      unitRef="usd">30000000</us-gaap:LossContingencyDamagesSoughtValue>
    <pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA
      contextRef="i17b1073570b241519f375ef761e56fc8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfNzgyOQ_9f13e421-42e4-4463-bff5-055823a585be"
      unitRef="usd">10000000</pcrx:ProceedsFromDevelopmentAndCommercializationOfZILRETTA>
    <pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum
      contextRef="ia28ed82e949f407abfcf436c06550157_I20200320"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfNzk5MQ_bc88040d-5ff0-4d46-9b3d-dcd9ac95d518"
      unitRef="usd">32500000</pcrx:CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="iea1a035c480c4e9cb20e78a99005a535_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJjYmRmNzQ1OWRiNjRiNzQ5MDA1YmE0OThmMmQxOGZlL3NlYzpiY2JkZjc0NTlkYjY0Yjc0OTAwNWJhNDk4ZjJkMThmZV84OC9mcmFnOjEzNDUyZjJlZTg0MjQ3YzVhNWM3NDllNWQ5ZjAxMzI4L3RleHRyZWdpb246MTM0NTJmMmVlODQyNDdjNWE1Yzc0OWU1ZDlmMDEzMjhfMTA5OTUxMTYzNzIxNg_21191411-77af-4253-ad99-34e33c4903e7"
      unitRef="usd">10000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MOP3L&PLUB64@=^@N"!EZR*(%$SHPLX9MX[;3M7NV#LX8VA!N4,(-3H%[9*M
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M['I*L]PG[2K,'-24L;(_CMFLC '0+R!#JAUCC@C4CJKFN/\+9KTX25037G[
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M+I4&Z-G"8S(1)7$T)&@#,4PB$A$/Q4ZD4/*BTK$0[%X40ALQ==:/*"AV/UM
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M;4L!=,17 FN^,4;*RHS21S6Y#ON&I11!#(%0%%C^K& (<:R8I(Z?!:E1GJF
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M;"_T,)(=(# 5(/?GE(KGB>HQRI[2_P-02P,$%     @  W1C5>2IPNGB!P
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MZXYA#L%\/]+]),CF>[JQ -EP,&*I2.^<B=TYOT_AGVDVW2RH&8+YH5XO +"
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M[0URK??(L1Q'LY_IV\UMG9S_YSWZS]Y/@N$VA>*6?.YK?!)+ @>$1&R-IJR
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M76B]")260&D411--U0<0CCZ >%&\JV>/[L"AP86CV,O+5CTG0'?S@M((E)9
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MA1@J2J"T!$JC*)IHOSYY\?3)R_."9T\.-2;27T_5*X^V(72W,2@MAM((E)9
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MFE^XU'Y"#_PQKRHU&9"#L.7(Q<P:@LGJ<!R&<7]/;[%+DL3%2J:1SOQ(]T3
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M^0 Q=OSKYN?WUQ\^7 R 0.!E4VAR%I  '4; KU1"?8J*6L=!MOLK(*'R( )
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M%OTKJDSU%%2%) 0:V&Z@*J2A.S7-HPCLL_:#8M_$ZK$EMR03F%^_YTJV$Y9
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M*U0RFER%O%QIAKT^(W&O%<M,^9R@[JB 9HGL"F/%Y]'HIAM,VG 2[[850[&
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M0,SUGKD6&.:__+NNQ0_0R^S)84A%EO8V!.R?DZ^WYW=W(YYKBIA5@'3(&I2
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MS'XGW8GN]E0LJ0J)TTM+Q[JCCNTPU21#OC)'<HUGC "7$1OP ,WD1QW@]T(
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MAF2)N<$)B, VS:T6,$$$S Y@S2A)VF)@!C:4O(^.9P.GIK;PP[=:6 ]WX:K
M0^9<)50.)EF&'(XJZ_RSDVEO30EOK8BPTF64W1@M%^SQ@;';\ XRQ#&=96 !
MWYL#GS85FQ[R]_+ZYITHJL/S;GN;HR&S>6FTF2T>:]ZZ_'Q5BC=BBX=!5NI
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M1[QP *\M>R16J#A@'^ ;, ,F0'DVUC2*' X?V)K[ABST.DWN)&?,(T(*C(5
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MYQ_E?^?BQ2_F8!V;K)=V;'PHBP;96HNN(XT]DL=MD+N,+SHG]<D::NL*>Z:
M,D4,TG3_A/VS$!TC_\K7K?P[[^(#W>YH?>.9>_T7@CI?.Z^&&#L7JV ZF_*%
MX>5XAO\GBV YH3_F00@2-SOJ?_]9I];V92!CD:OQ5"P6"S$)5O,%"*V6B^%Q
MM8$O5G/0OY[-,"8<+P5RR60V%V^,*JR<O/UZ<X'A@CLX"[H?&(ROY_C_^CK$
MOQ/XP.22KA>.P\5E?1EZA:_IAN(RF$YIA9/K8#6EPZ4H4J>3I?B%]QM;",>D
M@\P/3//1;"*>B<5H.<9_\Q'667^J.V,RUO4F\<V7WSC0/Q\O[)8F3>'P2SAT
MST+1%:],EJU*PL2HEMSZ)47'S9W;^/FAQB;NEBEO:[BV'/G1AHW8EF\4.^.X
MW?_8*'M/LFW'='Z K@W^<MHJZY,Z9O:^,6IW[]F<>/3Y;"10-PH;^9AD<C!@
M>O3H@F1DY-S;9ZL7R2W9(B'[YEWL7#WOC>O^F@&JX)1P+8.$YD)GLV=E, 0Y
M=\<MAIDVA5YKQ]3\^HDY:7(G\]A-<,#VP)%2IN<Y$8'X8G[QA,_Q)% A;8G!
M$6\B%BO1^J33)*([;:.AGY2X\G[?8Z?R._X5$ZYILM+\U$?];?U#*3?F]T&:
MU\VOK+SGVPZ%2-4&0^EL^)DI"MR'4N_YUT+6NBSUCO_<*@D\32_@^49C5?8#
M35#_?,RK_P=02P,$%     @  W1C5<G_X+R+$@  '#D  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&ULQ5MM<]NZ<OXK&%_GC#U#RR(I69+S,N,XR6UF
MDC2UD]-.._T B9#$$XI4 -*.SJ_OLPN0!&7*<4[O;;_8$@DL%HO=9]^@%_>%
M_F;62I7BQR;+S<NC=5EN+\_/S6*M-M(,BJW*\699Z(TL\56OSLU6*YGPI$UV
M'@V'%^<;F>9'KU[PL\_ZU8NB*K,T5Y^U,-5F(_7NM<J*^Y='X5']X"9=K4MZ
M</[JQ5:NU*TJOVX_:WP[;Z@DZ4;E)BURH=7RY=%5>/EZ1.-YP.^INC?>9T$[
MF1?%-_KR/GEY-"2&5*86)5&0^'>GKE66$2&P\=W1/&J6I(G^YYKZ.]X[]C*7
M1ET7V;^G2;E^>30]$HE:RBHK;XK[?U%N/V.BMR@RPW_%O1T;CX[$HC)EL7&3
MP<$FS>U_^</)P9LP'1Z8$+D)$?-M%V(NW\A2OGJABWNA:32HT0?>*L\&<VE.
MAW);:KQ-,:]\]>[]IZM/U^^O/HCWGVZ_W'S]^/;3E]L7YR5(TX#SA2/SVI*)
M#I"9B8]%7JZ->)LG*NG./P=+#5]1S=?KZ%&"MVH[$/$P$-$PBAZA%S?[C)E>
M?&B?,M7B=YE52KQ)S2(K3*65$?]U-3>EAFK\=]^>+<E1/TDRETNSE0OU\@CV
M8)2^4T>O?OM;>#%\_@C#HX;AT6/4GWXPCY+I9[*7MO!$]%%)D@^,KS3V^1T_
M3PUI/)9(A#2B7"NQU>E"X9,L87Y5EHBY@JTN%$PM$64A8'^9D+ ^8X PA:;W
M6YGR.P@^-TNEA119*N=IEI8[D>8UW7R1;F5&<S:%*85,[F1> BB*RL "]#?0
MPV#0+G2B=+:S]"1;^T!\*?!V 9PR2BP*@(@I5;[887R"[YNMU-Z*RW:+&V_K
M ;/R[NKVM5"FE/,LA:%AZWBLE3K+U)W*Q#I56NK%>B?NU^EBC=U_KU+2+7 &
M(K0"]@J333?IGXHI5N"I6(IB3N<!LA!LOJU*P\S!R!^,K/*'8^_7*G?<IOG*
MVP+VOE:61<$L&B)Q8(M":G4I?OO;-(HNGHL/O*/P4OQ;5938*9^N$2=5+I,_
M $8J.669,Y2Z0S#V]$$'SS':I,0DGA#_WE(BD:42<"-6%PP=;'WLJ3*6:X_+
M5JXK+&:U;0V,Q4D07X5VDG4\.[$,]O8278I_;47G]M,P3'B>"#@')].\*,5W
MN_5B?YN!F%<E5$?K8EYH26/FNUH1L3>YOW1\*;[VG%NS>$5K\RE" B4&0"!Y
MX5,D>Y-W,LUH_I,$!!_;+Y^XD0]164BM=Z0UEA*I1YI+&!SL+<V!B)55#EA0
M5B4T<"'-VMH.?2 5QU1K(SCUHJ+1UNYYKS2R>;Z5._MPN]4%S(#T ,QB(S"3
MK;)2;C<&C %/A _@U*P+79Z52F]$+DNH$C&+%["+M%2;AVIC7XMK,O%\1R<2
M3IX;@H [I4O63:/RE&5=*M9_["E;5!D?:55"'_^D';MS('60!"E&+'6Q8;P!
MI3,L<L;[ WX!>!)O"NFX9=$N<>)4\?2IS,H%Y&M26O5,*\L8-E!B#3(DAC-
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M4G:R7[\C)2LND!CK/@V&)1YY]_!Y3KJCAENE'TV!:.&I%-*,@L+:]7D8FJS
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M W12GQLO[O7I^YGI%9<&!"XI-#KIGP:@ZQ.M-JQ:^U-DH2R=27Y8T$< :N=
MZTM%W;0QW ;M9\7X'U!+ P04    "  #=&-5N\ F@WL&  "*#@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6R55UM3XS84_BMGTAO,>!/?XU!@!EAZ
MV;9LANQN'SI]4&(E\6!;64DFT%_?[\B."=U VQ=;EL_UTW>.I-.MTG=F+:6E
MAZJLS=E@;>WF9#0RB[6LA!FJC:SQ9ZET)2P^]6ID-EJ*W"E5Y2CT_714B:(>
MG)^ZN:D^/U6-+8M:3C69IJJ$?KR4I=J>#8+!;N*V6*TM3XS.3S=B)6?2?MQ,
M-;Y&O96\J&1M"E63ELNSP45P<AFSO!/X5,BMV1L39S)7ZHX_?L[/!CX')$NY
ML&Q!X'4OKV19LB&$\;FS.>A=LN+^>&?]!Y<[<ID+(Z]4^7N1V_79(!M0+I>B
M*>VMVOXDNWP2MK=0I7%/VK:RT7A B\98577*B* JZO8M'CH<]A0R_P6%L%,(
M7=RM(Q?E6V'%^:E66](L#6L\<*DZ;017U+PH,ZOQMX">/9]]>'_U"TU_O;B9
MG8XL#/+T:-$I7[;*X0O*$_I-U79MZ+K.9?Y<?X1 ^FC"7327X:L&9W(SI,CW
M*/3#\!5[49]=Y.Q%+]FS:G&W5F4NM?F.KC\WA7VD&V4E_7$Q-U:#$W\>2KNU
M&A^VRG5R8C9B(<\&* 0C];T<G'_[59#ZW[\2<]S''+]F_=]6Y#\KDTO^S24H
MF].5JE#&1KA*^+"6;D+4CZBKA5K5Q5^0,4Y^[N07^_+R@<>2BIHL5#=2%RHW
MY'*O+:2%H:4J4=^&CIR0:HRH<W-\ E]:RF<TH1O$_'R&5YL?P=[H2AE+:DDK
MQ;X,UI"^IL!+)I/V'81XQUX<3OKW+>(1>K$F^$9EWJ/C;- _+,3'681GD*00
M':<!13 4T S-H*A7'JUD+;4HG:+(468%DX/[!4V\R/<I\X(@I3#UPC"A,/*B
M**4/RD(%P81>FG$T@0\_,091XL5!PH/ B^!S]A*R2ZVJD_8WJ0U/&6BEWC@(
MW#M.,KQ#W_,C'@03+_''G*?5Q<+NUHR:NK"&$F\,\=@+PI2"V$NRC +DG,9T
M76U*]8AU:,4W#4!",+0I14UA$,&#3^-L0FF6_(^TNGJZV J-)6)6M2P I&3%
MO)0&V=86.P.HT^X?KA'/L3DX)G4D_/:K+ S&WYLNO!8(MQ;Z4*8>*4VWLX]>
MV](Y!!AW!FNF5M522SIJH:-86<VE[MO*#N_W'=XWC?L-JNUF?G>M',H7]V#%
M2M+U@]2+ H!-$8RDHRGD9VNAY3&];ZRQ")5S%I;>RD7G+?!:'J>>G_A>$OM,
MT\DP"NE'+5S5!%C5V LCGU)_"';MO.1TE*9C;Q+[QX!\&&2$_6<I"]8YRC+P
M-SVF)!Z"$M</FT+S=(@*B,?'6,3A./UG4%]B@*@B/_+28$Q).(R#?4JUZ'QT
ME'K"IOW^ AF7"V'GD?2#*#1]$F7S'*"/]3UL<Y,XA,XD2;QP/ 8VB /DVV&3
M3#(O1:D#F3BB3ZV%HPB5!ZH@>P VWH<ES3S?!UY),O3C9SX/),]%$:(9))2,
M&45F[G:7F>@R6W(Z]RX=I&^>E>BJBS)OM./Z?V0>;06AOL-DF*;<1<DP1,.V
M<GIWYF5_6ZDE(;,"E83/QNR\7Y8"#6:VP%;'^FT!L;6VXBJ52SY8V+63?JK2
M+[(6!J>SUNO)/ZQ^L?87O>R!EGX@>Y!5.H;E*-H<(-%C(='6;Q24;PMS]V;)
M>T6!5+GN23.KP(KXFR?5>U4BI9)K/D9I[/^"5L70[4"+AY.0'K$AF*?^UW)[
MNNM_4^Y_/]?TKD$$'*/W<EOJ3A$D-ANM[MD?)"^J=JVY5W$)N64)_2!^U:5K
M8->SZ;1=>AZ!&C#=6;,*("QPQ(:\XU9?A8XPCB#81L"VCB=V#:)7XI'FLMTI
M&]AI.Z(S/G]$A-C8\H*A07=/?)_KI;.W%\92"MNP"[M59(J'-X[2<+B4CNK]
MW@_SC*U'NJEK_L-;&;T3=8.C/06<@T,5W8W!>=>4W>Q>#QBB4/?C]$AVJ!F7
MC3NZLP[O(KJ8-^"#6&*=WUCQ0/#.C@T+]#M:!Q#@R))O&">VO2B5JQ178[AZ
MW.&NTU?VH05_!BX?@% Y79P]$CFSL]MV>O<\Z=%V7>#NA"JAPA!*!P"__7^=
MPJ,(AP <:;I\7.'OO+1T*U!]CH5:-:MUC^'PT ETM'<_J*1>N5L0I]G4MKTJ
M]+/]1>NBO5\\B;>WM-^$7A4UI[6$JC\<)P/2[<VG_;!JXVX;<V5Q=W'#-2Z+
M4K, _B\5CM_=!SOHKY_G?P-02P,$%     @  W1C5<^VI3C*!@  21,  !D
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M$Z"T668S<DT^#$PDKN:-QU1R%8"Y1O*(S&R<U"=?DGEPPVU'VG -V*9&4A:
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M9:D>BF-"@QVU,Z#W*Z7L3G !JE]%^!=02P,$%     @  W1C5?DS!=\4 P
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M?W5MU[/XQDWNHH'D9;19(N2#V%\5X@O?B\#M$.I0XACJ6=/T9NYKR=@J/W@
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MX+^*.U&(DZ11$^CV_HNX;US08-+R3G8==^&KBXO4+OWU[(XCJICZ#MN.;E\
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M^)JUM?VB[G_EO3^ITU>JVO@OW'=K<SJ!LC56-;TP6M (V?W9MQZ' X$%>4:
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M786=@.[>&%W'JIV_UZ^4Q5>";V[Q6<:U6X#S:X5X]1VWP?#06_X'4$L#!!0
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MR0#]<X4RMWZA"9HOR.?_!U!+ P04    "  #=&-5?FT+MF<#  !'"   &0
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M=R@20(TE2I9?FAA(T@PML*1&G*P?AGV@I7/$11(UDHJS_?H=*5FQ9\=+L<*
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M26VH,?:;ZWFDP(D1M?"MR&F@,T ;\CKEQY87HH$W"@.((B\:QG86^;Z=!8,
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MPRB- ?U?"ZI>O3 $S<,^^A=02P,$%     @  W1C58_E=6V- @  N08  !D
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MM@(F6'2@%YQ!&(0A%%)D9:I!X=I<#MV"WVMJT'/XO5?P)X*G!DD2=T\65#W
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M:]#HF>,GRU)==K3(77G<"&V*K6MFYG4#:0W,_%8(?>[8!:KW,OH#4$L#!!0
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MZJ.>NB%H49V6/% A:%9=[C#:8*8"Y/.$4O'44 <P[8%;]#]02P,$%     @
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M$736>P*_H.3F58VH;Y#4$W8IUT^8TKO-I(*1 [QJ/EP/8O;4U;Y<]:+>JMM
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MX'J"&B\8DV\=?6<,5W[V&U!+ P04    "  #=&-5-HN NJ0"  #Y!@  &0
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MS&X\<'ES/[L)+R^N?#!;+/S[!?@#W$#&H H7\,E# N*4?Y:MWQ<>^'3R&9P
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MUFNZ87(C_+[+)>ON-L:V#VQNUS[6YTZ:OE;-0"M;J(NM[O5.O<9J]?HA001
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M$;P#?@3N5S3A./+XP!226CJ Z18T+G(:: ^-/OA*(['BX#+RB*?PG^C](=(
MF#(G96+02V(ND!9Q3N)3T+$^ 60AI"*D=Y\25[K#S!UJZ'3*>>ID>)T]>&/W
M9^(SXH$O?N0+<G(M%[^GF)Q_KJ4CF D2\G]5TY"/<J8>):T9YSS&+AD:LBAP
MPM;$&+W_"SK69U4*6@*K)>2L3,B9#GUTQ2CG8((9>_:C)?B.@X2H LY1G PE
MK6GKD=VWK+XU,-?;H1PTJY&T2Y*VEN38=9,P";"0<S4.*1/^?SBM7BJB.9*]
MQ>"D:UF]W@Y1A1GJPG2)JH@Z)5%'2[2QD#Z!&R)4-)W&^+9L&1;:H:DP<U#?
MZ:EI=DN:W58FO=L8W;%A<](/FM5(]DJ2O99RV6LFJ0>;N6R:.:BS-Y?]DF9?
M2W-*UK*)QW)E"N*N(AK0I4^4I5N+<VS-: FL%C*TJFYGO4D9+89I*2=MH=63
MLB4!8"N[JH"Q=XJDM;NM#MO5B:***&JMG!90N_74[NZ25=BAKM7O[B%;-6RH
M;7]'E($"J-9\8+]_UMFEJK"31=7J[*%:M5*H[Z6/F=@EWLEX39@4[^"!DT42
M@'1WJ,6<'@]:X)E@QH$-PDR5*1?]_\*H1UKU8ZAOR)-,41,FOT"";.GPE1^K
M0]0"';W#6T*KAUUU=^B\3=G3JHBCD](26CTIE9: [8B) F9[VS64A-ZF3K#2
M$5 O)(XJ=TV1<-*!NRP51LC>0[/2$5 O)(XH='V%RM[EV+1Q]E!$5=M'V@YZ
M?($[@/=2G)3?A7_B6H^KZMQ(W[G+?3V[O7N/P_CS5!F,%N387=L66CWD2@,@
M]":E#&FEQM%):0FMGI1*:R"]UGAM*4--!>' IH [:%:G6>D,I._IKZ\4J/D]
MKB1ZR"PG:FZ=C\GFO\R.#3EP:1*)_*BL?%H>38ZS SFS,L_/-;]BMO0C#@*R
MD*[6:5<64Y8?%>8W@L;9:=L3%5)I9)<K@CW"4@/Y?D&I>+E)!R@/;$>_ 5!+
M P04    "  #=&-5+'RF63\%   [*P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U-BYX;6RUFF%OJS84AO^*E5U-K;1;L(&0=$FDM>9JG=JINFGO/DS[X"9.
M@R[@S#C-K;0?/T,HQ"EU0WOZI87$Y[$Y!U[.&QAMA/R>+SE7Z$>:9/FXMU1J
M=>HX^6S)4Y:?B!7/]#<+(5.F]*Z\=_*5Y&Q>!J6)0URW[Z0LSGJ34?G9M9R,
MQ%HE<<:O)<K7:<KDXQE/Q&;<P[VG#[[&]TM5?.!,1BMVSZ=<W:ZNI=YS:LH\
M3GF6QR)#DB_&O=_P:43"(J <\2WFFWQG&Q6'<B?$]V+G8C[NN<6*>,)GJD P
M_>^!G_,D*4AZ'?]6T%X]9Q&XN_U$_U(>O#Z8.Y;S<Y'\%<_5<MP;]-"<+]@Z
M45_%YG=>'5!0\&8BR<N_:+,=VP]Z:+;.E4BK8+V"-,ZV_]F/*A$[ =A_(8!4
M >30 *\*\ X-\*L _]" H HH#]W9'GN9.,H4FXRDV"!9C-:T8J/,?AFM\Q5G
MQ8DR55)_&^LX-:'1V0WZC,Z9E(]Q=H^^L63-D5@@RN\4.J)<L3C)C_60VRE%
M1Y^.T2<49^AF*=8YR^;YR%%Z%07+F54SGFUG)"_,..6K$^2YOR#B$M(2?FX/
MIWRFPW$9CEO"J3W\CW52A[LMX9$]_(K)IW <FN&.SGR=?E*GGY0\_P7>;9;S
MV5KR>9GOMF1:XPL9.<U7;,;'/:T3.9</O#?Y^2?<=W]M2RTDC$+"(B"8402O
M+H)7TKT73RE]JE]DN9)K+8$*_7VI!Z +Q=/\G[:2>) E@8112%@$!#-*XM<E
M\:W7Q:7([C\K+E,M^NW7Q3:^7\87=\.'2>B'@U!?TP^[Z7T^#+O^D'A[XZAU
M.5TS!P0S,A?4F0NLF;LIDG8I6(;.T!<VBY-8/2*J-5T+7A_]AZ:OZ(V5WO7D
MAH112%@$!#-*U*]+U ?5FSYD22!A%!(6 <&,DH1U2<)WZDWX3$@\WPOQ<$]O
MML."W6'!T!^&>W)C74W7Q '!C,0-ZL0-K(D[%]D#ERJ^2[B6EBP6$OTI%,^?
M)"=HRZ45V?6$AH112%@$!#/J,JSK,@35F"%D22!A%!(6 <&,DF"W\5JN]6*9
M*J;TK3?.M-+P7"&I=]$1RQ%#*RYGND['K7YJ2\5D1U7<$]<-@SWQL4_?-?&@
MM B*9J9^Q^;B]^F4;HU>-V/V2;I>)J T"DJ+H&AFN1I;C FH?&%0FPQ*HZ"T
M"(IF%J:QRMAJ^PYHE"J T2D-@P#O.[-JG-$J>6Z?[+=*]@5U3M]'N%K<V%IL
M][5OO0/XA]X!('TL/73:"&I:,ZN-Y<5VSVL5]ROV6 B\WYI74+<+2J.@M B*
M9E:H<;P8UO)B4,\+2J.@M B*9A:F\;W8;GS?*DA;*O9,9?"\YXH$:74I*"V"
MHIFY;ZPS?H=W?I*MP_I24$<-2J.@M B*9I:L<=48UE9C4%\-2J.@M B*9CY&
M:ZPUL5OKU_O2"K#;EP[Z/MZ3JVK4;E=*7$S\O=_YJ'TYG9]^?80Y)HTY)N\S
MQVV/:<_LS,Y/)D&],"@M@J*9U=EY1 SKA0GL(V/89\:P#XT_P@N3Q@L3NQ=^
M8^]44?=[)_*\=[+/WSGWH$8:BF;FOC'2Q&ZD7Y6L@_HF^R2=+Q50\PU*BZ!H
M9KD:ATX"6 T#->:@- I*BZ!H9F$:8TZL_O*0OJG_K&_:_RFO90@.PD&P_U.>
M?2V=,_<1SIDTSIE\B',F[<ZY3?U!G?/!\T:'C-SFS-EY[[!XK?2*R?LXRU'"
M%SK2/0GUN2VW;VIN=Y18E:\BW@FE1%IN+CF;<UD,T-\OA-;P:J=XN[%^7W;R
M/U!+ P04    "  #=&-5!G=G+)8@  !_7P( &0   'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6R]W6MSFVBZ[O&O0F5U[4I796R!SKW3J4K"^0R96:OV2V)A
MF]62\""<=%;UAU](QD:/A!])F?_L?C%C.^)WZQ!?00]<XOWWLOIC<Y_GM?+G
M:KG>_/[FOJX??KN^WMS<YZML<U4^Y.OF3V[+:I75S;?5W?7FH<JSQ6ZCU?):
M&PPFUZNL6+_Y\'[WL[CZ\+Y\K)?%.H\K9?.X6F75CT_YLOS^^QOUS?,/TN+N
MOM[^X/K#^X?L+O^2U_]XB*OFN^L795&L\O6F*-=*E=_^_N:C^ENJJKLM=C?Y
MSR+_OMG[6MD^EJ]E^<?V&V?Q^YO!]B[ER_RFWAI9\W_?\L_Y<KFEFCORSU9]
M\S)TN^'^U\^ZN7OTS:/YFFWRS^7ROXI%??_[F]D;99'?9H_+.BV_VWG[B,9;
M[Z9<;G;_JWQO;SMXH]P\;NIRU6[<W(-5L7[Z_^S/]IG8VT#37ME :S?0SMU@
MV&XP/-Q@_LH&HW:#T<$&P]<FC-L-Q@<;-,]%_P:3=H/)N8]AVFXP/;Q+PU<V
MF+4;S,Z=,&\WF!]L,'IM@CIX?N4&Y\Y07U[LPU=[/'MMD^>76SW[]5:?7W#U
MZ!5_=9/GEUP]?,U?W^3Y15</7_77-WE^V=6S7W?U^857CU[Y5S=Y?NG5W6M_
M_?2KN/L]UK,Z^_"^*K\KU?;VC;?]8A<&N^V;7]]BO0VN+W75_&G1;%=_T(U/
M?U?^IH19567;!%'>ZGF=%<O-K^^OZ\;?WNKZIK7,)TM[Q5*5H%S7]QO%6"_R
M1<_VKGS[X:GM??GV\U/;AR?NOR8!KILG]N79U9Z?W4^:5-3SFRMEJ+Y3M($V
M5O[Q15?>_M+WQ'Z6,^[CNF$&.T:3,+J<^?A072D#5624S7U6Y9L>S9!K0?9#
M&6A;3)V^8+\HUZ^#YHE'F36/<C!YNGL]FUOG/]>JY$FR3SW7RQ=F<-[C<DX]
M4=6SV#U3?;\=<N9+_G#\ET!9* _9CV9'HI;?1>]\6_;<^3]S%Y_OX$+9Y'<'
M=_7U>QPP]S@\_R^-[#<K.H,93'?,1,+$Y_P&3$_>F^2<!W7ZN4G/>5"3ECGQ
MF@GQ.'SYQV>XFS"4_>/S,=05TPD_AI^=T%*B3[YC??R[$X5?>N[QIR=OU.]M
M=_)_VSQD-_GO;YJ]^$U>?<O??/@__Z%.!O^W+W1)3"<Q@\1,$K-(S"8QA\1<
M$O-(S">Q@,1"$HM(+":QA,12"!/2=_22OB.9WOP36M?+?/</\D->%>6B>1]P
M4ZZ_Y55=?%WFS;O_KW7[@W:9XI^/^:;NBV7IH$MCF<1T$C-(S"0QB\1L$G-(
MS"4QC\1\^:_::* LLA^]N[GDO0A)+"*QF,02$DLA3(C@\4L$CZ5_+SXORTVQ
MOE,V69.W#U5QDRMOB[6R*)?+K-IL8_EI9_M7Y2_Y^[M/TCF7)C")Z21FD)A)
M8A:)V23FD)C[A,UVV/:@R+</X^&5.G]__6T_6LF1_EDC W)D2&(1B<4DEI!8
M"F%"CDY><G0BS=&/J[+9:?V?;'<HK+Q]VG5=%)N;\K'9NWW;3%P5CZN^-9!/
M4OC2X"0QG<0,$C-)S"(QF\0<$G.?L,E>BDWFX\%@<)"<QS<;ST:CH]OYQ[?3
MU,'TZ';!\>W4J38Z'AR2#S8BL9C$$A)+(4R(O.E+Y$WENX[E:E6NG[@O=7GS
M1U^X28E+PXW$=!(S2,PD,8O$;!)S2,PE,8_$?!(+2"PDL8C$8A)+2"R%,"%P
M9R^!.X,/5LW(]"4QG<0,$C-)S"(QF\0<$G-)S",QG\0"$@M)+"*QF,02$DLA
M3$C?^4OZSD_L[KX<AVK>W^\?IMKD-X]541?Y9K=V^K1$NETP?7VQ5#KJTF F
M,?T)&^^_71NH8TT5WZP9Y$R3Q"P2LTG,(3&7Q#P2\_O^!FG'ZP+DS)#$(A*+
M22PAL13"A#!5!R]INCU_6[9@NOCOQTV]/?:_4>I2R1:+8KMVFBV5AZQ8*$V.
MWF0/19TMWREE?9]7?2DJ'W%IC**:WFK[ZU[#P>Z_@R1%QYJH9J&:C6H.JKFH
MYJ&:CVH!JH6H%J%:C&H)JJ64)J;O7N="E:;OW_-JI?AEME8^*69V4RR+^H>B
M/^:[TX=[HU;J71RUI*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J
M*:6)>:QU>:S!2[LM2 4RJ>FH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6H
MEJ!:2FEB('>],%5:?/C@Y]_R*KO+E6TIN7RW;3P7J\=5;Q*CE3!4TU'-0#43
MU2Q4LU'-036WU=31_@KKU71\<!X7.M0_;VB #@U1+4*U&-425$LI3<S.KM6U
M_5MP>7:^4[YER\>\-T*EX,412FHZJAFH9J*:A6HVJCFHYK::<%+J>-"W/.^A
M@_WS!P?HX!#5(E2+42U!M932Q"CMVEFJO)[U7[M/O<H72M9&:K&N\V90O<W6
M_)V2U<I#V?QL>[RL+E;]X8HVLU!-1S4#U4Q4LU#-1C4'U=Q64[6]D!M<#>:'
MYY!XZ%C_W+$!.C9$M0C58E1+4"VE-#%8N[J6*N]K20^ *7\I7[;G=#6Y&S6Y
MN]YFL&(6ZVQ]L^W*IDWT*F^_1&;ZZ]Z?.^M%_J?RY7OVL+M!;Q*C52]4TU'-
M0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;64TL1,[_IHZI0^B(;6TU!-
M1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4$U5)*$P.YZZNITD+&AT_9
MIM@H3Y]GKM3?2Z5<*]^RJLBVK8GJM9UDM+2&:CJJ&:AFHIJ%:C:J.:CFHIJ'
M:GZKS<4EC>E ^.]H?0.MJ:%:A&HQJB6HEE*:&+U=64V5M]6$Z"W7^7G1B];2
M4$U'-0/53%2S4,U&-0?57%3S4,UOM8/H/<I:M,6&:A&JQ:B6H%I*:>(5%KHJ
MFR:OLIU:2VZR.']U35AN7YJYJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%
MJ!:C6H)J*:6)V=P5W3057A/6T*8;JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:
MB&H1JL6HEJ!:2FEB(&M=($N+&X<+$Z<7)>3>Q7F,%MU0S4 U$]4L5+-1S4$U
M%]4\5/-;[6!18G*P*('.#%$M0K48U1)42RE-S-FNP*;)"VRG%B6"8KTM9?R[
M3G63W[N+4QLMQ:&:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:@FHII8GI
MWE7LFB_A98T1&LBDIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:@FHI
MI8F!W!7U-'E1[S]/+F.@+3Q4TU'-0#43U2Q4LU'-0347U3Q4\[7^JM[@Z.,D
MT+$AJD6H%J-:@FHII8G1VE7UM'^MJM>M9,A/M$#+=ZBFHYJ!:B:J6:AFHYJ#
M:BZJ>:CFHUJ :B&J1:@6HUJ":BFEB2G=E>\TNGRGH>4[5--1S4 U$]4L5+-1
MS4$U%]4\5/-1+4"U$-4B5(M1+4&UE-+$0.[*=YJ\?'=Z10(MVJ&:CFH&JIFH
M9J&:C6H.JKFHYJ&:WVJ'*Q+J\8H$6JY#M0C58E1+4"VE-#%:NW*=)B_7G;\B
M8>:+O,J62OIT+Y1/V?H/);I5PO_W[O6%"K2%AVHZJAFH9J*:A6HVJCFHYJ*:
MAVH^J@6H%J):A&HQJB6HEE*:$-[#KJTW', +%4.THH=J.JH9J&:BFH5J-JHY
MJ.:BFH=J/JH%J!:B6H1J,:HEJ)92FAC(745O*+\6W<6-$+EW<1ZC#3U4,U#-
M1#4+U6Q4<U#-134/U?Q6.SJ5XG#= IT:HEJ$:C&J):B64IJ8M%J7M/+NW>>]
MB]9_R==%62EA6>>;Y[6+<6_:HOT[5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U
M$-4B5(M1+4&UE-+$3.YZ>L,AO1R!5NM034<U ]5,5+-0S48U!]5<5/-0S4>U
M -5"5(M0+4:U!-522A,#N:O6-5_*=I*_U-GV@DO"A9:4M]E&R92'O+K)U_6O
MO:DL52].95+34<U -1/5+%2S4<U!-;?53G8H/'2L?^[8 !T;HEJ$:C&J):B6
M4IJ8I5TK;BAOQ3GKHBZRI7*S6WC8%.7Z*4[+V^9'JU7S[:8N;_[8!JORB_IN
M,!AL_^BA*M8WQ4.S7;8J']?U]F>[=8K>W$5[=:BFHYJ!:B:J6:AFHYJ#:BZJ
M>:CFM]KVTFK"66S#^5 ;'>8S6JU#M0C58E1+4"VE-#&?NVK=4%ZMZ\GG)GQO
M=@&]WJT,-[O!I9C5;XNULBB7RZS:[')[<Y]5^:_*7\HORO73-_TYC=;O4$U'
M-0/53%2S4,UNM=E>W$S5J^E,C!H''>J>-]1#A_KG#0W0H2&J1:@6HUJ":BFE
MB:':->&&TF+'AR"K_LCK+DC[=F?7K^[.HJ4X5--1S4 U$]4L5+-1S4$UM]74
M_2O2#Z[F\^%AG*)UMS.G!NC4$-4B5(M1+4&UE-+$/.V*;$-YD6W_K(5%_K5^
MUR1JOBH>5]N3Q?9W37OS%"VYH9J.:@:JF:AFH9H]["UK#;7QX7XG6E]#-0_5
M?%0+4"U$M0C58E1+4"VE-#%UNX[;4-YQ^[PL-]M/ -YD3>P^[<O^[#M_M,^&
M:CJJ&:AFHIJ%:G:K[;\?'H^NU.EA J-%-53S4,U'M0#50E2+4"U&M0354DH3
M$GC4%=5&\LO*G3Q;MTE>O=D?5M)\D:\>ZNWJ[;:9O%'B:GOCNE3,_&OUF%4_
ME.&[[1;#OGB6WXM+XQG5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+
M4"VE-#'%NW;;B+X W0BMMZ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:
MC&H)JJ64)@:RU@6RO 3W]_M&O2^7B^?3>;.[_/DTM-TR1UT5=W=YU1O-:!<.
MU714,U#-1#4+U6Q4<U#-'1U?[TV].CPTAX[T42U M1#5(E2+42U!M932Q,3M
M*FZC$Y>B>TG<NLH6VT7E1?9CH_RE+'HS%JVWH9J.:@:JF:AFH9J-:@ZJN:VV
M?\ZL-CB,6+2TAFH!JH6H%J%:C&H)JJ64)D9L5UIKOCPO8F_*]2:_>:R+;_EY
M<2N%+XY;4M-1S4 U$]4L5+-1S4$UM]7VXW9X%+?D1!_5 E0+42U"M1C5$E1+
M*4V,VZ[7-I+WVG[^T%SS17/C[+;.*^7CX]WCIE94R;$YM-R&:CJJ&:AFHIJ%
M:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B64IH8XUW];32AC\VA+394TU'-0#43
MU2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;64TL1 [JIS(WEU[E\Z-H<VYU!-
M1S4#U4Q4LU#-1C4'U5Q4\U#-;S7I<<, '1FB6H1J,:HEJ)92FIBX7;EN)"_7
MO7IL;I/?K9H [DU:M%.':CJJ&:AFHIJ%:C:J.:CFHIJ':GZKR8X>!NC$$-4B
M5(M1+4&UE-+$H.WZ=*,3UXS[^2-T:'\.U714,U#-1#4+U6Q4<U#-134/U?Q6
MDQT]#-")(:I%J!:C6H)J*:4)<3ONRG-C>7EN=_2M6&_JZG&[&_MN?T&A[S-Y
M;LMJ^UD2#X]UMCM:U]RFZH[=[18?^K)9?B\NS694TU'-0#43U2Q4LU'-0347
MU3Q4\UM-6'0XB&9T8(AJ$:K%J):@6DII8C1WC;BQ_'IOITZ>T'J#%BW%H9J.
M:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FJI90F9K+69;(&GPDQ1JMP
MJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:6)@=QUYL;RSMQ/
M7H5(KEZ<RFAY#M4,5#-1S4(U&]4<5'-;31WNO>D?7 VTX=%EB-"Y_MES W1N
MB&H1JL6HEJ!:2FEBFG;UN.;+?V7)8=2;I5+SXBPE-1W5#%0S4<U"-1O5'%1S
M4<U#-1_5 E0+42U"M1C5$E1+*4W,Y*Y#-Q[32PYH&P[5=%0S4,U$-0O5;%1S
M4,U%-0_5?%0+4"U$M0C58E1+4"VE-#&0NS;<6'XQN/]?ITR@%3I4TU'-0#6S
MU22'URUTH(UJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEE"9&<]>+&\M[<2?7+Y2_
M%'.9_]D$;V_DHM4X5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&U
ME-+$=.XZ=.,9O9*!-NA034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U
M!-522A,#N>O:C>5=NY[+VN_.GRAOQ4O9;R]B]XOZ;C 8O':=YO"UZS3+[\'%
M"8Z6\E#-:#5UOW,UN!H,I\.1>O"1 B8ZV4(U&]4<5'-1S4,U']4"5 M1+4*U
M&-425$LI3<CG25?.F\C+>3WY_/3Q/DWBKG?K&L6Z+L6L_LF+C\KOR:4YC6HZ
MJAFMMG])3FUR-9T=1#0ZU$(U&]4<5'-1S4,U']4"5 M1+4*U&-425$M[?IV'
MZO1J]/+K+&9OU[Z;R-MWNZ-\7?"^:[]^.MFX._;W/:NJ;%UOMI]67!5W]\U7
MQ6;SF"]VAP6/]Y6W\?R4PMM,EN0QVN-#-1W5#%0S4<U"-1O5'%1S4<U#-1_5
M E0+42U"M1C5$E1+6TV=[N?V]$IXKRPFM]8EM_S"==*#@$'VX]43F>7NQ9F+
M5O50S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&UE-+$7.ZJ>I,A?/AO
M@K;T4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354DH3 [EK^S5?
MRG:4?[([+5<O3F52TU'-0#43U2Q4LU'-036WU0X[S,/C[C0ZUS][;H#.#5$M
M0K48U1)42RE-3-.NIS>17^ON2W[S6#5QNELX_FMW&3O%+[.U\DDQLYMB6=0_
MGD]#GO3&*MK:0S4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0K48U1)42RE-
MC.>NM3>AKV$W00MXJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J
M*:6)@=QU]2;RKIY>;&YVIT1LEQUZ\Q=MXZ&:CFH&JIFH9DV.+Y&V?1,LO@.V
MT9D.JKFHYJ&:CVH!JH6H%J%:C&H)JJ64)N9JU[*;R*]4=_3Q%+?-K/;TL]Z8
M13MVJ*:CFH%J)JI9K3813H<9#W;_'68M6J!#-1?5/%3S42U M1#5(E2+42U!
MM932Q*SM"G03>8$NKLJ;/%]LE-NJ7"G;/]WLRG-5OBCZPQ:MPZ&:CFH&JIFH
M9DUZKHXV&<YZPQ9MPZ&:BVH>JOFH%J!:B&H1JL6HEJ!:2FE"V$Z[-MSTPDO5
M/:Z;O=JJ+OXG7RB+=C6A+W3E[J6ABVHZJAFH9J*:U6K[H:NJ@TE/YJ)S'51S
M6VU_/WTV'P^/'H2'CO7/'1N@8T-4BU M1K6DYPE65:UGCR"EYHHIV/72IO)>
M6IQ71;DH;I2'[$?[\9//';/>[$-[9*VV_RS-1SU/DHZ.-5#-1#4+U6Q4<U#-
M134/U?R>OYCJK&^'/D#GAJ@6H5J,:@FJI90FAJC6A:B\(A8^KK[FU>[#;)Y2
M=/M)"LHZ_[-6;IL=R6RI_,BS2OGK^8][DQ5MBZ&:CFH&JIFH9J&:C6H.JKFM
M)BQ:'.YSHA6PTP,#=&"(:A&JQ:B6H%I*:6*8=KVNJ?P2;'&5MS&I/.3K;%G_
M>/E(]'=/.:KVYB=:[D(U'=4,5#-1S4(U&]4<5'-;[>!$!NTP0M'2UEDS W1F
MB&H1JL6HEJ!:2FEBBG9EK.;+?RU%>Z_W+E<O3E%2TU'-0#43U2Q4LU'-036W
MU4ZE*#G3/VMF@,X,42U"M1C5$E1+*4U,T:Z$-967L$ZGZ%#)U@NEOL^K/+NM
M\ZHW5-$J%JKIJ&:@FHEJ%JK9J.:@FMMJ!P&G'H8J6K$Z:V: S@Q1+4*U&-42
M5$LI30S5KCHUE5_PS"_7=W^KMWW61?ZU?RT4K4JAFHYJ!JJ9J&:UFK!@-YZ/
MYM.>0^QH#PK5W%833H4=#:?JO.<@.UIR.G]P@ X.42U"M1C5$E1+*4W,Q:[!
M-)4WF"YI_#=__J79"\VJHGRGF&65WV2;_BA%6T^HIJ.:@6HFJEFH9J.:@VHN
MJGFHYJ-:@&HAJD6H%J-:@FHII8F9W;6CIO0UR*9H/PK5=%0S4,U$-0O5;%1S
M4,U%-0_5?%0+4"U$M0C58E1+4"VE-#&0NPK5]$2%ZL+S6>='[]'4D=ISHM]G
M^=R+DQ8M1Z&:B6H6JMFHYJ":BVH>JOFH%J!:V/,[J,WZ?@<C=&Z,:@FJI90F
MI.BLZT;-Y-VH3]ER66XO#]8>_*I+Y6O>?%<L^D)4CEVZ2XMJ.JH9J&:BFH5J
M-JHYJ.:BFH=J/JH%J!:B6C3KJ3BU'8F#W([1P0FJI90F)FW7OYK)^U?_6&_V
MEGU[TQ6M7*&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ64)@:P
MU@6P!J_@SM"F%JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DII
M8B!W_:^9O/]U^O0P.7!Q *-5+U0S4,U$-:O5A ]@&8SFVK#G(UC0R0ZJN3V/
M8SJ:SJ;'#\-#!_OG#P[0P2&J1:@6HUJ":BFEB<'85;J:+\]?*E#^4J17IM4&
MVK@W/*5#+@Y/4M-1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&UE-+$
MD.X:8[,QO9R ML-034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+4:U!-52
M2A,#N6N;S>1MLTNO7R#G+HYCM'N&:@:JF:AFH9H].VYBC9JW1SV'JAUTL(MJ
M'JKYJ!:@6HAJ$:K%J):@6DII8M9V#;;9B6MP_>Q':LO=BT,7;:FAFH%J)JI9
MK;:_(#D93=59SWHNVD!#-;?5]L/^:!T7K96='AB@ T-4BU M1K4$U5)*$].Q
MZXK-Y%?2^E)G=9.#Q;K.&_[I0H7*VVRC9,^?*?-K;S:BA3%4TU'-0#43U2Q4
MLUM-U?8SXVHPF(X/=T?1+MBY8SUTK'_NV  =&Z):A&HQJB6HEE*:&)-=@VLF
M;W ][41N-H^[K-S6M[YM@_)AV8Q\[<.SY>3%&8E6O5#-0#43U2Q4LV?'M:#A
M?-!W?KF##G91S4,UO^=)>64E(T 'AZ@6H5J,:@FJI90FA.F\*W+-Y46NTR=3
MR8%+HQ/5=%0S4,U$-6M^?#6KX7 PT7H^:PL=[*":.S_N! WGX[':<RX5.MCO
M>_[Z!P?HX!#5(E2+42U!M932Q%SL:E?S2VI79YQ+U?MIV?(A%V<G6LU"-0/5
M3%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354DH30UKK0IJN9LW1:A:JZ:AF
MH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I*:6(@=]6LN;R:]=/']^7N
MQ;F,-K90S4 U$]6L>4]C:Z[UU+70L0ZJN:TF.[R/#O1/#PS0@2&J1:@6HUJ"
M:BFEB>'8U;.:+_\-A_?EZL712&HZJAFH9J*:A6IVJZE#\8"W-CPZOG_V+=VS
M;^FAC\4_>VZ S@U1+4*U&-425$LI34S!KO\TEU\QZV>.WLO)BR,0;4"AFH%J
M)JI9J&:CFM-JXJ54QGWG KCH8 _5?%0+4"U$M0C58E1+4"VE-#%ONWK3_,)Z
M4Y4_/%8W]]FF"> 352<Y?7'NHE4G5#-0S40U"]7L^7'529WU)J6##G91S4,U
M']4"5 M1+4*U&-425$LI3<S=KNHTEU>=TN<+PVZ4\O;UDZO07A.JZ?/CMH\Z
MGLQ[DL) !YNH9J&:/3_N\FBJVO=A] XZV$4U#]5\5 M0+42U"-5B5$M0+:4T
M,3Z[+M1<WH4ZX[Q4M/:$:CJJ&:AFHIK5:N(_$M/9N.^\5/0B6*CFMIKTH!%:
M>3H],$ 'AJ@6H5J,:@FJI90FYF!7=IK+RT[&GW6QOGLL-O>[ZZRTNY+O9&_:
MT:H3JNFM)J3%I+>R8Z"#352S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354DH3
MTK9Y=_82M]NO97G[\>ETI:PNRO5SVKZ<N:2\;::NBL=5[X'Z$_2ER<MR^C.W
MO\?QM]&L+WK9R2;+62QGLYS#<B[+>2SGLUS <B'+12P7LUS"<BG&'02QNA?$
M< %KU)_): .+Y726,UC.9#F+Y6R6<UC.93F/Y7R6"U@N9+F(Y6*62U@NQ;B#
MW-;V<ION9#V+6$:CK2R6,UC.9#F+Y6R6<UC.93F/Y7R6"U@N9+F(Y6*62U@N
MQ;B#C![N9;2\IO633803[.5!C=:T6,Y@.9/E+):S6<YA.?>9.ZP8#(^K#>QD
M__S) 3LY9+F(Y6*62U@NQ;B#@!WM!>SHU,E?[3FVD@-U)Y#+XY3D=)8S6,YD
M.8OE;)9S6,YE.8_E?)8+6"YDN8CEXF=..+E[KDUZ#O(D[.@4XPXR=[R7N?)B
MV>4+QLUMS&7^9U&N^^,9;9VQG,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%+!>Q
M7,QR"<NE&'>0X).]!)_@2\=H0XWE=)8S6,YD.8OE;)9S6,YE.8_E?)8+6"YD
MN8CE8I9+6"[%N(.,GNYE](57\#I1(3[A79[0:,6-Y8QG3FB'#=1AS_LODQUM
ML9S-<@[+N2SGL9S/<@'+A2P7L5S,<@G+I1AW$+^SO?C]MUPB[ 1[>0JC;3F6
M,YZYTP=M3':RQ7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LEV+<00C/]T)8WLF[
M;*4YR'Y(3D]&RWHLI[.<P7(FRUDL9[.<PW(NRWDLY[-<P'(ART4L%[-<PG(I
MQHG9K>[U^]0!O<:LLK4^E--9SF YD^4LEK-9SF$YE^4\EO-9+F"YD.4BEHM9
M+F&Y%.,.,GJO^J?*JW^G/_OGA'!Y)K.U/I0S6,YD.>N9.UCSUD;SXT\ 8D<[
M+.?V/9+99*0>7YJ2'>R?/3A@!X<L%[%<S'()RZ48]Q23UYO[/*_UK,X^O%_E
MU5W^.5\N-\KN8R>V0_9^JE3Y[39%?_NHO;D^^KFI_N:H/3]WU=^\OI_[ZF_!
M[N?7W=@/[Q^RNSS(JKMBO5&6^6US%P97T_$;I2KN[E^^J<N')MC?*%_+NBY7
MNR_O\VR15]L;-']^6Y;U\S?; =_+ZH_=P_SPOU!+ P04    "  #=&-55M3L
M#$@&   F-P  &0   'AL+W=O<FMS:&5E=',O<VAE970U."YX;6R]FUUOVS84
MAO\*X15#"S2Q2'W966)@B42T0SL4=;)=#+M09#H6*HF>1"<ML!\_ZB.2*2F,
MU)[L)K'L<QY2?,TC^A5U_L"S+_F.,8&^)G&:7\QV0NS/YO,\W+$DR$_YGJ7R
MDRW/DD#(P^QNGN\S%FS*I"2>$\-PYDD0I;/5>?G>IVQUS@\BCE+V*4/Y(4F"
M[-LEB_G#Q0S/'M_X'-WM1/'&?'6^#^[8FHF;_:=,'LT;RB9*6)I'/$49VU[,
M?L5GU#2*A#+BCX@]Y$>O47$JMYQ_*0[>;RYF1M$C%K-0%(A _KMG5RR."Y+L
MQS\U=-:T620>OWZDT_+DY<G<!CF[XO&?T4;L+F:+&=JP;7"(Q6?^\([5)V07
MO)#'>?D7/52Q#IFA\) +GM3)L@=)E%;_@Z_U0!PE8.N)!%(GD+$)9IU@CDVP
MZ@1K;()=)]AC$YPZP2G'OAJL<J2]0 2K\XP_H*R(EK3B12E7F2T'.$J+;]9:
M9/+32.:)E>=?7J,3M);?V,TA9HAOD<=N!7KM,1%$<?Y&?GBS]M#K5V_0*Q2E
MZ'K'#WF0;O+SN9#M%Y1Y6+=U6;5%GFAKS?:GR#3>(F(0,I!^I4_W6"C3<9F.
M!]*],>G&D^F^/OVW0]RT;@RD4WWZQR![3,>NFCZ7DC6ZD48W4O*L)WA7/+UG
MF8ANI69KED8\0[]SP7+D'5C117M('BVRJ&%G^3X(V<5,%JF<9?=LMOKY)^P8
MOPR)!0GS(&$^)(P"P121S49DLZ2;3WYEY4Q\G^8B.\AB+M!?'V0 >B]8DO\]
MI*\)J2\DS(.$^9 P"@13]+4:?2WM)%Z+0+"-K*J"2;A F3Q$KX,<!6C/LE!*
M_F9(Y@J*JU)3+!WN5\:I8;ARSM\?*ZAM?*J"D# ?$D:!8(J"=J.@_4-E>.@R
M=ZE%3IVFD# /$N9#PB@03!'9:41V0,NP ZDO),R#A/F0, H$4_1U&WW=ERC#
M%12;:ADF9J\.:UN?*B$DS(>$42"8(N&BD7"AEY"%ATQJ6$[5?]$URQ+T@0<I
MND0T"*,X$M\>2[(SI*66/G7*0L(\2)@/":- ,$7O9:/W$K0D+R'UA81YD# ?
M$D:!8(J^V&A]"6/TRBJO5E9IL;(:M!TJE'-4B4W;(;;1*<1#<:YM&)TX3]^U
MJ:* TB@4397ER"["6ED\MF5946FW41JD893>H9#G8EB6"F4?#?>):;N+KBH#
M899EF5U1M!V;+ HDC4+15%%:+PCKS2 ORD-^D&60IV@C*^.@&*0_RHNE;7;%
M& C#V'!Z4X3TII*,(]VIY.M[/GF<7\*-P:T=@[5NP.J:BR N1_@M2IDHS-+B
M &T>QS](-X6M/7Z&F+W1-BW3Q<NN*@-Q]M):NEU50'T64!J%HJG:M58+UGLM
M-VE^M$8<% /2E;@"I7F@-!^41J%HJK"M X-MT*4@!K5?0&D>*,T'I5$HFBIS
MZ\%@K07P K77Z5W!7,M=N+U%H].KO=BPEL3L71)!W150&H6BJ>*U!@O6.RQJ
M\94_T+_K]I6^D<DS%]26 :7YH#0*15/%;ZT9O( MT*!F#"C- Z7YH#0*15-E
M;AT9K#4$OM=%K:G/W\W2-S]92%#?9>Q)4*AFU3T#K:E"X$P5TC=++%F8N[_P
MKNHX^YDX3]^UR??X04T5*)HJ2VNJ$#A3A0RX)<YRV5-E(,S%MMT5!=14 :51
M*)HJRM$&FQ\W54C?+>D),6"H.):+%UTE8+? P.Z!>0G;A;2V"_F?;9>Z/<4'
M7MHV[FDW8+N8AD.ZMHN^_Y.U [5=H&BJ=JWM0J;8+B-6_H,[)O2-3-ZY!FK-
M@-)\4!J%HJGBM]8,@;5F"*@U TKS0&D^*(U"T5296VN&Z*V9[USYU]01&RCT
M[4]6$M2G&7T6=$RDJD#KKQ"]OS)I7>_V+GZ]ZY[;M[P<HW^?5-^KR2,):GI
MT51%6M.#Z#>D3%K2+YY?1?9#3@CIWB+5]VFR'J#N!!1-U:-U)XC>G1BUFE\^
MKT,_Y 0O26]B@+H+H#0*15-WM+<6A*FW(, 7\V;?I^BJ-A"";7=A=]?Q^JY/
MWJ8.:E% T2K9YD=/#!5/D'T,LKLHS5',MA)OG+KR&YY5#V55!X+ORX>(;KD0
M/"E?[EBP85D1(#_?<GF]J0^*YY*:1^-6_P%02P,$%     @  W1C507.?[BU
M P  L@P  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN>&ULK5?;;N,V$/T5
M0ET4"; ;W6^I+2"V5'0?=A&LL^U#T0=:&EO"2J)*4G:Z7U]24A1'HMVTS8LM
M4F?.\,P,R='B2.@WE@-P]%B5-5MJ.>?-K:ZS-(<*LQO20"W>[ BM,!=#NM=9
M0P%GG5%5ZI9A>'J%BUJ+%MW</8T6I.5E4<,]1:RM*DS_6D%)CDO-U)XFOA3[
MG,L)/5HT> \;X%^;>RI&^LB2%174K" UHK!;:G?F;1)*? ?XM8 C.WE&4LF6
MD&]R\#%;:H9<$)20<LF Q=\!UE"6DD@LX\^!4QM=2L/3YR?VGSOM0LL6,UB3
M\K<BX_E2"S24P0ZW)?]"CK_ H,>5?"DI6?>+CCW6%Q[3EG%2#<9B7!5U_X\?
MASB<& @>M8$U&%A3 ^>,@3T8V*_UX P&SFL]N(-!)UWOM7>!BS''T8*2(Z(2
M+=CD0Q?]SEK$JZAEG6PX%6\+8<>C.%D]H ]H(^HO:TM 9(<^UAPH,(Z21U&-
M#-!5#!P7);L6P*^;&%V]NT;O4%&CAYRT#-<96^A<K$4RZNG@=]7[M<[XM=$G
M4O.<H:3.(%/8QY?MPPOVNHC!& CK*1 KZR+A!IH;9!OOD658EF(]Z]>;FRHY
M_\][\I^]OPB&/5:%W?'9YZH"MAS%!4M+PEH*Z/>[+>-4;.H_5)GNN1PUESSH
M;EF#4UAJXB1C0 ^@13_^8'K&3ZHPOR59_)9DR1N1O4B(,R;$N<0>K46QR_BW
MN!0;;]B?T.]/54IZ-J]CDU?%(0IMQU[HA]-0ST&F;S@O0?$<9'F^-4$E<Y1K
MRD(^*#2[HV;WHN:[BE!>?,?=A2+.I4P69<%8B^L44$H85YX[/:E[*MV8*I]C
M/,^;")]CK-"=@)(YR Q]3ZW;&W5[_UYW)C8C:6NN4NS-U83N1/$<XP;.--=S
MD&4:_D3R'&2*>G#5FOU1LW^YOG%3<%P6WR%[KF]QLR#"<Z#HZC/A@+QKE7I_
MMIX/IA%,]2M006!.]"M 5N!:DP H4+9AGDEZ, 8@N!B !R+DJ^0%\YT<3,MP
M/0?YMCTI^G@.LH+0G@0J4:!,V_+5ZL)177A17;+;0=<1/B>78I%14>!<"N]K
M_$JT% W0%&JNS'3OP[1.UF;<&*XS2=!:C?,FA1R?H9L>!,D_TO4AT4^:L KH
MONM^&>IV;7_SCK-C@WW7]963^95YNS85\[%HR/O^^9F^[^8_8;HO:H9*V E7
MQHTOBI/V'7(_X*3I6L MX:*A[!YS\5$!5 +$^QT1^VL82 ?C9TKT-U!+ P04
M    "  #=&-5V<0[T;0(   ]30  &0   'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6RUG&EOV[@6AO\*X1D,6J 32]3F]"8&LK287#1!$3=S/S,V$Q/5XA'I
MI 7FQU]JJ2E:ZK&E'GUIO8@O^9*']$,>16>O6?Y5KCE7Y%L2I_)\LE9J\WXZ
ME<LU3Y@\R38\U=\\97G"E'Z;/T_E)N=L519*XBEUG'":,)%.YF?E9Y_S^5FV
M5;%(^>><R&V2L/S[)8^SU_.)._GQP;UX7JOB@^G\;,.>^8*KA\WG7+^;[E16
M(N&I%%E*<OYT/KEPWU]%LZ) ><7?@K_*QFM26'G,LJ_%FYO5^<0I6L1COE2%
M!-/_O? K'L>%DF['/[7H9%=G4;#Y^H?ZQ]*\-O/()+_*XO^)E5J?3V83LN)/
M;!NK^^SU+UX;"@J]91;+\E_R6E_K3,AR*U66U(5U"Q*15O^S;W5'- IHG>X"
MM"Y ]POX/RG@U06\TFC5LM+6-5-L?I9GKR0OKM9JQ8NR;\K2VHU(BV%<J%Q_
M*W0Y-?]X<W=Q=W5S\8G<W"V^W#_<?KC[LB!_DH],Y.1O%F\YR9[()\$>12R4
MX)+<<B:W.5^18A#(/5]N\URDS^2222')FVNNF(CE6ZWQL+@F;WY_2WXG4R+7
M+->%14H>4J'D._VA?OUEG6TE2U?ZO;G@5L2Q'F%Y-E7:8-',Z;(V<UF9H3\Q
M<TINLU2M)?F0KOC*+C_5';/K'?JC=RXI*+C@FQ/B.>\(=2CM:,\57/R_VU@7
M=\OB#M <;S=87JGG_6RP1,K2I6!Q<T#>=_53I>-WZQ1+PWNY84M^/M%S7_+\
MA4_F?_SFALY_NDPBB5F6_9UE'U*?7\69+*)+LIB332Z6G+S1,;+*XICEDFQX
M7D7.VZY>J*1GI72QGKW, ^_$/3V;OC3M@0T8:"_8V0M@>UGZPG,E'K6[!4]%
MEI.[3.EY<*TGGHZ:H,L6*-EW<)'$+/?ASGV(%,\AIF4D,<MRM+,<@0.^4$SI
MM5.DBFMQ17+]EKQA4B^E.I:7/%6=D5R)NK01RLZ)XT3!7BR#E0^T-MM9FXTW
M54'IO@,\:\][_\2-=GUEV3O=V3L%[=WHWZTB5)?EE"TQIC*I?Q_3<L[J0<WT
MUTFBO](_W,NO/?R?MIH<N2?1;&]X#UUE&7,=PP#.KZU"Y%]RR[Z)9)MT_BB#
MZGT'#TO-[HL&#[E(:U(MA&4;2<VV38UM"H; -7]4.H"ERK<:TM6[.LS+F'AG
MQSQ/Q#8I0[MBMLYXKJMSW>8D/ GWXAENU%#3!J=<$%V.BON'5!:(J]?LHHLZ
MK:+"%I::W24&MUP?*_R1N*FV/0:%N0;#7)C#!OXLUZJ'?Y>/N-!NN4$H%\25
M@S'L'Q?#J("%I69WB4$L-\**821>JFV/05^NP2\7YJ^A,5RINIX=FI[7#F(D
M2+/]&?YR80"[YYLL+QQ6QQ+U.43Q:]5I"Q3K/;1(:O8IA $TZAP9T1=2<M4=
MS!05P[#4;,<&PRC(._,/_VR%^JZ#^46'<C'&G<=!M4C8"%TWF$717N#"=0WU
M8MB*PFS57**KG4+.EUR\,/U!IZM*+FBB$Z7^OJDQV(D:=J)89U$4E8^PU&S;
MAH\H?!YUL=2!*45Q!/UGSN-RQ=5TK/3&5P=I\5**%==+K[Z@LS/\UMAZ/G5:
M@SL&#E&#0Q3&H9\OM9HFOO \(9\REI)+\I$MBZ'__H,V0OW]X@!KP'7WCH<Q
M#K"HP2^*=81%41$+2\VV;1"+PL=8S25-5M19KFR=QJ..D/>BUCDL7.502P:?
M*(Q/8,SC[!3A%O0.@3%PC!H<HZ=8D8^*8EAJ=@;&H)AW_%G9H<BOI:S(/PT"
MU]F+?+C*H98,:WDP:_U2Y!^WOX1;T#LA-0;/>8;G/(J5AD-BM-KV&,3G-9*/
MQY^6'8Q\KQ7YL]!W]^-^#);S#,MY,,M]D$HDQ28Y>VKFN^WX_\1?>$S<3I.H
M)V!8:G9G&.3S@E_?8GJHZ(:E9CLVZ.;!)V?';3%KD68DMY;O,5C,,RSF'<]B
MQVPOO3:/M1R-@6*>03%OAK7 HA(5EIIMVQ"5!Q]P_>K>LI8'!W8,>/(-//DP
M//59<1%VFG!K^D8'EIK==X;2?*S$I(\*6UAJMFT#6_[QAV>'J,-O'YSM3P"X
MMJ%N#$/Y,$/UG  XVTZX3;WC893;P1KW@V$E*'U4/,-2LVT;//./OU'LX#0(
M#D^#,=#+-^CE'T OW&EPW!X4;E/O>!@#^GP#?3Y6CM-'S7%BJ=FV#1GZ!^XQ
MZS,-9H>GP1C YQO@\V'@ZS$-NNX^OH3E>P_M&&P8&#8,$'*< 2K18:G9C@W1
M!1@YSEH$"F.XGJ$^#*(%N/G-X#"FP34.=60P+<!*;@:H;(6E9MLV;!6,F]P,
MVLG-UL".<K=]XW9[&*/ZK+@(&U"X-;VC8PQH"PRT!5BIS@"5M+#4;-N&M *\
M5&?0G>J<[1]\PU4.M60H*H IJN<LP-F%PFWJ'11CD%M@R"W 2GX&J(R&I6;_
MN8YAM! O^1EV)3]/_=9<@*L<:LE 6'@ PG#GPG%;4;A-O?^>:0S\"PW^A5CI
MT! U'8JE9MLVC!CBI4/#SG3H_@TP<(5##1GZ"]'2H5ZG2=3S-BPUNS,,*(8(
MZ= 0%>^PU&S'C;_%Q$B'ANUT:-<=MW!=0[T89@MQ4Z)AF]LZ[KB%*QUJRE!;
MB)45#5%1"TO-MFU0*QPW*QJVLZ)==]S"K1CZ5\&&K"*TS*B'L#&%6],W0K#4
M[+XS"!=A948C5.["4K-M&^Z*\#*CT>$C-[BVH6X,3D5HF5$/;4\*MZEW/(S!
M;Y'AMP@K,QJADAJ6FFW;D%J$EQF-#F=&X=J&NC$4%J%E1H^9!L=M1^$V]8Z'
M49ZOT7C !E9F-$+-C&*IV;8-'49XF=%:*H2F 2KT31L/J$IX_EP^MTMJ=MNF
MJGI6U>[3W;/!+LHG8DW-Y=6#Q6Y9_BQ226+^I(LZ)\5\S:MG=55O5+8I'W?U
MF"F5)>7+-6>:$(L+]/=/F>Z6^DU1P>Z):?/_ U!+ P04    "  #=&-5AX<@
M-!0%  "B'0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6S%6=MNXS80
M_15"712[0!.)]#VU#216@C70!$&<[#X4?:!E.E97$KTD;6_^OM0EDF714\M5
ML2^V+C.'<XZHX8$XW''Q3:X84^A'&$1R9*V46E_9MO16+*3RDJ]9I.\LN0BI
MTJ?BU99KP>@B20H#FSA.UPZI'UGC87+M48R'?*,"/V*/ LE-&%+Q=L,"OAM9
MV'J_\.2_KE1\P1X/U_25S9AZ63\*?6;G* L_9)'T>80$6XZL:WSEDDZ<D$1\
M\=E.[AVCF,J<\V_QR70QLIRX(A8P3\405/]MV80%08RDZ_B>@5KYF''B_O$[
M^EU"7I.94\DF//CJ+]1J9/4MM&!+N@G4$]]]9AFAI$"/!S+Y1;LLUK&0MY&*
MAUFRKB#TH_2?_LB$V$O0..8$DB604Q-:64+K,*%[)*&=);0395(JB0XN570\
M%'R'1!RMT>*#1,PD6]/WH_BYSY30=WV=I\9WTX?KA\GT^@\T?9@]/[W<WSX\
MS] %FND)MM@$#/$EFD9;)I5^V$JBK[Y:Z>F#GO0<\X,WY#+%A*Z+SG7L'?4%
M^D*##4,?]0WJ!_*3QGJ9N>CCAT_H _(C]*S3)8T6<F@K77]<A>UEM=ZDM9(C
MM;;0/8_42J+;:,$6AOP)G#_XMWP7SL<$ +"U\+GZY%W]&P(BSMCZ$K6<WQ!Q
M"#$1^F_I+ISN,D^GXR0= VQ:^5QJ)7BM(WCGS),G'@1(O\$[*A;HS^NY5$*W
M@K],DR,=O&T>/.Z/5W)-/3:R= .43&R9-?[U%]QU?C<)VR28VQ!82?1V+GH;
M0A_?T(!&'D-4:8T]%LZ92+'-#S:5$H2L*V4*UDW XF5F.\9]TAD,[>V^1H8H
MTG=('E4BW\G)=T#RCQOAK737-S83,+4NR12LLU]^RW&< Y*&J![N]\PDNSG)
M+DC2]>/7RE<;D71C/W_+3*1!J+JDNQ4Z%QAWV^2 =4-CEL3IY>+T0'&FX5HW
MDV-J]"J3[@([E<<VZ1EX5L-<L)(S>?9SGGV0IVZ1VL)$VA((P2+O#='%WYNL
MV9J8@VAUYT'?H$^G?Z".(:C?-\_\04YZ<&IOTTN=VF]NQQ>]FT&E$(*Q@P^>
M^4E1;C6JW-M*M+!3F"X')';[?>.KMWUC971#($C=A]@HFML46EG /=>*?Z;5
MR$9O2ODFT=RFT,K*DT)YTKS?@#%KZTFJ;V4;D][!NVL*.VXY<.%R,>CG8-,!
MY]9FVJI2P+W.X<)D"B.#[A'?@0MKB6%O6<MYP%BUF;=/\QY-C5I6J/"?&#:@
ML/V DVM+4G671IO2U*AE20JWBF&[6M>IP'"U1:IZUHH^4$B9=.%",6Q#SW,J
MN&H\M:_J'32RR6EAKBFLU!;+W KGB6'K.>'ZO1?*CY?3!ZZ8U"NMQ_QMO+X:
M637J/1M%<YM"*TM9^%D\^*FV!;33M95O$LUM"JW\G:UPW 1VW&?9%ABSKIX9
MVO[[V<:MPP7-$'6D.Y'"+1/0$\*.!<ZM31(;K$C%L!BBVH0<XUEX4P)[TUI^
M!<:JS;MJ-BND&QJP+$YA6PEL6V&K B?75J-J2"MJ_!\?34EA;0EL;>NZ%!BN
MMCXF=UOYHF**.O9)A126E<"6]3RKDH'N?TKK$-(^<"HG1;F&J%(C3(G9>YM:
M(1.OR>:@1![?1"K=W\JOYAN0U\FVFUV$I[N7]U2\^I%$ 5OJ5.>RIPL0Z89@
M>J+X.MDBFW.E>)@<KO2RS$0<H.\ON?8]V4D\0+XM._X'4$L#!!0    (  -T
M8U5EQ09(M@L  ,"3   9    >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;+6=
M;6_:3!:&_\J(7:VZ4AOP&PG9!"G%\R8U496T^WQ8[0<'AL1;@ZEMDN;1_OBU
MP<$,3 :<WML/#9@YUQF;V^.#;X]]\9QF/_)'I0KR:Y;,\\O.8U$LSKO=?/RH
M9E%^DB[4O/QDFF:SJ"C?9@_=?)&I:+(*FB5=M]?K=V=1/.\,+U;+OF;#BW19
M)/%<?<U(OIS-HNSELTK2Y\N.TWE=<!L_/!;5@N[P8A$]J#M5?%]\S<IWW0UE
M$L_4/(_3.<G4]+)SY9S+P*\"5BW^&:OG?.LUJ5;E/DU_5&_DY++3JWJD$C4N
M*D14_GE2(Y4D%:GLQ\\:VMGDK *W7[_2V6KERY6YCW(U2I,_XDGQ>-DYZY")
MFD;+I+A-GX6J5RBH>.,TR5?_D^>Z;:]#QLN\2&=U<-F#63Q?_XU^U1MB*\!U
MWPAPZP#WV "O#O".#?#K /_8@* ."(X-Z-<!_9T SWDCX+0..#TVPUD=<+:;
MX:WO85 '#%9R6']_JR\_C(IH>)&ESR2K6I>TZL5*0:OH\CN/YY78[XJL_#0N
MXXHADS=7-R-Y]87(F[MOM]^OZ<VW._*)W$19%E4Z)!]"541QDO_]HEN4":NP
M[KB&C]9P]PVX0Z[3>?&8$SJ?J(DAGMKCO4/QW!X_.!0O#_3?M0"ZY9;>;&[W
M=7-_=JW$F_3IA#B#C\3MN0[Y?A>2#W\U;E@[)E3C$^(Y!S&A'7.UR$I,K\(X
M PN&VC%W:O&*<5T+AAV/L:T4?T=OZEU)90:>P'1+ON,K([EZ*(\<A459WF9'
M]E9\[PW^*)V/2U*UTY;'D-LX_T'^]:5L0V2A9OF_#1W^O ;Z9F!UE#W/%]%8
M77;*PVBNLB?5&?[M+TZ_]P^38)&P$ FC2!A#PC@2)I P"8)I2O8W2O9M]*&<
M+:(XJW8+DDZ)^KF,BQ<2SY]47NSO*VLE6X%ME8R$A4@87</Z*UA5Q3X-G=[Z
MWT7W:5NER*S\V*P"F56"8)H"@XT" ZL"1X_1_$'EI>C(N#S^Q^6;4HSERSR>
MJ/4(:U*A%=I6A4A8B(11)(PA87P-"[:4^LGUO(&_+]5@3].?7,<_W6LH0?W3
M9-C?R+!O'PCGA2JI1?FC<JSBI^@^42;962%M9==_8V?7-TN(S$G[>U^;;QK4
MD#GY_GJ:<@ID3GEPVVHJ.=VHY-2JDIOE[%YEU:%R%OTGS3:5;F[2BA755BM(
M6(B$422,(6'\=$_KWH[DD.GD?CK?K+:SC=K.K&J[FJ7+=6$6)4GZ')4_.LBT
M5-TD7=X7TV5"HO&X:F%4GQ7=5GUG>ZNV.T@AT]&#Z1@R'3_;&RMVAR9D.FE+
MI^EDL-')P*J3;_3+%?D<IR896"/;R@ )"Y$PBH0Q)(PC80()DR"8)EFGUYP+
M[:'/H=1$D)BAM!!*HU :@](XE":@-(FBZ9K>.K_O6 ?BKUDZ5FJ2DVF6SD@>
M)>KHLRIV<FMM(VDAE$:A- :E\9JV77D,3+_)!#2M1-%TV;J-;%VK;.E:H+D:
M+[.XB%7^L?P5'"7QGVI"DC0WEI=V9&N](FDAE$:A- :E\9JV74NZ?:->D6DE
MBJ;KM7%?'.LI\>%5_;-GZUP-^2_1"XJL*BCN7W9^IY?-KO4%Z=QXGL?>@];R
MAAHV4!J%TAB4QJ$T :5)%$W?!QK?QO'AY3/4N8'20BB-0FD,2N-0FH#2)(JF
M:[IQ@IP#5M#^"/XARDE$%BJK/C!="?#9SFRM:J@5!*51*(U!:;RF#;9/:IUX
MNZ=;H3FE.:?Y5)K3^$".W0A"%A?%L_&<G+T'K26+I(50&H72&)3&H30!I4D4
M3=\'&I?+.847%U"W"TH+H30*I3$HC4-I DJ3*)JNZ<9+<^QFVON*"ZB+!J6%
M4!J%TAB4QFN:?J!WSG:+"ZA)9\SIOE%<-$:=8W?JH,7%8Z;,YRZ@GA^4%D)I
M%$IC4!J'T@24)E$T_;+\QOISX=:?"[7^H+002J-0&H/2.)0FH#2)HNF:;JP_
MUV[]O:N\L#-;JQIJ^D%I%$IC4!JO:0?*"VA.:<YY:JXOW,;)<^U.'K*^F*9+
MTPR>S_8NM!8MU/F#TBB4QJ T#J4)*$VB:/I.T-B#+GQVE@NU^Z"T$$JC4!J#
MTCB4)J TB:+IFF[L/M=JO;RSO( :?E!:"*51*(U!:1Q*$U":K&D[98CS1AG2
M&'FNW<ACB?I5Z?1J/B'7+^G=.%;5M>M7XY_+.(_?FM)EA[:6*]3)@](HE,:@
M- ZE"2A-HFBZK!MKT.W#"PNHU0>EA5 :A=(8E,:A- &E211-UW1C];GV&6U;
M8_*G3"51H2:MYN':\:T%OC^'*C@U7= 80O-20U[/=TT3(Z%Y>4WK'\PKH'FE
M(>_>=M8%U?ALKMUGVQS[#QSLH<X:E!9":11*8U :A]($E"91-%W'C57G#N '
M>ZCQ!J6%4!J%TAB4QJ$T :5)%$V_:U%CO'E6$^2W#_8U7IO)[P:!X7@UJIMJ
MLZ'[IFG_H;W/;95IR.L9IT0P:%Y^=%X!S2N/V<ZZ6AI+RSLPFRUZ6=T8J%#9
MS*@&>WB_1R;1BVGRT,@>V79H@](HE,:@- ZE"2A-HFBZ6!OGR[,[7^^\C9"W
M/X'*#TP%^*ANN;VC.::&H;VCK>6XWT'3>,N@6;DAJ^.=&4<SJ'.$HNDBVKJM
MGWUBF>&WR]H^?=73:%M/Y4=?U)-*B%>9IRK*EYE:#9AROE@6'TD8YRLWEMR6
M!]JRR1^KF\&6A]RKIY+P8+QVR][!MB4DE!9":11*8U :A]($E"91-'T7:8PH
MST?_+/*@-A24%D)I%$IC4!J'T@24)E$T7=.-7>79[:KML3M>C]VM:@BH;P6E
MA5 :K6F.=N^B$\?W=XL1J"-U9%8!S2I1-%V3C=?DV:>A84N1KUEZ']W'276;
MAW1*[I;CL<KSZN6M>E@F49%F+^0Z3E1>I/.RBCZR6(&:6U!:"*51*(U!:1Q*
M$U":1-'TG:@QMSSX/#8/ZF=!:2&41J$T!J5Q*$U :1)%TS7=^&N>W5_[W6(%
MZKM!:2&41FO:3MG@[I8J4#_MJ)P"FE.B:+H>&Y_,LT]INWY)\^.N[[*#6DL/
M:H]!:11*8U :A]($E"91-/U1"(T]YL/GI?G0>6E06@BE42B-06D<2A-0FD31
M=$TW)IYO=^%^U_*UXUL+W-GW%<PN"C0O->4UFL+0M/S8M *:5AZSE74Y-3:;
M;[?9#GG"]O#6<H%.#CNP:F_[U13:#P:E<2A-0&D21=/%VMAYOMW.>Z<G;*>V
MUC#4@X/2:$W3+K=U/<.HZ!D&E&"PUY ;@(,@V'_4BS T-#\3!K7"NH2V'H]E
MM1Z&HS:Z@?I<4%I8TTP/EMK9XA2:F$%I'$H34)I$T72E-B:6?_#FB4:E?B3C
M99:]]2PWJ'4%I850&O7WGT+E>^;GN4'-JZ/S"FA>B:+I:FSL*]]N7YG/"J$N
MIC%*&6I&06DAE$:A- :E<2A-0&D21=-WB<:,\N%FE \UHZ"T$$JC4!J#TCB4
M)J TB:+IFF[,*/__:D;9Z:WU#36CH#3J&XTAQSW;+3Z@=M21604TJT31=$TV
MAI3_'D/J-TH/^FNAQM5YT\T%,J0^#6;4--3E@M)"*(U":0Q*XU":@-(DBJ8_
M;KEQN0*XRQ5 72XH+832*)3&H#0.I0DH3:)HNJ8;ERNPNUR_68?8Z:WU#9W=
M!J718/\!9[OG/Z )^>&$ II0HFBZ$AN#++"[2/5UNT:50;TQ*"V$TBB4QJ T
M#J4)*$VB:+IV&[\L@-\X,8!Z95!:"*51*(U!:1Q*$U":1-%T33<&7G# P'N?
M!VRGMM8UU,N#TFBP[PRN)T#OE@7[[7;=7T,3QSOS#/;O89A$K>5:-]W\4:DB
MC(IH>#%3V8,:J23)R<I2J))L+269FE9/<CB_<CO=O>4CYSQT#,NI<\Y,R[ES
M+E;+NTW:X<4B>E#74?80SW.2J&G9A=[):5DC9=6DF]<W1;JX[)35S'U:%.EL
M]?)11:5JJP;EY],T+5[?5 F>T^S':C6'_P-02P,$%     @  W1C58 \'D#;
M P  EQ<  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N>&ULQ5C;;MLX$/T5
M0@466R ;B?0]:QO(I4$-Q$$0I^W#8A\8>6P3E42%I&P'Z,>7I!3):6VYO@A^
ML4F1<S@S/)HCLKO@XKN< 2BT#(-(]IR94O&%ZTI_!B&5YSR&2(],N BITETQ
M=64L@(ZM41BXQ/.:;DA9Y/2[]MF#Z'=YH@(6P8- ,@E#*EZO(."+GH.=MP>/
M;#I3YH';[\9T"B-07^('H7MNCC)F(422\0@)F/2<2WQQ1=K&P,[XRF A5]K(
MA/+,^7?3&8Q[CF<\@@!\92"H_IO#-02!0=)^O&2@3KZF,5QMOZ'?VN!U,,]4
MPC4/OK&QFO6<MH/&,*%)H![YXC-D 34,GL\#:7_1(IOK.<A/I.)A9JP]"%F4
M_M-EEH@5 US?8$ R V+]3A>R7MY01?M=P1=(F-D:S31LJ-9:.\<BLRLC)?0H
MTW:J?SNXO[R_'ES>H<']Z.GQR_#3_=,(_8-N*1/H*PT20$.@,A&@MT*A010G
M2B(:C>T@M9G]^P8498'\^,[N+)M\ANY@#@&JZ=%K'BD630V2;DHV!F$ANJ[2
ML1B/7#_S^RKUFVSP>P3Q.:IY9XAXA+PW=W4*\CR0/ _$XM4WX U?N?091#Z@
M2_\E89+9T'[\'OT9NF'2YXGN/U(%ZUPO7<J\9Q<RIC[T'/TB21!S</I_?<!-
M[]^20&IY(#6+7MNTH3MLW!/XLXB])"#1?W<:!PT4A/+_=2'5*@BIGH=4+]^;
ME3A8N@5^021_&Y%2<-RTZ*9*S?O>.2;MKCM?XU0C=ZIQ-,)\6L:Z",$8#5D
M^I76F7Z@KV;&.G]+U]TSU<T\JN8IV-.L(*16'E*K2O:DX(U5\JPG3COWIUWN
M#XM8F(2:*;<!+$TB#R\XI2ONF=].'D_G%)3I5! 2]@I5]*HD38:.6^]K3JVS
MH>C@%;G&QV;/;M6G?/U]$U_(,":G8!.N0I)QH<FX5!\/IE/M3XL0+C05;Q'5
MG$A'_?0I7W7?1!>BC!LGH4\5FHP+4<:E GDP?9IKJQ$AC0TD*J05;]'6O4BT
M8T$J=6'?W!=JC=LG8505DHT+S<:E^GDPHSI_6I!((;EDB^32Y=&_B\J7W#/+
MI!!K@D_!'5*%1).5D_*6H_)AW,G0?ZU&]59K X,*E25;5'9W!NU6BLK7WS?Q
MA623^DGH5(5DDT*RR9:#](%T2M%Q_1V=R 8N%9)+MDANSJ7CW@Q5<1(FA5Z3
MUDD85(5$DT*BR983]8$,:J\_K/UV0^2N7+.:*^LA%5,6213 1!MZYRU-19'>
M J<=Q6-[\_K,E>*A;<Z :E_,!#T^X5R]=<QE;GX7W_\)4$L#!!0    (  -T
M8U6#?'F#$00  %04   9    >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;-58
M78_:.!3]*U:V6K72=/+!QPRS@ 2D:)$*&@TSW8?5/ICD MXF<6H[,//OUTY"
M2*K@%JU?.@^#D_@<WWNNK^WKX9&RKWP/(-!K'"5\9.V%2!]LFP=[B#&_I2DD
M\LN6LA@+^<AV-D\9X# 'Q9'M.4[?CC%)K/$P?_?(QD.:B8@D\,@0S^(8L[<I
M1/0XLESK].*)[/9"O;#'PQ3O8 WB)7UD\LFN6$(20\()31"#[<B:N ^^VU6
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MLCP'EGD*D(F0XGTFAZM#E3O?9MW]:NN58%C%,K!2/&L/WM7MY 9<"<&#IY7
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MVT(%R@U\V"\30Y3C3>"9,G%L]N$+W3[.Q-#V,]CB E.45>4")7E:I*)!1O(
M4*E_E/7-R:F3+=+*%NMBZ\;GN$V!@;Z*,;KE>7-0=+)%6MEB76S=H!PW4W!\
M-_6NBA$.3E F3G^_M%2@0K'[ZU>,(<KV;;N_]5#!',?I[SW,DX/G'--M=>+/
MA+!]P>M3Q7:T?:MP79VE]\87\&H)%>.1? M1'70?Z>M7&-\0W:8% QG>B*FL
MRT"4-UJ_%:AO."FK8^][PCG)J\L=1@FF$B!^WQ#"GV_D!.V[F?E_4$L#!!0
M   (  -T8U6Q&/O0GP0   $4   9    >&PO=V]R:W-H965T<R]S:&5E=#8X
M+GAM;+68:V_;-A2&_PJA#4,*K)9(W3/;0)*VV["U,>(E_<Q8M"U$$C62ME.@
M/[ZD9(M*)#&VA^5#=.7APR.>]Z4YWE'VQ->$"/"<9P6?6&LARDO;YHLUR3$?
MT9(4\LF2LAP+><E6-B\9P4G5*,]LY#B!G>.TL*;CZMZ,3<=T([*T(#,&^";/
M,?MV33*ZFUC0.MRX2U=KH6[8TW&)5V1.Q'TY8_+*;J(D:4X*GM(",+*<6%?P
M\AK%JD'UQD-*=KQU#M10'BE]4A=_)A/+440D(PNA0F!YV)(;DF4JDN3X=Q_4
M:OI4#=OGA^B?JL'+P3QB3FYH]C5-Q'IB119(R!)O,G%'=W^0_8!\%6]!,U[]
M![OZW="QP&+#!<WWC25!GA;U$3_O$]%JX**!!FC? %7<=4<5Y0<L\'3,Z XP
M];:,IDZJH5:M)5Q:J*\R%TP^364[,9W_<WOS%YC]??5E#MZ#N?SHR28C@"[!
M7-#%$[B6(T[ #<WE-."X2N252F0JOH&+#T3@-./OQK:0*"J@O=AW>UUWBP:Z
MC<%G6H@U!Q^+A"0OV]MR",TXT&$<U\@8<$[*$7"=7P%R$ (_ QOP-6:$[P^&
M'MPF4V[5@SO0PY=-_DB8RLQMJ?+ ^T9=A_#Z0Z@*N^0E7I"))4N($[8EUO27
MGV#@_&8 ]!I SQ1]>KL17. B28L5>"2KM"C4F>0M"4MI B[28I^-=^![;U[J
M,=2]^%4OJJBWT\#Q'=]SQO:V!\]O\'PCWN\,%X(<C^%W,*#C>L@=P @:C,"(
M\?&9L$7*3P ).B#O@R",A_(1-B"A$42*RI*DIV0D[()$41@$_1Q1PQ&]D9 R
M92=01%T*Y'E>V$\1-Q3QT9.7%,D9TS;N3EO7<0,X  8=K9".L?"_5LHN,W2U
M)4PZ%3A,(3!CZ8* BYF4A;GBZA="YW_0!-C2=_B?52&A68895[?J!*M,:PWM
M'57=:]1*MQ>/7#20;*1QT=$J<0Y6'1UZ+]1K! =J!&KQAT;I?B4;YY"Y73+7
M'\%H@$RK/C3+_DL=.8?,ZY+YWL@=(M."#\V*WU:6<[C\+E<8C<+ T7]P@%&[
M 33;0;L\L.B1GG/ @TYM^&CD#;%JPX!FQ[@C7$C%49^Z7IS=%ZG@X.)N?C^P
M!C/&.U=ZM+' Z,@54P7:2VCTIG,)M>E L^O<%UN94YE/^>E[Q?$8XX%=YXE]
M'X4#QH.T\2"C-6@M/(9B'ZM-X<=1$,<#%-I D-E 'NH,'0<!NXL#%[D1&IC[
M2/L",OM"2^6. D$]B[9("L8 A_8!9/:!]HQY)19'<;G=52T,$/3] 3!M \@[
M;952S1X@?Q02\ FG##S@;//F8@49O>;,>D3:,9#9,=ZLQPU/3E'B?7>OE#@:
M2K9V#61VC:8R3^4)>I<GGCL I*T!F:WA4*2G\H0]UB^72T/2I:4?F7]4M,KU
M5*2H!\D?.=X DM9Z=+S6OZK<4Q'C[JP*N^LEN[4KDQ.VJO:>.%C032'J#9KF
M;K._=57OZNC7Z\VQSYC)8N @(TO9U!F%<EZS>K^IOA"TK/9X'JD0-*].UP0G
MA*D7Y/,EI>)PH3IH=OVF/P!02P,$%     @  W1C53GT!/"- P  K@P  !D
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MR=,OT!":6+Q4<NVNY%2?C:<>22MM9-$(HP4%$_4__=(XHB,0A<\(1(U ])W
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M,;LGSY]P-:&1X M(G!?_P7.%-0<@V.6,))4P'T$2I>6O_ZM2Q($ YY$+H$H
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MB0:F /+YAE+Q/%$!^K8\_@502P,$%     @  W1C5<5Z3\=M!0  K"$  !D
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MQA'><,W$"&-HX/]<!RQ(\^'?-V(,C3F)V#\52QQND<UJI"P65VSE^:2GB&K
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MUC5NPM/\DBM/*)'H6YRU4$I$^G$'-(0TRX#?-T*HET160'G5./H'4$L#!!0
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M7Y;?.R?W^ 7G^K9B>/H+4$L#!!0    (  -T8U7.%<Q?#P(  .HK   3
M6T-O;G1E;G1?5'EP97-=+GAM;,W:S6[B,!0%X%=!V5;$^#?3$;"9F6V'15_
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ML^DOONL_4$L! A0#%     @  W1C50=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  #=&-5,LV&E>X
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @  W1C51R:W\@+ P
M7PH  !@              ("!GQ4  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    (  -T8U7DJ<+IX@<  !8L   8              " @> 8
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  #=&-5?SVE
M5KL#  !L#0  &               @('X(   >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @  W1C5;9XJLL6#@  O)\  !@
M ("!Z20  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  -T
M8U6( ?)>"PD  !$K   8              " @34S  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    "  #=&-55]Z6!I4)  "+%0  &
M        @(%V/   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    (  -T8U4!$5#6B00  /\*   9              "
M@<UE  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @  W1C
M55>FK&KL!@  >!   !D              ("!C6H  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    "  #=&-5\EJC&+P'  "&$P  &0
M        @(&P<0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   (  -T8U52EW6^)18  $I&   9              " @:-Y  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @  W1C5<G_X+R+$@  '#D
M !D              ("!_X\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    "  #=&-5<2\(4E\#  !B"   &0              @('!H@
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  -T8U6[P":#
M>P8  (H.   9              " @5>F  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @  W1C5<^VI3C*!@  21,  !D
M ("!":T  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  #
M=&-5KO3%UNX#  "S"   &0              @($*M   >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  -T8U59-7SJ6P8  #D2   9
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M970R-BYX;6Q02P$"% ,4    "  #=&-5#LHU\J$&  "M#@  &0
M    @('RVP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M  -T8U7+B^T&G0(  )4%   9              " @<KB  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @  W1C51ED-98O P  DP8  !D
M             ("!GN4  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    "  #=&-5^*_R=;H$   I#   &0              @($$Z0  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  -T8U5-^0B+OP,
M ",)   9              " @?7M  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @  W1C5214X.(K!0  ] T  !D              ("!
MZ_$  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  #=&-5
MVI5\/R((  !-%@  &0              @(%-]P  >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    (  -T8U5^;0NV9P,  $<(   9
M      " @:;_  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @  W1C58U@ .>%!0  \0P  !D              ("!1 ,! 'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  #=&-50@ DD^H$   5#0
M&0              @($ "0$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    (  -T8U6INV9XZP(  &,&   9              " @2$. 0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @  W1C55]<:;:?
M P  Y <  !D              ("!0Q$! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    "  #=&-5C^5U;8T"  "Y!@  &0
M@($9%0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (  -T
M8U57#8:)+P0  -D9   9              " @=T7 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @  W1C52-2L_F1!0  >2L  !D
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M=#0U+GAM;%!+ 0(4 Q0    (  -T8U4@D,@5\ (  #((   9
M  " @?PS 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
M W1C53C=M0V- @  P@8  !D              ("!(S<! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    "  #=&-5&2*UZ ($  !\$P  &0
M            @('G.0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    (  -T8U4AMAT'*P0  /<6   9              " @2 ^ 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @  W1C5<5@0+%1 P
MGPP  !D              ("!@D(! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    "  #=&-5TL)CUF,$  #R$0  &0              @($*
M1@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (  -T8U5,
MD8[=UP(  /X'   9              " @:1* 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @  W1C53:+@+JD @  ^08  !D
M     ("!LDT! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
M"  #=&-5C8;C ?($   7'@  &0              @(&-4 $ >&PO=V]R:W-H
M965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  -T8U6_U\H%B 0  +P5   9
M              " @;95 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L!
M A0#%     @  W1C52Q\IED_!0  .RL  !D              ("!=5H! 'AL
M+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    "  #=&-5!G=G+)8@
M  !_7P( &0              @('K7P$ >&PO=V]R:W-H965T<R]S:&5E=#4W
M+GAM;%!+ 0(4 Q0    (  -T8U56U.P,2 8  "8W   9              "
M@;B  0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @  W1C
M507.?[BU P  L@P  !D              ("!-X<! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    "  #=&-5V<0[T;0(   ]30  &0
M        @($CBP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   (  -T8U6'AR T% 4  *(=   9              " @0Z4 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @  W1C567%!DBV"P  P),
M !D              ("!69D! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    "  #=&-5@#P>0-L#  "7%P  &0              @(%&I0$
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (  -T8U6#?'F#
M$00  %04   9              " @5BI 0!X;"]W;W)K<VAE971S+W-H965T
M-C0N>&UL4$L! A0#%     @  W1C54[Y7RP-!@  UR@  !D
M ("!H*T! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    "  #
M=&-5TO)DI74%   )(0  &0              @('DLP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (  -T8U6P"N(KKP0  *<9   9
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M970W,2YX;6Q02P$"% ,4    "  #=&-58G+47RD$  #B%P  &0
M    @(%>T $ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    (
M  -T8U4A BX$;P,  *(+   9              " @;[4 0!X;"]W;W)K<VAE
M971S+W-H965T-S,N>&UL4$L! A0#%     @  W1C5<5Z3\=M!0  K"$  !D
M             ("!9-@! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"
M% ,4    "  #=&-5&;PM:0$%  #>)   &0              @($(W@$ >&PO
M=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (  -T8U5%E=K)] ,
M '84   9              " @4#C 0!X;"]W;W)K<VAE971S+W-H965T-S8N
M>&UL4$L! A0#%     @  W1C5623_!%Q P  7Q@   T              ( !
M:^<! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  #=&-5EXJ[',     3 @
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8;6Q02P4&     %0 5  #%P  E?8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>349</ContextCount>
  <ElementCount>393</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>98</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - FLEXION ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITION</Role>
      <ShortName>FLEXION ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - FIXED ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETS</Role>
      <ShortName>FIXED ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - STOCK PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANS</Role>
      <ShortName>STOCK PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - NET INCOME (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - ACQUISITION???RELATED CHARGES (GAINS) AND OTHER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER</Role>
      <ShortName>ACQUISITION???RELATED CHARGES (GAINS) AND OTHER</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/REVENUE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - FLEXION ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONTables</Role>
      <ShortName>FLEXION ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FLEXIONACQUISITION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - FIXED ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSTables</Role>
      <ShortName>FIXED ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FIXEDASSETS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/LEASES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DEBT</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - STOCK PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSTables</Role>
      <ShortName>STOCK PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKPLANS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INCOMETAXES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - ACQUISITION???RELATED CHARGES (GAINS) AND OTHER (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables</Role>
      <ShortName>ACQUISITION???RELATED CHARGES (GAINS) AND OTHER (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - REVENUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUENarrativeDetails</Role>
      <ShortName>REVENUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails</Role>
      <ShortName>REVENUE - Schedule of Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - FLEXION ACQUISITION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails</Role>
      <ShortName>FLEXION ACQUISITION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails</Role>
      <ShortName>FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails</Role>
      <ShortName>FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIESTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails</Role>
      <ShortName>FIXED ASSETS - Summary of Major Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - FIXED ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSNarrativeDetails</Role>
      <ShortName>FIXED ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails</Role>
      <ShortName>LEASES - Summary of operating lease cost and other operating lease information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails</Role>
      <ShortName>LEASES - Schedule of maturities of operating lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails</Role>
      <ShortName>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - DEBT - Carrying Value of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTCarryingValueofDebtDetails</Role>
      <ShortName>DEBT - Carrying Value of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - DEBT - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofDebtDetails</Role>
      <ShortName>DEBT - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - DEBT - Schedule of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails</Role>
      <ShortName>DEBT - Schedule of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - STOCK PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSNarrativeDetails</Role>
      <ShortName>STOCK PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - ACQUISITION???RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails</Role>
      <ShortName>ACQUISITION???RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - ACQUISITION???RELATED CHARGES (GAINS) AND OTHER - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails</Role>
      <ShortName>ACQUISITION???RELATED CHARGES (GAINS) AND OTHER - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="pcrx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: pcrx:AccountsReceivablePaymentTerms, pcrx:DebtInstrumentMarketPrice, us-gaap:DebtInstrumentConvertibleConversionRatio1 -  pcrx-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="pcrx-20220930.htm">pcrx-20220930.htm</File>
    <File>pcrx-20220930.xsd</File>
    <File>pcrx-20220930_cal.xml</File>
    <File>pcrx-20220930_def.xml</File>
    <File>pcrx-20220930_lab.xml</File>
    <File>pcrx-20220930_pre.xml</File>
    <File>pcrx-9302022xex311.htm</File>
    <File>pcrx-9302022xex312.htm</File>
    <File>pcrx-9302022xex321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pcrx-20220930_g1.jpg</File>
    <File>pcrx-20220930_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1059">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pcrx-20220930.htm": {
   "axisCustom": 2,
   "axisStandard": 31,
   "contextCount": 349,
   "dts": {
    "calculationLink": {
     "local": [
      "pcrx-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pcrx-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pcrx-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pcrx-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pcrx-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pcrx-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 652,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://www.pacira.com/20220930": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 69,
   "keyStandard": 324,
   "memberCustom": 40,
   "memberStandard": 52,
   "nsprefix": "pcrx",
   "nsuri": "http://www.pacira.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.pacira.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - REVENUE",
     "role": "http://www.pacira.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - FLEXION ACQUISITION",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITION",
     "shortName": "FLEXION ACQUISITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - INVENTORIES",
     "role": "http://www.pacira.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - FIXED ASSETS",
     "role": "http://www.pacira.com/role/FIXEDASSETS",
     "shortName": "FIXED ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - LEASES",
     "role": "http://www.pacira.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - DEBT",
     "role": "http://www.pacira.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - STOCK PLANS",
     "role": "http://www.pacira.com/role/STOCKPLANS",
     "shortName": "STOCK PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - NET INCOME (LOSS) PER SHARE",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARE",
     "shortName": "NET INCOME (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - INCOME TAXES",
     "role": "http://www.pacira.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER",
     "shortName": "ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - REVENUE (Tables)",
     "role": "http://www.pacira.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - FLEXION ACQUISITION (Tables)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONTables",
     "shortName": "FLEXION ACQUISITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.pacira.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - FIXED ASSETS (Tables)",
     "role": "http://www.pacira.com/role/FIXEDASSETSTables",
     "shortName": "FIXED ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - LEASES (Tables)",
     "role": "http://www.pacira.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - DEBT (Tables)",
     "role": "http://www.pacira.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - STOCK PLANS (Tables)",
     "role": "http://www.pacira.com/role/STOCKPLANSTables",
     "shortName": "STOCK PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables",
     "shortName": "NET INCOME (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.pacira.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER (Tables)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables",
     "shortName": "ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ConcentrationRiskNumberOfCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i83900fda6b8c4a46b2ba5b9e74f8e079_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ConcentrationRiskNumberOfCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "iee927a1f7d744aa1ac841e3f8a7ca36f_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:AccountsReceivablePaymentTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - REVENUE - Narrative (Details)",
     "role": "http://www.pacira.com/role/REVENUENarrativeDetails",
     "shortName": "REVENUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ie1b49e2cbe8d4f398e562b2bbcb95303_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:AccountsReceivablePaymentTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - REVENUE - Schedule of Disaggregated Revenue (Details)",
     "role": "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails",
     "shortName": "REVENUE - Schedule of Disaggregated Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i61b7f09cd3fa46f7bef2e7b988c8c155_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - FLEXION ACQUISITION - Narrative (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
     "shortName": "FLEXION ACQUISITION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i45cfadbc2d3841f896c79ed64a43633e_D20211119-20211119",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i494d0416c7804e05936f5c4b14a63791_D20211119-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
     "shortName": "FLEXION ACQUISITION - Schedule of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i494d0416c7804e05936f5c4b14a63791_D20211119-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)",
     "role": "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
     "shortName": "FLEXION ACQUISITION - Schedule of Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ie759ea9768334d9f9aba5b4b91e0e643_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.pacira.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - FIXED ASSETS - Summary of Major Categories (Details)",
     "role": "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails",
     "shortName": "FIXED ASSETS - Summary of Major Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - FIXED ASSETS - Narrative (Details)",
     "role": "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
     "shortName": "FIXED ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:NumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.pacira.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:NumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "role": "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails",
     "shortName": "LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails",
     "shortName": "LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails",
     "shortName": "LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i7f168810ed0344c59194941cdbda381d_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0661863911fa4ee69bffbcb43e697fc9_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - DEBT - Carrying Value of Debt (Details)",
     "role": "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
     "shortName": "DEBT - Carrying Value of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://www.pacira.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "if14d12e11ebf4258a8f69637d5c05212_I20220930",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - DEBT - Schedule of Debt (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
     "shortName": "DEBT - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ie1806dce28b54192bab8601ab3c1447b_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - DEBT - Schedule of Interest Expense (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
     "shortName": "DEBT - Schedule of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i33df00d3d4b243f9ad70111a564bd482_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i56972a5601f94b26a9156a919f19b57a_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i7601e3ac14b4439db842e414e541e541_D20220101-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "pcrx:DebtInstrumentConvertibleConversionPremiumShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "iaf5db5136edb4258bb25992f7a708439_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "idad438652c2a484a8de75c3c8971bdef_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pcrx:NumberOfMajorCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "customer",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "iba4b68f7ebb74b26a54592d12d2be099_I20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i9e57fefd18bb42ddbe9674fd60b5a57f_I20220930",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i3893292d0c1143de8fc3cb71826752f4_D20190401-20190430",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ContingentConsideration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia5cc90199d454f10b36d87b70479ee68_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Schedule of Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ic44364ce38c044838833d136327e1683_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ibc550af62b504ae58f1e161f47a65942_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - STOCKHOLDERS' EQUITY (Details)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "iaf5db5136edb4258bb25992f7a708439_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "iaf5db5136edb4258bb25992f7a708439_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - STOCK PLANS - Narrative (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
     "shortName": "STOCK PLANS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i34432db649744b62b15fef5547cddb1b_D20220101-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails",
     "shortName": "STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i34432db649744b62b15fef5547cddb1b_D20220101-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "role": "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
     "shortName": "ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "ia858f8d17c074ea2b33dc5e11dfeca59_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER - Narrative (Details)",
     "role": "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
     "shortName": "ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i166df1f4bcd2446d844456bfb7f76005_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i4fac746bbf294b19acb69210d7229116_D20201001-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i4fac746bbf294b19acb69210d7229116_D20201001-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20220930.htm",
      "contextRef": "i0783adf1b42a4ba0af064d28105581cd_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 98,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pcrx_AccountsReceivablePaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Payment Terms",
        "label": "Accounts Receivable, Payment Terms",
        "terseLabel": "Accounts receivable, payment terms"
       }
      }
     },
     "localname": "AccountsReceivablePaymentTerms",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-Related Charges, Product Discontinuation, And Other",
        "label": "Acquisition-Related Charges, Product Discontinuation, And Other",
        "totalLabel": "Total acquisition-related charges (gains) and other"
       }
      }
     },
     "localname": "AcquisitionRelatedChargesProductDiscontinuationAndOther",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AcquisitionRelatedFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Related Fees",
        "label": "Acquisition Related Fees [Member]",
        "terseLabel": "Acquisition-related fees"
       }
      }
     },
     "localname": "AcquisitionRelatedFeesMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "label": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "negatedLabel": "Acquisition-related charges (gains) and other"
       }
      }
     },
     "localname": "AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.",
        "label": "Agreed Milestone Payments for Sale of Product in Connection with Acquisition",
        "terseLabel": "Milestone payments for EXPAREL agreed in connection with acquisition"
       }
      }
     },
     "localname": "AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.",
        "label": "Amortization of Other Assets and Unfavorable Lease Obligation",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfOtherAssetsAndUnfavorableLeaseObligation",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.",
        "label": "Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition",
        "terseLabel": "Annual net sales threshold"
       }
      }
     },
     "localname": "AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of presentation and principles of consolidation.",
        "label": "Basis of Presentation and Principles of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_BupivacaineLiposomeInjectableSuspensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bupivacaine Liposome Injectable Suspension",
        "label": "Bupivacaine Liposome Injectable Suspension [Member]",
        "terseLabel": "Bupivacaine liposome injectable suspension"
       }
      }
     },
     "localname": "BupivacaineLiposomeInjectableSuspensionMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_BusinessCombinationAcquisitionAndIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails": {
       "order": 1.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquisition And Integration Related Costs",
        "label": "Business Combination, Acquisition And Integration Related Costs",
        "terseLabel": "Total acquisition-related charges"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionAndIntegrationRelatedCosts",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration",
        "terseLabel": "Fair value of contingent value rights (CVRs)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Debt",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Debt",
        "terseLabel": "Retirement of term loan"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpenses",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilities",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets",
        "totalLabel": "Total identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]",
        "label": "COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block]",
        "terseLabel": "Schedule of Acquisition Related Charges (Gains) And Other"
       }
      }
     },
     "localname": "COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments to be Received, Maximum",
        "label": "Collaborative Arrangement, Milestone Payments to be Received, Maximum",
        "terseLabel": "Maximum milestone payment to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsToBeReceivedMaximum",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_CollaborativeLicensingAndMilestoneRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Licensing and Milestone Revenue",
        "label": "Collaborative Licensing and Milestone Revenue [Member]",
        "terseLabel": "Collaborative licensing and milestone revenue"
       }
      }
     },
     "localname": "CollaborativeLicensingAndMilestoneRevenueMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_CompensationExpenseFromEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Expense From Employee Stock Purchase Plan",
        "label": "Compensation Expense From Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "CompensationExpenseFromEmployeeStockPurchasePlan",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_Compensationexpensefromstockoptionsemployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation expense from stock options (employee and board of director awards)",
        "label": "Compensation expense from stock options, employees",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "Compensationexpensefromstockoptionsemployees",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConcentrationRiskNumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers",
        "label": "Concentration Risk, Number of Customers",
        "terseLabel": "Number of customers"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfCustomers",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ConcentrationRiskNumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number Of Products",
        "label": "Concentration Risk, Number Of Products",
        "terseLabel": "Concentration of products (in products)"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfProducts",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum amount of Contingent Consideration related to the acquisition of a business.",
        "label": "Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsideration",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Current",
        "label": "Contingent Consideration, Current",
        "verboseLabel": "Contingent consideration, current"
       }
      }
     },
     "localname": "ContingentConsiderationCurrent",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ContingentConsiderationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Noncurrent",
        "label": "Contingent Consideration, Noncurrent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationNoncurrent",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationPaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Payment Term",
        "label": "Contingent Consideration, Payment Term",
        "terseLabel": "Payment term"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentTerm",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ConvertibleNotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Receivable",
        "label": "Convertible Notes Receivable [Member]",
        "terseLabel": "Convertible Notes Receivable"
       }
      }
     },
     "localname": "ConvertibleNotesReceivableMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2022 [Member]",
        "label": "Convertible Senior Notes Due 2022 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2022"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2022Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2024",
        "label": "Convertible Senior Notes Due 2024 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2024"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2024Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2025",
        "label": "Convertible Senior Notes Due 2025 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2025"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2025Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due May 2024",
        "label": "Convertible Senior Notes Due May 2024 [Member]",
        "terseLabel": "Convertible Senior Notes Due May 2024"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDueMay2024Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information regarding the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Axis]",
        "terseLabel": "Debt Conversion and Redemption Terms [Axis]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsAxis",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Domain]",
        "terseLabel": "Debt Conversion and Redemption Terms [Domain]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsDomain",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount",
        "label": "Debt Conversion, Converted Instrument, Warrants Or Rights Issued, Per Principal Amount",
        "terseLabel": "Debt conversion, converted instrument, warrants or rights issued, per principal amount (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentWarrantsOrRightsIssuedPerPrincipalAmount",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_DebtInstrumentBasisSpreadOneOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread One On Variable Rate",
        "label": "Debt Instrument, Basis Spread One On Variable Rate",
        "terseLabel": "Basis spread one on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOneOnVariableRate",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentBasisSpreadTwoOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread Two On Variable Rate",
        "label": "Debt Instrument, Basis Spread Two On Variable Rate",
        "terseLabel": "Basis spread two on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadTwoOnVariableRate",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.",
        "label": "Debt Instrument, Conversion Obligation Premium on Common Stock",
        "terseLabel": "Convertible debt, premium on common stock"
       }
      }
     },
     "localname": "DebtInstrumentConversionObligationPremiumOnCommonStock",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConvertibleConversionPremiumShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "label": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "terseLabel": "Debt instrument, convertible, conversion premium (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPremiumShares",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_DebtInstrumentCovenantLeverageRatioMaximumValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Value",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Value",
        "terseLabel": "Leverage ratio, maximum, value"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximumValue",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_DebtInstrumentDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Discount Rate",
        "label": "Debt Instrument, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DebtInstrumentDiscountRate",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt market price, per $1,000 principal amount.",
        "label": "Debt Instrument, Market Price",
        "terseLabel": "Market price of principal amount of notes"
       }
      }
     },
     "localname": "DebtInstrumentMarketPrice",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.",
        "label": "Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price",
        "terseLabel": "Debt instrument, percentage of principal amount for computation of redemption price"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year",
        "label": "Debt Instrument, Periodic Payment, Principal, Number Of Payments In Next Fiscal Year",
        "terseLabel": "Number of payments in next fiscal year"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipalNumberOfPaymentsInNextFiscalYear",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 1",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 1",
        "terseLabel": "Prepayment penalty, percent, year 1"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear1",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 2",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 2",
        "terseLabel": "Prepayment penalty, percent, year 2"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear2",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter",
        "label": "Debt Instrument, Prepayment Penalty, Percent, Year 3 And Thereafter",
        "terseLabel": "Prepayment penalty, percent, year 3 and thereafter"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyPercentYear3AndThereafter",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate",
        "label": "Debt Instrument, Variable Rate",
        "terseLabel": "Variable rate"
       }
      }
     },
     "localname": "DebtInstrumentVariableRate",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms on or after August 1, 2023",
        "label": "Debt Redemption Terms on or after August 1, 2023 [Member]",
        "terseLabel": "Debt Redemption Terms on or after August 1, 2023"
       }
      }
     },
     "localname": "DebtRedemptionTermsOnOrAfterAugust12023Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtRedemptionTermsPriorToFebruary32023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms Prior to February 3, 2023",
        "label": "Debt Redemption Terms Prior to February 3, 2023 [Member]",
        "terseLabel": "Debt Redemption Terms Prior to February 3, 2023"
       }
      }
     },
     "localname": "DebtRedemptionTermsPriorToFebruary32023Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "label": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "terseLabel": "EXPAREL"
       }
      }
     },
     "localname": "EXPARELbupivacaineliposomeinjectablesuspensionMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "terseLabel": "Net (loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase",
        "label": "Employee Stock Purchase Plans, Shares, Amount Authorized To Be Sold During Period, Increase",
        "terseLabel": "ESPP increase to shares allowed to be sold"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlansSharesAmountAuthorizedToBeSoldDuringPeriodIncrease",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_EquityMethodInvestmentsAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments and Other Assets",
        "label": "Equity Method Investments and Other Assets",
        "terseLabel": "Investments and other assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndOtherAssets",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Foreign Currency Gain (Loss)",
        "terseLabel": "Foreign currency adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments",
        "negatedLabel": "Impairment of equity investment",
        "terseLabel": "Impairment"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FederalReserveBankOfNYRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Reserve Bank Of NY, Rate",
        "label": "Federal Reserve Bank Of NY, Rate [Member]",
        "terseLabel": "Federal Reserve Bank Of NY, Rate"
       }
      }
     },
     "localname": "FederalReserveBankOfNYRateMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "terseLabel": "Amortization expense, first period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "terseLabel": "Amortization expense, second period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3",
        "terseLabel": "Amortization expense, third period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4",
        "terseLabel": "Amortization expense, fourth period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FlexionAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion Acquisition",
        "label": "Flexion Acquisition [Member]",
        "terseLabel": "Flexion Acquisition"
       }
      }
     },
     "localname": "FlexionAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FlexionAndMyoScienceAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion And MyoScience Acquisition",
        "label": "Flexion And MyoScience Acquisition [Member]",
        "terseLabel": "Flexion And MyoScience Acquisition"
       }
      }
     },
     "localname": "FlexionAndMyoScienceAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FlexionTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion Therapeutics, Inc.",
        "label": "Flexion Therapeutics, Inc. [Member]",
        "terseLabel": "Flexion"
       }
      }
     },
     "localname": "FlexionTherapeuticsIncMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FortisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fortis",
        "label": "Fortis [Member]",
        "terseLabel": "Fortis"
       }
      }
     },
     "localname": "FortisMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_HongKongPharmaTainuoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hong Kong Pharma Tainuo Ltd.",
        "label": "Hong Kong Pharma Tainuo Ltd. [Member]",
        "terseLabel": "Hong Kong Pharma Tainuo Ltd."
       }
      }
     },
     "localname": "HongKongPharmaTainuoLtdMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_IoveraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "iovera\u00b0 [Member]",
        "label": "iovera\u00b0 [Member]",
        "terseLabel": "iovera\u00b0"
       }
      }
     },
     "localname": "IoveraMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the largest customer of the entity.",
        "label": "Largest Customer [Member]",
        "terseLabel": "Largest wholesaler"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LegalFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Fees",
        "label": "Legal Fees [Member]",
        "terseLabel": "Legal Fees"
       }
      }
     },
     "localname": "LegalFeesMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 6.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 5.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 2.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 4.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 3.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 1.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "terseLabel": "2022 (remaining three months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "terseLabel": "Number of leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Investments [Member]",
        "label": "Long-Term Investments [Member]",
        "terseLabel": "Noncurrent:"
       }
      }
     },
     "localname": "LongTermInvestmentsMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major Customer Four",
        "label": "Major Customer Four [Member]",
        "terseLabel": "Major customer four"
       }
      }
     },
     "localname": "MajorCustomerFourMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer One [Member]",
        "terseLabel": "Major customer one"
       }
      }
     },
     "localname": "MajorCustomerOneMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Three [Member]",
        "terseLabel": "Major customer three"
       }
      }
     },
     "localname": "MajorCustomerThreeMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Two [Member]",
        "terseLabel": "Major customer two"
       }
      }
     },
     "localname": "MajorCustomerTwoMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MeasurementInputExpectedMilestonePaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Expected Milestone Payment [Member]",
        "label": "Measurement Input, Expected Milestone Payment [Member]",
        "terseLabel": "Measurement Input, Expected Milestone Payment"
       }
      }
     },
     "localname": "MeasurementInputExpectedMilestonePaymentMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability Of Success Of Regulatory Milestones",
        "label": "Measurement Input, Probability Of Success Of Regulatory Milestones [Member]",
        "terseLabel": "Measurement Input, Probability of Success of Regulatory Milestones"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfSuccessOfRegulatoryMilestonesMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.",
        "label": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]",
        "terseLabel": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]"
       }
      }
     },
     "localname": "MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_MyoscienceAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Myoscience Acquisition [Member]",
        "label": "Myoscience Acquisition [Member]",
        "terseLabel": "Myoscience Acquisition"
       }
      }
     },
     "localname": "MyoscienceAcquisitionMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_NuanceBiotechCo.Ltd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nuance Biotech Co. Ltd. [Member]",
        "label": "Nuance Biotech Co. Ltd. [Member]",
        "terseLabel": "Nuance Biotech Co. Ltd."
       }
      }
     },
     "localname": "NuanceBiotechCo.Ltd.Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_NumberOfLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Leases",
        "label": "Number Of Leases",
        "terseLabel": "Number of embedded leases"
       }
      }
     },
     "localname": "NumberOfLeases",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_NumberOfMajorCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of major customers of the reporting entity.",
        "label": "Number of Major Customers",
        "terseLabel": "Number of major customers"
       }
      }
     },
     "localname": "NumberOfMajorCustomers",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents earnout and milestone payment made which is associated with the acquisition of business.",
        "label": "Payment of Contingent Consideration",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromDevelopmentAndCommercializationOfZILRETTA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Development And Commercialization Of ZILRETTA",
        "label": "Proceeds From Development And Commercialization Of ZILRETTA",
        "terseLabel": "Proceeds from development and commercialization of ZILRETTA"
       }
      }
     },
     "localname": "ProceedsFromDevelopmentAndCommercializationOfZILRETTA",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from shares issued under Employee Stock Purchase Plans.",
        "label": "Proceeds From Shares Issued Under Employee Stock Purchase Plans",
        "terseLabel": "Proceeds from shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Money Stock Options, And Common Stock",
        "label": "Restricted Stock Units, Money Stock Options, And Common Stock [Member]",
        "terseLabel": "RSUs, In-The-Money Stock Options, and Common Stock"
       }
      }
     },
     "localname": "RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ScheduleOfInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of interest rate expenses related to convertible notes.",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of total interest expense recognized related to the Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseTableTextBlock",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Operating Lease Not Yet Commenced, Payments Due",
        "label": "Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]",
        "terseLabel": "Schedule of operating lease not yet commenced, payments due"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_SecondLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second largest customer of the entity.",
        "label": "Second Largest Customer [Member]",
        "terseLabel": "Second largest wholesaler"
       }
      }
     },
     "localname": "SecondLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_SettlementPeriodConvertibleDebtConversionRequest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of trading days in a settlement period for convertible debt conversion requests.",
        "label": "Settlement Period - Convertible Debt Conversion Request",
        "terseLabel": "Settlement period - convertible debt conversion request"
       }
      }
     },
     "localname": "SettlementPeriodConvertibleDebtConversionRequest",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Number of offering periods for ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "terseLabel": "ESPP purchasing period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_SkyePharmaHoldingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to SkyePharma Holding, Inc.",
        "label": "Skye Pharma Holding Inc. [Member]",
        "terseLabel": "Skye Pharma Holding Inc."
       }
      }
     },
     "localname": "SkyePharmaHoldingIncMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stages at which milestone payments for products are payable, in connection with the acquisition.",
        "label": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]",
        "terseLabel": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]"
       }
      }
     },
     "localname": "StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_TELABioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TELA Bio",
        "label": "TELA Bio [Member]",
        "terseLabel": "TELA Bio"
       }
      }
     },
     "localname": "TELABioMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_TermLoanBFacilityDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Facility Due 2026",
        "label": "Term Loan B Facility Due 2026 [Member]",
        "terseLabel": "Term Loan B Facility Due 2026"
       }
      }
     },
     "localname": "TermLoanBFacilityDue2026Member",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThirdLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the third largest customer of the entity.",
        "label": "Third Largest Customer [Member]",
        "terseLabel": "Third largest wholesaler"
       }
      }
     },
     "localname": "ThirdLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThreeLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest Customers",
        "label": "Three Largest Customers [Member]",
        "terseLabel": "Three largest customers"
       }
      }
     },
     "localname": "ThreeLargestCustomersMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.",
        "label": "Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]",
        "terseLabel": "When annual net sales collected reach $500.0 million"
       }
      }
     },
     "localname": "UponAnnualNetSalesReachingDollar500.0MillionThresholdMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ZILRETTAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZILRETTA",
        "label": "ZILRETTA [Member]",
        "terseLabel": "ZILRETTA"
       }
      }
     },
     "localname": "ZILRETTAMember",
     "nsuri": "http://www.pacira.com/20220930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r54",
      "r56",
      "r126",
      "r127",
      "r319",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r133",
      "r141",
      "r230",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r522",
      "r527",
      "r528",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r133",
      "r141",
      "r147",
      "r230",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r522",
      "r525",
      "r527",
      "r528",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r133",
      "r141",
      "r147",
      "r230",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r522",
      "r525",
      "r527",
      "r528",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r133",
      "r141",
      "r147",
      "r230",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r522",
      "r525",
      "r527",
      "r528",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r199",
      "r385",
      "r389",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Major Customers [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r294",
      "r296",
      "r297",
      "r298",
      "r318",
      "r354",
      "r407",
      "r410",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r635",
      "r683",
      "r687",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r294",
      "r296",
      "r297",
      "r298",
      "r318",
      "r354",
      "r407",
      "r410",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r635",
      "r683",
      "r687",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r199",
      "r385",
      "r389",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Name of Major Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r196",
      "r296",
      "r297",
      "r385",
      "r387",
      "r637",
      "r682",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r196",
      "r296",
      "r297",
      "r385",
      "r387",
      "r637",
      "r682",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r280",
      "r294",
      "r296",
      "r297",
      "r298",
      "r318",
      "r354",
      "r397",
      "r407",
      "r410",
      "r442",
      "r443",
      "r444",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r635",
      "r683",
      "r687",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r280",
      "r294",
      "r296",
      "r297",
      "r298",
      "r318",
      "r354",
      "r397",
      "r407",
      "r410",
      "r442",
      "r443",
      "r444",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r635",
      "r683",
      "r687",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/LEASESNarrativeDetails",
      "http://www.pacira.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r55",
      "r56",
      "r126",
      "r127",
      "r319",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r142",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r142",
      "r147",
      "r292",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r197",
      "r198",
      "r385",
      "r388",
      "r685",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r385",
      "r388",
      "r685",
      "r709",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r142",
      "r147",
      "r292",
      "r408",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r611",
      "r613",
      "r616",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r134",
      "r135",
      "r136",
      "r137",
      "r204",
      "r205",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r493",
      "r494",
      "r495",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r565",
      "r566",
      "r574",
      "r575",
      "r576",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Reclassification of the equity component of convertible senior notes to liabilities upon adoption of Accounting Standards Update 2020-06 (Note 2)"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r124",
      "r600",
      "r652",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable, related parties"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r274"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r66",
      "r73",
      "r74",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Net Unrealized (Loss) Gain From Available For Sale Investments"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r63",
      "r65",
      "r66",
      "r671",
      "r695",
      "r699"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r62",
      "r66",
      "r73",
      "r74",
      "r75",
      "r130",
      "r131",
      "r132",
      "r512",
      "r599",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r58",
      "r66",
      "r73",
      "r74",
      "r75",
      "r512",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Unrealized Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-Average Useful Lives"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r449",
      "r450",
      "r451",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r134",
      "r135",
      "r136",
      "r137",
      "r147",
      "r204",
      "r205",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r449",
      "r450",
      "r451",
      "r464",
      "r465",
      "r466",
      "r467",
      "r493",
      "r494",
      "r495",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r565",
      "r566",
      "r574",
      "r575",
      "r576",
      "r577",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r639",
      "r640",
      "r641",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustments to additional paid in capital, other"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r413",
      "r453",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r202",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Amount of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r88",
      "r106",
      "r338",
      "r569"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount",
        "verboseLabel": "Amortization of debt discount (premium)"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r81",
      "r106",
      "r338",
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r106",
      "r260",
      "r267"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r214",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r106",
      "r271"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment of investment"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r278",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Asset retirement obligation"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r18",
      "r119",
      "r185",
      "r188",
      "r194",
      "r226",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r509",
      "r513",
      "r548",
      "r601",
      "r603",
      "r645",
      "r668"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r41",
      "r119",
      "r226",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r509",
      "r513",
      "r548",
      "r601",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r208",
      "r239"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r206",
      "r209",
      "r239",
      "r651"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value (Level 2)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r406",
      "r409",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r406",
      "r409",
      "r483",
      "r484",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]",
        "terseLabel": "ACQUISITION\u2013RELATED CHARGES (GAINS) AND OTHER"
       }
      }
     },
     "localname": "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHER"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Pro forma basic net loss per share (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Pro forma diluted net loss per share (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Unaudited pro forma summary of operations"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r480"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r497",
      "r498",
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r105",
      "r504"
     ],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails": {
       "order": 2.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": -1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Changes in contingent consideration",
        "terseLabel": "Changes in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails",
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Additional amount payable to holders of the CVRs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r496",
      "r499",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Acquisition-related contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input, contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r490",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "FLEXION ACQUISITION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Severance-related expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r488"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "negatedTotalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "ASSETS ACQUIRED"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Short-term available-for-sale investments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "In-process research and development (IPR&amp;D)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Identifiable intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "LIABILITIES ASSUMED"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Fixed assets included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r12",
      "r108"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r102",
      "r108",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r102",
      "r557"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash Flow, Operating Activities, Lessee [Abstract]"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r116",
      "r119",
      "r150",
      "r154",
      "r157",
      "r159",
      "r161",
      "r169",
      "r170",
      "r171",
      "r226",
      "r304",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r352",
      "r353",
      "r357",
      "r361",
      "r368",
      "r548",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r51",
      "r653",
      "r675"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r299",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $0.001; 250,000,000 shares authorized; 45,864,319 and 44,734,308 shares issued and outstanding at September\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "auth_ref": [
      "r395",
      "r396",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]",
        "terseLabel": "STOCK PLANS"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r69",
      "r71",
      "r72",
      "r79",
      "r656",
      "r678"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r199",
      "r545",
      "r546",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r199",
      "r545",
      "r546",
      "r700",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r199",
      "r545",
      "r546",
      "r700",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]",
        "verboseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r175",
      "r176",
      "r199",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)",
        "verboseLabel": "Percentage of revenue from customers to total revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r172",
      "r175",
      "r176",
      "r177",
      "r545",
      "r547",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r199",
      "r545",
      "r546",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "Convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r83",
      "r119",
      "r226",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r548"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r173",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "verboseLabel": "Concentration risk by major customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Issuance of common stock from conversion of 2022 convertible senior notes"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r332",
      "r339",
      "r340",
      "r342",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r118",
      "r128",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r347",
      "r348",
      "r349",
      "r350",
      "r572",
      "r646",
      "r647",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r21",
      "r343",
      "r647",
      "r665"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r317",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price of notes into common stock (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r48",
      "r317",
      "r369",
      "r370",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate of common stock per $1,000 of principal amount of Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r315",
      "r347",
      "r348",
      "r570",
      "r572",
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r47",
      "r335",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate on total debt (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r47",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "DEBT AND FINANCING OBLIGATIONS"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r49",
      "r118",
      "r128",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r347",
      "r348",
      "r349",
      "r350",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.",
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "terseLabel": "Balloon payment to be paid"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r49",
      "r118",
      "r128",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r341",
      "r347",
      "r348",
      "r349",
      "r350",
      "r369",
      "r371",
      "r372",
      "r373",
      "r569",
      "r570",
      "r572",
      "r573",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r328",
      "r569",
      "r573"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on debt",
        "terseLabel": "Debt instrument, unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r328",
      "r571"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r106",
      "r120",
      "r463",
      "r470",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Decrease in deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r106",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r106",
      "r183"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation of fixed assets and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technologies"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities",
        "terseLabel": "ASU 2020-06 convertible notes if-converted method adjustment"
       }
      }
     },
     "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUENarrativeDetails",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregated revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net (loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r80",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r148",
      "r150",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r528",
      "r529",
      "r657",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net (loss) income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r80",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r150",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r528",
      "r529",
      "r657",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net (loss) income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Weighted average ESPP purchase options"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Weighted average number of stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r73",
      "r74",
      "r75",
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r168",
      "r230",
      "r368",
      "r374",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r527",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r599",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedLoss": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Loss",
        "terseLabel": "Equity securities, realized loss"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r220",
      "r666",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Investments"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt, amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of key assumptions used in the valuation of contingent consideration"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Investments Without Readily Determinable Fair Value Roll Forward [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r535",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r535",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of investments without readily determinable fair value"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r531",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r532",
      "r608",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r531",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r330",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r330",
      "r398",
      "r399",
      "r404",
      "r405",
      "r532",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r398",
      "r399",
      "r404",
      "r405",
      "r532",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r532",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of carrying amount and fair value of the long-term debt"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r535",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r535",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of change in contingent consideration recorded at fair value using Level 3 measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "terseLabel": "Divestiture of investment"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at September\u00a030, 2022",
        "periodStartLabel": "Balance at December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Fair value adjustments and accretion"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance at September\u00a030, 2022",
        "periodStartLabel": "Balance at December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r330",
      "r347",
      "r348",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r608",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r221",
      "r222",
      "r223",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r341",
      "r366",
      "r517",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r17",
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Amortization expense, remainder of fiscal year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r261",
      "r263",
      "r266",
      "r269",
      "r638",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r266",
      "r642"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r261",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r266",
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnContractTermination": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails": {
       "order": 3.0,
       "parentTag": "pcrx_AcquisitionRelatedChargesProductDiscontinuationAndOther",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.",
        "label": "Gain (Loss) on Contract Termination",
        "negatedTerseLabel": "Nuance Biotech Co. Ltd. agreement dissolution costs"
       }
      }
     },
     "localname": "GainLossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r86",
      "r106",
      "r207"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss (gain) on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r16",
      "r246",
      "r247",
      "r254",
      "r258",
      "r603",
      "r644"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill recorded in connection with the acquisition"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r253",
      "r479"
     ],
     "calculation": {
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "Acquired IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r121",
      "r473"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r185",
      "r187",
      "r190",
      "r193",
      "r195",
      "r643",
      "r654",
      "r659",
      "r680"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r121",
      "r473"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r276",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r460",
      "r461",
      "r462",
      "r468",
      "r474",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r145",
      "r146",
      "r184",
      "r458",
      "r469",
      "r475",
      "r681"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r155",
      "r156",
      "r161"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive effect of convertible debt securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r161",
      "r415"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share based compensation arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Value",
        "verboseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "negatedTerseLabel": "Capitalized interest and other (Note 6)",
        "terseLabel": "Capitalized interest and other (Note 6)"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r76",
      "r182",
      "r567",
      "r571",
      "r658"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r88",
      "r336",
      "r346",
      "r349",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r90",
      "r337",
      "r349",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r100",
      "r103",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r244"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r39",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r35",
      "r244"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r34",
      "r244"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r85",
      "r181"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentSecondaryCategorizationAxis": {
     "auth_ref": [
      "r702",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by second categorization of investments, which may include, but is not limited to industry.",
        "label": "Investment Secondary Categorization [Axis]",
        "terseLabel": "Investment Secondary Categorization [Axis]"
       }
      }
     },
     "localname": "InvestmentSecondaryCategorizationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsBySecondaryCategorizationDomain": {
     "auth_ref": [
      "r701",
      "r702",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in the \"Investment Holdings [Table]\" and the \"Summary of Investment Holdings [Table]\" are often categorized at two levels. The first categorization is the investment type. The second categorization can vary. The usual secondary categorizations are industry, country or geography.",
        "label": "Investments by Secondary Categorization [Domain]",
        "terseLabel": "Investments by Secondary Categorization [Domain]"
       }
      }
     },
     "localname": "InvestmentsBySecondaryCategorizationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r590",
      "r592"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Lease expense, net of sublease income"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of operating lease expense and other operating lease information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022 (remaining three months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r119",
      "r189",
      "r226",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r510",
      "r513",
      "r514",
      "r548",
      "r601",
      "r602"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r119",
      "r226",
      "r548",
      "r603",
      "r648",
      "r673"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r46",
      "r119",
      "r226",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r510",
      "r513",
      "r514",
      "r548",
      "r601",
      "r602",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Estimated settlement fees"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r329",
      "r344",
      "r347",
      "r348",
      "r647",
      "r670"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt, net of debt discount and deferred financing costs"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Noncurrent available-for-sale investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r49",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate, at point in time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r291",
      "r293",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r172",
      "r175",
      "r176",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r102",
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r67",
      "r70",
      "r75",
      "r78",
      "r107",
      "r119",
      "r134",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r158",
      "r185",
      "r187",
      "r190",
      "r193",
      "r195",
      "r226",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r529",
      "r548",
      "r655",
      "r677"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net (loss) income",
        "terseLabel": "Net income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income\u2014basic"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "totalLabel": "Adjusted net (loss) income\u2014diluted"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r141",
      "r147",
      "r165",
      "r204",
      "r205",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r449",
      "r450",
      "r451",
      "r464",
      "r465",
      "r466",
      "r467",
      "r493",
      "r494",
      "r495",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r565",
      "r566",
      "r574",
      "r575",
      "r576",
      "r577",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r639",
      "r640",
      "r641",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
        "label": "Notes Receivable, Fair Value Disclosure",
        "terseLabel": "Convertible notes receivable"
       }
      }
     },
     "localname": "NotesReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r185",
      "r187",
      "r190",
      "r193",
      "r195"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r583",
      "r592"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r580",
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities, net of lease incentive"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r589",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (in percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r588",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r507",
      "r508",
      "r511"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r68",
      "r71",
      "r507",
      "r508",
      "r511"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss (Note 11)",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r59",
      "r63"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net unrealized loss on investments, net of tax",
        "verboseLabel": "Net unrealized loss on investments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r60",
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized (loss) gain on investments, tax benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Loss on investment"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r281",
      "r282",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other acquisition expenses"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration to MyoScience, Inc. securityholders"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r93",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid to acquire business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.",
        "label": "Payments to Acquire Long-Term Investments",
        "negatedTerseLabel": "Purchases of equity and debt investments"
       }
      }
     },
     "localname": "PaymentsToAcquireLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of available-for-sale investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September\u00a030, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Debt issued in private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r97",
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.",
        "label": "Proceeds from Sale of Long-Term Investments",
        "terseLabel": "Sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "terseLabel": "Sales of available-for-sale investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r96",
      "r448"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercises of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net product sales",
        "verboseLabel": "Total net product sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r14",
      "r273"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant, and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r275",
      "r603",
      "r663",
      "r674"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Fixed assets, net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of fixed assets summarized by major category"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Assets:"
       }
      }
     },
     "localname": "ReceivablesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedTerseLabel": "Repayment of convertible senior notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Repayment of Term loan B facility maturing December 2026"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r455",
      "r636",
      "r726"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Weighted average number of RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r281",
      "r282",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r374",
      "r603",
      "r672",
      "r694",
      "r699"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r230",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r527",
      "r690",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r179",
      "r180",
      "r186",
      "r191",
      "r192",
      "r196",
      "r197",
      "r199",
      "r384",
      "r385",
      "r637"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net product sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEScheduleofDisaggregatedRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r386",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r587",
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets recorded in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty revenue"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r175",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r66",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of short-term investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r483",
      "r484",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofAssetsandLiabilitiesDetails",
      "http://www.pacira.com/role/FLEXIONACQUISITIONScheduleofProFormaInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r49",
      "r128",
      "r347",
      "r349",
      "r369",
      "r371",
      "r372",
      "r373",
      "r569",
      "r570",
      "r573",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of long-term debt instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of composition of the Company's debt and financing obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computation of basic and diluted net income (loss) per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r150",
      "r154",
      "r159",
      "r161",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r446",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of recognized stock-based compensation in consolidated statements of operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets acquired as part of business combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income before income tax, domestic and foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r36",
      "r37",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of components of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSNarrativeDetails",
      "http://www.pacira.com/role/FIXEDASSETSSummaryofMajorCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of recognized identified assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r412",
      "r414",
      "r416",
      "r417",
      "r418",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r419",
      "r434",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of the company's stock option activity and restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r172",
      "r175",
      "r176",
      "r177",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of percentage of revenue comprised by the three largest customers"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r19",
      "r646",
      "r669"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of long-term debt, net"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Stock-based compensation from:"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (shares)",
        "periodStartLabel": "Unvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of period (usd per share)",
        "periodStartLabel": "Unvested at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value (Per Share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)",
        "terseLabel": "Vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "negatedTerseLabel": "Vested restricted stock units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding end of period (in shares)",
        "periodStartLabel": "Outstanding beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price (Per Share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Closing sale price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, ESPP (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r40",
      "r649",
      "r650",
      "r667"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term available-for-sale investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r705",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r114",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r116",
      "r119",
      "r150",
      "r154",
      "r157",
      "r159",
      "r161",
      "r169",
      "r170",
      "r171",
      "r226",
      "r304",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r352",
      "r353",
      "r357",
      "r361",
      "r368",
      "r548",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FLEXIONACQUISITIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r53",
      "r73",
      "r74",
      "r75",
      "r130",
      "r131",
      "r132",
      "r135",
      "r144",
      "r146",
      "r168",
      "r230",
      "r368",
      "r374",
      "r449",
      "r450",
      "r451",
      "r466",
      "r467",
      "r527",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r599",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r168",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r52",
      "r333",
      "r368",
      "r369",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible securities (in shares)",
        "verboseLabel": "Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9) (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r23",
      "r24",
      "r368",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r368",
      "r374",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r53",
      "r368",
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock upon conversion of 2022 convertible senior notes (Note 9)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r23",
      "r24",
      "r368",
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r53",
      "r368",
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r119",
      "r203",
      "r226",
      "r548",
      "r603"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Stockholders' equity attributable to parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r353",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r374",
      "r375",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r585",
      "r592"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r214",
      "r215",
      "r221",
      "r222",
      "r223",
      "r341",
      "r366",
      "r517",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofInvestmentsWithoutReadilyDeterminableFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r134",
      "r135",
      "r136",
      "r137",
      "r147",
      "r204",
      "r205",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r449",
      "r450",
      "r451",
      "r464",
      "r465",
      "r466",
      "r467",
      "r493",
      "r494",
      "r495",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r565",
      "r566",
      "r574",
      "r575",
      "r576",
      "r577",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r639",
      "r640",
      "r641",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r281",
      "r282",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/ACQUISITIONRELATEDCHARGESGAINSANDOTHERAcquisitionRelatedChargesGainsandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r125",
      "r398",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. federal agency bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBondSecuritiesMember": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities greater than ten and as long as thirty years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bond Securities [Member]",
        "terseLabel": "U.S. government bonds"
       }
      }
     },
     "localname": "USTreasuryBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTCarryingValueofDebtDetails",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r584",
      "r592"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Computation of diluted securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r149",
      "r161"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r148",
      "r161"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=116646717&loc=d3e6290-110844"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.2(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r727": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r728": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r729": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r730": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r731": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r732": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r733": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r734": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r735": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r737": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r738": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r739": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001396814-22-000068-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001396814-22-000068-xbrl.zip
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MC8M5/H6L00NM]"QR58W04VN5\\D62(G8[BK,PJ>Z@"98:XKVES.-=OZL[U4
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M03:K$3 V.,5.6,@2V#-;#-+4OT*1(1J'#:A=-T_^^<>3X%/;P,^N>S*C#R$
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MR0!$)I<QF6R=+]FS54P+HE67S==ZQR=C&EX?P4?O#,KX P[O=@OF]#0K!XV
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M$B($O*IGUD"C.Q,B*J?'<Y0V1:F0:_P8$8/T&@TCE+-0]G+O9C.1F241G1Y
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M. XFR 2&3S6A\,I<@C7[=7T2;$HE)+ N "7CHRY9.$^8O/4-:\8]>T#O)G@
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M\W5LO7?<'9P13=#9.E[4PNH^:^T9IQAD F%2P)P*Q61U*.S4["60]@I(>_=
M_L"XV=N/FYV27<)L%3M['BL'.;@@F.,%T"G:DI)P"Z8 "R+ZUX67!J7P@?V#
MB\._7G[IZIA7DV.NSGCK(DPA@\NQ@-.20*#WTM7"']YZ4U3!W*!,SL=5(*/G
M@^$F?;C<#5@'9SCH\\LTB1"^7%)R>13'$+6$5QZ].<Z,5ETQ*>PBYG0P9151
M91-%A!2S-Y;?JHOY*!#8T*"<3B-!GTEVIZYD<#Z:X#1"T1Z]!:6-<4"8R.8F
M^8(F@CX;XB00E4REAO=@4T'PV5GF32"2+T(U*,_32-!GLT*"?3H&=N.3\C"L
MZ!ZB<1%01I=<=DWRZ7,4]MR_GW9&,B$K5GJ; )6(*O ?)[54R7IJTDJ(N0%R
M-BL>@E#$X2F?TX(0AN/84HR.)57_B[9)9GB.@)S!Q+>AI$H.'!U)\& \E$!!
M*TF1O-6V^:9U9EG;^S>OUJ8<=0S@3 80QIO$47#A$%@(+U)NOGF=#9BSF;Q&
MGR&EB([I3T@53)?9N!J9;!"I2:M\YPW,^S>S0FNTSL54G =%/EA%SFL"2KD4
MN6@,=A&-:PK*"%#2*%-3SPPAF2QE5%)G:ZA)ZX;F ,+9[(,Q*D0% %)*R.B1
M4&9O,^NAU0IR\TWJ/4,X [ZJ1*&04%(.$&+&5$(H6J? /I&ULDF&E,^0.]V3
MNE[G8R>/]=/4/<F4GP\'O;II]&0\6?VS5=9QV._T#T:O:+ASB$-Z>O;U$\PZ
MC)F)<0Y)@RS*!E\(1*C=7CPJD%I;94*.33+.BRD6,S'XLFAC4%FC:R%I-<D:
MJN*2*0&LU4WH8;'@8C&3202;9#:R5/-00%D=C %+(#,H=+$T:A)A,<5B-MQ"
MQ&"% @=$D(M&GW(L3LEBH]&-VHAY+V*Q0_W.8+@Y&"_F1I$0 N4</]8( @ID
MG(D96#*T6G**68G#3+B$L2'JG#* $5 4Q:2B=<9/@I'B&K7T;+'$839;0A5R
M^$E&Q;KYP  J;1,PEP JJI!<<H@96H?[YP[D<\A0UV"C )+*>U/[7A=//ICH
ME]QA- ^Y_]DL3A3!)387M< D")V]B@J"\RQ^R@EL5.)X<45C)IPB"ADA6^&,
MRTPQA1>0632<M>3JJO8EIY@'T9@)OW!!F2B\U4E:<(G="'DKM19.!:]EDRK2
M+K!HS(1KA)PS6(1H!8*T*0 [$A-"JLO>$99S('^7OEI$AJ%*,,$SN9!2U3KQ
MS"]8'C"1DX8%0BX9QJ\VT1U*\F!%##ZPF4A1E2BB(J%-I9RTY!6+O^GN,X$P
MT;!K ! "JE@4YVTTEHV"MLZ7)9OXU=910!;9Z: L>C"ZQ%)TUJC8D6 HLDD%
MKR;,[R2-3^JNT5HK=+6?:P&SX7OZI+7A:OJ?D\ZH,^FX2)-ZV\]I,><MP!$(
M:XJ.Q0,Z&US0R3J'Z(1SQC2(#<PQM#/QZS88%92/28L()@EV[B'HVLTRDY>A
M27Y]CJ&=B8<V9*/7*B#&2MELB,'%F&Q*TI-M5(G).89V1NL*@C!,O 3P0!?C
MD9(H)&6*)0D(<I%\[=6!6^-#&MXX>A%=K:H-#ZV*C&X&_B<*)W.4Y!C+4O)"
MN=J9(3L33TL<+B6M,>@<0.>"(',PR97(L33Z)F7FYQ?9F3A: B=815.@F"#8
MY-&CJIVEB123JR8EUN<7V9GX653)<9@34X$(EO'%DIA/!>>*+JS%#?*S3T]&
MG3Z-1I^0I$^HT_,NG?([NPPJ'M/)N)-&&_VTB X6<E'"$ 5?=[6&@H+?T,9)
M!!]\;E(%W_F$]/[MKQ*4.%;5)1H/R4/@%U*AI%CKZ4,3=IR/AN/'SVH1%AH>
M\Y"=;6+OT\AF\P3[B9YV!F-*A\\&#U^.\\-%5$[21!X,EB \Z.)#,9J]:'0$
MQ6O3A$TW\X?D;/;)! '"V^)9_T#'^B<$;RTH$2TK:0/,[/PA.9LZZ)A1"Z2B
M,4)T.F2MG65%96R==TU8ECI_2,YF16GVLA:Y"I:1!,'DAT)1!.PLBXYZ85IJ
M3D!]20?8O47^;[ILZY,/%]$_>U&R]TY[,@G D5=2*?2E5N&R II@U9<2-%-O
M@LF"%3XJ[3(S/(&V)L1<S"D5A]XWP)LL)6BF7LS5]@'H@<FE!D+C,;M$F*0@
M*4%0 V*$I03--C:Q-A=9(*:L &SV &!L+-$59X4P#;)!M5[+5ED=#K%_,)&A
M7Y#60L'DP,985( H Z9H \.6G5)!RHOT#Z-Y 2>_F+\V/M\(4)X/AN/.74]D
MBY84M\1N<NC'%C\_HXHNU@6#QHFH0!H9BG:&6 TE&5LNTP3B2A7%/+9@RM2Y
M,-/KD_OYV0SLS\K*OP;]@__BGU>'..SA+G;Z)P/6_#L7GELKOKC9'^JG9F<\
MA[2* H3"X2S&VC!7VR2L,8(CW4E+(2&TFCOS_:O*S"<MC%AB-.OT]6C^> LC
M0HE"<T#J10(**2I!SF,([,K1:#._G:7F$)8?["SUJ'/Z>$BCP<DPT>CBUT/"
M/+F?W'G_Y#?^ZW*#8HJY.*@EM"Q$!Q6EB!!\45GZ0G]6 __Q.Z/Q69?QZ'7Z
MK4/J'!R.'RMW//[/#YT\/GS,/OW_?S Y[LEOHV/L/_DM#A_QMR]>7YSDBU/5
M&VYAMW/0?YRH#OV#O_[R+;YV]7D:= ?#Q_\F)G_^L_# M KV.MVSQ_]GEQ$?
MK6S2AY7M00_[_^<?(^R/6B,>RG)QX*AS3H^EY^>:_/KAXD$=GZ?+9/WJP:6J
M3_MF<V-W?6UE9W=U=WUG[N]V9_W9F^V-W8WUG975S;65]?]^]J_5S1?K*\^V
MVNV-G9V-K<V_?(0>#@\8]3@8CP>]QYHO=_</I6[U4&]Q=-CI'XP'_7^LK#U\
M]G!%"0/AN[ 88^S2U0%Q,&1-:?'M=_%X1(^O7OQG[HR.NWC&6CBYB<F7_O/F
MN!B^X_?$]#!A]_(BD^M=?'RI)QH>!K!55<:LD.-\=>%++7HXT:)'X_SE9\$_
M#.*O/Q8/Y?5GCR;G'EX=<#EBC-N#R??XH>KX_/.!?O#9<X\'QX_E\7AE-.AV
M\LH5?,>8,P_R8[$B)Z?X>(U'DW&XE<1<OE.O<#\"=#NM>+ZUW?[?_R:M^,_?
MV%#V!_W-DQZ?*:U<VM-M*G6'C?,:.5"-H! B"BS"0E9>"F.\3%_M1K/2Q^J^
M*K]8&Z23Z@%JB/C@PO9F_<=97!N\?ZFVW^_I]DD^6G^__R(<;?5^/]KK;?<V
MSU_+K;?;G<TC_CE_;=IKJW*OMRZV=@][[=[KTZT7^]V7>K.[=W[<V5._O]L_
M2F)SM_MN[VA/[/'KK=W5#YMO?S_<7'L'^T>_OVOS]_;_\*<OU?[9WMMDV^>'
M1^WSO;/-W?QN\\7SWN:+]OG6VH'8VUU76VN9?W\M]_F(3?7F?7[Q!^1__=[=
M5]WW\6APOL7';AYMR$WU6NR]Y>N=MV%K;?NPO;L'FVI/[*_]T6N?MS5?3[3/
MWT%[[;7:W%T_;^^^4W\"Q8+DH"5K6@@<J):75%I%8!+2YX(N/'C"0<WKB>OZ
MB,A?^X/;F:>EGM^!GL]^H)EX/!07X_7=(_U00;C50'_/6;U_:,Q??_4K^/T5
M6%=XJ./3BLB74OWYZ/0Z.7=IVI8T?,N03D;_W]LX?+>RU:?_N-;3R\?_FR?[
M4M*F.!HLY+<?BM5A![LK;_J=-,BTTM[Y*Z\B/QL,^.I@W(,O>7W"80H-NV?;
M=#P8CA^LE %')F.^P.GX<>F<4FZ-AR?-=#?/._'%&[N_M@&;YVW%/V+_:)//
MW>UN'AV<[^^V3;NW=[ZWN\GW\>9T_^W5=_[@:YG^_N[QN_;1@>;K\<]VKZWX
M.=Z^X>ML=MD=G=5SM14_\^[S[N0>=U?'[1W!_[Z#37Z6/Z7W.7$DVW)98PM*
MR2TL4K=\=*J(HGV$_.#)__ZWX,#^YU]ZJ6]+_U<DN4OE2YOW/7(\+78]$>/7
M;U:W=]>W7^ZM;*^_VMK>77GU9GOGS>KF[LKNU@K'$[L<-%R0)ZE7MK97I/GW
M_!\7;VP]7]G]U_K*)T''=<"Q^FQW9>OYY?>"AALC]G5W,^7'M]]2X@DU7/GN
MD&[F<:NX'><=#%?&A[1R;4)6+MJQKJSW,^65>S!>%]=;O\@WWC1=F=]I]?B:
MA_5KK8QGK3/"88OZC31E/\R<3]F$_>D*4#+.M80H3)93%"UFR:%EE!96Q.C1
M.([LZ7@\R3A=Z)06_UBI@_^Y9?I^>;YGA;NX_1G>YBWU9VO[/BQ#@VBTE.8N
M:+3UMSMM(XCCYZ(U,^*X.^3[N]R9^U?,L6!WU&SJV/ZPW]N ]M&ZVMQ]<[ZY
MMJ$W7VR(3;7.-GC]PSY3OZT7>VK_Z-V7U/'\:6_OZ.",;;+<W&V+-M_CWM%K
MO;?;AKW=I]WVVS=\G_N]K3_\AR^H8RT2:S&&%F5DZIB=;@4/I86@4461M%;^
MDCK"0E/'W>W5S9V-2A!GS1T7C+2-K]5WY6(&:*4,![V+$?GR[Y7QX.K)[NBF
M)V=\W!GS$*5;/,8\D)#FW/(M9>/9H-?KC.I$YLKS#I,&-BC,!A_?)9._F"VO
M5[NX6".=Q0^3\[/VVL'9GQ!D;8@K6LJIT (?5"LFI)8PD<V\M#H0U'EJV=*&
MZ?K/\?%E^OKC<U\^R9UEL'_0+71Z!RNC86(OG8:GUUKSYX%\>'1\\& %N^._
M^NCF" 1[?/HCH"G@+SYX-+V'G,6\[^VF[>[<LFW306=4?>VXK@3Y]:S;^9\F
M)^/1^U9MB-D"8#OGM8LMHTTV2=F803]X\FKUV<;VZLK3C:V=9QOKF\_6=_YQ
MP3PV-I\]_"N".UV)@5M)S R]^.<3*%_/?OS[^BFF\4H5MY5!6?DH@"LX6MDY
MIE17-N653G^E,QZM/#N<Y.[^8XZXR=\E=:YN<^G%[L:+W1P<.Q=3X"X\!&U^
M9/3!/P1G?RBE]/>?6?BQLW[S9OT"S?=^.^BXZU35A0NN6W*&QX/A9"/.9&?.
M9('F\.S9(-^<-.!'2'6A\YB.AX/W]3P-G2VXR%ZUU]I\[L/N)K_??ON\N[G6
MEOLO-D[W=I]W]L[KO6T?;?9^[VVMI<^R5X,/[?/MSM:+-XJ_>;KW]HUHG__!
M]_K\L/WV]Z/V[FO#UU=[/7;Y\BO9*TK%JUP\>_LH6Y CM:+6L54,9:%0\+_N
MP9,UZN(''-)/I*]N6+:E,MQ"&7;Q=.-R>?/%SK0&A]WW+>4;G^5H4<?:IJ=E
M2.@6:!9UKPRV;%(R:/).J?C@B9$M864 Y_Y6SIMATK_)0"^6\$R,[,I@N#(I
M*;;R^\FP,\J=-$DV#LHD5KQAE">'#@^PWSF?_/[#2W\68? V'FX_W'FX<EE<
M?#@9K<M0Z(;BKFP.'O['KY.WOG/+N)KSL.ZBO?CG)=^ ;*15_*EP7?X9E7,^
M K2$1]4"8U,+E3$M69(H(+,R =BJ@9 K;VDT7ODOZO<IGZT\'9QTZ3T.\S]6
M=DXZK/X^_&2F<I&E[!F_W!JR!VHFO_PI&5-_$IB8!896UL">$Q!;/KO4(IM3
M A8TH?6#)[O8.\;/1>@?=S\9<0G1Q(EM#5]Q)-#IIP4-%'X&R*3^5)"*=2&W
MJ"0V%B*D5M!6M9+3(:!WQJOPX,ESUMU.GB&4KP:,57>_<WP1\?UJ.)W_*2C]
M/_;>MJF-7.L:_BM=G*ONRE19C-Y?,N>FB@&2P]S!),&9><B7E%Z#B;$YMDE"
MZOKQC]0V";&! &Z;MJTS)PG8[;9:TEI:>VMK;QXD%T (&*TR93G0-K@H50TU
M%'E/9 0<(1RJ&G'V/?V=XT$N=-<5<8R+-,C)\_FZ'W';/M>=8N^KMV4EE^(P
M1/GD!T_H[IQ7S.BB5\IG<P1O6AVW^UZO)5P_?OG  F16*@4(TB9JL A7PUQ<
M'QF$1B'*M7<;6Q*12;#^-D]*3;EL.J]/>MUUW:J/-C]AS@2O/>#2,4 -4T!Y
MKH!@B#"DM#-$1W7,".!<UDG_WI-+?^P6_9]_28S$'X.BY3O^/(WZ.!RD443;
MO7.1+.HB@;3DVX<3ZD/-SI'5WNXF&[C<W5W\/A1,WOD?Q<"*?ME9ON]=<7[1
M'URD/;9AKXA7E/8YPL_,;VDA2N%6VW;X_&DVKQ3=C#KL,=LG1&QR3"K?/HE?
M^<A-F;L:BU1\S,?NYRRZL81O"D&?9*]G-#>>R+W=:@\[I3;SVIX4MJ,'@R=V
M]3UM=_1U2:.#RS/3ZZQS3UQ%*Y3SPG^U)RGY61%)],M).[[R@VD?XC2_UR'E
MNO7/PN/YQPO:)<*FA.=2RKKQ5E#+M=__<T .S@ZB7'M'FKOV2[-UTCD^_?/L
ML+7'CE,H_K<W\&#JI&?O:Q/_%=MJ+X^_[<?/Q+9^VT:'+_]N'[P\9@>MSDGS
M--WOS=<;3WIZIXF"B #"=92%P@J@A32 8&4"8H%P[D;AM7%*E^5"&\6Y[A>?
M=>?"%_^3CLR@%(9=#$[FOB&:47$?5(RI^:ADY@R)>T!B8G?48"X%XQXXYR6@
M''L@@[1 \6"\A58$*3>V7N^\_?_R='_ZZ7ZU".R-E]Y1L.JDQSLMS$OL[%XT
M(MY,(,(H80VSP!@9  V* $F0 P9Z'W5/P-B3I(0&3O^W>-GI&=V)MF0G6I-%
MRHGAA[\.(%C4YN\</_:D%G[I!-GONK3%[@MS6=@3;S\59RDER9<37T8S)&N^
M_R.H]AD:GS8[T8,BM#O>%;K3B5>D,Y')1_#?BW;R$ Q[A?'C"^*-QTZ"[R?7
M>OWK)]?&3H-KOH8K8"9'0A+*Z=!:X<HJ;>6EYWUO?6E,(#RZ1WGV?5 \BW>.
M."X&%U%'#TYZ*=KWZL37\$0/)Y_GB_ZYT:G%HP^/'^FW1NEI?X:O/;>)E! O
M,J=ILL8/E=?'3Z;VC&^6CHP.RI:4S=6#8:'@Z Y.7PXV?X[O772VE7&(\3@3
MQUP/NMTGRGG>^V([%_U^'(_1P=TD<X9Z>#%82E*?R=4./V#%+&=6 VHLC,H=
M"R"EE@!*;Q72*$IWM;%U[ =3OMRBJ,N4I368LLW>%*VO+N<GRHML=]8>#B-)
MEDMTO]=-,K%S6?@H&2^+_;3L:5MN.N[JH1X=J)Q8#7[<X[K_^.U%QX\ZE4(V
M/L)QT=$_EHLCT"J>I1_%^'0N)GAS?.WPI#V(3Z#/TZ&.A2P0HX?X3OE^L/E;
M78"Q%EQ^;::EB3:F]K7C<DL^>.Z#5A8#*:P#U&(.%%,&("N-<8$X)?R-7#X^
MXUX43S]E,Y<OF,LC7>JBH_M16FMK(Y?W=2+DQ&3]I'1O?+6(DP?<^,;@+"X"
M\5OZ5](J(OXL=L)E(TG\>+LHA-,6WL?B8[_W97AR]?9F%/N^;)OSH=TM$S,,
M$J&G?5@<'_/F%I;OHC\:5Y?]\H);V_?]PB3NQQ??TM;QI>D(X8^U"F$#\-5N
MYW5K97.&R;2LJ8R0V"3H<3NG=]T6TTW$[W=$["'OX4V.\1QV3BEZW%V7J@ON
M;&R\K:HT]]1L&W_]Q)+KXM+\D5FDOQ/Y\&.O?WF#1[.\J&1*.[YHN9V;+_?Q
M^];VM_>G;_#![L'7^!EZ?/H1O__GS9?#W3]/W[^,VFFWTS[XMC=U&.KX]'WG
M8+=YUMP]_A+?CWKKI'VX^[[S?G>;'KQ,.5(_PL-_]K\=E FK]GYV;D(+A>;(
M@E2D"5#$%9!$(D"XT#!5EJ2:;FR]NGD5JS:!536>^VKSL4V8(W/?XJ\?TK>G
M!WTE!YD^>I#7= EHWB2E\^18O8$^NLWT6+W!GKNL*?ORJO#G*F;>7)"0B0+F
MW<]"!C-)B H"6.%)VA4@0'*L ))8R;B&*X%"%9DWYTS]3W[I4E#2WLT.CDQ(
M#R:DJYY\67;DSJ@?,S$]FI@NIXB):4*$AP(0BBF@-D@@C;1 <"@Y55YPY.9#
M3/,NHS"9JN]11^)JX'<.=_AW&T7[9K=T.]RTNUCN*48QW.V56X(7@Y%O.#ZH
M+VLKW)"]M]<OOZMSF;[\2SM^=?S:HAN?K9<TU^?VH!377=VUB5FBY$Y9D,KP
M\Z'N.MUW@YN/L9!G^K<;';MUV>:[IJK79+]B<.([G:NI53R+$Z;<-1BE];N'
M3_ZW.HS=_$5RZJ657(IF"GKY^L$:8H6A'"#C+:"(** DP8 8R)&VPE*F?KF4
M/-W^Y'&\87VB;^H09+#D.[;;Y4YGL_?Y6O49-"H^\SU)Q(LRQB&N1Q?=]H@D
MRK,2T?C]B3BH-<H@[!Q,26R4U(Y2;!"TSC$C&!I5CD:1.#8B9]IVM*,'_W=C
MO_GBAB"Y\KA&>5KCJ/RJPXMAN53&-?-G.NE>G '7&X+Q#:.DBKH_W@NN%[E\
M/6Q]1!^0")&\@P?:&0ZH2Q'.T@7@J*=,>Z^CB-W8HJPA)6Y *:_XY6J MT:'
M8 97ZU9_^DBR'1VD&8P.TEP=G_E^GN;[09I&\<7W?='[,6[3F]%7<_UZ*>KS
MWDA;/>_[%'?UV4\5I_ZQ"5WN)\,?']%FT.M<#&__R$."HR?K7=^OW+;8N/K,
M2?^'NO_H@>E[_0GH$+_TN>Y\T9>#E.7[YIK<%&\*=FM9[AL8(H2Y,<3(NH[H
M&N>+>WX1*:N?KHIMTK5I2W'23QSTKWN-4*N,98AS?"?15W<X^/?O^L;17VCN
MC_M5R_Y%LNX'G@I8=.NGJA$>-HM4OKD8%0NN>>MC2\NJ-N.G*/::NZEV_-[K
MUM[!G_'W'U7;%G.F8]'/W]K^\]5><?BBV#ELMO::K:,:1Q IM2D9>4P D=RD
MJ/JT Q)MJCG<EF^2>X;D/#Z9P4U5J>;D.K[7@?6?K8\E.(=?[5/=-_7\$S_U
M_4I.OX[:J/C7KS,+J!^/K^VGC_U>7/K!N(V!IO_N>N[;ZZH]CF4KTC@W=<E3
MZ:T'MN7^>@O!)%K>ML8J9;-XL=_<;N[L;[\JHND7U_[M5$;N!@5V>V$&Q.ZJ
MS# ]/\K_W5R2H2[W^%4ZC8HF_7>H/X4U\82S^X%M><#L)AM;^T,_+MZ'-F^9
MQWE4:]"6AXWJB^_;-64VVM$9VF?ONOK"M8?>_3;WD5[DEOT]PZBF%,K#:>MG
M#GS"&JB/?>1%/&G&<44XYBGS3_*QIPW8^%.IE,M0QS]U)\+;%T<GWM_H )K_
M6%^G[:<3H6LS$>C=&G/>B_12<MALEE6>NE5,774KAUT3)KU0')[[T=?,S&8S
MB]#,9G.?$JPR-LN*++/9PJ8NQO=DLQ0[U/<G\;KV9U_.]65]W.+9JZ5N?V\P
M^&VI'R E3>^=^:SQ5Y]:>-;X6>/7I2T/F+KLGJMB&1%WTNO$KQB,0[**O?]>
MM(>76?.O_A016?-GS5^7MCQ@ZLK[:GX]."E>='I?LC]V#::$REHM:[6ZM.7^
M4Y>@E#=C&-LT[!6WT-I->\=9H*W^O$"P#@HM([V:$4W%MG_$]N"98WORD-9B
M2 ]T5W\L.?G[H:;=]L!># ;IB%M*P;G=U9W+0;O4I#^H/'']Z-AWNN:M'UQT
MJMYXR[*U_M.'X#KHUDP(%6VE(GF=Y,G3!'#F,:U\3-^D7!KM87F$M"3L^$+G
MZO?$]YW>X"(===TVO8NK*C_%V_;@4Q;J:S ]:'7>ARSKGGY(,;K.XC1+]149
MTW1 NQ]'K&3PU_V>]2Z1=M;9:S#VK#IG2FT<Q/?-5_LD'N*5>]0:UA&][QF:
M.\^[SK8ZY?.N\SWOBNE/!U[W-XO#UG_VWB[LM.O/L'C<2=4YWV-!(CN?BZQ\
M;HMJC[OF8:W-L+[R'W5GI+'+6H599*_#J#-4!Y&=@5S5N77X$S]O9W?VB@QJ
M<DP7+[0=]OHYDF0=!KQ"8L[.S!H,*<FQ)*LXIN^ZHQRY/E7D/M*=4>[<T9&,
ME,;_HM\>MOW(?_UN4"8='4OLK*_787YD?;U:0\ISM,@JCNFN#[H,YWMWWNM&
MWNZV>_UK])T5]QK,@:RX5VM(50X)6<4Q/8B?B4H[^"BPK\7Q936]!F.?U?1*
M#2G%URF:936](F-Z6!;/V^^.ZC3%6V7]O :CGO7S:@TINT[./.OG%1G3O:\G
M;=/.*8_78K!9/JRX4D,J-[:.8K_J814F;VU"Q9\^4CQSU=-/;$;NXJK?RTIP
M3U,CMWA<A=^):IY/4MFTLJY2F^Q>??5:VW9?%W^V>T>V[;O6#QHI_^IF4?QO
M4;PA97W$XD4T#,N2C^6K90TP4D7UU51K:O;RJUANRO-<??4!;9E;]=5YX_VV
M&JO?3V\498X0_,=M5<MNY(7*VDONU=S;Z&EN"_1]FW%?U)*-)Q_RZX<:OC_(
MG!I2WO%Y>QCIVMZC:3]FWE%KN[5WD JO_ER(:D&C_\!VSZ<;R:RMJ6TW/1@V
M?.,&T3%W(7!O#JUGG>K[M7[GL+F[USS:VTVECH\.7^WO1N3M%G]NOXI0W"N.
M_K.W]\#JQY4^!7TL(3^=6KRYB<_VN\7PI'<1;^*B4/1?K4_U;$]T?Y2TY=SW
MKWX[BQ;=<##-=O5[IFEJ7FSIZRA9-^%(MCZT]K6@FTS@RJM4([@IL'C4;>]^
MC\ZKL:K*FMKW.#];DU/L]RO:?!1!ZL],Q":!C=(&_JGJ_:^?<M4Z9-?;<7^@
M[_V!9BN4::WW,_C7%[QHEKVP?71T?55\B(=N_+1C:ASVSN^H:_ZHT^@3W3G+
M/1[>R$4?=U^PCZP<_)V+?C_BLM"#@1\.GL\I6?\B:^+./X%)]37%E[7+5HL>
M[WKLV_XN:Q\DR6O3#_Z_%^W/NC/RCOT\M1[2);!8AH[YGYD>L=YS_=_MK\^[
MO>Z+OK9EZN"+;GOX-OE*+P9N(T[U;FI]^4+;4DHXM9Y("RF51$I"'"*<8.$1
ME^3#?E)94!&X43AOVV>Z,_B_&R"BI*O/?+HC^*CU^?,TD[:[+OVS]V,:;0]W
M=+]_&;OM;]VY\!O%*#@K?N_7X?/NQ1EPO=*YFVX;<1>[SY<(+'T1COQ]:79[
MGU_AMY^/R<&%.]W[_/ZE.CT\^^OT^.SM6?/;&W3XS]MV\S3^^?:&'>QNH^.S
M/7C8.CD[.'OS]?#E^\XKTNP<?SMO'^._/KT_M;#9ZGPZ/CV&Q_'GP];VE^8_
M?YTT=S_1]Z=_?3J(GWO_M_S:;*LS>_:B>WBZ]^7PGW?LX/03>M\Z^')P^@9&
M YT=?_N$CT___O2^]>;K\>DG^+Z5ON?MR?'9UT[\##N.[8GM^-9L;=.#;[%M
M+_=9\UMZ_X <_/-7YR!^U_$W=W+UF?A=%^_Q.W[0ZL1K_VH?MP[0P>[';_%S
ML9V?2//EB_;Q-_OU^.S=Y<'9V],F?A$.+N'75ZV]X<$19(>[QZ2Y_<$*9+T+
M'GA/%:!4$"!M$$ I@J#C(A#C4K)XU:"8_OOWGZ?(+2O* YFP>" VJA13F:%6
ME*%T8,ZP2$G>&8J9- 8SI7 06D!)B2H9"B%,4&:H>C'4MPF&\DH'#K4!5B(#
MJ- $:"LL4%AA*HV#C*<<!)(UF) U8JAUL*3NUHE')[W^$ Q]_ZS0GW6[DYR$
M("(%#"(>BG;WLQ\,SV[2C=^["S^LNVYDZ*6FL:J$5CD4K3@2^S]Z/;-65:S5
MW)G253Y82: P  DL &4F1$FE#)!"4,89ELC1C2V,5(- -"MKW<P<<]55]W4(
MK#V"JQ(B&<%S1O"D[D@ =CI"5FEM 44. F6# H@'*90W@L.H.P1L2%(G &?W
MU+:UY?YKT??61\4>54>CZ/KAHU3&?>W I>:HJE3&5<^__=[Q33\<>]LS5U7&
M54=3:D/BX 3Q'$3&DH#&T8IJ Y6&DO*2, U#V-A2I$'%S%Q5/R=.!G+58B,#
M>4% GA0=6!G("90 ZH !U2@"&4$'A$;"$<4LARP"F3<(RKZ..HF.I,J[PUZ_
MG0X1/%9LK(5!5)78N.KQRTA-F9,JXZ3VE+B@DE''K ,\>!T-(<^ E$X#3U"T
MA1A3$LJ2DX12-3*$LB>CIN(B W=.P)W:.1':!X%]1"IS@+JH*"1&"A"+!26.
M,2I%!*YLL%2_JC; S1Z,UWU_KMNN\%_/?7<P3LG;*S/5V)]BU[)+8]XJ8SP4
M>Z.1V.ZZ,F'0=MG[V2"JFL.FXU.X"YPZS8%'-HH/:2#0-M#8O9Q'44*-B\O-
M%J(-BGB-#*+LV:BI^,AX7BR>)S6)LD0K33@P48( JF7$,S<:0"HM=TY[K4*)
M9U$K3V5V<-S]=ZLWU)TJQ,FXW^YU<&$UF:ZRS9C,:?/@M,/I6 ^$%68>$B!@
M5":4N0 4-09X:9TST>)B,"6$)22*E*JVBN\-D"5RGZPQZ"O;N,F@GQ/H)X6,
M=<%BH1P07$0A(Z$&6DD)F,8:$JJP5FYC2W+>B-)F64"_#JZ79J_[7:=4'Y6Z
M%L9851+E5:_[,8>TS8NSIL-$@O8B6,> \8H#"F6(G(4%(,9P JU1B-!H?(D&
M42MXUB?CMVJU\4O\AO97[\ WW^]EZ#X,NI-RPW@6!X9&K$IG (UP!8HA#3S7
MP5EMHA:!R80O,\#5"+OKX#AYD6;YV.F1@S\6M"W3.X\]</FZH[O#[:Y+9_/.
M$P'E/>4J3^.UMA,'E3+BL/41Q^?_(+RUV'('O( .4&45,,)%X\=PP:EB#F$3
M-80B#4YGWI')X2#UA7)U.S(9R@N"\N7/4,986V*\ 4))"B@V&!AF2^<EX=H[
M EW:BY&R06MU1FT=O!1OT\^@%\#%P,\L+=;"J*E*6AQ&-M+#V$^OO![X<AP.
MP[N!+UVKF9"J(Z2]*6WAK8(61RYR!%M M>9 ^\" $RP:.Q!2D0J%<-7@'-?(
MQLG^B9I*BPSEQ4%Y0EL8'XF60@LPYC+MB1J@5!# 0F\TMBY@3#>V!&]0-'/L
M:797/ B(+WL]]Z7=Z60OQ;REQ%5/9ZJICFKVIU2#%- RQ!A@.OY%G>= ZJ"!
M#49*B;S@4D8SAHD&X74R8[)'HJ:R(<-V+K"=4 A24FL(ID#3 *-"L!H8!''4
M_H9IBQUWR*=(4-9 @M4(MNO@?=CO#G7W8SM5 LB^AX6>:;WJ]U$@5],/][[:
MSD7JNLQ*U;/2P;28D- 'S@EP@1% O7' \(  BFR$L(/*BE3_3Z(&A-D'L<*0
MKNZT:X;T@B$]N<WA,*'4<L!#X("&H(!V5 "+A&!:&"(]V=CBF#04STDU%@O(
M71]\O^]=,=1?*S@VLMJ45)7*N.KT_:[MG?F6_OJ=F3(154=$;Z:TA1&*>F(,
MH$HJ0(WW0'EB@2?*.&5#T(HD1P5KL%JE%,R.BIIJBPSD!0%Y:G-#<FBP!Y0%
M&14%Q4 SHX!APC(=R=EXE8!,&I&O:P3D]7!=?(]%OI8V(Z?+F*^T.+?]K\]3
MY-;P\L /3WKNVC#\?,@^,U-US/1N2F(H"IF C@).12KG@B30GA" K'+64^D5
MQ!M;F#<(JY.ID[T7-5,8&<]/A.<)I1$Q:]/Q<1#%1,H'*@E05-.(;,B)XD[H
MI#0P:B@I:H3G=7!=S)XNXV91,M]3\K7KQOO7JWKP\Z\,FU>;$B0S=G6,?3SM
MY(D3ESJ% 2&8 >JQ W&THFT(TZO(*<M3-$I#$!JMPZHVMI<E'4@FMTQN<TU]
MDLFM4G*;D*.>"L@##X!X+ &%(?(:LAPP+PC1,G A392C#2A8M##)LI#;+^2J
M:P_.._HR/8F_FP\7=>5J.?+$C13R:G_[S_U7^ZW]O:-BN[E;'+4.=_[??PY?
M[>Z]/2K/N8L_BKTW[_9;QX^J:#[ND6MSB\39XWH7*>CIELE5;\Z=H;S[??TJ
M:]^AZV#8CK.'%9VV-NU.>]CV@^>/FE6_?O:E&/.JMS_7H,M6:WV:J0C=N;Y,
M&<9FJLJ]8K;.2A<>K[J6WNO1_,DI':LV;TZG<YLX'X@3#@)M% &44@9,-$0!
M,M(H3YABW&UL(=Q09&;;IGZ[9YF25I22JJX*F"EICI0TZ7$)7C!K*"!4,T #
ME$!A;T%@2(J G-0NA1K!!J-UHJ1UL)-^*0#[%_Y'#9\<UKP Q91Z_-4/LS4S
M5.4,=4/2%JBI4S*=O&8!4(P@,$YK($RP<52%4!J6F1X(FSE$(0<UUQ?&%:J,
M#.,%P'A":+ X>MY# [Q*Q0(I="".'@3*HX %ATCIM&^-18.Q?!R[3DJC3&YT
MW5N;PYP7FR/NBJHN,U%53E33Z5Z4-QPQ@D T?W0D*LU!M(0PX,Y+300C 4:]
M(:LX>E$_'TV&\GQSQ&4HSQ7*$YI#$.$4CZ8#Q)!'*,LH-WB @'"F*,6>X)2Y
M232DRK4 ZZ0X=GK=LK%I9W_@N^U>O^CVACXGOU^,^KC6_;O>#&^DJEQYXY$L
M-9T21IE .)(*N, -H$(Q((FW*=.<PO&/,LSF>;#Z\R#@.#I,(2"]"8!&J0FT
M8@$PQS .!LEH'-]>@J5&)G-V?=54B]X'T%F#SHCJR1-VD#,DI %.J\CIED(@
M&?9)B!)%>!PXA?-D6)/)X$U:T#D'#CL(:$ 42,Y%RM7B6" &:0HWM@B##<JG
MB]O4B.+7-:)]M+20FEM75Q&VY[U^R2:]4'1ZW8]@Z/MGD1/,,*?;7(B /O+V
MHN]=IM>YT.MT=@JBH):.<A"(3O0JXUH;M 684&>08P[:2 B$-*3(N357&+]5
M2:2,WSGC=U(>$>L"E%$/1;@"BCP&&O&HFGVTB+GP@1.YL85I(P*Z1OC-#MM1
M@KB49-/?>B(AF_-5RXM6ZNZ[@F6S<^Z1U#2==H% ;:@F$!!F<:0FJX"R-@!&
M XR+"T5!JLKJ(V=?7'W!6Y6VN!&\&:0/ ^FD?O":41D(8-BIM)-B@&*2 F^)
MLD$[#XG>V*)8U0B@.;[L/JFL[/29X5G<%[.E@5EJ_JI*?.3XV7ERFYT^.TAI
M$$XYX"B.!I)%$"C(+%!<<:>5%-BENN@$-1B>N2[Z0V&R1)Z/-89^5=(E0W_.
MT)],!XXC/2/) ?<41N@+!B0.%EB/-'*1T(6 &UL,HP9"567=?>J<2"OA-,EQ
M;'6*8VOVNC;35=5T]7%*J7#H>5".@+BNL&B%(0*D=1(X[;4P4!H";;3"(&T@
MELN0K#".YQ2IDG$\)QQ/UC7SFD,B*2 :I6C4%)E(4O2\(9A[ICB6(>VFJ@;F
M=3IYNPX>E5<YG./)PCE2W[=BUR<NR@Q4'0-]FHZ(AG'I$(@"+I  -!@!I+,&
ML( (AHPS8TQD(*@:DN9R(RN,X(H#.C*"YX;@"0T1**,,0@:<\B9J"*J QE"D
M#9H O3+&IWI!A+"H(7)^H05KB$K.]:^%)3/G<_W9HID#&WV;SK]HN1&:! VT
M2(Y4IC!0BFF K.8TFCO!6;JQQ5F#PNR86&$XS_EL?X;SG. \F5)(8DM"P!&_
M(L)9(0.44S JC$C,GFHB4J8.@1H"+Y%_8F7/SM1:#.W$*V);4XQ)I(I!VY7(
M[G6S5V6N)5U_=/O.]5[/##H/!IW.=10@4EQK!ACG 5#)#9"4": MUCA ;1")
M@HC0!H9U"KC/_I6:":*,Y2? \G0I5P2QD, $:4'RN@#-<!FF[@E%CGND-[:8
M:#!5)U_I.GA:RG+&V=.R4$]+ZO)K@6J9A>;!0M-);(SC$'IK@?8*I11&'DA.
M-' &0>6UTMJ0C2VD&G$UJ9%-EETL-5,4&<<+QO%D\(?1"A,E8H=B'RT#K8#F
MS 'A77#<B@CQ$8[5[$?I<^S'@D_3Y%,T=9$IUY@M\UEU?/9FNHJ$1(9;[@"$
MD<IHP-$Z4H)'F4(YY8@9HOW&EN*T@6E5N4'R\9F5POP<CL]DS%>*^4D-@Y7W
M2EH I2H3JW*@O"5 8:FUML(Z!Z.&:1!*&XK.7'1B54_.N/;GI]J3.3MK#\]\
M*G.JNZY$8^E@M!$ZQ;-F;^@+Q'_[/D!E0ZLPY^:C [X.VL^[[<[_W1CV+_QT
MC/OW9]WNNIWK3_J=!V#F@7OPP'1:,$J\L!);8$1*P:F# P9!$0T:A[F-K(XX
MWYC.KOCDU9D?/AT?LD3EZ;BHZ3CIJ)=>6J<)T%;S:%J3  P)' 2J*0Q068;1
MK=-Q'0S<HV'/?CKI=>(R.B@SZH@_"O_?B_;P\G%UXG_=!?73I3/4B;^OVE^#
M+GL"J71U[_$M0+K^.<+E$#Q%K[SN^^#[?9^$:X15HSC7_>*S[ESXXG_N6EE>
M^_[1B>[[2HR@_>:+R17F>[M*M+_6_</^T5 /O?L[M>W'M^?%Y@&+C1T>[/RT
MV'QV+_^F[C]_==[CSF=SVJ/-W6/6/-N/;7W1>;^[#0_^^3NUZ_)PU])X/QSO
M<QJ?Y<OAW_+;P9L/C/+ XZ($N#844&6B=!(: ZV0@DHRPB&]6Z'<,H\>YT#+
M\VA)YY$V6&'CHBD.O0/4<I4V""EP(CCO<+3*4Z 1W(0W!%Y/O?!'<>N$&Z3!
M'BQFKI43:[!],3SI]2,AN_LY<_($7/P$;$8;T"FF@O9 .A(G8&(S20T'GABI
M5)P%1J [B.S&>36GM3#/JR6:5R&R2+3C*$B)!P$EM$QV88"C2$JKE2GC'5@C
MBKSTY]?D5HRF6J&_C_]#Z6ZNTW)_,+B8G)(WI)G-LW'ALQ$UOWP0#)G@B #<
M.0:HQ!+($*>D-0%S+CDAY*YB,XN?3H<7P\%0=Y.EE.=4/>>4T=@82P-0PA%
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MJ7:H-Q88R#'04;- :+4C'&UL"0$;<7E:EMSZN:+&,JJ;#/TY0W]*W2CB.*(
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MX3KDO9V]S%!O*G/N++$-]\ZDN7K,.)=\BHGCQO%9V=E:(<<=3+DJ*%>$&X*
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MRN%H=C'BO"-"42\WMFZHV)J!NQ+ K<!?DI?D)T?UI!^%<!$8M!:P(%($HE)
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M]J][_3*X9CCLM\U%66ZRU7NM^[X[S,Z5A^022DZ5">>*-%(R#"5P@F! N6)
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M,#&+81CX-(T>)8H5XLQ:I)VA2/!(@Y4.A :<C6A2^%H!L><-8C9RZ8/AW,O
MB2%:"B,49X%IJX')%:MT*1!NKEN<-,H:H@2R25G$M>7($&&0M+ I@?PHEGIE
M#5AXESP>L[1TDGKF5Y8%\,RO?&[ET;>^QMI7P]@9)/AJV$([@^.,T,^M7OK-
M4AZ(3I$D*F/C2G?"1"6<Q18;2WRDKBEV2:;%+LDUCP)M#X?C&#;'-<Q=VP"W
M38EHWMQKQ3*55R@$Y@8$9EK0XYR)QB-VWDN"L(KY_#D&_J*X1I@90KDGRGH
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ME"!KI>+8ZN2,65FC@G6UFF] >OUTMP)U!>J6$.IN@'0$6\^DY5AYR45VYY
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MK YMDZ9>:J0IY8B[7 V9"HD24<$3@YG(O11%E^ME"LN75*$"5O=<1:> U0.
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M[5%.&^HU]: ^.-J(1>T1_D05FO4(#34A&@-VE&B".',<:;"F"#LC:+2<$NI
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MOQ+$5R> XX-\%8S)+LU8&H>#3(K^X^X=*;6VL5<L'FA;YCD5L-B-FU;RQEV
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M?(J:T:9FMYVM7^'PYC,'A.<2A7[FR_2<*&V-VT^#V[-,EC"N+/4.R:@<XL8
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MO=%F+VS_OY/.<3XTM'2'54AK<J+]\Y>SCWLM]G'+LX\?0"DOWG9:6_M\?^\
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M-;SK\RRW]%DDSDHM<)0^<4V4%=8YR;%+*43XN&9G2X95\T=9<ML*01-'P?L
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M-7;]I-AU[X;I=V%7C5&WP:@E U5YP8D&4'+4(:ZU1T;!G\Y8*['4-)FX]@H
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M/E[WCN'.9V!J?6W'4W 4P$;O]+H'8P-^)N[:A@^V^\<Y_G%Z&+OQ:^S#KFC
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M/S]]:_W9.FQ]WN7-HW^E2=7I;(<('H2P4F5Z>HDX-@X9KC-W)C,\$1,T 7>
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MU@'?^[/UI4G?D.91DS6WWA[MC<U5JV.@CO&<>PZ[%Q8=62<(>*(N2>(C#93
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MK1#^?[7]=MD#Y3(G,?O6H/P;8%]G@NI>F?C-< 2:"0SB<NF_MM]^S*'M>+-
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M-4/!LW,(@G0(BW*A ;;37_DAWN>GW0''Y> E]T:"^V?V%YP\I3$9I 3H Y[
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MEF=@T_]GU*Y"@\\.):8Q]DL>*!<M-9I@@-&\HXE:GWXHE\87!3=34WK+NK]
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MSSRQUZA&SQH]%_:P[_;U)6H(O1&$CNO02EN5.">(Z,"SZ]PA8YA'S& /ZG/
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M/G=!+%^PZH$401YGF[XTKLOS!*!@$*[E_<4Q7$B#?&)1O36?!%36<?_,(CZ
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M=*77P!B#L:1<<,<-(<9HH1+57!L)MF:<*RC53LP[XU'SW64\XI)0X95#C'#
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M:54L4\IKR*TAMX;<^3;.X)Q)[B/3'G.NF=:,!<(D \@E4K,:<E\ Y(X[3K@
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MGZ840_E"ELMOONL &QV>9+TI3)<OP%IY"PMO>WO%4;<#2EGHW5;J*$L](42
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M[=MI<_-?!\WUM9/M_0;-@H53@7U.T=,!Q D7E"%+&$4XQ,B-\LXD71X"T\D
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MM9UW__FXL;6U!BOP=^P,\]E6+YYSA0:XR=^95N6#N/U,;B^0KWR)[!)OV?8
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MK9&3P,T5ETPIXX+6\F9UD6X5OE*6]WZ65V&OG#815M82L+IL0!:[A*0Q(EG
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MS]"-J."%>7KH9L _<RO?:R6-/T84(0>NS/;<33AD'[[$RXLNXO)BRK0H2HC
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M)\ZXZ(L/<-$!\&C*!ZB)\H"!"7FP>1'G)B)-:$#1FN04<0DKGTU@I>>5G+)
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M5N:\:Q:C3)QZGM-55L@B-3DJWJ,WW5Z*K>(_>IILZ(X.I/'B#WMG&%GHTKQ
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MMOK?4>K%6+6R_ -UK7JP-^\U/.=N4_C2@8K?*U#E_? &ML.[\6X8 54!I!L
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M&7Y]]=TOCI;[$!GC($98<ZL2B(_PSGO%5<0!-LC/!6-QG$Y@M(,\=( [MCI
M$&/U"]#*_J]GF1F9[0&U\<-V[2)V1Z,HS%/>-_5+.QC9.36 U(;/B':.=#S\
M?C K2^O,4WSQ^]US/6#/96F-+%Y@H*VL<L,E#W#^4@OT' ?M81_N#B,'AE$=
M=#.^MFS[1D]^E7=S$??:VJ?/F5M@A.7HU"!T#_+<P3.?NBC&N769^_7B?X>M
M/!/GC)F\$,/QX4(K(9_36GOY&OMQL-NM#R!.%WGB!.)TGMM'9Y,_GFM@]M7X
M6JV\W"&ZP7G+?L:MEF'X>\/^H$ZWK?(&V[>AWBCY!^'Z^_)DO!F+8%):%XRW
M:M>&ZNS6M=TW,<X\?74F2ZO7'X"M=I0?-EJ_.]XJU0$\8>:;("YKYX8\'FDG
M@Z0=P 2<?P8;0$1L?4!S+EXQ_LA.@#HSINM;M1R=)M+,&I:%2>\/:D^' YSI
MSQP [,LN$+MZ"$!01OZ266='=3[.Z)#)7;R?'?W"1=CYM=MK; &?H,2;_'1G
M9TBMSLB2RS/>B]]LKY:Q<[MSN>K'6#5APU3TGAU0-SR_7*X^#??WLZ3 (WX"
M4Z*56CYW*5OS/I\]Y0=YWX5KM>*CYH&N5.]AZGMYK29$^\)!99;ET:X>Y$.Q
M(7QMY)Z8)<Z30IMU]Z _+;=/$1K?7Z($ #O:PS""LDN.4+.)7.NHX<$8">*X
M!VT=07-.BUQ(I!NM0RX*,!:8CY\^]VO<O>#[.1._VI5\>C#[RUG"W<RE^W4Y
M(YD].("]F$>W4CVG9<E0&7_42Q/.)N;GH#]&>]CXP"EJ[!D#(#PLW"2_/*H.
MN\-VR/ &,MTZV?  FQ>58"\>=&M]8.M[Y7O4*JQ>C=T<8C[;$U>=.>$ZW4L4
M8O3 -08 'Z!Z_LZ8&CLGNS# BS'6GST$;)#SSUV/Y>QQ1Z,"?)Y)6QXJY7?2
M/*M)[UHGC-GC0N7V/H;)EDOB<.F<L IYB\%DB\(BQZU!1C&3F,%.>3MI@MU1
MB!^]4L+6A?S?<7IM'-2R=,IJ+NQT5UM+&21O0/ N2F;^\8FS_%$/MZZL;Y%'
MFAN85;_48M\=PNT"Z T /OC%.2&W==A+_]=7UX3X/,('SV<F&*_@D9OPI@G-
M7*QH:N:?>DQ6)+G=9:_*D[[\IF6PBSA8>KT6XN,8\(G#"\I&XG0QIKG7/;QQ
M!=9+8Z3-TTRUWJH1]WRN=7T:=($/S:/M]1.=GJE,]"MF9_;V(WS6]KL(ZPN=
M(WV]R9I*R[_# U\G%^$Y31R9AY ]T[DIFVHNF^IYY6M>@M<GKMI7=TG3G-MF
M>O3:&F60]S+(EY!I.-TOI0F&_-B"']GSX\B!VN2_2Y'UY];W?=8C+G9!W\O;
MN0S[D\D35@N=="#*8\6CI8ZQW&V6D)"BM^*D38.Z)-P093F!!X97D^Y(V&#O
MZHWU']ADI_&"[&FZ&\=5=O]J-^B?^\WU-[O-X\^'S;T//W;6M\7F5@-O'S=$
MD^[L-_8^[C;?[NQ-YC8VOWP^WM[?QHTO&ZRYM4;A&M^;>]]%X_CC7N/X.]N!
M\33?;N"=_3JO^L=$;F/BVOM<P5N9B!$/42&;RWA+A3D/R4:NT]*J--/]/I]R
M5Y4".T\)=FZ .LY:SYGSUJ; N3*:4/C3B=PQ"$>":]0A)ZA#9J'.3\'F.I'+
M!8FNA43'4RV>(B=!:\1-9(@+P9 UE"(950R>:!X$65HE:EG*Z5S%)]^DO"#2
M,T6D.Z9=%$1Z.$0BD]W0G=$8$XFBC!S!^DEDN<4H$D8"(\E[FFM@R65,IKOZ
M%D0JB+28B*2LUKF_BF.><T.\2Y)J;P+C##/*3C@2*1SIT1&)35;!HLHY0AD2
M,7>Y"X0C U8:PM$++7+!<^J75KE:)F21.-*<?,KUO=6"@\SYV.SS$96=[B"'
M(<X(M3X+?[[4&_WR^D/-WYMT$;/6QW%ZGT[#]#827&JPV:ECVB8#W>HV4%=6
M/RZH=C6J-5]/^:!4DA9,OX"TU@%QIQ5RF% 4,7>1A\@%3=G3/$I 6YQ>3Z4+
MW*)[;XJ4/YZ43_IWO,B]_51$&MM<E(<0I G1" OC520B>L6+E+\ *9^[1^3N
M4E[,E#N)^J3CQ+,8(S>@P9T&,\6SA(QC! 6,E<5<JDC-TBH#*X4607^^@CYW
M1T-1YX\GXY.N"$^TYRHY6+IH$,^+:&, &:?2!>, M[E91'5^A2_B)$L"!AM_
M#@SEFQ>_^3*CG49YV./\I5EA3^/\IENY=G[:\FXRU/2)Z(\%C"%:.U>@8JO[
M'C1'9S#.:"Q:XB9:HC7MVM%<B9 H2EIRQ#4VR#JAD<6)>N&BC0G/*;SH>E+R
MR(=J+U;L%R:&YZ?"7FS"N2'!I/M'^12%B03ID'L> Y0C9QQ!N:"ABUYYB>F<
MPWL*(CP31+C?&)J"" ^#")->HJ23@15T*%@"B* 41=H:>,43,XPES[586J5F
MF=!I>E 0X44CPOW&L!1$>!A$F/0I":5$2I@BQZ-"7'**K"0<6<4TQE)&(><=
MWG*_B%"<38_C;%J\ 3^5;Y:)+1/[M+Y9)G91'/I/L!+ ^EG-U#O5 EB4)/5R
MC6M<XV6>5'V9K+!]:97LGR7LW\0X?4XFZ,R6.G./2CY9H[71$ITT_AMUU-D\
M6Z$ZW*&8HG/+M-AJ9#.T/KS:W/I&X?F_<HZ5IC0@QKQ$L%LL<L1YA),E)B6E
M9#2YX?BR9L\P^:N(^7T>2!4Q?SPQ/[HHYB&ZX(/D*&D5$ >A1DX0C2P@NW(X
M)X!B$'.^S)4L8OZLQ7SNITQ%S!]-S)L3VER9% AQ%%'*&.*1.F2IP(@ >9,$
M.ZL"J[4YG]$(NXCY<Q+SN1\=%3%_/#&?T.9".*F52(@I:7*.48XTDQ&9I#G!
M0:8H6*W-B5@DTOZ\/&VSA?3U[%879VTRBO_MI5QC3OZW4@[@):MQ$[@*+G'%
M2.08=#I1WCBCI1:))AMN['M[U_&]NA>[;8_;K->WO1@+\KI>K3X,;S.M1S<X
MRT0J>49ST>F?IQQQ20K,(E6(*DX03PPCERQ'&,=HO>*.*#NW1*/"W1=:Z*T/
MU%D:A,..>Q>TD/"682)%$[DT-_;$%:%?$*&?(/+*$2QPDDAC$A&7FB!K@D3P
M@N1>PL;E8I!%Z%^"T',ML-).&,4LP+^V6G+*A,A';C[*F_OEYBKTQ82_F^1/
M>NJB,-Y*JY'A DQXACG2-&JD!:P^-CYRJY=6Q;+$NLC]LY9[C:VEQ"="&>'2
M ^?304DO&<=>)TQO[*@KRGY!1'Y"V;LH#?4APC(2DL_@0-J3Q,CG,[EHK NY
MJN'B*?N7X+:;CB,Z*<)1Q;KV1MW8^'P_Y%+$\&>'#X$K:[QQ+C(>@<IH[H1R
MW!*GO KJ?KP6)[UZ8WAOC_*7UWH]V_E6_Z[ VGQ@;7O*<:$B%1);AA(5"?'D
M [+*6)1XPL(R;9QWBU@AI=1!N@>Y%T1KDB31TG-+L:,&_J<((]1+'>W]."ZN
MD/LBWS>3[PG:XI-T6I*$G-82<8X9O,(">4.DDSQ9(MG2JJ:JR/:SEFW&.:,!
M5MPHSIVDCH@4DQ!<^1 <<??CGRBR/4_9GO1",.."ECA'_R8')@FC2,,;2#F'
M>;#>8Y^65@TKLOV\9=L:3".6&'2RA.L)9TA*@KGDL__1ROOQ0=R KQ?WXQT%
M?S*"* 8CL68HLJ@1CTJ X >%*/5&)B,BL7QIE2P3MDBE2U]F1M,,3\3'3Y]O
MYX!X*4Y5*J*G*1@M$N&:"\V3B891$EW4DLGB@'BJ6.:G'!"YWI9F1"'G+4%<
M4(=<,@E)6&C*8 ,$KQ;1KUH.4^8O]U+ZX)@SN1PCF*I""\](3)HHC#4>)S<4
M!\1BR_=D[E+ U":@*=%+D&]K,3*8)Z1,4E; JZ09<)7GV"ZSR/9YV6:.<4FB
ME2QPQXUF*7%'8',$BD'FBP-B\65[*@S"RH0UB'4T(2$.D(R,!@5N3'(V\BB<
M]DNK5-W9"BFRO="R[:T.W'MGE0K<Y"Y_7@6AN"!>&NS-HS@@BFS?3+8G]#:S
M#"@8CBCF.&:N#$<:U@U9YD6@+EFIP](JN[MS<?%B'9Y$SL8,OX(_C0JJ#D!\
M6L/]"EX.=F-.[J!5,V=SE,"'ARR54H*Y%@'<ODTY'1B1D7KID4X$B(MU\(I*
MBXBQ7#-C)6:L1#V\#*&?>^&4(O0+(O03C 8[%R2-&%&'LR="161X9$C%H#BG
M@/JA]'9\(4(_]S(J1>@70^@G713>81EP8"#OTB%.=43:,XI")$PYP[1(I6WS
M"Q'ZN1=5N;/0%^&^F7!/:'30YI%%:Y'QN;VC8P&YZ#W"D1J7*)&,T:75NU=1
M6;P@B*?JHMCX]/Y]=3#L^5W;CW=*QG@IOE6P1*U4ROFD-*=1&]CT0%XBCSZD
M1$HRQI/%L^]3;@G'A#!>)"1,M(@39I"E+B(9@S-4RI380N:8E3.5>SA3,51@
ML$H%%8H' W(?15T=D+ @14R/$@M1Y'X^<C^96YH4 V@7V3,!EHKB'FDA8,LG
M$8/2TBH7B]R_#+DG-CNIN$G19;E7!D<B#6?>R>0]5B5.8O'E>]()P;GVFA"!
MA#0><<\5<M03)*6D"KO(% 'YGE?_P"+9BRG96(!52CGGA! >K+;1DJ!E "XO
M&>6A1$D\ <F>U-R$$0.$#,&&$(A3Y9%S3B$-?UO),14>+Y9DETY4I1/58S;L
M&=?4O4L<RLOH)_NHS7S&C62GRH.7O+ZY:9.]C2G_#U',J,P.K0-%PI,UR&7E
MHHT+,00>7.3S:N=S(UEZ0J=8+Q@<'JH%4 &'!P&'R:1?S )Q(B'*7>X_;QC2
M*3BDA$LL!*,Y'7<'D7?FFP4<GATX/%3CH (.#P$.DQXF*U6 _T=$H\.(1Z>S
M'>I18,D+A9433BVM"KH,*UO H8##([4;*N#P(. P6:?<"JF #")+/44\I+I<
MB$;<$X:=XCZ*6#,'J?B3 (?G54ED=M/O9AQ4O[2[_?ZO5:OCN_NQ.HB]D5OE
M=DV(QG-P;F483'_H#G.GEY/GN5,[G>L>!I11+OHH7Z8OL^Y]5W5F"MYYM^9=
MX@9GTH>%FYO_N=,C+C8S^N52:C3LA_>Q5Y.3^;I=,_F$YP:B-,F3-FRO _/6
M/[GON/WBF/#@0GBN07BFVZ('G@O7!H>TR33'T)C]J 8EFDOE24<L3TNK> 5/
M%R;X]0D'^Q<<>DHX= L8NJ.#EQ;TN1?TF:QX!,LDN*"(^!P38+U %L>$K%"&
M4AZQ9#7Z\'EY8@H$%0AZ* BZHQNY0-"]0-!48:9DE6/6(R*215R%@)S5'$D"
M*R>U)9[)#$'B&9:&+A#TS"'HCL[J D'W T$3+,@P30VL"K*,Y>+T7"#G,$94
M1&J(-%$08$%D!2\2!#TOQ_*-2E3',$_/UW5CNA=N=JZ/M;,><;&Q=J$]7^--
M6'#W1KC[8<KW10F@KLUMO&*NIXV#1M9IC(PQ$F@AT8&3._N^%B_3I"#14T*B
M!?1]%?RY)?Y,ABD21B/)!7>DIH _2B*G1$(LA$ 983I:D_&'F05*BBD@5$!H
M$;Q?!81N!T*3_B^-O296&Z ^Q" >-4?P%D7":&Z5TR1&7?N_9 &A D)/#(3N
MV_]50.B6(#3!A"(5C% 7D(E@?W'A--(\X=PG(5#L#!$"UQZPA4L/_JW.'8?_
MAM;?JR>#:P[W88O[T=]Y0[8Z0UN/]E_PM9/!C3<WIRM*@  <=/NM_)U7O=BV
MN1;8[X>M,-@]V?SG?C@:QBM\]A/K^MV\$R_]R;DG\Q$$I#=O&38KXBHAIGE0
M[ZUO]6SU1ZO[R;=BQ\?^<O6NXU>JZG^KZ@,;E5]_T^WM5P2C#_6[[W.N;.ZZ
M.U[BT4R?^W>W=_(8!_!5Y'K1?D<VP5.^LNU#>]1?^NW"9.RW.FAB\B?G[=+9
M2>E^$ XF9[3] 'VZO7JSO()M&WOY6S FNS!CJ79[&5O_T7+>A:2X,+E7KE/<
MY'Z:EAN=:" ZQ:]J:74K2T>N9O<ZPW)GT/_7;W9UUDI.[M46W*\S>$5IWE<C
M[#\O2".8Y3Y$QCB, F>RDN#NPCOO%5<1!\#R$YTQ%L@Y,-2+^N"3WXUAV(Z;
M:0W&%L9%_,[*5F[\\.UAB.%-K[O_NKM_,!S4H]],DXID"T;U1[OKOS]-!=*.
M__YXM/,E'#C*9?Y=8W^;;Q]O\.;>QE%SW=/&7GMO<ZNYV]Q[L]?<6R/-XS6Q
MO57'X+/FVE?/4PPV$22%DP@6(2%KG4)64"&$])8'LU1%T+('>8/TAO'A.4@-
M7UN[L4K==KM["*M7U=A?]8?[^[8'%^G7#23.Y?'#Z&!)3VHW+M?=+"OX:-Q^
M8M"J?QX[K6ZOZN26$W !.Z@.8R]6<;QUJ@1[I[YPN/;90P4JRP_;(TEQT=MA
M/]:7&%67[&>!A)_"]>NGV(WP\4$WRV?+MD_J$=2CL.>V-?RDO@C<K=4-_=PX
MHY]U2:A^J3_I#F%F0__7TYC[\?2<**TZM!H6JFT/^O'5R8O?3PI$M#KU=-<_
M^ATF]!N@]%C3982>4,4U2(P^/@/O%3P"\/&QU/C.XX]7ZH\F",+H,RY6-#67
M?HQ7R*6?_>RRA*Q(<KO+_OPSP2Z_:1GL(@Z6\FM=]HI#U2M3',S45V<8K2,"
M^#"FG;E6 L\64(I8->![N_UJ S1_^)?K_;;Z*1X,8LZ&JQA>OD8BSW.=GB:\
M<Y/9N>LN.N=1N2PW;49ZVF+/869PU\D%N\X#O[2)(_.0O6<Z-V53S653O80L
MNJGZ7YTZU3N3\0MV0JGW=:O$?+#04S3>DA@,-RY8GXQ)C'ECL ]&W[C>UQU-
M^K5]6)_!"TC7W_\+QI+'T&PWCQM\9^O#<1[;-OU,M_<^[C?@?HWC]F[C;>-P
MTF^\\^4=:VS!<]#/K'&\VVZN-UASO;VWL[73:KZ%^^UO',.]#K>/_TB-ULAG
MW/B$!8PMNPV(#9$JY9 APB!N#4<66XDT,\Q$RC@Q?&E5+C/^-)+U2R6/AP0,
MXV&#)"J-3I%C8QT3VE).&),T.S5O7 .L ,:B <;Q!&#$I&1PWJ*0/$/<&(V,
M<1A% (N4J-)&!6 GRVINH=8%,)X/8)#$A+!4"B8U]Y0[H1Q-RHMDN)2,W;@N
M6 &,10,,,@$8P3,@E8XA(0-&G$2.3. 8$9(LK+\+F,H,&/SN,7H%,)X=8$A/
M@B I4XK$J61&""XC)X%3JURB-ZX55@!CT0"#30!&HBS"6@),T)#;93./#(X4
M4:>C$E&PZ(%AD&5MQ), C)>0YO7ZDM/8TFSO9^X6[(R$C:YXC#PD9K4/+BE*
MDG1YEQ=WRQ/'MJ,I=PNGPDN/$PK&*\3A#V29H<"(M(_! AL.0(;$LL1Z@<+T
M2G^>>W"=&!-#<)HSYKE61/-HHE# A[G-/:,7P77RW)KN/9S<3WI-;$@ X!BC
MD+A$7!)@-TH$9+5FBKGD@G.EY][+D'PAP1H./G N,$\T.D^=5$+7!R])W;SG
MWIPDOTCX321\TLT!BCT8*P22)N8J@)8AQQQ!BHG$9 1;)M=$5^;.7M$BW0LM
MW8;:W#]'4"<B-X);RJ3GDAD>$TV1+(+#HNCUVTK]I*\B8[837(!>9QAQ9RW2
M  !(6RDE-H8PG!91K[_P8)$<17Z7&)%GCV)1!Y,[@!%G,8^$:BTD!Q*KHS;"
MZ>*:>.)0UGP]'0G"G7>*4;!)'$,\!8R,] (1QB)C@''6V>QV)?H95A(MPG^^
M"A,VR@./X9@KCEG0U%%NE :Z0A6VZ;%<$T6^;R+?DRX(&;D3E'$$=HI'W%J,
M;& .)<:5Y9)X0<G2*I/S.H4MTKV8TNTP<3Q(K(0*7"NL,0\@W4K*J QGOK@?
MGH)T3[H?M!#$:,,1)SR ]C8*:>$3$D)ADZ01A.:P++5(]2^+=-]#;S5#A<-:
M,D\D5Q[H>M02*!Q6U&A&U&.Y'XITWT2Z)]T,VGGFM79($P^Z.P:!G&8"J:0M
M"T8E035P<S9=9;%4MWU0%\/&I_?OJX-AS^_:?KQ3-LJ+\9>&$+BTW$EL.9'>
M<# RA#%>"VDM7XB<D^(OO1V0?9IR,MAHJ.;,(D95!)HB.#*8$038YIVRF%GE
M%]%?6DY*[B'\*1EAM.*8$,H)D8YR$'SKHR("))\4-\-3D/!)-P/C+D;M"4I)
MY<;Q)"'@G1J!T)O@A#+:)S!$GF$IQ"+<YRM#F>0UE]AEH]1)[VARV-&(F<@^
MQ+@(B1Y%K=]6Z">]#PKLS! (1U0D$'J9%#(V,)289X0D(6@.:RQJ_65(OG "
MB#N'B_$L_TEIZ80$3<ZDTJEX()Z"A$\%.FA)-:,, 5B#,G>L[N_N0,LS8F -
MF<=\:761JJR_A!"'Z>XZT_]N=0>V/8>"&.-"<A--O5]R;MH=N]64((E%A\'I
M<AF1>$>T,["@EB(.]BMR@EGD$Q#<H*D@1F1'[/+\?+'_G[TW;V[;6-:'OPK*
M]]Q;=A4A8U_L<_V6(LF.$DMR+"6YSC^N 3 089,$#T!*HNOWX=_NGADL7+18
ME$7*R*F3V"0!#&9Z>GIY^NEU;+\MRM!TVF95WO9^+6DZ;;/YVF8^EA+ST$X]
MP]%#)P6C*[!3/3(3!XG=O3!BGN]BU0@HFR7MM3IETRF;>SAQ]VL]TRF;S5<V
M\S$<EOAA&C"F6W[$=<>Q?3WD!"-)73!OXS2Q2=FXYKT[2'3*IE,VZVLQTRF;
MS5<V\^$D[B6)9P2A'ONNHSNI$>A!$&-,*6"FX<7()H:D0(9][T31!BB;=IN;
M&QO<W*Z=AWA]I+%N-P/!ZT@D;VXN$CY;\C#9-P"G(JP>]' *9('=EII$')^<
M'6BFHS(&#]N"Y)!:0)RQJ_VLC =Y.=V<9B(GIW)[?WD[_#3\)_L'FX)8?\R.
M8'L>6Y^<H[_?XOVMD[,_9Y_./L+UA^Y\,Y&CO_&ZWX;_?.E_^6?_< ;;T_[G
MR_G5I[]!9>Q_<H_/X+GO#HRC+X/T!)[_.;%2)S:,1 \\Q))RY*=(>:@GH<53
M,_4CSS6$"@>9Y<DNJD@/OK-"*XR-U'1,'H61$R0QMP/7#T/?7F@]<GB\=W)T
MH)WM_M_!Z>*6:,KSTK8U-S^N/3PW#%C@NC ;"4J'&4:>$8.(($HR<2S_![:Y
M$=+V"X?3A=>2!_\I08'LCI*W\#FH$&K[\].*X=GN[#.+8"'3V-#=R ;OUPIM
MG?$XUHTXC@-F>RYWS86.-BL5V>N52O0'&D>DV\2B:Q%)@.H_,V%77#2VJ3_0
M^-68CTJN83\:5LJN.:7V/,'&+X7&R$XIM>6M8VY6[%USF2UK@=(-MFLNTS67
MV;CI>2K-9> V71.0K9JUKJW,4Y2HKJW,#PY7KK;(7]U&B.Y,*WM7Z?KNJ'0W
MR(T>Y,]0(K<(2%.QCON  I?F03;NW?]UKU?<TA3/M$P>&B<G]/7[O"Q%+H<B
M?3!O)V,N>FV7<^$U7BJAVXZLSG?&VV16Y^#J^.RO+\?OX'[?8O?3V1_6\?#(
M_6=_UX;K^T?O_C2.OOWR]9]WGZ[FLSJ?S@[,X[^/C$]#S 0-X+Z?K$_?!E^/
M]N/9\;N#2\P0';W["._Q=AF[<>283FR%GNZ&L2P#8*GCZ$GH)A[W$HLSX]F;
ML&?9]Z80VKPB@$Y]/5'UM7;@7:>^-D-]S</M(H>':9@DNA\ZKNZ85JK#,D=Z
M8CN6X9F!'T0N>$ANS_2>((MKI[^>J/Y:.Y:OTU^;H;_F$7Q>$IJ.Y_EZ%+)0
M=\*$Z4&(E%#,#"W/B>S #I^]L<.>9W;V5Z>_MD5_K1T>V.FOS=!?\Z# &!;5
M2NQ$9[8-]I?KV7H4AZX>&D; (Q9R.)N>O?&\7NC=N]ZA*S2]9Q1/PI1^,A;M
MYS\V[%7""\.?UJ# Y')U^FM=^FL)@W9DF9[G^@SF,V2ZX_NA'@:.H=L&<VSR
M+-W@V1L?W$=S07V]Z @XG\*>7T.LZ 'V?+>M[[*M%XBSK30P7![IKA4;8);
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M>S7%8Q-_!6-B&S,6#3P0.!3^Z^8E\I^].:,3$8X;3+B(T!=[LVSY5]ID#VZ
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M4I?TJK#=ILJ/$GHZF8V84G/EE%A)R(_#XGN1G!)A@%G="5$4C\ ==VO#7*G
MEMX2&((B*[GRNLBJKALJ@2D-OAP78QNQ"I4A"_TQG][4A:3B$SZ6'?RD?F\6
MO*@H?B/P7A4)" 8=06:!/H)HYK2LO?!V65U_\\5^5Q2*QO,(W+%LHCJ"5(M/
MOK[*1R#_3TE'*)98#265#Y8F<?2Z!Y);1ZM;FXA"0UGH5E1KFW!!8<L;#6=A
MIBD^C 3^Y:1B&*C;#(F &Q?$,L5DQ(NR5Q]3O;;S*@V0K^H#X9<QV0=^K$PD
MP<V1,B(#GDKK41@T5?/014X'49HF*TB$:*DO89BP'=3/\NF$5+2*-[!SXA-)
M0,XI$8U>X0^HH7@RFO@GKX^X=G-O>UH$2>Q!Q?R*NI@B<;=EA1YCU&=TK@]X
M.GEE>W.E;+KY(T#)J_D:K0=*[]]N1[7FQG3$VI\I?)UL4TM=/C &B6Z5=H*V
M@:C"_O/TP]E)3T4_VVV!'=?J>:&)ROLDGN0R]6.I8S6CQG-]5(3DS R5 :](
MP?"A1$!>$6;+8P![*NTJL!Y5SE>-D"C@VD!T:0?_F687B' $?_M U*@+:K1&
MMNB$>B=HO^3Y5Y4HJF O2#E&P^E)Q!D>1S1]=<=)V5-Z &YK/<C&37LB0BA(
MG4;-CL"JYO,W!HH%O%:<'=&D^&^)FY9-)I"A[#B?2,*AW<$@OZ000M66C19"
M,.2W5J[9^4V1I+$J\Q/-A-=;JK=L)FO!)J.^>*HO,^7LR#H0*]*<'=&L3-9:
M+\[ K?L+=3OUCCOU<%0SN:OMA7;O0G,ZF&&\8]VDCB3GDAH4@4UMMSL_8%NZ
MC#=9,@1>M=D^;1X VP("+T"3J7<=B"T"SJXFX#%@1*#5D$[!\J@EGM(2BE<B
M:8]C&0A7!? 3%&W,<3#!/U(G(ALM\D3&C5!Y!-;+$2DW$5P89[]C=E>&ZT4
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MR"\_W17>ZM0Z]6W;U!^@A7UWO1;V>J['.E?3K+7-WAXFV^@V]S'9>F.[80]
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MT]S**I!9Q-W42;PPB%DX8$#A.&:3*,1?LMCVX7.#*!R+?YY'W+<3[C([0X3
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MATUS1^PRK+%/B2N<RGOZ$PXC43,SER[O EV  %5-J&$QER/X:-'Q\VWG.TV
MW7OD?$9\F,),PVB*/9]'#^!2)B,;1G?YGZD RHSM 3PD.\5&*[K]VL3E1'B7
M7BP_0@UD/0<?0_^Z!G2LUDYX4&="[80O,X>%NFFQ'1^2 !7U  Z+Q?I\#\"@
M,]J\&[NN7[ _)V!#7A$OV-F5Z&C^!K??<,PKY]T\BJE8X ^:<C#2^) \%XJ%
MB[C(02$0$6%& QY6"4!.SU7/M4IS?1[@H?48"-:JU.271T(L>Y;TBT(D/BOM
M_.1A[79-TV,6V-V@+>Y<7I^P2R<BR"LLNKF-1=]EP4HIQ]@& W*[[6\72S@J
M\+FU4/N>10E-Z@UP_DJOOT?%D8H*?^7HO'O)/P7H2W&E<XW\Y'&"L;!BF%##
M*)T4C))I6(VF1KK4HGP$HMS1_;JW6E/)BPP.7O&G+4/5+8/1:9V*;7@L&KD1
M7F!%,&*ZYJY[L9>2K2=O\D\!"'#N9"83&DX,&?"L9W1;[?5KJTL,^'2D#.H8
MC4;C*!AT=(A<C::& ]Q"HJVNT6NTCD*DCY5#IM&P.D?!H>,S.NV-, #+!S*M
MG]SMDZ=SBR+RWY<U"MOD0%Y%@VS6C59O\\Y"93Q;'RF'FAL<HDK,G:,#S=E?
M//O8)=H$)["]><^7,DKUD7+(,MKU^E$PZ!3,SK8QU?5R(:L'Y;U81[;I>5,#
M'[X<@4IN"LV>85D;V,*=$Z@L\8XU(E*/+OJX[BO/.H95WP Z=H<4*HM '%T
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MGX(YV:69"P/M&/SUU5^\OM-W!YUFJ^?VV\U^I]FKUUM]N]GK#BS7[ [X_W1
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M*RGYHXJ-2A#[^+49'5#OQ#,OB6K(V58.3Q@"MLRG4.(_@N_R*!\?K+/"5D7
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M7H=2F5Q,P04_!J9-OTPBC_+A_3 8@M?L<]L]3X@: [P[%/Z+W:>[=9%,AZ=
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M#OZ_[8?N%/YGE(S]G_\_4$L#!!0    (  -T8U47J!JO A<  )\$ 0 1
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M'BH#$:<2 I".EJ.21Q/'/;. 406"(@9"-%*A<D$=I(GHQ.H;U<*U0S(A$JF
M.5X<:>+0EZML5$&E$D<A8*GXND;%I(FX9NZ6OT6NCJW2;G !!R%NJ>@\9]N]
M\BQ@V21PRF7&V7TWIF<ALNP1VX#>4M[L*7:^DN6=_@>A/<]QR091IQ*P9Y,N
M4HJ7J0Q"A1P^O!RT2"%+)=$FA36*/>7-4O;M>M*M7'1'Z)MJ&,2S76RO)I38
M\*?!CR^=0Y=*2!/J3BK144EWH 5*U 0EV89&ZDE0K1GIE$VB!U0)]CQB(8JI
M?$E8- *(0F9-AB.RNC!*^FI%T8I=W#9%#\CV:F%4CJ,0N%2.)0(N;I<3,I1
M2",!31?UZDVU$GR$X*72,5EEPJ;/P/1 1U-'=1SD.KIM#K&^P!9F=_4<B6(Y
MYD)H4XF>;&CC<]27IX! )2;Q"?,#6,!'8/<IZ@-[R?YA$D\&>0%O(>*I9)(8
M<1"G<'E*3& C 8]5YRN!F4$G!"HCUQ3;&M# P8\5^6?>9J/371A)@K>P(K2R
M42W/3PA6*L^4V$T T\D7$(LR]S*:CF5-OZ: @1"MXKT?3?=D_'T9]6#)H14A
M\BIO<\@3%FP8]N:)7?2HLQ2$A70'&83=QFL2=XUH\AM<T^DXG3@AXJF$S![Q
MF*W<BU&X'(4U@7N>O!&IKW'#W9, OKV?"$/A4>Z>'V)IU0Q$CI(@U(E4>B?2
MB9@[&LG,4A&KX3'),0C]WCF_%H",)SV050_X9YNX.^0"V!MD&\@\OWTHDBK4
ME51F,=25FJKB/X+6*- <9=^>YXU4HH(=IO7\PRH,A="G\I*"S:M-=R8+!G\
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MP3U8:T-K"3Y(Y?VB=1E+LI&TJ$3QJGYUXY5,3EPR'_N-5,G>1F_+T),!8;%
M<?N3[\C0ZI''K.,-!O4PUCWR8NB:+XK[4$0A0X^&:*5;XHUUJ==D:'N.KS B
M_CTG=G["OP2EK G#VM>.L3S3Z2\S\[G*.ECL8D1MRGY<9J).YR-M&EW ^F&J
M:?S&Q)+K9!U6DJR,67N86=$FJE@&6YC'=FP/1J4MT678R9#;.N[BI*K!S)FD
M25TMB_0A\*I8]!(JRR=VARQXD6/*3U\$9[7 USZXFZ)0]TXDX3QYQ](./;\8
MD1VVC*Y956TS:*6%')XO<XB%37]*P5_&3FRFCF4KB<FJMQO]9A>_,&"^1KOH
M9H"B"W'.)4V>*W2*(IRZ26[9,MRUKQ!,7AUX^BL*#_G_^,TCY6M2^>FI2CQD
M6/OGVE"%0$Q0CDV^)(->]UFN3Q"?)=^1H=6B2\:*+WXI2RU#3_U;M!!E6Q>V
M?-+;YHPL79CZPIJXF%*.'F9ZHKUZ479/]A#[M!O=1NC['E>)R9.U9A)T(':R
M/5@N^=PNN+&GF.S'KZMUTRCLEL*3YV9\IK).LLJ]FB)FK4RVDZ#$AO93L9=U
M^#)L1BPT@76$W?ZQ"JY"#JZW8E>Q5S%")1G*:F4R52"$FU7[)CHV^9G)>E-0
MP$I6S<G]?8:QC8[]B8<,%E)L><[X<61V85!NB;C4IHQRC/Y2LZ/(0)[.U/Y5
MYL:=3K\BM\IUNPF*'[JQL8[3<(0MK,995OC[.J;\WOG8'8@LZ7=ODP4[).W?
M, HA&W-!B<UNG@H/+D!, X/!32'WOH,?8O1C'6,7_DA*_F:?[R!:VKI![@\W
MB*^O*4/ZPW>;Y@3"L>BE:@R=(/WQ<<^,Z62U8RR%)#(D/4XX(P>;+3#CE87O
M80 2XJ2=]-KGB3K5AHOH5F\KN-4;[V_U=DI>#5Z/EPQ:%K^_\A8]((N$B4"^
MD%(#Z];^ /+_#893;3Y72]V&68&;K#YJV,)B\ _?D@'6\L61*P"'W?6.=.8C
MG:#:<LA0AM++X9W2H*>+P#L<+V>>88!/R7Z!8L5^.)30W;X@*RA[',_WNRH+
M_VE2QUBCC?[^I_\'4$L#!!0    (  -T8U6N>*2N2BD  $RC 0 5    <&-R
M>"TR,#(R,#DS,%]C86PN>&ULY7U;4UM)LN[[_ J?/J\GQW6_3,S,#MK&W<1Q
M QOPS.PG15VR;.T&R7M)N.WY]2=+"',Q8"'5$@N?" =&(+3R\E569E96YE__
MX_/9Z8M/V,W&T\G??N)_9C^]P$F:YO'D_=]^>G?R!MQ/__'W/_WIK_\+X%\_
M'[U]\7J:SL]P,G_QJL,PQ_SBC_'\PXM_9IS]_J)TT[,7_YQVOX\_!8"_+_[H
MU?3CEV[\_L/\A6!"W/YM]Q>>=.8^%^ H.*AD(D17,MBB>%8,!?/\_[S_BU$L
M8 H!>!02E'$%O)#T!X;%Q(N)/KO%AYZ.)[__I7Z)888OB+G);/'R;S]]F,\_
M_N7ERS_^^.//GV-W^N=I]_ZE8$R^O'SW3\NW?_[F_7_(Q;NY]_[EXK=?WSH;
MW_5&^EC^\E^_O3U.'_ LP'@RFX=)J@^8C?\R6_SP[32%^4+FWZ7KQ;WOJ*_@
M\FU0?P1<@.1__CS+/_W]3R]>7(BCFY[B$987]?]W1WLW'ODQI'$7_IRF9R_K
MKU^^.MA_O;M_O/N:OCD^>+OW>N=D]_7/.V]W]E_M'O^ZNWMR3%PL/G7^Y2/^
M[:?9^.SC*5[^[$.'Y6\_?4S=9ZCJ9EZR2LO_7N%37U[1F\)I.C]=B.<MO5Y^
M=B6O*>GX>8Z3C!>2NGSVZ33=>--IU=.TN_S+TQ#Q=/'3T?D,WH?P<70\GZ;?
M/TQ/,RVBW?\Y'\^_C$S1*C+IP6MG06D6P*4L(%A3A(H\8U W15;9FA%?"_V6
M,(L+)2\?\;+*\B6>SF>7/UE(=R'9^ZFXD.CZ?!T28=AUF!<?_8]P>HXCS;4V
M$0L$PPLQ)AW$F (@BUIA=CH4WIBQ.\BXR=DUM.QTZ<6T(Q&0)?OIQ1]8[<[2
MJ%W0%+KT#8QN+JGE.U[.SL_.%I\)XSF>7?Y]M7!-M3^?MA7ZA7*)B4VU_VIZ
M=C:=7*/"%Z4<4Q%""@Q4C$2/SQ&\05-LLB7'W%CUMVE81>_B>>I](W$W4_I.
MSN/*>S@]#..\-WD5/H[GX71DLTBR8"#<+1#('3B3,BB1HTS"><5D8]W?0\HJ
M$)#/$P(MA-\,"4<X#^,)YMW03<@5G.TD<ONJJ#&_QC).X_E(62_0&*+&,^+5
MF@31F.K#"9&35D)*WQ@4WZ=J%7RHYXF/QBII9S2NZ#B8?\".3-G'#C_@9#;^
MA'L42YSAV^ELMH_S@W(2/H\*FLB#(  [1:Z\$@Q\\@:LRSE($6+*S8W)XTA<
M!43Z>8*H3V6U0]1LAO/9JW/R@R;SD9#$9[3$J>.!H)PY!&44:(?.%*Z<;H^7
MZP1L[$F%V8>=2:[_505^"J?TH;.=^:O0=5]H(2_W>ZZD$UP!*;9*VS&R\L5
M*9*58+5BI77(L!)A0_*UU\?%-^Y6<YTT __QAVDW/\'N;&_R"6?SFFN9C5A
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MVPY?WSW)M]UIW#*C>KV*OKH80<D(,50[Y .CS:IHJ"PR,E"6V]:!P!UDK (
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ML) QR$U@;S(/D_?C1;:A8"I,A C&UV'9%NMP429 1):<,2RF-.13DVNL#&D
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MZ0VZZJ_)2B/GY-[CJT6?K<+4HD.D0:?K1%L)CFL/.7*=BN0DL-:W!1^BI\'
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MMP3*BV?,IFKI+EBU0BK& F'U6(K%9><!-;-D418%(48+G*2A4?%@PN-EU"P
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M.5D>K5<AV]9)#&U'\ S(N@>J7>IE;G$Q?9ZC<U06"&S\ZONU[^:GEU%@%"&
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M.CE].WIU8CO_'6L9%-I2ON(HG. ?8RP7I^_[!7N9,:_)$X"B:E-ZH<EX45R
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ME MO+@D'"V.,LC<',7.*-15F<!PU9,:4Y,5B,7T'-5Z*TI94XH%)\=Q35F/
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MN3L\D+Y+KDN^NH<EZQ3+K)=J-X%+&^\-@,06IN]PB-PC83"L<!UES0DIC</
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M(%PD/63TT@\:=?R($/7 W=)> 6J,>SH Z>.7V7Q%KW!-Y(N<4S+A;"G@?!T
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M;*G2J[^^'<U7_\V52LXX;9E5M<SA*(J2!KS( ;+0SBJMLK+-IXRW5^,GXO<
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M[^Y7'2 B<?"V. @FIFR-B2&V[F[84-3I=]*&&+JY)T[AK@[UKA_$/DR>MNC
M/ 3M!44DCK9O&RR8D&D/<#[(FV]3VV)G>D1,XK;[H#+*YAV"KE^.CD\K(<-'
M3*=S,C8N7I6":?GN9*7PS16S(@:L$XJ=SK6W3&;2WB<++I$=*'((SEF,2K6>
M-+V)G,\#3MT]V*&@\J.=ELOY4:2(866J]R3CR7*E%.;#6'3*JPA51$\!928Y
M T^0*<Y4+@D*56/7TVR];,\#75T\U:%><8-!XN(A]-F3J&NCL"^-8G1!KAQ"
M*,G7)]$"(BL<G+"1&RF-;=X%.E;&)Q4@=750AX-QJ+PK$U'B6YG3/%+B6Y=
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M Y=!*8R28VI=8[Q'G">$K59&[SK<[ [M%R^^7_O=V;6)83$54U](^$)VX#%
M8$(1DKVT*A*R3>N*P5@9I^J7[(:7KD[9EV;)=1678CBM@J+ 1D>Z1%3@H@\@
MBZ8U8:TWJ77/_]Z6N7NX?V"M>XP;=E.Z'"#@SUKW:%>.KV%NX(>= ":;7 )*
M"\%X5>LSIC)<2X@F!N-T$#JT9@E^7+7NOC@98_Y.M>X[:G8Y*5&L!^,S@A*:
MHG&, E 85RS#6.P-3-Q?YWX4U<]1GKBCQKV=&:>L;PN*M)*1IK[I#?0/Y2%:
M17)9%0H7B9DTK(WAD=6W-_9P*V-VV.!?GZ395_RX#,M5'/JF_@<7.Y<+,@5I
M)'BO>&T#91 35U#0J"*D-!@'U:I&;.WWB/,LXL96[NB0TZX1[7QM#!&N4]QX
MKV"[B1F;N7$8/+;PP71;RKF01@J5! \@C,R@G$0(T522")MLCK8$T?J%S0X
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M!AV[O,__N/XC4J#___X__S]02P,$%     @  W1C5=>/$Z$,:0  E&P  !0
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M[!CK,1865@Y65C9V:+ <Y^3B8.?\M_WO)/\._W<4]&(_QG*,_?_WH#<#W,>
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M@*R;#W_:7Z=]G;[/?+^_MY<WFTE:;L!>0S.Z=TVJ19EM338ZT#\D'?MI>?'
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M0@94A=Y>7<).R2\CHG2 Y$D3#4043-W',>.N+/>FWOJ?#U&"V8FL]=7,%I&
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M6#?0?Q/FLLA8N49$H5Z^*S+BU?3*+?SGE2EFEK]B8L$"9'-=QO\,8-Y:F\K
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M=(_6?S+1)YN&B;'=>19ZC\ET\,W#BBE2Z5[H,3/!'!*&QEY##)]97/,C!5F
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MCR=&ZN,XOZN\Y(7BH*4L8Z'F'T%\6J/L/JTM09\!90NLJR/DANF?P'*XB"N
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M^,P!X:2(Y:?7;!-#N(F%1]Y%L5W:L#<R",F;^E;TZ'K <_.0@"KHO33K(06
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M.@PJ^D:%"FCUD2M$N3P(NX'HWF\X WU^Y0(DV<22Y.ZQ\J!U/(M"\5]1&)%
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MTMR*S^#B@7[6-KU4_KMGR)^P<\D:3)2RU3],Y8>JL1 3I6D.K8R3J_,:YJA
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M1+T(^(,(,.&Q2>3>]K\16<:-P\"(Q&6/EO].1>4R ;U)DE#CAM]4##6@ZRX
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MK3RV42A<@^8P+J/'0D^H(]<U0KP25K>ORY-I7[6"]..XI<W,?2FC:(RB%'6
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M]'82X*9B<F&'BSO3#QV'05>R=G;7.+:,AWF 3/S7>,8M<KP"JC[XZ4#5.#0
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M3<X9KZ">+1]C\QZ[E1;NE6AX4+=3?\.#@;FO&ZV#C_Z%2[=AO2KC802+VJ=
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M@9STAUF9I+3M*<K5%)]&M+P?+?0Q2NDS*P-=+^DJ#V-;MDDP_.":PUQG>_[
MS<L5E#)]2X)/9/;STW<7AV<L&WN344+ERP=1O<_(A0M#,\OO:,XZ$X!T]3F%
M.#8J_FP=P2ATOH/:EDPN6+..4@RDWKF1DYP"E=E\SA,:LC#FJA(7PEMWN$P3
MJ,R4X&5%&K?9F"P,$+"5H3G-)_GC)WV &7 S  WJ9#7;!EH G%#S9Z+L>E?"
MDCP;N\A"9_Y R<N6V_,=.SQV[YS.O/#+^?ZZV4Q*FG%O,CGFT)&%$:YC"Z'
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M^K=V.:I]^/KU9^:/HA4>HRL#9G@Y-A<O.S=K(>D>U,Z 4GN#06Q.G^6ST&=
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MJ.37KMB2AE5PAD%-O.NCBS:M+=PZ#W4S_CZI=UV.)^^7G#">D7M)S,A5<#4
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M[ 'L?%)">,:#NZSK$[RW;Q_1DQUE>(*ZZDD("2#K!?H1ISYAI020T6!X@@+
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M3;$BZ.+S(5!3?*MLY],2PNM2"0$!0AMS)PUX 50@0[&![\'GVB>\,LW&G)+
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M:GV.F8?_%^:T)J^T8K_.2N1C(PR"_3&0["TV[)0]8=#UYV;'<T"N]^9M&'*
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M]%#D-'-X*I^%3;&%A\R@P;/>J.CDA-OSO2D&S>$ :$E<+(/4 HU42@@J$L*
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MAI<5SQ@:6IE;KE1^_NGPUM.=U=GQ_[%"XI"T90=Q_M(Y[/G?AO7?#7*+H/V
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M)X'!2L_XK"$A__EGZ1_-;TY))0MHR0>7">B*O3OSTJ:?*?VP%MP&NI('-,>
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MO^S=%OPQIWJ\IBR/5HL%OLW\%OTLTFQ;?FX12L)C=-9E5146[F>55%M,8*)
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MT^]K/N]5=+#P7+;_'<\,TU=(=R1(4IQ%5E6#R?A&;'B<Y3"T<?3(SJ2L$X)
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MEJ&W:#HR"1_',G=AT&Z-8 L9/HJAY?HQ2B*Z2Y9NS%I&SEX'"(N7$%L"K@@
M];&PU/H"3FUVSI<BQ<QNI,U&U<(\-DI(Y!QBDSN9#XB4_\'>>T<U]3V/H@=0
M0:I2190@11!$!"E*"XIT,:+2A:@@O=@H:DA4!)0B @H*0I"JTJ6)(*$7$:E2
M0@FA2D\HX4 *]T3]?+_?W^^]=]=ZZ][WU[MKY62=L_?,GCV[S<PNLXT)>]8?
MPB=6(6YE02OF&2KTCX//IARB,L&P7&CDAV&9V#$,24\V!A(.98ZL%HGUCS75
M>:LETB;>U$$[ZN#*P/R.4*TG2]EUT-"824'F8H1XNHX;1%'7AJ).&#<L+6?
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MC61X_?(>?&"P*?^]$Z_KC=3>5NKORXRJ"1QF/2GU=M+YCIYXB,$]V<4/5+=
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M:IV-HE^CJU$(OAE3%&E(O-1Z.&&<1Y?'M'WR3"2I?7^KJ/P]=D]>+>M8!IY
MLH"%8$@(PN[!.<S>TOZ2BI]FQY(R;?5\_'C.YFN\GMC'8BUU;.$][Z[%QM.4
M*#&#8E)?A&>V>U]\W_Z@)[N]/3V]^1MY2HS?750U8+&TU -8'@*LN)WPL3QQ
M27)_ PQ4BM14"JO2R )7;4EK7]0*0E%:X\+\[M:3@_I^4RHFTB93HIDO"E4
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MK,J)G,)@S(TV-34;%7ZNJ/C\PH"GRGB#>VFI8:<E$&M2 _3/PT-U=X#Z-=N
M8)7)A+F47F$/S6*"P_M=GQ_'Y1Q"7C6D@W_^,5+__:H-\)UUE^SUB<UB$%:
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MRU6$9!X%'^95!%>+_,-3>W0)4(CDN<F@:=JOJ>Z)HG<&KJ($>!!.TVG8F(^
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M5O!!05=$6:J6P\'\GD?/O) 6KSPH3F.FU3:VDQR;2T($=A[N,UT$="K)KZP
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MI-^4 ^4V85G"QS!3OW(-7!CLGS!N"S"/$>_2LZ"OMTV@+P0U)H*^B-WQ/LB
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MT\B37S*^(:<R.="N$8V<XVO]YI/=R2.FVYDSNB/$UMR=Z_K1W$^^Q-8G)O>
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M8RY= +'Z"P_O7T$L,,2M:)U%(K8ZK8B7.#"X"SJ8U]/F.M;1K&$[)M 8TO1
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M/1.MB4.PH[VK$M!,B(6'8.:*=F4 <66R]2 >S37C@TD;>%;_ILR!B>^]&$%
MR&8[5-[:\Z/[O:SCS),(#^X$*(HM+O)VV4J1.K"(4V7@ NY?47($*7=7T8;1
M'_=#V4<T:S%(%?N+&VV9'\7COQMK4H[1)UQ/ O<8 H>'5D(]B#_CRX%D Y@I
M*BY"!Y6OQ5*49>/S8?//W^A4=QR[,HTY8>T%T89W;-$/-C,ZG_,=0NR_"N"A
M]^[[V,$6&[\DT")/PT*_7/*WY0]A+O]F:Z3P[M;ECY4+[7D4L;!K?EBBK<6L
MHFF;4T%8G:ZY]$%V?H'GI_TM/I:]/&K/$]4AP)1#A"WF$8P9K3E51P*GTX6
MU4XT*UQLVC=PN4AB \4RH1K\*RG+Z^%GHPZ!^ZQ6=BR"F(M"L$NT:/1-:(K8
M$$&=H4B!)90UG#*3I#C''CB_G0JRCVPY [OLE<Z9T<3DK$$D8%(.J(C:% ]0
MERC[X7-B4"J? 6ZRE*BZ2$[$5W%"@0C[YJ91S4<:+YK&@IWDIYM-Q5\X-)C4
M9%F?H/,9R!S_E3DMTSE_F%8.67@^?X965AFI_B;,[IUPNU1JEQ1?K&.]GXNQ
MM4B#5^O)=9D!VN=H[;GK:O=RT]-!=Z ,L>Z-QK206P$*:>B=_@$2-%%/_1G
MUM=<FA+68CU*J/08J^#[9N*/FHWP2%*J%-+.+BT(/WQ<J6Q]IXS*CR27 4WA
M%*M("X"-5&LY$FF&'THDU^]49"8%K1[QUC0S3:EWX;VB+Q0&PJ2<FZ]H39_8
M0[VANZ 'T;2WB+6*%>C.U4 +@)>9L=KVDX&%3QEO5+MHFL/9T8LT%O>[:3'Z
M3X?9YO[??#(<H73F9M%P9[G^.K,+;C.'A%U=V<>-+X$$7<G<2Z^>U=@LN?^0
M<;UT.TJO6P0W3*VA*^$ST%K;6N+J!5)7&"@LOCC5:ORJF5BJA?=!-:>XC1L8
M"<( *^59'LO)*J^\G3%H!;.Q,$6?RCV"\$3?HXL0P8DW?J(0'#XD^[,F71>M
M(W\V4 *^%J(9V//,'C$Q:#7<@'$C#IQ\%N9&YVMJ%43@: %G/*>L,]YA>>OE
MW;RI:"V5]AOUA!G6DQDOVA\@6LPA039'D!)[?JUW03<R$['U92F1HC[!I!M8
MG%=/U0$O6^+7-9TXA'\*]VF.2\J71DS.?^#+R=<^GU'\[=0L] "BXR+:C2)>
M:(=KN%>I?P)()<<"VXLT^)39O:6FI)YGWBLB'T=FC7Y&Y7W,P;LII;WKX^R^
M)AM'?[:GSE]6C<'6AR:7UZ&37=D:2%)598X5Z6W3XRIK7TT$YR;5)G_V.AB8
M'>D84O*%SE31#\X1[<CG)]S10#AQRW X^+1 &3D6U= P\NK35[/4Q/O65XML
M[)GO9=TZ:: #SF3H)TOQ$._UF08[P*[R7+ _SMRU7W%?KMJ!;R@3!RFAY,?V
MK.G/T_/NO.U/BX6J KKT@WZD+ASY@==3'W ]6X9_I$R9["W':42G-DM>"%'Z
M=8E9T-C]??&@ZR= O1A*'@ 1,YB,UK/#0]8*RH$WY$MC=''O79 @_0B <!B[
M46]/O9$?:U'^^0,_JV?1>0,3V=.?G^7),.O>X8YF**Q$DRI)ZLWZVA%]3?AH
MNQ:0LY!JEO3#<]@_* QE@_;>MBGRR+4-?L_R)6 AJW_Z^I;NY@OT76_VNRKI
M_KC!0T,6-?'^:^5'S"+"\G[TB!VWL5H#[6MU(V_2$O0T*1%440N.U8;0NYKT
M@K#\C,SRF9?:.A[],2W1L@%&MD<>R$#DWWO82BW OYYL%GNKSPTA&D%YJ<ZY
MG7V+H01^$AN^(3[H@RU>DLO_4Q[+Z'&9H,&EC^ZG9+A^-G\E=H57-40JXM(A
M'5*B;T=0J;I1NA='E=UJ:E#WM S]6+SY3HU$*+R.9GM:<6@S%GA5T>^43G V
M>DS1#=,V M9?42_7C]A")%9V'+\WW"W#>'K>'W&1N""CXF;5K'':AH4@>JP%
M/CZVY9LB.E_;:H/WAW2XBH\'%SK^Y()<'/4O:6MK+B0;^G/ZNII*D&TL3?5C
M4!%3XJ2I!8OX79 /.%&XG9>4$]_["D<X-U)9CD<WU@B+BZ@EA,D:*S8RHY[P
ML1KO>P0N0!(MT--C!K1ZA/^Z%'SDZG*H%I9C*$5NG*I9-G\KN(4D<[(EF%.K
MY [_L4D6X;R RWULFP6+QIWFX,6A3A@/H-W-.W L'6\FKZ02IUIC8R?R.3V&
M^567_.&T>QW+CG!6XK%L(KKCKD6B!H=(T*"P 2JCOW=4B="0H,G^^J#L$]!I
MV0?C]\U]D"UGP7Q[9!=.\L,%)+(EM,I1K,.&C(BN1>TV"05RB;C&)E32'1FG
M!R=TSWW?!Q+^"F+?2<2I=LH0QQ8^(7&29MU2ATD/9F<'N+Z]J9A#;37'7OST
M4QC^U*/_=>S/PS9L7UE;K/9.RULWR(,/ALG1#U2_BI2?J*.!.Z%2],, %)>9
M],,QHHIS>3BNP$^A^&6SFN#G]UK"/]5L++4(3W;6U^P8C!5/Q*Z9D2!]^?18
MN$I%I&-]+B8J<YI:7.QTMIS3U>M1KV=6CN<=@?N/.V3S=\[LC%DX/JOM1'@A
MIHO ]Z H= \B.<]5.J];K*J[I?%+RK%:K463AO-?SG(_ZG3E=+MM<_C""59S
M;_HDMC8QM5U_%H C6*EV).W.N:M=/P</YYG'.6-6I+QR3P8R!?'%'9AENLE\
MY)2>735Z_@7DHC?W@W9)!N=2_V4VE.8J0:KJ0:<6R0%U+\/4%J#>N8$S+QY?
M]P@ZX%'0;QQ9\S ]@?UKL7@#=V[[*WB.W)Y]0'7:@U+-9O:@O8URRWVFX^/!
MLH7FQM;UBL\$"KE^%^RESU-^_GJ)K3!5=4S?&6-*W+,*&)I[$?J"V7A.4P(]
M6@(.&K^S"[KX5)JPYUAL+S$/L+NB\GMWO!"3#R?MV#P\L6<6$+YZ";[)Q/EP
M1B<_:"\IK;X@M[<]?HJVX[?U6OA<C35;J<71LW=M+E1733[+V]G;569( ::*
MV64KZ[W$YL@OD;W]\5?0=6OK$3=PQ;FCE_<VRJ-]5JW&$RN,;5E@\\_NOX#_
MXGS8FX;DBUI5W:%D[DPL*V3^RU#@H9"1CECRSGCQLY?("GN>#\-C\C^#-/HK
M8Z49/QBU8HJH,)XO%_H"V_(5IDSL;1[3?^W/@ER\OKY9AMY+*T#).]866Z_M
MEJT@\T^]TYO9DRGC%7L[Y6^JW55'G^6U7:(IB$9,, G?==LJVV)TNT3C[&^K
M@,<[XVI!FH:/FS.I"4H00AD]]NJXV+_NQ\Z>W)GPRZCS^)UZQG%OO69;OHJ>
M?PDNO<*4B!Y]#L^17]]\B2RUY(7,OY3=LQG@L]0PD+MJ-7X_6%/2V\',:96-
M%@I=-8/XFL/*P;_F$!5*M%<5[ZI4[V:4Y+49VUZ1?O#L9<DK]^^^\O+/D\ _
MQE4G7^R=!7!\>X31=T;F=YK_>3C^][[X5?3<2]D5WW<5?VZ)VWFN6I=#%@<A
MX&^^[^Y?3+C\XL7]9P]>/1VN4/WU$MQF\3OUKM^GD[!886[Y.?B%XW35T?.T
M%1\%X?6S[Z$5>[OR9? Z9AIFF#UWSVRR,B%[Y\KLKP?T9C'C9>N4"Q:3;P;H
MY1.)_[ 02%$8F'^:MRY6]'N??#+:)F]G(KS]E_U??[Q]&Q3-?IL$..2M3_CH
MY)=875ZLL,LKM6]D?+_L6)%B>!H]R?WJ]5@4MK?\7WOESS4,_3*7;=!?"QT:
MZ3E.=(?)U!M)_[ 'J#3?6BF<0E1X7U$<H/D\W$94J%4(,="0Y7_NG.H?EYF;
MFU99!%<=2NVSL[-.CX#5D="<Z06%>Q]DLT "]M.#K^:[_/TY&X2%#U4;"IBX
M? TYQ?[TCJDL:#^\A[& Y2 +#[+HG\BV4%ZX](SA[<6!.+YE3-!3G;!PD:AO
M:P$F>LAMK^' !ZY&MY]8#;RD.#8WU*Q@MT.]6"%@BX,611&;+KU[U3#TC;UZ
M)H7^#_5 (ZXB2[70 A_5V0',I[;0$/J7%IF-5EN%%]+%KZQ6&+V]]:0+6JKU
MA":/^NWG+?//&'$OH7\ZZ#LKUOZ'$[Z*=3#B_7GPSA+-_-KP?]?_'$.;<:>E
M0'!A\!DT%_VXG^M1]>]@S@HY?^W.P;(?Z77R9H@R4>I(?Z:<;[@Q*T]HX+TU
MNM*(.TDNODY91WRV4,N/XN!?W-)PH]:Q]IF5-,\YSI(O@>/LP\^C(7H(-S '
M?0)*9*"[>#-B._B>OC!073*](BP<4G1TE KS*0X?T/OX(X /KZY1PRJ[/GW
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MZ8FW\O&BOSZ%(.52DOSETXB^E=$WD0^KMFB<7"UDSZW%5O\N*!UTS<H)2WS
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M(>UD/4@PV<78+$64+UQ,'G0T5/9FFK&N2_4@G*$Z=/!"%@H=MP@P8FP/6B@
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MP^P".,DEULURF%16!;M@$C/R->PG^QW$PASQX?5?OIBV/4Y.KSFY(;=VAB(
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M",:+F[B-XR/CPD1+]MG<E!!X?^I4U1#W=.>&+=&.RI](G@)LPE_/KS1#.B'
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M[5RYXFSQQ4"R&G1QZ)A1S\$6Y>Q[#[)3?H*3X!!:=NLY"@2H[8)P[((\N:6
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MJ#,T]XR&)%8DRC:,W5&5CGIBK-G!XM+1UY]QE.T;"NP?'P75AIH0:X6+8:
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M,#BP _&TW(&<AGXSH?XQQW2 =5T1M&+?@4SX[T#Z+/LO(VQJN1CNB\>.[;[
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M+-9WZS$[$*&[4!!'^S02#P+Y5D[RK1,<%4XS4Y661\./+-^3KBA;"GMC)O_
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MLG%:T4JC_E#>L K:H%_:BWI'+[D8ZU[;[/'0NX:WN\RQKMH/J8IMSH?_\".
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MEN"#G7TQPU.B+[/DT/B8Q%"S2+OXKGS$)Z^Z(5PLI/!5U4^7M 5;S8$FS*V
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M0@$8$<Y*EQJBL^4OWG-OGG"-\7SB:1>"EZ*IQG'/?#I^\Q!S2W8S"YK823^
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M1%2TFX?IS6"Z!+,),_L#$02Z"5.1P^<!2MX7B<[A<FB,-KP([4<BK,K#+&)
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M$@%B)X$YZ@,H]\N+%IGE,%MB6-IX@;]*@6RCFS2;/>$.V]D+&N[_U3 &E3(
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M 69$B.)1*N%N%M5+]$Y]2G9L0Y?+4@+SZO6=XWAXHR,29@]0'U4%SQ6S^0*
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M;N(S ?+62Q0)3TI7W'IQ(Q".2 (E#D6*GE#WL A^T8%#;O4BT..,K;-EQ^I
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M-#XZ,9V<_C!QPU_(UL *P$>(/4YKH5K%K*AO#+2Y )!N@&&XY9-Q$;<]1=U
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MSCEH$P5PAG\D<2R@"1ZF+Y$\YM(%RN=[4+07I8OV:6X[6KYN+WYR@+\3+HB
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M&,4%^0$>B1];L$ED['W?O7J ;+)W\HFNLXVS+\-/]BK'''I_;9^R@3X40 ^
M>A,X]CDLV0(+:A2U?1)I94,\U58G^J"NOH\P>_[GLK%O3L7SQEM^?('%"Y_?
MW]V"J9'J^S=#-A/)O,R]JS0-3)_.F<?-#OO O*SQA>H/TFI5_E7^ ?;C1G^X
M#B$\HR05$DX*<9XY[!R/=01G*+1&H!S9/$RWG.H2\' 0[E9\8S#DW^=M\SST
M@GM=10+?N_.'C_N]V:>P$LW<=Y[Q6$<$T[4%8],6H2A!ZO1$!;%C@4!^J9]Y
MK3UC.!?K\T PJ?ITT:NW(Z)?8CU/?LO GOIP:;<BT&B*<$/$ .3+O* ,?'%H
MBK2O$9@R<VO&"Q#0T1<K8K[G>W;=\;D52I&"JWR0"]LXLJ-E-*$H^'8W_&'@
M/DB7/C)_8"LB6A90NT&MR5NO"\"$34N>XC>#(E4HK]L'EF)GP_A_AFGL;4D_
M]28*U&)R&6[!=GV@1#0JX95,R<D-V*>7;>'<7*^5A/'J$9/)KO1[82LIRTL_
M)H20)]7Z:NCM,1:,D.TS9H?OM:,.:+--^$;"R]/#R(:3I>$/O#36S$R1?6;O
MCO[9Z30ZVJE=6QD_FC]R;U:2F/WBE^HO OD^HAG'"RI1T\A"S+A,]TVSC:<J
M]J^_6TQ^^Z8ATY]',R"H^>GOMFEH^R4]]=F\:Y P;$G] YK1[@"^6["F$@J*
M+KT%(\>( 4L(,,G!-NCUDH1OXA8,SM=>Z_]":>R'VFI,#)EP /(09:ARFP:L
MV'7THQ9 J *]_DC$_=:-OL525?WJ>+3+0\4;B4+]Y"M5NCOY]AR^AR!;%(LT
M8]_;T/?;3_$^Q>P'[9NV8+RJ"D5B]L9'R<O1/HZ]JJVC:C=^7HCBDK]6/WA&
MKB;^.\8::%1C'K:G:X+L&!RY6;-TB>=H6="QUZW(&V?7Y O5HM&(2=3MYR\[
MA$_5.%T5IA4%NS.F075*5^,6K,(P)(LB&T(WSD;GZ249/''PV-CA8BRR*\O[
M[C,V"ZO@PR<UIFUX(8L@8#D %X5:>]33]+,]=*T@?S%3H13;6R51QSCNA.]\
M"#LSD2CVB3N5O@S%;8^8@G0K4)UF&WBY>I I BX0<<U8@=\KGL*#J;^2'^U4
M&SHU;J#HT^OU!*F:Q+G,YBU\XX"L.#V:N:>#G-6,8QG2,40+#DZW?Q_==F]X
MI*I:*"EK;^6[U8[;!0>3X#5SAYP]6W0OO1%_6\#-L&.\!B:RMV#L."\L7YH8
MI.0M9V7M!S%W4P/?=]WPU] ?;=.XY1P[S?90A@VV>TV#Q%3%=#MP,-X$GO@T
M](QNDXE&7HRGO\KK+^GEK3 .]3/(7HXG<^*#W^RX$X)Z!HD9U36<U81]W]Z.
M? +PZ0AX5#%A ^OM]37N%5=;BS\7#\0DE0JU7"[]*@:OF"@,QM4ZG#FS*<+<
MVT.9H@)D0BLIS*Z]E9<3C)ZL;M%8$WIQD6R-O2W5FR5RXEWY-;E=P^,7CL6'
M$D/3*-CGJ0?7.1J[0(7JQ1D*J2UI7)S<U<IS(LAIO<J^,<CY86[DR,XPFX_A
M*L?O-(5_U8"Y1*V1\,[4(C+O8M#$'NW+%+$6+N+W??/4LVIB+SSNW'>IN>]_
MM>G<LS\*@A%:MW>\2:5S0J;YAGXQ8O)$P839S0ZJ8PTC5<;HUI.[AAXR+W6D
MS!WOH_L6DWJ6(^YT9-P\0F0[+&]#()!OJS\]0;?=@NTL!LT*/07^;&PF1]Y_
M5)OBMVM5YH4ASLW[&,PEX39,D&V=0: +;DPHXEK%E1H!\@<5CSJS=\>\O!30
MMV2;!<>EXGN5XTWC_KA)*<QR5=]IQ02 LTRNVH(M6/,/15P91J8%N+G^N<+X
M'K%L=>3U,69W^X/JD;LG+KYJT_G=H# T"IG32P39N.N)-<"F(T1W'*A@V#B
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M"47?!@+91[W%0[7(*_K"D&._JIGFF4G^<CMM\EL-<;]:@^6<X&_OI>2O8.L
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MDM9PU8'5&O67%UZU^?&-G2E59,1HJQ>B.R;5Z8*F1MVKC.K"!?^J  P;8DY
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MA=2=(F*/PD'#M8($XK)/ST8=_W&+3D&3!E*";<<)2J41F\U[J!YKY<_)>J5
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MK[L6H+U> \P>02H>$YM$OA'Y(^$_(SW!8B-;5H:J4R50D+"71  \Y5O&X3]
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M%.>%+4Y#6F[)Y8:D6C;:_<QZM7T(9%2E=BEPK=FQOZ 0>G;6"Z,5'@L#LX2
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M_:QVR_ !X',5G@J?E'L M!5R<"%,RC70Q[.PF]92-."R/_L!A7U'GQ=S.BX
MH/[K<R(Q;]-!W]K_. <^2X@AOET\J*6?5I_[2KNL"/B,T4GBL+4Y-%7_F&B@
M_. _GA0W=\PX?"(Q%_K_L&_B_Q1J_?_Y&?^[H3) :L_"1)68)IC(3*\G<S9<
MTX!DQ;(*W$[:Q^0F=73:5/:[.9L47CUX)*'$=D_%E9(K7VDO7\VU(]$L$VP]
MD)<0BY4?8;C#6ZNOW%>_4[EQ9O>S]^U7@-F.G5#.*\SO>G"O8G'8HHN0G=-D
M.&V+\&C(F#(8E(HH\7=I8>4@I%)+6_E:U&(@MWG>^([JR<[>&7&KA"2GE!BM
MME?O(WK>N$>NT*=6DIB6^#MQTNAJK)WM]*ZV$&3R2_7.MK6;P-LROKK4# Z+
M^%=<E+AS>ST[O)QR8L3==H"CZF_'?0QW/R5):O"@NUTX1>:[#RS9LE-1-D5#
MK6U5I(;>&,6(^L'5(HKW@\G;SI95BER5G6Q%7W'?&^[JH#"ZF.Y+,GK;<<M'
M.G<U:F08'U[M*_>8_X]SRB3BV[SF&?5F$&/CU,W 1-P1B#N91-]8Z A(&N8F
M$>RZJ)UKLKE)F# "E\HM9>E?&-F2R]#,<QJ/_/8E*OZQ_/V^GZ*EU;(7@S>K
MDUQX4(D)W)V>N)+_=Q/&B'.\2]Y&*[?NNBMJU),@IWQ +'U'N)ZI//GQAG -
MOQ_*Y^PCKL9\AN:#PM"P%K@[BYYO?)LBFE7!F6C]6A+3M4QFU13#:7OQSYCP
M@AB'$SZ#KVT.D7>W+V7?\UW7TD;/CD4E9\O@?/R83:]:&$6Z(=ZT"55Q]N)F
M/3W+&"RF^8A]>"1_3VC7OCYGJWV9/>_/6UF9"P[W#Q]XR%1#5U9ARS+Z)A#E
MU/SRGKXBB=*U!XI%W%1;W]UT<U_T+?_"E/<]4_T/*FS[DL4!???/#*2AJ]5Z
MU\(E+@/<)Y?]];JK_5=XGFK86!PF^FC&G >%PFT6;?OU#EQ!5VZ4L=V%TQ#P
M V(^-7''%XAYI)WM L0L\V\QYWUUR1@<5O8O/Z0DOEQO7.8.FMPX2-]/F[#L
M)973YFPV=V&E'[VPY!V6+7B@+(@J"(S&5%CJ9?3EANN\;8ZQTLHGQ,NDJA[Z
M*11E/MD<_24_(BGTX4#<*;%;77)-/WZ&2,X'_L(SK=7:>5 %G7F,T&ICQ,H/
MFLY:,=)6G-%[-T DN;DGSL:I-ZKY]_4KV2:RJVL^!D[9#>JOG:'_D&4'-<$N
M]!\3/;/E!M<:B&^:]2U34L?[5R\;=5M7\-CFZXIO)=<^0#GBB6D9%"VXQ EV
MPU%YD 0/LJ>)HOK<I\5B-OYZ+1=9Z^EWIHM()O&4^'0CJ8R?)_?FUSQ1?;F]
M>Y-_?9G8!\L-EIVTM_3Q5SWP#QRVU(Y)[U4*.V62GJ&Q)4-C7$OFE,Z,7ZMB
M[)?\\'Q!>:L?W>.1.K*N;B6Z@;-C_(R-%-U,8)[*:K]901/>A%0E8]]MEY-O
M*5]N"_L\H3YBZE"H\85^R2I!E_[H7?SU13_3MY%.^XLM;&Q+SYU%)8RK8#G_
M34G<F^9,V^!7/SN<XFX5^U^/BXBX_V%R[8$?%T,#[]P6$#DLO,Q;^+AA!ERT
M;UH3R>E10W2D^ZHJZ-"/X>(EB,Y3[_S>Q2J:O[,V/TYQL8S1BODR)G6J6=GZ
MS*VS-2JFN9<K.T6R?I!O)6YI]+_*?%7FVYR=^O49D$"TJU_ \R_A4<Y37Y<5
MWMMQ;HVDP];]$,5VC^;9/5VI&*ZRF/]G6A9<<E:#A"@MB4]R\KT>ID]B25>(
M<Y.)]?H\:+N*S56EV*'OEFHAYT;7OD3'USW)[*38(6!1"_GS V=[6,29HH]D
M<W018R+B U]Y6=D^OKKERNWS>9NO>EYQL\K)E>D^D[WF#)K[B7OQ.:$S*P+3
MADL<_<5 SH.)T%.QVL1U#9<U$7TC3[G[SW\U?'_78/0"K_XM__WY L<8^<>1
MM>U-YEE?>D;+#'%@V8/\^C)>!G$OPZ_,HCMTB8UTB?KO9[L^T%6+YV9I/GF=
MS(C$YU5KU3_VW-PN9"6[Z= %,7P2+%F\VUNEVS:"#/?!T@BII%D[.B"Q<^A,
MT[F&WD33U'<*1[_(O!'YI/-)LR!I]!1%L6Y<<[WN[S8>1*0';W>[G)%J=?Y#
M:..N0Y$IMT^=7+JA.VAI5B6045<Y#Y+:CI)Z$E1LF+]ONC'CZJ>^,SMSR!NT
M9_,C7&C.8?93H0(KKM,V+5DZ]VBP&"1S06KH(>YS?2*SKR2.6,Z O,%:$_:8
M@)Q'>TQ=2GM()YOV53C%.%C85%^1:_GF]6UG0KNW[:D;(P&=W"V1='5]D!T)
MI2 5'%-*'46!*3WVF)FV%[GIW*-$<&W)BW_29KLQZO:AS^_SPS2\\!^WJ6N$
M!0<MOU<T.R8,QEUCQ5;0VC[.=DM7$4)VH ;(B\77JETN*=K9^]8=</!FJW^0
M";4VO[_ION+Q*P<%KJ1ESSX>/>1K.32!2LIBHF8O_9=Q4S(HHOYKF!KP*HIB
M+FN_1R9#\_6NCS%:U>M4UP]8M'TWV5JI_J3GW1PYE-Z=UY5+'C-CF1P 'L^9
M$;1VQ<V>FNM[LCL1SY^Z!W<.%EX+>#XHTB'X;*?P_A_WWZ\4F$])<":E^C,X
MKG")43<WWE#,6Y;$5+JE2;RK.U2A8W>W5/=RU+=7+Q0^;5\\$*0W)KZR>^LJ
M]^]U,20JI@.7V/*@2[@?I7W[66J5Y!N)(G7^@IDC>(>;8Y9'6_RI._8U5/GH
M&FL_6!>HJ/(^^1Y= 9H/YYYZ.90!)CP#E^Q)0T"FL;BXB/NT4- Y922:F#)L
M_3S>[<7EN Y*JZ>KJ&*ITL%M:Q)N;K&7K[T9+DY:Z2V*K1!$AEE?ILI6TW&8
M2"N2/!;AD*A:]*;>4_:S?W6"8(J(1/0E ;>P^L*"1XYKY)T_XQJSUE-J.R'D
M;&^&WAZ6=J0^OJ?#Z_322QH=1*MWN07%G9BUSXE#/5WN0<E..N<#:Z[1\@E5
M169L6^[]0K\^[JKZ4LXI9G',;,P]DDI>;M1E"](.!16IKQ=O?'KBN=Z5I8V)
MKN^="&^K0B7S]\56=4HS.Q_V&FQS&_?'+TG8XAI@=Y1J4:"EO8J6JV,9LW_#
MN1IQ:'F2)P'&:CL-@#G= )<H882?E%I;$28M<.:11X]<M.NS[V\S*HKMU!2#
M+V?NT?LN_"WM9M6^TW(U@%D1W'>H!2> \B764(<52>OA:I\*L?U0W[Q^K<BS
M_)W&DMM37K_]TIZC</%WE6#8?*CA#$4>+ME,OT2F$E; =A'$$KH MAQ$T7[I
MSA\[.E^]=+6.%T^SGKB]Z!WK:8R":OM&]]Q#LFIR4F\%.'Z8B C08#+_+?Q@
M8B]>U#N_[%WQ>M;L[7.<2U_34H)*)]M]*ZU.'70,.W#_QD6'2[<7XPLE!<?[
MF@L=V2CWS38>=)[4"I]!J%>?F?:2QEZXC?<V)']<37?R>7[H]O"1X@K9T,\'
M]>W6]?MOXQC#)134C:.#M=(E,;F:;M(*).0HLS\B%7'HK+M\H5%-[5O,R&T?
MKX]O+_FT7[SR:J=X^OFHIE87&O,$X6[<++HJMD^:BFU'99F##WNIRURNQYVA
MR+&D0\CGZO-<_4+'DI>XZJ7MVDW*W<F#K((L?+W.!8 L=/$<-]^-<)G1&H4+
M%=Q'%MG7XK4ZNI7AGV\B$"(;7_/C1I9.]8GZ(H4>N"I+T-_]76%LB:$ZDQ9^
MH>'QJO%I ]NNXS8GNQ^N6G/V74S;C^_JN?.6I; HW05WE["6T'WW<.]$, ]:
M42S3YAK]-7VXY>.2QX[<QRG.\T?ROIPQ(8N>>6JUIZSOVX:H?GDE*28#%3?I
M51M7Z-8I5D@;F^M6$_9N(L<?D=L00.FY<':W6KOA-S/MZ_VW.ZX6+-K/R1M&
M]^!!UO5N"%U]L(R]B_NF<"<SD0AU("&<ZZ(ZOS6-FII;QFC.";W'[\T1!^V<
M%&./O1^/9J?0F^F[0?($,JE\S:%/>$39JR1+R,9_-V+1:]F8,5WP/F]BY2]3
MOU?#V]Q?U%SNLGMRJ/A8W=(K>P@[&9<L[?G;R0)UR/%.9E_D/D/UF.0>8N E
MU(TE7;YCKV[>6*1;1J>71YC <GN9G\&=WRX:'5"IKMXB,+MSV)181-K$WT".
M,:[9RX,B)GIP5,*27(;PZ0ZG!A<MZ\&@RMYRXKKTX@/?8Z7%DW?I29EM\*^Z
MEZ)E.6K.::P[N?J(F^X1-]&K'FMXD&^<KQEMPHQX)!L:/KQI"_A 6OQ;=;2C
M<-%>U_-IJ=ODATWV/&K=$AFZ)3+NYS,\OZ\[=\1Y^-B>?0G.T^6CQ.<"H"\1
M^,;4E6MYT/7'1+C@Z$N!MV;.]69.6_?_>\">>U\N/1BY]*#.SIE_F^WYX=F:
MTV(&R@JIX/-4X&.8IR;X0,9*9B?D'JHFF![P/2ZH_-;LQ=OC0JX3<W8\Z.RI
M1-\&-?H E>MI[3.Z1YSN>\EC:,(T,G?M3\7G#2G/ZV45^/>@S)KO33\_%%H?
M,KS/X]G\\=-M?ZJ(!M[Q-5,>2MWU FI5SAU6SMMST)=?-]; 17L"9'EM87K'
M-22_5]*.CCFM"XN%60N5N@0Q"\W]7B !8'<Q"0-FQP^U*H>D&AXY/VPJ( !<
MR\E$D)U:/?U#%=1FQQT)V(G-G!8!*2=[T>W\YG:L0&WFQ8@8.2.?>YTT:M:8
MO)<Z^R)KUIG!_W;Y9*]UQ%/K".0&!AGR>7[C7Y4K7,_);M)*V*3U:/D_,WY+
M_(2%@0*V]RI&^%:[>+I5N;%URR+M8=,TPA$W(7G\[Q:82>HS0;0\&SR5G#5>
MR"X=BG8B7L48Z>.-7L(WX(+C<GD)1ZX^\;FH7'+8BG:N3/=,Z=N#7Q6O;?F3
MX^-2#0L%N_,KTYB7AI^/'*MW/HF_S]A<F]C'I9UH3_^-*][_7P.\+7X=>?":
ML35#2=C!,&S+Z^5?_I'4FVNHS?GSH*PT["'EAL(_=C 2R*J_\XORP'C/BA0#
M92 QZ%LCW&^0!K>3N$MR50@G0(+-3@ "@*?7UOYG_<ED Y<CX3/_59-R.6W%
M#!W,5$U(=3Y%_G>RGRX !)[H:_:?>RC]>5_:"7JQ53?J#U[_J"-K\?(?;TX?
M%][;VX6@5"YCU,KBU;^:YI!E-*6#@-<DMGJQ#[!FR\7XGLV2^>[!_^#9FEW_
MJY#"'CEQI@([FEM$<()O D]0&=RCUIJY7K9B]>%TJVU]+O<9_?2M5J<&;BB>
MZS.8*^DM4L*6W>1<08]R PEV5$$DS;0>E<CTW]NB64,H:WMBMO>:!RW7Q/&J
MZOCE1(]KMZ;.E9*CY6T&JZ5ZZ&^JQ@TXI[WMV+J(<YJW-MNNOM"TQU4-9[W_
MN4N#]Q0Q+^"@^)I%=A(?<_T^CI^__V1=GV81#Q)>T75V!,[&E?I%[*OB[,+Z
M>@VIFVIH3W("HLS.4VP-1LO&+QSL*:DT@CPH&MP4PF5ZH)SL!Y9V:+&XOPSK
M>TBJ6EO6F+Y"NFU9.C=!)_JKQ.'-@U6F]S]THQ'UQ='<.X1+/&@9I9,$7=(/
MZ%'++2&K,NQA.W=JKG/L_>!=>_HOXA_6!>)]%/??."S8\FJ*CBV=Z4?<V1QN
MKKY>DJ)2V6I#M?SWH6ZL=:NUU0R?;@I5F'^EAM_*?0(MV?-4C%^0#)6"*TEO
MO,KI(MYV/;.W-8B2(^K.ZDAT^7V74U/5;%--Q]-VWN&[GNVSNJRMI[(UV"Q(
MVVX\*X2T4B,KK'-1'6KR[&P%G.S:?)74>N; R*CJR2WV.B>-]W_'G6D9HJ(2
M4Y]B2$PS8GA7'J%23=P&KMC6]R,5L>^I?PIII(0>R,J_ZC:6].7LEY(#MTW3
M G,^ %._R-^B\3(,#+^DOP)KW4UL%3VP<U,!<[Q_LYV"HI@J5:9_R;)--NF-
MXJ6ET'#>'L.)I \$JN_#2BI3O3+V>G2-JY?K,Y+I\MH/A^4]\Z^]?JVS?.EB
M\<\;Z?P]8Q,).?2%G8(7<\,+=_;A);!Z.9#XQ=W5S ^1WEOT<((<+NTE_M7S
MQ;%)$4>[S4BY#7LL3'U\#_ZEI.4 <4P@%:NG,<UH-^<3:.'%VJ,PKE";V<PF
M+Y5EB$0O*<@:V>%S3:/%R^:F5(1BJ)>\V?9C/07N]%H2TY@<T;6R\!AEE[\:
M$MWKXT_.])=EV3C5NDYMWDS/AW=LGZ0XR#^[_G75IT/2[D*2 NQ4*:3U.<B$
MCJ*"''MDJ,)6 <GA'$=-$96G1B\.N_6HB2"+MNTGO@^J7K&ZESTBJW.K_LB.
MZY?UCHVY+=[( 8R7Q9:=O>KYS)]2EY>USH6P!L0ICD?(DDZ4'=''XIHY9@VW
M=M5L*_KT^.3^79++4J-5#]!W[ET/4>Z?(-VE@Q2,#$-8@]R:]ZS82E*[0F]^
M&6G=B+NI9LAM?2&W%S]^=<J&*%4'F4?65+1O%W"8TA%VOG:M:;H+E;C;6W6'
MT)U.RTX+0^5[X=!$G;>-_D*]T:DVR&R)I=K3+N^P+YHX\DZO?2/?17W"ZA2D
M)N_Z#_P2'.%!/PK8E<S\\1;FKO8J;&5N\YC'W?@/8X41UDM[/D8>BG>]?+K_
M_HYK2^49PD_6A;U@DBMI:SVSVAQ[#6/[2$N]R<;(V>=S>&:(ZVJO?28=-@JS
MQ==$GH3[5:S6!8FZ;[$$#[KI#U],[J6UYI?!JZK*)^Y^/-^@O]>7S@S[@=PR
MZHE_\\ALR.I1Y&3[VZHK.LL.+LWRX884JR&O*DA,"[!*2^?3[LP4$<OB1)TF
M4H=CO=X279^O#LX/2-3:=%[L?<Q2Z(* SH9S@N,N*I,A; '$C36!+</UD$-W
MN,!X?_=NN@!"JO3-?.SLGN*B?CB+9'OY]E[9GY\'DG*#U%=_[E-Y_W5#M[LM
M_RWWAT@)2^(@,LYB=!N7D]:XP"LW(8=A9^[=+)<-F@,UJ55Q/Q+W676\V7B^
M*.'V[-EVBST0)RD,S>3&3,.K^"J#"7I/]!'"Z<Z,4!XDZNEW]LAO_)C:,N\[
MPQ^-;[I=('PT>671-KGS3,) LN.::E4Q/QA=:8 2^Z@_2@EWY%18L>5T*1>*
M6D'4^F)EEJA+<VU&2H/18*OP7D45^4UGK?J_[EFJD H%5)PQ'I=GC1IS8XN7
M(+%5\]QWJ5[)WM:UG1UE:9519SX'!O5J>ADIJ>J^F6\ADV3@$G>*$,@#OG%O
MHY:]).2HOQ>_\,L^C_@7/.AM[EF;L3B'HL&B]ZWI^]]PGTE\_;(\LWZB14-@
MQK&4&!KG54D+-I1A14;FJZ0@.8?SFB_%]"PZNN%]\.9PW: ];IF[!';K]+?4
MP$PC8ANY"I^7/T9P[,/=T>U"%>4VQEH5Y;K2L]O;'+:T[MO^65PB//%Z_VPZ
M@;\+W%LK9#_' -5A,5#5B;N)2B1)1/B(74_72N];MK^L#\>UM5UEZ\'*1S?J
MK^D3^'SZQPO&8G_@FA9?YE*+52A-</89BG$E0Q)59JYX_+)S?ZJ5M^%^U_01
MZ:/[30T:NV\OS1AXN?')RJS2(7>(4G6"M!SD1B!1IJUK\];K2PLL5O6.FJJT
MY$$Y6)%6G.9P\I+1X]FAFZ /U<YXKDS7KM7N@S>^'>KKAT%F7V*D+\RQM1ZE
MJ"$U'&M_,X3PTD7[FO%31*\'U8T(+@YTE/V<'9!Y^E*_S0N2?+65[KG5P^LV
MX'.F+0>-QSPY?DA.'VU,G&,U[-87SX-DSJ *M9[.^NI][7Y6N5]K3C;;R YO
M<]1I5?3:N6;7E9=FU_R_'9P2'HOE*%)J2?FQ8W8])%EO*CN6-1N4I>9A'U(6
M8[N^^'V$]>[ 2+V$@U<WQ/4ZG]&C?[\B<Z5,5E)P>K[0&%NVE^573A(@G*>'
MVNY@)C[C@CQ5\+#V*6G* ;.Y5>2]!1=??OXI4:8L-41G'E1KBZ_@07FT,:+S
M:V1R:!Q3J?6\6[,$FZY:Y^9=^\#^NGB/]N*'YO>6''%\4=T)_,0G^(LZMA/^
M(42?ON0A,$S*KJ)ZDL/H;Y5*Z9*N+21RB__A;JZ">>-E_Y2[X]+JK?M5L[(7
M)?V^;A<,+>^&=F<=RHK!EJ.:+.T**K+)L21 H90NKF8HW9D?B.H8?"]PMI-J
MK&M[3A,T7>L3_DH&^*.8QU_Z=BML+-["S354X._#,L\TI/;1;A'>688;*B$%
M>YM[\IK]E7H)>"LDTF#?JO6;%C7:)[5=DY4/^[UXUT>5X\*C'5(L$BKIV)L6
MB@(C*R3$I>:>E2[W9=]/1N+/-LLWJZKFB;B-YUTT>O,C7SQ9Z*&E7_?N#>1+
MGII*J+1Q;TL893FEFK*F"57HW48NTXU'1DW>^65L9YM8V0?'7*M3EQ=*OO#J
M@8Y9X#TGP?%E*MTD1!570;@KMYS["K:?P*&;6.:)ZYL+[>',X7&IFL:OJ6<^
M1);N'B@(7-%:OLA*T<CSRIJ ABC<8\H/&H[_G&6)R@2&][=YRWUFJ.!OTC"!
M$IV?(O'[6,L[W8(;U7_?CULJ\^W*P#GE2;&1BT)GQ$IO$$[\R@JE=Z? LI@B
M,LI^@5APM%$U%@'=H!M2KN(7X6K+TC]D/5E&S.]LW\9P)&^VO;7S_)J?86<2
M"]CGN7>*MU&^DM9KO.I"2')J"(TY.5G:N][K""NAO:-KKU?>4>W5T2N'',R5
M[[P5DHWW"'[S5 KNCB/D=D42G/#A<&[FP]YQ,L>Z[!->/"MW_2*U[/82MNB6
MH815JN5A%TN3(NI7VT6:!KB2[O.@;/)8'TN/'<]]Q8-<.F3+Z)(S<+"M8 Z2
M^HKQ\JRWUZSOX(OK+;&BZPYKH]G!"IWE+ZH=;&5EB'Y \9S\]R"Q3#)[$"GA
MZ"!357$MY35J)1_=,HN>NL:5^>3WRJ#Y%Z-..8!I^@:D5WP3N#7>EK(,XC2'
MJ4Q2,9$I9E=?%2HI7487/]]L:(!,E73A"K?UG34S?4<[V#A(7DGJN!Q$5,Y,
M<7!R.Q]>D:WP:;.SP)IU-RB9EM6D_P?V+5,:$Z&S2+W$$EH[W!LRQF!)5TKS
MH%7RS,IHZ3!_[5Z#8X?Q)UR5O,6?/?XI 9+L0W>CAEP5;ZQ>OAC> 9?(TNTF
MPKKR2&.6^/NLG K",G_!YR[Y]X9/V>+NM8WH!C>L;"!Z[I8/4O%QN9.V6(7Y
MX><G?':C906>>7 B$EZ)6@A7XH.[5A4:7^TS('?GAQT+)&>=2><<?.;*^=RW
M2\M$SZ&#YA%,6W7C6[FE,,N/;?V6*=-HA]SGP,AL&0^2<!"[NH@>\=I_6VKR
MO?7:SN<1JI*B2F#> X' S\*_$J3FYCCRE)^$-<7J<(E4H1%K\V>ET&*57ZOG
M@U,?EOX(W53D=%'68<?! EOST.IETBOJMG=[:5VA=\=WKLSE)D]30S "<V@\
M@K6_O%CCA'.Z=T%I7$R>5$W\O>%--53VQ1L&'VG;#]WZ<GJE3-\%W 9\BJ3E
M$!Z5PF'+%,C=/*A=8B^BDHZ>:BQ>BJQM,*&>89%"<S-T>X=.TQWNK?'@*-U6
MCEOU13 W%:KL-A$8,.FG"Q+(/ CG+\U]1Y%$_'KPXU(LA;ZNH.*-KBI/O6\>
M8.5*MWC-ZWUG5@G]E-9>N4<K1/%MI+A%9(O:0XA[/2NJ6!>KI>6IA1FJ>M/V
M(=N8\27L-N%@ATB!7MSZGS_WX^^LJ_JXUW&QJ>RE4_('PBMDG3=,37)=;84Y
M-I1:@BRVTCM*A7R; #7T9M[?_.BR0Y-Q^-CT[9P/'1MVR%K=J]ZR+/O]EBZM
MR:>+=NW9/8$H":.22K;<5X46+&%^T>7_B[TW#X?R_1N&I\V:)EL+,4F^=EI(
M9;DJE20F>Q&3D#TMLA2NTC="3+948D2(DF2+8I(UA>Q,V;>L,V,9,V;FFN<<
MU??W^]WO\=[/\?SS_O&\]Q_CZ)HY/_L^G7.>6(%N?_4A0I5@?X$[;9_6\9M&
M[WIZK<Z$-WW+.!)37MGP;G_0RT6O8&^X$LTRS? O&2ZIC7*ILXG.Y9V1'3**
M+Z=:ART:;RW,:GG50GON6V]W_TT49;3>:M6S=3>TD3NLXQV:=NC!V?*;J3TU
M+SP>/KE>O7S]U?OB<S]>>;8<_QY0M?_TE6:=TSP= =#,=::CORU-E9)W=Y&P
MR<;#SRI8A:J:=3?7Y/'::QJ;M?B5G\?RQNS>N+%BZ'U2S%U=HA[1@:\(^SWQ
MDU$N:#"+,34X'E:PL<FL+O83KVE$TY<3,1?]JY733^;(GQ:0JO?-OGS7\MOM
M5KBRLK^ 0 ).$JS)0?U-'M*!O_=!+0N8Z2V+KUR?^$[=+*!]]_ BO/\@N3_Q
MRF!_M.N:A;$(>@DMAR[_"JG"48S145H2O#5Y]U,4.YJ2:4QCQVKD+X]>HY,/
M--PB/?X^T2<G&[MJ*G9W',&9G?C!.L?_#L)?0R&?([;GD:^_[ \E>2TV/;MR
M><[NW#F]1-'"9D6Y)T=&\B]<-90_D(KV2N-.,H[-W]_7](.N8"#$)K&&#5NW
M?\ -E:^Z+GA3N]=]TJ@GXUVBZ;[.3+=MCW<>C?493-+>[*J$JLWZB._&T.Y3
MM2IQ0H$F'%0H@3J-$2]Z*>GE^I.44$?ZH(QYDKV]\&'+U4=S]5;^7:M*Q'FS
M48M$^HZL&:UA/.D[#5- #:N6\D9$T,)&K_I(FOW=,S-[Q3R?;7;B"Z_%:E^]
MV=591)]@2M/WUB([N1>&7R^W'>R/ *,T).XO6RT1%IX[WJ+)KY+Q(>+[XX$'
MZ8K^7U5E UQD4O8C9H?$:9@9?5 612.-0)K5/L?R:O'6J\GU+ZC:>#BS*%6I
MTR:C>].L[ ]_CX G5I_E$=TFK2L/T&\5\M39D7I2],A!['3Z@)1@S7)3?A[]
M=9M!J/%%IF7%$]JD[6>#I(.%!;MC0NJG(]]17J2N0ZV:_'^<?K>*].?!NEEO
M.[:G!!%(& PRJK*Y39&O45A0?.TYJRH51GL8M:,^_VL+X>'8=Y47.O4-ER0O
M5POC]*T_X0H369+9S/U(2X7>!^KVMU3OVXM2)D-&[T<I39DQMKV-L@7O&=;"
M)C$C);WW=MQ?KS"^'?,((Z G/@&]=6%M$QI$\P;R4Z6:[_FH[JWUM>*YGGS1
M-5?.0B+YY8E=;^]=\(B7SYMEELW/XL146\>1#8W%9X5WFKZ<B%ZC=LB9TE'*
M.\FW]N9M7 ;FS3A+Y.9 "4MT<M;+X*,]IBRQNL0JK6D8US';./9,Y9Q(ZN"%
M>[NW>BMI]-Y^>O>T@CN.8N@=2B*RQ,"8$1EE77O5?]0Y^DI64/$/MU7#;9V5
MZ(?;Y]]%67)074'4YB]SIWFKB!3?F@]> _#MUGA])9R'PFOK,<O=/=QST:VA
MPQ/VZAP4KY3_30O\('FZ(*?,Y5A2)4_K9E1@";]4>CUZZU:#R*TZ,YX^FLOE
MP-J@$0IQ8$'@;R(=KI* HQ>A31.&@]KALRH9WRX-A!S?JZ3\DO&MX7GPS(F/
M:QUS_3!;84<,*O@;H> H3D#'Y7DR_*F8MH]V>6NWX,N+(;NW60LWI(HE'V(V
M\%S]&/*JX= !-,F/ED9W QEX;1^8;HSLX&/E]*!L^A&*6\F^V1"I0T;>.TUM
MCT85!KP>.;K#<R/CN,#A-?,%B% !W>&U.^9-W8P,S$.XHB+]%W8Z=Z_[MKYS
MQQROE8OFCXW)5$YVD&T,6!)33*V)"L6PTTD6]/07-L>_)YUZUYE[]U75I5V-
M4CF-]^?GZC?<'(Y@?AG(^DCF#V[""2UP4'S^F$-M+,W!<I5=Q?D%1X0%1;Y6
MQYY]'+ZS0*3Z::SKFCE>1$B-&OPXW0,CO<!\/^7A\7E&P_C(_HS+&;D#7H<O
M)J;L>Y:RO:[D4=$8)%"AZG]MF,#:UN4X1.!W+R:-AQ5AQ0UIVLS+?<;U>"/_
MQP\>:*DMG-]R^>-J_K6BRZNH>8A0-?MI\+Y V_?4*W=JI<6]CI!G$FU,;K\X
M[)5Y:B3TLJS_3M>$>P?.)*-^^,X,2Q$^@6E-9OPC.00J4K^#*/N;]5?;2&<-
M)!TM>M.J>NF\G=I%6S=5%J,N;OS+;I'-+GN=GZZ^NN?YFH'F<&BNV)C(ONM#
M9A\__TK]>U>U;S\/-# &"=&3:LWUG0>+.UBZ =[7E-9LV\1!70A!:[[[6<(O
MH]JT>KR8=R*:>PW[8[H7:-0JCVZF);[K"'26C[8Z,RX!?U>M?2"MJPL,=@&M
M?:\#Q_;KW\8BREU"^@B44_B[$,74#FU20K^=.2GL_F1/F1NI,^ZJ:I&@QE7!
MU(O6!D<.:3L9H$9N\1\(.D1_B6Q(HK<-:I-[1#]6K"^A\B1>&THB;K;UB)EX
M8R)'F-[=;5_;M7ZS]NFB:ADCQ^#A$AE;S'ZX\A@+RN'>\[8:<M8]N;;W^1E[
MOCP^5/S#$Y<^Q-X<YE=H/I4@=2*O= %-W]=&\Z&0/QG?K!(F1H]_Z&)E)%:+
M3OK.N1>W&.PQ'M5'\#0?*]?VO0':#2.7*C47,;>)%^ P1(P=HT&^O40RI5I7
M,854?1(+.VGG# -$BBES>W)6*00>+%NK,/DJZ63(AM1@!Z2.0#'"WH/ $&4W
M"&_\B2DQB)[Y@'E!#Y;4U:^B?9H+@JH&;+<3C&+@PI;5AW)'$W:GQ:-F!#Z5
M$VB^[+]U5)E"<*4"T3T)(\"R;@E6LYU*V=*%=+R8\*54K?N;XB9:V_E5]MW3
M@ A;%<'56@JD@\E2MHB0'SM9O>AZ:>0Y^DMG/J_:5JF+7S\='[J26.A2NY_9
M\W$JQ6.2&(JA8#&A'!0/Y-@O&BA,R<W,3O?7KGGB^\SAA9'4X!-&XS0/?Z;(
M2:G QK^]&A(DK4=E0ZZOX7X_H&F.#8%Z/(:<6RM%?C0.O1B*/7_G:XQ(ZXX<
MVVP!NWJIDI+LO/;1GQZ?H/-8NGQB"#3P%%Z_B!>@2S.KRY)32G*DK,:&SY6%
MWL3OJMEV6*Q&[,1&OCD]NYZ+7X1OZ?;>D'B=&HR!*R_F/:-S#U8GT8\-$;9\
M%LKZ>WM2U<'GB7MJQHZ)_RT1SCQ\W5*N^-&8W&43ON$'RF0"776\%D0PW0/A
MQPV7DC6]]DUB)+IMS[JNWCJ<R+0YFQ$^[*_G>2+GUM>SAI]D'%+V3H/^ YY6
MI8S3:'0W=&BPS 0Z0"B^WZV-/+-S3GWA\X8U&GL&!G:A]CRP?%-J9GF"X0*D
M9TGJ,_?[*]<*3Y;$!1ZAZA9Z?W"S>9W/]Q;:=1[=,Q!AQK/[COSVIR/SI]"B
M('\Z(K45O.SGT$ XK4^07O+BN[\UEMH<I:Z)$737VFQ*:DK,WIPH]A"YM,E
M>5VWPMXR&;7=2XDU>OL@[G>B/"S_]$^.5?!6#0*&I4?=/>^Y8%10)O@B3>YI
M4+1!3&[+G4SGXOA+*JGY'WD7"V@I@*!?H#K[%>1BMWG0Y9Y&P$(S+_W2F&3Y
M7UW'DJ:AGE;]]6\,1@?$/T:[\72:'6C:HSP.W<%0O,C3XY0[=5:DWFYJ7E1-
MNK>Q=O6-J _%*MW[U;=MHB1NW3YS4>GR'K[Z[2U  Y1K6O?0U5#WU$!8^&#)
MS9O&UN8>N=$#A7_=E$O8N/R49V3]E5GE64PW6XYJS1+Y/AC\..T'J2+_1:!2
M6^ZT=:/]10F+W7[#@K)*Q?YK![I@IC52C_"PBQ T=H!P[Z"Y^Q/E'W4W^:/-
MU]/\A$=46DX<,!!H*IU]W7!U2P0UKUL>X9NBY"'\/51Y"ZI+2!%&PKVL[V6F
M7LS.LE&6J(HO667/VYRJM?K: _='1A874P\2\##E.+XGO9I06%>-D:!CJW"%
MN'"]5?0$QZ*'JEHG/?Y^1]V/G]%S^2+56WJQ>(VVR=S:V4.G7V'[<*M +W>_
M>*6E2[7GIY9$@<'T"I5W:--C'TV%0J\+7X6\SYZ0V8Z:QWW9?>);]DY9!Y[]
M6V1_$#V\Z3+HCSC2U%!P^K#4R>9J>]&NHH=[)D7]W6<E3Y"S5$MGI0_(Q.AT
M[22?3P^02U(SDH*[\0A?"05'$Z;';+ZOHY*BV*ECZK&^F+8<7?+B5?.EV)"\
M(IEHA3F+A,]'+ANOT\4W0ST&-<O>E6CZ?N;0V@KM=D\-QVS_1/OBMO'WGXX[
M??#ST!"ZKZQCMB/D2FSW9]7F,KBRE2 6J.W-W!<(46Q_?(<BU5@GRWY83=9?
M#*E5MGUAU^URX^47#0>3??GAC ;K+DR).DL$/XAFB?%:ONW0\<IR]]7;WC9#
M:E5U.59J:]MY[^G?5^LGMIO'ON\HGO6\KCD&%1!9DL-,[>#F%,T[N#@L53V:
MK/)<U*9F*/+G:R^OD;4;^T[MJMKVJ'+(\OH(]0$?BB%+FV27Z2DC'PEO$J?;
M*%F573 EC!YI3['+H.5GSQSV<T_;W^%UNGY?M?[>@*C[(;=XUO@&WD$$R$P9
M.I/FSDYF2>4$'F)G:_9'+E4H=;0.-7_J\O/;2]H9?'3ZNN0UU?:(^J3875\$
MKER_=6@ J0DF]5.PH,,F4DZCUYYQ)6Y<>)_=?SPAJW516?*.=U!F0?S\4>^0
M#"?AG+=E;Y\J?G2VPCTNQ-/WO:1=;]41?>EF9A>H3RQOI_$5W8RR1Q=//'.*
MJK\E5U8Y'^!L&"NO[12X\;+EXM;1?@D.:M3J/<1$_>Q?#BK*\P ]M__T]@+N
M/0;TBR>>12BJ%069G.W9J/BXYLOVB[+9I(A2W?@-MZR+Z.\1_I8!>&MPI6EP
M4]NDGOR=RET]-F<BZ]6>23RSO?EB-N%^%'_D-<.-O<Q7YQ^LIAA@F9C@SQ42
M['"]U6[0A@]R5U[9NY*.EHC*U68?-/;;V[BWH8:D<72@HJ5H\]VMGS^K'0HV
M Y6Q\K0FGB5N/="[\/U"H1ZF=7.CRZK#QO94@MXM7O.X.KU:XC%HX'67Z0^X
M4K-BK]*)Z&^N]V.5WORUKU_T_/*V/4]O"$_90B402Q0W&,82DSW:.DCM?9C!
MDY'&:RN$,WQGZS'E Y=+CQF <N[U.BIDS^Z'S1C*'82/02D9P$^_',[[^\:^
M].&]J:QCEG;VR- R;_N6;,8IS^W"BFO6L$VW; L)R.1] %<6;9I LT3KS)R.
M6B766C>-J D2"DCK">:W>+\),(@(G\=J&R",BYYVC8C*E;H,_]NF8@X60E?K
M4;P.N"PH'YHV'X2Z90>R*>IWO#6GV(J+6XNT"-;O(CP2'UH>\WPT''5YK3M*
MX*#?:WF:/?<<CD!M=BP(<'AKH"VE-FN(L<A!21X+$AI-8(^(=-O*=?SPNR1C
M>=M)TE[.LE\VL+1I>/XT[WCS]%3F]TD<Y1HV(KAE[5Z&1'&>1O %GKE>'\:^
M-\W'I?"FN$N 2W_BJ!A!')H5YJ"R(B4F=4!*6?N6'D"9IXUUP*Z"QM8U\_1F
MJX=C;JIJ:C--2:+8S?&CLF<VF8@]O?1@D5QSPWO&B[G;%2K&3C.&T*&(_/N.
M:1](F$V8V3MQM4Z<%+!Y][G,VIB=AQ/O'FZ0YJ_=P'>>>\;U6O?\1'/N&0H_
M; ^]'WM71%UO^OK0CZ]+J/4I!Y]0O.F:Z1;%;75U>+TAOGUUSTX%?EX]I(&T
M]K$X*('9K;H\!KG!CX+K"&_#0HD7\+?*K*N:^7^X+SW1BU.9!PZVY[>#]0B+
MAC"/M]N+N<CO9)4/@_Y RY;F3ZVK#F#I2_@W'RXI>YP5=[QU<?^%-K^]>S?F
M4 KO$?>M?AZ1(X9:!\8/4.%+.:CXYL!U'-0;[S#B O,FSOS7-N/$E'7L"F1/
MSV09NMI8^R,'M240NA!3>-EPVUQO;5)&B5OJ69$S/8;:%\\]^/MRY4:T-9O[
M,XV'_6C(0YV46$G<] &;32\#_=/N'GT79P>_M5:;%3W\Y$C\"<_<-HPG)!2?
M(*KM+F1UW.5N?)-$A)$?')289*V>$J&&9'UO9V%$@VV4I&FTC-)QDT]FKAFG
M#S'\48[% :GH>'@@"5>\5-O\=S_%-(ZY.]"4>A=??5/[8L4;O"7S2%^SE\Z^
MM_:A3)S(EP2#XX8E!W=_GV,X>RR>U5L,_,X4!0U=L'!PY9.:VOQ!22%K"ZI4
MM>JEZ\E71]7R=H2'R\EVQ]1)7UVE<.M!JDA <ZOA4G;:<Y5XDD\\:=/0S]W<
MW[)E0=S?V5U8U1I[TA2\_K4/(Z2S"GO21K_UX>W=;TVE1$RE-$N/<-?&CS/;
MVUJ?WKI[L&TBO)-P:O6?C3(GMVLB,WM2N)M?+-8X<?>B?+,(_1?$;9EX[EX-
MQ;3:MIW,,<*I./*3-Q(WS Q.@M>A-=?%)CW "Q5MDIFFJW3VX)-["ZD\YDY9
MYDZI EU_?M*5B8._8)8G"^<[;\D&+W1/-/<E2;EJOC,TSC(T?K[O./='DUFY
M,A.G8D0ST*U_3^@OI.87;9TRLW#)7;-Q(=.\^:2SV:\=.>ZW[B^^Z"\_P=W\
M<DLVO4C,-]55,3E*[W'WMP/B:AS4,/(=X67EN(>2$6B&.  W9*;&O#5'GPR,
MKVI]LGI-YX.%#.XFFX+#*R(IK"JL8[8O.[(GWXA$*#R;7O>OO2X2?WZWDWW\
M#H9LCIMM(W#_=MSZ+]ME4/KR^J>R/G]K4^K\N&]E8](N[K:D[ G,G"">BEQ\
M#?7EW#!@A0RSX,>I_!,K&X+6>K<FF03'DP2.0+TOT#;)R,QU G^PR+G 8^T?
M>OPJ,PYU/SE_X $'=467C?6NW_*T7;91-<3,U/I"X$ZZP17J9K-YYWZ>A#47
MW,+.HI=$^]MIK-O+ZJ?:SK<LT+V\TLYX#1R*25LXK:A1KM9_M"VML/#N]I+;
MO@82&\0L(RCY6\(M@PT2K%XFS0DHI)5^C?C_R8Z7VW"E6:#0*^Y1%2&!@=;?
M6+H9N*D;3<^>E=ETG_G8]J-WEX]7?FUJ0?&J3[<,IY7[75/1XF#I57]U*[H?
MDX<EVW*]]^#\B4X-LN"9&C]G/^&(H4ZLG&'T46C/_B:!-^M,#J-"E,=!WMN/
M'C2(U%,-KD<$[E0B8E3Y^^J%,&9B.:,Q.BS+"/9Y..$6F"N?N$7U5NOVIEV"
M][MZ+4[S?B*!F4)<?AA3W2A--J![,>4#W8JI=NWK55X'GLT2DC0NOMKPK._L
MF[!5X:0S+JXSL0=4E6FGJ !(M!_A]Z"&3JAJXN]Q4!@]5<,K>D5J=YVOY1AK
M]DX]NB91L^6"3(1;UIX]M\<*YCZF=?TL$EM%P4[W<N<*UBK*^$>\ "E0GZ+.
MVFF_WUAO7R>9NQU0TD&U+;#IV?8R8=3=XM7IZS=*9Y:2;V/>BI-9HEA$H%$,
MLR$0/91(EZ6Z5$4Z'FC+G2TR@C9,;DQ0ZM+:8#=TI+Y:(U88>4@?/(1MN:&P
M)HZ^E'7. [-&Q\W-;6V7M9^-^,*N*H'-L2X>?@(YZ;'5#U#;8CTJH8$(&'V=
M@[J+HYS*"WV"CM#0=:RZ,1-&RR+YS)@U&&F_#UK.'0FO4%Q=-GO<:NNVT+67
MCP5ACZ$"P8"X5I=N/03_W;]&3YGD_[+JR5+HI45,A$T%R/$OL[XXRW44?.]9
MFZ(98U'H:7KK2H*<"9KG.;<58\E1L54<%*F-5M2Q2-XP=4/M\1 L)=>$OPX[
MRWVP>:[4=?3+FOVK3U!W!$XE:)=UD<1.\XX1IX->LPP!N%[-$/ENBBQ]-U5[
M"%LU<?U+,NX3:$=N^13DGJ*<9!ZUWL6('$F.>2E]=>NCP,H[7>T$M$Y0'M)/
M1"$[_.$:2)#E2$DZ0E6+5 OSD+]WW^.%?<;HJ_RO')2S>86,R <XZ/:%KWIF
M4;@CIH<P3^%\XLP!*@[A;Z;P- ]P4-5Y/5-#'%3D(F8=XR%I7]& U):ILDO9
MGE];LQZK42XH.7W_""DP(RSNT/JG>ZC7J@F2>IC&U_Z)@T@1I<^WXJ&@L;IU
M:81M3^XW!='Z_-@=*LAY/L/]AWJJ!!8D%-;,VR)\XT/-$9C\V3 7IBX];\"Z
MVJF\A*HZG2BM&MWE';:CV'F#RV;/9Y@$&4O^WH3*'R?1YNP(O8W^+RLABA6:
M1*B6((9IEFL?HHK\;,YP3]QD)O<P<^U6[QT7=$H%1G@$JK/K]V^/8-I$H.AY
M"-]-2EXU!\5?P1-H74BU#M,DK^^=A,2*@HZT2EEC'S88O70I><NOX[$CV[4[
M'36L=/*IM) S\@7#Q_(8P-$5"3,!0\K)&%,*+6E(4FJ/L:!]NZ>3G=I$9WOR
MQ&[I<R^WROI;R5W6/Q^B/!LQ5K&'M:> WD6!:X*%VIT>2D$U9;I]D==WXH+W
MOS[O?R[OG?7^5'0-OAM+NU1*[Z6@#:C'BYA;H5J&YW6I8V/4 7H,.TX]?*=M
MJ9.;1*L!KFCFZH4^/]ZY^M$[JL'AP5\)%%-XG7M_ODNU+FQ(D5NZY0W:\A+?
MY;K;WJM)AIFZN1]BCWGB"Q7.ZJ1%^/*LWR+^T_8N?1U3">F!\\F?IJ#0/EYJ
MWC0'-43@<8W:>= D>\A#R*S?JJC$=Z=\@O>CBG,/3\^.JUCDGW[71G%A"9/F
MD:U3-7KB5.L:*2-+*KH&WF1+)PSIY;ME"9KG';D_9YAE^^H2P24JN8*Q8?<'
MOOA=%JAE?9H*^SF.]H&=^$&&NL-X'6M/GW)Q[(A;U'5:NN<F-UE,^=QPWY;M
MYWTW2!+-079=)TD__#KP)CM43\'?H,IJ*B#/XZ#89T?/YC>])]\].)J5.=Y3
M=.UV:>B)K;)='PX,?E?G\[]19=BFFO:VS>>]_XRJZM 6(W_'T_<BM%&IJQ9>
M%JZ:XP53)>T^E7 _6)1N/I@8CO"S#.F^'-0&'5GGC-XI>YG\?0\E_J9E"^7(
M%2]:Q]>_F(M-S5E;*7_U80.(.QZ6,A6J;*;+=T1'#I$W>/2)=XK:$1^_THS2
MLY5,..Y$JCU@:>M6Q[M%DY8!LMU*FJ3!70MDDCGM<PG5)4R3C3E"[8^8=[A^
MW0V$>>[S-(K&P[FW,P^\8H*=Y->%!N0=!..42B 8E$+, M4( W75:-!*;]*3
M^8E(M[\>I8R'!TO_S+(IKBA\<GBW2*V3.?_\SIA26;)73X*+=ZN-PIK1/ S+
MBEHW@P.Y:8G^LXN#XF,Y#.@>7_ITHS/IV<_E&*,H\[/S&CU'Q$ON;3)PPURH
M^[)[V_77B0@_;J#7<7"<)=HU:!*9-V'S,.S5!$FIQL_AA4UY4>-+1K3O9\E;
M#9<-UFXH6E@GMHH*LS:^'U3_M0%!OE7';K#WUP8$BU(C.Y TN1L04&]SWJU+
MOY ;MM7\3HA'.S20(RW4J2<#^FO=8&77,IZ$;(\G3>EIA58/)8)>_OC1"ST*
M\[R2JE*'HJR:P!T"N2<%4XR;'J9J#5FSA(T&^N\&JJ=Z+)4UA_G@!9N'\ +'
MY\[TNW=:+=_(:$J9J H3>=237CO@,&B$4AXC?T\?- MN@?-[6BO6!U<AN^E!
M0>G-'M=RW$EA=U+S.RUX+3P\CA[J*HEHWO,P#K4VZO,YQ>_,PR"I&P"W"Z*K
M4R7(=9@UB$;@ 4H!G38_$%IR'7[A[][]IKQ]YG5PX[O*PKV;3#VM!:(_-KP2
M_K0+TH,K3U3L8OER?ZD0*-+R2D>7N9]UF$*XHX$1.>.N%3M5+"IU QD\5YN]
M[F]WIQ.F]@8!9\1EMSW; G<L*ZP9(M(5FC\11>G#B( @$^-AHQZF.8,SH#2]
M?V7\"M?C-O?#UDUARB'_]<YCRB+%=9575W5W_W3'TM6R/N'$6([L!SI0EK]1
M55E_^*(@5M+-K\#&S<K,WN2!0K(-5FV7K7OBN:=7GJ8HSP@HK!F$Z(KDC_WW
MD%7LW&"1X%:B8*#,S>%&@\'1\MJX(56!REOEY6U.(HX-]C;FD9&WQ(5[SL:$
M/-B@BZ%YL@LJU(/;,9(^+R[018<(H00AK^VE0=Z6U%?'OYBEV#TJB>C\?O4-
M>^#"=,-409G(^XJ,M%MZRD C6&[<5!&BX2*O_GN!!_)<K5)VT#->N$N<(D43
M5%_=2"XX=TX\A>?ZZC/USC)M2H>WS9L%BM.-AI)%$<&[U+B:KF"ISAF6XBOZ
M9FQQ?J?3VP=G[+X2'(5$L%%1VW=7G):J<MM?$_3L&$J<L0JX?3'[%?(7\D5Z
M/3WK6E:@%!53HQZZG%B=[&SCS?=QZ<;8X^P<&^^S7@RT)W6+[]M;EK%VU2&I
MP<2N1@S%J+^["]2#?.A3/\8U1:GBF_<LRWRXW*":AL_ JN37>5T1>KOCA%/T
MGIT\F^I1K_FJI"^O&L513'!_0Z)ZNY ?.#'(#1]N+]Y>(64P9+<#(TC'5=F$
MK/V QPJMS57]-'!0SVMHL%1=I4K@Q>/N__.$TC^]AF)0BXBQTS@HSPFUA2CO
M3[G#&+''+.V<OAZCM9L=.N>=JT7$ORMEQ^XY*7K_5D#>8\BQ/_1JH"#=\24=
M4P>_ 75;3R'P*M.K.7G(RT._N'T!VGC.\)I*3*-:MO^IT]O/6IY-Z\-\^5&]
M;88- ^NA ).6KI (=(% EWN8+M7\B8,2F>K3^!9HY&/]:3K+^$.[S,UWCK%G
M3GV>5ZIV2MA?':*S6LLIP+H.C\8A?81"=)64QR!NNHZ*'417ZRK76#T9O_?!
M;TAUE8[&&]*SZH8F2:V,$I%KX;M%;FW15F!; )K"[#>(2* A^Q%Q(%U"?D9Y
M +/.G2 2>. %W?G#[B'V&H.KI ]7LMTVW?2?TZE\-(,<VA(GNG[UY,0D<1WW
MN](4!3J#:FW0HD'H^3Z,"RW4SMZJJ7NM]H:3S7J;"W]?_)%?\-XX5OSR\ZM]
M'0N-8BCK6D2;>TDZRXU-T-OAGVA S9IN&08YUXW_E1U>:,I^=0G2$<%!G1+=
M5>1QSS3Y65+#:=PU-<-!,6&<$\A1A'X*MO\6,/]^N%)?)X!I"IK:9'*5KO;9
M5O/#%'*HYEK![$(]NS>B/X1ROLQ]NOI:B_P@3W!C[Y)Z=;.P>\I&NO>0D*U^
M"Z:ZK#,Q\T?OQ/*1<X*^'9=DPU.4'137'G>ZG/TN9+/OY2NV\:=Y1Z$9\BL[
MD#_U66(^6*'@.@YJ,TN;VG#SB^N,CL/+G[M=:<OJ,;L<MW?X!;-79]98?QHZ
M[G3>\MHL!T4YB^EA#LE7P]WP()W2%!4 1!1E[:=:Q0SIFC5]N68WF>WA=46L
M46"=VFSKR2SW;,]-V[>=9U>!C)@P1-Y(+T$$8"9?X!G*$$N+BO]DQ+Y0:Z=N
M$%9K170DG'ZTHV'K,R:UVDD0\^@P9O=Y23<;2G-/&ZV$G>;)W;B-9@F\83_2
M<7:F\E8M;],3-?:S[749/),[4&+K7!X[<4MDXZW=$?)R]5[WKVXBGE1(13?B
MN_MI$E276IB^O3B/XF??4N3-2R\XJS5'ZO%X:'[&2.JK31AI)K ]QK)5*U:A
MTA.3$%[E<Y"P&KJ41SK8/+ OC/*ZF>9*[<77>&TV"3ML#)\I]M=1YH]T$KPI
M]\7EJT"2DU-44H!0T;V\EH,KZ5<&_LB&!]59HN.(,"3E[V+6DF?R/KON2I:'
MA,_#L2%>9[M:Q02CH\/[Y2Y_[*K%%5A/#P\IP .9F^"W=Q>?7PN4H^L/)Y$C
M=E7ZV 3(%^ZC).ON]$R($6ODVW[[8>G3??XGV<_R$J#SWMTN-404Y I'8\2"
M92:#,1T?S*GFMJ)G."BG9I5\-Y*GE^RQ57OTMZ)#CT'^%_@0S]EZW@Z?_Y-K
M+C0/FLHI;$F]_VV-(HYL7BP@,!:=>OR&N7FN\1LSOH\SV!?"GT^4(PF*]R5T
MWO">/'C[++(H^*T]4R8EGJ\N0_NVD#HE6%,]5E=A+BQC\VH)1_9DP:AZALQM
MK'=G9-1&]1\:I"+:9=Z3V(*\K*EC5=FFRZ92MOOJ;P87"EIBJH[5]IQ8?*ZK
M1.XQ;UM,GX[AH/P6L[YN5I"WL9ZP/O;4D0Z;G_1\ !QBTG7,6O#QXKG%7#C?
M@-W?WH[K 5/EM46-'W&"\= =2J85H5NV[@?;6+Y[!T*>=!T_?$UUV4R^+Q<W
M_3.)#ID?:MN!J5Q^<N#;N<_<[U4ZD:^13$)V.E,-PQA??A+X4\W)0'\A]TK&
M$6B4,.EZ\)P\<A;)C/;1<]QR_7GB<F<S[1SF!P=5%R4[<5H8R5O4N)8ZMJOY
MI'O0Y'?D\QTD ,F\G0Y 8UB-TBU"G_=N.NEU24IZ#0>EPD&9&[+QO*QY+K!
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M27YL4/J^>1S)GMP7RT%=<AMOB%OS]3/)G^'.0?6,(" ']FN@&A0YJ-_@+;0
MZ!T'M=2(VA,!_UD0E/*+SOHT NTL- XLT_\7ON $-)KT"_S^8C;RB\%,2;>]
M2"[@..Z0< OVMR!@*?QG*:#D'(<$$-ES_YV8/*98I@IAOI&+R. /%ZNB!OM
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M"XG_&_WGPO_I?_?_KS4!<-)U63L!D_]X[TG"C?\M!SC*LOY_<##Q[QQ4B5G
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M#R_K%DA# +3H&^2^'L_=7C1"YGKH7[H*4DK!S\* C \+ G$K #8XDI\L<HC
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M&3\88/'&?UO&/]%2@;;6J@<T/8>>Q-SJC$4NM"<:;\ G7LZHYRI0+EL&SR!
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MME);7FR#?<3)=@]08S,L#TFGK-+O ZB4!W5V\THU!43/>"/)81,$UCX)T=V
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M/S4;.V]IE>)PW&.>E1S'K;>WK*(DC?_;-T2NBG]4>ER%/D9$\!A+4Y;M/NK
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M(UW:/+G0E<%I)D+ NYD;QKZO]AKO->;H-Q#=J\_S3%"Z@8VW7.#9">1Y,[T
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M:Z"J_C[%KC$'E;7#5>WB@?J?X7LSKY_1NVE#9J^O8,@S+]%@!H[I0S>I*)%
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MZ7QXGM @713B?^I69Y!RHBE^@"'&B7%#,W<8$\,0=?R=Z MT0JQ[OTJQ4CF
MR<T%F8UN1ML>'%<(ON3X[).'J-(!K?//]N5:3J%_L$ICR.4-[4I]N #U,>R'
ML;C-M(C'B:/[>YR-&-[/=O2'F/<\B'=UOQ2EL/F*B,H@_("G4T<3YE9L&-Z^
M;\H?8*R#=+\^_1!U%E%XY,Y-STCJD6:UC<]6[J]*YW]J:K'MP_K5H[?6"$,2
M+$&K44R&/EOT2PTZZ^73C^EC\+HY]#JE4/P^E[==:P*^&7@.N%RYHUAG[;%M
MT*[6Y,E3!UT=((Y,CJ_V3I8S6YN9Y4U'GZ.?RNJST>I?E9;PP].B\VQ<Q<F
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M56Q^L]O$LG-VMQTT;?4/ND[<^! 0GGASAOADU0!O,XMD6YFVDNV UI"PW!.
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M_B'2P".C+)&YC\39R]BC+Z11IU$XW>%GZ/8F)>0H>F$[:*X1W?X%,R,!J$Q
M)X^"3B;/=2RQG)GT\B9\906R S#39EPHZVTGPZF!74V9-@$G9',J$$ZA->@D
MSNSC3V.6VB1HK@TQY/6RFO-L'J[#<2$%+L32G"/N)>XEM;WG0AJ]?IW-DUZJ
M['W\''W,M!$ #F8FXQ\? T$TL %<G(@:6^JH+9E-O8]*-9_T6L]YJH%>$(('
M>5.G)+A"&6X&[J8 L^R]^9_K/]=O&^-Q#9R+>=D@@VLW 2)].(^ %,RH#:=<
M^4J= <;Q&8VTVWX!HC);Y,!#;&&?J\FWJTW&HT@+1*!V\+D&\%!?)&7TXE_W
MM@R9 8_!M9(8 ?(+E!5H8%1T"\ZC/+BNC M%HCF9,=3,5?KL,,R"+!?J5.D$
M:G?F?3#9>]!?F:K3J-262?Q,/[5]?5I];+@GY3DLLOF<S[?;#8NU+;@? YB9
M/?!/#!BZ9<98G)RDZ@\NY':%9=-H[3/NVAT'GR@>9IER7@<AN#+X(3"LCWTD
M6C6(.7NXT!*5F35C+W#'1T!H0'V<W.*V!@;'<89#L8([SI&&V)L6^%O?S6MO
M1JH**4,@"-4"9W%-XD(5HG#S%R[T9 KIM)T;9A&RO1!J&OIODM%Y-G$Y_..Q
M![N.LG *J"*;RKR$P(-7 0>@2%<R@=>$]F^YQ"DM4%8BA^?>%3>0.ADR#>PZ
MX(/&/*(*UMKKF&DU^*<&Z&K;-P*<-Z9/FEC\SDD._CT@GEGCI^%+FXD+DO#T
M<R! )PJMK AX:Q/H7 /2B3W&ZY@,G(.9.&DY0UC#]AMS+T3TZXFLE70N)&^)
MF&%8KGK4#Z=,V.'8A9.@T9Q9[PL7W9(XY [BWR11@.3K,&/E *)'82<">^AP
MXOCFH1>D,-/ DCK?CZCFL$P9%%PK<>+"$DG@DM'+#^6"&;?/)'IZ/Q W\,8\
M,RE$8*(0N4IE)\*,T47L!#R.9/N0.20@AES5WV+X30E<9 6-IQF02;9C.04/
M>6\73,.#0'JUEESH.CD):4,:QO3!C*V=XXBT5G$A3"_ETY(/X4NIM%,ON%!=
M'Q "">D^B:&= D.K&_A]BC5=:I&8 QQOL0EI^XL47O(37?T6  )>[D0'J[VE
M].U2,!ZVIV02)D71"Q-62HA %C 4>1)R!L-R]]GGTV^2X;)_?]RIJ=P%DN[X
MM1\?1R)N6Y:T\31$#D5@H"&?NY09PNJ%\Y3>F$[*$$A>M?J@\V]Y:X,<@6HU
MX9_ I_+:0)LNC 27+G0AZ-"/:GBI/]BE_ACCF%MM3=@1E 5 .3$+C/>^W74N
M]+R3"VVC<DI*LED>+$P:&OS+82Z>Y2#!!C> >+/DG>NG3=A::T@+TB"$A@-%
MC:3Q2DET80:!U]<"F\*1TW6[>5+LI+1SG(#O#F!(-.P@^G?+QW!,Q7H@,_D:
MQ!1F^>RA]#[UI@QY 5)5'BFYY&]21Z3]=Y]_.ZW\ &^KH#2>]D! V4;BE #+
MY&WOF#+U^[2D\H].)W/RPI=DQ87^<GG=;71]MDA[FF2-C(;JL$V-1'7H_.TX
MN*VE!HSM=#1Z6A?-7L^%YH_[>*4QDUGB'82!.M;96FL.&[C\7>^SU E5!L8*
MDTNG-/ "R,1:?9Y-$L.PB(":->) 9;_F$6L@TF <9O/(:1!6WY1\0QH!G@ B
M-.(0@34.:2UP(6".G/BEV/&(?ALN4]2 @6L"(U)%?B5IL$6TY)$3_,AI"J!N
M_I.:.%'G,8, +^ D!O\FUH++Y#3@KX>![$ Z=C.S1@2662/. L"H>>>6G=@.
M[#@A&W:",X !=-?\)<P,S)(XML!,^04 =117 -,$X*1@.U#FBKL[X,'7:+8P
M#.10[GX!_7&Q$7;F0AG ^ HC_B%0^F\.4CBF? 9NX2UIX1 7FHRYQ%N:MA$S
M;0I/W^-"W>KS& :9A0;QBP(Z >PQ@PO-S/ ,H<-S*:"A!3'L]2\H[&;0B0<\
M";BU.@3 O>$3[QQOG"+(9A^?QP=6+%2+$Q<6R!1*#@4$X1K*8HM1!;(3Z6F4
M*YS6)FMX?*$<J%C?)M/,A5K7PFPV6QX(]W<<>T0;@,LVA:(6M@'H)C"%C"2!
MYARYT'<##-,$GC?V&>:D(36(SE%GEGX7!UPXMV>I@\0%%,M,#)@JL-%>GDLI
M;^1",9$P[25OD.&4WN!$RE BFJT$LY)*6$@[%TJ"F7/H3LQL Q>2248^#*&7
MN/ SDE1XL4>_%$L;C.="QW> % ;R?;?Y9TQO4)+)0@H0ND #,DK^AIH@+3H
ML&7*R>)"(*;01S&MFRL0 @'8XQ:DI0K6 (ICLW!,V1'<0DHR(*,@H\!6A'OS
MV,W *QX R.QN^0O#:.#L T)Z^W>GQH2 4C 8@)V VG(R8)[:,#IH9/55D(45
M0:;H _[:?997X$I\ Q=2Y_U'G?>?19F.GN\(0# R24NKSILP;&\NE&;"N5P'
M#P_WH8']7\,NV7_]N@W(ZEL=@9W[Z'OBIZ_'R9+6#=_9T\#V.<NK?:2@ '\^
M@V$:P_-G"0\<D7V2>1V4[[4^,7V]K(7NO,VS\^])G90EP0%$;(ID#&'^DAV(
MVSQ/T1\V@LM6KX&_ B9 ,/-G0;SP.P[,*S0)A(P4(+2"L5D'E@<"8L$ E>.,
MR8-'2 A QZW)2.95S%_JQ&[Z';_D9^Y1>N^OI R]([&W8ECI;Z*1U9+G*8/O
MT4NG%,-_DB=H(JA%\E^#MJ^C_#5H/);G@D3>;WOW>7MDQ*3#-)"L)@N [_12
M<^&%]_Q .SADC-Q(81I@1J*7F,4C(JA%D.>)\!S ,>>S5!<6F/K D3/">![U
M: ',D&BX%)XO C/LVPD4X+X!+BOVIPRED=B*,"N38@SW;0$ZQ3(!JK<B_I-S
M,I(U!,_,+XWR'U%:?F:C"5,C" 1*=3? #B"0[BC>4XG"A&%D%\C/Y2 +%JK,
M+?]GIU)0032X^;<$X3$](%4,/'V.-SMPM5N*W01++&!0]'45V0&DRC6NSVQP
M *>4;Y_?'\:%&H;O?@ #N&ZV&T"O<I@&0.)D+4>GB/XIN^7:!*'.>L(;P>V;
M=)48B7"FLA5(LS6_U7T63CN?S.8 1&>''$4ZJW\G3'8FS-00("$NP/;+ ?HL
M5,8P WZ"V*$(FNJ3!X/)603>)*#$V;,4#YKA<H!G3\+T*20'/6;K\D??!^"E
MOIMCV%+7ZN'!3#0;@-)<H/1U:4Z8H2S0P*U 7F'34="K <23Q )Y)4W_C^.S
M2.Y5"F\'!46>?#VD_Y+OM ^EMT,/>)8B@ -](-5V R 6X$_YE8UF@PZR<BGG
M*'U*Z)E*+D3% IO\\[BUJQ/AS;# @  RO3Y 6>HB '.5:D#OQU_]@V$@LB[A
M(CR81?H'1W#AGVR<Z*?1T[QCF*>P.Z[_'/2_< 2)^?C?783_]3QGL0)($<L!
M2@/ZX(D1 *"3&& ?/#G^)Y:\G6;5P/^//Z?0 "2?[#!A!CP*9+<"_/$ YLEQ
M# 6,=;9B:;HW9OJOW-/:\_Y2]>&_$LFC!6# PHUYG(W_8- $]TN"J=:;.IBW
M-]-D!X>7&,C(,QB$.(XSCJW(A69!K@=M\]S(.@NW &:PD35LOS]4XXW(IN 6
M=X!&!5#(1/R_G)%;59E&-6P:9IZZY$5_',\5 C!)HBSL@#]A\FY2>1D>HY!-
M8>ZGSZ&S'0;6Z ^>^D9D)MRFB(,YM'(;^Z@Y=?:\]5]L6UQ5^W<W?VU8E#7)
MJO\&I]9/Y \G%X.K#S[!#1^Y4,E_*X$6#<Y&"V#K8"9<"-P_R#D6"56!^V3_
MUA&0!0F(R.?WL/]G///^R=,)Q9:RJD!<MO]U[C(7BFP W'6'$2"^L3,:X1":
M/@E/4?[O],XS)?6O0.]1E-]Z834P]#D/\2HL";8B[^?$:YW9O!\!4?_Z(R!C
MBFD<R&:16%-+7K6U O%IX !?:DW??,<[HOIH>[^SK4YJ]."CK\%U&0>"IL]&
MM7TFZ"VO_,%*6S##)R%CA+/?-,++B4P&9GX&L !>+O )B (8!8Q9;!E\L97_
M";4;5TO<3BF@1H&P5'X+,PPP K4!#(3V@KCP%]VAS3/E@SZM[)02,/J;%.5?
ML367]-G>:-8"+\P#@<["#0!%4D@<9VBX*!I=3HV2,8/=P8UPGPYZ9A2>&EZR
M%A-]]B)IB>B5D'N_*P7<$7L\.(#L,IVWV#(QJ7*-R>1; @ ("*@,VP.;HA\=
M9UPNL7O0\+Q)2>8)GV7-HRQJA;_2O$_@QU15H(!\:M0=S?E@RH?)]=JD?7<G
MZ\?M9M]A:!_^:.?V)WA2XZ<^D'H7KK8 PSPGC_B8<-B_W6O-BC\ZKAV(#!#,
MO5"<:O9[$![][V.&F_\AB__E^+\<_Y?C_W+\7X[_O^;XZ]=_^^CO_^S';BXA
MD9#]Y+_=2^ _?<S=%?67GB^)ZVIQH6<:''\P+VE_?_<#WH,+[<:Q! _SMKV<
M@T1-C_^7C_JBF5-#8^Q_61HK?G>>'1&#XA3!OY;EJ:!LN="C)L FC\B!+'Y"
MHC5C)DD8*^C$OSU\VHV_V08PP8<G&):ZJX5JA.8(AB$"\/S5M'?_,M*PN3=^
MK;\/53;U#;.#&20:AK/NO7,&00;^1'+B0LNYT+<.W_TIY,:7QH0G4,<?C4AR
MMO,V"GFU%L</UUDBY?O@$^VI?QS_?L[WC O=)9V$BP\)_..!I&E<CJ+>W6^K
M=,$D6/YJ*!<"N&J6SUJ,F,J%/K6_X4*=,!A<U9)8]/^-Z.^GFJ;-4=)+=US^
M<R.]5)+@'#"T,00[8M6\I!,S;*)F#&<;7_:_R7@=X4G'[=FD)8;+,/^RX<)K
MN-#,D3(MGL.%TC^SJR!G)@LY(@RN849=5N45_;$9PW]30\="Z#W=J$(3%3%+
M68/U##V21=__<?-CIX)C\W1]^*V"\U?YHWR7%.Z=/1?YRE?T\;=OJ^9X9&)^
MO5,AMA+,X+<N&^/0](W^Z=V>=R>R.1;2NHC*<[4O40IJ&][MV6,@^-"45NI7
M(U;\NS5 AN*1D9-[;)C6E5:;@EW=QO*:)H<:R?U%$:T_ET7?Z]A_,7.;O:*0
M^"J)S2$]_Y\\WOVWFNJ?R1U9B& 3?8KQG/<FE3,UBSQ>$*,:J(K7\O!(LATK
M2$L]\W5GRW-<#F6JT>#-/<G]P;#;^/#0BNNG*:DYS$0NM'(3KW8PX1LFLVWB
M<SKRG925S" %;6F><R%N,%P5O2WZ7&-Z,KQW=&/.%JE"KRN1QAF5F1ND]FI>
M\LCG;Z-FZ(=B7$D/X!S;V%Y5XM,X269P+T[X?-<%_0$?P9X#?4V* 5L?'D/,
M=[OVU 4'O[*I>7*U8V[>AW".5U&%"_7V21]E/&)^36#+,;_VQ>HLK[Z;5N&T
M2,A)5K'NO-"MW&O=;6U@='3?WMU=86=?MFCG+Y+ .*_OH2M5<2':S<#P(FE:
M3;6&[FJZ1H1=(WM_0?.9@L])Y[^\^?'EQO<HV:C[>N/[HURI[E%!%_E87X\3
M %XN.\];J!Y#9J^?.L>\27?HPU5.;;9QCBENSVB>DSY!U^U27UU>'RDO]];;
M:X7KLT147NWIKUOPJE12KD,5>@/21J6=(OKU' P=V!_.TF#J5S]EW(T.5W<H
MCEQ3_MAJ:J.%XFJO-2?1@S/R.R4')_D>^A)\3;%?T1/O7R'UZ*RG+_NF)) Z
M4C:ZDBC*-LUIK6%DE.1]S'U\2?]A3X4[P^B&8(/DLL2?JL,I_*NK*,>X$*ZA
M<T-_6RCOUQXN!*+->O;VFVGG/ ,K6Q?/4D+57??>BMZ?&W<AH\O&*V2Y7M:%
MJF6Y7<*[! ?#(OD6'V/5P(#-X=XWC\#?O5S(P56UAMRWB1[O7++%[W!$F3MF
MO#=<L;@.<8JNC?;=&51=;R2DIS*=C C$LB0)]>CLGN!>CF4Y)3N9J+V>96!5
MG/BUI21186-&\0^?GN,))]=//KDFJ%V8=%EXG]Z]^ZBK7,@/A(TKZ#4CR$I:
M3<VY=/<HN@\CS:ZW?0+/K'_!>$,U_2@ROGU(($\N_5CL?N+'_*>O4$V4'\.,
M,).. <9%FF7EL]GH;Y;5DL[8ESKIA,9K/R(3M;^F%"U+7I=S:T_I"'8S7*9$
M<4!US/2I3CRF*UDQI_I=X;-,&$Z^H)]X%.Y/;'%-5U4H"C%(S,D3P;1_ESW?
M?#\#3CTD>F\:3&EIA\E,18\*BC]%$-E,^,;0)(?MPKOVFPC5*65]+,K3O++J
MZK:A ZTK'VN9+7=+U;4K&T!CX+("#Q$;(#\S+N0H8.\1>5ZMV["[Z^?+"+*
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M795S/..<Z55\XX?)/ER\C1%FW_#$J2_-E&Y8(/T# P+*2+??#%]7L,U4MY_
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M9(+?PJ%$!^Q6#]RP.>OA^4$WA/I*X5M((0>\R_7H(0$AN0=I.V%@<;= DRN
M5$)GMWWQV=IZ%JCJF6694/OJ9RT:HCIXYW#=F\;F7"OW4'[USH 8-G=Y/0ZO
M35U0$$; 4G(A.R_KR)%@.*ON]>F=D2[$J2:2652@%FXB2*L<)VK1EG9A+7Z1
M_5)$RX^W(9]BS^TUM(9O,R![%VS?88G7>5)_1@?P>C1]'Q9:L#Q=?WY/^.7)
M_H\[5H1<?B9 VR=HO@HX%$<5:.W+TR7!'ORJ",89)1=]\JYH,!%.ZO#-"0[@
MF@_EU;HP]$E%^F#+A>L:TOW[4QT+840S1^"$[$,&9*X )?ZK$,2OT6#_5756
MR!FD>_GQ>]5L!ZP\BW_&Q'_P=<8!29/+:P<7I#QYWS?KAV<80!!'D9TO[Z6C
M>Y#)&0^_G>PO7E9N>W!YPC7S^RO9?&FYF\&8<+ET6MFOU75 9HLJSAY :NJ7
M%""=6>JF5!CBK]6WC><;P^IYMXR?36<*W4W+ELHT5A4[W7CDS%E+6!LH(!]F
M#_N(T3EV_7I^F"JL'5/WV^^!Y=O,60U7P?98EDD,11/M!C*S^ QCWNX)"REF
MLJ:VW@F(<AQ!K@T1F_IA]>L$5N(XV7UB"9UX<9SJ=:_.HU-G:DSTVIZ5NUPE
MTD9<B;I?9ZZ7)^V;74.6HGFQ#AX(\4^*@:M0@NFY68RQCW?;0A3A[NOTM-#D
MG\6+3,&2>^]Z;?#0]^VZY>@!FHDFY'(@@X3",R!Q&68D1 53HG%8Q;F1Z\]"
M*Q<\E!3//QI2>CQP4(HE]T/=.]6D6 A-?UQM,%S(M*FNKBEV;&Q,/7;?X20C
M<>573.;7[_!#(,P1K&;_P^7/OS_]J\87:1[_\VG&5RL74_ZQBOF7==._SAS^
MERNW_YQY^_MAO)._UK<EU*"4D-T9-5]+R78&1*H8I.,'W8%4#$".ITZB+B'J
M(8__-L=X$\!79C @MXXAR9Z8<D?QH#'DF@P/?<CV^I\KRB2R:L!6\4?44JE[
M9)N/ )M#[HA93MS>-2C2=,?I; S(BP:(SY\7(_^^\"L\R[U[3(H6[4I_4F?]
MY\@?(X$R_9?N[EIJ!.\_E]<*SWA>3/J5OS_<C6XX)$2?84"^[VF4@]X 6=:!
MX*01M+0A%7^T2\K?\OQKB:ZP],3IWREZB57V9G3T OU)Q0U=@=52!F2*BAYK
M^&-:],^3G']NXG^N .^28OGKJNFYOTT>0B;^/#_H%_*G)=4(CHTJS/C<'L0G
ML)N#DW0EW[_6>-@A-X[I<:Q 8[A>2)]$*MU=A[P:^&&7@J^XK\#/U(WX@&;!
MTW+0;E6L (?"V5\NQ)14GY<Y2]'G?#''NNKS'&QOWF;G;&Z,W+O8=XD!J8>^
M17(CQM%[=?3G8(*8=FP<U<2+[%643#86V2^I95ZMEZXE(&',LM?@W1FYVH((
M7;:/H!)*E)3[A!#K!5%EGV-]5@\//_7DN,)08S;NZ5I,DH?HMYGN )7AD0 6
MQZ-'MB$'7^D+6W NGYZB\G%2'.GLKJ@Z,^I1NL.[PU%T7MB:]]+@ITD&!.:R
M02'\9$ FM[[2A\(=#2!.<&TBBGH(QK.IP#E"<20KHOQN+6V'Z:R?4#>EW/7/
M;>Z[K/IIZEW>+MIPA7N0E**KVH1"*78ABQNXV1+AAM;Q'VWJ'AIU_I[GXN(;
MKLGF9D(B9T+WZ\OMF:9<38!LK^+!T=<,-]67^CG'!! )D*"AXG2T?7R?*:R<
M;E]$^>]1>3E\ 3.L_T[\YE[>=WN_1.I ^V%$ T<1> C@"(O3/8$8F]4&(C(M
M(R4XM#;7ZZP_7Q:Z_=7NK:+(NHMYJY?.ZVFG3.]J&&)43Y)K=R3:PO%@5,G*
M'SNX@ &O'(H2CT>CY>3]BMK$L$2O,EOD847\56NY XXG>F.G12X'/-NP50)D
MU_N7UZX9@)WO#17]$G*;]^JI<JJLDT?9]LW<%PT2!+EJMDRI19VYP*KJ[_G[
MU :A:T,:LS/#>?@UDKR#]TB'\;T(3>4?_2*RDVWZ\U5K%@P(IR9Y#; E5=%Y
M'6N070WCZVNP&G1=VP@!VG!61YO*@*B%AL'7\(/>A#[#NV<P8#-IDR-^WW>7
MT8MN<%GO,XN!"C<@HW65I[R/C#<,/1,7G<A[G7:D7TR-[_31N8=1\E QIBLE
MTM.T+.1<]AA]&-;(74&*I<P'Q\.#*T(2NT;R/0OM&@WS%G&5N*=VTJ\&:GIJ
M;'MYWTIUS>4R(%VZKT 1$TVD[YMZ#:C.N_4H/91D!G#S57O@^B1L0@.7?X,<
ME[)S34+7RC7-S[)UH?>^"']]7MX[GLDV*%QE1GL(FWMNB:H-[E'B!T"S"*$^
MV2%+O4)ZK(SQ=#@Z<?C J<:SP@?ZA=U.%/4*WB7T*#-%M-$4#"#P1!(/G1U9
M_AT&A9N2I.:0O02ON<9V?';F4D]FS??&G<7LUQ_V)[EJC->^'K"Q\NEIY'RG
M)S9TOV2MBJ(1,C-77%KAV:$-],]7);1TU(F;IX6Y[<TML5Z3-SGKP6VI,A,!
M4\;I5;D61.C(DEEI"6A<G"X4Z ;U0'06G3<5,-&Q#YM'P2C::XXNE/-W9-.:
MAC(06%GMGZJM/Y("5M""",'O*+$.$:_9 R29]!51GGAYE_'U?*=(TH67ER=7
MRE6?W!JH9CF@5QF;  &J0/!/O.28B&4)W-<F0UPEEY#,8G7%I[\(U8[ZMLDX
ME<Y^?NL\>RMEQX@[GWLOG_O20N>1=A[R UH4:.U,D77&Z#S&)+^>FAM# 6(A
M* =TG0G-ML>RRTFG<?7HINV=,0%(S)V:OIHG+E_$ED6/,2\B,3-T=A0.#8+$
M?7#V?$#;W"R&?@BP#?+2C(:?O76+W)HL>.JDSJ/]#X>3]F1D:P5::C\\1!T'
M,9H4#:6 ]N !3J#69N:4>%<P2::E@*W5AKJ/PM"3B?9O@DVJW<'<8_!&DX>%
M:5;2\'SQ!)IB)5\OLLXH$NY'FNG"\OXZ(T30U2#:M_=6)I>&UP92Q*_UD08Z
MKKZ)WY).4?G>XXMGX8!L)W:CB!>P!X I/$]TFPFI#%\5WZ'L@6#IL#<Z__''
M9DC]JD'V98M*C0$Z4DY$B[/U%M>3VPW3] DH\;*ITSR6(%M,=03<2%;6P%D2
M!]=)=TP,H2-#L,+K-4;.[WKZK)&!]$F['_)%AJBC5D'A)J X/2'"0'%"$EO)
M?6,=ZJN@-=9F@E\7Z'_YU6.G=&+MB$&K"@DZW7.IU&._TZD8\TY7IS=NS&C
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M__S^\SM3_=6U0A>(#'_KL=TOVBZ2]A"-!/O'WODL!5DN8G]D7?C([/YRVG
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M2(]^;5">=/Y'?L3LM7<OXNVG]T/8L(%6N?1!QP:C!PR(-SK*)CA5%^IUO!Q
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M9KJ'7:^EJ2;&5<S26#S.Y3:[0KV3K/LP1+>EH.,0")8\D1CLKJ/K-ED2]#*
M)%[%XZ82EB*M-Q\&Y=1/5:SE1H1B[L%<M?4"ZA6I<][OU"?_OP@Y!],OI7CU
M[W %W SM,LXU+/PTQJ34DA\K=>+X;8&PY]QL 0X!%''$E*X8K8F^]P9<C_@R
MI;7D^]24*J:?N\I/7.CPB[M)%Y*_G5,Y=6()RW) I0,";.%UD)QMMOZDJ&Y=
MSE&X07Y]B5DS<6&S2?1>#:_^FXM2C[9KN.;^^,,$+,!JL53^!:HC*')M.>0H
M(*/$8U)E6>Z^7T6@A?N+9O<?F'U2,:YI"?71/4\]N.UKE1_E,Z^NR,V9\I';
M:8T(&:IZ'9"!2XW$<CH1$65>M!(GW&K[Y47' V;N PX:W#(I1S[D7)"T=DK[
MN>?.&2^<&Y4_<H0<"\KH'0"/=XO>+!H/PK)]M^G9NB]9Y! XKFXB9H1:&ZM]
M^.$A,G#;/KJH4%OL1#[TRJAC+HH3.9>/;>@GV!/9+I.FNJJB.O;8:W"=$BM#
M'7BO8UHUVX=>9K[<9!MSY,"W K7T:B<Q>&=MV2\HE:^;/%9':T>[2LC-LW8\
MH<4%J_>016/S%'4_-F8=U-AGU95>_E+<>0\S_CFH0&+^-YTP^V].G(&(8J,I
M:YL!>:&(=I6;\P."-%/0N!T8<1P[T\$+"IW8X @Y.->?5H&FL%%4?4=D!_JS
M-Y:&AF>G\WFRVQP+D=V/87-OGODV>9:64(5I^3?&S&L.-XS;A$Z-/+RM<P+S
M5>=NC-Z>3AV/UG71;^BY+Z@#7P&3?FR#:]G-5 5R=D'%U]I#@SII[^^O0#K?
M2W/W?_?:1-$Y=MVGDZK!KDE##-8!,()&BU7\9EG]A,Z9TF&>+(^[^872,=>;
M8R]\??(X>-]G&=801^J!=3J["'X=.)KZ$''8$Z%-8HOZY0&_X>?BY<8=I?YA
M5;1K7+4^5>WD')VDQV3;<>&['FP7[R?J*M->JF$?,B"\\%M$*"XN4E<NI#1]
M5/VK8V_P<?)7-;LS@_25&WX53W-BDS^4*!H_4&T".E[2GJ)O(3%;=F 1VT.L
M\.LI"%[ %C?4,)P_%I)@QK-RW_/SMI(G\?(B:UN>5?K-GCKX!^?P[:LJ9YA[
MT,1ST"3'VA*":CFP1;X -!>%,)M-IHV0#=N<0P@L22:V!\FA\V\>:/()Y8H$
M=GVK4WH6CB<?HR7!/-?WTT=;W%([=.D?+3ODJ\=\%&^:[0\)=>!2^;60.FB4
MS2OFGN.&%8EY>/.DH?$A*&A$=)X-V@>;RT42_94B=4\8NWNW:<TWES=XM<;;
M<08FK(BH#9TSN'U2Q.K#XU*MP:@G^]]L5Y')1$05!4[UI;VFGW'?"CX=%ZLK
MLOHL_+F5I,UVL*6?UGC^9[0<4RU_UF%CSG3 ]:MC)9)HFPK(' 5-+E85('RN
MD>A;B&N']CGP=#R7Z6N0)\Z,N)Q6RA$)<4IK8C\2DW7,"+MP-R";PHKLE*A"
MNXT LK*]T&A)V$2@J5,O5* ('6YR=6SQF;4"=3 H=L8[O2^E3\-,6P&*38O[
MP'8(FH<DFF,Q95? MB^L6O,@DONOQ"Y9D S3/'<^-OJL/:OX.K\\5A]=P]E0
M<?1.N4K9<7GKDU);@UVZ_.-4=IRIJOZ83_K@Q=&*(S6U3><N=K)<X%5C2;\C
MH/=M*8%:#!*]#C9;!^H TIEGADT/2"-I]^3MF:S'[K/YHI'A5/C%WJ&Y-4U2
MS95OINO5*YET/4/\(NLAY@V>R=<0ZCLP^QJR4ZGC.'T<*0)G):%PTH*2QZ?:
M>#Q8D_MC_>C#3D]NMJ2O',>GX+?X]HR='N2/6[J>Q I/LT#>- /D@_K[T#/,
MW2@.F#LR"A,<U:'VN;TOMPB(D==0N_8XX^1VP-[,F:'D&\&]<D7EV""!LEG8
MW M8;2K!B&2"]\W!0Z<I^'LY<V(7U+Q\--;U)GI2;^F0[+Y<](U\ZBLU^U[E
M,&W2^MR+ITE,X'A2TT\]Z#4/AS824 1FR@7XE3%J$#Y<U"6O;_R\E6#MN^HV
M\_J4VQ&&:9'E-0:\I3>#>379(-M.=(Y$(L48J&! V$2IIX@_VMVX"PM6MN@B
M31UUV?H&P>QIP3TK9UG%]Y1K1QK<=Z1*^!&GSHTB^.$B$VOU%;H#]#'RNF&*
M;9@U_I9K=6'_WG-+@X8L!6Z>ZW!NKZ]HCRI &MD#2\82K1U9Z!]/(UKG!AU9
M <]5X^;FNC<MS?1/&6OP-Q<FF0]^T6-626G6?3*%[/1#SSUS +%GY!.X,E$C
M<<[>MLO&8BHVR"1QIF2JLO)0ROGT0Q&'8]F-M<2_\51 0E,)B42I3@8$M%;G
M9NJKQZA:A6>YLJ(")3PU*/RV#$B]C ;"Y\<]!J2_>[O6]]&MAVFQ=_P=0!.7
M)1P8FEN/AA'U_!)$EWH&37)MWV:>+JXJ]KP?7O>T&-W4&CO)4UM8)B5W<4N;
MV9?U4O:7D\ID-.$,A1=(Q!M1>;N6YBR?O':O#LENDWOYW=_1OK[T]C@F_&D=
M[ZOA@TEL+(>E[LRW(<F&8%W4'4/$Z.SZ8)>.S#L^#'Q?I>-6:N=Y=442ZN$2
M9981WI;YH?AZ_,MIF?++ Q;,SL7^&P=X'B'XZ!A4/9+ 21$!ZDR @Z!-=.0C
M?8_!K3"G8):URE*_;T^>) X&>RM6"AS(RGA_SQ5C[9S\%485A;WZ8E)"#:_W
M6/2R=B921[OLGN*#19_>X_PHN"\BCR)TAC40NA=LK@18PWI7:MQ]5">%!R/5
MU0+ME/#TD.J(NQQ[0UVV,:WSJ6&JMRC?(85FJ1:.Z<.)>]774<3S,$!&:?>.
MB*=94(&X))VS./M[2J)#Q97/,&H9==*6*._!2S+Q&JKA+Q$6BGO'-R2/,6\L
MT?>]H!P%V,AE8%,44:U2YWGBRJGF)8!ID(+-X.4.<YG'65",\0&/ IC\:T'#
M;>@)XV_B'!0W.C</8()#1L*(QF(C/(!V-T8S9O.8SC4G'1O$$S>)E^5FTF/O
M%IST!.Y^,&/>K# #I->IO+!YZ-IQRFWJ%2!QGA;<^2PV V]BF^.C.V/4TOQL
M'J:QK<CTV(3%\\UUY@77;Q1GFBFHY]AH*=YH/[-IN5['_57J6H$WU.L3O!3.
M\GV@2'Q2*1I5/6JX*?_@QOTGKIU<D1"= #K7)@/R6!\NQ8"\&:'G5:VN#5!_
M@%5S1':>1GM6?4[MUQ4F3L733P)R5P$AG/'Z8F+W??N:])6M$9/TG*+T4>DD
MSOC,VY'!]F\?Y#7L2.E!8V$0V()7& -"$5%?IRG/6HVCB$&.U,+Q3BS97!Z]
M.5,ZAIAA0(@&58D.,C0TEAQ/RZ-+A_AU29YL"WR3*1$.=0$'?V>-]/><^Q0%
MQBY4[[]KE/3^J)C8]2!44PF53Q;$T:!"9YD@\G1SA?7/[B<)]=IS]KKUB"ZB
M7VTW"@K5$#Y97)5I:KS-(?-E']OCQ(=/26\/27I1KC$@ V4V;K0$26$&9+P2
M91]'%?.G: %'9NCL/3H7Z:)COK_0D@Z>&C:$KQ.UPSLQKR]]5"C[P;8E)O24
MOBS?$VFZV[X:@,0KQ!"4Z(LHF^-R^#%,L22FQE$UBQU&7*UGWNO<K\R3_CG(
M>CNGEK^V]- >BX '/V6IO(5D=EHQW)S"I8_WF\;C,[/G'NH>MIN=]MH1K&(V
M8-$]GZ[7I#'%R=4M_2&?:[2?KW+BB'X,!U,:6$TIXE4/--&" 4F&\M2+#5T>
M[]RR87L8&(KHU[J;F88UV,^[?CAV\TNK\Z'GZ/ >"6@TEAOF"0,T47UYBE/Y
M@$\^W BP>O7%,,C><Y;5-6]81/>&SO?X-[4RSGVRQH<M70_;14YL!5-Y^^G[
MFOQV72D"YG@1)1T+V@N2?K^H=XL=9O9YK4QC/!/;H*V+C/U3W6F1SZ4R!XZ9
MOLSIA0> &89 :7D0LH2K?$E<NDHKUN$K#^'L.= 0^VJJPX^<W%N66UN20Q;,
MC3(\>8W (:YZ6-LZG8GL1N7%DFN!,(H+?: ZI!4W$J, YRFN+ WR*'6W)'_L
MRA2-M?1 ?WI=F,4GW4J.G/6U9DZS<Z0*M1*0Q&58(@-RFP&Q)X=K!IO]<L0T
M(MP<8!/K6YM+ K/(3A7T32Y9.GLK1?GLG(2F9?-4E9_2M\F@Y'/7?XZMD*WG
MXS_X?]OVCXZ5X4Q'V&6D>Y736NA,F@1CBCC5F,BB+#_5<?2C8D6Y0+8%XO.!
M]AJ9:@A?N?.WE%PC&\BV"9TKYTV*'W!4)KVP4,WAZ*=TO1(9,>5&GA>=;-\-
M[L&(Y@P(<+BIJPHXYA>OV&:O/EDRE_JP;J9<J7+Y=5TWPMS\B.:]8;VLP?.8
M_7Y\:?6JM04/-JJHHB](->I*TPS(O&.W25.*A%D79L?+O%/VO5;LBD!,WVR1
M=&;;<WBQ!<O/@A80#R([%6!>Z.F9>5UT&$4''+>NA+CUW(^9S ],%3XW5OS4
M+?NE<[+#[(^C?JW9@J>,!^&%SR/@%I3]\/- -]AA"+##J@ D&3G1=G&G/R9H
MG??S=TQ*AM_=L>5@K])08]9-<_1.=EP.9\V5<GA!T@U_>R.".3&N&RN)G/N^
M#9>;;]>0<.K>R:LJ4E](PJY49BKQ8#Z\P@./ZKV:S?:K\.SMZ*5%@%HU5A35
M.8)Y0#]-O0O$,""<JO-A'_QP)M>?R*^M6]\J\; K,VNX_&Y\(/D T\_GQ\QB
MD',O'.O6=N_GIHHCYWF8;$)2-KJ$6FCD],:6B2+#&YOO"XBTHM$/"1+L)TBE
MN$\[!T+S>0I@<ZO0&$FA,00K]0B)JS*KY/-JR[TRC1@OF38O3B[8VJ*9E.>#
MI_B0\9O?\YSP8L/P #JG5(5GWA&P%;00_4(M'Z:L1)/[LIG?JP_#I[,HIQ52
M>GY.FY;X+]2E7PYP6,!7 8=3"5(4;[@WL6&*H$ :[,Z3(UI%WZ@@"!G$%Z+3
M)YZJONY1N!5[_"6[<*CU /;$-W1F03N>SGD8;.L2DA4!2Q3#944BA!Q"8-V9
M>9#FFX]6@X-/=DN\:KIP.T657U7YQ &>'''NX@A=?[!,*\@!#K2;$F5?B!L#
M8D[!;$&GI\A.1#D0^[7_G$[E\M@7Q(#$;-V?^#5@<[Y)2 CME(=3%#5M]I!*
M>V_H38!P/[<R -64 DC* 5@G=X&__G Y0 MGZM9EF7>8*+&8IKZP6.'OS_JD
MR\8C6.-NJ.LI%WA6]@56M@'N"X>8?T Y8,[M;F]11%,)[;F7LR^+C>>%=?;0
M!9^1)1;?^^:]SW>[>EWKH;8X[XN$) (+ 0+-!I6Y'A+J2=]=U;6F3V J4Q7&
M/'4E:SHF M?K)#*,[CX[/UR>Q'1SIB!5XH[>VRH.,)U,2#?Y!5$C S]R #$"
MV]<A23W?W-82.VXSV6:@8QSN\<CY@.$ZTGO6%I4;L9_S1/K=0F@QE@C6#)!I
M2H+-H9"L"*D0LWE0(T?] JA^8>(/U$S*LG%>R,,%:=(JW>PL/V"!DMH)Q%Q-
M^KY;E+.(7JA8F_X\SS0,[YN(4V#ND;EJJMD3\Z7\(OOU)XA!?]9NPZ%#*8;Q
M]A8S;/*]$5J[T'^-BW(M1)/.L>Q':IH7ZEKGIFH2EQX:%LQ*)9[[5(^M9E)_
MG% JT69US63CJSRO\K?,+[W-Z@] ^.G[9;JCG2C)?Y !<9?I:-DX*"G<,U3R
M\.?G;[XW[JCVGU$=F8%66ZT%4"Y1M0'*[D4ZJ0R(9%;_18R)!SE/=)2YLRC^
M>8]I=Y]4I,2[FMK*SYK*CVN".JUV)Q7#F.D8)-'&+ K+JG XRKQVK' \D&:X
MK_*&<R(A@%:\]NXL;79&F8]:>&_V[MW7$)@;0M1^$$G$=V^,2&>8:N3X2*=?
MZ'UF^'^Q]^[A4'[MW_"($$EVR78J^UV2;7:3A"1-*10Q14(V$X61,8-"]J$H
M0H542/;99(R]D"*[$69&R&:8(=/%;#R7^[[?^^Y[_WZ_]WB>YSW>]WB/X_G]
M,9MU'=>UKK7.M=9YGI^USHV6BGQZM_SOTOI_,Z^&.9UV7+3^7P?O_PS^>6\:
MMW$/.VHGR,JJ+>;IQ*Z!RMG[ BA#%_F?AF?]RYG%GZ$-8LNP7?//MR#CG>P(
MM<#W?PFC<([C#*9JTWW].=>_17#@Y/G3$-GMSR *?^DF;[^3LHG7WXM_#3A?
M4_Q'-/K7G#>S6"K?1N:/"_P9B;9L(/OLMI%F!S6$V8Y=DM/_59KUY_^_.16J
MI/Q^\ZN3\>V?H1W$)!;M+GJ60OYZ('3I+_Y2?R,)UYU_>^(_GL1I1M]=P*YO
M031_E=[L_E?\A+\/A>[FA3=E Q%2_T[=/Z.MRK$(V>!:>MA>Q@J&SZJ*,ZKU
M0)EZ, &QN937>XZ[[ ^'GK#.J=6]L>RZ+<B%2SH01S':"CV>ZKF$)]K3]%-T
MNQI-7NC^T(/Z9NSRL,AR($0V5KL]SRTY?O[;0[7JM_6?XSS))H=]-$X,$-B?
M2,$]R #A'M'\KX\CN<*].$E3@'(M4TR<*!B'=<,^D.1.G<X31 U>H67<"\J?
MESR;G=T]4__A0<'93Z(/F#4>Z9JUW$<XIJH<B]C-#G-_L\]P1YM"]^D:&*ML
M07B7,RINIB\,\CJ>$=<_\\5<Y8"OQQHYP5MBM]ZJ)?P=TY25CA%CRM-VWZV-
MQDBB8=3/Q7O0#1-*K37!CD(SE_?()^M>>QSL^G%_\FQ]GBP:]@6C M@MFM%,
MXPI0*>9-8_0<HXN5R:L#T^XE<4TJ'):$A9*C!JJ\/\[QS+ S&3?1BH.@Q&L@
M9*9X /=( <2&%8XD0QDOA-IEJ<B9=*&'MTI7]062[WWS_ (CEKHJ5U+A[8)C
M1?3\+\YL8<T=@+[CZGHV2V7@ZF;0^$GWC*.\ZGRLY[MS"G-$'W^_O3["-/I-
MU&<):=Y' %;>4\P;'^5.417C2"O<[:0> :G3Y=1?^Z;<$FQJJY*-#(CCM=V7
M+G+MJDUZ[B[M%@&#P8A%4U0[>"RL*F7I:1"UDCCWX"J00.,A]]()>IFOO(\T
M-&I5_1SHUENW3_AQ(N+8[MV1Y>4N&2E,41&2)+L?)HHCY@W;7;$V3:?^;G/
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M!)G+[?4/,BSXWLH=7S4XQ3X'X03?_A](MQM3]:AL..U_/8Y(<L'KG__ .W\
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MXUOHWZ_(B'+DO[(F#?B;]E6RPD(_.&Y!+G<LXZ(O3^7G+;-MKR#^V'&"3$V
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M")K)%N0!NX]JU2J\7\>6DR$\K)4=AUAZ_OV^R%-A7ILN_O<31TAFQ[6POE/
M,1/8]2T(X79'WAX_#/\5( <MAO)=UE6DP4?OE^A%35ZJS+PY\VT'XHTHQV:<
M1>C*4A'CU$]$]<H2C02/DY44>95$;H!5FXO.[*[Y7/*UAW])(:3SD*&>H+WN
M&@]3[!Z;'_$2BS_"]"&E\!=%%=&FXHS-W @%P_F.DM>#]^6Z6TC'P!7=>E>M
ME/E$KUJVY49$A+=:H!M JK_>@D1E.F/Q9]E\BTWJ*?@U0'7N^+"4=59W]<'7
M\GEUR?:I'JLOC6,/O#%+^G@6M1G_=]56;;68O0>$%%%/F)ZLZ"9=M,$ 1AQX
M!]WCO=F4:L)^P>^M%X+S3?7D?9&%RGFTDPL=C:'-O3+Q9/-[@+/L/) )OOK[
M$%NJE0CC!K"(*IJ/"__X1[>!!51;ZI/[P=0GUQ/52V3Z>R\]Y!:_]U 0IUR"
MC<V:^1W'Y'BQX)23/E^?\:)H_/O$6/U1W8)^R<H.^Z:K]G'[C6E]VV<E*"13
MM'8:_@#GB1PU(F.3T IWLY!QQB8O/W[."_YB95"3>?=U>!JWI5S @:.ISZ[+
M/IZ>HIKU$P;)@I0<AM D"D=VP&U!=BD]>$DSF7U6B[U64]DFU.K?E:TQG61P
M%&9TNW][%\O[JZL/XP;:<JA)$-.Y!1%K='G^.:-^+KI1IGAA\TZ_\*?WW\?'
M;-7/G(]TX/AZEO? =-:&-EM@E55CJH3Y#JTL2EJ?BC=5W(+<S[,?,#ZEKJ'$
M_EQ5L7J5H6[G.XX4O8FYX9ZV:ZX4$L[8ACJ@HJNV7O"7%;O(WK4% 8DI W32
MQMG\]K0PDGY<HU/FE"!:(XQL%*Y]RD7ULY!OS=V(*,$I^1,W5)]^GM]C+4]_
M+OC-Z>]#N,+F;P4KD ;7O 1[ +:+>8PZTOZ&5*K6%@P/>-.A4ZS6T8"L5G?7
M"!"-/GYE^L94X^U<K<VXXSO%UAR98EL0>BP-N50$CN0\D# ]M6/!.A\H-G<Y
MYHMT&E9+]??\5NKW?2.PV+*SYW'S]X(=9IUB<>"]%UF%C7X,<,;!F/K3R >&
M(TQY627<-UU>I8\,Z7VY;A:!/^_U1 IK14-N-?[N@X1?^R?BPVPG$MV_!2'F
M8\%OG[+QM6G!>XWAY&_#C5JD8K7Q)$VXK>JG(=^GNOM)9ZQ%;=2BD^*9RV,+
M@:%EWTY#E,MZD9Q@!588#>:>[?/T1>R.)D7@K8 /J3-^N2"A5:OFJ0\/W9/P
M4MR!KZ*5ST91<//@&C^Z,T!)JG^^[[_]WOZ/]'NS$)M&4,^5)=:O+&TP1-'6
MM,P8I9C!-LE]">K#XL(ME1I5!?<OZ^G9QR]_Y]Q1QQGXONN ;(\%QI<I4<VJ
M;0QCJ**PT]R/:5/X>L:"TY&1]);-LFCUTA<?'G3T_ZCN/:*VD1V0Z.LRNK-E
MIG@1!BCI4Y)A_OUCYL>!2,6,>KW"P-6QFPX!Y5[N]=$U=0]RT36D;]*/!:HR
MU#Y$A.7\0^"BS[.J14AYE$%J)[$8"%B1(I_-QF*RFIM&U05*M&W>XV=R2/?E
M_2<_R-_RXOS^?YNVOBP12ZR9$FVTI>83L2W%.'Y4@@MU:#B?9G[J;[F[9RK3
M%L8H*_S-%"D5K]&W:;&JIQ.3=X;G;+>C T:UQ\:[*@(AM%:Z0Q45E(W5$WPC
M;3!1'1;,/A:.RR"8G!U[I]%J9IC/H7Y=:R=4U<SX]G&HY]]&VU6"K#E^WM@(
M9$?\7S"<^K&2EB.-!R95;6\AB"<=0LF,8[6K&_LC:K8@VL4<M1_#_B'['5OR
M:JWBC+UI##8? NP_=PJ-IWUJC[%2$,DY;Y^/8Y/81S_8Q293C[;S;;6<!GQ^
M,=S?W:R4L)_$EP0CMR "*Z9[F<I?C76Q9+_;'?I.QE!//\_+CVRP:$[A4NT(
M_0]VX@$S-3]^I'EQ%O]/[8(T8NE55&0'4GP+T@*N#SYL^Z0TM6@T:/2=L0VK
M]*8B^\N@U6:76^]14K^)<06J+2$Y/ I<F66)&%FT'4UWA2GNWHD1RFYS6FH2
MJ000^UYPQ_]>K<G9V=U0?L%P/&-U^(Q1$BGD6G:N+20\Y[_,;KOM'41<2<SE
M!2Z_=D(C:<A88P]RMV[H;-7'KWX6C4*71!,M1)1CH,\,'J5743_IZVF[_HMA
M_>%K$0.#;D%F?,($&1(Z4);6V,AR$$80,RRK\Y4M@\4/<#K3N$M?_70ZG$T6
MX//I,S]7;^/L?*DCUC,SS>K@^?#N'1&P$/]E\OOJM- ?R?NOF<NGG<([Z'+*
MIZ$@>]8W.-S!L;[ >HTCOD%4P^+0,@Q5:Q*."]!N=<?2Z67>HB5TLEU<D-$5
M\\/]1F];'FJ_YCE&:,,DN6*&IG;!O&7$[:F:4:9:S*/#C?9DOZ.K/6>K!AHO
M>(8&#TB%[KH3+^%D.?KB&46"+S',\4<L4RJ% 0>TZ5+ #"V=M-+.<H+&2H(S
MU!0OK4'>YV(Z3 @WGDQ(")UY]+95<_,$13!B?+]G\-!5P2L %FRF!ZL 2\S%
MU2PG4-/I[PUYXGX)"O?LL"#;FG[>OWMOGTJ\T:@3+]E:8ZAUEQS*X9R(')=?
M>@FK $<L0$CAKN<!AY'131) 0OLY5Z84[2/[23W(I6P?N5J4;B:8'?RP.HR<
M<%4ON?2IN<13#N#I S7?RYJ);.BV-\EVZFRV($J0)%MT;5JD4.%=NF+QJ[.'
M?7]\R/K9IYFQN&I\JT6,8!'8^&'Z6G\U>/<0C$.7F^K9TI\H>;+V?0\I>^..
M5/<!=<GQS^WM)?A'LR9ENXL;&JSW=QET<:<PI?G!WB&!/(84.H0:$H$10M6,
MM&8FY->4E9W."LIA)MYX5"!TY$.R16)TW!2$^Y"]4E0U!5J+8(JN. /;?D_.
M5%Q'"M\"S:O)A,;.>6E>>*731^![<%92LW69W-C1);]4\[OYRI8S//['H%SL
M'E/N(2SQ [:JEB)!$VESV*707M0J/_BKP0;5V.47%*HAE]R+[DF/\_.7WSB1
MMJ%Z@H90_@F3:+1@.&,^;T%VX&Z4JG[O?NUMJHV+QX_5\D@^JGFY<XY#3"&-
MECW;(2U2*W$ ^CX+RA2#=B(J>)A"V!:8!/N(:^LT-%[62',+PLMZMHF^>W>B
MNO43/<:^]B1"Q>_<61=[?96+ G6/QSMUD/$@BD!(L7LH##,G8(KT.8>D<N<>
MV<M8?C,H:\*VB+<MZJ+ S2DY\Z<18>]G4(PVA: \ZFWX$B,L'R2]"5O*AM3@
MDTG%M?K=F&Q9V/_UR>5QDS<UM5DGN(?L@Y+5GZ%'>'DFRY[BP*D/*,&7Q&F+
M= _J5#SS L,,B&UQ5?4S/$B6D3M/<TTIM/%^+:_L[\ ?E@#7):WQA_H6_C[,
M3<9'0!@,^B5P9I0NX&HTF<*>Y-KV!BD_S5:LL*D,$.;$\*@N6RFEK%#NS-5%
MS1H4JD_:S/!>YM]=D%!'3T?L9'_&4>WSQD?H(X ?2([?+<X.-,4&4O_1%5>:
M\5W93.FBL&/QWT-?9]PTKMJX:#5GQ(,WV-%4"W P3)D[ 3EPP.^S7B_#/+<@
M$D!Z)T9BB*E+-@@2L+GD6S$Q/B_\)E[=V3DF42U*6HU[JC5U\.D6Y-ZY+<B/
MKQ@%[.@D[%<\'X1U!+"^3>:?BC:5R&ZOH1)0;UT4A]9?'U)UC_G5$G/'KJ0G
M4I&J5RY]Z]0L3AA&_"$H[L*$@?VM91X8J6*9K/NP1%KJ=5G5\?X38>I.GU\<
M.JD7%=C[ L6UUEPV$;_M+WDO'NW)TXH%U,7Q9<(NXY,NEU'(ELW#94%B!=?F
M4'[K.9;>>CN.*[GIV_&\X<R"4&"^*^.<;#XYAAC3A#K7H2FUP-XQB%8KFTP(
M2^'WKK?]^,G+KBN99AY2+W<T!A+Q=<(ZQL+Q5B]G. F$7!9!*8E0JHV7J3%:
MBZJQ!4E"N[SV3M4 A7Q^!MGB6]_ Y7ZA2_A44I2[_/V(PA<)P>?T2*OZ3/$P
M-I\SU9D.RJ H3_Q+%+0S2S!NO4QF:M3%:;[&\83-.*];JF?JNQ<2/L'[+XX=
M[E#OA%!\0^?B,0>8%\!GT%A\S=2>P\9:MXL!][9<W1&"4<^X5RY_G]39CVF;
M)'EKK7K%U$.U.\RJ4JJ2"O2&#\CT4\RF^P$5>'->)*&L(P?;D<??>.R%U^NL
MF$)BW]'/GV>GX?=[.2V=;+PY7^_6KE@?1TZX#:TCF"(A;+Y4=X8=%G^L&IXD
M:^QLL@?)D;V(%/OXR"Z4C_ZPL-5:6+I<<W?Y$0N--=,OUF2<;.,%ACJ[+Q!<
M$3K][4G8Z8Y*,BSY;M++\,P6ZJ+>0/?.Z?>*NTISQ>M'\_MN/*FW2H/(I^(6
MX("\9@L%.0UG2BTRK #/UH K5Q:S<AM*$M1\[GAFT4\.W.G>6:^ZVG^X=;],
M3^1QJ;S*%,H(XQ86[XP.(Y>&$&-JB8+1LES44F+TH:&EZ5RCI+D[P2O:A._=
MZBVZWV=UXRS98V:N\PQSM!V IUU@\]ZFU2.2,2(UU,R47S9A?;*S1EY.RKH&
MSS,@F:E1O7Q=-NBN=BEOCY:'^<TP(@$W/D72;(:/N7?F<M.FDGY!=_HXL!4R
MVP+TZL+%DCZNEPQGO/>+_'%M]G39348^9[ ,7\Q&#<N,@6037'>PZF#$AU-5
ML =LZ05QIZ9[SZU,(Q5^U93Z9U[HT%#TC$/L<1^_%:&MFF8>D"C,09UCBFQ!
MV'SW0&R%U\,2$VI## -'%Q!":/MI6[NIUBR_CFE)2FVE\,0G46QQ0B"ZX$WP
MU>?3 8@!!""_LY,B0.X?JV2+"!*@[9K%/IC#7LN_PB7]A$=LZ[Z4BJ.XL8>4
MU^3''$<_G;DI(J]]5(E4"R*/:WZWMWT#W>9Q5651R^MB(R [:2*W7HX_%NCG
MMY?0[1,&^7RQ-4 ;R?\LSI[Z4O\&"]3@H^!@ \UU^@'ESJ4WKX!G'PMK$ZM<
MZCWCJT:=H1X?[:%-)XT?>$(;SS[WF/[>)R()68>.:Y/U2JEA=!A02J9PWZD>
M,=8@4A".@Z]0&?8QLY.?O-W<$OG>[XF_9<8C/3+CN"2W[>+/^@ C%L!VQ]['
M2$ZB3G1>HB[:ZC]H.@3$PJ/VWSO5ZU?J'J\LN1?/\7D\=#_)QI?S*.89V#!+
M4'F1S9.%+>4 8 =M:\4V/+8@W%\PDU-\.,^56(PQ$#[=OV_>E7^HVN2B3XUC
MUL0W!T._WD.\)*_VMN2]I_D\W=T/Q@R,7GTN6P9ROBRPOPW,JS1Q2GL)R$>K
M?#,<756M-=75=47+HP90ZU)VJ]9(I8=O.-OE3\\>$[(\$Q")Z]MM$D9_"&0S
M;K&_PJK@B8TR5',S:ED+8@?J[+RO'].=7&QW8WC&WC%48_C2*T%^SYN/:H)(
ME8>714BXT?XK]^BS(#]+#=)\@.%USL;QS&=]I+_??! 9KUOX,<')0HOH>[EP
MM68%O^-\:FK-AP2L."@9\&=AQ%=;$"&F+@/.]!PRW8\RLJC_=K!\<%E79U!#
M0[ZZ\5+^>[/ 5Y/<E^X7YEI,?GX6<T.'8[UL:5OW/LUZCA':KD.*?H.57PW;
M@WK)7EYCF 1E\RN_]/&>_#+A5'6#8#!$SG$56FM[EST2W&M0N@*HA3!%PZ:A
M2SU@%3: -G6PF:UA*XAO4JGX^D[7^6#AY2O5TU<6?NL-S%Y^&;IW_TL+*8F
M;NDU1!ZN A9E*H76 TF[ O"; >9D@0OM"$&=O'V$<6^GFGSYP'ZTP^BN*71
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MHO&PL_W55D?8 H6LAB;Q;=0JP P@0J% L2W5\DW)@GN;9/AR0X!83'88).[
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MI[5"CSGE,2!HP"MC9]QA*5-T45HL.Z<=$B0K"[;W)?L;R*C@4X!R66S3/LR
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M*_P=6>RN! N0X=Z]Y;-)C8@5KU)"'^;X,J:LKPX[D$X;IP@2VXR7Q_KNH66
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M"#*8N0R&.D7<F">.-%-68%G39SY-9+NH271E[X,I6RW92&8*O81L 75&Q'_
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M#(A3Q;A,R)Z?=@C9,:E$<7/[^ZU'\1OL"1==+Q?Q2#\^7A)Q\#%KA!8/0&
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M]4R.FI@[S9_\GO.@ O_PWT*@_^SWUUU8_PL_-DB9C&[&K?S5GRS5MHWU.O6
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MF?4=6A$>0+;RH=<(V,TN4 ))9(-4.D*,#AKH4C^G.NU8S9#&O?/15+C&3GM
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M7--RK?!HVH9UT118&S@ZI>YP99N".Q>^":JLY/CMP!QNO8$C_LTT7>_R2%!
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M#:**!_]%E7I:-Y<L$E]H];.G$0>?68D?9?'Z1[/XK1HL+:N'*=4@PN&K7SI
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MKFQ!N*"_&?[*&+1>QSGGOWZ#>FATC@@ #I1KF$X>L)<?+$&28.3S0"8[3);
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M_S20B>#L([E$?,@@PB8EBC$3QS"1&C2=ZBK0))3:@5R\PYD3G^ -Y]3'RR7
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M/VTH3EO[V?[^7R/Y4O36LS=D7GI!LHIP+U9RK_TBE>LRWY;!HZ&BQB:T4K,
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M*_>QF?R2[54WU$W:A<(7N2.GJ2*"'<&49WDY%I&K%[=EX(.N?+[O.9:>^N:
M@]+DY3#!Q02T4"40 7U82 ]\=(E^_MUPGFD)]XS(D_&#7($'?IA>6EJ9*KA=
MO1%,S=FXZ"6R"48R6Y!^\0N;MR@BNWW98GU3 \&NLR:&\&JNPKKZ]$N/=EE!
MWE9"@LPFU\LA5:Q]8L3W&&YVKR(/4(I1*XID!I"AHNXG>:R%4\M<QZW"IAY7
MUN_N99\J8QX'RLF8AR,HP^Q]]+WAY,S3Z:AGWH/!?&5YJ;2S@[XRYM>X;QS]
MH*]PVO#JJ[J:DH"7OB&&M;6[7)Q'3O;W&"_Q41_HRZ4/8P5RN:V-(?MJ7E #
MY&QI,?3M[>6%YKGEKQL";$[GNYISV34[:!XS"%!:Z#YP*V.),.)$L8QJU$2W
MPB2#=7?.CAA&5_V@/7W+5?=U\7)]F-5^3S7#]K80R*E3MSI72V5^(438^P $
MI3U+GQ2)M\X%GGX=@>_U72D_KM5)0?%49QC\);=-7O&&Q778."X",Q&&60I4
M!(.PRFC,M-Z%-?6H1AWD::JJ;$T6&28#W')NJ'G8<>-VUCFYC]<$'UWPOO@]
M=5+>6[XD5[A\TT'$!@AA\VLSM$%O!@9L03IJ8;0JU'9J7HB\'2NEY1YA=!PZ
M?G!YP5+1(>M=NQS,L*L#AI@F2.-5RF>-VC,]*3G"[C.FBDZACD0A&YF]_=R/
MI;O#:T]R\1[[T*[!DUL(&Z\(_$"20\G03YRK>P/Z7OB#%+G/$F.W=J2_,@]1
M>]?]O:Z]M;A'?KTBF;WJL^,4..PJ>U.V( &$%2Z7"Y]0'G23G@>W-5<S3706
MW>J_ZC%FO^F-VIW9?)C\P?VO>$C'_52! _R?A45LF*6L.H(?9N3X:*LIE,AT
MN(M#:5?2M^/?^FSJ8$ML+ZG:E6KL)=NW/O)P,KW.-\67KF4&Q06#SB&&5H:(
ME'VRV=-,$AH;LUG^/N;K^-96Y7E58F^)E^EDBJL#BW,F5*N+6 ]]")5:,)6;
M,3TS.O75^UH7WZP,>_/^)ACQ)RO"1.9Y)[1/M*QOXA4-:0\W'5,U'JVMF7B-
ME<]-FHA:\\R?.F)\<$=M%5;<MU&)MF+4\.C%E?L%;BUKT8$!4\[:/^)DQM]H
M[G.2GY0_?U;@YH^G+3?/):2O/4TI=9W-N&9X)T6MK6JV\>@N6@N3?>%RXT&
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M39/V@D"XL9(!?.&GJ+K#NE%V]:\GD//>Y7<]<(Q[**%>?<VR1?9AIOH;?&W
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M"5VMI@+TJ0CC2_HO%[--Q%QK!F0E.F4NB57:/_5HS".&'3/2P$7")BI)-,<
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M0\215D[UR2W6SZ ?CWJ#[R^]EK$G<Q5YX_)IML2[64@N+D1VQ0JC$PE_4+P
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ML-8NCM5HH=3",,OTC@S]#?LQ$[B_QLYL18_.&W4?<]5X8O9G0WK?;:P]Z(F
M*"U'((9^E&'Z;6]+AVX^^7;S.]TL?Y.?@R+:5M1]_[:$S10GAV\Q!*@<A.^^
M_PP#:[GO/J1"I;H0'-V%_BJZI,OL:-R'L -#:\[[D(0P8IS/])3+&9C_LXK'
MR@5FSN+FWK.J+^M(CF>'?2=-'"FP@7]9##$?+5$\"7H,GB"Z/7>C!B045W2W
MJEX.I*._.@Z3)BJ7Z'BDN^H?AG 830\H(F'GUBX!?RG5EY/ZVA/>3N4N^?NS
M%827+NIS^O4<L2Q5O!2<+ATQR*?+OFP[%T?>Z4XLP;N,=FL=C=J'D/8A*;\#
M":;^.R$-@M<,%),'OD>+VM]M[;'O"5HA=Q6#LQ@"EG;(OIO^%.6^0LK#8GJ?
MH$75+?P^Q.15\<!)B0='$Y)_&-VOM<, *M-;4LOS7/=W^-##2W)C>I_<%,0>
MD-I=I;//#WWB;[5[*EWTOJQJ36\&]* +W LKC)Y$--CD[T.XMAK%6*J4FA\3
MDE].\J1]_*R>-\@54MOAJ>*A(_AH6( O7#UO8!^RF\@%W\P'K?BS7?5O&8L;
MNP]1:62683;P#ON0<;-;#4 <W0H5Q,QYB^8&,9QS#\/]+J>,7^$F5;0V6-=N
MR:F'5Q7/9PMA+K_RE_74R;5EBSP"@C#%%O/879]BP3CFNOPEZRU@T==NTU S
M%U#G_R_\>XFN6.';.2<SP=XAQ8=?+KP3^Q[T.)>K6H):B]>:(S@#Y^G2@?L0
M:*-HZ[@/]4O[UNN $C>.B!0.GJ\#ZV%MG_"/CBH8#HXBJA$46^C,&AY3[]N]
M(5=Q:S:PF)!,3-V'7)\^;EL &"5FR"M_WQ5Q7?UR.K?OT Q,'CV(H-@LABT[
M;K(M@P4DJA;O4IN NJ;W?0)E^*\_;?9*"[>_@+3EBSZ=8ZL-;)FOO"HXZT"S
MPACGJ=8]LE)37>*HBQ1$ZOT8+;X0K.6DGI1$V:/*)Z+6]OF)GR">'WBT#UM[
M/FID(^,HR!9&%OP8?*,7=*GY57<,!4D\7+AUP)FM@ ;B!Z3=9 U*+YS,'T&_
MT537?NIAY\6'<BE2L5Q".BT*&97B)M--F![^KL-1TR2#5);\ E#=:ZI$^2SF
M4*#MVEQ3,>)-2X2>D>-X4TXQVOJB<SH]O7(33M$:Z!('(^L]XR95LY($$_I9
M*M/1,;W:/*FE.UNSN5W@=D[\\[WV^+R[QH7^9V[E=)]X9!)'ZP1@Y:QN#,4.
MFB0&.^JR8_[^@_Z#^&N\58HQ]_[HG#<YO] @OJ3=F*B1O7G4 M&$"T  JD@\
M85:+W%@J0!7-7^9EVJ@YO5NZJC.V9"GBQ?'FN]6R\7L=]*U[9S8.MM ?]@!D
MEFV3L<T6O4P$GB5$U?Q0/NOB,A@66>F?YW8Q:!BUW6N>87E%C?V79RJ3'_/!
MA8V,;>#<BB'5SAM<3.I#B]5-OU5OW#)?OIJOY^I'SGGE))^=O[N28]F7QG#F
MN <YCDT#*1^.L'N6H;</J>7=84KPHY-03E21Z7C=Z/! &<TUUP]CFUHA6[\W
MPE)J5S(/;1RZB_8]KD+<Q<<A"K M^Y!4M!9ZX=].8BV&= YE2<$Q%+[:'AG=
M')XG-$:_S7C*+#C;.KOS]"OGNFT/\J]"Z;%]R'L]+"OY\@]?.EA\4#_I7.@Q
MEC[0 J&,III"@5K2:DOB[R@A&>N;Q]0?Q%7,-*M^0HJ*/^Z -$/.;&%?KAV,
M@J#5P<@RQ'DZP8.QHAM&^BUD?@LKRG2BI_7?FLW8OW^.78G@3^BQ_^MQQJ/F
M*^2,8HP!0^0Z:YEFQ\2:2C&.4@:JT$LP_6FQ!_'C79I:^3Z+TB'75/^B/3_V
MW[UWW82YT )B'H<U %N&)[BK 0EAY"QN( M_;=%EII\]H#UH"N%W^Y>0@.4;
M5_9W8/PL*YBF@,X*8";M[<QE]3Q03NZ4$S9 RU&*O^3^7-DJO-Z<%^BA;R(A
MF"=WU( ;QGG7_G8#"9MNJLM\T@1[K%4>I=R+$%)'A05+(WRGPKD5=G=D+(6B
M?VB^,G.X/BC8QW6[];@OW/8J^ HQ((NRP^)Z@=0H;8H.?!N5=@W)]>RZU8J!
M^[739THEV/ARGWB<*OCT8^39S* ]46M^GI8VJ5L"A>(V1\G,P/X![6,(?'#D
MX7)\)@H/FQUZ/?\'ASIR#VVWFU6%\\,"RHZ9N)!10$FOX#'YF?(E"FZ@[55:
M']Q+H\0UIK78.W/"]*_)!]INOG(,9#NL>SE+S$$P2;TI:*WO9FI&$9BX5W8
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M78"UP4C1[S%2,?%MK*'&%L==LO\-%2_? @>,1M$IA;\ITA"T(Z9'$D-\JG_
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M7>)*T:8?TB\RV9877!=T[[^7?#,IZV[+Q39Q 8+.5HCMYP/NO0^9J25A!W8
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M\N(W'P;^%\O_Q?)_L?Q?+/\7R_\K6&H*_=O>D_V9.R%!9:4GG0_[##NRK7"
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MP/G^X/[]I/RN8V<QK!:"NKA=W'\^(>QIQV .12:FT#RJ9-DHZ1E73FWV"JC
M?S]+96G/;>!?4YY#Q203V9N5(9'B[]^9Z-95UM4MQJWYM)[>99Y/;0I WW(6
MV:Y\J]YOFV()>6\L=93TM+\[YVGLX-.M M.GXL*7$1_,BJ SKY<9?$>?3>MJ
M[@T)EQ19\E'7](*O('>\S@X^E._^X\FHLY"[A0K!E>26&RO,D$]*KURA=V@
M":MSL!]9:X867$//&-43'EAH=FXT&.3KRO6&AC.,]3D=!)NN@?J-!G"3@VY@
MLB%8DZ<3W:7WY.6=LRZWU$7;&;979LO)<DX%"MX1>,)H* CLG=@JLNHSV@5M
M/U\R'^NLV>H:_LA.>Y@"?KOE.99=[6AC;?SE#\VD<ZYL?#F''.FO1S8\T-/3
M_@J$?%H!J7'2P7L3R$1]'!33%]4,P_KR2R&CR=[\V:_07<6.TSW!34=,GW3.
M'QYC.LR[+?!1/-CL(=FO@'P9=SL#*\JX)V^L.[KF_*&Z,5[=/5J7K8P.2(A0
M$^?J#_>@-VF,@Q0&F:U!2+?)"I1499\C/3U4&9/#.YVL$M\="J-&5FM>\UFK
M^V"?E'P)5Z5[]VLRN_PQRJ-O\@W&9C47*R]K2'R(K<-M4^NXWM4DUJXT/92[
M47]$@<WTM2HB$/FY5D;L[5_^G@*#X2433<]/@YG!0W+.E&67ISNDX4\RY=UZ
M^WU!<\^*P^BMH,5PFBC 5*ZX-]1G[[R=5\H6EB:\50HIU*.<D+RQ=+DXY^GG
MZF3!%7/H3&F?_4/J]IG'Z'(IV>V"<J ''S,]A%BA*JS8IV7,<32!IN9O!\Y)
M+A=_P15+L+UMNZ$S189FB ^74\(EPI[VD&IWEBXCFJSI]Y=SBQC<_PV50Y>H
M@/_0+"T7;/WFJ(_B))=1D$HQ#7A,O;K.952C5Y$@*,!H;?5$YY?LW!ODBE,R
M3G\N/M#(8*O<_L*$<W85F!LTI59S/S=/.?%DH:,7E.&:E,4<&J"K(F/M,3(0
MF1_^^?,] 3%LMI-AZ]\7!6^LH#?.>T )^'TOT%299@A5WX2).@/=HG-X"EA!
MRK7 ^83NKS7HOU(;OL=1FMIN#D(<J;-M45L!87\W@E RZTO^L2I[=C2.P_[/
M;1DL)G=#>@+12@.V5,I?=Q&#:,"QT&(R!PVXZ 5,@*+,7WG/G-[C;U"\MXJ&
M<@M5PA6;16F (HQTZ"M%UJWJ[S=_EKS!=@U5I&X#4G\M/^H%#Z<)KF@+[/61
M$S,5* TTH/_@+6NM&AH@X19/V[>B0>IX 0M=7CK1_RKS[R5,?<LK]W_GB/_/
M"GOU?P(Z>__Q%.]['KVW\A@'='F!L2638JB1SV^N*N]9>?8-9OU9"04[8]$
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M,)S_6'O(&L\<M-V,K\-[?I$_F&&/]_B)*M'F^J'G#T3NO#>.FE#[F%B570Q
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M/2N46==KC2)T.)ZU2^V:E]YKNYN==_:&V=?@=;+(V3+R"?RI%#0WP@WYN 7
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M3I8,CAP72+4\ G.[A S1FN/-0FKSTZ-Z9=NHBH@VN-(ZZY<2KY9#Q(MS$)%
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M6W/5ZN26W800)(DXT%0VRIU8G\N(V&[X6EB?5M+E4A.-:)BQC94>^G*KM7-
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M@'"XA-Q%%)_N$O=(N\GK,=GQR>#+7$EW%G[/ Y&><:-O?-XED"2#G'O[]K^
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M2-OOF9__DCQ(6,:R^6%__O!R5,D:^7JP*J:7XWZ\\_W!:'+L?:HQX=,MY!Y
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M5^X" ,!U_N+#S05\ 4TH%,]%)),1Y\C)C_7@V2\F3^U.(WZ:L.I3?<Q/+O%
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M & IFL]H _FKC/-EC"]"_G@SNOYG)W^?-]9FFJ>_Z0RKWZ?^C(;D&=SK>-O
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MC1A_P_%/4?O<3NN$C%.N[/_SR-5_,/[]5?/[?XC\5UW\;4K&/RV.HI4&+K-
MY":8Y7X-&79_'F1EZFIK^7?^G,XZ5-"39HYY#@S_CT-7_T'X!_]W$>V+N+'W
M)?:;_-9,8,"9X?CP.#J8">SC!A>PZ\=#;<;_56#[S8ZJ',H4!/N Z9TH0L;I
MLK\;NWY]?OQ@S_B/G@?]_N6QYM_;9D2N.>!4>7A-.@UZJJTC 8@/WT)<I?JC
M=T)FA$[.65D%>HJE(:D&*YCJ0GGTT?10K (O7_E0\_4I18 _'9"V-"/'462@
MQ2Q&[[@,])M4W(055&'(VZ$N3#3H'>U%&W.V=A=\#[IGNK^R,?QBOK(/P4>*
M34*GYK8UU9'56SF^DRA*3NAE\ J_10= +Z:P7*BDF5,[EHTK>]=238EO>W9'
M2:CD=8>^<N3\%9!@);JZ3\+#2XEZ#E,'%R^!C9RA3F&)FU/VO*[I<N3;J;+)
MDVGPIJ?'YKZ&& H9B^0ZQAKQBTF@V+B/)E;EQ48L[CG(3L"&X$@7U*)3X(NK
M^+@8)K"[YL L0Z>FMZ2-:FXG$D.<[*T:E#VA4D+UCW))"&MU"3!R;(I,:O6^
M#!VBRJ!2"2TT$>R45K/.PB*O/3_M;,]:FXQF/T^6.R0[/#Q\B/^;T^Y<%3XG
MC^B[1OJ_8)FS;V"I#$5&BYX\&4L3&2 4-%>:&Q@B!2!$@^57E?77/>?*>\P.
M?ADD'XS.4'61')TWZGWHWJ%W'*S3PQQ%:](_TXS)R90 <GG(FAD3D*V3EMW/
M2K\B\W.TT4N1P!=3.2N)"@<IK[YA,]JOD^>H7I' IGN#?1&\:=&;8@_UOJ.=
MA=+<INQE:)9=JFL?39(DE==@@L6#'9Y"^@^/<=Q^IEND?#.5_9=CA?=Y>E@-
M!PN)%<.),7@$L#"PQW^\D!"L835FGO-MQ<:$,%04/1MMW*Z=NV69UZT/UV)Y
M*#70";N;T0@'UCMY4*D7N_UU.@R:M(;;A=T2SI&#TV_NTA]W=CV+K3P)[%(_
MTEQA#ZDNT]YA)['T>G"-[&1O:_F:T0\6RX92G3&=+%C?  J/S5.TX4\8G917
M:Q5.D8NZ42\_778R2=C;5O]F&L8QQ?6,C1S[B"K/&+ N)Q*R4>+U<$G=W;ZD
MD<;['#[9.9-2#R+(I\*R?N(Z[RB8#$D;*1Q.6+9DEQ@JU5^'1=N3S J*6*-6
M](</=1*:&,EB6;K7G.^DU#U >7^Z;!&R,AD4;2H?PK ) S2[I[,#/AGWLP)$
M*>Y1%3S+-2E.(^GKJ=>:1ZH:)27E]".O/V0[8?$:.#9<,LO>P=K1H=KA%=1]
M=K135//7UOD3H1,-.-<V*;]7>3$U-/Q1_993QV+'/O[FBX/V>^5/34 *F CJ
M*2BN<8]MQ-,UDRK(WQS17E%HDUF9A(+\8X8UK32UOG./FG"Y<BW>/\B^ND )
MI[/0KOORR#'*G3X].-H0BB>YFY>L))A_Y0Q;8@)"2*G,9_G$%2..W7F1"DS
M.#0A4A,_'3PRF5,_,:Q4+RM%X@"Y=2U)/_81%GEEU*RZ=2V=[FX%KY&;GRC&
M3HYANHZ&U],RIB_=C[<W9JWN84P+MM"^T9N;T<<X#/TFQS6.[^ZC!4^:L[+)
MG<D$LT,W>_S:]B<=PEC=;BRJU#!E%-ZKBB%R\S6BS"B"T#I5A'::[($MQD7K
M2=E!PLW6T5\K44XMGR>"]HBVQS;5?*>\<JP,4&LWNFJ$;Z^,&[URD2N!\3U]
M-]1*6%2Z^A5JF5SF045<J:&>*"XDC2=1RJROG_76>.I,)S:-/=Q\")S-9*M^
MN+:\&W0%ZQ'!]$0*8M&^N)6B5KI$1:25;&)N3Z3>)KIXG_AQ>%J$;?,MF858
MN.FE"#=X%%Q UV42)H;IM%A \/I+'C\E3/1^WR)\;MF+>.!:J>>\>8D3\+[.
M*X@CN)5ZV(T)B/EUAM_+:79?YKPCJZK5HW$/9>4BIN1>JENJ=T]^,_7QJRD)
M^92UKP?96W'N,#ZT\T")BM@"OC-25_ZMN[4G(6FKI;$,II>6IV_Y)-VD+D7Y
MB'1+B(&L$2>JH*Y@L&!*L1$^HM4 W\/08;F6 0KVH;)JR3+,U8ZGJ((*WSJO
M)E)L?NK'@1]#TD&@]F\.D<W0X A# /V ZHEIA(M5N5,=(:VIY#JD"'3,C.P=
ML<:C>SPH!_IP*.8Q)>MWO*VUQ-C&TA>/N.2E?6,;SRLIVZ^#@#0C>BY&D*8T
ML)?,2,Y 8R"D%B4[K>"T:[>;EOB]('-=<[$!.;FNIO"C-=?4]Z@KW(([6.C#
M7V-+6FC"-I0L>JFNL!,3X).?Q+'R][+9E+32\31"OJ!4JCGWXEWGBG0GGG2K
MJJH/\@=^*IO<:MNYQ<?@5:+R+H"EIB3C: P<2H'MI%E"]KF:;PD=%Z:O#U^
MN[SR]"DY%N3A="'@2_/ZP39YRUZ-BUPS$XN>K-3Q.SV7"7BQ-MB&&%P(<XBF
M:XX\GWYH[13[&9N/YCS3JAS%8]^[-'K4ZZ6-:JP:3%KN18=365W"2 .&4 5U
M%_I*%\W ES,V42N\0#6K*AVAKB->'CUJ?+<M.EXZ7N&E-.VU WZ@T)*=BF1T
M:ELNVI+@C0B8?X>Q=4])G+"AM'B@]OG"IH#<HLPPB\S8LVQEGAYO-ZT*0T,
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M&)8Z76,Z!<?J>M]6Q#_/ -RVL 9)$?/PU49PPIVA ?ZOZ/^*_J_H_XK^IVA
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MN<_#Y>G4U?;RYFNY!@!C2U4=PWNND(<:5'^ZCTE92N#@6"P;7'+U,_X6=+!
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M)S\< ],($O"@XZ\/-GK_*Q/-OW^/I@C^E>()WNQ3X3$ W3T&#,=+D<S[H\?
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M"0/=1!FESR?JY9!AU=#)D=LC97*EB@1&)8*KE953JI3;!YWA%-&;=WCNWP.
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MK9:(O6Q&9$5A$]*\I(U1*O-@)<V&+E@S6N0+%S^$N&?^B#<*OD#M9B3!MA<
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M9K')NFD1"ZD43"1:HL#UWQ>JH?\LKY.7\71I+3R=!GP__1LY=S]L"'"])G,
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M 6+>+?$)1Q,GYS,!Q\YNF/<V>\$/9',C#)6)@,, ,$+W2"8[G4;!^F^ ^5R
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M>ZGJC%T.2Q G;'QM-DK/>8\5?CLU(KUL5%9QH,UB=_+FD[5%XBK_7ZT'J(;
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MB?E&7DSW]CH5]T'D0M^P_#A5AU?*O.G8-\$]THZ[3._KA3 1D=[S.$W.>7E
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MI*+G:;V![Y'+A8+#C[>-13P6OY# L>.>S=GI&DP-N@,]#$QUM**XPKO&^<!
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MU20$I'MZ>OO'13FG;]9B+VL('T9%+(:_(7V<[Y-[3Z[(PG_$2W[CJ+!W<C:
M>70-Z2M9F#B.]1-'=*G+X=ZK>^-*EP,_M;[ZH%>X$"=X\(S#] ^.C#%+LXL'
M8,G]_LY@<$31=Y\[KB:A&7),]<" 8$DMR2 4WN2A7I2H$"TZ&K,^'-Y41UV
MAGD @%?2N6$BRS;GH+HX&P+$^@94'M@,E=1D:HWK3RX<$T/HLE:NKGGM\J+&
M048_C.4/PSVGPM;P) ]P1PP@Z4N4R).Q3#ESQKK2C"S[1.GV3?E;,O3>I3<@
M].*/?"H<!ZCX/:*J-\@,,TR_=+,3:D:626C 2)FHC*"%*:,1]M,V!F^',[62
MFWJZ?#O,51-E&ASO_-AJ8'![L^"]_<L$<(<#1PK+3Y0.\*G?WHTUL3%,J@V
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M#X#3S1B&$P\0 /-M&-@$;*VN9UBN=> +L[R3J^%BDI]NY8N-)S^^FD'J4IZ
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MED#3=&8H-&(_B?8HLY$J^C.C)T>NXM9(F&]L#O;$@T77*_V+\@NAET:%@;4
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M-SJ_(F+. V!G7/A"X7^M$O/_Z\7K_S]02P,$%     @  W1C59WFYFP"/P$
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M">5*SW$@D;^#@K.8(;G*"WEH,G^SJ-O4YG;W#S<7_Q?<7I]_N3=C-YO^TB/
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M5*MKZIYG3XX.E'J@UL^("_;AUOWEGXC&T-^Y 1!&C9 /F-RK]_'VLT9K=WS
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M8Q]B''J>+P+70WB4I4XO]:?&^:O S5\7J>EIT,B>'W@9,[@_I[^$J2$ :QB
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M48282_57 >;RIT94#U]YSK'2T.!;[0&[!J4-"^; Q&<:TU5!7D=V*4N&!=^
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M3EM 86.>;>-Y/8O[-&_50]9$%;2Q"+SX.<^*8L8]!T5<".BY/H*(8SGU#J(
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M,35*J@].R4YU6-;: O9 RON.K\KCR%B<HHZ!]U@;+GMQLRTK@#(#M.P C2'
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M%6&B9AJB'.Y$$$@3C*!DRA-'&4X)L^H4XE6KJ<TTYH"T:!V0/FU-,SEV&^,
M,=:9WH5L9Y^^IMQ:J"]G_2,5+QAKYWB!<49P[&B"[WN#M[4+7.T&[^/^X.V,
M ]_?:_!Z!R.,,X@CA2K\$$_J<2:Q9/T@SGV'SU7=(^#-MZCO?/L]-GUK3.O1
MU;(I?E4U-[1+89D:6'\>) #B\I%R"(^X0-A[!4]<CD]':(6'A_>8QX]4WOQ>
MKEX*_>:1Q?52D=&C^6U3.GY79_I:-\9\6HBUN.+_^5RMM0TMYV0>XI02(A@,
M,2,0Y6D*,4,IC!&A08(SDN:Q3=&&8=5TFNE'*_S0VEMSH/KAQM)BXI[$" T\
MDQ\OQ-PR$[3L;'5;V)7LW]DZ SMK]Y:5DQAPA\E^$@,_TNS_OB^ V]0^^+AT
MSO7#21]O\A\<P3UO8'AI_;:;O^O8@=7R:KW=@MC^\*FHV&*E]R!^$X]4E/,@
M#(6D<0*C&#.((C7[8Q(S&*0TC6*42L:<#OT=9$]MR=ZHKC=[=_N'FRW#1^N\
MG3ZC8+=I.Q"V0Y_VGX,5_+W6V>-F:@^D/.V1ND@>=>NS!R1O=S3[/*)OZ>TU
M4=3*-_W1-V05Y%Q&*(*9WGY$"%.(44B@)#*-\DPD)'%J&79<S-1XJ1W^]TG(
M@A6.3'0"33O2N1RC@?EEHR#8:#@ GW2#X*UZ]E$A(Q?.[C+TL&9VY]4]O9=R
MQ83@U1>EW"W1D4:W#XIX[D3Y>+U\$;6S5,WSB%.,HA2R.,00)7D$L7):8)JI
MIP:$)@EQZE=N)W9JW* U->7CR0LI%OKX""JO$U;JUZ#8J>WHN=B-@*73XAW7
MH?V51F&@OPZ@5=;X&J6AUAI<6^#J[K$XP>3+6;$3.JZ?X@3$@8OB=G?/ZMHZ
M6.CCJEK/$4I"%+ 0ADB8K!$.<99QR+,LDBB,PBP+7,K<;I\\M4U.HQ@0/W55
M(C$#2V'Z?53/BG#T/Q1Z/>O8KVZ'HAV1],)F8*XP.NGDU\ICB<H#0WV5L]X^
M=]RRU6_-.2A/?7!!WS9?CX^KI:EJV7BXF*5IEHH49CC3S;U8!HD(8QA((6,2
MI$'&G;I3'DB8FCM0*_BO_Q*FP;\;-5U[>+U%T.[3O B7@3_16C=@E!M@97#2
M=&^MN=X^?^2&7"?,.VS#=>K"2[.6/C\^+5:O0MR*\J70R:)'B^0MS% U9ZV;
M/H1UHVQ-+=4N0#((TH2Q)(=!%JLY&Z$ YIP3_4<>A4D4$YGV2W/RK.G4R*4=
M/%ON6IF:DO>0FMJ>K%T#M(ZLK5:+@IN]BVJM_K/M=]5D**@+^J9/^7XQ[+AN
M$L,],&<>+=>Z*T,Y Y]K1[!N5=O$RFN[9IN(J"$C90<? >\)8+[U?*>,L8'@
M/IUB-I3 ?E.2*:JJ)9?B00DO7H0YQA.ZO<HWL;Z1=^3G=HM\5\7^;E77L)\K
MIPS)., P2F0(4:SKDJO5(XQ3AC 7-!.2NBP6+]1G:DO,.HYF96H_L[958*$,
M<ILD+ATJ2E-."(IA+/6Z/LM#2"C*8)9(BL,PR!+AM' 8<ZA&\ 1N3@P2^.7;
M:BU &#H6@;]TN.QF[A$'8>#YN<9_SY0Z3$6 7[0U?YJ!;_4.C3)I!C8GL$/W
MUO $L*?I]U)M1IUD/4'W=BKU]=@>8:I?5\O[-]NNFU/<+(IIDF(H$$LA"F4,
M\SS*(!(T(#1F:8RL$K:[Q4R-,[^I%Z$NKVF9>WT&Q6[.\X?-T#NH2L>#8Y7S
M^S0N2#E$1GI!;*3(QI[(N84DG@6D,Z3P]-WCA02>M6 OI._\U?W6#M^>]4/T
M N5)T:WFV%MQ7Q^C)BGG"1(,T@3IOGX!,Z4K((U#*M(XQSFQ*I)]7M3D*-%H
M6F\G;70%5:.LFP?9@:^=<^@'M8')<@?83DUP>PXP9S_N/!:>7+0.0:-Z7^<-
M?NM86=QQX=FRV4#;;4ZB!-,T5HM1GB<Y1&D20!)&H?*<$(]3KM:ETJU?\W$Y
M4Z.(V^?'1U*^MC:,E_=@T3Z,-EN0]:[!VRN*701VSZ/I-X/@>%#=']KQCJT'
MW:D]@X3O<^TW4M[GE/NXJ2?/O$]<WH\\CB0D;/L^KS^V2YMLD@U>YS26"4(X
MAW$02(BH^H-0$L&(BA!E$<4T<BJ?U4.'J9'.%?NOYZ(JM(ZP%'7@[:D:,6[$
MTF> [$AG8-@')J3C65H[ \">!;O<J]-=M9VYZ@( /?%8'PU&Y;@+('K+?Y<\
MJF^3^N;T^>."5-6--*$*5S^+:HXD%4*WBI5Y'BD&E#G,":7*OY)IEA',J7!B
MP).2IL9S1C\3W%H'QV@=78N9GD35\C3=!U8#DY,;3#TZ4I^!P%MCZE-R1NY/
M?<;<PS;5YVZXD!#J:KL()0%))(,RHKGN1B0A3@B',<-I*$*!\]PM+&CO\5/[
M]+?:]:QAO(^=X[<^M7K$]F#T_[@'J3"\__#W^8R[JP4?OVIJ[>7_(JJU+L=>
M!XV<[Q:>98H3>( A#A,"D<C53Y(GD&D&B6@6LG B'>8=+9L:3=7J3[7#O.MK
M8TF34]%W2@P]6I_YYHTKEJ!&Z7]2L_F>XS_Y?O.N=OT/:3G?<SC'ZSK?5T'W
M+L2?FB/W__-,2C4O+5[K<YEY&/$$(9'"5.JS52;4TCZ6! I!U((?A4F0654W
MZ9 QM2ESHR;8ZMD<%MIW'3Z%9O?\Y0FC@6<2=WB<N@R? :!7@^%3SQRMM_ 9
MH]IMA<]=ZNU<8Q?I?<V5O$*:9N:;/DJ*F4K%-$O>*JJD_DVIQNM+YCA(HC@,
M!8SR$"D7'G%(\RB!89*G)"6$RTRX!&/[5]&)6$:+SZ[;B5Q\ZG'I\/4^%!EQ
M4-[ES&1G'V@;V/22 QL3S:EYNS)^8^6LN7#0<Q5/8S#<L<NE"K[WJ8PG@"T.
M;7Q)ZA-@+.[)XHL0VS#/5+),1)&N7BLA"N-8MZ_CD(4Y(3K &,6Q?5CQ_L.G
MYN09]8#6SR5"]@U@W1QZ*0R#A[!L$.@5+/SVW7$($>X/R5B!P>=?#L<@X.,F
M=X?^OKEGQ(#?X]KNA_F>N*9G>Z?G<EFLGTNAF.Y+\5/_M'FQ4(1$@ ,$!=85
MZTA"89ZD#,99DJ6<I ESJUAW6M34*.I&2ETC7VX4-AZ'V/0(=&R4=!I@.T?0
M#VP#4]J7/:@V:@Y0L^(\&KX:!IT6-&[;G[,&'S3O.7]'/ZZH_9Z/=2;0MFDB
MBE&6!H3"5->T1#F)(0VR'$8(Q3F369 3I\/GHU*FQA"->LV2TK$CY7$<[=C@
M8G0&)H)-W^\-0$.TD^S$P-/G?US&J%]^IYEO/_KNBWL6#=C$I)N(WVTPVRX;
M4*U;HER$C,(@STQD?P3S.$V4Q\!EE 51$ JG_)^S$J?& W5M.><&&O8(V[&"
M5]P&9HA=R]DFE'^K[@SL%/:8V6V+C:_<[;/RQLW.MC7_(/_:^L8+&\LV.RY[
M.RU'F@VJ"Y3L<J_WH+Z_Z3+('I;%?SV+ZDW:2R;R+"$QAFHU(R$*1 ZQ$.HG
MQ5RQ"*(4(:=PEU&TGAK+M:MG_4.\:J_GN>X(56V;CNDN8R\;PYHN8AZR#L9Y
M2RQ78E,;^Z$7=<=;'I@FGW57]JTU8&?..)UFQQ@"WZUG!]7Y?7K1CC$,)YO3
MCB+<;7*KRO7\APX^,7D$DL<RDV$$":$!1%A2F*<8PRS.8QHBB:(8V4P^>T^=
MVN1@%'-*P-@'J9M[>YL^,#?JZ."B6A>,+/;[P7C*L#AJ=Q<AJ1M:9*3^MB.B
M_6>-0A1'U=]\R,?_T5?'!5T&8_VFW'^*,&<)%S",N5JG2ASHB(D(!DD4!EP@
MAJG3.M5*ZM0^U$T[ %%'D^Y:+%S:8>$8XG8>E7<<!_[JC_=7.%K-9LCV"AT@
M#=9=X9C,=VZNT '#^=X*73?WI*(ZOM2TS^U.!_U2+,F2:=>$K8N7N@<FRM-
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MAB3B(121I#P0(HI1[)8X=QF4XZ3&#02F8]A"+X"&]G3=D.D?J7!@O._PA)V
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M_:HN7%?72^5W%2O^:[FJJGF4,Q*EF, X9S%$89)"$G+U$XOR%&<T#F,G(AE
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M9+_3J; #+*>/AET>,AR;_1#:^F)1A]V\";00 8HR1@4,0LX@PC&&--:1W4'
M:18&(A=.[20O56AJG->.UZ@>5N4:FD/?PB*W;9@!\\>(OH9AZ&/;U@@<X<>=
M/6#?H)%B:2[#=T1*[51G<BQK UX?XK5Z;N^H<5UX2XL0Q8M^<K-W0K*,I33)
M8)2(3%=_2&#.TQCR" N1QDAFDCN==IP0-#7NW.@)RJVBSF'<QQ&U/)SP@-/
MY+:%:*?C$.5WSP#A+_SYN)BQPYD[C3T2GMQ]?3\VT/%#K?U3%-. AG$,,YR$
M$-%<+21U<08ILS"G6$0Q=3KQW'_\U+Y\K9W#+OX)S.R^\OY(#/QM;T$8X(L^
M;K2G[_C-PT?]>H\;]O:;/7%5WQWCQ\?5TC2T,YL;<RFP#.-$P##3WVK()20R
M$S!.2)HE7.:,AO,74=*5_5;QO@B7M[0M:,A-3ZWA8<?+_S?X<Q"$_PZB))@%
M@?G_)JF5/*_5@D@7M_EW@))9GJ)9'&)S?([0+(O57X-\<W%15;JNK?['=C(L
MT?L?3VLSC/_Z+V$:_'L<S(!^(\VEGQ0GM_XI-/\4ZN)1E8YT*U[$XM5U _O-
M8-ON6_<?P,&WJ\W(->TTC78S<&W@]KE;?=Q^;YO4;QX_\M[T<>,.MZ1/7->3
M=TA9OJJ/X(=X6I4ZM_51^R';N,Y/1<46*[W+VDR'+$*$Y3* ,<X11(J+(,8H
M@"R5"8T"FO',J5"*H_RI^1@;M0]WI!T9P7$8+ EC.' 'YI/3N [@Q_2$R1?M
M.$H?EY7Z07- 6CT?TR/@Z8K]UW-1F>8E/X3)]_PBQ"[DDW >16H!I)9"$.7*
MO:)Q&D*<$X91*&B,$^M@IRY)4^.IEJZPK)4%4C@U>N@$MIN/O,(U^&;(5DW0
MZ FTHGT"FCHA<PAF\@7=2(%,IR#T%,!D@T9G\%+G \8+7+*Q8R]HR>J&?FZ@
M/@2^7E;KTKP?W]3@UF'%<^7LY7$F8L@$4_X>9@'$21[  "<:5IZSV*FK^2E!
M4R-,<RJ^4W0&M*H]H]Y/@FOGQ?F ;&#2[(F6LZ=V#@I/+ME),:/Z7N>,?>MD
MG;V^YQYRT_JEQ3[FQU)L7N,@XH*D+((XC4QWA51Y54$$.2<X(91F* ^=MI7/
M29P:66Q;,;4TGH&-SCU9XSSNEEO3/M$<>K?Z0B#=M[!MP?&UJWU6WK@;W;;F
M'^Q]6]]X&>FT^DU=+]?BOB0M[^?CJEI7\U0F0F:Z#F>L2_<BY::0D".893@-
M1(#4;YWJ<-J+GAH-W0I=F$X-_':)Y];-L0?X;A3D%]*QN&BOOUY+[^W:QFCN
MGY/LT?),3A:"WX6E[ $Y15<.3^@9"FDR&[[IQ(;-F7L6"+56RB -<]V2%G%(
M*),PI$A$,>:QE$X]L0\D3(V%3B5Z.(8H'@!I1S47P3,PH]2Z :/< -O8)TWW
M%=]W\/QQ _9.F7<0@7?RPA[;R;H@J! W3T)3Q?+^JR#J ])_J.?_3:SU:9Q0
MZO.O!:'%HEB_?GH6?Q.DO%.@BSF)>2;B',& 1@*B*":09#2 G$B! I[16-HG
MUUZDRM180KU=B<-.ZF7#8+$[/1JX W-,;<<,;"T!QHI9_1_-/4"9 [;VJ'_8
M6#0#RB:@C0+&JM&&QV$G?+1A&FFK?(SA<MM=]X)PY_;[91+&VY_W@L3>!KZ?
M)UY0Q/'#^1I?'][6^*I;\>PV%BM3BN3N@2QOZH)?OZI'K*OK9=WD\$V1=/./
MGY1[O3WLG6<)%1$A""9,3XHX1C!/*(,\(SA $4HX=?.(IV+9U.98HZ%N\?!<
M<:!>NCH,KD]9R"F@ZU)%<@KZ3L@I\%!TLNFJUH*G79+H9E.#LL8(%,NFJ^T,
M'+3%,)< #56KDJ7G<I53&G^?U2TG8=?XQ3 G8?:IU>;D%.RQROUX\]MOGW]\
MO+[Z^OWJQ]VWSS]NK[Y]NKG[C\\_KG[]\?GS;Y^_W=V^20$-8RQ(DF.(@XQ"
M%.<AQ"*D,.8R%[' (<N0]=+67?[4YMJ]!-$C\2\?U3MP+RKPRZ^D6%9_ E=+
M7A.HPRJKQRA9K'R'Q7[@F6VG/-AH#Y3ZP.@/=@:XY.%Z =YA33OL (RTD!UB
M(-P6KOUA[%RM]GCL>$O4_C;OK4LO>(R/<+/6B4']8V4ZL!1,A/-4(!3J>H1Q
MBO4.:J*F&1X+&-(DP"1):!Q;1>PZ2Y[:!'.]5!,*60"VU1,\:47UA&/.5Y33
MO5[I'BG;%"K3"H#K:J%EU7O]9S]4=NNS009@X%GF(+RMI?;F+V9$C.9#A;M9
M8#5(_%N7W'<,B+. HSM"SN8!%Q?$6:X+TVFS>&G5?_C\DRV>N>"ZW[5>-3S7
ML_.-_$S*9;&\KY3+;Q8-.W\"89P**2CD88@@2G7J-@TD)'$F.2(A#4C6LT2.
M)Q6G1IAMC_Q)$>32T.?&4B"D%&RM_U%YX:#:%7 1C>5U5WG]CXPLF&X=IK]P
M=?VF<^I"%Y7?TFKO"CR^WA#+[;%W'?>A][G:B["6>>WZ/)_WAK=EHKYI8Z3>
MO:IWP\8JX.-Y,/R7]/&EX'L5^?$,<$?9']^2O$50ZK)#]TN=*W_--1W*0K_:
MII]ZU41O\JOE]O1):6W:NJA?UI=0-7,2MI['6&8AS@*8AZGNO!U$D,HHA:F(
M@AS)A-'(:2X:3M6IS4E7M[>?U1KXZN/_^?WZQ^=/%X=E^AI1N[EC&N,T\!QR
M/.QS9R=H&PIJ,S81ZG5IB9:QH+%VMKGP[QN+!XAA'VY8AHLO]:7H>\>C>@;<
M(G[5M\0^IP:;+CYZ*5457-3AM*UZW#E*0BY# 8-,5SN/ @0QX@E,PE!-'6F,
M QS;'Q*<$S<UMM\IK'=M=AJ[[#R?A=AFA]\G<$-OZ.\PVU/6JOYY'_Q<-NI]
MXCC6OOPE>#INP-O"T[W??O8I(VZOVUJTOYMN?=?[>_:?A!1*)WY'?M97SU.$
M(T22$&:,9Q"EB80YRB7$(0UQ'M$X<\M7&%3;J3'^1D&P)C\!,2J^GX]_.+;C
MN_D7C=@[>/J7._K;5T"9W-PU35?_Y-!,T-L_U/6?UN$_"?N0/O]IH?VFH"]*
MH24KR*(EZD@UI^W^@DC#2 81A4&4$(AH0-2DDN802YGF-.,X3YVJB#C*G]HT
ML56_32'_YC93N Z!'?</".S ;'X4TW:O])WV@^S"]$3.$]FZ2A^5/GM"\Y80
M^SZF)\5MGMR2UI0AY#>:B94OK[S\#Z0JJM^7*ZH;R6DVOEX^/:^/%/B?XR",
M$AI2F'.=]A#S'-*84RA"DD4AYVDNG7;-?2LX.9+<?KJSO4]Z8R.HO;7:2F#,
MG(&VH<!8>KPAAV,M%N\O@R4;O^,0#TW7[S.Z[K0^T!#XXGW?ZHT[,0P$[L',
M,92<?E/+][)QQTT59W/J6UUMZYC/@T F$0\HI%G(]/$J@21D"90LHSC)A:#4
MJ=U?M[BIT?Y6VTT9^(-"[R:LL?ZM8RSC&>#M2-D?G -3[ [)IBQ[K2O8*>N/
M)NU \41Z9X2-2F%VAK\E),N[^M'+VX@236OLZ[:;91[+1-<YABC79W*"<9B'
MF,*0(4JB&/&$.36"ZA8W-7HYC/":&>^"S70"9-/&X.."5)6N]:1C=K3_<??'
MJOZE\D_4*'&[AIA]1L>.@_QA/C 'C0FW,VG9H>B)M,X(&Y6T[ Q_2UJ6=_7U
MB5;\F>D3,R:6ZZ8N5U']HRG^E*4LS!$5,!)I#%&013!7EJN?A,B1<HHRXM2Y
MJEO<U$BKT1;LJ0NTOJ[^3R?(MOZ/+^@&]W].H39 \2T[5+PY0)W"1G: ; P_
M=("L[NK;TZ9ZT/_7&=8O9"%,7[UJ719,5_E3_W"UY/N_:%TYCW5H$L41#"B2
M$+% 0,RY^BED*1:"A%',YT\F)_MV3<JU'>%<I)/+1_56LP%#2Y22YAR4Z1_$
M3ETUMXO[8JDG"Y-\831R[8=SR1 *BG@6!,K%I81#E)H*,R*%>8QU_P_$6$::
M(?R\Y),<P(U>[S)\0C=(>X^!LYN!1AN*@2<HK=D,F''XW(9_ISNH+]&C].:7
M[3M\=D+R@*RWODB7Z#)RER0/L!WV3/+QT'XSJ*E,H=-42O$@EE7Q(M3B;/4H
MOJZJZLNJ%,7]\J.)96.O=R595H29HB=+;OY6I\I=\?]\KKO3?Q/K&WE'?LXS
MF0=,,@Q11C.(>)A G/(41C@(,HR#. J=CL"&47-JWG]C"6"-*6"]TQZ0K?J.
MD68##;$=@[__P U,[75MK#T+06TB^$4;^:<9V SKQE#0LM0P?LM6L#-V!I2Y
M>G96!OLC_F$'Q-.,,)"2HTX5PP+]=@X96%J_R:6E@DF&U-'2SVJMT-3%7"VK
M#T(JY>KKE#RQT76>H1P%(1<P)7&@UF9(32 B"6 :8,RHR)*<616=NER5B4X2
M;G/ !2-AQ_/CX#LPE^_Q]B9M?&,)V)FB5KW:E@W/&VNV-.^/JB_'U!,=7Z#(
MJ)1[.6!O:=7#$WNDVWUX?E+N/2/%4GPMGE:5>O3U\C\%6^N0A-OG2A<?5+*;
MS5S"LB@/T@BFL<"Z<1_2X682II1@$C.2XT1:I]XYB9X:-;:4!XM&>U!LU0?5
M5G^'Q#*WP>AFRV$A'I@=V^AN% <[S<%.]3X=5-U@=LCE&PSND?+Z[&'WE-W7
M"[#.3#^W)XZ7]=?+TKT,P'Y/Z'G8L7I\+.H- .6W;W,/62&J74STKDI0&I.$
MIPF&!.EV1"1CD,0DARC(19(Q$6(>N'C0;N*G-C7HPH?7=W5A2EVM\N/-M[OK
M;[]^_O;Q^O.MX\:WVSA8[G0/AN[06]L[Q<U>QI[J>ZD8@Q16ZH>;KXUK-^'C
M[E3W N9@:[K?4_H17"MFM]ZK6&]SFI)<(A:D(50+_U#7H$Y@3BB#L>1A&H@D
M29E3Z\?3HB9'7+5ZRI_MFS_6 :L=-_D!:V >:BDY QO0ADC_.H^&)W;I$#0J
MDYPW^"UK6-S1.W:,"<'-8MP$U#8%]#__%"4K*L'GH60RS%$$HQ0IKR>) [48
M3B)(:8I#%N52Q$XQKV<E3HTO-@K7VU>B4;/2YPAUJ>!5;8!S/-D9X.VHQ"N<
M S/*/I)&VTW[$[#5UVM<V?]'W;<V-XYC6?X51,Q&3W6$4<,'2 +3GYS.S!K'
M9*6]:=?TSM8'!9Y.=LN21Y1=Z?WU"Y"41+TH@ (I5L1,M=,FB7L/R(,+W)<=
M-/Y"RTZ,-W1TF9WZ!P+,+&_LONV:SQKA^[=%\:I?>,9CQA*9P 3S#"(6IY &
MA,$D(50*&H=)X!2H>F2<L?'+3:/L^#IE)R]%[9ZN<PQC^[W3F<@-L$G2H&UE
MYUR!2DR_>Z$6'#QN>@Z-,OCNID750]N8MLN[,L-.3.N7=7('8B+A,F)0IB&&
M2$3(%$[-( L2DDF2A=H6<2.'8T.-CQ_V8["_=$VA:4%8(H1BE.D=H:(Q1 1I
MA#.40!HQ'&<1CU@83][D@LV'Q;@YY% H:]ON5_J/^4+O>S0O/^M9]@:S+0/[
M@*YW$N[V9G;@X5-H>*/BHP,-S,:G%-XGY)-W=/";FJX/FP8/==<'*3:-(/Y.
M%V6KM;O%-]-CK5X&[N7B?I'/>/Y"I]?/\]?9<I)I*DF99NU49@(B90[/0TP@
MBU3">,)08&?<^15K;%Q?=DO9M*FYJG\VD<MYHX?*'[5Z>B+!HE2P-ABORJ8*
M+RLE 2VU=#<C/4^^A0_W(E/:,S^6LWG3F,VU6EL=<5::@;L%J'2K#=FK,O5S
MK1^H%+S(##JXAR\RDP.YC@>>43<WLW?@6UW0_D8;SCWM':$MU[7_IW?-X7O)
MEW3ZZ<>+G(E\^6IV9U7]7/'A=5GU2[^GN9@PP424!10R&@9Z3Y4H2&7$840R
M1 .<!BQQ*BUH._#85MW/^0]3EK0J4YK/ZB8W>LVDG)OY*, +?2]#0XP_5O]R
M8<YF&OXCUSPOR_FQW"KT@'K?&X=*9-"4&:R$!NQU";38X%TN@1'<9XZ6&U3>
MTK$LAQTX\\H-C/TD*\?[O97L;C0)KGL$W\P+4W\[Y@+33,),IHGQ:4<0"Q["
M*.4II4(D(7;B,_NAQ\9H#3'AHFZCS(V@9Y?4/H:]'5?U@VC/;'6XK<W!3M6M
M$/LH67T"K?[J3Q\;^-+%I$\ 8E$9^M03SLG4>= ;DK*3_1<SV7J$C_-GFL\F
M611F&6,IC)/$%)+*"&1EFY<P24F2(G,BXIZ,<V2TL9%3G>2QEA:LQ 6_5P([
MGFFW0VU'3-X [)F+SL"N8[;,"4R\)L0<&^L".2\GU#Z<UG+JILLW+=ET4FG\
M[<M\]O0H%\]F SO).)59@#'$G$1Z4YC&D.(PA2BAC&8H31AUZAH^J/1CHSHC
M&]0#/0.AI;M</Y/3T][9?AO'9%[$!#R[X<D& K 5;5F^-@8&\+'MM;EH#Q3K
MZ1MA3Y33LE_:K.U_6OKLF6(OA-N**&0^N=;KJS!K[.<I?9IDDB>4T CR@ F(
M@HB;L) 0JBB+5$PIY<+*K;CWY+&M)&OA@)'.;B79AZN=Y<\"H6<&MM3?FA*/
MZGJ K@K)?WZ:O_V;OJ=B*OW#AJ#VGS0(>1Q58/5A'[^@FQGZ52Y-I:3[Q?PM
M%U)\>/^M,,Z-V]F;+$P2RS5?YF_EESZ1 @G,PDC;D('I<IV8!&K%8!RI*,H(
MBU$23Y;S)9W:V9#V0SM]MFL!^GMM3<&9LDC<:U&Y%/*5S("NA7:S"QWFP<ZH
MZP?=GOG  %L6<UN);8HB__1;A?)?P5IX<'T:9F<[RATQ3T:0P\"#6C#N@.R:
M'QV>T+$^6U5H8O;T1=)"FJ.^B4P"H;CIK9QBO=&EVGY@2F]^>9QQS!51W"W%
M97^(L5D3E<=S:L3KXA<X@*$=U9R'3,^4LA8.E-)=E<?Y'NN$'=7=5XVO_0&&
MK<]U5,&]VEK'K^SV49L]Q2;.XK.>WSIN2<94,(49#..80"2EA!C1 -(092%G
M@9*A=/FTCPTTM@^\#%1JA@PJ?5T=#NCVK1^%UNZ+]P%8S]]]B54S?,M(Z2TT
MRQ8(3R1P=)A!J>"4LKN$</+Z;K10YJ=4458?7TV;JONR+'/9S^K3\\MT_BYE
M><V]?I>^:RJZUR_&A"0!IX(JF!'*(4J8A"Q (4QP&*I492E/0Q?.Z"3%V BE
MF:6VRDY[G>FI +)6H?[;2ZT$>-'WNU%-M^FRXZ'>)Z%GDJJR92L%0*4!J%2X
M6O4"7*E19]:N% 'W;1/AS&-G >F)Y+K),"@#G@73+CV>][#.6;J[I4_7E8J)
M(H0&80AYRA!$$8\A)AF!,DE,J0 N-%&ZG.^TC#6V YWMNL0_3<O"EGDILG.&
M[E%\[2C-$VH]$U=K(>=-/>8K<+U<+G+V6M5@6\[!/34.!*_)O*?@\I?0>W2D
MH9-Z3ZE\(+'WY"W]=X7>%/L*A<IH$J901J'>P$5([]VR((9*!!BQ0#),G,H6
M=Y)B;,;8 _\NQ:O^3/2WP^EB\5Z>)U>Y7L;9K$R'X+>R=;N^8OE=@ND9@0C=
M)LZ.PWJ?CI[9K4,OYKK1,NBE>MM9>%Z@L?*%:KF=!=,Y+9+/K>Q6)AK]^CXO
M>"ZUIHW8U;J.:Q(I%28\A"R.8]-X*X)$LA#2*(IP2EB6X=@ZS[9EH+%1XD;4
M9F2V0ZYD&ZCM7.83JI[IZC!*7:H+M\'ED"SJ";:!TC^[PN>6QVF!26MF9MO]
MP^5:6FBQE3UI<_UY\;.-YQ;WB_GG^>*9?I-O<O8J)SA1D4)!J.&,41GK"IE4
M N(LY%QP3(A;9V>+,<?&H(]F]PP6E7 =$X7:(+8S"#T#US.?KN-"&^)>F9 $
M4 H,:HG]1W!:P.,Y[K)MQ(M$2UI <"S&T>;6R\?J-WXS$2P2BC .TS2)-#]E
M#-*0)# @">>$,A5DR.7$K2<YQW9:5W%:YTSMOF;3C0HO.$=#T:??L/HO%O-]
MT=CY [,QPBCYII1_VGCX U#W&?E^:+AN*\GU&\VG9E2].CW0J30N\@=SEE -
MQ_6&Y[7,5OUE,2^*WV8+2:=&X%]H/JM:*)5M0Y- (B08%#0UV5R$0QQA#.,
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MNW;GR^^_S>:LD(LWPW"WLY?796$R!&<\G^:K?,%&D9_2)W3[_*(?5OJ*)DG
M4":$@$E )$0419 & 8)4J"".&<^2S*JZ1(\RCHWA-J(Y."1ZFCXF5!BD%,$H
MI@*B& 60!93", IQIGB* YY-9F8YE&+<$TBJ"6S*.L04FA5*5L[L?.U"O?R\
M6GCY+O^Q];P&-@O8-70$?V@E05-+4*D)MO6\VJUN=U5%)%R!AKJ7GVD'+^3E
M9WP@Q^5%9][-]]GOG+2Z2WL:>C@/:[_8;3EE>QZJVX[RB]3/D]L=1TP;0G/Z
M-:O"B0F-HX296O]4VVA(AA*2-(R@TO99DJ $(^S4).3TD&.SMLI>HZ63HI+/
M;?]H ;'=]M$O<#VOG)6P5V"O;= *S)M38#KO'>WQ\;1UM!APT)VC/0"[&T>'
M.[WV&BG/X8NC1?KUYB*6"F=Q H,XU0PD)#.U]",H!$)!%*.42.*AV\@I.<;&
M2-WZC8"?<GU/J:JK/[7C]%DZ2_N?E+X]H2W]1RHUVAN0>*S$=2:8_?8@.2G%
M&+J0V$)EV8?$^G%NS%HLEI,;4]->+E[H8OG^5;^>US_R8H*YB&.:I3 -)(((
MLQA2BA)MN2F5AC*F06C5]/G8 ./CPHV,P @)?C=B6OH,C\+83ET^P.F9DYQQ
ML:::4\JW<8B^M\$?^E\;[CCZV$%(X912JZ_]Y'7GEC;8KZXGA45MO=*_V' #
MJA"+,$.0,-/Z/:(88D6I:4?$E4QED"5.G4$\RS<V$FFFWB\V%3;SM8;KD-UF
M?<U&Z53S=Z-FURH(?F;=TMZZW%SV;8<UIO% H53]HV69U%[;D/2$O_<*"WZD
MNU#]!:_0'J_.X'>8,V*</YP.>/NP&_!V]U(6^;Y[719+_2%HD_7K:YF7%$HE
M$(LS&"H3C"95" DF%*HL(FF0IDG&V>2E,F^7>A6T7$-\R^G"/+O2]D="#3$!
MDT_YS)3O,(Q4B7#&+MS[/",L$Y;%$4RQ2"$B409Q2AD,I(HQ#E6,A*KG^=/L
MA/=V1+.\DG68.98F-7Z,LVMI#5QROOJV!\Z/4*^UU#]L]+P"E::>P]+[F 2?
MT>A>Y1L^"+T/> _&GO<R4,<ZZ9OROF5"_H$&EJ;9:!4:G1"52,0YE!'C$ 4T
M@$0*!%$<)QRIA)+,*03=9?"Q;0B;!;6K6A(MK5J[A:D[S8T=E_>%>,\T[1=L
M]RKF'5#S5:S<9>AA:Y)W &6O]'B79W0IZ'3T<+TZ?+\NF[]>ORZ_SQ=FJ_8X
M_R ?YM.M8WHMSL*X/2>"9Y0@G,"(J@0BI@+(*$:0IBE241@0_4?[ND\>)1L;
M1999FGDMG.E)79F]@$ZG\S_TEZQ_PR0HM#8NY8U\3F4[:5YT@GIFU%9GX\8G
M66D'-NJ!QSGXH._2&N[Z,5=:7FHR74I:76A2AZI\=8')=2R5U<,$M%?4\CG@
M@(6W>L!INSY7'P-<OOG?ICYD,4E"&;!0Q3 @+(8H(1EDB<)0I D2$<Z$E%:M
M 'J6<VRK]U;SN#.+SO0UM7:;GA%,6,^K>4^= #_GLWPIX1=MC#=+Z8ZT+>"!
MJ1EA6\"FE'_:MH 'H.ZS+>"AX;KVBS&[RL7+O,K]-4TG9!FLL7B_F0LYR4+)
M(\01Y%DD($I3#K%2!(8,ZV6")(HCY=8VIG6\L7%^)3+8DOFJ[(4B@<GUK20'
M1G373C+MN+<3>0]H]KV]\@!DAQXS5O"<T6JF_?D#=YRQ4G:_\8S=;=U,V/O%
M_$4NEN_&@%YJ*C/5;U_,AN^K7$Y"E":2:T:1@IAR"XGFEH0F4)* A))QSIE3
MQ%7;8&,CEL^-JH978"8=4V1:<94A89R9KJR9P!"96FLDU.RM9$AY2B1F.'-I
M[NT-UP$Z=/>)JYUQ[0NMG@EY)>95>0BR+&W>M:A7X&L+<LY&K0TDGBS3UJ$&
M-2]ME-ZU$:WNZ<;$VZE*M2.UF& A9!J& 4Q5%$ 4(@QI%&8P2F048!1%*K4J
M)=$^S-C8]X86W\$+S050VOB8KS/NIN7!?"-(M:00$ZM2_24OR^3HW9\;JQS!
MWHY/SD>T9R;92UA<R>B/0-HQ\$0=1P89E#3:%=VEBQ-7GQM77YUVE(<=N^UE
MUKO3XIXNEG?JP.9V$V.=9"B.30XB48G>0P8IAH0%$BHLJ90!%Y%=MX'>)!P;
M/36#LE5UY#0MCYSV3AT;T?4%,-D5YA:V.OSB&UV[1MG[>@?LN.ZB,]LS338G
M]<@YXOY!9 'NZTD]=*(Y4,R]Y[GP'G7O2[X+Q=U[AO=XY+WO@;JM+WZJ>JS.
M1-]_H?G,A,14+3V-9JOVCY,,QZ$4D8*$QGH?+$D,:8(DQ)*'L=3_Q")<U=EZ
MM%]^!E/ BKRV2W ]#G%T80K]O!D  !7_>&WVD**<+Z3[<C/<*V&W#(UKAO^L
MA;O6^E\!@\ J&'&%@C9FUCU[_:U:@T^=I]5L.+D'7>4&GX[=U6]X ;JMBEMA
M)U5H>]WQ*F)*(1D*R(F((6()A3B0 121X!&.>!)EL<ONZ>A(8]L%[01M5:*Z
M+2S'44U"*3E1 8RRE$"4"(UJFFA300@1IH)$F4HG;W+!YH/BVARQ/V3_+O.G
M[R9TG.KQZ),$LS)SPFPSJB(X\RJWPA?8=JNN%P#[WL0=2GO:Y*JLDI].=[]S
M7MA.HN-I(3H^SJ +QTEU=XG^] W>@O!,A2]-^7J^]4]%+N1B-V>I^&9^NE-W
MKTL3LE^4*]!_Z(]N@H,8J2@1,!"FMD0<!!"'60@CDA$N,\E5Y%0;T*]X8UL"
MKH7(C>QT:KJ^F=C<%_I>&J'+.?@^GVK="L-:R^\2W/S7M_.#\,Z96CN6N]R$
M]4R-AT/N-KJ!+>6:K*GW"J5^9B97&EZM]B)&RU[#ZSR@WU]4W3G"73J8S@.P
M%C%T/D89N(C$>D]21O-5IM:G'R^2:Y/LO^93_1BSU?A&EW+"52PB$C.8!9A!
MI(B .(HRF.K/,> \#HBT2JT:4.:QK2$K*<';6LSS.^7U/.V6WI)Q3>: IG?'
MR@2;,R[0T/P*K%^1C?+ :#^":@7N4W7I^@4.$O\Y*AJX3X&W&@<=ANY8]<!D
MH%*-X^?YXN/\E2W5Z_2:<V-RFX,QF9<'93>OBX46;9+(..:15% 2*?6J%""(
M$TQ@DA*$, L"GCBM2DZCCVU]J9,&M>U*5VJ4446B5L0X14I-'&L=.,V(W8+1
M&\X]4_]*1K 1\@I<;Z%]LY!ZJPC,V:S>=%0:>*QWT 4X7P4/G,8>MN)!%UCV
M2AYT>HC7HNHEQ38.CC3':M,PUV0\X6$8I0(Q&$I!(2(!AC0+F;;"*0ND"6 2
M/LJI'Y=@;'2W$NS,PV+WF;"TB?O$MV\+MZ4F>GT:TG2%%&"M1._%T$_CUV\9
M]);QQU  _30\EJ7/+1[4C?F^RN6F?,SU<KG(V>NR+*DYOZ>&63_FTU=M54ZR
MC-(TEC%,F8H@XK&$1)%,\Q\541A%G,6!2_*([<!./#= (LEU&=JB/T03 /[3
MM Q=R$M%_O(O6 /Q-U')[49[UM-@QW9]@-LSR6F1=ZI3->4VY_J5Y%?@XPF
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M@J(XPP%*($O"%*(H4I!%^I^8J8!Q3*ED3G7OVX<;FP&QD:^FBW.J:^YA:W<
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MR6E$6JV4EMN'LUA.Z[!EO5A<WF]2CTD@XI-(R0"G@D,F(P0120ED/.8PC).
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M.-:>L)\,.Z[J!>*^#<-*9G"[!>Y:;%#*W4MQ"6>T/#&7_;B#DI<S'+O\Y?Z
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M7T78T]?E]_G"U%3Y&YC-]3>;%\6KB<<WQR_;)S(/^B4K ^+^\B]A&OPM#JZ
M^23*2S]*WOQ36/XI=*/I0S-IQ[QGSD[/9+J9EH=J6FIBO2V1]L>.+2AX(KQ#
M(PS*82TJ[M)2VZ5=F6;^(A?+]WL]N\OKF?BDS<X70VD;0R%D+,8\)C#&20)1
M0#DD))'&=\")?CN"('.*.C@]Y.@,MMO_\^DCN'YX^/3XX/KYGX37E@U\@M8[
M.53"7H%2W)),UP+W9$;9 ^2--TX..#"-V *PSRK6=W;T;?+O4KQ.Y9TRR:*/
M98=G^6/Y08O_SXG -&%A%)JR%-JN42*#E%']3RR9H$S%F%G5QK$9;&S$LI+5
M.(5,9/B\[@2C_[G\+DN' IV]_VM15D#<B<N<LVG^5)[0.NX<6V?#TL_C">.^
MG3,->,OT[]]+48&1%93">B0@&TQ\.3_:AAK68V&A])Z;P>8>KT$4ZZ!O005-
M5 (SSE*(,D4A52F! J59(@W_A%8I?';#C8YLCJ6AF&EUC.T^ ?19WN+Q17&?
M3#I9A7G760R]!'3;H=6O>_4BH=MVBELZ,_T$:7^3;W+V*C]K64T IWGBW_/E
M]YO78CE_EHM//_CTM6PJ6!12_Y]XI#\F*4XY29(,*J801#'.($ZQWE714+!,
M\2 )G4HD=)!A;(Q4-6N9R25X6<S%*U^"@DY=?8U=YL*.GWI&N&?2JJ4OV1VL
MY =_: 7 2@.3+5?K %9* *V%/](Z T)/3-9%@D'I[0R(=CGOG$=US599O,Q-
MG:X/\YG8-/BN$]8Y24,>2PRQI RB1"A( A+ @'*BK2W!<)BZY:NTC#8V<EL+
M"YB6UI'4VG&UHR]O:/5,5!N@C*!@(ZG' @!.F'A+4FD;:^ T%0NU]Q-5;&[J
MN%$S>Y'*5_!1/W?V=%]%:Y?^FZI2LVF1=*<:59LW(DQ2D:4DE!ED+(T@"A-D
MFHM**!FCB: JE*%CL:_S!!J?V\RH4GJXJY.ELOQ46?W\]47_R-<*F;^7#B^^
MT0L4<I;/%V V7ZYSZ\A?N]>H.G.R680PCIF$(DP(1"10D&8H-?_!2B(B0R:=
M=NV#3?4PRTQS*K=G<4VDEYHZRW. P2:D[W."\@NK- &5*J#2Y:JN0+9J5+":
MKX9&C87/XZ&!%VA]'2J<)\RPAPY>@-L[E/#SU(ZNWNKDZO-\L4XZW>XH^"6G
M+)_FR_>[E_(W>J.PKOTP89I]8TXEY!D.M"U/]>)+4@$#S'&D1)@:-\VJT:N#
M,_@<H:P^_9T>M -0\NJ(L.+C6JGMGK2.7N2S9L[2P=S[1 SD>Z[!5]J V6BR
MT_)UK8O)OJFU 1MU/'JE?:#JRV%]EBS#^K)]P+;GYO;RT+-+O/]*%_^4RRJK
M+B0JXFG&8! *!A$E M(PE)!%(B 4"YPIJW24]F'&9K)6HM7MLDPZI%X)>?Y"
MIX ^5RW_5+7WZ%S0O(EQ._WY0ZYG7MLK7UZCV)X-Z )4Y\+O'0$;LN[[<^.5
MNRJ3;?]76$:,[KY[QPN;GE,(_@!"#G7@FW=?J@S\ 0U:JL ?NOK,9)0JYZ7.
MEQ!WLV_&+%[4-7^+WV9S5LC%FPDFN)V]O"[UG[6.FLVK7MG-:".9$-,.)Y0$
M(I1B2'"((<<AB<(P5 (Y'4E[EF]L5-V,H*D*Q%55A(P;:?ZZ! M)13Y]!T)J
M:9[S61E>HTRB11FBW3&EQ=-<VQF^%YS!GI>,9L)+I=PJWTB8KKIK_<I*Z(7I
M%[M1$90Z@FTE>XV?ZFD>?*?%>)+N,EDR?J$]FC3C>1CW:E@W\S>Y6$<CA0$)
MN:D]K%200L2C!&(<AS )8D1D%-'0KFS>WI/'QM:E<."%/DG+^NS[6+5SYED(
M].Y&-,K[C+PZJFVGRE;;3QJLI-5!!9JUK Y?</8VM_S4'UZ,@?#XQ_QNMM5C
M2J:1D"A , N9WO=&5$&<QEQ_FYGB,DR2V*$?JOVX8_M>2UE!40H+EG_,S:K\
MYJ7[62OZSCMB7Y@.O46N\*T$!UIR<#?SU#&M%=_.&VE?.%^JHUIWO,_97-N@
MYK#;;GW<I;;?-CJV[,>M;N^V0=\>J-P?3#"+(QP3"A,A0HB"-(9,I0A*3@*&
M(Y4&F57CRI8QQD;ES8WRE_GL"9K],-CY0HIZ V79#Z8-8KN][9G ]>TNW\7L
ML1-FSCO-%E0\[18/C3#HCJ]%Q=U=6]NEW2CA=J9??EDL;^;%LKBA+_F23DTR
M_B1("8[C*()<Q:9+(&*0";,;(U*BC*E8$X,++QP;:&SDT! -Y+7,53&"Y7>]
M9ZDBK%R+EQ]%.8H50Y+H_2U.)40$IR:U,H "ARR,TQA3&73PU)\%]O!.^&$Q
MMZ-C'^]KSYR\$A&4,H*&D/[X]Q0,GDCXZ#"#,O$I97?I^.3U9_I1RA.WXHM\
MD]-XU=D04Y(&"8$92F)3KRN!+*(<8J1H1!*6\="IP$/+6&-CYE(V$'?T4QS
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M-><F#+SX)KG,RQ"UVO RIG$QR6*<H2 CD"=80H33#.*$F7RX) Y4R&(N(NO
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M)HC%F2 D@(Q*#!$*&&1A)&$:$1QF*@X<JRP='VIL!+ MZ>H0XJKNSN?& 2T
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MMS!%L^J6UYO/F\=,X8QC6$1,0%Q(#/.H$!!)D21IHM5(8556UG[*L:F-W<S
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M(3^[S2NP5 ;>D5INP X[$[!E".QQM/7G_9B 75E6;/G;63QB[&F[\$%1T#W
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M]<D/T_'HT'\9HI\UT"PG;W,@++A,).?E5%AIHIUA61HF@JAM8EX@I=^D8T?
MJ2'V!C:G,YCYX0C2D9^,T&V;'L1X<WUSY6?ES#@/XQ!W<04Q0LQ$<*V7,T62
ME^C(0<Y42<FK.]1O4]5OLK$C3%561@/P6N%@GJ4H(R@F\!E&T^%76%QI^CB>
MEMM,I_G"?T/VO*#*&9+I_*#'1.0,><P2/4A-HV&F-M8V)+'?1&57QJQ#-36
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MO'&34S#6(<Y+V;JU9916$L08SHT#ZX59KW/ZAB_NYX"K/F(Z%WH#MN;.;\/
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MZNW]<!KGW9YNYNR63?]N[&"93\EE I^I)@$PFI"BW"G@SA.E%=<I))W9HSZ
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M9&OWAMZ1Y)XOSC:\(+K0>0/G\<]P>K<U,A.#-1Q(AG*-RD5/7#*,:*&LR\J
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M6TBY 9@<I#1OGN*O/OEA.AX=^B]#=-.7S+@$1M,@2,3 %X,.9XG/TI#DE'%
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M.G2UUAR]#B;>A-Z."FHB,_"4J^/15Q3Z>%(:,7CC-$N>$VMP1Y$4' G!:Z(
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M1:_F>0_#FSB[F2P:7LQC@C.X*DVY#\?3V4J)BC74JL X82G@!@[.D8!+LO3
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M?9;YN[_?+YZ@@[$F2L)8F3NL)$9GS&<"F4>-OHFTPKX%K@IT--L29!.@/!C
MMT>]--"]\%?_7^/);>.!Z8*9QRQ9Y1@D;4E0F:$H;1&E9RC*Q -E.:7JDW37
M(*O?GH65D=>5.AI V G\OB*LR7B$7\9%C/4\?S(YP7@V1&B) 1?R2ERDFAAP
M)@<7%+?U!S=O1F._,R$[PEZGBOJ1_;<+'ZZZ]-Z6S]^;[_8</]U[;C*IY&@
MDJ@I-ZT0E38J3G@(W 9T^"W4;A[?82>W^!G2S:TW$*$T\5FDDLZ&TW^\^U[^
M_8#O&:\T\W$\*1%4(#QQ@P*PF7C/--'<!9M]L#[5;CBP!9G-.G2;X.=)^5C'
MZFK3NBU;K6UOOAX^H%[SMPX-T+KMNTJKT>1PH^2EB[ZT9>^2IHQC,S8:56Y(
MU2Y@W5,+N/?#J;^\G)3YG@N$+UX[E_G*WHU>0G8YD@@\E")M1;QVCK!($_C
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M6K!6;QV#JAB<-DR2$#):=6H\L5I'8H26#B!H5KT5SP]>@; 1 C:M0-A$'0W
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M4C^#_U@O)$G_/WM_UN16CJN-PG_EQ+G'NSD/$=^-RV7WZPB7[;#=N[]]I>
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M "=_7ZQ_84&+G!,:HC[7-H32:&*A1#"J:,>YY-:WKEZZ@XR)AW.WQ\JAHNX
M+3\?S]>W:%Y@(>>.-EA6V0B%02!Y@,$L4\ZRM&\<< \I/05,K;.[^\F[ ]A4
M8_I\84PS(M%89@/H))%,B"03G/4@-'KO#?>A>5KWYOH]I>SV5.@=#LM>TNT
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M$=-"IH%BERVEW %,[FM0)81BWN0(!NN('.0!0C$2LA21!1.%9>..^'B[4]]
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M]U'' N1H&NL C3<<FZLO_^\<5T34UQ]O\3N>;/T;%D5A:!3H+.M#$I_!>VE
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MS7'>T&BAK3#R<A%=)8$U@+W3\>UMFA06?7;?TF1)A$)^&)\L4&;PD@FTK);
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M!]C>])7XC[G\'OCB/??1>@+$\[ <SV)20N;XC%8KROJ[R@]%VY%ZG&])"?<
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M74 9J@4+BD1;>]7IJP?IQ\'L5.2;/(%OQ?\F<DDOR;C/T.*EGTR4'%#Q OH
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MV]TD?'73='*->E12JR])6NH6,U0RY$+IO(U0N(*!A%.0F55E;0739J-JOU_
M:.,#]7-;U9'YN&L!]'U1?;IS:$O?#<>S%+Z>CO_MXRS^V]*<\D Q(G41B,H<
MA"<:O,. U%&MHY'>JI?=,"ONJ=7?T1\T.I+FN#YK&XBCUN1%/SYT[T0K/4'"
M0,C2-DE"1L/L"2@OI)1E!0JQFYB=.N\4'[=J#>RL>;6!QXK=)-0 ZNZ]R-/Q
MK1^.YB(K9677BQJ-I_P;4&^-RC0!\00]O[*8T<C@0)CL%)Y->MI5?NC7IVOV
M36-'9*P([BN+J4T OE(1,J<L6<X(+3WC<WJDP,B&8*@:90C4BV0$.0  5YRN
MWV"P#P#6$%/?GMEZLN8%PJ]KF7>*)"$5:.$9"&Y365DG0.@DJ.0A8B2\D=^V
MZPGZ#28[P]OAI-*F[5L42E[//>71=!B7Q9)/5R"<?BT_GH\6[=07><4_^3AT
M?G@SG/V@ R<EE21*X*8,_V%4EDV+&IA6P7AJ(ZV^+?- I/7K>/9A=7L'R/9Z
M8Q=Z,TK715.OJJE/*1 M#147<Z:4\C?\[-LEGP:*,:F9+M%D2B7[Z<$%&2 )
MI61Q@YS+E4&_]D ;054>+53K":-_@*TH&5G6)7^>C"-RLM3-+ZK:[ZLT%\ML
M$\O*T:1 (L5X\T@+GO( ,>'U0XTP1/ZRH'N? VR$,W5T.#N83*HU2/70:?#)
M38IM_YXZ;R;XZ9L.UB^PGL:F6@)R-"11Z\ 1,I^<AC@7GH/W0EEKD\)K]VVW
M!+SR2#E]]^/)[Q99.45\R*IXZS9K$-07EC%1>M$XNO(Z*%6[0F3;,[Z%YH!M
M\+BZ.: #F384B[TLR<F*"F>R .U+^[K':-)X9"'/DG*GM56AMANY3U7< 3H"
MNI#_AJ5QVPBC44P]+]&(*F97FK:=LJ)44RCPG*)&*N^4D8Y)5WL<Y)&6QFTE
M^JU+X[:10]\YRV7]UBNE.3$(EDO?OXT89#')P"?/(#%E\KQQ5_.-(H]5W] >
M,O:0XBLE<?NQM&]<K*O:8DRHH+@J.5&'OP@,@+1 .K1PF;) 5-BL8O*(R^%V
M1D<MQC9P(RV:\A]<PX_E']Q;6.-X<%QQL%;0TAM!P <J("<E,N-<)=_- +-7
MC]-*#\ !O)U:0FD77TL-5)R)P*@#IG@$87@"YU5YK=%!1Z]S5_,W5QRHA2%X
M%<2^&9QVD$'?-]K'=.UNGC3J:>Y*^: $%G)I;N=HO,ODX*"$S\*EE,5FFX=?
M?'"3.-A%7N-*S&O DBQZ^)X\:\WUPE/)$_<!J"H/O,RA7F2?($3B<C A!5-[
M5\.K!VFEE/L M]/^@F@ 34^?1T]&\=-XY![_RQ7^-'5ASKRELBCJN!$Q@HVF
MK*?0!$RB!%5/RS*?/$M?.^NSY1%;:-'>"Q0O9\MW**&^[[$U1<I&6T\Q6(!@
ME 41: 0CT$B+TGBNB-8J^(VNM-;JOP\BUPTKP;=A<@/&ZA6C_OAVRHWA(E$#
M2B0TY<H@:Q@/H)*0&(M*E4WM237KSM-*Y7<_2>G=Q-(0Q#8HYR0&=8>H4D]L
MT0'52H,5RH%6A)NLE&&\=LM!Y:K;0V8D=T3$[M6VVXBG3>!U4M'F8\P!U1F,
M+"8_*P8^HMYSX@DS/CFM-VKS/-*2QT.F63N#?._ :$!?/B*+K^<T7*;9[&9.
M]7)\[X S%803$H@2&-$[X\ ::8%R)T3RG*90>][/FN/T&Q)WALM: FAS@.WI
MQ1]_G%_]<?;IJM17G5Y\NCK_]-O9I]/SL\L]2L@V^-0*Y6+;GKU2:1@:J-OA
M[#Z>>3 X89BFKXQ2QN#":JD#1.?*L[7"<,8F"5ZC&RHRS^)EG\C>.KK5 ?>V
M3^-BLI]\Q<+/IE+36%QL]$#0RA(9P%&2(!#OLHF.V%R[H.OUD_3K(':'E9_,
MU/YR:'%:AW6*RI+]#DZ4Q@1T<7WI)9,8OU.:(A*S4>=*5],Z.D-.#7G^:C#'
M-LP]FL$<)EKCO<.XGI>7,V$-.$\,4&M1@QC!B_GO/)AC*YGO-)AC&P'TG9C]
M,)[,A@^9QZ0LPU :3/8"1$P,(VDKP<9$B./H-7KY*\_GIT\]AN$;6TEL7(-]
M?<O]]_'H^M_Q?Y^_NLFMNT(FW(T_SN*2DJ2M%8PA S*R0MB((:*+!B6--W2*
MY;%T,R"L_9I^XO@#(:,>@WN$2DS#Q2OZ&=[#LQ^+P4;:**Z(A5(P!D*2##YS
M#O@?-7>E4]*LRRM-4_BWZ_'W_XX?O;A=\(?'B^65+^PWVU/1"]F7F3WC8''J
MI5J$+ .-(9>9Y*@6E"6P/H<RL3QQ'8CS8=T:BU^#X.FW]7.#["VN<07>]7U-
MK)V4B5>:5($;X#JA$6->@T'@0S2:Q[(_2WNVF;O0W!#2_82V\:S1;3C80BKV
MI3%\3#!JR60*S(*SH8P5%TA)+.$[15LH"!<LU=YKL_HT_29B*UX9E1G?'(1^
MO'>W[CI-+\=WUU]G_W W=VG '%%H5"V@>X4V-G /QJ)3C:Y6]I)EXZO/./KE
MH1K+A.PH_;6@VE<4?=]4GR?CD%*<[Q9]G[ZGF_&W>55623K>WJ9):0A=MH]>
MY/]S_O'+V=75R2 +23E)$323\P%A&2QQ%J)2P47GD8V;%1_M]/6-N;;[P>I
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MVS82_MY?@2K3U)[1^TLL2XYG$MF=TUPOR3FZ9OKI!B26(L8@P1*@9/77WRY
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M8F!0PS#L?3'76_6EVY^_]^&]B6EW:1+&+.8S8#G,),PQ,=A8&O9;P7,,%K7
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M7PAGL'6C>$VS3F@VUTUX@%Q;V/U-]FGNO=>3RT]_6=I=V[[\'U!+ P04
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M[-U"!GT(6]F?"'@V"#CX&'X=P,5?@\'A.@Y:7AX^41T_NDA<Z'"3>A!^-YS
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M>"TR,#(R,#DS,%]D968N>&UL4$L! A0#%     @  W1C5=>/$Z$,:0  E&P
M !0              ( !@JD# '!C<G@M,C R,C Y,S!?9S$N:G!G4$L! A0#
M%     @  W1C5=WW%/2$D0< ZP ) !0              ( !P!($ '!C<G@M
M,C R,C Y,S!?9S(N:G!G4$L! A0#%     @  W1C59WFYFP"/P$ ;S<- !4
M             ( !=J0+ '!C<G@M,C R,C Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   (  -T8U5A1OVX/\@  '86"0 5              "  :OC# !P8W)X+3(P
M,C(P.3,P7W!R92YX;6Q02P$"% ,4    "  #=&-5+=W_^C\(   1+@  %@
M            @ $=K T <&-R>"TY,S R,#(R>&5X,S$Q+FAT;5!+ 0(4 Q0
M   (  -T8U7$2SR\. @  !HN   6              "  9"T#0!P8W)X+3DS
M,#(P,C)X97@S,3(N:'1M4$L! A0#%     @  W1C5:7QO$ Z!0  ^A\  !8
M             ( !_+P- '!C<G@M.3,P,C R,GAE>#,R,2YH=&U02P4&
/  L "P#: @  :L(-

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
